PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Balaban, NQ; Merrin, J; Chait, R; Kowalik, L; Leibler, S				Balaban, NQ; Merrin, J; Chait, R; Kowalik, L; Leibler, S			Bacterial persistence as a phenotypic switch	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; ANTIBIOTIC-RESISTANCE; SOFT LITHOGRAPHY; LETHALITY; MUTANTS; DEATH; HIPA	A fraction of a genetically homogeneous microbial population may survive exposure to stress such as antibiotic treatment. Unlike resistant mutants, cells regrown from such persistent bacteria remain sensitive to the antibiotic. We investigated the persistence of single cells of Escherichia coli with the use of microfluidic devices. Persistence was linked to preexisting heterogeneity in bacterial populations because phenotypic switching occurred between normally growing cells and persister cells having reduced growth rates. Quantitative measurements led to a simple mathematical description of the persistence switch. Inherent heterogeneity of bacterial populations may be important in adaptation to fluctuating environments and in the persistence of bacterial infections.	Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA; Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Rockefeller University; Rockefeller University; Hebrew University of Jerusalem	Balaban, NQ (corresponding author), Rockefeller Univ, Lab Living Matter, 1230 York Ave, New York, NY 10021 USA.	nathalieqb@phys.huji.ac.il	Balaban, Nathalie/AGI-1487-2022; Balaban, Nathalie/AAH-1004-2019; Sandstedt, Sara A/A-3001-2010	Balaban, Nathalie/0000-0001-8018-0766; Balaban, Nathalie/0000-0001-8018-0766; Chait, Remy/0000-0003-0876-3187				Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bigger JW, 1944, LANCET, V2, P497; BRADFORD MJ, 1993, ECOLOGY, V74, P1129, DOI 10.2307/1940482; COZENS RM, 1986, ANTIMICROB AGENTS CH, V29, P797, DOI 10.1128/AAC.29.5.797; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Massey RC, 2001, CURR BIOL, V11, P1810, DOI 10.1016/S0960-9822(01)00507-3; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Mukamolova GV, 1999, ARCH MICROBIOL, V172, P9, DOI 10.1007/s002030050733; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; SCHERRER R, 1988, J BACTERIOL, V170, P3321, DOI 10.1128/jb.170.8.3321-3326.1988; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; WOLFSON JS, 1990, ANTIMICROB AGENTS CH, V34, P1938, DOI 10.1128/AAC.34.10.1938	18	1886	1969	17	495	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1622	1625		10.1126/science.1099390	http://dx.doi.org/10.1126/science.1099390			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15308767				2022-12-28	WOS:000223891200044
J	Song, JJ; Smith, SK; Hannon, GJ; Joshua-Tor, L				Song, JJ; Smith, SK; Hannon, GJ; Joshua-Tor, L			Crystal structure of argonaute and its implications for RISC slicer activity	SCIENCE			English	Article							PAZ DOMAIN; RNA; DROSOPHILA; COMPLEX; INTEGRASE; SIRNAS; CORE; TRANSPOSITION; INTERFERENCE; RECOGNITION	Argonaute proteins and small interfering RNAs (siRNAs) are the known signature components of the RNA interference effector complex RNA-induced silencing complex (RISC). However, the identity of "Slicer," the enzyme that cleaves the messenger RNA (mRNA) as directed by the siRNA, has not been resolved. Here, we report the crystal structure of the Argonaute protein from Pyrococcus furiosus at 2.25 angstrom resolution. The structure reveals a crescent-shaped base made up of the amino-terminal, middle, and PIWI domains. The Piwi Argonaute Zwille (PAZ) domain is held above the base by a "stalk"-like region. The PIWI domain (named for the protein piwi) is similar to ribonuclease H, With a conserved active site aspartate-aspartate-glutamate motif, strongly implicating Argonaute as "Slicer." The architecture of the molecule and the placement of the PAZ and PIWI domains define a groove for substrate binding and suggest a mechanism for siRNA-guided mRNA cleavage.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Joshua-Tor, L (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu	Hannon, Gregory/AAB-3568-2019; Song, Ji-Joon/C-1721-2011	Goldsmith, Stephanie/0000-0002-5010-1657; Joshua-Tor, Leemor/0000-0001-8185-8049				ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; KATAYANAGI K, 1993, PROTEINS, V17, P337, DOI 10.1002/prot.340170402; Lai LH, 2000, STRUCTURE, V8, P897, DOI 10.1016/S0969-2126(00)00179-9; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lubkowski J, 1999, BIOCHEMISTRY-US, V38, P13512, DOI 10.1021/bi991362q; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; WINTERSBERGER U, 1990, PHARMACOL THERAPEUT, V48, P259, DOI 10.1016/0163-7258(90)90083-E; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3	29	1036	1143	5	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1434	1437		10.1126/science.1102514	http://dx.doi.org/10.1126/science.1102514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15284453				2022-12-28	WOS:000223761900039
J	Smith, KD; von Seggern, D; Blewitt, G; Preston, L; Anderson, JG; Wernicke, BP; Davis, JL				Smith, KD; von Seggern, D; Blewitt, G; Preston, L; Anderson, JG; Wernicke, BP; Davis, JL			Evidence for deep magma injection beneath Lake Tahoe, Nevada-California	SCIENCE			English	Article							RANGE PROVINCE; SIERRA-NEVADA; SILENT SLIP; GPS DATA; BASIN; EARTHQUAKE; FAULTS	A deep earthquake swarm in late 2003 at Lake Tahoe, California (Richter magnitude <2.2; depth of 29 to 33 kilometers), was coeval with a transient displacement of 6 millimeters horizontally outward from the swarm and 8 millimeters upward measured at global positioning system station Slide Mountain (SLID) 18 kilometers to the northeast. During the first 23 days of the swarm, hypocentral depths migrated at a rate of 2.4 millimeters per second up-dip along a 40-square-kilometer structure striking north 30 degrees west and dipping 50 degrees to the northeast. SLID's transient velocity of 20 millimeters per year implies a lower bound of 200 nanostrains per year (parts per billion per year) on local strain rates, an order of magnitude greater than the 1996 to 2003 regional rate. The geodetic displacement is too large to be explained by the elastic strain from the cumulative seismic moment of the sequence, suggesting an aseismic forcing mechanism. Aspects of the swarm and SLID displacements are consistent with lower-crustal magma injection under Lake Tahoe.	Univ Nevada, Nevada Seismol Lab, Reno, NV 89557 USA; Univ Nevada, Nevada Bur Mines & Geol, Reno, NV 89557 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 92215 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; California Institute of Technology; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Smith, KD (corresponding author), Univ Nevada, Nevada Seismol Lab, Reno, NV 89557 USA.	ken@seismo.unr.edu	Davis, James/D-8766-2013	Davis, James/0000-0003-3057-477X				ALTAMIMI Z, 2001, EOS T AGU, V82, P273, DOI DOI 10.1029/EO082I025P00273-01; Bennett RA, 2003, TECTONICS, V22, DOI 10.1029/2001TC001355; Blewitt G, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000570; BLEWITT G, 1989, J GEOPHYS RES-SOLID, V94, P10187, DOI 10.1029/JB094iB08p10187; Dixon TH, 2000, TECTONICS, V19, P1, DOI 10.1029/1998TC001088; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; HENRY C, 2004, EARTH SCOP NSF GREAT; Ichinose GA, 2003, B SEISMOL SOC AM, V93, P61, DOI 10.1785/0120020063; MCNUTT SR, 2002, INT HDB EARTHQUAKE E, P383; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; RUBIN AM, 1988, GEOLOGY, V16, P413, DOI 10.1130/0091-7613(1988)016<0413:DIFIRZ>2.3.CO;2; SCHWEICKERT R, IN PRESS TECTONOPHYS; Ukawa M, 1996, TECTONOPHYSICS, V253, P285, DOI 10.1016/0040-1951(95)00077-1; Wdowinski S, 1997, J GEOPHYS RES-SOL EA, V102, P18057, DOI 10.1029/97JB01378; WERNICKE B, 2000, GSA TODAY, V10, P1; WESNOUSKY SG, 1994, GEOLOGY, V22, P1031, DOI 10.1130/0091-7613(1994)022<1031:OSSPSA>2.3.CO;2; Wiemer S, 1998, GEOPHYS J INT, V134, P409, DOI 10.1046/j.1365-246x.1998.00561.x; WONG IG, 1983, B SEISMOL SOC AM, V73, P797; Zobin V.M., 2003, INTRO VOLCANIC SEISM; Zumberge JF, 1997, J GEOPHYS RES-SOL EA, V102, P5005, DOI 10.1029/96JB03860	21	81	82	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1277	1280		10.1126/science.1101304	http://dx.doi.org/10.1126/science.1101304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15297623				2022-12-28	WOS:000223624600037
J	Cuttini, M				Cuttini, M			Intrapartum prevention of meconium aspiration syndrome	LANCET			English	Editorial Material							CONSENT; PARENTS; CARE		Paediat Hosp Bambino Gesu, Epidemiol Unit, I-00165 Rome, Italy	IRCCS Bambino Gesu	Cuttini, M (corresponding author), Paediat Hosp Bambino Gesu, Epidemiol Unit, I-00165 Rome, Italy.	cuttini@opbg.net	Cuttini, Marina/AAI-1987-2019	Cuttini, Marina/0000-0002-3284-6874				Burgess E, 2003, ARCH DIS CHILD-FETAL, V88, P280; Dickersin K, 1998, CLIN OBSTET GYNECOL, V41, P315, DOI 10.1097/00003081-199806000-00012; ELLIS GB, 1993, 933 OPRR; Manning DJ, 2000, J MED ETHICS, V26, P249, DOI 10.1136/jme.26.4.249; Mason SA, 2000, LANCET, V356, P2045, DOI 10.1016/S0140-6736(00)03401-2; Morley C, 1997, BRIT MED J, V314, P1480; Niermeyer S, 2000, PEDIATRICS, V106; Protection of Human Subjects, 1996, FED REGISTER, V61, P51497; Snowdon C, 1997, SOC SCI MED, V45, P1337, DOI 10.1016/S0277-9536(97)00063-4; Stenson BJ, 2004, ARCH DIS CHILD-FETAL, V89, pF321, DOI 10.1136/adc.2002.021931	10	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2004	364	9434					560	561		10.1016/S0140-6736(04)16863-3	http://dx.doi.org/10.1016/S0140-6736(04)16863-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313339				2022-12-28	WOS:000223275100005
J	Haines, A; Cassels, A				Haines, A; Cassels, A			Can the millennium development goals be attained?	BMJ-BRITISH MEDICAL JOURNAL			English	Article								To achieve the UN's goals worldwide, less developed countries need to address weaknesses in health systems and policy makers need to look beyond aggregate national figures to inequalities in outcomes.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; WHO, CH-1211 Geneva 27, Switzerland	University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Haines, A (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	andy.haines@lshtm.ac.uk		Haines, Andy/0000-0002-8053-4605				*AFR DEV FOR, 2001, ALN DECL HIV AIDS TU; [Anonymous], 2002, INT C FIN DEV MONT M; [Anonymous], 1994, INT C POP DEV CAIR 5; Beaglehole R., 2003, WORLD HLTH REPORT 20; Gwatkin D. R., 2002, WHO WOULD GAIN MOST; *HM TREAS, 2003, INT FIN FAC; *HM TREAS, 2004, STAT CHANC EXCH 2004; Lee K, 2004, JAMA-J AM MED ASSOC, V291, P2636, DOI 10.1001/jama.291.21.2636; Narasimhan V, 2004, LANCET, V363, P1469, DOI 10.1016/S0140-6736(04)16108-4; STILWELL B, IN PRESS B WHO; *UN DEP EC SOC AFF, PROGR MILL DEV GOALS; *UN GEN ASS, 2002, A56326 UN GEN ASS; UN General Assembly, 2000, 552 UN GEN ASS; United Nations Development Program, 2003, HUM DEV REP 2003 MIL; Wagstaff A., 2004, MILLENNIUM DEVELOPME; *WHO WORLD BANK, 2003, RES AID EFF HARM; *WHO WORLD BANK, 2003, MON HLTH MDGS	17	83	87	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2004	329	7462					394	397		10.1136/bmj.329.7462.394	http://dx.doi.org/10.1136/bmj.329.7462.394			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YI	15310610	Green Published, Green Accepted			2022-12-28	WOS:000223433600025
J	Chang, S; Johnston, RJ; Frokjaer-Jensen, C; Lockery, S; Hobert, O				Chang, S; Johnston, RJ; Frokjaer-Jensen, C; Lockery, S; Hobert, O			MicroRNAs act sequentially and asymmetrically to control chemosensory laterality in the nematode	NATURE			English	Article							NEURONS; EXPRESSION; PATTERN; SYSTEM	Animal microRNAs ( miRNAs) are gene regulatory factors that prevent the expression of specific messenger RNA targets by binding to their 3' untranslated region(1-3). The Caenorhabditis elegans lsy-6 miRNA ( for lateral symmetry defective) is required for the left/right asymmetric expression of guanyl cyclase (gcy) genes in two chemosensory neurons termed ASE left (ASEL) and ASE right (ASER)(4,5). The asymmetric expression of these putative chemoreceptors in turn correlates with the functional lateralization of the ASE neurons(6). Here we find that a mutation in the die-1 zinc-finger transcription factor disrupts both the chemosensory laterality and left/right asymmetric expression of chemoreceptor genes in the ASE neurons. die-1 controls chemosensory laterality by activating the expression of lsy-6 specifically in ASEL, but not in ASER, where die-1 expression is downregulated through two sites in its 30 untranslated region. These two sites are complementary to mir-273, a previously uncharacterized miRNA, whose expression is strongly biased towards ASER. Forced bilateral expression of mir-273 in ASEL and ASER causes a loss of asymmetric die-1 expression and ASE laterality. Thus, an inverse distribution of two sequentially acting miRNAs in two bilaterally symmetric neurons controls laterality of the nematode chemosensory system.	Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	Columbia University; University of Oregon	Hobert, O (corresponding author), Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.	or38@columbia.edu	Frøkjær-Jensen, Christian/ABB-4637-2020	Frokjaer-Jensen, Christian/0000-0002-3178-0906; Hobert, Oliver/0000-0002-7634-2854	NINDS NIH HHS [R01 NS050266, R01 NS050266-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050266] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bulyk ML, 2004, GENOME BIOL, V5; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Heid PJ, 2001, DEV BIOL, V236, P165, DOI 10.1006/dbio.2001.0315; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Palmer RE, 2002, DEV BIOL, V252, P202, DOI 10.1006/dbio.2002.0850; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	17	269	315	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					785	789		10.1038/nature02752	http://dx.doi.org/10.1038/nature02752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306811				2022-12-28	WOS:000223233600043
J	Jamieson, CHM; Ailles, LE; Dylla, SJ; Muijtjens, M; Jones, C; Zehnder, JL; Gotlib, J; Li, K; Manz, MG; Keating, A; Sawyers, CL; Weissman, IL				Jamieson, CHM; Ailles, LE; Dylla, SJ; Muijtjens, M; Jones, C; Zehnder, JL; Gotlib, J; Li, K; Manz, MG; Keating, A; Sawyers, CL; Weissman, IL			Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; BETA-CATENIN; GENE-TRANSFER; CHRONIC-PHASE; BONE-MARROW; IN-VITRO; ACTIVATION; EXPRESSION	Background: The progression of chronic myelogenous leukemia (CML) to blast crisis is supported by self-renewing leukemic stem cells. In normal mouse hematopoietic stem cells, the process of self-renewal involves the (beta)-catenin-signaling pathway. We investigated whether leukemic stem cells in CML also use the (beta)-catenin pathway for self-renewal. Methods: We used fluorescence-activated cell sorting to isolate hematopoietic stem cells, common myeloid progenitors, granulocyte-macrophage progenitors, and megakaryocyte-erythroid progenitors from marrow during several phases of CML and from normal marrow. BCR-ABL, (beta)-catenin, and LEF-1 transcripts were compared by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay in normal and CML hematopoietic stem cells and granulocyte-macrophage progenitors. Confocal fluorescence microscopy and a lymphoid enhancer factor/T-cell factor reporter assay were used to detect nuclear (beta)-catenin in these cells. In vitro replating assays were used to identify self-renewing cells as candidate leukemic stem cells, and the dependence of self-renewal on (beta)-catenin activation was tested by lentiviral transduction of hematopoietic progenitors with axin, an inhibitor of the (beta)-catenin pathway. Results: The granulocyte-macrophage progenitor pool from patients with CML in blast crisis and imatinib-resistant CML was expanded, expressed BCR-ABL, and had elevated levels of nuclear (beta)-catenin as compared with the levels in progenitors from normal marrow. Unlike normal granulocyte-macrophage progenitors, CML granulocyte-macrophage progenitors formed self-renewing, replatable myeloid colonies, and in vitro self-renewal capacity was reduced by enforced expression of axin. Conclusions: Activation of (beta)-catenin in CML granulocyte-macrophage progenitors appears to enhance the self-renewal activity and leukemic potential of these cells.	Stanford Univ, Sch Med, Dept Pathol,Inst Canc & Stem Cell Biol & Med, Beckman Ctr B257, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Inst Canc & Stem Cell Biol & Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA; Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada; Univ Calif Los Angeles, Los Angeles, CA USA	Stanford University; Stanford University; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of California System; University of California Los Angeles	Weissman, IL (corresponding author), Stanford Univ, Sch Med, Dept Pathol,Inst Canc & Stem Cell Biol & Med, Beckman Ctr B257, 279 Campus Dr, Stanford, CA 94305 USA.	ljquinn@stanford.edu	Manz, Markus G/C-7588-2011; Sawyers, Charles/G-5327-2016	Manz, Markus/0000-0002-4676-7931	NCI NIH HHS [2PO1CA49605, CA86017, CA55209] Funding Source: Medline; NHLBI NIH HHS [K23 HL04409] Funding Source: Medline; NIAID NIH HHS [5T32AI07290] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA049605, R01CA086017] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL004409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AFAR DEH, 1995, P NATL ACAD SCI USA, V92, P9540, DOI 10.1073/pnas.92.21.9540; AFAR DEH, 1994, SCIENCE, V264, P424, DOI 10.1126/science.8153630; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Chomel JC, 2000, BLOOD, V95, P404, DOI 10.1182/blood.V95.2.404; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Domen J, 2000, J EXP MED, V192, P1707, DOI 10.1084/jem.192.12.1707; Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; GISHIZKY ML, 1993, P NATL ACAD SCI USA, V90, P3755, DOI 10.1073/pnas.90.8.3755; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Haraguchi K, 2004, BIOCHEM BIOPH RES CO, V313, P841, DOI 10.1016/j.bbrc.2003.12.021; Huettner CS, 2003, BLOOD, V102, P3363, DOI 10.1182/blood-2003-03-0768; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; Jamieson CHM, 2004, RES PER NEUROSCI, P157; Jones CD, 2003, AM J CLIN PATHOL, V120, P42, DOI 10.1309/60A9C8WGEGHRNXEE; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NOWELL PC, 1960, SCIENCE, V132, P1497; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Raaijmakers MHGP, 2002, EXP HEMATOL, V30, P481, DOI 10.1016/S0301-472X(02)00787-7; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schmelz EM, 2001, CANCER RES, V61, P6723; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Sirard C, 1996, BLOOD, V87, P1539, DOI 10.1182/blood.V87.4.1539.bloodjournal8741539; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; Uchida N, 1998, P NATL ACAD SCI USA, V95, P11939, DOI 10.1073/pnas.95.20.11939; UDOMSAKDI C, 1992, P NATL ACAD SCI USA, V89, P6192, DOI 10.1073/pnas.89.13.6192; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	58	1155	1263	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					657	667		10.1056/NEJMoa040258	http://dx.doi.org/10.1056/NEJMoa040258			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306667	Bronze			2022-12-28	WOS:000223225500008
J	Barnes, W; Sambles, R				Barnes, W; Sambles, R			Only skin deep	SCIENCE			English	Editorial Material									Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England	University of Exeter	Barnes, W (corresponding author), Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England.	w.l.barnes@exeter.ac.uk	Barnes, William L/J-7111-2013	Barnes, William L/0000-0002-9474-5534; SAMBLES, John/0000-0003-2721-0692				Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Kitson SC, 1996, PHYS REV LETT, V77, P2670, DOI 10.1103/PhysRevLett.77.2670; Pendry JB, 2004, SCIENCE, V305, P847, DOI 10.1126/science.1098999; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059	6	16	16	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					785	786		10.1126/science.1102271	http://dx.doi.org/10.1126/science.1102271			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297653				2022-12-28	WOS:000223104900027
J	Smith, DR; Pendry, JB; Wiltshire, MCK				Smith, DR; Pendry, JB; Wiltshire, MCK			Metamaterials and negative refractive index	SCIENCE			English	Review							PHOTONIC CRYSTALS; ELECTROMAGNETIC-WAVES; LENSES; SLAB	Recently, artificially constructed metamaterials have become of considerable interest, because these materials can exhibit electromagnetic characteristics unlike those of any conventional materials. Artificial magnetism and negative refractive index are two specific types of behavior that have been demonstrated over the past few years, illustrating the new physics and new applications possible when we expand our view as to what constitutes a material. In this review, we describe recent advances in metamaterials research and discuss the potential that these materials may hold for realizing new and seemingly exotic electromagnetic phenomena.	Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Imaging Sci Dept, London W12 0HS, England	University of California System; University of California San Diego; Imperial College London; Imperial College London	Smith, DR (corresponding author), Univ Calif San Diego, Dept Phys, 9500 Gilman Dr, La Jolla, CA 92093 USA.	drs@physics.ucsd.edu; j.pendry@imperial.ac.uk; michael.wiltshire@imperial.ac.uk	Smith, David R/E-4710-2012	Pendry, John/0000-0001-5145-5441; Sanchez-Fernandez, Gregorio Esteban/0000-0002-6059-7182	Engineering and Physical Sciences Research Council [GR/S49537/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Cubukcu E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.207401; Cubukcu E, 2003, NATURE, V423, P604, DOI 10.1038/423604b; Cummer SA, 2003, APPL PHYS LETT, V82, P1503, DOI 10.1063/1.1554778; Garcia N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.207403; Grbic A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.117403; Houck AA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.137401; Kolinko P, 2003, OPT EXPRESS, V11, P640, DOI 10.1364/OE.11.000640; Lakhtakia A, 2002, INT J INFRARED MILLI, V23, P339, DOI 10.1023/A:1015038701978; Liu ZW, 2003, APPL PHYS LETT, V83, P5184, DOI 10.1063/1.1636250; Notomi M, 2000, PHYS REV B, V62, P10696, DOI 10.1103/PhysRevB.62.10696; Pacheco J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.257401; Parazzoli CG, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.107401; Parimi PV, 2003, NATURE, V426, P404, DOI 10.1038/426404a; Parimi PV, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127401; Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773; Pendry JB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.029703; Pendry JB, 2003, J PHYS-CONDENS MAT, V15, P6345, DOI 10.1088/0953-8984/15/37/004; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Shen JT, 2002, APPL PHYS LETT, V80, P3286, DOI 10.1063/1.1471933; Smith DR, 2003, APPL PHYS LETT, V82, P1506, DOI 10.1063/1.1554779; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; Smith DR, 2002, APPL PHYS LETT, V81, P2713, DOI 10.1063/1.1512828; 't Hooft GW, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.249701; Valanju PM, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.187401; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Wiltshire MCK, 2003, OPT EXPRESS, V11, P709, DOI 10.1364/OE.11.000709; Wiltshire MCK, 2001, SCIENCE, V291, P849, DOI 10.1126/science.291.5505.849; Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025	31	3196	3338	62	1454	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					788	792		10.1126/science.1096796	http://dx.doi.org/10.1126/science.1096796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297655				2022-12-28	WOS:000223104900029
J	Rietjens, JAC; van der Heide, A; Vrakking, AM; Onwuteaka-Philipsen, BD; van der Maas, PJ; van der Wal, G				Rietjens, JAC; van der Heide, A; Vrakking, AM; Onwuteaka-Philipsen, BD; van der Maas, PJ; van der Wal, G			Physician reports of terminal sedation without hydration or nutrition for patients nearing death in the Netherlands	ANNALS OF INTERNAL MEDICINE			English	Article							LAST RESORT; UNCONTROLLED SYMPTOMS; CAREFUL CONVERSATION; PALLIATIVE OPTIONS; ASSISTED SUICIDE; END; CANCER; LIFE	Background: Terminal sedation in patients nearing death is an important issue related to end-of-life care. Objective: To describe the practice of terminal sedation in the Netherlands. Design: Face-to-face interviews. Setting: The Netherlands. Participants: Nationwide stratified sample of 482 physicians; 410 responded and 211 of these reported characteristics of their most recent terminal sedation case. Measurements: Physician reports of frequency of terminal sedation (defined as the administration of drugs to keep the patient in deep sedation or coma until death, without giving artificial nutrition or hydration), characteristics of the decision-making process, drugs used, the estimated life-shortening effect, and frequency of euthanasia discussions. Results: Of respondents, 52% (95% CI, 48% to 57%) had ever used terminal sedation. Of the 211 most recent cases, physicians used terminal sedation to alleviate severe pain in 51% of patients (CI, 44% to 58%), agitation in 38% (CI, 32% to 45%), and dyspnea in 38% (CI, 32% to 45%). Physicians reported discussing with patients the decision to use deep sedation in 59% of the 211 most recent cases (CI, 52% to 66%) and the decision to forgo artificial nutrition or hydration in 34% (CI, 28% to 41%). Hastening death was partly the intention of the physician in 47% (CI, 41% to 54%) of cases and the explicit intention in 17% (CI, 13% to 22%) of cases. Limitations: The generalizability of physician reports about their most recent cases to all terminal sedation cases is uncertain. In addition, the findings are subject to recall bias and may not apply to other geographic settings. Conclusions: Terminal sedation precedes a substantial number of deaths in the Netherlands. In about two thirds of most recently reported cases, physicians indicated that in addition to alleviating symptoms, they intended to hasten death.	Erasmus MC, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, NL-1081 HV Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	Rietjens, JAC (corresponding author), Erasmus MC, Dept Publ Hlth, POB 1738, NL-3000 DR Rotterdam, Netherlands.	j.rietjens@erasmusmc.nl						Billings JA, 1996, J PALLIAT CARE, V12, P21, DOI 10.1177/082585979601200404; Chater S, 1998, PALLIATIVE MED, V12, P255, DOI 10.1191/026921698671831786; Cherny N I, 1994, J Palliat Care, V10, P31; Chiu TY, 2001, J PAIN SYMPTOM MANAG, V21, P467, DOI 10.1016/S0885-3924(01)00286-X; Coyle N, 1990, J Pain Symptom Manage, V5, P83; Emanuel LL, 1998, JAMA-J AM MED ASSOC, V280, P643, DOI 10.1001/jama.280.7.643; Fainsinger RL, 2000, PALLIATIVE MED, V14, P257, DOI 10.1191/026921600666097479; Fainsinger RL, 1998, J PAIN SYMPTOM MANAG, V16, P145, DOI 10.1016/S0885-3924(98)00066-9; Jansen LA, 2002, ANN INTERN MED, V136, P845, DOI 10.7326/0003-4819-136-11-200206040-00014; Kvasnicka John H, 2002, Ann Intern Med, V137, pW2; Letvak R, 1998, JAMA-J AM MED ASSOC, V279, P1065, DOI 10.1001/jama.279.14.1065; LETVAK R, 1998, JAMA-J AM MED ASSOC, V279, P1066; Loewy EH, 2001, ARCH INTERN MED, V161, P329, DOI 10.1001/archinte.161.3.329; Morita T, 2003, J PAIN SYMPTOM MANAG, V25, P357, DOI 10.1016/S0885-3924(02)00684-X; Morita T, 2002, J CLIN ONCOL, V20, P758, DOI 10.1200/JCO.2002.20.3.758; Morita T, 2001, LANCET, V358, P335, DOI 10.1016/S0140-6736(01)05515-5; Morita Tatsuya, 2002, Ann Intern Med, V137, pW1; Muller-Busch H Christof, 2003, BMC Palliat Care, V2, P2, DOI 10.1186/1472-684X-2-2; Quill TE, 2000, ANN INTERN MED, V132, P488, DOI 10.7326/0003-4819-132-6-200003210-00011; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Quill TE, 2002, ANN INTERN MED, V137, P1009, DOI 10.7326/0003-4819-137-12-200212170-00026; Rousseau P, 2002, ANN INTERN MED, V137, P1009, DOI 10.7326/0003-4819-137-12-200212170-00027; Sasser CG, 2002, ANN INTERN MED, V137, P1008, DOI 10.7326/0003-4819-137-12-200212170-00025; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Stone P, 1997, PALLIATIVE MED, V11, P140, DOI 10.1177/026921639701100208; Sulmasy DP, 2000, ANN INTERN MED, V133, P562, DOI 10.7326/0003-4819-133-7-200010030-00023; Sulmasy DP, 2000, ANN INTERN MED, V133, P560, DOI 10.7326/0003-4819-133-7-200010030-00021; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; Sykes N, 2003, ARCH INTERN MED, V163, P341, DOI 10.1001/archinte.163.3.341; Vainio A, 1996, J PAIN SYMPTOM MANAG, V12, P3, DOI 10.1016/0885-3924(96)00042-5; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; VANDERWAL G, 2003, MED BESLUITVORMING L; Ventafridda V, 1990, J Palliat Care, V6, P7; 2004, STAT NETHERLANDS CEN	35	133	134	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2004	141	3					178	185		10.7326/0003-4819-141-3-200408030-00006	http://dx.doi.org/10.7326/0003-4819-141-3-200408030-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HG	15289214	Green Published			2022-12-28	WOS:000223068600002
J	Burgers, JS; van Everdingen, JJE				Burgers, JS; van Everdingen, JJE			Beyond the evidence in clinical guidelines	LANCET			English	Editorial Material							RECOMMENDATIONS		Dutch Inst Healthcare Qual, NL-3502 LB Utrecht, Netherlands; Univ Med Ctr Nijmegen, Ctr Qual Care Res, Nijmegen, Netherlands	Radboud University Nijmegen	Burgers, JS (corresponding author), Dutch Inst Healthcare Qual, NL-3502 LB Utrecht, Netherlands.	burgersj@knmg.nl						Burgers JS, 2002, DIABETES CARE, V25, P1933, DOI 10.2337/diacare.25.11.1933; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Edwards A, 2003, BRIT MED J, V327, P691, DOI 10.1136/bmj.327.7417.691; Eisinger F, 1999, LANCET, V353, P919, DOI 10.1016/S0140-6736(98)07516-3; Field MJ., 1992, GUIDELINES CLIN PRAC; Garfield FB, 2000, INT J TECHNOL ASSESS, V16, P1050, DOI 10.1017/S0266462300103113; GOODMAN C, 1990, IMPROVING CONSENSUS; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; Miller J, 2000, LANCET, V355, P82, DOI 10.1016/S0140-6736(99)90326-4; Pagliari C, 2001, J EVAL CLIN PRACT, V7, P165, DOI 10.1046/j.1365-2753.2001.00272.x; PRONK E, 2004, MED CONTACT, V59, P493; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Thomson R, 1998, BRIT MED J, V316, P509, DOI 10.1136/bmj.316.7130.509	13	39	39	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					392	393		10.1016/S0140-6736(04)16778-0	http://dx.doi.org/10.1016/S0140-6736(04)16778-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288718				2022-12-28	WOS:000222998600004
J	Greenstein, RJ; Collins, MT				Greenstein, RJ; Collins, MT			Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic?	LANCET			English	Editorial Material							CROHNS-DISEASE; BIOPSY SPECIMENS; NOD2		Vet Adm Med Ctr, Dept Surg, Bronx, NY 10468 USA; Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Wisconsin System; University of Wisconsin Madison	Greenstein, RJ (corresponding author), Vet Adm Med Ctr, Dept Surg, Bronx, NY 10468 USA.	BGAxis@aol.com						Behr MA, 2004, LANCET INFECT DIS, V4, P136, DOI 10.1016/S1473-3099(04)00935-1; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; Collins MT, 2000, J CLIN MICROBIOL, V38, P4373, DOI 10.1128/JCM.38.12.4373-4381.2000; Girardin SE, 2003, TRENDS IMMUNOL, V24, P652, DOI 10.1016/j.it.2003.10.007; GREEN JP, 2002, DRAFT GUIDANCE CONTR; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Hermon-Taylor J, 2004, PATHOGENIC MYCOBACTE, P74; Mishina D, 1996, P NATL ACAD SCI USA, V93, P9816, DOI 10.1073/pnas.93.18.9816; Mortensen H, 2004, J DAIRY SCI, V87, P2108, DOI 10.3168/jds.S0022-0302(04)70029-6; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Sechi LA, 2001, J CLIN MICROBIOL, V39, P4514, DOI 10.1128/JCM.39.12.4514-4517.2001	11	62	63	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					396	397		10.1016/S0140-6736(04)16781-0	http://dx.doi.org/10.1016/S0140-6736(04)16781-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288721				2022-12-28	WOS:000222998600007
J	Jones, AM; Bamford, B				Jones, AM; Bamford, B			The other face of research governance	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Research governance is designed to ensure that "health and social care research is conducted to high scientific and ethical standards."(1) Currently the same process is applied to all breaches, regardless of their severity or likely implications. Although we do not deny the importance and relevance of research governance, our experience leads us to question how it is applied.	Southmead Gen Hosp, Specialist Treatment Eating Problems Unit, Bristol BS10 5NB, Avon, England; Somerset Partnership NHS & Social Care Trust, Bridgwater TA6 5YA, Somerset, England	Southmead Hospital	Jones, AM (corresponding author), Southmead Gen Hosp, Specialist Treatment Eating Problems Unit, Bristol BS10 5NB, Avon, England.	carrie.sambrook@awp.nhs.uk						Glasziou P, 2004, BRIT MED J, V328, P121, DOI 10.1136/bmj.328.7432.121; *MED RES COUNC, 1997, POL PROC INQ ALL SCI; MORGAN HGP, 1998, BRIT J PSYCHIAT, V152, P367	3	21	21	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2004	329	7460					280	281		10.1136/bmj.329.7460.280	http://dx.doi.org/10.1136/bmj.329.7460.280			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284155	Green Published			2022-12-28	WOS:000223133300024
J	Bruggemann, H; Henne, A; Hoster, F; Liesegang, H; Wiezer, A; Strittmatter, A; Hujer, S; Durre, P; Gottschalk, G				Bruggemann, H; Henne, A; Hoster, F; Liesegang, H; Wiezer, A; Strittmatter, A; Hujer, S; Durre, P; Gottschalk, G			The complete genome sequence of Propionibacterium acnes, a commensal of human skin	SCIENCE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; HYALURONATE LYASE; ANTIGENS; PROTEINS; CLONING; LEPRAE	Propionibacterium acnes is a major inhabitant of adult human skin, where it resides within sebaceous follicles, usually as a harmless commensal although it has been implicated in acne vulgaris formation. The entire genome sequence of this Gram-positive bacterium encodes 2333 putative genes and revealed numerous gene products involved in degrading host molecules, including sialidases, neuraminidases, endoglycoceramidases, lipases, and pore-forming factors. Surface-associated and other immunogenic factors have been identified, which might be involved in triggering acne inflammation and other P. acnes-associated diseases.	Univ Gottingen, Inst Microbiol & Genet, Gottingen Genom Lab, D-37077 Gottingen, Germany; Univ Ulm, Dept Microbiol & Biotechnol, D-89069 Ulm, Germany	University of Gottingen; Ulm University	Bruggemann, H (corresponding author), Inst Pasteur, Lab Genom Microbial Pathogens, 28 Rue Dr Roux, F-75724 Paris, France.	hbruegg@pasteur.fr; ggottsc@gwdg.de		Liesegang, Heiko/0000-0003-1792-2047; Bruggemann, Holger/0000-0001-7433-0190				BOOTH RJ, 1993, INFECT IMMUN, V61, P1509, DOI 10.1128/IAI.61.4.1509-1515.1993; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Csukas Z, 2004, MICROB PATHOGENESIS, V36, P171, DOI 10.1016/j.micpath.2003.09.002; Farrar MD, 2000, FEMS MICROBIOL LETT, V191, P183, DOI 10.1016/S0378-1097(00)00387-6; GRIBBON EM, 1993, J GEN MICROBIOL, V139, P1745, DOI 10.1099/00221287-139-8-1745; HERMANS PWM, 1995, INFECT IMMUN, V63, P954, DOI 10.1128/IAI.63.3.954-960.1995; Holland KT, 1998, DERMATOLOGY, V196, P67, DOI 10.1159/000017870; HUJER S, UNPUB; Ingham E, 1999, CURR OPIN INFECT DIS, V12, P191, DOI 10.1097/00001432-199906000-00006; Jakab E, 1996, YALE J BIOL MED, V69, P477; Jappe U, 2002, BRIT J DERMATOL, V146, P202, DOI 10.1046/j.1365-2133.2002.04602.x; Koreck A, 2003, DERMATOLOGY, V206, P96, DOI 10.1159/000068476; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Makris G, 2004, MICROBIOL-SGM, V150, P2005, DOI 10.1099/mic.0.26942-0; Miskin JE, 1997, MICROBIOL-UK, V143, P1745, DOI 10.1099/00221287-143-5-1745; Singh KK, 2001, INFECT IMMUN, V69, P4185, DOI 10.1128/IAI.69.6.4185-4191.2001; Steiner B, 1997, CAN J MICROBIOL, V43, P315, DOI 10.1139/m97-044; VANDERENDE A, 1995, J BACTERIOL, V177, P2475, DOI 10.1128/jb.177.9.2475-2480.1995; Yamada T, 2002, J PATHOL, V198, P541, DOI 10.1002/path.1243	19	307	410	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					671	673		10.1126/science.1100330	http://dx.doi.org/10.1126/science.1100330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286373				2022-12-28	WOS:000222992100049
J	Knoll, AH; Walter, MR; Narbonne, GM; Christie-Blick, N				Knoll, AH; Walter, MR; Narbonne, GM; Christie-Blick, N			A new period for the geologic time scale	SCIENCE			English	Editorial Material							FOSSILS; SNOWBALL; AGE		Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Macquarie Univ, Australian Ctr Astrobiol, Dept Earth & Planetary Sci, Sydney, NSW 2109, Australia; Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON K7L 3N6, Canada; Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Harvard University; Macquarie University; Queens University - Canada; Columbia University; Columbia University	Knoll, AH (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	aknoll@oeb.harvard.edu	Narbonne, Guy M/I-7518-2012					Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; HOFFMANN KH, IN PRESS GEOLOGY; Jiang GQ, 2003, NATURE, V426, P822, DOI 10.1038/nature02201; KNOLL AH, IN PRESS LETHAIA; Martin MW, 2000, SCIENCE, V288, P841, DOI 10.1126/science.288.5467.841; Narbonne GM, 2003, GEOLOGY, V31, P27, DOI 10.1130/0091-7613(2003)031<0027:LASTOC>2.0.CO;2; Narbonne GM., 1998, GSA TODAY, V8, P1; PLUMB KA, 1991, EPISODES, V14, P139, DOI 10.18814/epiiugs/1991/v14i2/005; Xiao SH, 2000, J PALEONTOL, V74, P767, DOI 10.1666/0022-3360(2000)074<0767:PAEFTN>2.0.CO;2	10	199	227	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2004	305	5684					621	622		10.1126/science.1098803	http://dx.doi.org/10.1126/science.1098803			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286353	Green Submitted			2022-12-28	WOS:000222992100026
J	Angelaki, DE; Shaikh, AG; Green, AM; Dickman, JD				Angelaki, DE; Shaikh, AG; Green, AM; Dickman, JD			Neurons compute internal models of the physical laws of motion	NATURE			English	Article							APERTURE PROBLEM; PROJECTIONS; HUMANS; MONKEY; CEREBELLUM; DYNAMICS; AFFERENT; THALAMUS; NUCLEI; CUES	A critical step in self-motion perception and spatial awareness is the integration of motion cues from multiple sensory organs that individually do not provide an accurate representation of the physical world. One of the best-studied sensory ambiguities is found in visual processing, and arises because of the inherent uncertainty in detecting the motion direction of an untextured contour moving within a small aperture(1-4). A similar sensory ambiguity arises in identifying the actual motion associated with linear accelerations sensed by the otolith organs in the inner ear(5,6). These internal linear accelerometers respond identically during translational motion ( for example, running forward) and gravitational accelerations experienced as we reorient the head relative to gravity ( that is, head tilt). Using new stimulus combinations, we identify here cerebellar and brainstem motion-sensitive neurons that compute a solution to the inertial motion detection problem. We show that the firing rates of these populations of neurons reflect the computations necessary to construct an internal model representation of the physical equations of motion.	Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA.	angelaki@pcg.wustl.edu						ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ANGAUT P, 1970, BRAIN RES, V24, P49, DOI 10.1016/0006-8993(70)90273-8; Angelaki DE, 1999, J NEUROSCI, V19, P316, DOI 10.1523/JNEUROSCI.19-01-00316.1999; Angelaki DE, 2003, J NEUROSCI, V23, P2971; Angelaki DE, 2000, J NEUROPHYSIOL, V84, P2113, DOI 10.1152/jn.2000.84.4.2113; ASAMURA C, 1983, BRAIN RES REV, V5, P237; BATTON RR, 1977, J COMP NEUROL, V174, P281, DOI 10.1002/cne.901740206; CARLETON SC, 1984, BRAIN RES, V294, P281, DOI 10.1016/0006-8993(84)91040-0; Dickman JD, 2002, J NEUROPHYSIOL, V88, P3518, DOI 10.1152/jn.00518.2002; Draper NR., 1998, WILEY SERIES PROBABI, V3rd ed.; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Goldstein H, 2002, CLASSICAL MECH; Green AM, 2004, J NEUROPHYSIOL, V92, P905, DOI 10.1152/jn.01234.2003; Green AM, 2003, J NEUROSCI, V23, P9265; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; KALIL K, 1981, J COMP NEUROL, V195, P25, DOI 10.1002/cne.901950105; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; KOTCHABHAKDI N, 1978, BRAIN RES, V142, P142, DOI 10.1016/0006-8993(78)90183-X; LANG W, 1979, BRAIN RES, V177, P3, DOI 10.1016/0006-8993(79)90914-4; Merfeld DM, 2002, J NEUROPHYSIOL, V87, P819, DOI 10.1152/jn.00485.2001; Merfeld DM, 1999, NATURE, V398, P615, DOI 10.1038/19303; Movshon Adelson, 1985, PATTERN RECOGNITION, V54, P117, DOI 10.1098/rstb.1998.0333; Newlands SD, 2003, J COMP NEUROL, V466, P31, DOI 10.1002/cne.10876; NEWLANDS SD, 2004, SEMICIRCULAR CANAL I; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; SHIMOJO S, 1989, VISION RES, V29, P619, DOI 10.1016/0042-6989(89)90047-3; Zupan LH, 2000, J NEUROPHYSIOL, V84, P2001, DOI 10.1152/jn.2000.84.4.2001	30	223	227	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					560	564		10.1038/nature02754	http://dx.doi.org/10.1038/nature02754			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282606				2022-12-28	WOS:000222946100048
J	Comas, D; Petit, F; Preat, T				Comas, D; Petit, F; Preat, T			Drosophila long-term memory formation involves regulation of cathepsin activity	NATURE			English	Article							CONSOLIDATED MEMORY; GLIAL-CELLS; GENES	Whereas short-term memory lasts from minutes to hours, long-term memory (LTM) can last for days or even an entire lifetime. LTM generally forms after spaced repeated training sessions and involves the regulation of gene expression(1,2), thereby implicating transcription factors in the initial steps of LTM establishment(3). However, the direct participation of effector genes in memory formation has been rarely documented, and many of the mechanisms involved in LTM formation remain to be understood. Here we describe a Drosophila melanogaster mutant, crammer (cer), which shows a specific LTM defect. The cer gene encodes an inhibitor of a subfamily of cysteine proteinases, named cathepsins, some of which might be involved in human Alzheimer's disease(4). The Cer peptide was found in the mushroom bodies (MBs), the Drosophila olfactory memory centre and in glial cells around the MBs. The overexpression of cer in glial cells but not in MB neurons induces a decrease in LTM, suggesting that Cer might have a role in glia and that the concentration of the Cer peptide is critical for LTM. In wild-type flies, cer expression transiently decreases after LTM conditioning, indicating that cysteine proteinases are activated early in LTM formation.	CNRS, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Preat, T (corresponding author), CNRS, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	preat@iaf.cnrs-gif.fr		Preat, Thomas/0000-0001-9976-1763				ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Armstrong JD, 1998, LEARN MEMORY, V5, P102; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Boquet I, 2000, CELL, V102, P797, DOI 10.1016/S0092-8674(00)00068-4; Boquet I, 2000, J NEUROBIOL, V42, P33; Callahan LM, 1998, NEUROBIOL AGING, V19, pS99, DOI 10.1016/S0197-4580(98)00044-X; Comas D, 1999, INSECT BIOCHEM MOLEC, V29, P821, DOI 10.1016/S0965-1748(99)00058-2; Dash PK, 2000, NEUROREPORT, V11, P2811, DOI 10.1097/00001756-200008210-00040; DELARIA K, 1994, J BIOL CHEM, V269, P25172; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Epstein HT, 2003, NEUROBIOL LEARN MEM, V79, P127, DOI 10.1016/S1074-7427(02)00020-5; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Igaz LM, 2002, J NEUROSCI, V22, P6781; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Ito K, 1997, DEVELOPMENT, V124, P761; Kurata M, 2001, J BIOCHEM, V130, P857, DOI 10.1093/oxfordjournals.jbchem.a003058; Kurosinski P, 2002, ARCH NEUROL-CHICAGO, V59, P1524, DOI 10.1001/archneur.59.10.1524; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wiederanders B, 2000, ADV EXP MED BIOL, V477, P261	25	68	72	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					460	463		10.1038/nature02726	http://dx.doi.org/10.1038/nature02726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269770				2022-12-28	WOS:000222801400045
J	Stone, EM; Braun, TA; Russell, SR; Kuehn, MH; Lotery, AJ; Moore, PA; Eastman, CG; Casavant, TL; Sheffield, VC				Stone, EM; Braun, TA; Russell, SR; Kuehn, MH; Lotery, AJ; Moore, PA; Eastman, CG; Casavant, TL; Sheffield, VC			Missense variations in the fibulin 5 gene and age-related macular degeneration	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALATTIA LEVENTINESE; ALLELIC VARIATION; VISUAL IMPAIRMENT; STARGARDT-DISEASE; MUTATION; ABCR; MACULOPATHY; POPULATION; PREVALENCE; BLINDNESS	Background: Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the developed world. The study of a rare mendelian form of macular degeneration implicated fibulin genes in the pathogenesis of more common forms of this disease. We evaluated five fibulin genes in a large series of patients with AMD. Methods: We studied 402 patients with AMD and 429 control subjects from the same clinic population. Patients were examined by means of indirect ophthalmoscopy, slit-lamp microscopy, and fundus photography to establish the presence and phenotypic pattern of AMD. DNA samples were screened for sequence variations in five members of the fibulin gene family. Results: Amino acid-altering sequence variations were found in all five fibulin genes, many of which were observed only in patients with AMD. Several of the altered residues have been conserved during evolution. Seven of the 402 patients with AMD had amino acid-altering sequence variations in the fibulin 5 gene, whereas none were observed among 429 control subjects (P<0.01). In addition, these seven patients all had small, circular drusen, which are commonly referred to as basal laminar or cuticular drusen. Conclusions: Missense mutations in the fibulin 5 gene were found in 1.7 percent of patients with AMD. Many variations in other fibulin genes were also found in these patients, and the evolutionary conservation of the affected residues suggests that several of these variations may also be involved in AMD.	Univ Iowa, Carver Coll Med, Ctr Macular Degenerat, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Southampton, Dept Ophthalmol, Southampton, Hants, England	University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Southampton	Stone, EM (corresponding author), Univ Iowa, Carver Coll Med, Ctr Macular Degenerat, 200 Hawkins Dr, Iowa City, IA 52242 USA.	edwin-stone@uiowa.edu		Lotery, Andrew/0000-0001-5541-4305; Kuehn, Markus/0000-0003-3940-198X; Stone, Edwin M./0000-0003-3343-4414; Sheffield, Val/0000-0002-6282-0835; Russell, Stephen/0000-0003-3776-1367				Allikmets R, 1997, NAT GENET, V17, P122, DOI 10.1038/ng0997-122b; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Attebo K, 1996, OPHTHALMOLOGY, V103, P357; BUFFONE GJ, 1985, CLIN CHEM, V31, P164; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gass JD., 1977, STEREOSCOPIC ATLAS M, V2nd edn; GASS JDM, 1985, AM J OPHTHALMOL, V99, P445; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Heon E, 1996, ARCH OPHTHALMOL-CHIC, V114, P193, DOI 10.1001/archopht.1996.01100130187014; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; Lotery AJ, 2000, INVEST OPHTH VIS SCI, V41, P1291; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; TIELSCH JM, 1995, NEW ENGL J MED, V332, P1205, DOI 10.1056/NEJM199505043321806; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Vogel BE, 2001, DEVELOPMENT, V128, P883; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817	30	247	259	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2004	351	4					346	353		10.1056/NEJMoa040833	http://dx.doi.org/10.1056/NEJMoa040833			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839RC	15269314				2022-12-28	WOS:000222801200008
J	Armstrong, BG; Mangtani, P; Fletcher, A; Kovats, S; McMichael, A; Pattenden, S; Wilkinson, P				Armstrong, BG; Mangtani, P; Fletcher, A; Kovats, S; McMichael, A; Pattenden, S; Wilkinson, P			Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people	BMJ-BRITISH MEDICAL JOURNAL			English	Article							23-VALENT PNEUMOCOCCAL VACCINES; LARGE-SCALE INTERVENTION; OLDER-PEOPLE; COMMUNITY; EFFICACY	Objective To estimate the protection against death provided by vaccination against influenza. Design Prospective cohort follow up supplemented by weekly national counts of influenza confirmed in the community. Setting Primary care. Participants 24535 patients aged over 75 years from 73 general practices in Great Britain. Main outcome measure Death. Results In unvaccinated members of the cohort daily all cause mortality was strongly associated with an index of influenza circulating in the population (mortality ratio 1.16, 95% confidence interval 1.04 to 1.29 at 90th centile of circulating influenza). The association was strongest for respiratory deaths but was also present for cardiovascular deaths. In contrast, in vaccinated people mortality from any cause was not associated with circulating influenza. The difference in patterns between vaccinated and unvaccinated people could not easily be due to chance (P=0.02, all causes). Conclusions This study, using a novel and robust approach to control for confounding, provides robust evidence of a protective effect on mortality of vaccination against influenza.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Armstrong, BG (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	ben.armstrong@lshtm.ac.uk		Wilkinson, Paul/0000-0001-7456-259X; Kovats, Sari/0000-0002-4823-8099; Mangtani, Punam/0000-0001-7074-2999; armstrong, benedict/0000-0003-4407-0409				Armstrong BG, 2003, EPIDEMIOLOGY, V14, P467, DOI 10.1097/01.ede.0000071408.39011.99; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Ashley J., 1991, Population Trends, P16; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Christenson B, 2001, LANCET, V357, P1008, DOI 10.1016/S0140-6736(00)04237-9; Christenson B, 2002, EPIDEMIOL INFECT, V129, P515, DOI 10.1017/S095026880200780X; Fleming DM, 1995, EPIDEMIOL INFECT, V115, P581, DOI 10.1017/S095026880005874X; Fletcher AE, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-21; Goddard N L, 2003, Commun Dis Public Health, V6, P238; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Hedlund J, 2003, VACCINE, V21, P3906, DOI 10.1016/S0264-410X(03)00296-2; Mangtani P, 2004, J INFECT DIS, V190, P1, DOI 10.1086/421274; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Pattenden S, 2003, J EPIDEMIOL COMMUN H, V57, P628, DOI 10.1136/jech.57.8.628; Schwartz J B, 1996, PDA J Pharm Sci Technol, V50, P197; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Voordouw BCG, 2003, ARCH INTERN MED, V163, P1089, DOI 10.1001/archinte.163.9.1089; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	19	57	60	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					660	663		10.1136/bmj.38198.594109.AE	http://dx.doi.org/10.1136/bmj.38198.594109.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15313884	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-28	WOS:000224042300021
J	Bridgewater, B; Grayson, AD; Au, J; Hasan, R; Dihmis, WC; Munsch, C; Waterworth, P				Bridgewater, B; Grayson, AD; Au, J; Hasan, R; Dihmis, WC; Munsch, C; Waterworth, P		NW Quality Improvement Program Car	Improving mortality of coronary surgery over first four years of independent practice: retrospective examination of prospectively collected data from 15 surgeons	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LEARNING-CURVE; SURGICAL-PROCEDURES; CARDIAC-SURGERY; EUROSCORE	Objective To study the "learning curve" associated with independent practice in coronary artery surgery. Design Retrospective analysis of prospectively collected data. Setting All NHS centres in north west England that carry out cardiac surgery in adults. Participants 18 913 patients undergoing coronary artery surgery for the first time between April 1997 and March 2003,5678 of whom were operated on by 15 surgeons in the first four years after their consultant appointment. Main outcome measures Observed and predicted mortality (EuroSCORE) for surgeons in their first, second, third, and fourth years after appointment as a consultant compared with figures for established surgeons. Results Overall mortality decreased over the six years of study (P = 0.01). Of the patients operated on by established surgeons or newly appointed consultants, 265/13 235 (2.0%) and 109/5678 (1.9%), respectively, died (P = 0.71). There was a progressive decrease in observed mortality with time after appointment as a consultant from 2.2% in the first year to 1.2% in the fourth year (P = 0.049). This result remained significant after adjustment for time and case mix (P = 0.019). Conclusions Mortality in patients operated on by newly appointed consultant surgeons is similar to mortality in patients operated on by established surgeons. There are significant decreases in crude and risk adjusted mortality in the four years after appointment. These findings should influence the nature of practice in newly appointed surgeons.	Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England; Ctr Cardiothorac, Liverpool L14 3PE, Merseyside, England; Manchester Royal Infirm, Manchester M13 9WL, Lancs, England; Blackpool Victoria Hosp, Blackpool FY3 8NR, Lancs, England; Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Leeds General Infirmary; University of Leeds	Bridgewater, B (corresponding author), Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England.	ben.bridgewater@smuht.nwest.nhs.uk		Grayson, Antony/0000-0003-2940-0828				Bridgewater B, 2003, BMJ-BRIT MED J, V327, P13, DOI 10.1136/bmj.327.7405.13; Bull C, 2000, BMJ-BRIT MED J, V320, P1168, DOI 10.1136/bmj.320.7243.1168; Dincler S, 2003, DIS COLON RECTUM, V46, P1371, DOI 10.1007/s10350-004-6752-5; Dyer O, 2003, BRIT MED J, V326, P1053, DOI 10.1136/bmj.326.7398.1053-a; Ford WDA, 1997, J PEDIATR SURG, V32, P552, DOI 10.1016/S0022-3468(97)90705-3; Gates EA, 1997, AM J OBSTET GYNECOL, V176, P1293, DOI 10.1016/S0002-9378(97)70348-X; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; Hasan A, 2000, BRIT MED J, V320, P171, DOI 10.1136/bmj.320.7228.171; HOSMER DW, 1989, APPL LOGISTIC REGRES; Ikhena SE, 1999, ACTA OBSTET GYN SCAN, V78, P632, DOI 10.1034/j.1600-0412.1999.780712.x; Keogh B, 2002, NATL ADULT CARDIAC S; Michel P, 2003, EUR J CARDIO-THORAC, V23, P684, DOI 10.1016/S1010-7940(03)00074-5; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Orr RK, 1999, ARCH SURG-CHICAGO, V134, P764, DOI 10.1001/archsurg.134.7.764; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Soot SJ, 1999, ARCH SURG-CHICAGO, V134, P278, DOI 10.1001/archsurg.134.3.278; Waldman JD, 2003, HEALTH CARE MANAGE R, V28, P41, DOI 10.1097/00004010-200301000-00006	17	47	50	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2004	329	7463					421	+		10.1136/bmj.38173.577697.55	http://dx.doi.org/10.1136/bmj.38173.577697.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849EA	15298881	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000223520300013
J	Spahn, CMT; Jan, E; Mulder, A; Grassucci, RA; Sarnow, P; Frank, J				Spahn, CMT; Jan, E; Mulder, A; Grassucci, RA; Sarnow, P; Frank, J			Cryo-EM visualization of a viral internal ribosome entry site bound to human ribosomes: The IRES functions as an RNA-Based translation factor	CELL			English	Article							CRICKET PARALYSIS VIRUS; COLI 70S RIBOSOME; METHIONINE-INDEPENDENT INITIATION; 80 S RIBOSOME; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; EXPANSION SEGMENTS; CRYOELECTRON MICROSCOPY	Internal initiation of protein synthesis in eukaryotes is accomplished by recruitment of ribosomes to structured internal ribosome entry sites (IRESs), which are located in certain viral and cellular messenger RNAs. An IRES element in cricket paralysis virus (CrPV) can directly assemble 80S ribosomes in the absence of canonical initiation factors and initiator tRNA. Here we present cryo-EM structures of the CrPV IRES bound to the human ribosomal 40S subunit and to the 80S ribosome. The CrPV IRES adopts a defined, elongate structure within the ribosomal intersubunit space and forms specific contacts with components of the ribosomal A, P, and E sites. Conformational changes in the ribosome as well as within the IRES itself show that CrPV IRES actively manipulates the ribosome. CrPV-Iike IRES elements seem to act as RNA-based translation factors.	New York State Dept Hlth, Wadsworth Ctr Labs & Res, Howard Hughes Med Inst, Hlth Res Inc, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 10012 USA; Charite Univ Med Berlin, Inst Med Phys & Biophys, D-10117 Berlin, Germany; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Purdue Univ, Dept Biol, W Lafayette, IN 47906 USA	Health Research Inc; Howard Hughes Medical Institute; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Stanford University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Frank, J (corresponding author), New York State Dept Hlth, Wadsworth Ctr Labs & Res, Howard Hughes Med Inst, Hlth Res Inc, Empire State Plaza, Albany, NY 12201 USA.	joachim@wadsworth.org	Jan, Eric/O-1923-2019	Sarnow, Peter/0000-0002-2043-2770	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055440, R37GM029169, R01GM029169, R01GM055979] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR01219] Funding Source: Medline; NIGMS NIH HHS [GM55979, R037 GM29169, R01 GM55440] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Alkemar G, 2004, RNA, V10, P403, DOI 10.1261/rna.5135204; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; Dube P, 1998, J MOL BIOL, V279, P403, DOI 10.1006/jmbi.1998.1804; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Frank J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P45; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; MATASOVA NB, 1991, ANAL BIOCHEM, V198, P219, DOI 10.1016/0003-2697(91)90416-Q; Morgan DG, 2000, J MOL BIOL, V301, P301, DOI 10.1006/jmbi.2000.3947; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Nishiyama T, 2003, NUCLEIC ACIDS RES, V31, P2434, DOI 10.1093/nar/gkg336; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Sachs AB, 2000, CELL, V101, P243, DOI 10.1016/S0092-8674(00)80834-X; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Spahn CMT, 2001, MOL CELL, V7, P1037, DOI 10.1016/S1097-2765(01)00238-6; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Thompson SR, 2001, P NATL ACAD SCI USA, V98, P12972, DOI 10.1073/pnas.241286698; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	50	209	217	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					465	475		10.1016/j.cell.2004.08.001	http://dx.doi.org/10.1016/j.cell.2004.08.001			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315759	Bronze			2022-12-28	WOS:000223650900009
J	Kerr, EA; Gerzoff, RB; Krein, SL; Selby, JV; Piette, JD; Curb, JD; Herman, WH; Marrero, DG; Narayan, V; Safford, MM; Thompson, T; Mangione, CM				Kerr, EA; Gerzoff, RB; Krein, SL; Selby, JV; Piette, JD; Curb, JD; Herman, WH; Marrero, DG; Narayan, V; Safford, MM; Thompson, T; Mangione, CM			Diabetes care quality in the Veterans Affairs health care system and commercial managed care: The TRIAD study	ANNALS OF INTERNAL MEDICINE			English	Article							MYOCARDIAL-INFARCTION; PREVENTION; VA	Background: No studies have compared care in the Department of Veterans Affairs (VA) with that delivered in commercial managed care organizations, nor have studies focused in depth on care comparisons for chronic, outpatient conditions. Objective: To compare the quality of diabetes care between patients in the VA system and those enrolled in commercial managed care organizations by using equivalent sampling and measurement methods. Design: cross-sectional patient survey with retrospective review of medical records. Setting: 5 VA medical centers and 8 commercial managed care organizations in 5 matched geographic regions. Participants: 8205 diabetic patients: 1285 in the VA system and 6920 in commercial managed care. Measurements: we compared scores on identically specified quality measures for 7 diabetes care processes and 3 diabetes intermediate outcomes and on 4 dimensions of satisfaction. Scores were expressed as the percentage of patients receiving indicated care and were adjusted for patients' demographic and health characteristics. Results: Patients in the VA system had better scores than patients in commercial managed care on all process measures (for example, 93% vs. 83% for annual hemoglobin A(1c); P= 0.006; 91% vs. 75% for annual eye examination; P < 0.001). Blood pressure control was poor in both groups (52% to 53% of persons had blood pressure < 140/90 mm Hg), but patients in the VA system had better control of low-density lipoprotein cholesterol and hemoglobin Alc (for example, 86% vs. 72% for low-density lipoprotein cholesterol level < 3.37 mmol/L [<130 mg/dL]; P = 0.002). Satisfaction was similar in the 2 groups. Limitations: our results may not be generalizable to all regions or health plans, and some of the differences in performance could reflect differences in documentation. Conclusions: Diabetes processes of care and 2 of 3 intermediate outcomes were better for patients in the VA system than for patients in commercial managed care. However, both VA and commercial managed care had room for improvement, especially for blood pressure control.	Vet Affairs Ctr Practice Management & Outcomes Re, Ann Arbor, MI 48113 USA; Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48113 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Kaiser Permanente, Oakland, CA USA; Pacific Hlth Res Inst, Honolulu, HI USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Univ Med & Dent New Jersey, Sch Med, Newark, NJ USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA; Kaiser Permanente; Pacific Health Research & Education Institute; Indiana University System; Indiana University-Purdue University Indianapolis; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kerr, EA (corresponding author), Vet Affairs Ctr Practice Management & Outcomes Re, POB 130170, Ann Arbor, MI 48113 USA.	ekerr@umich.edu	Krein, Sarah L/E-2742-2014; Young, Alexander/A-1523-2009	Krein, Sarah L/0000-0003-2111-8131; Young, Alexander/0000-0002-9367-9213	ODCDC CDC HHS [CCU916380-04] Funding Source: Medline	ODCDC CDC HHS		ADAMS K, 2001, PRIORITY AREAS NATL; [Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clark MJ, 2000, CLIN THER, V22, P899, DOI 10.1016/S0149-2918(00)80063-6; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Curb JD, 2002, DIABETES CARE, V25, P386; Demakis JG, 2000, JAMA-J AM MED ASSOC, V284, P1411, DOI 10.1001/jama.284.11.1411; DERR EA, 2003, MEC CARE RES REV, V60, P158; Doebbeling BN, 2002, MED CARE, V40, P540, DOI 10.1097/00005650-200206000-00011; Eddy DM, 1998, HEALTH AFFAIR, V17, P7, DOI 10.1377/hlthaff.17.4.7; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Flynn K, 1997, HOSP HEALTH SERV ADM, V42, P323; GEISS L, 1997, DIABETES SURVEILLANC; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; HYNES DM, 2002, QUALITY ENHANCEMENT, V38, pI114; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Kerr EA, 2001, AM J MANAG CARE, V7, P1033; Kizer KW, 1999, AM J MED QUAL, V14, P3, DOI 10.1177/106286069901400103; Krein SL, 2000, MED CARE, V38, pS38; Lenfant C, 2003, HYPERTENSION, V41, P1178, DOI 10.1161/01.HYP.0000075790.33892.AE; LITTELL RC, 1996, SAS SYST MIXED MODEL; Murphy Patricia A, 2002, Eff Clin Pract, V5, pE4; *NAT COMM QUAL ASS, 1999, HEDIS 2000 HLTH PLAN; National Committee for Quality Assurance, STAT HLTH CAR QUAL; O'Malley Ann S, 2004, Jt Comm J Qual Saf, V30, P163; *OFF QUAL PERF, DIAB MELL DM CLIN PR; *OFF QUAL PERF, CLIN PRACT GUID; Petersen LA, 2000, NEW ENGL J MED, V343, P1934, DOI 10.1056/NEJM200012283432606; Petersen LA, 2001, CIRCULATION, V104, P2898, DOI 10.1161/hc4901.100524; *QUAL ENH RES IN, VA OFF QUAL PEF NAT; Rosenthal GE, 2003, MED CARE, V41, P522, DOI 10.1097/00005650-200304000-00008; RUNDLE R, 2001, WALL STREET J, P1; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Snijders T.A., 1999, INTRO BASIC ADV MULT; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stineman MG, 2001, MED CARE, V39, P123, DOI 10.1097/00005650-200102000-00003; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vijan S, 1997, J GEN INTERN MED, V12, P567, DOI 10.1046/j.1525-1497.1997.07111.x; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554; VETERANS ADM DIABETE	41	234	235	2	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2004	141	4					272	281		10.7326/0003-4819-141-4-200408170-00007	http://dx.doi.org/10.7326/0003-4819-141-4-200408170-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846BX	15313743	Green Submitted			2022-12-28	WOS:000223290900004
J	Forrest, D; Barrett, J				Forrest, D; Barrett, J			Commentary: ethical pitfalls can be hard to avoid	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Amnesty Int UK, Hlth Profess Network, London EC1R 4RE, England		Forrest, D (corresponding author), Amnesty Int UK, Hlth Profess Network, London EC1R 4RE, England.	steve.ballinger@amnesty.org.uk						*AMN INT, INV MED PERS AB DET; *AMN INT, 1990, MED RISK DOCT HUM RI; *AMN INT, 1989, MED TORT MED RES; *BRIT MED ASS, 2001, MED PROF HUM RIGHTS; British Medical Association, 2004, MED ETH TOD; CAMPBELL D, 2003, GUARDIAN        0125; Harding-Pink D, 2004, BRIT MED J, V329, P398, DOI 10.1136/bmj.329.7462.398; LIFTON RJ, 1987, NAZI DOCTORS; *PHR, 2002, DUAL LOYALT HUM RIGH; ZIV H, 1999, PHYS TORTURE CASE IS	10	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2004	329	7462					399	400		10.1136/bmj.329.7462.399	http://dx.doi.org/10.1136/bmj.329.7462.399			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YI	15310612	Green Published			2022-12-28	WOS:000223433600027
J	Hasegawa, H; Fujimoto, M; Phan, TD; Reme, H; Balogh, A; Dunlop, MW; Hashimoto, C; TanDokoro, R				Hasegawa, H; Fujimoto, M; Phan, TD; Reme, H; Balogh, A; Dunlop, MW; Hashimoto, C; TanDokoro, R			Transport of solar wind into Earth's magnetosphere through rolled-up Kelvin-Helmholtz vortices	NATURE			English	Article							LATITUDE BOUNDARY-LAYER; INSTABILITY; MAGNETOPAUSE; RECONNECTION	Establishing the mechanisms by which the solar wind enters Earth's magnetosphere is one of the biggest goals of magnetospheric physics, as it forms the basis of space weather phenomena such as magnetic storms and aurorae(1). It is generally believed that magnetic reconnection is the dominant process, especially during southward solar-wind magnetic field conditions when the solar-wind and geomagnetic fields are antiparallel at the low-latitude magnetopause(2). But the plasma content in the outer magnetosphere increases during northward solar-wind magnetic field conditions(3,4), contrary to expectation if reconnection is dominant. Here we show that during northward solar-wind magnetic field conditions - in the absence of active reconnection at low latitudes - there is a solar-wind transport mechanism associated with the nonlinear phase of the Kelvin - Helmholtz instability(5). This can supply plasma sources for various space weather phenomena.	Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Ctr Etud Spatiale Rayonnements, F-31029 Toulouse, France; Univ London Imperial Coll Sci Technol & Med, Space & Atmospher Phys Grp, London SW7 2BZ, England; Rutherford Appleton Lab, Div Space Sci, Didcot OX11 0QX, Oxon, England	Dartmouth College; Tokyo Institute of Technology; University of California System; University of California Berkeley; Imperial College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Hasegawa, H (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.	hiroshi.hasegawa@dartmouth.edu	dunlop, malcolm w/F-1347-2010; Hasegawa, Hiroshi/A-1192-2007	dunlop, malcolm w/0000-0002-8195-5137; Hasegawa, Hiroshi/0000-0002-1172-021X				AKASOFU SI, 1981, SPACE SCI REV, V28, P121, DOI 10.1007/BF00218810; Chandrasekhar S, 2013, HYDRODYNAMIC HYDROMA; Cowley S. W. H., 1984, GEOPHYS MONOGR SER, V30, P375, DOI DOI 10.1029/GM030P0375; DUNGEY JW, 1955, P IONOSPHERE C, V225; Fairfield DH, 2000, J GEOPHYS RES-SPACE, V105, P21159, DOI 10.1029/1999JA000316; FUJIMOTO M, 1994, J GEOPHYS RES-SPACE, V99, P8601, DOI 10.1029/93JA02722; Fujimoto M, 2003, GEOPH MONOG SERIES, V133, P241; Fuselier S. A., 1995, GEOPHYS MONOGR SER, P181, DOI [10.1029/GM090p0181, DOI 10.1029/GM090P0181]; *GODD SPAC FLIGHT, 1999, NASATM2000209883 GOD; Hasegawa H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019120; HONES EW, 1981, J GEOPHYS RES-SPACE, V86, P814, DOI 10.1029/JA086iA02p00814; Huba JD, 1996, GEOPHYS RES LETT, V23, P2907, DOI 10.1029/96GL02767; Kessel RL, 1996, GEOPHYS RES LETT, V23, P583, DOI 10.1029/95GL03083; KIVELSON GK, 1995, GEOPHYS MONOGR SER, V90, P257; LEMAIRE J, 1977, PLANET SPACE SCI, V25, P887, DOI 10.1016/0032-0633(77)90042-3; Matsumoto Y, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018195; MITCHELL DG, 1987, J GEOPHYS RES, V92, P7394, DOI 10.1029/JA092iA07p07394; MIURA A, 1982, J GEOPHYS RES-SPACE, V87, P7431, DOI 10.1029/JA087iA09p07431; MIURA A, 1984, J GEOPHYS RES-SPACE, V89, P801, DOI 10.1029/JA089iA02p00801; MIURA A, 1995, GEOPHYS RES LETT, V22, P2993, DOI 10.1029/95GL02793; Nakamura TKM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.145001; Nykyri K, 2001, GEOPHYS RES LETT, V28, P3565, DOI 10.1029/2001GL013239; OGILVIE KW, 1989, J GEOPHYS RES, V94, P15113, DOI 10.1029/JA094iA11p15113; PASCHMANN G, 1979, NATURE, V282, P243, DOI 10.1038/282243a0; Phan TD, 2000, NATURE, V404, P848, DOI 10.1038/35009050; SCKOPKE N, 1981, J GEOPHYS RES-SPACE, V86, P2099, DOI 10.1029/JA086iA04p02099; Sibeck DG, 1999, SPACE SCI REV, V88, P207, DOI 10.1023/A:1005255801425; SONG P, 1992, J GEOPHYS RES-SPACE, V97, P1411, DOI 10.1029/91JA02377; THOMAS VA, 1993, J GEOPHYS RES-SPACE, V98, P11425, DOI 10.1029/93JA00604	29	499	517	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					755	758		10.1038/nature02799	http://dx.doi.org/10.1038/nature02799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306802				2022-12-28	WOS:000223233600034
J	Koshiba, T; Detmer, SA; Kaiser, JT; Chen, HC; McCaffery, JM; Chan, DC				Koshiba, T; Detmer, SA; Kaiser, JT; Chen, HC; McCaffery, JM; Chan, DC			Structural basis of mitochondrial tethering by mitofusin complexes	SCIENCE			English	Article							MEMBRANE-FUSION; MAMMALIAN-CELLS; MORPHOLOGY; DYNAMICS; MECHANISMS; DIVISION; DESIGN	Vesicle fusion involves vesicle tethering, docking, and membrane merger. We show that mitofusin, an integral mitochondrial membrane protein, is required on adjacent mitochondria to mediate fusion, which indicates that mitofusin complexes act in trans ( that is, between adjacent mitochondria). A heptad repeat region (HR2) mediates mitofusin oligomerization by assembling a dimeric, antiparallel coiled coil. The transmembrane segments are located at opposite ends of the 95 angstrom coiled coil and provide a mechanism for organelle tethering. Consistent with this proposal, truncated mitofusin, in an HR2-dependent manner, causes mitochondria to become apposed with a uniform gap. Our results suggest that HR2 functions as a mitochondrial tether before fusion.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Chem, Pasadena, CA 91125 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Chan, DC (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd,MC114-96, Pasadena, CA 91125 USA.	dchan@caltech.edu	Koshiba, Takumi/A-3996-2013	Koshiba, Takumi/0000-0001-8535-5043	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062967] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR019409-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM62967] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chen HC, 2004, CURR TOP DEV BIOL, V59, P119, DOI 10.1016/S0070-2153(04)59005-1; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Gurnon DG, 2003, J AM CHEM SOC, V125, P7518, DOI 10.1021/ja0357590; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; MEEUSEN S, UNPUB; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Mozdy AD, 2003, NAT REV MOL CELL BIO, V4, P468, DOI 10.1038/nrm1125; Oakley MG, 2001, CURR OPIN STRUC BIOL, V11, P450, DOI 10.1016/S0959-440X(00)00232-3; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Whyte JRC, 2002, J CELL SCI, V115, P2627; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	22	634	665	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					858	862		10.1126/science.1099793	http://dx.doi.org/10.1126/science.1099793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297672				2022-12-28	WOS:000223104900047
J	Sazonov, SY; Lutovinov, AA; Sunyaev, RA				Sazonov, SY; Lutovinov, AA; Sunyaev, RA			An apparently normal gamma-ray burst with an unusually low luminosity	NATURE			English	Article							25 APRIL 1998; UNUSUAL SUPERNOVA; JET MODEL; GRB-031203; REDSHIFTS; SPECTRA	Much of the progress in understanding gamma-ray bursts (GRBs) has come from studies of distant events (redshift z approximate to 1). In the brightest GRBs, the gamma-rays are so highly collimated that the events can be seen across the Universe. It has long been suspected that the nearest and most common events have been missed because they are not as collimated or they are under-energetic ( or both)(1). Here we report soft gamma-ray observations of GRB 031203, the nearest event to date (z = 0.106; ref. 2). It had a duration of 40 s and peak energy of > 190 keV, and therefore appears to be a typical long-duration GRB. The isotropic gamma-ray energy of less than or equal to 10(50) erg, however, is about three orders of magnitude smaller than that of the cosmological population. This event - as well as the other nearby but somewhat controversial GRB 980425 - is a clear outlier from the isotropic-energy/peak-energy relation(3,4) and luminosity/spectral-lag relations(5,6) that describe the majority of GRBs. Radio calorimetry shows that both of these events are under-energetic explosions(7). We conclude that there does indeed exist a large population of under-energetic events.	Russian Acad Sci, Space Res Inst, Moscow 117997, Russia; Max Planck Inst Astrophys, D-85740 Garching, Germany	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Max Planck Society	Sazonov, SY (corresponding author), Russian Acad Sci, Space Res Inst, Profsoyuznaya 84-32, Moscow 117997, Russia.	sazonov@mpa-garching.mpg.de	Sazonov, Sergey/J-6881-2016					Amati L, 2002, ASTRON ASTROPHYS, V390, P81, DOI 10.1051/0004-6361:20020722; BAND D, 1993, ASTROPHYS J, V413, P281, DOI 10.1086/172995; Barraud C, 2003, ASTRON ASTROPHYS, V400, P1021, DOI 10.1051/0004-6361:20030074; Bloom JS, 1998, ASTROPHYS J, V506, pL105, DOI 10.1086/311655; FENIMORE EE, 1993, NATURE, V366, P40, DOI 10.1038/366040a0; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Gotz D, 2003, 2459 GCN, V2459; Heise J, 2001, ESO ASTROPHY SYMP, P16, DOI 10.1007/10853853_4; Kulkarni SR, 1998, NATURE, V395, P663, DOI 10.1038/27139; KUZNETSOV AV, 1986, SOV ASTRON LETT+, V12, P315; Lamb DQ, 2004, NEW ASTRON REV, V48, P459, DOI 10.1016/j.newar.2003.12.030; Lutovinov AA, 2003, ASTRON LETT+, V29, P713, DOI 10.1134/1.1624456; MacFadyen AI, 2001, ASTROPHYS J, V550, P410, DOI 10.1086/319698; MAZETS EP, 1981, ASTROPHYS SPACE SCI, V75, P47, DOI 10.1007/BF00651384; MAZETS EP, 1982, ASTROPHYS SPACE SCI, V82, P261, DOI 10.1007/BF00651438; Norris JP, 2000, ASTROPHYS J, V534, P248, DOI 10.1086/308725; Paciesas WS, 1999, ASTROPHYS J SUPPL S, V122, P465, DOI 10.1086/313224; PROCHASKA JX, IN PRESS ASTROPHYS J; REVNIVTSEV MG, 2004, ASTRON LETT+, V30, P430; Schaefer BE, 2003, ASTROPHYS J, V583, pL67, DOI 10.1086/368104; Schaefer BE, 2001, ASTROPHYS J, V563, pL123, DOI 10.1086/338651; Soderberg AM, 2004, ASTROPHYS J, V607, pL13, DOI 10.1086/421722; Vaughan S, 2004, ASTROPHYS J, V603, pL5, DOI 10.1086/382785; Watson D, 2004, ASTROPHYS J, V605, pL101, DOI 10.1086/420844; Yamazaki R, 2003, ASTROPHYS J, V594, pL79, DOI 10.1086/378736; [No title captured]	26	126	128	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					646	648		10.1038/nature02748	http://dx.doi.org/10.1038/nature02748			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295591				2022-12-28	WOS:000223085400036
J	Neilson, EG; Johnson, KB; Rosenbloom, ST; Dupont, WD; Talbert, D; Giuse, DA; Kaiser, A; Miller, RA				Neilson, EG; Johnson, KB; Rosenbloom, ST; Dupont, WD; Talbert, D; Giuse, DA; Kaiser, A; Miller, RA		Resource Utilization Comm	The impact of peer management on test-ordering behavior	ANNALS OF INTERNAL MEDICINE			English	Article							INTENSIVE-CARE-UNIT; LABORATORY TESTS; DIAGNOSTIC-TESTS; CHEST RADIOGRAPHS; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; HEALTH-CARE; PHYSICIANS; COSTS; INTERVENTION	Background: Laboratory testing of hospitalized patients, although essential, can be expensive and sometimes excessive. Attempts to reduce unnecessary testing have often been difficult to implement or sustain. Objective: use of peer management through a resource utilization committee (RUC) to favorably modify test-ordering behavior in a large academic medical center. Design: Interrupted time-series study. Setting: medical center with inpatient care provider order entry (CPOE) system and database of ordered tests. Participants: Predominantly housestaff physicians but all clinical staff (attending physicians, housestaff, medical students, nurses, advance practice nurses, and other clinical staff) at Vanderbilt University Hospital who used CPOE systems. Intervention: The RUC analyzed the ordering habits of providers during previous years and made 2 interventions by modifying software for the CPOE system. The committee first initiated a daily prompt in the system that asked providers whether they wanted to discontinue tests scheduled beyond 72 hours. After evaluating this first intervention, the committee further constrained testing options by unbundling serum metabolic panel tests (sodium, potassium, chloride, bicarbonate, glucose, blood urea nitrogen, and creatinine tests) into single components and by reducing the ease of repeating targeted tests (including electrolyte, blood urea nitrogen, creatinine, and glucose tests; electrocardiography; and portable chest radiography). Measurements: Pre- and postintervention volumes of tests; proportion of patients with abnormal targeted chemistry levels after 48 hours; rates of repeated admission, transfer to intensive care units, and mortality; adjusted coefficient of variation for test ordering; and length of stay. Results: Voluntary reduction of testing beyond 72 hours (first intervention) decreased orders for metabolic panel component tests by 24% (P = 0.02) and electrocardiograms by 57% (P = 0.006) but not orders for portable chest radiographs. Prospective constraints on recurrent test ordering with panel unbundling (second intervention) produced an additional decrease of 51% for metabolic panel component tests (P < 0.001) and 16% for portable chest radiographs (P = 0.03). Incidence of patients with abnormal targeted blood chemistry levels after 48 hours decreased after the intervention (P = 0.02). Postintervention-adjusted coefficients of variation decreased for metabolic panel component tests (P = 0.03) and electrocardiography (P = 0.04). Rates of (adjusted) monthly readmission, transfers to intensive care units, hospital length of stay, and mortality were unchanged. Limitations: other activities occurring during the time period of the interventions might have influenced some test-ordering behaviors, and we assessed effects on only a limited number of commonly ordered tests. Conclusions: Peer management reduced provider variability by addressing the imperfect ability of clinicians to rescind testing in a timely manner. Hospitals with growing health care costs can improve their resource utilization through peer management of testing behaviors by using CPOE systems.	Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA	Vanderbilt University	Neilson, EG (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, D-3100 Med Ctr N,21st Ave S & Garland Ave, Nashville, TN 37232 USA.	eric.neilson@vanderbilt.edu	Dupont, William D./I-4430-2012		NCI NIH HHS [CA-50468, P30 CA-68485] Funding Source: Medline; NLM NIH HHS [LM-06226] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA050468] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006226] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		ALEMAYEHU E, 1991, CAN MED ASSOC J, V144, P1133; [Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Ash JS, 2004, J AM MED INFORM ASSN, V11, P95, DOI 10.1197/jamia.M1427; Auerbach AD, 2002, ANN INTERN MED, V137, P859, DOI 10.7326/0003-4819-137-11-200212030-00006; AXTADAM P, 1993, MED CARE, V31, P784, DOI 10.1097/00005650-199309000-00003; Bates D W, 1994, Qual Manag Health Care, V2, P18; Bates DW, 1999, INT J MED INFORM, V53, P115, DOI 10.1016/S1386-5056(98)00152-X; Bates DW, 1999, AM J MED, V106, P144, DOI 10.1016/S0002-9343(98)00410-0; BECKER BL, 1984, MLO MED LAB OBS, V16, P32; BENSON ES, 1978, POSTGRAD MED, V63, P20, DOI 10.1080/00325481.1978.11714798; BOICE JL, 1983, J MED EDUC, V58, P61; BOX GE, 1994, TIME SERIES ANAL FOR, V16, P598; Brainsky A, 1997, CRIT CARE MED, V25, P801, DOI 10.1097/00003246-199705000-00015; BROWN JHU, 1979, TEX MED, V75, P59; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cardiff K, 1995, Healthc Manage Forum, V8, P38; Chueh H, 1997, ACAD MED, V72, P512, DOI 10.1097/00001888-199706000-00016; COULSON LR, 1985, P ANN C RES MED ED, V24, P163; DeKay ML, 1998, MED DECIS MAKING, V18, P19, DOI 10.1177/0272989X9801800105; DIGGLE PJ, 1994, OXFORD STAT SCI SERI, V13; DIXON RH, 1974, ARCH INTERN MED, V134, P1064, DOI 10.1001/archinte.134.6.1064; EISENBERG JM, 1977, MED CARE, V15, P915, DOI 10.1097/00005650-197711000-00005; Emerson JF, 2001, AM J CLIN PATHOL, V116, P879; Epstein A M, 1985, Med Decis Making, V5, P401, DOI 10.1177/0272989X8500500402; EPSTEIN AM, 1984, JAMA-J AM MED ASSOC, V252, P1723, DOI 10.1001/jama.252.13.1723; EPSTEIN AM, 1986, AM J MED, V80, P865, DOI 10.1016/0002-9343(86)90630-3; GOLDEN WE, 1980, JAMA-J AM MED ASSOC, V243, P1932; GREENBAUM DM, 1982, CRIT CARE MED, V10, P29, DOI 10.1097/00003246-198201000-00007; Greene J, 2000, HOSP HEALTH NETWORK, V74, P14; Grzybicki DM, 2002, ARCH PATHOL LAB MED, V126, P19; HALL JB, 1991, CRIT CARE MED, V19, P689, DOI 10.1097/00003246-199105000-00015; HILLMAN AL, 1989, NEW ENGL J MED, V321, P86, DOI 10.1056/NEJM198907133210205; Huber P.J., 1967, P 5 BERKELEY S MATH, V1, P221; Huff E D, 1996, Clin Perform Qual Health Care, V4, P44; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; Lied T R, 1999, Am J Med Qual, V14, P255, DOI 10.1177/106286069901400605; Lundberg GD, 1998, JAMA-J AM MED ASSOC, V280, P2036, DOI 10.1001/jama.280.23.2036; Mantyselka P, 2001, PHARM WORLD SCI, V23, P232, DOI 10.1023/A:1014550614037; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; Milstein A, 2000, Eff Clin Pract, V3, P313; Peterson S, 1997, SCAND J PRIM HEALTH, V15, P68, DOI 10.3109/02813439709018490; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Roos N P, 1988, Health Care Financ Rev, V9, P53; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, V13, P737; Sanders DL, 2001, J AM MED INFORM ASSN, P583; SCHROEDER SA, 1981, ANN INTERN MED, V94, P534, DOI 10.7326/0003-4819-94-4-534; SCHROEDER SA, 1973, JAMA-J AM MED ASSOC, V225, P969, DOI 10.1001/jama.225.8.969; Solomon DH, 1998, JAMA-J AM MED ASSOC, V280, P2020, DOI 10.1001/jama.280.23.2020; Sonnenberg A, 2001, AM J GASTROENTEROL, V96, P3247; Stafford RS, 2001, ARCH INTERN MED, V161, P2351, DOI 10.1001/archinte.161.19.2351; TIERNEY WM, 1987, ANN INTERN MED, V107, P569, DOI 10.7326/0003-4819-107-4-569; TIERNEY WM, 1988, JAMA-J AM MED ASSOC, V259, P1194, DOI 10.1001/jama.259.8.1194; TIERNEY WM, 1990, NEW ENGL J MED, V322, P1499, DOI 10.1056/NEJM199005243222105; TIERNEY WM, 1993, JAMA-J AM MED ASSOC, V269, P379, DOI 10.1001/jama.269.3.379; Valenstein P, 1996, CLIN LAB MED, V16, P749; van Walraven C, 1998, JAMA-J AM MED ASSOC, V280, P2028, DOI 10.1001/jama.280.23.2028; Wang TJ, 2002, ARCH INTERN MED, V162, P1885, DOI 10.1001/archinte.162.16.1885; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; WERNER M, 1981, HUM PATHOL, V12, P111, DOI 10.1016/S0046-8177(81)80098-6; West AF, 2002, POSTGRAD MED J, V78, P319, DOI 10.1136/pmj.78.920.319; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; WILLIAMS SV, 1986, J GEN INTERN MED, V1, P8, DOI 10.1007/BF02596318; Wilson ML, 2002, CLIN LAB MED, V22, P491, DOI 10.1016/S0272-2712(01)00004-X; YAGER J, 1986, GEN HOSP PSYCHIAT, V8, P152, DOI 10.1016/0163-8343(86)90073-3	65	108	108	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2004	141	3					196	204		10.7326/0003-4819-141-3-200408030-00008	http://dx.doi.org/10.7326/0003-4819-141-3-200408030-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HG	15289216				2022-12-28	WOS:000223068600004
J	Squire, SB; Tang, SL				Squire, SB; Tang, SL			How much of China's success in tuberculosis control is really due to DOTS?	LANCET			English	Editorial Material									Univ Liverpool, Liverpool Sch Trop Med, EQUI TB Knowledge Programme, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Squire, SB (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, EQUI TB Knowledge Programme, Liverpool L3 5QA, Merseyside, England.	sbsquire@liv.ac.uk	Tang, Shenglan/AAO-7403-2020	Squire, Stephen/0000-0001-7173-9038				Chen XY, 2002, B WORLD HEALTH ORGAN, V80, P430; TANG S, IN PRESS HLTH POLICY; TANG S, 2002, INT J TB LUNG DIS S1, V6, pS149; World Health Organization, 2002, WHO TRADITIONAL MED, P1; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1	5	11	11	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					391	392		10.1016/S0140-6736(04)16777-9	http://dx.doi.org/10.1016/S0140-6736(04)16777-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288717				2022-12-28	WOS:000222998600003
J	Green, DR; Kroemer, G				Green, DR; Kroemer, G			The pathophysiology of mitochondrial cell death	SCIENCE			English	Review							CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION-PORE; MEMBRANE PERMEABILIZATION; ENDOPLASMIC-RETICULUM; APOPTOSIS; BAX; INHIBITION; ACTIVATION; COMPLEX; P53	In the mitochondrial pathway of apoptosis, caspase activation is closely linked to mitochondrial outer membrane permeabilization ( MOMP). Numerous pro-apoptotic signal-transducing molecules and pathological stimuli converge on mitochondria to induce MOMP. The local regulation and execution of MOMP involve proteins from the Bcl-2 family, mitochondrial lipids, proteins that regulate bioenergetic metabolite flux, and putative components of the permeability transition pore. MOMP is lethal because it results in the release of caspase-activating molecules and caspase-independent death effectors, metabolic failure in the mitochondria, or both. Drugs designed to suppress excessive MOMP may avoid pathological cell death, and the therapeutic induction of MOMP may restore apoptosis in cancer cells in which it is disabled. The general rules governing the pathophysiology of MOMP and controversial issues regarding its regulation are discussed.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Inst Gustave Roussy, CNRS, Unite Mixte Rech 8125, F-94805 Villejuif, France	La Jolla Institute for Immunology; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy	Green, DR (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	doug@liai.org; kroemer@igr.fr	KROEMER, Guido/B-4263-2013; Green, Douglas R/N-8083-2018; Kroemer, Guido/AAY-9859-2020	KROEMER, Guido/0000-0002-9334-4405; Green, Douglas R/0000-0002-7332-1417; 				Badley AD, 2003, TRENDS PHARMACOL SCI, V24, P298, DOI 10.1016/S0165-6147(03)00125-1; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Chang LK, 2003, J CELL BIOL, V162, P245, DOI 10.1083/jcb.200302109; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Haouzi D, 2002, APOPTOSIS, V7, P395, DOI 10.1023/A:1020026923038; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; Mattiasson G, 2003, J NEUROCHEM, V87, P532, DOI 10.1046/j.1471-4159.2003.02026.x; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Polster BM, 2003, J NEUROSCI, V23, P2735; Poncet D, 2003, APOPTOSIS, V8, P521, DOI 10.1023/A:1025546525894; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Rajesh KG, 2003, TRANSPLANTATION, V76, P1314, DOI 10.1097/01.TP.0000085660.93090.79; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Thomenius MJ, 2003, J CELL SCI, V116, P4493, DOI 10.1242/jcs.00829; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108	39	2638	2804	13	398	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					626	629		10.1126/science.1099320	http://dx.doi.org/10.1126/science.1099320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286356				2022-12-28	WOS:000222992100029
J	Bachrach, S				Bachrach, S			Eugenics - In the name of public health - Nazi racial hygiene	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US Holocaust Mem Museum, Washington, DC 20024 USA		Bachrach, S (corresponding author), US Holocaust Mem Museum, Washington, DC 20024 USA.							Bock Gisela, 2004, DEADLY MED CREATING, P61; Burleigh Michael, 1994, EUTHANASIA GERMANY 1; Friedlander Henry, 1995, ORIGINS NAZI GENOCID; Kevles Daniel J., 1985, NAME EUGENICS GENETI; Proctor Robert N., 1988, RACIAL HYGIENE MED N; WEINDLING P, 1989, GERMAN POLITICS NATL, P1	6	35	37	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					417	420		10.1056/NEJMp048136	http://dx.doi.org/10.1056/NEJMp048136			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	841OJ	15282346				2022-12-28	WOS:000222939700002
J	Diener, HC; Bogousslavsky, J; Brass, LM; Cimminiello, C; Csiba, L; Kaste, M; Leys, D; Matias-Guiv, J; Rupprecht, HJ				Diener, HC; Bogousslavsky, J; Brass, LM; Cimminiello, C; Csiba, L; Kaste, M; Leys, D; Matias-Guiv, J; Rupprecht, HJ		MATCH investigators	Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial	LANCET			English	Article							LOW-DOSE ASPIRIN; ANTIPLATELET THERAPY; PREVENTION; EVENTS; MANAGEMENT; BENEFIT	Background Clopidogrel was superior to aspirin in patients with previous manifestations of atherothrombotic disease in the CAPRIE study and its benefit was amplified in some high-risk subgroups of patients. We aimed to assess whether addition of aspirin to clopidogrel could have a greater benefit than clopidogrel alone in prevention of vascular events with potentially higher bleeding risk. Methods We did a randomised, double-blind, placebo-controlled trial to compare aspirin (75 mg/day) with placebo in 7599 high-risk patients with recent ischaemic stroke or transient ischaemic attack and at least one additional vascular risk factor who were already receiving clopidogrel 75 mg/day. Duration of treatment and follow-up was 18 months. The primary endpoint was a composite of ischaemic stroke, myocardial infarction, vascular death, or rehospitalisation for acute ischaemia (including rehospitalisation for transient ischaemic attack, angina pectoris, or worsening of peripheral arterial disease). Analysis was by intention to treat, using logrank test and a Cox's proportional-hazards model. Findings 596 (15.7%) patients reached the primary endpoint in the group receiving aspirin and clopidogrel compared with 636 (16.7%) in the clopidogrel alone group (relative risk reduction 6.4%, [95% CI-4.6 to 16.3]; absolute risk reduction 1% [0.6 to 2.7]). Life-threatening bleedings were higher in the group receiving aspirin and clopidogrel versus clopidogrel alone (96 [2.6%] vs 49 [1.3%]; absolute risk increase 1.3% [95% CI 0.6 to 1.9]). Major bleedings were also increased in the group receiving aspirin and clopidogrel but no difference was recorded in mortality. Interpretation Adding aspirin to clopidogrel in high-risk patients with recent ischaemic stroke or transient ischaemic attack is associated with a non-significant difference in reducing major vascular events. However, the risk of life-threatening or major bleeding is increased by the addition of aspirin.	Univ Essen Gesamthsch, Dept Neurol, D-45122 Essen, Germany; CHU Vaudois, Dept Neurol, CH-1011 Lausanne, Switzerland; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; Osped Vimercate, Div Med 2, Milan, Italy; Univ Debrecen, Dept Neurol, Debrecen, Hungary; Univ Helsinki, Dept Neurol, FIN-00014 Helsinki, Finland; Univ Lille, Stroke Dept, Lille, France; Hosp Gen Univ Alicante, Serv Neurol, Alicante, Spain; Johannes Gutenberg Univ Mainz, Dept Med 2, D-6500 Mainz, Germany	University of Duisburg Essen; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Yale University; Ospedale di Vimercate; University of Debrecen; University of Helsinki; Universite de Lille - ISITE; Universite de Lille; General University Hospital of Alicante; Johannes Gutenberg University of Mainz	Diener, HC (corresponding author), Univ Essen Gesamthsch, Dept Neurol, Hufelandstr 55, D-45122 Essen, Germany.	h.diener@uni-essen.de	Diener, Hans-Christoph/AAF-7275-2019; LEYS, Didier/G-2955-2016	LEYS, Didier/0000-0003-4408-4392; Kaste, Markku/0000-0001-6557-6412				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Algra A, 1999, J NEUROL NEUROSUR PS, V66, P255, DOI 10.1136/jnnp.66.2.255; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bhatt DL, 2000, J AM COLL CARDIOL, V35, p326A; Bhatt DL, 2002, AM J CARDIOL, V90, P625, DOI 10.1016/S0002-9149(02)02567-5; Bhatt DL, 2001, CIRCULATION, V103, P363; Diener HC, 2004, CEREBROVASC DIS, V17, P253, DOI 10.1159/000076962; Fork FT, 2000, SCAND J GASTROENTERO, V35, P464; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hankey GJ, 2004, CEREBROVASC DIS, V17, P11, DOI 10.1159/000075299; Harker LA, 1999, DRUG SAFETY, V21, P325, DOI 10.2165/00002018-199921040-00007; Ringleb PA, 2004, STROKE, V35, P528, DOI 10.1161/01.STR.0000110221.54366.49; ROBERT A, 1979, GASTROENTEROLOGY, V77, P761, DOI 10.1016/0016-5085(79)90235-x; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Sacco M, 2003, DIABETES CARE, V26, P3264, DOI 10.2337/diacare.26.12.3264; SLATTERY J, 1995, GUT, V37, P509, DOI 10.1136/gut.37.4.509; STALNIKOWICZDARVASI R, 1995, J CLIN GASTROENTEROL, V21, P13; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; TOPOL E, 2003, CIRCULATION, V108, P16; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; Yusuf S, 2001, NEW ENGL J MED, V345, P494	21	1513	1599	1	67	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					331	337		10.1016/S0140-6736(04)16721-4	http://dx.doi.org/10.1016/S0140-6736(04)16721-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276392				2022-12-28	WOS:000222853300031
J	Iitaka, T; Hirose, K; Kawamura, K; Murakami, M				Iitaka, T; Hirose, K; Kawamura, K; Murakami, M			The elasticity of the MgSiO(3) post-perovskite phase in the Earth's lowermost mantle	NATURE			English	Article							SEISMIC ANISOTROPY; CRYSTAL-STRUCTURE; HIGH-PRESSURE; PSEUDOPOTENTIALS; PHYSICS; BASE	MgSiO(3) perovskite has been assumed to be the dominant component of the Earth's lower mantle, although this phase alone cannot explain the discontinuity in seismic velocities observed 200-300 km above the core-mantle boundary (the D" discontinuity) or the polarization anisotropy observed in the lowermost mantle(1). Experimental and theoretical studies that have attempted to attribute these phenomena to a phase transition in the perovskite phase have tended to simply confirm the stability of the perovskite phase(2-6). However, recent in situ X-ray diffraction measurements have revealed(7) a transition to a 'post-perovskite' phase above 125 GPa and 2,500 K-conditions close to those at the D" discontinuity. Here we show the results of first-principles calculations of the structure, stability and elasticity of both phases at zero temperature. We find that the post-perovskite phase becomes the stable phase above 98 GPa, and may be responsible for the observed seismic discontinuity and anisotropy in the lowermost mantle. Although our ground-state calculations of the unit cell do not include the effects of temperature and minor elements, they do provide a consistent explanation for a number of properties of the D" layer.	RIKEN, Inst Phys & Chem Res, Computat Astrophys Lab, Wako, Saitama 3510198, Japan; Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan	RIKEN; Tokyo Institute of Technology	Iitaka, T (corresponding author), RIKEN, Inst Phys & Chem Res, Computat Astrophys Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tiitaka@riken.jp	Iitaka, Toshiaki/GRJ-6733-2022; Murakami, Motohiko/G-2806-2010; Hirose, Kei/C-2165-2009; Iitaka, Toshiaki/R-7804-2019	Iitaka, Toshiaki/0000-0002-7191-7516; Hirose, Kei/0000-0003-4366-7721; Iitaka, Toshiaki/0000-0002-7191-7516; Murakami, Motohiko/0000-0002-2165-2994				Andrault D, 2001, J GEOPHYS RES-SOL EA, V106, P2079, DOI 10.1029/2000JB900362; Brodholt JP, 2002, PHILOS T R SOC A, V360, P2507, DOI 10.1098/rsta.2002.1078; Civalleri B, 2002, MOL SIMULAT, V28, P213, DOI 10.1080/08927020290014349; Fiquet G, 2000, GEOPHYS RES LETT, V27, P21, DOI 10.1029/1999GL008397; FRANCIS GP, 1990, J PHYS-CONDENS MAT, V2, P4395, DOI 10.1088/0953-8984/2/19/007; Iitaka T, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.012103; Ijjali I, 2004, J SOLID STATE CHEM, V177, P257, DOI 10.1016/j.jssc.2003.08.004; KARATO S, 1995, SCIENCE, V270, P458, DOI 10.1126/science.270.5235.458; Karki BB, 1997, AM MINERAL, V82, P51; Karki BB, 1997, AM MINERAL, V82, P635; Lay T, 1998, GEODYNAMICS, V28, P299; Masters G., 2000, EARTHS DEEP INTERIOR, V117, P63, DOI DOI 10.1029/GM117P0063; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; MONTAGNER JP, 1986, J GEOPHYS RES-SOLID, V91, P511, DOI 10.1029/JB091iB01p00511; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; MURAKAMI M, 2004, THESIS TOKYO I TECHN; Narducci AA, 2000, INORG CHEM, V39, P688, DOI 10.1021/ic991039b; NIELSEN OH, 1983, PHYS REV LETT, V50, P697, DOI 10.1103/PhysRevLett.50.697; NOEL H, 1976, ACTA CRYSTALLOGR B, V32, P1593, DOI 10.1107/S0567740876005931; Oganov AR, 2001, NATURE, V411, P934, DOI 10.1038/35082048; Panning M, 2004, SCIENCE, V303, P351, DOI 10.1126/science.1091524; POIRIER JP, 2000, INTRO PHYS EARTHS IN; Sidorin I, 1999, SCIENCE, V286, P1326, DOI 10.1126/science.286.5443.1326; STIXRUDE L, 1993, NATURE, V364, P613, DOI 10.1038/364613a0; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Warren MC, 1998, MINERAL MAG, V62, P585, DOI 10.1180/002646198547981; Wentzcovitch RM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.018501; Wentzcovitch RM, 1998, EARTH PLANET SC LETT, V164, P371, DOI 10.1016/S0012-821X(98)00230-1; WENTZCOVITCH RM, 1995, PHYS EARTH PLANET IN, V90, P101, DOI 10.1016/0031-9201(94)03001-Y; Wysession ME, 1998, GEODYNAMICS, V28, P273	30	200	210	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					442	445		10.1038/nature02702	http://dx.doi.org/10.1038/nature02702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269765				2022-12-28	WOS:000222801400039
J	Morris, KV; Chan, SWL; Jacobsen, SE; Looney, DJ				Morris, KV; Chan, SWL; Jacobsen, SE; Looney, DJ			Small interfering RNA-induced transcriptional gene silencing in human cells	SCIENCE			English	Article							NOVO DNA METHYLATION; ELONGATION FACTOR-1-ALPHA; NUCLEAR EXPORT; HAIRPIN RNAS; METHYLTRANSFERASES; HETEROCHROMATIN; MAINTENANCE; DROSOPHILA; MICRORNAS; MECHANISM	Small interfering RNA (siRNA) and rnicroRNA silence genes at the transcriptional, posttranscriptional, and/or translational level. Using human tissue culture cells, we show that promoter-directed siRNA inhibits transcription of an integrated, proviral, elongation factor 1 alpha (EF1A) promoter-green fluorescent protein reporter gene and of endogenous EF1A. Silencing was associated with DNA methylation of the targeted sequence, and it required either active transport of siRNA into the nucleus or permeabilization of the nuclear envelope by lentiviral transduction. These results demonstrate that siRNA-directed transcriptional silencing is conserved in mammals, providing a means to inhibit mammalian gene function.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; VA San Diego Healthcare Syst, Infect Dis, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Morris, KV (corresponding author), Beckman Res Inst, Div Mol Biol, 1450 E Duarte Rd, Duarte, CA 91010 USA.	kmorris@coh.org	morris, kevin v/B-5481-2011	Morris, Kevin/0000-0002-0157-0553	NIAID NIH HHS [AI07384, P01 AI45992, P30 AI36214] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, P01AI045992] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2004, MOL THER, V10, P181, DOI 10.1016/j.ymthe.2004.03.019; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sherman MP, 2002, MICROBES INFECT, V4, P67, DOI 10.1016/S1286-4579(01)01511-8; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Simeoni F, 2003, NUCLEIC ACIDS RES, V31, P2717, DOI 10.1093/nar/gkg385; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; UETSUKI T, 1989, J BIOL CHEM, V264, P5791; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WAKABAYASHIITO N, 1994, J BIOL CHEM, V269, P29831; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	31	746	844	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2004	305	5688					1289	1292		10.1126/science.1101372	http://dx.doi.org/10.1126/science.1101372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15297624				2022-12-28	WOS:000223624600041
J	Regev-Yochay, G; Dagan, R; Raz, M; Carmeli, Y; Shainberg, B; Derazne, E; Rahavi, G; Rubinstein, E				Regev-Yochay, G; Dagan, R; Raz, M; Carmeli, Y; Shainberg, B; Derazne, E; Rahavi, G; Rubinstein, E			Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METHICILLIN-RESISTANT; NASAL CARRIAGE; COMMUNITY; COLONIZATION; INHABITANTS; PREVALENCE; CAVITIES; VACCINE	Context Widespread pneumococcal conjugate vaccination may bring about epidemiologic changes in upper respiratory tract flora of children. Of particular significance may be an interaction between Streptococcus pneumoniae and Staphylococcus aureus, in view of the recent emergence of community-acquired methicillin-resistant S aureus. Objective To examine the prevalence and risk factors of carriage of S pneumoniae and S aureus in the prevaccination era in young children. Design, Setting, and Patients Cross-sectional surveillance study of nasopharyngeal carriage of S pneumoniae and nasal carriage of S aureus by 790 children aged 40 months or younger seen at primary care clinics in central Israel during February 2002. Main Outcome Measures Carriage rates of S pneumoniae (by serotype) and S aureus; risk factors associated with carriage of each pathogen. Results Among 790 children screened, 43% carried S pneumoniae and 10% carried S aureus. Staphylococcus aureus carriage among S pneumoniae carriers was 6.5% vs 12.9% in S pneumoniae noncarriers. Streptococcus pneumoniae carriage among S aureus carriers was 27.5% vs 44.8% in S aureus noncarriers. Only 2.8% carried both pathogens concomitantly vs 4.3% expected dual carriage (P=.03). Risk factors for S pneumoniae carriage (attending day care, having young siblings, and age older than 3 months) were negatively associated with S aureus carriage. Conclusions Streptococcus pneumoniae carriage, specifically of vaccine-type strains, is negatively associated with S aureus carriage in children. The implications of these findings in the pneumococcal vaccine era require further investigation.	Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Sch Med, Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; Soroka Univ, Med Ctr, Beer Sheva, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Regev-Yochay, G (corresponding author), Chaim Sheba Med Ctr, Infect Dis Unit, IL-52621 Ramat Gan, Israel.	gili.regev@sheba.health.gov.il		Regev-Yochay, Gili/0000-0001-7163-4607				Balmer P, 2002, J MED MICROBIOL, V51, P717, DOI 10.1099/0022-1317-51-9-717; BERGOVAC J, 1993, EUR J EPIDEMIOL, V9, P405; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Givon-Lavi N, 2003, PEDIATR INFECT DIS J, V22, P524, DOI 10.1097/00006454-200306000-00008; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Nakamura MM, 2002, PEDIATR INFECT DIS J, V21, P917, DOI 10.1097/00006454-200210000-00006; *NAT COMM CLIN LAB, 2001, PUBL NAT COMM CLIN L; Peacock SJ, 2003, J CLIN MICROBIOL, V41, P5718, DOI 10.1128/JCM.41.12.5718-5725.2003; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; POUTREL B, 1980, ANN RECH VET, V11, P327; Rao GG, 1998, DRUGS, V55, P323, DOI 10.2165/00003495-199855030-00001; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Shopsin B, 2000, J INFECT DIS, V182, P359, DOI 10.1086/315695; Uehara Y, 2001, CLIN INFECT DIS, V32, P1408, DOI 10.1086/320179; Uehara Y, 2000, J HOSP INFECT, V44, P127, DOI 10.1053/jhin.1999.0680; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Veenhoven R, 2003, LANCET, V361, P2189, DOI 10.1016/S0140-6736(03)13772-5; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102	19	215	220	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					716	720		10.1001/jama.292.6.716	http://dx.doi.org/10.1001/jama.292.6.716			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304469	Bronze			2022-12-28	WOS:000223177300026
J	Bonnet, P; Niclot, P; Chaussin, F; Placide, M; Debray, MP; Fichelle, A				Bonnet, P; Niclot, P; Chaussin, F; Placide, M; Debray, MP; Fichelle, A			A puzzling case of transient global amnesia	LANCET			English	Editorial Material									Grp Hosp Bichat, Serv Accueil Urgences, F-75877 Paris, France; Grp Hosp Bichat, Serv Neurol, F-75877 Paris, France; Grp Hosp Bichat, Serv Radiol, F-75877 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP	Bonnet, P (corresponding author), Grp Hosp Bichat, Serv Accueil Urgences, F-75877 Paris, France.	pascalebonnet@club-internet.fr						Akkawi NM, 2003, EUR NEUROL, V49, P67, DOI 10.1159/000068501; HAGAN PG, 2000, JAMA-J AM MED ASSOC, V283, P397; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Inzitari D, 1997, ARCH NEUROL-CHICAGO, V54, P866, DOI 10.1001/archneur.1997.00550190056015; Lewis SL, 1998, LANCET, V352, P397, DOI 10.1016/S0140-6736(98)01442-1	5	13	13	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 7	2004	364	9433					554	554		10.1016/S0140-6736(04)16817-7	http://dx.doi.org/10.1016/S0140-6736(04)16817-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302202				2022-12-28	WOS:000223132700038
J	Cohen, JC; Kiss, RS; Pertsemlidis, A; Marcel, YL; McPherson, R; Hobbs, HH				Cohen, JC; Kiss, RS; Pertsemlidis, A; Marcel, YL; McPherson, R; Hobbs, HH			Multiple rare Alleles contribute to low plasma levels of HDL cholesterol	SCIENCE			English	Article							ABCA1 GENE; FAMILIAL HYPOALPHALIPOPROTEINEMIA; EFFLUX; DISEASE; SUSCEPTIBILITY; DEFICIENCY; MUTATIONS; VARIANTS	Heritable variation in complex traits is generally considered to be conferred by common DNA sequence polymorphisms. We tested whether rare DNA sequence variants collectively contribute to variation in plasma levels of high-density lipoprotein cholesterol (HDL-C). We sequenced three candidate genes (ABCA1, APOA1, and LCAT) that cause Mendelian forms of low HDL-C levels in individuals from a population-based study. Nonsynonymous sequence variants were significantly more common (16% versus 2%) in individuals with low HDL-C (<fifth percentile) than in those with high HDL-C (>95th percentile). Similar findings were obtained in an independent population, and biochemical studies indicated that most sequence variants in the low HDL-C group were functionally important. Thus, rare alleles with major phenotypic effects contribute significantly to low plasma HDL-C levels in the general population.	Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Ottawa, Inst Heart, Lipoprot & Atherosclerosis Res Grp, Ottawa, ON K7Y 4W7, Canada	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Ottawa; University of Ottawa Heart Institute	Cohen, JC (corresponding author), Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; ymarcel@ottawaheart.ca	Pertsemlidis, Alexander/Q-7899-2017	Pertsemlidis, Alexander/0000-0003-1624-9372	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053917, U01HL066880] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL53917, UO1-HL66880] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASSMANN G, 1993, CIRCULATION, V87, P28; Hayden MR, 2000, CURR OPIN LIPIDOL, V11, P117, DOI 10.1097/00041433-200004000-00003; Hovingh GK, 2003, J LIPID RES, V44, P1251, DOI 10.1194/jlr.M300080-JLR200; Kuivenhoven JA, 1997, J LIPID RES, V38, P191; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mott S, 2000, ATHEROSCLEROSIS, V152, P457, DOI 10.1016/S0021-9150(99)00498-0; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tregouet DA, 2004, ARTERIOSCL THROM VAS, V24, P775, DOI 10.1161/01.ATV.0000121573.29550.1a; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; [No title captured]	15	841	866	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					869	872		10.1126/science.1099870	http://dx.doi.org/10.1126/science.1099870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297675				2022-12-28	WOS:000223104900050
J	Kosman, D; Mizutani, CM; Lemons, D; Cox, WG; McGinnis, W; Bier, E				Kosman, D; Mizutani, CM; Lemons, D; Cox, WG; McGinnis, W; Bier, E			Multiplex detection of RNA expression in Drosophila embryos	SCIENCE			English	Article							HYBRIDIZATION		Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Mol Probes Inc, Eugene, OR 97402 USA	University of California System; University of California San Diego	Bier, E (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	ebier@ucsd.edu			NINDS NIH HHS [NS29870] Funding Source: Medline; PHS HHS [28315] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029870] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Hughes SC, 1998, BIOTECHNIQUES, V24, P530, DOI 10.2144/98244bm01; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; OFARRELL PH, 1989, SCIENCE, V246, P635, DOI 10.1126/science.2683080; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Wilkie GS, 1999, CURR BIOL, V9, P1263, DOI 10.1016/S0960-9822(99)80509-0	8	277	304	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					846	846		10.1126/science.1099247	http://dx.doi.org/10.1126/science.1099247			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297669				2022-12-28	WOS:000223104900042
J	Oinuma, I; Ishikawa, Y; Katoh, H; Negishi, M				Oinuma, I; Ishikawa, Y; Katoh, H; Negishi, M			The semaphorin 4D receptor plexin-B1 is a GTPase activating protein for R-Ras	SCIENCE			English	Article							ACTIVE RAC; RHO; SIGNALS; RND1; FAMILY	Plexins are cell surface receptors for semaphorin molecules, and their interaction governs cell adhesion and migration in a variety of tissues. We report that the Semaphorin 4D (Sema4D) receptor Plexin-B1 directly stimulates the intrinsic guanosine triphosphatase ( GTPase) activity of R-Ras, a member of the Ras superfamily of small GTP-binding proteins that has been implicated in promoting cell adhesion and neurite outgrowth. This activity required the interaction of Plexin-B1 with Rnd1, a small GTP-binding protein of the Rho family. Down-regulation of R-Ras activity by the Plexin-B1-Rnd1 complex was essential for the Sema4D-induced growth cone collapse in hippocampal neurons. Thus, Plexin-B1 mediates Sema4D-induced repulsive axon guidance signaling by acting as a GTPase activating protein for R-Ras.	Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Negishi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan.	mnegishi@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117				Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Driessens MHE, 2002, FEBS LETT, V529, P168, DOI 10.1016/S0014-5793(02)03323-9; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Goshima Y, 2002, J CLIN INVEST, V109, P993, DOI 10.1172/JCI200215467; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Ivins JK, 2000, J NEUROSCI, V20, P6551, DOI 10.1523/JNEUROSCI.20-17-06551.2000; Keely PJ, 1999, J CELL BIOL, V145, P1077, DOI 10.1083/jcb.145.5.1077; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; RHOM B, 2000, FEBS LETT, V486, P68; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; Yamamoto T, 1995, J BIOL CHEM, V270, P30557, DOI 10.1074/jbc.270.51.30557; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	26	309	324	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					862	865		10.1126/science.1097545	http://dx.doi.org/10.1126/science.1097545			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297673				2022-12-28	WOS:000223104900048
J	Peeters, FJC; Acheson, R; Brummer, GJA; de Ruijter, WPM; Schneider, RR; Ganssen, GM; Ufkes, E; Kroon, D				Peeters, FJC; Acheson, R; Brummer, GJA; de Ruijter, WPM; Schneider, RR; Ganssen, GM; Ufkes, E; Kroon, D			Vigorous exchange between the Indian and Atlantic oceans at the end of the past five glacial periods	NATURE			English	Article							SEA-SURFACE TEMPERATURE; SOUTH-ATLANTIC; OVERTURNING CIRCULATION; RECORD; COMMUNICATION; FLUCTUATIONS; OCEANOGRAPHY; SECTOR; HEAT	The magnitude of heat and salt transfer between the Indian and Atlantic oceans through 'Agulhas leakage' is considered important for balancing the global thermohaline circulation(1-3). Increases or reductions of this leakage lead to strengthening or weakening of the Atlantic meridional overturning and associated variation of North Atlantic Deep Water formation(4-6). Here we show that modern Agulhas waters, which migrate into the south Atlantic Ocean in the form of an Agulhas ring, contain a characteristic assemblage of planktic foraminifera. We use this assemblage as a modern analogue to investigate the Agulhas leakage history over the past 550,000 years from a sediment record in the Cape basin. Our reconstruction indicates that Indian - Atlantic water exchange was highly variable: enhanced during present and past interglacials and largely reduced during glacial intervals. Coherent variability of Agulhas leakage with northern summer insolation suggests a teleconnection to the monsoon system. The onset of increased Agulhas leakage during late glacial conditions took place when glacial ice volume was maximal, suggesting a crucial role for Agulhas leakage in glacial terminations, timing of interhemispheric climate change(7) and the resulting resumption of the Atlantic meridional overturning circulation(6).	Free Univ Amsterdam, Fac Earth & Life Sci, Dept Paleoecol & Paleoclimatol, NL-1081 HV Amsterdam, Netherlands; Netherlands Inst Sea Res, Dept Marine Chem & Geol, NL-1790 AB Den Burg, Texel, Netherlands; Univ Edinburgh, Grant Inst Geol, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; Univ Utrecht, Inst Marine & Atmospher Res Utrecht, Fac Phys & Astron, NL-3584 CC Utrecht, Netherlands; Univ Bordeaux 1, Dept Geol & Oceanog, CNRS, UMR EPOC 5805, F-33405 Talence, France	Vrije Universiteit Amsterdam; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Edinburgh; Utrecht University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Peeters, FJC (corresponding author), Free Univ Amsterdam, Fac Earth & Life Sci, Dept Paleoecol & Paleoclimatol, Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	frank.peeters@falw.vu.nl	Brummer, Gerard J/I-1187-2014; de Ruijter, Wilhelmus/I-2541-2016	Ufkes, E./0000-0003-3257-0203; Peeters, Frank J.C./0000-0002-5678-9288				Be A. W. H, 1977, Micropaleontology, V23, P369, DOI 10.2307/1485406; Be A.W.H., 1971, MICROPALEONTOLOGY OC, P105; Chen MT, 2002, MAR GEOL, V180, P163, DOI 10.1016/S0025-3227(01)00212-2; de Ruijter WPM, 1999, J GEOPHYS RES-OCEANS, V104, P20885, DOI 10.1029/1998JC900099; de Ruijter WPM, 2004, DEEP-SEA RES PT I, V51, P383, DOI 10.1016/j.dsr.2003.10.011; Flores JA, 1999, MAR MICROPALEONTOL, V37, P1, DOI 10.1016/S0377-8398(99)00012-2; Garzoli SL, 1996, J GEOPHYS RES-OCEANS, V101, P897, DOI 10.1029/95JC03221; Gordon AL, 2003, NATURE, V421, P904, DOI 10.1038/421904a; GORDON AL, 1992, J GEOPHYS RES-OCEANS, V97, P7223, DOI 10.1029/92JC00485; Gordon AL, 1996, NATURE, V382, P399, DOI 10.1038/382399a0; Hodell DA, 2000, GLOBAL PLANET CHANGE, V24, P7, DOI 10.1016/S0921-8181(99)00069-7; Howard WR, 1992, PALEOCEANOGRAPHY, V7, P79, DOI 10.1029/91PA02994; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Kunz-Pirrung M, 2002, PALAEOGEOGR PALAEOCL, V182, P305, DOI 10.1016/S0031-0182(01)00501-6; Lutjeharms JRE, 1996, SOUTH ATLANTIC, P125; LUTJEHARMS JRE, 2000, S AFR J SCI, V96; Macdonald AM, 1996, NATURE, V382, P436, DOI 10.1038/382436a0; Niebler HS, 1998, MAR MICROPALEONTOL, V34, P213, DOI 10.1016/S0377-8398(98)00009-7; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Rau AJ, 2002, MAR GEOL, V180, P183, DOI 10.1016/S0025-3227(01)00213-4; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; Schneider RR, 1999, RECONSTRUCTING OCEAN HISTORY, P33; Schouten MW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014542; Ufkes E, 2000, MAR MICROPALEONTOL, V40, P23, DOI 10.1016/S0377-8398(00)00030-X; van Aken HM, 2003, DEEP-SEA RES PT II, V50, P167, DOI 10.1016/S0967-0645(02)00383-1; Weijer W, 2002, GLOBAL PLANET CHANGE, V34, P293, DOI 10.1016/S0921-8181(02)00121-2; Weijer W, 2001, J PHYS OCEANOGR, V31, P2385, DOI 10.1175/1520-0485(2001)031<2385:SOTAOC>2.0.CO;2; Winter A, 1990, PALEOCEANOGRAPHY, V5, P479, DOI 10.1029/PA005i004p00479; Wunsch C, 2003, QUATERNARY SCI REV, V22, P1631, DOI 10.1016/S0277-3791(03)00152-5	31	280	283	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					661	665		10.1038/nature02785	http://dx.doi.org/10.1038/nature02785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295596	Green Published			2022-12-28	WOS:000223085400041
J	Jamrozik, K				Jamrozik, K			Research ethics paperwork: what is the plot we seem to have lost?	BRITISH MEDICAL JOURNAL			English	Article							MULTICENTER; APPROVAL; SCOTLAND	Researchers in the United Kingdom now have to submit their study proposals to local research ethics committees using a nationally standardised form. The form overcomes the problem of inconsistencies in the paperwork required by different committees.(1 2) It is incredibly long, however, and threatens to overwhelm both committees and investigators with paperwork.(2-4) The administrative burden is likely to be increased by the advent of a research management and governance framework for health and social care(5) and the requirement for ethical clearance for all research by students on humans, including their tissues or data.(6) Current trends are not sustainable in terms of time, money, or their impact on the environment, and it seems we have lost the plot. In this article, I examine how we can streamline the process.	Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London W6 8RP, England	Imperial College London	Jamrozik, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London W6 8RP, England.	jamrozik@imperial.ac.uk						Ah-See KW, 1998, J ROY COLL SURG EDIN, V43, P303; Al-Shahi R, 1999, J ROY COLL PHYS LOND, V33, P549; *DEP HLTH, 2001, RES GOV FRAM HLTH SO; Dunn NR, 2000, J ROY SOC MED, V93, P511, DOI 10.1177/014107680009301004; Jamrozik K, 2000, J MED ETHICS, V26, P334, DOI 10.1136/jme.26.5.334; Maskell NA, 2003, QJM-INT J MED, V96, P305, DOI 10.1093/qjmed/hcg042; *WORK GROUP ETH RE, 2004, ETH GOV REG STUD PRO	7	60	60	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 31	2004	329	7460					286	287		10.1136/bmj.329.7460.286	http://dx.doi.org/10.1136/bmj.329.7460.286			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284159	Green Submitted, Green Published			2022-12-28	WOS:000223133300028
J	Ward, HJT; Cousens, SN; Smith-Bathgate, B; Leitch, M; Everington, D; Will, RG; Smith, PG				Ward, HJT; Cousens, SN; Smith-Bathgate, B; Leitch, M; Everington, D; Will, RG; Smith, PG			Academic medicine campaign - Obstacles to conducting epidemiological research in the UK general population	BRITISH MEDICAL JOURNAL			English	Article							RESEARCH ETHICS COMMITTEES	Experiences from a national case-control study of Creutzfeldt-Jakob disease show the tensions between protecting individual patients' confidentiality and the access required for the benefit of public health.	Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Ward, HJT (corresponding author), Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	h.ward@ed.ac.uk	smith, peter/ABH-9627-2020	smith, peter/0000-0003-0080-7560				Al-Shahi R, 2000, BMJ-BRIT MED J, V321, P1031, DOI 10.1136/bmj.321.7268.1031; Alberti KGMM, 2000, BRIT MED J, V320, P1157, DOI 10.1136/bmj.320.7243.1157; *BRIT MED ASS, 1999, CONF DISCL HLTH INF; *GEN MED COUNC, 2000, CONF; Lux AL, 2000, BRIT MED J, V320, P1182, DOI 10.1136/bmj.320.7243.1182; *MED RES COUNC, 2000, PROF INF MED RES; Strobl J, 2000, BMJ-BRIT MED J, V321, P890, DOI 10.1136/bmj.321.7265.890; Tully J, 2000, BRIT MED J, V320, P1179, DOI 10.1136/bmj.320.7243.1179; Will Robert G., 1996, P119	9	60	60	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 31	2004	329	7460					277	279		10.1136/bmj.329.7460.277	http://dx.doi.org/10.1136/bmj.329.7460.277			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284154	Green Published, Green Accepted			2022-12-28	WOS:000223133300023
J	Belmaker, RH				Belmaker, RH			Medical progress: Bipolar disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LONG-TERM TREATMENT; MANIC-DEPRESSIVE ILLNESS; PRELIMINARY DOUBLE-BLIND; MAINTENANCE TREATMENT; I DISORDER; PREFRONTAL CORTEX; POSTMORTEM-BRAIN; MOOD DISORDERS; LITHIUM; TRIAL		Ben Gurion Univ Negev, Stanley Res Ctr, Beer Sheva, Israel	Ben Gurion University	Belmaker, RH (corresponding author), Beersheba Mental Hlth Ctr, POB 4600, Beer Sheva, Israel.	belmaker@bgumail.bgu.ac.il						AGAM G, 2002, POSTMORTEM BRAIN PSY; Akiskal, 2002, BIPOLAR DISORD, V5, P1; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; AVISSAR S, 1988, NATURE, V331, P440, DOI 10.1038/331440a0; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Baldessarini RJ, 2000, BIPOLAR DISORD, V2, P3, DOI 10.1034/j.1399-5618.2000.020102.x; BEERS CW, 1953, MIND FOUND ITSELF; Begley CE, 2001, PHARMACOECONOMICS, V19, P483, DOI 10.2165/00019053-200119050-00004; Belmaker RH, 1980, MANIA EVOLVING CONCE; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BIEDERMAN J, 1979, ARCH GEN PSYCHIAT, V36, P327; Blanco C, 2002, AM J PSYCHIAT, V159, P1005, DOI 10.1176/appi.ajp.159.6.1005; Bowden CL, 2000, ARCH GEN PSYCHIAT, V57, P481, DOI 10.1001/archpsyc.57.5.481; Bowden CL, 2001, EXPERT OPIN INV DRUG, V10, P661, DOI 10.1517/13543784.10.4.661; Bowden CL, 2003, ARCH GEN PSYCHIAT, V60, P392, DOI 10.1001/archpsyc.60.4.392; BOWDEN CL, 1994, JAMA-J AM MED ASSOC, V271, P1830; BOWDEN CL, 2001, EXPERT OPIN INV DRUG, V10, pA1205; Calabrese J, 2003, EUR NEUROPSYCHOPHARM, V13, pS227, DOI 10.1016/S0924-977X(03)91835-9; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Chengappa KNR, 2000, BIPOLAR DISORD, V2, P47, DOI 10.1034/j.1399-5618.2000.020107.x; CHOUINARD G, 1987, J CLIN PSYCHIAT, V48, P29; Coryell W, 2003, ARCH GEN PSYCHIAT, V60, P914, DOI 10.1001/archpsyc.60.9.914; Dixon JF, 1998, P NATL ACAD SCI USA, V95, P8363, DOI 10.1073/pnas.95.14.8363; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; EBSTEIN R, 1976, NATURE, V259, P411, DOI 10.1038/259411a0; EMRICH HM, 1980, ARCH PSYCHIAT NERVEN, V229, P1, DOI 10.1007/BF00343800; Frank E, 2000, BIOL PSYCHIAT, V48, P593, DOI 10.1016/S0006-3223(00)00969-0; Freeman MP, 1998, AM J PSYCHIAT, V155, P12, DOI 10.1176/ajp.155.1.12; GITLIN MJ, 1993, J CLIN PSYCHOPHARM, V13, P276; Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Goodwin FK, 2002, J CLIN PSYCHIAT, V63, P5; GOODWIN RK, 1990, MANIC DEPRESSIVE ILL, P15; GOULD TD, IN PRESS MOL PSYCHIA; Guidotti A, 2002, ARCH GEN PSYCHIAT, V59, P12; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Hlastala SA, 2000, J ABNORM PSYCHOL, V109, P777, DOI 10.1037/0021-843X.109.4.777; Huxley NA, 2000, HARVARD REV PSYCHIAT, V8, P126, DOI 10.1093/hrp/8.3.126; Jamison K., 1994, TOUCHED FIRE MANIC D; JAMISON KR, 1979, ARCH GEN PSYCHIAT, V36, P866; Joffe RT, 2002, ACTA PSYCHIAT SCAND, V105, P427, DOI 10.1034/j.1600-0447.2002.02360.x; Jones I, 2002, J AFFECT DISORDERS, V71, P189, DOI 10.1016/S0165-0327(00)00384-0; JOPE RS, 2000, BIPOLAR MED MECH ACT, P179; Keck P. E. Jr., 2000, European Neuropsychopharmacology, V10, pS297; KETTER TA, 1998, MANIA CLIN RES PERSP, P263; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; KNAPP S, 1973, SCIENCE, V180, P645, DOI 10.1126/science.180.4086.645; Kusumakar V, 2002, J CLIN PSYCHIAT, V63, P23; Lenox RH, 2002, AM J MED GENET, V114, P592, DOI 10.1002/ajmg.10624; LENOX RH, 1992, J CLIN PSYCHIAT, V53, P47; Lenox RH, 2002, AM J MED GENET, V114, P391, DOI 10.1002/ajmg.10360; LESLIE RA, 2000, BIPOLAR MEDICATIONS, P249; Licht RW, 1998, ACTA PSYCHIAT SCAND, V97, P387, DOI 10.1111/j.1600-0447.1998.tb10020.x; Lindenmayer JP, 2003, AM J PSYCHIAT, V160, P290, DOI 10.1176/appi.ajp.160.2.290; LITTLEJOHN R, 1994, BRIT J PSYCHIAT, V165, P827, DOI 10.1192/bjp.165.6.827; Manji HK, 1999, BIOL PSYCHIAT, V46, P929, DOI 10.1016/S0006-3223(99)00165-1; Massot O, 1999, NEUROPSYCHOPHARMACOL, V21, P530, DOI 10.1016/S0893-133X(99)00042-1; Merikangas K, 2002, CLIN NEUROSCI RES, V2, P127, DOI 10.1016/S1566-2772(02)00038-5; Mitchell PB, 2002, ANNU REV MED, V53, P173, DOI 10.1146/annurev.med.53.082901.103933; MONTGOMERY S, 2001, EUR NEUROPSYCHOPHARM, V11, P79; Nemeroff CB, 2001, AM J PSYCHIAT, V158, P906, DOI 10.1176/appi.ajp.158.6.906; OKUMA T, 1981, PSYCHOPHARMACOLOGY, V73, P95, DOI 10.1007/BF00431111; Osher Y, 1996, J PSYCHIAT RES, V30, P353, DOI 10.1016/0022-3956(96)00023-4; Pearlson GD, 1999, SCHIZOPHR RES, V39, P133, DOI 10.1016/S0920-9964(99)00112-7; PERT A, 1978, SCIENCE, V201, P171, DOI 10.1126/science.566468; Pies R, 2002, J CLIN PSYCHOPHARM, V22, P445, DOI 10.1097/00004714-200210000-00001; Plomin R., 1997, BEHAV GENET; Post RM, 2002, J CLIN PSYCHOPHARM, V22, P1, DOI 10.1097/00004714-200202000-00001; QUIROZ J, IN PRESS MOL PSYCHIA; Rajkowska G, 2001, BIOL PSYCHIAT, V49, P741, DOI 10.1016/S0006-3223(01)01080-0; SACHS GS, 1994, J CLIN PSYCHIAT, V55, P391; Sanger TM, 2001, J CLIN PSYCHIAT, V62, P273, DOI 10.4088/JCP.v62n0410; SCHOU M, 1979, BRIT J PSYCHIAT, V135, P97, DOI 10.1192/bjp.135.2.97; Shaldubina A, 2001, PROG NEURO-PSYCHOPH, V25, P855, DOI 10.1016/S0278-5846(01)00154-3; Shamir A, 1998, MOL PSYCHIATR, V3, P481, DOI 10.1038/sj.mp.4000470; Shimon H, 1997, AM J PSYCHIAT, V154, P1148; Stoll AL, 1999, ARCH GEN PSYCHIAT, V56, P407, DOI 10.1001/archpsyc.56.5.407; Suppes T, 1999, AM J PSYCHIAT, V156, P1164; Verdoux H, 1996, J AFFECT DISORDERS, V38, P81, DOI 10.1016/0165-0327(95)00084-4; Vieta E, 2001, J CLIN PSYCHIAT, V62, P818, DOI 10.4088/JCP.v62n1011; Vieta E, 2002, J CLIN PSYCHIAT, V63, P79; WALKER RG, 1993, KIDNEY INT, V44, pS93; WEHR TA, 1987, AM J PSYCHIAT, V144, P201; WEHR TA, 1987, AM J PSYCHIAT, V144, P542; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Winsberg ME, 2000, BIOL PSYCHIAT, V47, P475, DOI 10.1016/S0006-3223(99)00183-3; Yatham LN, 2002, J CLIN PSYCHIAT, V63, P275, DOI 10.4088/JCP.v63n0402; Yoon IS, 2001, MOL PSYCHIATR, V6, P678, DOI 10.1038/sj.mp.4000901; Zubieta JK, 2001, BIOL PSYCHIAT, V49, P110, DOI 10.1016/S0006-3223(00)00981-1; [No title captured]	90	387	400	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					476	486		10.1056/NEJMra035354	http://dx.doi.org/10.1056/NEJMra035354			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282355				2022-12-28	WOS:000222939700011
J	Trotter, CL; Andrews, NJ; Kaczmarski, EB; Miller, E; Ramsay, ME				Trotter, CL; Andrews, NJ; Kaczmarski, EB; Miller, E; Ramsay, ME			Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction	LANCET			English	Article							ENGLAND	The meningococcal serogroup C conjugate (MCC) vaccine programme in England has successfully controlled the incidence of serogroup C disease, as a result of high short-term vaccine effectiveness and substantial herd immunity. However, the long-term effectiveness of the vaccine remains unknown. We assessed surveillance data from the 4 years since introduction of the programme. Vaccine effectiveness remained high in children vaccinated in the catch-up campaign (aged 5 months to 18 years). However, for children vaccinated in the routine infant immunisation programme, the effectiveness of the MCC vaccine fell to low levels after only 1 year. The number of individuals in these cohorts remains low, but alternative routine immunisation schedules should be considered to ensure high levels of protection are sustained.	Hlth Protect Agcy, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; Hlth Protect Agcy, Immunisat Dept, London NW9 5EQ, England; Hlth Protect Agcy, Stat Econ & Modelling Dept, London NW9 5EQ, England; Manchester Royal Infirm, Hlth Protect Agcy, Meningococcal Reference Unit, Manchester M13 9WL, Lancs, England	Health Protection Agency; Health Protection Agency; Health Protection Agency; Health Protection Agency; University of Manchester	Ramsay, ME (corresponding author), Hlth Protect Agcy, Ctr Communicable Dis Surveillance, 61 Colindale Ave, London NW9 5EQ, England.	mary.ramsay@hpa.org.uk	Trotter, Caroline L/H-5077-2013; Ramsay, Mary Elizabeth/S-8281-2016	Trotter, Caroline/0000-0003-4000-2708; Ramsay, Mary Elizabeth/0000-0002-7156-7640				Borrow R, 2002, J INFECT DIS, V186, P1353, DOI 10.1086/344324; *COVER PROGR CHILD, Q COMM DIS REP COVER; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Ramsay ME, 2003, J INFECT DIS, V188, P481, DOI 10.1086/376997; Ramsay ME, 2003, BRIT MED J, V326, P365, DOI 10.1136/bmj.326.7385.365; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7	6	437	457	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					365	367		10.1016/S0140-6736(04)16725-1	http://dx.doi.org/10.1016/S0140-6736(04)16725-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276396				2022-12-28	WOS:000222853300035
J	Backwell, PRY; Jennions, MD				Backwell, PRY; Jennions, MD			Coalition among male fiddler crabs	NATURE			English	Editorial Material							NEIGHBORS		Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia	Australian National University	Backwell, PRY (corresponding author), Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia.	pat.backwell@anu.edu.au	Backwell, Patricia RY/C-8883-2009; Jennions, Michael D/C-7560-2009	Jennions, Michael D/0000-0001-9221-2788				Backwell PRY, 2000, P ROY SOC B-BIOL SCI, V267, P719, DOI 10.1098/rspb.2000.1062; CRANE JA, 1976, FIDDLER CRABS WORLD; Dugatkin L.A., 1997, COOPERATION ANIMALS; Elfstrom ST, 1997, ANIM BEHAV, V54, P535, DOI 10.1006/anbe.1996.0492; GETTY T, 1987, AM ZOOL, V27, P327; Hemmi JM, 2003, NATURE, V421, P160, DOI 10.1038/nature01247; Morrell LJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P385, DOI 10.1007/s00265-003-0663-7; Stamps JA, 2001, AM NAT, V157, P154, DOI 10.1086/318634; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	9	61	62	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					417	417		10.1038/430417a	http://dx.doi.org/10.1038/430417a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269757				2022-12-28	WOS:000222801400030
J	Elvin, SJ; Williamson, ED; Scott, JC; Smith, JN; de Lema, GP; Chilla, S; Clapham, P; Pfeffer, K; Schlondorff, D; Luckow, B				Elvin, SJ; Williamson, ED; Scott, JC; Smith, JN; de Lema, GP; Chilla, S; Clapham, P; Pfeffer, K; Schlondorff, D; Luckow, B			Ambiguous role of CCR5 in Y-pestis infection	NATURE			English	Editorial Material							HIV-1 INFECTION; RESISTANCE; INDIVIDUALS; PROTECTION; MUTATION; ALLELE; PLAGUE; ORIGIN; GENE; AIDS		Def Sci & Technol Labs, Salisbury SP4 0JQ, Wilts, England; Klinikum Univ Munchen, Med Poliklin Innenstadt, D-80336 Munich, Germany; Univ Massachusetts, Worcester, MA 01605 USA; Univ Dusseldorf, D-40225 Dusseldorf, Germany	Defence Science & Technology Laboratory; University of Munich; University of Massachusetts System; University of Massachusetts Worcester; Heinrich Heine University Dusseldorf	Elvin, SJ (corresponding author), Def Sci & Technol Labs, Salisbury SP4 0JQ, Wilts, England.	dewilliamson@dstl.gov.uk	Williamson, Ethel Diane/AAQ-8878-2020	Pfeffer, Klaus/0000-0002-5652-6330; Perez de Lema, Guillermo/0000-0002-6244-1480				Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Jarrett CO, 2004, INFECT IMMUN, V72, P2052, DOI 10.1128/IAI.72.4.2052-2056.2004; Libert F, 1998, HUM MOL GENET, V7, P399, DOI 10.1093/hmg/7.3.399; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; PACKHILL J, 2001, NATURE, V413, P523; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; 2002, RECEPT CHARM, V8, P19; 2004, NATURE, V427, P606; 2003, NATURE REV MICROBIOL, V1, P55	10	53	57	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					417	417		10.1038/nature02822	http://dx.doi.org/10.1038/nature02822			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15272490	Bronze			2022-12-28	WOS:000222801400032
J	Hurford, WE; Kratz, A; Harris, NL; Medoff, BD				Hurford, WE; Kratz, A; Harris, NL; Medoff, BD			A 50-year-old woman with low oxygen saturation - Methemoglobinemia due to congenital deficiency of erythrocytic cytochrome-b(5) reductase.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PULSE OXIMETRY; PATIENT; MUTATIONS		Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Hurford, WE (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA.		Hurford, William/G-6386-2013	Hurford, William/0000-0003-1201-0313				ALEXANDER CM, 1989, ANESTH ANALG, V68, P368; Aravindhan N, 2000, ANESTHESIOLOGY, V93, P883, DOI 10.1097/00000542-200009000-00040; Baraka AS, 2001, ANESTHESIOLOGY, V95, P1296, DOI 10.1097/00000542-200111000-00041; BARKER SJ, 1989, ANESTHESIOLOGY, V70, P112, DOI 10.1097/00000542-198901000-00021; BOARD PG, 1981, CLIN CHIM ACTA, V109, P233, DOI 10.1016/0009-8981(81)90340-5; CHISHOLM DG, 1994, CAN J ANAESTH, V41, P519, DOI 10.1007/BF03011548; CURRY S, 1982, ANN EMERG MED, V11, P214, DOI 10.1016/S0196-0644(82)80502-7; Eagle KA, 2002, CIRCULATION, V105, P1257, DOI 10.1161/hc1002.104956; ELGHETANY MT, 1996, CLIN DIAGNOSIS MANAG, P636; Fairbanks VF, 1999, TIETZ TXB CLIN CHEM, P1642; FINCH CA, 1948, NEW ENGL J MED, V239, P470, DOI 10.1056/NEJM194809232391305; GOTTSCHALK A, 1994, ANESTHESIOLOGY, V80, P474, DOI 10.1097/00000542-199402000-00030; HEGESH E, 1986, NEW ENGL J MED, V314, P757, DOI 10.1056/NEJM198603203141206; JAFFE ER, 2001, METABOLIC MOL BASES, P4555; KATOH R, 1994, ANESTHESIOLOGY, V80, P472, DOI 10.1097/00000542-199402000-00029; Kuji A, 2001, ANESTH ANALG, V93, P1192, DOI 10.1097/00000539-200111000-00028; Pasternak LR, 2002, ANESTHESIOLOGY, V96, P485; Percy MJ, 2002, BLOOD, V100, P3447, DOI 10.1182/blood-2002-05-1405; REYNOLDS K, 1993, J CLIN MONITOR, V9, P211; REYNOLDS KJ, 1993, J CLIN MONITOR, V9, P81, DOI 10.1007/BF01616919; SHIRABE K, 1992, J BIOL CHEM, V267, P20416; Sugahara K, 1998, INTENS CARE MED, V24, P706, DOI 10.1007/s001340050648; Tanishima K, 1978, Nihon Ketsueki Gakkai Zasshi, V41, P695; VIEIRA LM, 1995, BLOOD, V85, P2254, DOI 10.1182/blood.V85.8.2254.bloodjournal8582254; WATCHA MF, 1989, AM J DIS CHILD, V143, P845, DOI 10.1001/archpedi.1989.02150190095030	25	21	21	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2004	351	4					380	387		10.1056/NEJMcpc049013	http://dx.doi.org/10.1056/NEJMcpc049013			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839RC	15269319				2022-12-28	WOS:000222801200014
J	Anttila, T; Helkala, EL; Viitanen, M; Kareholt, I; Fratiglioni, L; Winblad, B; Soininen, H; Tuomilehto, J; Nissinen, A; Kivipelto, M				Anttila, T; Helkala, EL; Viitanen, M; Kareholt, I; Fratiglioni, L; Winblad, B; Soininen, H; Tuomilehto, J; Nissinen, A; Kivipelto, M			Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; NORTH-KARELIA; AVERAGE VOLUME; E GENOTYPE; CONSUMPTION; COMMUNITY; SMOKING; PERFORMANCE; PATTERNS	Objective To evaluate the relation between midlife alcohol consumption and mild cognitive impairment and dementia in old age, and the possible modification of this relation by apolipoprotein E. Design Prospective, population based study. Setting Populations of Kuopio and Joensuu, eastern Finland. Participants Of 1464 men and women aged 65-79 years randomly selected from population based samples studied in 1972 or 1977,1018 (70%) were re-examined in 1998 (after an average follow up of 23 years). Main outcome measures Mild cognitive impairment and dementia in old age. Results Participants who drank no alcohol at midlife and those who drank alcohol frequently were both twice as likely to have mild cognitive impairment in old age as those participants who drank alcohol infrequently. The risk of dementia related to alcohol drinking was modified by the presence of the apolipoprotein e4 allele. ne carriers of apolipoprotein e4 had an increased risk of dementia with increasing alcohol consumption: compared with non-carriers who never drank, the odds ratio for carriers who never drank was 0.6, for infrequent drinkers it was 2.3, and for frequent drinkers was 3.6 (die overall interaction term "drinking frequency*apolipoprotein e4" was significant (P = 0.04), as were the interactions "infrequent drinking*apolipoprotein c4" (P = 0.02) and "frequent drinking*apolipoprotein e4" (P = 0.03)). Non-carriers of apolipoprotein e4 had similar odds ratios for dementia irrespective of alcohol consumption. Conclusion Alcohol drinking in middle age showed a U shaped relation with risk of mild cognitive impairment in old age. Risk of dementia increased with increasing alcohol consumption only in those individuals carrying the apolipoprotein e4 allele.	Karolinska Inst, Neurotec, Div Geriatr Epidemiol, Aging Res Ctr, S-11382 Stockholm, Sweden; Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland; Karolinska Univ Hosp, Karolinska Inst, Neurotec, Div Geriatr Med, S-14186 Huddinge, Sweden; Univ Kuopio, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, SF-00300 Helsinki, Finland	Karolinska Institutet; University of Eastern Finland; Karolinska Institutet; Karolinska University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare	Kivipelto, M (corresponding author), Karolinska Inst, Neurotec, Div Geriatr Epidemiol, Aging Res Ctr, Box 6401, S-11382 Stockholm, Sweden.	Miia.Kivipelto@uku.fi	Kivipelto, Miia/AAS-3557-2021; Viitanen, Matti/AAY-5163-2020	Kivipelto, Miia/0000-0003-0992-3875				Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; Carmelli D, 1999, NEUROEPIDEMIOLOGY, V18, P125, DOI 10.1159/000026204; Cervilla JA, 2000, J NEUROL NEUROSUR PS, V68, P622, DOI 10.1136/jnnp.68.5.622; Commenges D, 2000, EUR J EPIDEMIOL, V16, P357, DOI 10.1023/A:1007614613771; Dufouil C, 2000, EPIDEMIOLOGY, V11, P280, DOI 10.1097/00001648-200005000-00009; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galanis DJ, 2000, AM J PUBLIC HEALTH, V90, P1254, DOI 10.2105/AJPH.90.8.1254; GRAVES AB, 1991, INT J EPIDEMIOL, V20, pS48, DOI 10.1093/ije/20.Supplement_2.S48; HEBERT LE, 1992, AM J EPIDEMIOL, V135, P347, DOI 10.1093/oxfordjournals.aje.a116296; HEBERT LE, 1993, AM J EPIDEMIOL, V137, P881, DOI 10.1093/oxfordjournals.aje.a116749; Huang WY, 2002, J CLIN EPIDEMIOL, V55, P959, DOI 10.1016/S0895-4356(02)00462-6; Kalmijn S, 2002, AM J EPIDEMIOL, V156, P936, DOI 10.1093/aje/kwf135; Kauhanen J, 1999, ARTERIOSCL THROM VAS, V19, P3001, DOI 10.1161/01.ATV.19.12.3001; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Larrieu S, 2002, NEUROLOGY, V59, P1594, DOI 10.1212/01.WNL.0000034176.07159.F8; Launer LJ, 1996, AM J EPIDEMIOL, V143, P219; Leroi I, 2002, AM J EPIDEMIOL, V156, P747, DOI 10.1093/aje/kwf107; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mukamal KJ, 2003, JAMA-J AM MED ASSOC, V289, P1405, DOI 10.1001/jama.289.11.1405; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; PUSKA P, 1979, BRIT MED J, V2, P1173, DOI 10.1136/bmj.2.6199.1173; PUSKA P, 1983, BRIT MED J, V287, P1840, DOI 10.1136/bmj.287.6408.1840; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Rehm J, 2003, EUR ADDICT RES, V9, P147, DOI 10.1159/000072221; Ruitenberg A, 2002, LANCET, V359, P281, DOI 10.1016/S0140-6736(02)07493-7; SAUNDERS PA, 1991, BRIT J PSYCHIAT, V159, P213, DOI 10.1192/bjp.159.2.213; Smith GE, 1996, AGING NEUROPSYCHOL C, V3, P141, DOI 10.1080/13825589608256619; The 1999 ESPAD Report, 2000, 1999 ESPAD REPORT AL; Thomas VS, 2001, J AM GERIATR SOC, V49, P415, DOI 10.1046/j.1532-5415.2001.49085.x; Truelsen T, 2002, NEUROLOGY, V59, P1313, DOI 10.1212/01.WNL.0000031421.50369.E7; TSUKAMOTO K, 1993, J LAB CLIN MED, V121, P598; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495	39	189	200	2	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2004	329	7465					539	542A		10.1136/bmj.38181.418958.BE	http://dx.doi.org/10.1136/bmj.38181.418958.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	853DE	15304383	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000223805800018
J	Brophy, JM; Bogaty, P				Brophy, JM; Bogaty, P			Primary angioplasty and thrombolysis are both reasonable options in acute myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; FIBRINOLYTIC THERAPY; RANDOMIZED-TRIAL; IMMEDIATE THROMBOLYSIS; REPERFUSION; MORTALITY; SAFETY; TIME; REVASCULARIZATION; RESOLUTION	Primary angioplasty is increasingly being advocated as the preferred approach for treating acute ST-segment elevation myocardial infarction regardless of whether interinstitutional transfer is required. This review critically analyzes the evidence comparing primary angioplasty with thrombolytic therapy and concludes that reasonable health care professionals may still find considerable uncertainty about the superiority of primary angioplasty for all situations. The magnitude of benefit for primary angioplasty over thrombolysis is probably less than 1 to 2 lives saved/100 patients treated and largely depends on the choice of thrombolytic agent, time to treatment, place of treatment, and adjunctive therapy. There is little evidence that systematically transferring patients for primary angioplasty in routine practice will provide any health benefits over thrombolysis. Consequently, it may be most useful to view these treatments as complementary rather than competitive. Thrombolysis remains a clinically and economically attractive option for the treatment of acute myocardial infarction that does not require the radical restructuring of our health care systems.	McGill Univ, Hlth Ctr, Royal Victoria Hosp, Div Cardiol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Hlth Ctr, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; Univ Laval, Quebec Heart Inst, Laval, PQ, Canada	McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; Laval University	Brophy, JM (corresponding author), McGill Univ, Hlth Ctr, Royal Victoria Hosp, Div Cardiol, 687 Pine St W,R4-12, Montreal, PQ H3A 1A1, Canada.	james.brophy@mcgill.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875				Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Betriu A, 1997, NEW ENGL J MED, V336, P1621; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Bogaty P, 2003, LANCET, V361, P1813, DOI 10.1016/S0140-6736(03)13407-1; Bogaty P, 2001, J AM COLL CARDIOL, V37, P1289, DOI 10.1016/S0735-1097(01)01131-7; Bonnefoy E, 2002, LANCET, V360, P825, DOI 10.1016/S0140-6736(02)09963-4; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Brophy JM, 1998, CAN MED ASSOC J, V158, P475; Califf RM, 2003, CIRCULATION, V107, P1467, DOI 10.1161/01.CIR.0000065160.19016.26; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Cannon CP, 2002, J AM COLL CARDIOL, V39, P1720, DOI 10.1016/S0735-1097(02)01866-1; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; DEWOOD MA, 1980, NEW ENGL J MED, V303, P897, DOI 10.1056/NEJM198010163031601; Dong J, 2002, CIRCULATION, V105, P2946, DOI 10.1161/01.CIR.0000022604.56986.FF; Eikelboom JW, 2001, JAMA-J AM MED ASSOC, V285, P444, DOI 10.1001/jama.285.4.444; Ghali WA, 2003, CAN MED ASSOC J, V169, P35; Grines CL, 1998, J AM COLL CARDIOL, V31, P967, DOI 10.1016/S0735-1097(98)00031-X; Grines CL, 2002, J AM COLL CARDIOL, V39, P1713, DOI 10.1016/S0735-1097(02)01870-3; Grines CL, 2003, CIRCULATION, V107, P2538, DOI 10.1161/01.CIR.0000075292.29458.BB; Henriques JPS, 2003, J AM COLL CARDIOL, V41, P2138, DOI 10.1016/S0735-1097(03)00461-3; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Magid DJ, 2000, JAMA-J AM MED ASSOC, V284, P3131, DOI 10.1001/jama.284.24.3131; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Nallamothu BK, 2003, AM J CARDIOL, V92, P824, DOI 10.1016/S0002-9149(03)00891-9; Natarajan MK, 2003, CAN MED ASSOC J, V169, P32; Pilote L, 1996, NEW ENGL J MED, V335, P1198, DOI 10.1056/NEJM199610173351606; REIMER KA, 1977, CIRCULATION, V56, P786, DOI 10.1161/01.CIR.56.5.786; Santoro GM, 1998, AM J CARDIOL, V82, P932, DOI 10.1016/S0002-9149(98)00508-6; Somitsu Y, 1997, AM J CARDIOL, V80, P406, DOI 10.1016/S0002-9149(97)00386-X; Stone GW, 2002, LANCET, V360, P814, DOI 10.1016/S0140-6736(02)11010-5; Tiefenbrunn AJ, 1998, J AM COLL CARDIOL, V31, P1240, DOI 10.1016/S0735-1097(98)00094-1; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol EJ, 2003, CIRCULATION, V107, P1463, DOI 10.1161/01.CIR.0000063680.45780.A0; Topol EJ, 2001, LANCET, V357, P1905; Van de Werf F, 2001, LANCET, V358, P605; Vermeer F, 1999, HEART, V82, P426, DOI 10.1136/hrt.82.4.426; Widimsky P, 2000, EUR HEART J, V21, P823, DOI 10.1053/euhj.1999.1993; Widimsky P, 2003, EUR HEART J, V24, P94, DOI 10.1016/S0195-668X(02)00468-2	40	17	19	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2004	141	4					292	297		10.7326/0003-4819-141-4-200408170-00009	http://dx.doi.org/10.7326/0003-4819-141-4-200408170-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846BX	15313745				2022-12-28	WOS:000223290900006
J	Kawakubo, M; Ito, Y; Okimura, Y; Kobayashi, M; Sakura, K; Kasama, S; Fukuda, MN; Fukuda, M; Katsuyama, T; Nakayama, J				Kawakubo, M; Ito, Y; Okimura, Y; Kobayashi, M; Sakura, K; Kasama, S; Fukuda, MN; Fukuda, M; Katsuyama, T; Nakayama, J			Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection	SCIENCE			English	Article							EXPRESSION CLONING; MUCOUS CELLS; GLYCOSYLATION; AUTOIMMUNITY; ADHESIN; FORMS	Helicobacter pylori infects the stomachs of nearly a half the human population, yet most infected individuals remain asymptomatic, which suggests that there is a host defense against this bacterium. Because H. pylori is rarely found in deeper portions of the gastric mucosa, where O-glycans are expressed that have terminal alpha1,4-linked N-acetylglucosamine, we tested whether these O-glycans might affect H. pylori growth. Here, we report that these O-glycans have antimicrobial activity against H. pylori, inhibiting its biosynthesis of cholesteryl-alpha-D-glucopyranoside, a major cell wall component. Thus, the unique O-glycans in gastric mucin appeared to function as a natural antibiotic, protecting the host from H. pylori infection.	Shinshu Univ, Sch Med, Dept Pathol, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Grad Sch Med, Inst Organ Transplants Reconstruct Med & Tissue E, Matsumoto, Nagano 3908621, Japan; Burnham Inst, Canc Res Ctr, Glycobiol Program, La Jolla, CA 92037 USA	Shinshu University; Shinshu University; Shinshu University; Sanford Burnham Prebys Medical Discovery Institute	Nakayama, J (corresponding author), Shinshu Univ, Sch Med, Dept Pathol, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	jun@hsp.md.shinshu-u.ac.jp		KAWAKUBO, MASATOMO/0000-0001-5106-5742	NATIONAL CANCER INSTITUTE [P01CA071932, R37CA033000, R01CA033000] Funding Source: NIH RePORTER; NCI NIH HHS [CA 71932, CA 33000] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akama TO, 2002, SCIENCE, V295, P124, DOI 10.1126/science.1065570; Cave D R, 2001, Semin Gastrointest Dis, V12, P196; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Enroth H, 1999, HELICOBACTER, V4, P7, DOI 10.1046/j.1523-5378.1999.09034.x; Finlay J, 2003, J ANTIMICROB CHEMOTH, V52, P18, DOI 10.1093/jac/dkg286; Hidaka E, 2001, GUT, V49, P474, DOI 10.1136/gut.49.4.474; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; HIRAI Y, 1995, J BACTERIOL, V177, P5327, DOI 10.1128/jb.177.18.5327-5333.1995; Horii T, 2002, HELICOBACTER, V7, P39, DOI 10.1046/j.1523-5378.2002.00054.x; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; INAMOTO Y, 1993, J CLIN GASTROENTEROL, V17, pS136, DOI 10.1097/00004836-199312001-00024; Ishihara K, 1996, BIOCHEM J, V318, P409, DOI 10.1042/bj3180409; ITO Y, UNPUB; KAWAKUBO M, UNPUB; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Nakayama J, 1996, J BIOL CHEM, V271, P3684; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nakayama J, 1999, P NATL ACAD SCI USA, V96, P8991, DOI 10.1073/pnas.96.16.8991; OTA H, 1991, HISTOCHEM J, V23, P22, DOI 10.1007/BF01886504; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; SIPPONEN P, 1993, SCAND J GASTROENTERO, V28, P3, DOI 10.3109/00365529309098333; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	26	256	272	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1003	1006		10.1126/science.1099250	http://dx.doi.org/10.1126/science.1099250			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310903				2022-12-28	WOS:000223250700048
J	Anselmo, J; Cao, DC; Karrison, T; Weiss, RE; Refetoff, S				Anselmo, J; Cao, DC; Karrison, T; Weiss, RE; Refetoff, S			Fetal loss associated with excess thyroid hormone exposure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECEPTOR-BETA; RESISTANCE; PREGNANCY; HYPERTHYROIDISM; MUTATIONS; ABORTION; DISEASE; WOMEN; RISK; GENE	Context Maternal hypothyroidism and hyperthyroidism have deleterious effects on the outcome of pregnancy. While the effects of thyroid hormone (TH) deprivation on the fetus, independently from that on the mother, can be studied in infants with congenital hypothyroidism, this is not the case in those with fetal thyrotoxicosis. Objective To study the effects of TH excess on fetuses carried by mothers with resistance to TH (RTH) who are euthyroid despite high TH levels but who may carry normal fetuses that are exposed to high maternal hormone levels. Design, Setting, and Participants Retrospective study of 167 members of an Azorean family with RTH. Affected individuals had the RTH phenotype (high serum concentration of free thyroxine and triiodothyronine without suppressed thyrotropin) confirmed by genotyping to identify the Arg243-->Gln mutation in the TH receptor p gene. Main Outcome Measures Pregnancy outcome of affected mothers vs that of unaffected mothers carrying fetuses conceived by affected fathers, as well as that of unaffected first-degree relatives and outcomes from the general island population. Comparison of birth weights and blood concentrations of thyrotropin (TSH) obtained during routine neonatal screening of infants born to these 3 groups. Results Thirty-six couples with complete information belonged to 1 of 3 groups: affected mothers (n=9), affected fathers (n=9), and unaffected relatives (n=18). Mean miscarriage rates were 22.9%, 2.0%, and 4.4%, respectively (chi(2)=8.66, P=.01). Affected mothers had an increased rate of miscarriage (z=3.10, P=.002, by Wilcoxon rank-sum test). They had marginally higher than expected numbers of affected offspring, ie, 20 affected and 11 unaffected children (P=.07), while affected fathers had 15 affected and 12 unaffected children (P=.35). Unaffected infants born to affected mothers were significantly smaller than affected infants, having a mean SD score for gestational age of -1.79 (SD, 0.86) vs -0.06 (SD, 1.11) to -0.22 (SD, 0.70) for all other groups (P<.001). Only unaffected infants born to affected mothers had undetectable blood levels of TSH. Conclusion There was a higher rate of miscarriage in mothers affected by RTH that may have involved predominantly unaffected fetuses. The lower birth weight and suppressed levels of TSH in unaffected infants born to affected mothers indicates that the high maternal TH levels produce fetal thyrotoxicosis. These data indicate a direct toxic effect of TH excess on the fetus.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Comm Mol Med, Chicago, IL 60637 USA; Hosp Espirito Santo, Endocrinol Unit, Ponta Delgada, Azores, Portugal; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Comm Mol Med, Chicago, IL 60637 USA; Univ Chicago, Comm Nutr Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Refetoff, S (corresponding author), Univ Chicago, Dept Med, MC 3090,5841 S Maryland Ave, Chicago, IL 60637 USA.	refetoff@uchicago.edu	Cao, Dingcai/E-8404-2010; Refetoff, Samuel/ABB-1263-2021	Refetoff, Samuel/0000-0003-0164-8231	NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018372] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00055, RR18372] Funding Source: Medline; NIDDK NIH HHS [DK58258, DK17050] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abramson J, 2001, THYROID, V11, P57, DOI 10.1089/10507250150500676; Anselmo J, 2001, J CLIN ENDOCR METAB, V86, P4273, DOI 10.1210/jc.86.9.4273; BECKS GP, 1991, MED CLIN N AM, V75, P121, DOI 10.1016/S0025-7125(16)30475-8; BURROW GN, 1994, NEW ENGL J MED, V331, P1072; Collingwood TN, 1998, EMBO J, V17, P4760, DOI 10.1093/emboj/17.16.4760; de La Rochebrochard E, 2002, HUM REPROD, V17, P1649, DOI 10.1093/humrep/17.6.1649; Galton VA, 1999, J CLIN INVEST, V103, P979, DOI 10.1172/JCI6073; Glinoer D, 1997, ENDOCR REV, V18, P404, DOI 10.1210/er.18.3.404; Glinoer D, 2000, THYROID, V10, P871, DOI 10.1089/thy.2000.10.871; HARAKAWA S, 1989, ACTA ENDOCRINOL-COP, V121, P739, DOI 10.1530/acta.0.1210739; KOPP P, 1995, NEW ENGL J MED, V332, P150, DOI 10.1056/NEJM199501193320304; Mestman JH, 1997, CLIN OBSTET GYNECOL, V40, P45, DOI 10.1097/00003081-199703000-00007; Mestman JH, 1998, ENDOCRIN METAB CLIN, V27, P127, DOI 10.1016/S0889-8529(05)70303-0; MILLS JL, 1988, NEW ENGL J MED, V319, P1617, DOI 10.1056/NEJM198812223192501; MORREALE DE, 2000, J CLIN ENDOCR METAB, V85, P3975, DOI DOI 10.1210/JCEM.85.11.6961; Muller AF, 1999, FERTIL STERIL, V71, P30, DOI 10.1016/S0015-0282(98)00394-X; Phoojaroenchanachai M, 2001, CLIN ENDOCRINOL, V54, P365, DOI 10.1046/j.1365-2265.2001.01224.x; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; REFETOFF S, 1967, J CLIN ENDOCR METAB, V27, P279, DOI 10.1210/jcem-27-2-279; Refetoff S, 2001, METABOLIC MOL BASES, P4029; Safer JD, 1998, J BIOL CHEM, V273, P30175, DOI 10.1074/jbc.273.46.30175; WEISS RE, 1993, J CLIN INVEST, V91, P2408, DOI 10.1172/JCI116474; Yagi H, 1997, J CLIN ENDOCR METAB, V82, P1608, DOI 10.1210/jc.82.5.1608	23	171	178	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					691	695		10.1001/jama.292.6.691	http://dx.doi.org/10.1001/jama.292.6.691			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304465				2022-12-28	WOS:000223177300022
J	Edgar, D; Brereton, M				Edgar, D; Brereton, M			ABC of burns - Rehabilitation after burn injury	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Royal Perth Hosp, Upper Limb Rehabil Unit, Perth, WA, Australia	Royal Perth Hospital; University of Western Australia	Edgar, D (corresponding author), Royal Perth Hosp, Upper Limb Rehabil Unit, Perth, WA, Australia.		Edgar, Dale W/AAV-9394-2021	Edgar, Dale W/0000-0001-7336-9317				Schnebly W A, 1989, J Burn Care Rehabil, V10, P263	1	35	38	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2004	329	7461					343	345		10.1136/bmj.329.7461.343	http://dx.doi.org/10.1136/bmj.329.7461.343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846FF	15297346	Green Published			2022-12-28	WOS:000223300300028
J	Thornton, JG; Hornbuckle, J; Vail, A; Spiegelhalter, DJ; Levene, M; Van Bulck, B; Kalakoutis, GM; Sak, P; Schneider, KTM; Karpathios, SE; Major, T; Todros, T; Arduini, D; Tranquilli, A; Flumini, C; Tenore, AC; Roncaglia, N; Frusca, T; Ferretti, G; Groningen, AZ; Weinans, MJN; Leiden, AZ; van Roosmalen, J; van der Slikke, JW; van Geijn, H; Pernet, PJM; Wolf, H; Utrecht, AZ; Stigter, RH; Wilczynski, J; Vasco, E; Abdullah, M; Novak-Antolic, Z; Danielian, P; Jenkinson, SD; Welch, CR; Griffin, C; Gee, H; Tuffnell, D; Cresswell, J; Tariq, T; Sengupta, B; Tydeman, G; Kumarendran, MK; Churchill, D; Bewley, S; Fusi, L; Lindow, SW; Johal, W; Fairlie, FM; Neales, K; Mason, G; Scudamore, I; Konje, J; Walkinshaw, SA; Griffiths, M; Dawson, A; Mires, G; Johanson, R; Fraser, RB; Ibbs, PH; Steel, SA; Ramsay, M; Robins, JB; Heard, MJ; Tonge, HM; Manyonda, IT; Walker, J; Maresh, M; Yoong, A; Soothill, P; Cameron, H; Byrne, D; Beattie, B; Bober, S				Thornton, JG; Hornbuckle, J; Vail, A; Spiegelhalter, DJ; Levene, M; Van Bulck, B; Kalakoutis, GM; Sak, P; Schneider, KTM; Karpathios, SE; Major, T; Todros, T; Arduini, D; Tranquilli, A; Flumini, C; Tenore, AC; Roncaglia, N; Frusca, T; Ferretti, G; Groningen, AZ; Weinans, MJN; Leiden, AZ; van Roosmalen, J; van der Slikke, JW; van Geijn, H; Pernet, PJM; Wolf, H; Utrecht, AZ; Stigter, RH; Wilczynski, J; Vasco, E; Abdullah, M; Novak-Antolic, Z; Danielian, P; Jenkinson, SD; Welch, CR; Griffin, C; Gee, H; Tuffnell, D; Cresswell, J; Tariq, T; Sengupta, B; Tydeman, G; Kumarendran, MK; Churchill, D; Bewley, S; Fusi, L; Lindow, SW; Johal, W; Fairlie, FM; Neales, K; Mason, G; Scudamore, I; Konje, J; Walkinshaw, SA; Griffiths, M; Dawson, A; Mires, G; Johanson, R; Fraser, RB; Ibbs, PH; Steel, SA; Ramsay, M; Robins, JB; Heard, MJ; Tonge, HM; Manyonda, IT; Walker, J; Maresh, M; Yoong, A; Soothill, P; Cameron, H; Byrne, D; Beattie, B; Bober, S		GRIT Study Grp	Infant wellbeing at 2 years of age in the Growth Restriction intervention Trial (GRIT): multicentred randomised controlled trial	LANCET			English	Article							WEEKS GESTATION; EXPECTANT MANAGEMENT; SEVERE PREECLAMPSIA; DOPPLER; PRETERM; FETUS; CHILDREN; DELIVERY; SEQUENCE; BIRTH	Background Although delivery is widely used for preterm babies failing to thrive in utero, the effect of altering delivery timing has never been assessed in a randomised controlled trial. We aimed to compare the effect of delivering early with delaying birth for as long as possible. Methods 548 pregnant women were recruited by 69 hospitals in 13 European countries. Participants had fetal compromise between 24 and 36) weeks, an umbilical-artery doppler waveform recorded, and clinical uncertainty about whether immediate delivery was indicated. Before birth, 588 babies were randomly assigned to immediate delivery (n=296) or delayed delivery until the obstetrician was no longer uncertain (n=292). The main outcome was death or disability at or beyond 2 years of age. Disability was defined as a Griffiths developmental quotient of 70 or less or the presence of motor or perceptual severe disability. Analysis was by intention-to-treat. This trial has been assigned the International Standard Randomised Controlled Trial Number ISRCTN41358726. Findings Primary outcomes were available on 290 (98%) immediate and 283 (97%) deferred deliveries. Overall rate of death or severe disability at 2 years was 55 (19%) of 290 immediate births, and 44 (16%) of 283 delayed births. With adjustment for gestational age and umbilical-artery doppler category, the odds ratio (95% CrI) was 1.1 (0.7-1.8). Most of the observed difference was in disability in babies younger than 31 weeks of gestation at randomisation: 14 (13%) immediate versus five (5%) delayed deliveries. No important differences in the median Griffiths developmental quotient in survivors was seen. Interpretation The lack of difference in mortality suggests that obstetricians are delivering sick preterm. babies at about the correct moment to minimise mortality. However, they could be delivering too early to minimise brain damage. These results do not lend support to the idea that obstetricians can deliver before terminal hypoxaemia to improve brain development.	City Hosp, Div Obstet & Gynecol, Nottingham NG5 1PB, England	University of Nottingham	Thornton, JG (corresponding author), City Hosp, Div Obstet & Gynecol, Nottingham NG5 1PB, England.	jim.thornton@nottingham.ac.uk	fraser, robert b/B-9856-2009; Thornton, Jim/B-8336-2008; Mani, Elisa/ABE-7974-2020; Wolke, Dieter/C-5372-2008; Soothill, Peter/D-2814-2009	Thornton, Jim/0000-0001-9764-6876; Mani, Elisa/0000-0001-8943-4590; Wolke, Dieter/0000-0003-0304-268X; Vail, Andy/0000-0001-8274-2726	Medical Research Council [G9533539] Funding Source: Medline; MRC [G9533539] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baschat AA, 2001, ULTRASOUND OBST GYN, V18, P571, DOI 10.1046/j.0960-7692.2001.00591.x; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Ferrazzi E, 2002, ULTRASOUND OBST GYN, V19, P140, DOI 10.1046/j.0960-7692.2002.00627.x; GAUDIER FL, 1994, AM J OBSTET GYNECOL, V170, P48; HANSON R, 1987, CHILD CARE HLTH DEV, V13, P181, DOI 10.1111/j.1365-2214.1987.tb00535.x; HARRINGTON K, 1995, ULTRASOUND OBST GYN, V6, P19, DOI 10.1046/j.1469-0705.1995.06010019.x; Hecher K, 2001, ULTRASOUND OBST GYN, V18, P564, DOI 10.1046/j.0960-7692.2001.00590.x; KARSDORP VHM, 1994, LANCET, V344, P1664, DOI 10.1016/S0140-6736(94)90457-X; KEELING JW, 1989, ARCH DIS CHILD, V64, P1345, DOI 10.1136/adc.64.10_Spec_No.1345; Kurmanavicius J, 1997, ULTRASOUND OBST GYN, V10, P112, DOI 10.1046/j.1469-0705.1997.10020112.x; LILFORD R, 1994, BMJ-BRIT MED J, V308, P111, DOI 10.1136/bmj.308.6921.111; NEILSON JP, 2002, COCHRANE LIB; ODENDAAL HJ, 1990, OBSTET GYNECOL, V76, P1070; Parmar MKB, 2001, LANCET, V358, P375, DOI 10.1016/S0140-6736(01)05558-1; Schaap AHP, 1996, EUR J OBSTET GYN R B, V70, P61, DOI 10.1016/S0301-2115(96)02560-2; SCHERJON SA, 1993, AM J OBSTET GYNECOL, V169, P169, DOI 10.1016/0002-9378(93)90156-D; SIBAI BM, 1994, AM J OBSTET GYNECOL, V171, P818, DOI 10.1016/0002-9378(94)90104-X; SPEIGELHALTER DJ, 1994, J ROY STAT SOC A STA, V157, P357; SPIEGELHALTER DJ, 1994, J R STAT SOC A STAT, V157, P357, DOI 10.2307/2983527; THORNTON JG, 1993, BRIT J OBSTET GYNAEC, V100, P197, DOI 10.1111/j.1471-0528.1993.tb15229.x; Vail A, 2001, STAT MED, V20, P3777, DOI 10.1002/sim.1171; Van Bulck B, 2003, BJOG-INT J OBSTET GY, V110, P27; VEEN S, 1991, LANCET, V338, P33, DOI 10.1016/0140-6736(91)90015-H; VISSER GHA, 1991, EUR J OBSTET GYN R B, V42, pS73	24	235	242	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 7	2004	364	9433					513	520						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302194				2022-12-28	WOS:000223132700030
J	McSween, HY; Arvidson, RE; Bell, JF; Blaney, D; Cabrol, NA; Christensen, PR; Clark, BC; Crisp, JA; Crumpler, LS; Des Marais, DJ; Farmer, JD; Gellert, R; Ghosh, A; Gorevan, S; Graff, T; Grant, J; Haskin, LA; Herkenhoff, KE; Johnson, JR; Jolliff, BL; Klingelhoefer, G; Knudson, AT; McLEnnan, S; Milam, KA; Moersch, JE; Morris, RV; Rieder, R; Ruff, SW; de Souza, PA; Squyres, SW; Wanke, H; Wang, A; Wyatt, MB; Yen, A; Zipfel, J				McSween, HY; Arvidson, RE; Bell, JF; Blaney, D; Cabrol, NA; Christensen, PR; Clark, BC; Crisp, JA; Crumpler, LS; Des Marais, DJ; Farmer, JD; Gellert, R; Ghosh, A; Gorevan, S; Graff, T; Grant, J; Haskin, LA; Herkenhoff, KE; Johnson, JR; Jolliff, BL; Klingelhoefer, G; Knudson, AT; McLEnnan, S; Milam, KA; Moersch, JE; Morris, RV; Rieder, R; Ruff, SW; de Souza, PA; Squyres, SW; Wanke, H; Wang, A; Wyatt, MB; Yen, A; Zipfel, J			Basaltic rocks analyzed by the Spirit rover in Gusev Crater	SCIENCE			English	Article							CHEMICAL CLASSIFICATION; PATHFINDER SITE; VOLCANIC-ROCKS; SOILS; MARS	The Spirit landing site in Gusev Crater on Mars contains dark, fine-grained, vesicular rocks interpreted as lavas. Pancam and Mini-Thermal Emission Spectrometer (Mini-TES) spectra suggest that all of these rocks are similar but have variable coatings and dust mantles. Magnified images of brushed and abraded rock surfaces show alteration rinds and veins. Rock interiors contain less than or equal to25% megacrysts. Chemical analyses of rocks by the Alpha Particle X-ray Spectrometer are consistent with picritic basalts, containing normative olivine, pyroxenes, plagioclase, and accessory FeTi oxides. Mossbauer, Pancam, and Mini-TES spectra confirm the presence of olivine, magnetite, and probably pyroxene. These basalts extend the known range of rock compositions composing the martian crust.	Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; Max Planck Inst Chem, D-55099 Mainz, Germany; Honeybee Robot, New York, NY 10012 USA; Smithsonian Inst, Natl Air & Space Museum, Washington, DC 20560 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Mainz, Inst Anorgan & Analyt Chem, D-6500 Mainz, Germany; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Co Vale Rio Doce, BR-29090900 Vitoria, ES, Brazil	University of Tennessee System; University of Tennessee Knoxville; Washington University (WUSTL); Cornell University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Arizona State University; Arizona State University-Tempe; Lockheed Martin; Max Planck Society; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; Johannes Gutenberg University of Mainz; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	McSween, HY (corresponding author), Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA.	mcsween@utk.edu	de Souza, Paulo/W-2993-2019; de Souza, Paulo/P-7294-2019; Crisp, Joy/H-8287-2016; Johnson, Jeffrey R/F-3972-2015; de Souza, Paulo A/B-8961-2008; Moersch, Jeffrey E/F-7189-2010; Farmer, Jack D/B-9343-2019	de Souza, Paulo/0000-0002-0091-8925; Crisp, Joy/0000-0002-3202-4416; Johnson, Jeffrey R/0000-0002-5586-4901; de Souza, Paulo A/0000-0002-0091-8925; Moersch, Jeffrey E/0000-0003-3433-9419; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; IRVINE TN, 1971, CAN J EARTH SCI, V8, P523, DOI 10.1139/e71-055; LEBAS MJ, 1986, J PETROL, V27, P745, DOI 10.1093/petrology/27.3.745; McSween H.Y., 1998, PLANETARY MAT, V36; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645	16	225	225	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					842	845		10.1126/science.3050842	http://dx.doi.org/10.1126/science.3050842			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297668				2022-12-28	WOS:000223104900041
J	Holleman, A; Cheok, MH; den Boer, ML; Yang, WJ; Veerman, AJP; Kazemier, KM; Pei, DQ; Cheng, C; Pui, CH; Relling, MV; Janka-Schaub, GE; Pieters, R; Evans, WE				Holleman, A; Cheok, MH; den Boer, ML; Yang, WJ; Veerman, AJP; Kazemier, KM; Pei, DQ; Cheng, C; Pui, CH; Relling, MV; Janka-Schaub, GE; Pieters, R; Evans, WE			Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METABOLIZING ENZYMES; IN-VIVO; CHILDHOOD; SENSITIVITY; PHARMACOGENOMICS; CLASSIFICATION; ASPARAGINASE; PREDICTION; PROFILES; PROTEINS	BACKGROUND: Childhood acute lymphoblastic leukemia (ALL) is curable with chemotherapy in approximately 80 percent of patients. However, the cause of treatment failure in the remaining 20 percent of patients is largely unknown. METHODS: We tested leukemia cells from 173 children for sensitivity in vitro to prednisolone, vincristine, asparaginase, and daunorubicin. The cells were then subjected to an assessment of gene expression with the use of 14,500 probe sets to identify differentially expressed genes in drug-sensitive and drug-resistant ALL. Gene-expression patterns that differed according to sensitivity or resistance to the four drugs were compared with treatment outcome in the original 173 patients and an independent cohort of 98 children treated with the same drugs at another institution. RESULTS: We identified sets of differentially expressed genes in B-lineage ALL that were sensitive or resistant to prednisolone (33 genes), vincristine (40 genes), asparaginase (35 genes), or daunorubicin (20 genes). A combined gene-expression score of resistance to the four drugs, as compared with sensitivity to the four, was significantly and independently related to treatment outcome in a multivariate analysis (hazard ratio for relapse, 3.0; P=0.027). Results were confirmed in an independent population of patients treated with the same medications (hazard ratio for relapse, 11.85; P=0.019). Of the 124 genes identified, 121 have not previously been associated with resistance to the four drugs we tested. CONCLUSIONS: Differential expression of a relatively small number of genes is associated with drug resistance and treatment outcome in childhood ALL.	St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Div Pediat Hematol Oncol, Rotterdam, Netherlands; St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; Pharmacogenet Res Network, Pharmacogenet Anticanc Agents Res Grp, Memphis, TN USA; Univ Tennessee, Coll Pharm, Memphis, TN USA; Univ Tennessee, Coll Med, Memphis, TN USA; Free Univ Amsterdam, Med Ctr, Dept Pediat Hematol Oncol, Amsterdam, Netherlands; Childrens Univ Hosp, German Cooperat Study Grp Childhood Acute Lymphob, Dept Hematol Oncol, Hamburg, Germany	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Vrije Universiteit Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf	Evans, WE (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	william.evans@stjude.org	Relling, Mary/N-5032-2018; Evans, William E./C-2069-2012; Veerman, Anjo/AAT-2443-2020; Cheok, Meyling/AFS-4025-2022; Cheng, Cheng/N-8075-2018; Cheok, Meyling h/C-3822-2014; Pui, Ching-Hon/N-8076-2018	Evans, William E./0000-0002-9333-5322; Cheok, Meyling/0000-0002-7820-8026; Cheok, Meyling h/0000-0002-7820-8026; Pui, Ching-Hon/0000-0003-0303-5658; de Haar-Holleman, Amy/0000-0003-4929-2860; Veerman, Anjo JP/0000-0002-9309-301X; den Boer, Monique/0000-0002-5795-2921	NCI NIH HHS [R01 CA78224, R37 CA36401, R01 CA51001, P30 CA21765] Funding Source: Medline; NIGMS NIH HHS [U01 GM61393, U01 GM61394] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078224, R37CA036401, R01CA051001, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061394, U01GM061393] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Cheok MH, 2003, NAT GENET, V34, P231, DOI 10.1038/ng0603-231b; Den Boer ML, 2003, J CLIN ONCOL, V21, P3262, DOI 10.1200/JCO.2003.11.031; Dudoit S, 2003, BIOINFORMATICS, V19, P1090, DOI 10.1093/bioinformatics/btg038; DUI JP, 2003, ZHONGHUA ZHONG LIU Z, V25, P21; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Harms DO, 2003, BLOOD, V102, P2736, DOI 10.1182/blood-2002-08-2372; Hongo T, 2002, INT J HEMATOL, V76, P251, DOI 10.1007/BF02982795; Kaspers GJL, 1997, BLOOD, V90, P2723, DOI 10.1182/blood.V90.7.2723.2723_2723_2729; Kearns PR, 2001, BLOOD, V97, P393, DOI 10.1182/blood.V97.2.393; Krajinovic M, 2002, CLIN CANCER RES, V8, P802; Martell RL, 1997, BRIT J CANCER, V75, P161, DOI 10.1038/bjc.1997.27; McLeod HL, 2000, LEUKEMIA, V14, P567, DOI 10.1038/sj.leu.2401723; PIETERS R, 1991, LANCET, V338, P399, DOI 10.1016/0140-6736(91)91029-T; Pieters R, 2003, INT J HEMATOL, V78, P402, DOI 10.1007/BF02983812; Prokop A, 2000, LEUKEMIA, V14, P1606, DOI 10.1038/sj.leu.2401866; Pui CH, 2001, LANCET ONCOL, V2, P597, DOI 10.1016/S1470-2045(01)00516-2; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Ramakers-van Woerden NL, 2000, BLOOD, V96, P1094; Ramakers-van Woerden NL, 2001, BRIT J HAEMATOL, V112, P680, DOI 10.1046/j.1365-2141.2001.02586.x; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; VAN AL, 1997, GENE DEV, V11, P2295; van den Heuvel-Eibrink MM, 2000, INT J CLIN PHARM TH, V38, P94; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zembutsu H, 2002, CANCER RES, V62, P518	34	453	474	2	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					533	542		10.1056/NEJMoa033513	http://dx.doi.org/10.1056/NEJMoa033513			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295046				2022-12-28	WOS:000223069900006
J	Juurlink, DN; Mamdani, MM; Lee, DS; Kopp, A; Austin, PC; Laupacis, A; Redelmeier, DA				Juurlink, DN; Mamdani, MM; Lee, DS; Kopp, A; Austin, PC; Laupacis, A; Redelmeier, DA			Rates of hyperkalemia after publication of the randomized aldactone evaluation study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE-THREATENING HYPERKALEMIA; CONGESTIVE-HEART-FAILURE; TIME-SERIES; SPIRONOLACTONE; GUIDELINES; PREVALENCE; INHIBITORS; MORBIDITY	BACKGROUND: The Randomized Aldactone Evaluation Study (RALES) demonstrated that spironolactone significantly improves outcomes in patients with severe heart failure. Use of angiotensin-converting-enzyme (ACE) inhibitors is also indicated in these patients. However, life-threatening hyperkalemia can occur when these drugs are used together. METHODS: We conducted a population-based time-series analysis to examine trends in the rate of spironolactone prescriptions and the rate of hospitalization for hyperkalemia in ambulatory patients before and after the publication of RALES. We linked prescription-claims data and hospital-admission records for more than 1.3 million adults 66 years of age or older in Ontario, Canada, for the period from 1994 through 2001. RESULTS: Among patients treated with ACE inhibitors who had recently been hospitalized for heart failure, the spironolactone-prescription rate was 34 per 1000 patients in 1994, and it increased immediately after the publication of RALES, to 149 per 1000 patients by late 2001 (P<0.001). The rate of hospitalization for hyperkalemia rose from 2.4 per 1000 patients in 1994 to 11.0 per 1000 patients in 2001 (P<0.001), and the associated mortality rose from 0.3 per 1000 to 2.0 per 1000 patients (P<0.001). As compared with expected numbers of events, there were 560 (95 percent confidence interval, 285 to 754) additional hyperkalemia-related hospitalizations and 73 (95 percent confidence interval, 27 to 120) additional hospital deaths during 2001 among older patients with heart failure who were treated with ACE inhibitors in Ontario. Publication of RALES was not associated with significant decreases in the rates of readmission for heart failure or death from all causes. CONCLUSIONS: The publication of RALES was associated with abrupt increases in the rate of prescriptions for spironolactone and in hyperkalemia-associated morbidity and mortality. Closer laboratory monitoring and more judicious use of spironolactone may reduce the occurrence of this complication.	Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Pharm, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Juurlink, DN (corresponding author), Sunnybrook & Womens Coll Hlth Sci Ctr, G Wing 106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dnj@ices.on.ca	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				Antrobus J H, 1993, J Cardiothorac Vasc Anesth, V7, P76, DOI 10.1016/1053-0770(93)90124-4; Berry C, 2001, Heart, V85, pE8, DOI 10.1136/heart.85.4.e8; Bozkurt B, 2003, J AM COLL CARDIOL, V41, P211, DOI 10.1016/S0735-1097(02)02694-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Ghali WA, 2000, LANCET, V355, P579, DOI 10.1016/S0140-6736(05)73234-7; Hamad A, 2001, AM J NEPHROL, V21, P241, DOI 10.1159/000046255; Helfenstein U, 1996, Stat Methods Med Res, V5, P3, DOI 10.1177/096228029600500102; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jarman PR, 2003, BRIT MED J, V327, P812, DOI 10.1136/bmj.327.7418.812; JARMAN PR, 1995, POSTGRAD MED J, V71, P551, DOI 10.1136/pgmj.71.839.551; Jong P, 2003, CIRCULATION, V108, P184, DOI 10.1161/01.CIR.0000080290.39027.48; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; LARGE DM, 1984, POSTGRAD MED J, V60, P370, DOI 10.1136/pgmj.60.703.370; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Majumdar SR, 2003, AM J MED, V115, P467, DOI 10.1016/S0002-9343(03)00422-4; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; Pindyck R.S., 2013, ECONOMETRIC MODELS E; Pitt B, 1996, AM J CARDIOL, V78, P902; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Schepkens H, 2001, AM J MED, V110, P438, DOI 10.1016/S0002-9343(01)00642-8; Svensson M, 2003, BRIT MED J, V327, P1141, DOI 10.1136/bmj.327.7424.1141; van Walraven C, 1998, JAMA-J AM MED ASSOC, V280, P2028, DOI 10.1001/jama.280.23.2028; Vanpee D, 2000, AGING-CLIN EXP RES, V12, P315, DOI 10.1007/BF03339853; vanWalraven C, 2000, JAMA-J AM MED ASSOC, V283, P481; Wrenger E, 2003, BRIT MED J, V327, P147, DOI 10.1136/bmj.327.7407.147	29	1205	1230	0	24	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					543	551		10.1056/NEJMoa040135	http://dx.doi.org/10.1056/NEJMoa040135			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295047				2022-12-28	WOS:000223069900007
J	Venkatesan, M; Fitzgerald, CB; Coey, JMD				Venkatesan, M; Fitzgerald, CB; Coey, JMD			Unexpected magnetism in a dielectric oxide	NATURE			English	Editorial Material									Univ Dublin Trinity Coll, Dept Phys, SFI Trinity Nanosci Lab, Dublin 2, Ireland	Trinity College Dublin	Venkatesan, M (corresponding author), Univ Dublin Trinity Coll, Dept Phys, SFI Trinity Nanosci Lab, Dublin 2, Ireland.	jcoey@tcd.ie		Coey, John Michael David/0000-0003-0053-8452				Foster AS, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.174117; Goodenough J.B., 1963, MAGNETISM CHEM BOND; MOTT N, 1987, CONDUCTION NONCRYSTA; Prellier W, 2003, J PHYS-CONDENS MAT, V15, pR1583, DOI 10.1088/0953-8984/15/37/R01	4	1077	1089	8	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					630	630		10.1038/430630a	http://dx.doi.org/10.1038/430630a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295588				2022-12-28	WOS:000223085400033
J	Wenzel, RP				Wenzel, RP			Business and medicine - The antibiotic pipeline - Challenges, costs, and values	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA	Virginia Commonwealth University	Wenzel, RP (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, Med Coll Virginia Campus, Richmond, VA 23284 USA.							ABBOUD FM, 1959, ARCH INTERN MED, V104, P226, DOI 10.1001/archinte.1959.00270080052006; Powers JH, 2003, CURR OPIN INFECT DIS, V16, P547, DOI 10.1097/00001432-200312000-00006; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Skinner D, 1941, ARCH INTERN MED, V68, P851, DOI 10.1001/archinte.1941.00200110003001; Stewart JJ, 2001, NAT BIOTECHNOL, V19, P813, DOI 10.1038/nbt0901-813	5	160	170	0	20	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					523	+		10.1056/NEJMp048093	http://dx.doi.org/10.1056/NEJMp048093			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295041				2022-12-28	WOS:000223069900001
J	Webster, DW; Vernick, JS; Zeoli, AM; Manganello, JA				Webster, DW; Vernick, JS; Zeoli, AM; Manganello, JA			Association between youth-focused firearm laws and youth suicides	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADOLESCENT SUICIDE; MORTALITY; ACCESS	Context Firearms are used in approximately half of all youth suicides. Many state and federal laws include age-specific restrictions on the purchase, possession, or storage of firearms; however, the association between these laws and suicides among youth has not been carefully examined. Objective To evaluate the association between youth-focused firearm laws and suicides among youth. Design, Setting, and Participants Quasi-experimental design with annual state-level data on suicide rates among US youth aged 14 through 20 years, for the period 1976-2001. Negative binomial regression models were used to estimate the association between state and federal youth-focused firearm laws mandating a minimum age for the purchase or possession of handguns and state child access prevention (CAP) laws requiring safe storage of firearms on suicide rates among youth. Main Outcome Measures Association between youth-focused state and federal firearm laws and rates of firearm, nonfirearm, and total suicides among US youth aged 14 to 17 and 18 through 20 years. Results There were 63954 suicides among youth aged 14 through 20 years during the 1976-2001 study period, 39655 (62%) of which were committed with firearms. Minimum purchase-age and possession-age laws were not associated with statistically significant reductions in suicide rates among youth aged 14 through 20 years. State CAP laws were associated with an 8.3% decrease (rate ratio [RR], 0.92; 95% confidence interval [Cl], 0.86-0.98) in suicide rates among 14- to 17-year-olds. The annual rate of suicide in this age group in states with CAP laws was 5.97 per 100000 population rather than the projected 6.51. This association was also statistically significant for firearm suicides (RR, 0.89; 95% Cl, 0.83-0.96) but not for nonfirearm suicides (RR, 1.00; 95% Cl, 0.91-1.10). CAP laws were also associated with a significant reduction in suicides among youth aged 18 through 20 years (RR, 0.89; 95% Cl, 0.85-0.93); however, the association was similar for firearm suicides (RR, 0.87; 95% Cl, 0.82-0.92) and nonfirearm suicides (RR, 0.91; 95% Cl, 0.85-0.98). Conclusions There is evidence that CAP laws are associated with a modest reduction in suicide rates among youth aged 14 to 17 years. As currently implemented, minimum age restrictions for the purchase and possession of firearms do not appear to reduce overall rates of suicide among youth.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Gun Policy & Res, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Prevent Youth & Violence, Baltimore, MD 21205 USA; Univ Penn, Annenberg Publ Policy Ctr, Philadelphia, PA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania	Webster, DW (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Gun Policy & Res, 624 N Broadway,Room 593, Baltimore, MD 21205 USA.	dwebster@jhsph.edu		Zeoli, April/0000-0002-9084-1721	ODCDC CDC HHS [R49/CCR318627-04] Funding Source: Medline	ODCDC CDC HHS		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; BRENT DA, 1988, ARCH GEN PSYCHIAT, V45, P581, DOI 10.1001/archpsyc.1988.01800300079011; BRENT DA, 1991, JAMA-J AM MED ASSOC, V266, P2989, DOI 10.1001/jama.266.21.2989; BRENT DA, 1993, AM J DIS CHILD, V147, P1066, DOI 10.1001/archpedi.1993.02160340052013; BRENT DA, 1993, J AM ACAD CHILD PSY, V32, P494, DOI 10.1097/00004583-199305000-00002; *BUR ALC TOB FIR, 1988, STAT LAWS PUBL ORD F; *BUR ALC TOB FIR, 1994, STAT LAWS PUBL ORD F; *BUR ALC TOB FIR, 1998, STAT LAWS PUBL ORD F; *BUR ALC TOB FIR, 2000, STAT LAWS PUBL ORD F; *BUR EC AN, 2004, STAT PERS INC 1929 2; *BUR LAB STAT, 2003, HIST DAT CURR POP SU; Bureau of Justice Statistics, 2003, CRIM VICT US 2002 ST; [Centers for Disease Control and Prevention National Center for Injury Prevention and Control], WEBB INJ STAT QUER R; Cummings P, 1997, JAMA-J AM MED ASSOC, V278, P1084, DOI 10.1001/jama.278.13.1084; GREENE WH, 2003, ECONOMETRIC ANAL, P768; Grossman DC, 1999, ARCH PEDIAT ADOL MED, V153, P875, DOI 10.1001/archpedi.153.8.875; Jones D.E., 2002, RELIG CONGREGATIONS; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; LAWLESS JF, 1987, CAN J STAT, V15, P209, DOI 10.2307/3314912; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lott JR, 2001, J LAW ECON, V44, P659, DOI 10.1086/338346; Markowitz Sara, 2003, J Ment Health Policy Econ, V6, P37; Marvell TB, 2001, J LAW ECON, V44, P691, DOI 10.1086/323314; Miller M, 2002, EPIDEMIOLOGY, V13, P517, DOI 10.1097/00001648-200209000-00006; NEPHEW TM, 2003, APPARENT PER CAPITA; Perkins C., 2003, WEAPON USE VIOLENT C; Shah S, 2000, J ADOLESCENT HEALTH, V26, P157, DOI 10.1016/S1054-139X(99)00064-6; Shenassa ED, 2003, J EPIDEMIOL COMMUN H, V57, P120, DOI 10.1136/jech.57.2.120; *US BUR CENS, 2002, HIST ANN TIM SER STA; *US BUR CENS, 2002, POP EST 1990 1999 AN; *US BUR CENS, 2002, INT EST RES POP STAT; US Census Bureau, 1977, STAT ABSTR US; VERNICK JS, 2003, EVALUATING GUN POLIC; Webster DW, 2000, PEDIATRICS, V106, P1466, DOI 10.1542/peds.106.6.1466; WHO (World Health Organization), 1977, MAN INT STAT CLASS D; WILLIAMS DA, 1987, APPL STAT-J ROY ST C, V36, P181, DOI 10.2307/2347550; Wintemute GJ, 1999, NEW ENGL J MED, V341, P1583, DOI 10.1056/NEJM199911183412106; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd	39	139	139	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2004	292	5					594	601		10.1001/jama.292.5.594	http://dx.doi.org/10.1001/jama.292.5.594			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	843AE	15292085	Bronze			2022-12-28	WOS:000223045500017
J	Kaplan, SH; Greenfield, S				Kaplan, SH; Greenfield, S			The patient's role in reducing disparities	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEALTH-CARE; CONCORDANCE; QUALITY; PHYSICIANS; OUTCOMES; RACE		Univ Calif Irvine, Ctr Hlth Policy Res, Irvine, CA 92697 USA	University of California System; University of California Irvine	Kaplan, SH (corresponding author), Univ Calif Irvine, Ctr Hlth Policy Res, 100 Theory,Suite 110, Irvine, CA 92697 USA.	skaplan@uci.edu		Kaplan, Sherrie/0000-0002-8644-5849; Greenfield, Sheldon/0000-0003-4628-1998				Amer College Physicians, 2004, ANN INTERN MED, V141, P226, DOI 10.7326/0003-4819-141-3-200408030-00015; Cooper LA, 2003, ANN INTERN MED, V139, P907, DOI 10.7326/0003-4819-139-11-200312020-00009; Geiger A M, 2000, Eff Clin Pract, V3, P157; Johnson RL, 2004, J GEN INTERN MED, V19, P101, DOI 10.1111/j.1525-1497.2004.30262.x; KAPLAN SH, 1995, MED CARE, V33, P1176, DOI 10.1097/00005650-199512000-00002; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Kaplan SH, 1996, ANN INTERN MED, V124, P497, DOI 10.7326/0003-4819-124-5-199603010-00007; Lam TK, 2003, J GEN INTERN MED, V18, P516, DOI 10.1046/j.1525-1497.2003.21043.x; LaVeist TA, 2003, J PUBLIC HEALTH POL, V24, P312, DOI 10.2307/3343378; Miranda J, 2003, HEALTH SERV RES, V38, P613, DOI 10.1111/1475-6773.00136; ROST KM, 1991, DIABETES CARE, V14, P881, DOI 10.2337/diacare.14.10.881; Saha S, 1999, ARCH INTERN MED, V159, P997, DOI 10.1001/archinte.159.9.997; Saha S, 2003, AM J PUBLIC HEALTH, V93, P1713, DOI 10.2105/AJPH.93.10.1713	13	11	11	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2004	141	3					222	223		10.7326/0003-4819-141-3-200408030-00012	http://dx.doi.org/10.7326/0003-4819-141-3-200408030-00012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HG	15289220				2022-12-28	WOS:000223068600007
J	Abraham, S				Abraham, S			The Bush administration's approach to climate change	SCIENCE			English	Editorial Material											Abraham, S (corresponding author), 1000 Independence Ave SW, Washington, DC 20585 USA.							Caldeira K, 2003, SCIENCE, V299, P2052, DOI 10.1126/science.1078938; CCSP, 2003, STRAT PLAN US CLIM C, P202; *CCTP, 2003, RES CURR ACT; *CCTP, UNPUB US CLIM CHANG; Council NR, 2004, HYDROGEN EC OPPORTUN; *INT PAN, 2000, EM SCEN; nap, 2004, BIOLOGICAL CONFINEMENT OF GENETICALLY ENGINEERED ORGANISMS, P1; *NAT HIGHW TRAFF S, 2003, FIN ENV ASS NAT HIGH; *NAT RES COUNC, 2001, CLIM CHANG SCI AN SO, P20; *WHIT HOUS, 2002, GLOB CLIM CHANC POL	10	21	22	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					616	617		10.1126/science.1098630	http://dx.doi.org/10.1126/science.1098630			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286350				2022-12-28	WOS:000222992100023
J	Shan, ZW; Stach, EA; Wiezorek, JMK; Knapp, JA; Follstaedt, DM; Mao, SX				Shan, ZW; Stach, EA; Wiezorek, JMK; Knapp, JA; Follstaedt, DM; Mao, SX			Grain boundary-mediated plasticity in nanocrystalline nickel	SCIENCE			English	Article							IN-SITU; DEFORMATION; ROTATION; BEHAVIOR; METALS	The plastic behavior of crystalline materials is mainly controlled by the nucleation and motion of lattice dislocations. We report in situ dynamic transmission electron microscope observations of nanocrystalline nickel films with an average grain size of about 10 nanometers, which show that grain boundary-mediated processes have become a prominent deformation mode. Additionally, trapped lattice dislocations are observed in individual grains following deformation. This change in the deformation mode arises from the grain size-dependent competition between the deformation controlled by nucleation and motion of dislocations and the deformation controlled by diffusion-assisted grain boundary processes.	Univ Pittsburgh, Dept Mech Engn, Pittsburgh, PA 15261 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA; Univ Pittsburgh, Dept Mat Sci & Engn, Pittsburgh, PA 15261 USA; Sandia Natl Labs, Phys & Chem Sci Ctr, Albuquerque, NM 87185 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Sandia National Laboratories	Mao, SX (corresponding author), Univ Pittsburgh, Dept Mech Engn, 648 Benedum Hall, Pittsburgh, PA 15261 USA.	smao@engr.pitt.edu	Stach, Eric Andrew/M-6455-2019; Stach, Eric A/D-8545-2011; Wiezorek, Jorg/AAE-6637-2020; Shan, Zhiwei/B-8799-2014	Stach, Eric Andrew/0000-0002-3366-2153; Stach, Eric A/0000-0002-3366-2153; Wiezorek, Jorg/0000-0002-1358-0556; 				Budrovic Z, 2004, SCIENCE, V304, P273, DOI 10.1126/science.1095071; Chen MW, 2003, SCIENCE, V300, P1275, DOI 10.1126/science.1083727; DOBSON PS, 1967, PHILOS MAG, V16, P9, DOI 10.1080/14786436708229253; Harris KE, 1998, ACTA MATER, V46, P2623, DOI 10.1016/S1359-6454(97)00467-9; HIRTH JP, 1982, THEORY DISLOCATIONS, P837; Hugo RC, 2003, ACTA MATER, V51, P1937, DOI 10.1016/S1359-6454(02)00599-2; KE M, 1995, NANOSTRUCT MATER, V5, P689, DOI 10.1016/0965-9773(95)00281-I; Koch CC, 1999, MRS BULL, V24, P54, DOI 10.1557/S0883769400051551; Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/j.actamat.2003.08.032; Legros M, 2000, PHILOS MAG A, V80, P1017, DOI 10.1080/01418610008212096; Mitra R, 2004, J MATER RES, V19, P1029, DOI 10.1557/JMR.2004.0134; Moldovan D, 2001, ACTA MATER, V49, P3521, DOI 10.1016/S1359-6454(01)00240-3; Murr L.E., 1975, INTERFACIAL PHENOMEN; RAJ R, 1971, METALL TRANS, V2, P1113, DOI 10.1007/BF02664244; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328; Schuh CA, 2002, SCRIPTA MATER, V46, P735, DOI 10.1016/S1359-6462(02)00062-3; Swygenhoven H., 2002, PHYS REV B, V66; Van Swygenhoven H, 2003, SCRIPTA MATER, V49, P625, DOI 10.1016/S1359-6462(03)00399-3; Van Swygenhoven H, 2002, SCIENCE, V296, P66; Weertman JR, 1999, MRS BULL, V24, P44, DOI 10.1557/S088376940005154X; Weertman Jr, 2002, MA SC PR TE, P397; Yamakov V, 2004, NAT MATER, V3, P43, DOI 10.1038/nmat1035; Yamakov V, 2002, NAT MATER, V1, P45, DOI 10.1038/nmat700; Yamakov V, 2001, ACTA MATER, V49, P2713, DOI 10.1016/S1359-6454(01)00167-7; Yip S, 1998, NATURE, V391, P532, DOI 10.1038/35254; Youngdahl CJ, 2001, SCRIPTA MATER, V44, P1475, DOI 10.1016/S1359-6462(01)00712-6	27	764	784	18	472	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					654	657		10.1126/science.1098741	http://dx.doi.org/10.1126/science.1098741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286368				2022-12-28	WOS:000222992100043
J	Lottermoser, T; Lonkai, T; Amann, U; Hohlwein, D; Ihringer, J; Fiebig, M				Lottermoser, T; Lonkai, T; Amann, U; Hohlwein, D; Ihringer, J; Fiebig, M			Magnetic phase control by an electric field	NATURE			English	Article							HEXAGONAL RMNO3; FERROMAGNETISM; POLARIZATION; MANGANITES; BAMNF4	The quest for higher data density in information storage is motivating investigations into approaches for manipulating magnetization by means other than magnetic fields. This is evidenced by the recent boom in magnetoelectronics and 'spin-tronics'(1), where phenomena such as carrier effects in magnetic semiconductors(2) and high-correlation effects in colossal magnetoresistive compounds(3) are studied for their device potential. The linear magnetoelectric effect - the induction of polarization by a magnetic field and of magnetization by an electric field - provides another route for linking magnetic and electric properties. It was recently discovered that composite materials and magnetic ferroelectrics exhibit magnetoelectric effects that exceed previously known effects(4,5) by orders of magnitude(6-10), with the potential to trigger magnetic or electric phase transitions. Here we report a system whose magnetic phase can be controlled by an external electric field: ferromagnetic ordering in hexagonal HoMnO3 is reversibly switched on and off by the applied field via magnetoelectric interactions. We monitor this process using magnetooptical techniques and reveal its microscopic origin by neutron and X-ray diffraction. From our results, we identify basic requirements for other candidate materials to exhibit magnetoelectric phase control.	Max Born Inst, D-12489 Berlin, Germany; Univ Tubingen, Inst Angew Phys, D-72076 Tubingen, Germany; Hahn Meitner Inst Berlin GmbH, D-14109 Berlin, Germany; Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France	Max Born Institute for Nonlinear Optics & Short Term Spectroscopy; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Institut Laue-Langevin (ILL)	Fiebig, M (corresponding author), Max Born Inst, Max Born Str 2A, D-12489 Berlin, Germany.	fiebig@mbi-berlin.de	Lottermoser, Thomas/G-2828-2011	Lottermoser, Thomas/0000-0002-2941-7446				Asamitsu A, 1997, NATURE, V388, P50, DOI 10.1038/40363; ASCHER E, 1966, J APPL PHYS, V37, P1404, DOI 10.1063/1.1708493; COEURE P, 1996, P INT M FERR, P332; DZIALOSHINSKII IE, 1957, SOV PHYS JETP-USSR, V5, P1259; Fiebig M, 2000, PHYS REV LETT, V84, P5620, DOI 10.1103/PhysRevLett.84.5620; Fiebig M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.144102; Fiebig M, 2003, J APPL PHYS, V93, P8194, DOI 10.1063/1.1544513; Fiebig M, 2002, PHYS REV LETT, V88, DOI 10.1003/PhysRevLett.88.027203; Fiebig M., 2004, MAGNETOELECTRIC INTE; FOX DL, 1980, PHYS REV B, V21, P2926, DOI 10.1103/PhysRevB.21.2926; Hur N, 2004, NATURE, V429, P392, DOI 10.1038/nature02572; IHRINGER J, 1995, J APPL CRYSTALLOGR, V28, P618, DOI 10.1107/S0021889895005711; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Kritayakirana K., 1969, Optics Communications, V1, P95, DOI 10.1016/0030-4018(69)90018-2; Leute S, 1999, OPT LETT, V24, P1520, DOI 10.1364/OL.24.001520; MAICHLE JK, 1988, J APPL CRYSTALLOGR, V21, P22, DOI 10.1107/S0021889887008331; Nan CW, 2002, APPL PHYS LETT, V81, P3831, DOI 10.1063/1.1521247; O'Dell T.H., 1970, ELECTRODYNAMICS MAGN; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Prinz GA, 1999, J MAGN MAGN MATER, V200, P57, DOI 10.1016/S0304-8853(99)00335-2; Rebmann C, 1998, ACTA CRYSTALLOGR A, V54, P225, DOI 10.1107/S0108767397013391; Saxena SS, 2000, NATURE, V406, P587, DOI 10.1038/35020500; Schmid H., 1974, International Journal of Magnetism, V4, P337; SCOTT JF, 1979, REP PROG PHYS, V42, P1055, DOI 10.1088/0034-4885/42/6/003; Srinivasan G, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.134402; Sugie H, 2002, J PHYS SOC JPN, V71, P1558, DOI 10.1143/JPSJ.71.1558; Van Aken BB, 2004, NAT MATER, V3, P164, DOI 10.1038/nmat1080; VANAKEN BB, 2001, TESIS REIKSUNIV GRON; Zheng H, 2004, SCIENCE, V303, P661, DOI 10.1126/science.1094207	29	845	863	7	410	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					541	544		10.1038/nature02728	http://dx.doi.org/10.1038/nature02728			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282600				2022-12-28	WOS:000222946100042
J	Pawlotsky, JM				Pawlotsky, JM			Treating hepatitis C in "difficult-to-treat" patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Paris 12, Henri Mondor Hosp, Dept Virol, INSERM,U635, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Pawlotsky, JM (corresponding author), Univ Paris 12, Henri Mondor Hosp, Dept Virol, INSERM,U635, Creteil, France.		Pawlotsky, Jean-Michel/R-8159-2018	Pawlotsky, Jean-Michel/0000-0003-0745-7559				Pawlotsky JM, 2004, HEPATOLOGY, V39, P554, DOI 10.1002/hep.20065; Pawlotsky JM, 2003, ANTIVIR RES, V59, P1, DOI 10.1016/S0166-3542(03)00088-3; Sulkowski MS, 2003, ANN INTERN MED, V138, P197, DOI 10.7326/0003-4819-138-3-200302040-00012	3	29	34	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					422	423		10.1056/NEJMp048068	http://dx.doi.org/10.1056/NEJMp048068			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282348				2022-12-28	WOS:000222939700004
J	Wingerchuk, D				Wingerchuk, D			Cannabis for medical purposes: cultivating science, weeding out the fiction	LANCET			English	Editorial Material							MULTIPLE-SCLEROSIS; MARIJUANA USE; PREVALENCE; EPILEPSY		Mayo Clin, Dept Neurol, Multiple Sclerosis Ctr, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Wingerchuk, D (corresponding author), Mayo Clin, Dept Neurol, Multiple Sclerosis Ctr, Scottsdale, AZ 85259 USA.	wingerchuk.dean@mayo.edu						Baker D, 2003, LANCET NEUROL, V2, P291, DOI 10.1016/S1474-4422(03)00381-8; Clark AJ, 2004, NEUROLOGY, V62, P2098, DOI 10.1212/01.WNL.0000127707.07621.72; Compton WM, 2004, JAMA-J AM MED ASSOC, V291, P2114, DOI 10.1001/jama.291.17.2114; Fox P, 2004, NEUROLOGY, V62, P1105, DOI 10.1212/01.WNL.0000118203.67138.3E; GREENBERG HS, 1994, CLIN PHARMACOL THER, V55, P324, DOI 10.1038/clpt.1994.33; Gross DW, 2004, NEUROLOGY, V62, P2095, DOI 10.1212/01.WNL.0000127623.03766.75; Iversen L, 2003, BRAIN, V126, P1252, DOI 10.1093/brain/awg143; Killestein J, 2002, NEUROLOGY, V58, P1404, DOI 10.1212/WNL.58.9.1404; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Ogborne AC, 2000, SUBST USE MISUSE, V35, P301, DOI 10.3109/10826080009147698; Page SA, 2003, CAN J NEUROL SCI, V30, P201, DOI 10.1017/S0317167100002584; Sirven JI, 2004, NEUROLOGY, V62, P1924, DOI 10.1212/01.WNL.0000129703.59857.D6; Webb E, 1996, LANCET, V348, P922, DOI 10.1016/S0140-6736(96)03410-1; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1	14	15	32	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					315	316		10.1016/S0140-6736(04)16741-X	http://dx.doi.org/10.1016/S0140-6736(04)16741-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276375				2022-12-28	WOS:000222853300010
J	Payne, JL; Lehrmann, DJ; Wei, JY; Orchard, MJ; Schrag, DP; Knoll, AH				Payne, JL; Lehrmann, DJ; Wei, JY; Orchard, MJ; Schrag, DP; Knoll, AH			Large perturbations of the carbon cycle during recovery from the end-Permian extinction	SCIENCE			English	Article							TRIASSIC BOUNDARY; MASS EXTINCTION; SOUTH CHINA; ISOTOPE; EVOLUTION; CALIBRATION; HYPOTHESES; HISTORY; CORALS; REGION	High-resolution carbon isotope measurements of multiple stratigraphic sections in south China demonstrate that the pronounced carbon isotopic excursion at the Permian-Triassic boundary was not an isolated event but the first in a series of large fluctuations that continued throughout the Early Triassic before ending abruptly early in the Middle Triassic. The unusual behavior of the carbon cycle coincides with the delayed recovery from end-Permian extinction recorded by fossils, suggesting a direct relationship between Earth system function and biological rediversification in the aftermath of Earth's most devastating mass extinction.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Univ Wisconsin, Dept Geol, Oshkosh, WI 54901 USA; Guizhou Bur Geol & Mineral Resources, Guiyang 550011, Peoples R China; Geol Survey Canada, Vancouver, BC V6B 5J3, Canada	Harvard University; University of Wisconsin System; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Payne, JL (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	jpayne@fas.harvard.edu	Payne, Jonathan L/A-1240-2007; Payne, Jonathan/B-8088-2012	Payne, Jonathan L/0000-0002-9601-3310; 				Atudorei V., 1997, ALBERTIANA, V20, P45; Basu AR, 2003, SCIENCE, V302, P1388, DOI 10.1126/science.1090852; BAUD A, 1989, GEOL RUNDSCH, V78, P649, DOI 10.1007/BF01776196; Baud A, 1996, GEODIN ACTA, V9, P57, DOI 10.1080/09853111.1996.11105278; Becker L, 2004, SCIENCE, V304, P1469, DOI 10.1126/science.1093925; Berner RA, 2002, P NATL ACAD SCI USA, V99, P4172, DOI 10.1073/pnas.032095199; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Brasier MD, 1996, GEOL MAG, V133, P445, DOI 10.1017/S0016756800007603; Broecker WS, 1999, GLOBAL BIOGEOCHEM CY, V13, P1167, DOI 10.1029/1999GB900066; de Wit MJ, 2002, J GEOL, V110, P227, DOI 10.1086/338411; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Erwin D.H., 1993, CRITICAL MOMENTS PAL; Erwin Douglas H., 1996, P398; FLUGEL E, 1994, GEOL S AM S, P247; Flugel E., 1985, PALEOALGOLOGY CONT R, P344; Flugel E., 2002, PHANEROZOIC REEF PAT, P391; Hallam A., 1991, Historical Biology, V5, P257; HORACEK M, 2001, 3 VIENN WORKSH STABL; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; Kamo SL, 2003, EARTH PLANET SC LETT, V214, P75, DOI 10.1016/S0012-821X(03)00347-9; Kaufman AJ, 1996, GEOL MAG, V133, P509, DOI 10.1017/S0016756800007810; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; Krull ES, 2000, GEOL SOC AM BULL, V112, P1459, DOI 10.1130/0016-7606(2000)112<1459:CDPFPA>2.0.CO;2; Lehrmann DJ, 1998, J SEDIMENT RES, V68, P311, DOI 10.2110/jsr.68.311; MAGARITZ M, 1988, NATURE, V331, P337, DOI 10.1038/331337a0; Martin B, 2001, OPT LASER TECHNOL, V33, P201, DOI 10.1016/S0030-3992(01)00014-7; Mundil R, 1996, EARTH PLANET SC LETT, V141, P137, DOI 10.1016/0012-821X(96)00057-X; Mundil R, 2001, EARTH PLANET SC LETT, V187, P131, DOI 10.1016/S0012-821X(01)00274-6; Ott E., 1972, NEUES JB F R GEOLOGI, V141, P81; RAUP DM, 1979, SCIENCE, V206, P217, DOI 10.1126/science.206.4415.217; Retallack GJ, 1996, GEOL SOC AM BULL, V108, P195, DOI 10.1130/0016-7606(1996)108<0195:GCGBPT>2.3.CO;2; Riedel P., 1991, P465; Romano SL, 2000, B MAR SCI, V67, P1043; Schrag D. P., 2002, GEOCHEM GEOPHYS GEOS, V3; SCHUBERT JK, 1995, PALAEOGEOGR PALAEOCL, V116, P1, DOI 10.1016/0031-0182(94)00093-N; Senowbari-Daryan Baba, 1993, Facies, V28, P181, DOI 10.1007/BF02539736; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Tong J, 2003, SCI CHINA SER D, V46, P1182, DOI 10.1360/03yd0295; Twitchett RJ, 1999, PALAEOGEOGR PALAEOCL, V154, P27, DOI 10.1016/S0031-0182(99)00085-1; WANG K, 1994, GEOLOGY, V22, P580, DOI 10.1130/0091-7613(1994)022<0580:PTEOCE>2.3.CO;2; Wignall PB, 2002, GEOL SOC AM SPEC PAP, V356, P395, DOI 10.1130/0-8137-2356-6.395; [No title captured]	43	621	699	14	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					506	509		10.1126/science.1097023	http://dx.doi.org/10.1126/science.1097023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273391				2022-12-28	WOS:000222828900036
J	Tansey, WP				Tansey, WP			Death, destruction, and the proteasome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							APOPTOSIS; CELLS		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Tansey, WP (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.							Hideshima T, 2001, CANCER RES, V61, P3071; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373	5	13	15	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2004	351	4					393	394		10.1056/NEJMcibr041505	http://dx.doi.org/10.1056/NEJMcibr041505			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839RC	15269322				2022-12-28	WOS:000222801200017
J	Leung, TH; Hoffmann, A; Baltimore, D				Leung, TH; Hoffmann, A; Baltimore, D			One nucleotide in a kappa B site can determine cofactor specificity for NF-kappa B dimers	CELL			English	Article							BETA GENE-EXPRESSION; TRANSCRIPTION FACTORS; GLUCOCORTICOID-RECEPTOR; IMMUNE-RESPONSES; DNA-BINDING; COOPERATIVE INTERACTION; VIRUS INDUCTION; IFN-GAMMA; C-MYC; ACTIVATION	The transcription factor NF-kappaB regulates a wide variety of genes involved in multiple processes. Although the apparent consensus sequence of DNA binding sites for NF-kappaB (kappaB sites) is very broad, the sites active in any one gene show remarkable evolutionary stability. Using a lentivirus-based methodology for implantation of gene regulatory sequences we show that for genes with two kappaB sites both are required for activity. Swapping sites between kappaB-dependent genes altered NF-kappaB dimer specificity of the promoters and revealed that two kappaB sites can function together as a module to regulate gene activation. Further, although the sequence of the kappaB site is important for determining kappaB family member specificity, rather than determining the ability of a particular dimer to bind effectively, the sequence affect which coactivators will form productive interactions, with the bound NF-kappaB dinner. This suggests that binding sites may impart a specific configuration to bound transcription factors.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Hoffmann, Ary/R-2972-2019	Hoffmann, Ary/0000-0001-9497-7645	NIGMS NIH HHS [R01-GM39458-20] Funding Source: Medline; PHS HHS [R01-A1042549-061] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Berkowitz B, 2002, J BIOL CHEM, V277, P24694, DOI 10.1074/jbc.M200006200; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Brown CT, 2002, DEV BIOL, V246, P86, DOI 10.1006/dbio.2002.0619; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Escalante CR, 2002, STRUCTURE, V10, P383, DOI 10.1016/S0969-2126(02)00723-2; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; FUJITA T, 1993, GENE DEV, V7, P354; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KUNSCH C, 1992, MOL CELL BIOL, V12, P442; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; OHMORI Y, 1995, J IMMUNOL, V154, P5235; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Pierer M, 2004, J IMMUNOL, V172, P1256, DOI 10.4049/jimmunol.172.2.1256; Ping DS, 1999, J IMMUNOL, V162, P727; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; THANOS D, 1995, MOL CELL BIOL, V15, P152, DOI 10.1128/MCB.15.1.152; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Wietek C, 2003, J BIOL CHEM, V278, P50923, DOI 10.1074/jbc.M308135200; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	54	332	343	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					453	464		10.1016/j.cell.2004.08.007	http://dx.doi.org/10.1016/j.cell.2004.08.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315758	Bronze			2022-12-28	WOS:000223650900008
J	Pacala, S; Socolow, R				Pacala, S; Socolow, R			Stabilization wedges: Solving the climate problem for the next 50 years with current technologies	SCIENCE			English	Review								Humanity already possesses the fundamental scientific, technical, and industrial know-how to solve the carbon and climate problem for the next half-century. A portfolio of technologies now exists to meet the world's energy needs over the next 50 years and limit atmospheric CO2 to a trajectory that avoids a doubling of the preindustrial concentration. Every element in this portfolio has passed beyond the laboratory bench and demonstration project; many are already implemented somewhere at full industrial scale. Although no element is a credible candidate for doing the entire job ( or even half the job) by itself, the portfolio as a whole is large enough that not every element has to be used.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA	Princeton University; Princeton University	Pacala, S (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	pacala@princeton.edu; socolow@princeton.edu						[Anonymous], 2001, CLIMATE CHANGE 2001; *BP, 2003, STAT REV WORLD ENERG; *ENV DEF, 2002, AD COMM AV DANG CLIM; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; *IPCC, 2001, SPEC REP EM SCEN; Metz B., 2001, CLIMATE CHANGE 2001; *NRP, 2002, 954281 NRP; O'Neill BC, 2002, SCIENCE, V296, P1971, DOI 10.1126/science.1071238; *ROYAL COMM ENV PO, 2000, EN CHANG CLIM; SHAFFER G, 1995, J GEOPHYS RES-OCEANS, V100, P2659, DOI 10.1029/94JC01167; SOCOLOW R, 2004, IN PRESS P 7 INT C G; [No title captured]	12	1925	1973	20	575	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					968	972		10.1126/science.1100103	http://dx.doi.org/10.1126/science.1100103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310891				2022-12-28	WOS:000223250700035
J	Callans, DJ				Callans, DJ			Out-of-hospital cardiac arrest - The solution is shocking	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Sch Med, Dept Med, Div Cardiovasc Dis, Philadelphia, PA 19104 USA	University of Pennsylvania	Callans, DJ (corresponding author), Univ Penn, Sch Med, Dept Med, Div Cardiovasc Dis, Philadelphia, PA 19104 USA.		Callans, David/ABH-2176-2021						0	68	70	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					632	634		10.1056/NEJMp048174	http://dx.doi.org/10.1056/NEJMp048174			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306663				2022-12-28	WOS:000223225500004
J	Jiang, QX; Wang, DN; MacKinnon, R				Jiang, QX; Wang, DN; MacKinnon, R			Electron microscopic analysis of KvAP voltage-dependent K+ channels in an open conformation	NATURE			English	Article							ION CHANNELS; ANGULAR RECONSTITUTION; GATING CHARGE; S4 SEGMENT; RESOLUTION; CRYOMICROSCOPY; ORIENTATION; PERSPECTIVE; MOVEMENTS; PROTEIN	Voltage-dependent ion channels serve as field-effect transistors by opening a gate in response to membrane voltage changes(1). The gate's response to voltage is mediated by voltage sensors(2), which are arginine-containing structures that must move with respect to the membrane electric field. We have analysed by electron microscopy a voltage-dependent K+ channel from Aeropyrum pernix (KvAP)(3). Fab fragments were attached to 'voltage sensor paddles' and identified in the electron microscopy map at 10.5 Angstrom resolution. The extracellular surface location of the Fab fragments in the map is consistent with the membrane-depolarized, open conformation of the channel in electrophysiological experiments. Comparison of the map with a crystal structure(4) demonstrates that the voltage sensor paddles are 'up' ( that is, near the channel's extracellular surface) and situated at the protein - lipid interface. This finding supports the hypothesis that in response to changes in voltage the sensors move at the protein - lipid interface(5) rather than in a gating pore surrounded by protein(6,7).	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; New York University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockefeller.edu	Jiang, Qiu-Xing/ABF-1143-2021	Wang, Da-Neng/0000-0002-6496-4699				Adrian M, 1998, MICRON, V29, P145, DOI 10.1016/S0968-4328(97)00068-1; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; CHANDY KG, 1995, LIGAND VOLTAGE GATED, P1; Conway JF, 2003, J VIROL, V77, P6466, DOI 10.1128/JVI.77.11.6466-6473.2003; Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Hawkes P W., 1980, COMPUTER PROCESSING, P1; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sander B, 2003, J STRUCT BIOL, V142, P392, DOI 10.1016/S1047-8477(03)00072-8; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004	30	95	98	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					806	810		10.1038/nature02735	http://dx.doi.org/10.1038/nature02735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306816				2022-12-28	WOS:000223233600048
J	Jacobs, A				Jacobs, A			Time for the ghosts to take on physical form	LANCET			English	Editorial Material									Dianthus Med Ltd, London SW19 3TZ, England		Jacobs, A (corresponding author), Dianthus Med Ltd, Lombard Business Pk, London SW19 3TZ, England.	ajacobs@dianthus.co.uk		Jacobs, Adam/0000-0003-2792-3166				Committee for Publication Ethics (COPE), 1999, GUID GOOD PUBL PRACT; Larkin M, 1999, LANCET, V354, P136, DOI 10.1016/S0140-6736(05)75272-7; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Sharp D, 1998, LANCET, V351, P1076, DOI 10.1016/S0140-6736(05)79376-4; Wager E, 2003, CURR MED RES OPIN, V19, P149, DOI 10.1185/030079903125001767; *WORLD ASS MED ED, 2004, WAME REC PUBL ETH PO	6	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					487	488		10.1016/S0140-6736(04)16826-8	http://dx.doi.org/10.1016/S0140-6736(04)16826-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302178				2022-12-28	WOS:000223132700009
J	Vetter, RS				Vetter, RS			Myths about spider envenomations and necrotic skin lesions	LANCET			English	Editorial Material							BITE		Univ Calif Riverside, Dept Entomol, Riverside, CA 92507 USA; San Bernardino Cty Museum, Div Biol, Redlands, CA USA	University of California System; University of California Riverside	Vetter, RS (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92507 USA.	rick.vetter@ucr.edu						ANDERSON PC, 1991, AM J OBSTET GYNECOL, V165, P1454; BENNETT RG, IN PRESS CAN FAM PHY; Binford GJ, 2001, TOXICON, V39, P955, DOI 10.1016/S0041-0101(00)00234-8; Isbister GK, 2004, INTERN MED J, V34, P38, DOI 10.1111/j.1444-0903.2004.00506.x; JETER WS, 1983, TOXICON, V21, P729, DOI 10.1016/0041-0101(83)90278-7; RIBEIRO LA, 1990, TOXICON, V28, P715, DOI 10.1016/0041-0101(90)90260-E; RUSSELL FE, 1986, EMERGEN MED, V18, P8; RUSSELL FE, 1986, EMERGEN MED, V18, P13; Vetter RS, 2004, J MED ENTOMOL, V41, P593, DOI 10.1603/0022-2585-41.4.593; VETTER RS, IN PRESS ANN EMERG; Vettera RS, 2003, TOXICON, V42, P413, DOI 10.1016/S0041-0101(03)00173-9; White J, 2003, MED J AUSTRALIA, V179, P180, DOI 10.5694/j.1326-5377.2003.tb05493.x	12	7	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					484	485		10.1016/S0140-6736(04)16824-4	http://dx.doi.org/10.1016/S0140-6736(04)16824-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302176				2022-12-28	WOS:000223132700007
J	Dennis, C				Dennis, C			Cooling off	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					605	605						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15309806				2022-12-28	WOS:000223085400015
J	Braithwaite, J; Goulston, K				Braithwaite, J; Goulston, K			Turning the health system 90 degrees down under	LANCET			English	Editorial Material									Univ New S Wales, Fac Med, Ctr Clin Governance Res, Sydney, NSW 2052, Australia; Univ Sydney, NSW Greater Metropolitan Transit Taskforce, Fac Med, N Ryde, NSW, Australia	University of New South Wales Sydney; University of Sydney	Braithwaite, J (corresponding author), Univ New S Wales, Fac Med, Ctr Clin Governance Res, Sydney, NSW 2052, Australia.	j.braithwaite@unsw.edu.au	Braithwaite, Jeffrey/AAN-1467-2020	Braithwaite, Jeffrey/0000-0003-0296-4957				Black A, 2002, BRIT MED J, V325, P1290, DOI 10.1136/bmj.325.7375.1290; Braithwaite Jeffrey, 2002, Aust Health Rev, V25, P191; *DEP HLTH NSW, 2001, REP GREAT METR SERV; *DEP HLTH NSW, 2000, BETT HLTH SYST NSW R; Evans DB, 2001, BRIT MED J, V323, P307, DOI 10.1136/bmj.323.7308.307; Gaston C, 2003, AUDIT GREATER METROP; *I HEALTHC IMPR, 2004, COLL; Mintzberg H., 2002, STRATEGY PROCESS; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; ROEDER GH, 1998, PEOPLES CENTURY HIST; World Health Organization, 2000, WORLD HLTH REP 2000	11	22	22	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					397	399		10.1016/S0140-6736(04)16782-2	http://dx.doi.org/10.1016/S0140-6736(04)16782-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288722				2022-12-28	WOS:000222998600008
J	Dwyer, J; Reid, S				Dwyer, J; Reid, S			Ganser's syndrome	LANCET			English	Editorial Material									St Marys Hosp, Paterson Ctr Mental Hlth, Dept Liaison Psychiat, London W2 1PD, England	Imperial College London	Reid, S (corresponding author), St Marys Hosp, Paterson Ctr Mental Hlth, Dept Liaison Psychiat, London W2 1PD, England.	steve.reid@nhs.net						Allen D. F., 1994, HIST PSYCHIATR, V5, P289, DOI [10.1177/0957154X9400501901, DOI 10.1177/0957154X9400501901]; COCORES JA, 1984, INT J PSYCHIAT MED, V14, P47; DELAFUENTE JR, 1980, PSYCHIAT ANN, V10, P434; Enoch D, 1991, UNCOMMON PSYCHIAT SY; Ganser S. J., 1965, BRIT J CRIMINOL, V5, P120; Lishman W., 1998, ORGANIC PSYCHIAT; MCGRATH SD, 1981, P 3 WORLD C PSYCH MO, P156; SCOTT PD, 1965, BRIT J CRIMINOL, V5, P127; TSOI WF, 1973, BRIT J PSYCHIAT, V123, P567, DOI 10.1192/bjp.123.5.567; World Health Organization, 1992, 10 REV INT CLASS DIS	10	13	13	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					471	473		10.1016/S0140-6736(04)16772-X	http://dx.doi.org/10.1016/S0140-6736(04)16772-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288747				2022-12-28	WOS:000222998600039
J	Parker, M; Ashcroft, R; Wilkie, AOM; Kent, A				Parker, M; Ashcroft, R; Wilkie, AOM; Kent, A			Ethical review of research into rare genetic disorders	BRITISH MEDICAL JOURNAL			English	Article								Although some work on rare diseases is clearly clinical investigation and some clearly research, much activity falls uneasily between the two. Where should we draw the line and how can we ensure research gets appropriate ethical review?	Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ London Imperial Coll Sci Technol & Med, Med Eth Unit, London W6 8RP, England; Genet Interest Grp, London N1 3QP, England	University of Oxford; University of Oxford; Imperial College London	Parker, M (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	Michael.parker@ethox.ox.ac.uk	Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481				*DEP HLTH, 2003, RES GOV FRAM HLTH SO; *DEP HLTH, GOOD PRACT CONS IMPL; *GEN MED COUNC, 2000, CONF PROT PROV INF	3	29	29	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 31	2004	329	7460					288	289		10.1136/bmj.329.7460.288	http://dx.doi.org/10.1136/bmj.329.7460.288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284160	Green Published, Green Submitted			2022-12-28	WOS:000223133300029
J	Pirisi, A				Pirisi, A			Richard Darling, President and CEO of the FAIR Foundation	LANCET			English	Biographical-Item												apirisi@interlynx.net							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					409	409		10.1016/S0140-6736(04)16748-2	http://dx.doi.org/10.1016/S0140-6736(04)16748-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15290840	Bronze			2022-12-28	WOS:000222998600014
J	Bishop, KN; Holmes, RK; Sheehy, AM; Malim, MH				Bishop, KN; Holmes, RK; Sheehy, AM; Malim, MH			APOBEC-mediated editing of viral RNA	SCIENCE			English	Article							ENZYMES; DEAMINATION		Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 9RT, England	University of London; King's College London	Malim, MH (corresponding author), Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 9RT, England.	michael.malim@kcl.ac.uk		Malim, Michael/0000-0002-7699-2064				Anant S, 2003, TRENDS MOL MED, V9, P147, DOI 10.1016/S1471-4914(03)00032-7; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; BISHOP KN, 2004, IN PRESS CARR BIOL; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591	7	187	206	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2004	305	5684					645	645		10.1126/science.1100658	http://dx.doi.org/10.1126/science.1100658			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286366				2022-12-28	WOS:000222992100039
J	Edwards, IR				Edwards, IR			Intuition, evidence, and safety	LANCET			English	Editorial Material									WHO Fdn, Collaborating Ctr Int Drug Monitoring, S-7530 Uppsala, Sweden		Edwards, IR (corresponding author), WHO Fdn, Collaborating Ctr Int Drug Monitoring, S-7530 Uppsala, Sweden.	ralph.edwards@who-umc.org							0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 24	2004	364	9431					387	387		10.1016/S0140-6736(04)16730-5	http://dx.doi.org/10.1016/S0140-6736(04)16730-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276401				2022-12-28	WOS:000222853300040
J	Harrison, LE; Kim, SH				Harrison, LE; Kim, SH			Intussusception of the small bowel	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Harrison, LE (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, 185 S Orange Ave, Newark, NJ 07103 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2004	351	4					379	379		10.1056/NEJMicm990160	http://dx.doi.org/10.1056/NEJMicm990160			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839RC	15269318				2022-12-28	WOS:000222801200012
J	Hespos, SJ; Spelke, ES				Hespos, SJ; Spelke, ES			Conceptual precursors to language	NATURE			English	Article							SPEECH-PERCEPTION; CATEGORIZATION; CONTAINMENT; ENGLISH; MOTION	Because human languages vary in sound and meaning, children must learn which distinctions their language uses. For speech perception, this learning is selective: initially infants are sensitive to most acoustic distinctions used in any language(1-3), and this sensitivity reflects basic properties of the auditory system rather than mechanisms specific to language(4-7); however, infants' sensitivity to non-native sound distinctions declines over the course of the first year(8). Here we ask whether a similar process governs learning of word meanings. We investigated the sensitivity of 5-month-old infants in an English-speaking environment to a conceptual distinction that is marked in Korean but not English; that is, the distinction between 'tight' and 'loose' fit of one object to another(9,10). Like adult Korean speakers but unlike adult English speakers, these infants detected this distinction and divided a continuum of motion-into-contact actions into tight- and loose-fit categories. Infants' sensitivity to this distinction is linked to representations of object mechanics(11) that are shared by non-human animals(12-14). Language learning therefore seems to develop by linking linguistic forms to universal, pre-existing representations of sound and meaning.	Vanderbilt Univ, Dept Psychol & Human Dev, Nashville, TN 37203 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Vanderbilt University; Harvard University	Hespos, SJ (corresponding author), Vanderbilt Univ, Dept Psychol & Human Dev, Nashville, TN 37203 USA.	s.hespos@vanderbilt.edu		Hespos, Susan/0000-0002-7970-1330	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008124] Funding Source: NIH RePORTER; NICHD NIH HHS [F32 HD008124-03, F32 HD008124-04] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baillargeon Renee, 1995, ADV INFANCY RES, P305; Bornstein M. H., 1985, MEASUREMENT AUDITION, P253; Bowerman M., 1996, LANGUAGE SPACE, P385; Bowerman M., 2001, LANG ACQUIS; Casasola M, 2003, CHILD DEV, V74, P679, DOI 10.1111/1467-8624.00562; Casasola M, 2002, DEVELOPMENTAL SCI, V5, P247, DOI 10.1111/1467-7687.00226; Choi S, 1999, COGNITIVE DEV, V14, P241, DOI 10.1016/S0885-2014(99)00004-0; CHOI S, 1991, COGNITION, V41, P83, DOI 10.1016/0010-0277(91)90033-Z; EIMAS PD, 1971, SCIENCE, V171, P303, DOI 10.1126/science.171.3968.303; Hauser, 1996, EVOL COMMUN; Hauser MD, 1998, DEVELOPMENTAL SCI, V1, P31, DOI 10.1111/1467-7687.00009; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Jusczyk P., 1997, DISCOVERY SPOKEN LAN; Kuhl P. K., 1987, CATEGORICAL PERCEPTI, P355; KUHL PK, 1993, J PHONETICS, V21, P125; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; McDonough L, 2003, COGNITIVE PSYCHOL, V46, P229, DOI 10.1016/S0010-0285(02)00514-5; Santos LR, 2004, DEVELOPMENTAL SCI, V7, P167, DOI 10.1111/j.1467-7687.2004.00335.x; Santos LR, 2002, DEVELOPMENTAL SCI, V5, pF1, DOI 10.1111/1467-7687.t01-1-00216; SPELKE ES, 1990, COGNITIVE SCI, V14, P29, DOI 10.1207/s15516709cog1401_3; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3; WERKER JF, 1995, INVITATION COGNITIVE, P87; Whorf B.L., 2012, LANGUAGE THOUGHT REA; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542	24	181	181	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					453	456		10.1038/nature02634	http://dx.doi.org/10.1038/nature02634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	839RD	15269769	Green Accepted			2022-12-28	WOS:000222801400043
J	Kastner, JH; Richmond, M; Grosso, N; Weintraub, DA; Simon, T; Frank, A; Hamaguchi, K; Ozawa, H; Henden, A				Kastner, JH; Richmond, M; Grosso, N; Weintraub, DA; Simon, T; Frank, A; Hamaguchi, K; Ozawa, H; Henden, A			An X-ray outburst from the rapidly accreting young star that illuminates McNeil's nebula	NATURE			English	Article							STELLAR OBJECTS; ORION NEBULA; EMISSION; PROTOSTARS; DISCOVERY; ROTATION; CLUSTER; SYSTEM; SCALE; JETS	Young, low-mass stars are luminous X-ray sources(1) whose powerful X-ray flares(2-6) may exert a profound influence over the process of planet formation(7). The origin of the X-ray emission is uncertain. Although many (or perhaps most) recently formed, low-mass stars emit X-rays as a consequence of solar-like coronal activity(1,8,9), it has also been suggested that X-ray emission may be a direct result of mass accretion onto the forming star(10-12). Here we report X-ray imaging spectroscopy observations which reveal a factor similar to50 increase in the X-ray flux from a young star that is at present undergoing a spectacular optical/infrared outburst(13) (this star illuminates McNeil's nebula(14)). The outburst seems to be due to the sudden onset of a phase of rapid accretion(13,15,16). The coincidence of a surge in X-ray brightness with the optical/infrared eruption demonstrates that strongly enhanced high-energy emission from young stars can occur as a consequence of high accretion rates. We suggest that such accretion-enhanced X-ray emission from erupting young stars may be short-lived, because intense star-disk magnetospheric interactions are quenched rapidly by the subsequent flood of new material onto the star.	Rochester Inst Technol, Rochester, NY 14623 USA; Univ Grenoble 1, Lab Astrophys Grenoble, F-38041 Grenoble, France; Vanderbilt Univ, Nashville, TN 37235 USA; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; Univ Rochester, Rochester, NY 14627 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; USN Observ, Flagstaff, AZ 86002 USA	Rochester Institute of Technology; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Vanderbilt University; University of Hawaii System; University of Rochester; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of Defense; United States Navy	Kastner, JH (corresponding author), Rochester Inst Technol, Rochester, NY 14623 USA.	jhk@cis.rit.edu		Frank, Adam/0000-0002-4948-7820				Abraham P, 2004, ASTRON ASTROPHYS, V419, pL39, DOI [10.1051/0004-6361:20040138, 10.1051/0004-636120040138]; ANTHONYTWAROG BJ, 1982, ASTRON J, V87, P1213, DOI 10.1086/113204; Briceno C, 2004, ASTROPHYS J, V606, pL123, DOI 10.1086/421395; Eisloffel J, 1997, ASTRON J, V114, P280, DOI 10.1086/118473; Favata F, 2002, ASTRON ASTROPHYS, V386, P204, DOI 10.1051/0004-6361:20011387; Feigelson ED, 2002, ASTROPHYS J, V574, P258, DOI 10.1086/340936; Feigelson ED, 1999, ANNU REV ASTRON ASTR, V37, P363, DOI 10.1146/annurev.astro.37.1.363; Feigelson ED, 2002, ASTROPHYS J, V572, P335, DOI 10.1086/340340; Goodson AP, 1997, ASTROPHYS J, V489, P199, DOI 10.1086/304774; Grosso N, 1997, NATURE, V387, P56, DOI 10.1038/387056a0; Hartmann L, 1996, ANNU REV ASTRON ASTR, V34, P207, DOI 10.1146/annurev.astro.34.1.207; Hartmann L., 1998, ACCRETION PROCESSES; Hayashi MR, 1996, ASTROPHYS J, V468, pL37, DOI 10.1086/310222; HERBIG GH, 1977, ASTROPHYS J, V217, P693, DOI 10.1086/155615; Herbig GH, 2001, PUBL ASTRON SOC PAC, V113, P1547, DOI 10.1086/324420; Imanishi K, 2001, ASTROPHYS J, V557, P747, DOI 10.1086/321691; Kaastra J.S., 1996, 11 C UV XRAY SPECTRO, P411; Kastner JH, 2002, ASTROPHYS J, V567, P434, DOI 10.1086/338419; Kastner JH, 2004, ASTROPHYS J, V605, pL49, DOI 10.1086/420769; Koyama K, 1996, PUBL ASTRON SOC JPN, V48, pL87, DOI 10.1093/pasj/48.5.L87; MCNEIL JW, 2004, 8284 IAU; Montmerle T, 2000, ASTROPHYS J, V532, P1097, DOI 10.1086/308611; Ozawa H, 1999, ASTROPHYS J, V523, pL81, DOI 10.1086/312247; PREIBISCH T, 1995, ASTRON ASTROPHYS, V304, pL13; Reipurth B, 2004, ASTROPHYS J, V606, pL119, DOI 10.1086/421393; Shu FH, 1997, SCIENCE, V277, P1475, DOI 10.1126/science.277.5331.1475; SIMON T, IN PRESS ASTROPHYS J; Stassun KG, 2004, ASTRON J, V127, P3537, DOI 10.1086/420989; Stelzer B, 2004, ASTRON ASTROPHYS, V418, P687, DOI 10.1051/0004-6361:20040041; ZINNECKER H, 1994, ASTRON ASTROPHYS, V292, P152	30	49	49	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					429	431		10.1038/nature02747	http://dx.doi.org/10.1038/nature02747			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269761				2022-12-28	WOS:000222801400035
J	Mishima, M; Pavicic, V; Gruneberg, N; Nigg, EA; Glotzer, M				Mishima, M; Pavicic, V; Gruneberg, N; Nigg, EA; Glotzer, M			Cell cycle regulation of central spindle assembly	NATURE			English	Article							CYTOKINESIS; PROTEIN; KINESIN; COMPLEX; MITOSIS; INCENP; MCAK; PHOSPHORYLATION; LOCALIZATION; PHOSPHATASE	The bipolar mitotic spindle is responsible for segregating sister chromatids at anaphase. Microtubule motor proteins generate spindle bipolarity and enable the spindle to perform mechanical work(1). A major change in spindle architecture occurs at anaphase onset when central spindle assembly begins. This structure regulates the initiation of cytokinesis and is essential for its completion(2). Central spindle assembly requires the central-spindlin complex composed of the Caenorhabditis elegans ZEN-4 (mammalian orthologue MKLP1) kinesin-like protein and the Rho family GAP CYK-4 (MgcRacGAP). Here we describe a regulatory mechanism that controls the timing of central spindle assembly. The mitotic kinase Cdk1/cyclin B phosphorylates the motor domain of ZEN-4 on a conserved site within a basic amino-terminal extension characteristic of the MKLP1 subfamily. Phosphorylation by Cdk1 diminishes the motor activity of ZEN-4 by reducing its affinity for microtubules. Preventing Cdk1 phosphorylation of ZEN-4/MKLP1 causes enhanced metaphase spindle localization and defects in chromosome segregation. Thus, phosphoregulation of the motor domain of MKLP1 kinesin ensures that central spindle assembly occurs at the appropriate time in the cell cycle and maintains genomic stability.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Max Planck Society	Glotzer, M (corresponding author), Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	mglotzer@imp.univie.ac.at	Gruneberg, Ulrike/AAY-2351-2020	Gruneberg, Ulrike/0000-0001-8344-0500; Mishima, Masanori/0000-0002-8908-7485; Glotzer, Michael/0000-0002-8723-7232; nigg, erich/0000-0003-4835-5719				Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; BERLINER E, 1994, J BIOL CHEM, V269, P8610; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Gruneberg U, 2002, J CELL BIOL, V158, P901, DOI 10.1083/jcb.200202054; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Matuliene J, 2002, MOL BIOL CELL, V13, P1832, DOI 10.1091/mbc.01-10-0504; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mello C, 1995, METHOD CELL BIOL, V48, P451; Minestrini G, 2003, MOL BIOL CELL, V14, P4028, DOI 10.1091/mbc.E03-04-0214; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Patra D, 1998, GENE DEV, V12, P2549, DOI 10.1101/gad.12.16.2549; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Romano A, 2003, J CELL BIOL, V161, P229, DOI 10.1083/jcb.200207117; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; SELLITTO C, 1988, J CELL BIOL, V106, P431, DOI 10.1083/jcb.106.2.431; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385	30	210	215	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					908	913		10.1038/nature02767	http://dx.doi.org/10.1038/nature02767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15282614				2022-12-28	WOS:000223369800046
J	Morrison, EH; Rucker, L; Boker, JR; Gabbert, CC; Hubbell, FA; Hitchcock, MA; Prislin, MD				Morrison, EH; Rucker, L; Boker, JR; Gabbert, CC; Hubbell, FA; Hitchcock, MA; Prislin, MD			The effect of a 13-hour curriculum to improve residents' teaching skills - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL TEACHERS; FEEDBACK; PERFORMANCES; PROGRAMS	Background: Although resident physicians often teach, few trials have tested interventions to improve residents' teaching skills. A pilot trial in 2001-2002 found that 13 trained resident teachers taught better than did untrained control residents. Objective: To determine whether a longitudinal residents-as teachers curriculum improves residents' teaching skills. Design: Randomized, controlled trial from May 2001 to February 2002 (pilot trial) and March 2002 to April 2003. Setting: 4 generalist residencies affiliated with an urban academic medical center. Participants: 62 second-year residents: 23 in the 2001-2002 pilot trial and 39 more in 2002-2003; 27 of the 39 participants were medicine residents required to learn teaching skills. Intervention: A 13-hour curriculum in which residents practiced teaching and received feedback during 1-hour small-group sessions taught twice monthly for 6 months. Measurements: A 3.5-hour, 8-station, objective structured teaching examination that was enacted and rated by 50 medical students before and after the intervention. Two trained, blinded raters independently assessed each station (inter-rater reliability, 0.75). Results: In the combined results for 2001-2003, the intervention group (n = 33) and control group (n = 29) were similar in sex, specialty, and academic performance. On a 1 to 5 Likert scale, intervention residents outscored controls on overall improvement score (post-test-pretest difference, 0.74 vs. 0.07; difference between intervention and control groups, 0.68 [95% Cl, 0.55 to 0.811; P < 0.001) by a magnitude of 2.8 standard deviations and on all 8 individual stations. The intervention residents improved 28.5% overall, whereas the scores of control residents did not increase significantly (2.7%). In 2002-2003, 19 intervention residents similarly outscored 19 controls (post-test-pretest difference, 0.83 vs. 0.14; difference between intervention and control groups, 0.69 [Cl, 0.53 to 0.841; P < 0.001). Twenty-seven medicine residents required to learn teaching skills achieved scores similar to those of volunteers. Limitations: The study was conducted at a single institution. No "real life" assessment with which to compare the results of the 1, objective structured teaching examination was available. Conclusions: Generalist residents randomly assigned to receive a 13-hour longitudinal residents-as-teachers curriculum consistently showed improved teaching skills, as judged by medical student raters. Residents required to participate improved as much as volunteers did.	Univ Calif Irvine, Coll Med, Dept Family Med, Orange, CA 92868 USA; Univ So Calif, Los Angeles, CA USA	University of California System; University of California Irvine; University of Southern California	Morrison, EH (corresponding author), Univ Calif Irvine, Coll Med, Dept Family Med, 101 City Dr S,Bldg 200,Suite 512,Route 81, Orange, CA 92868 USA.	ehmorris@uci.edu		Morrison, Elizabeth/0000-0001-5018-0351	PHS HHS [22 HP00006-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*ACCR COUNC GRAD M, ACGME OUTC PROJ GEN; ANDERSON DC, 1991, ACAD MED, V66, P29, DOI 10.1097/00001888-199101000-00009; BingYou RG, 1997, TEACH LEARN MED, V9, P10, DOI 10.1080/10401339709539806; BINGYOU RG, 1993, MED EDUC, V27, P259, DOI 10.1111/j.1365-2923.1993.tb00266.x; Dunnington GL, 1998, ACAD MED, V73, P696, DOI 10.1097/00001888-199806000-00017; DUNNINGTON GL, 2000, INSTRUCTORS GUIDE TE; EDWARDS JC, 1988, J MED EDUC, V63, P603; EDWARDS JC, 1988, HDB C TEACHING SKILL; Furney SL, 2001, J GEN INTERN MED, V16, P620, DOI 10.1046/j.1525-1497.2001.016009620.x; JEWETT LS, 1982, J MED EDUC, V57, P361; KAAGAN SA, 1999, LEADERSHIP GAMES EXP; Liaison Committee on Medical Education, 2000, FUNCT STRUCT MED SCH; Litzelman DK, 1998, ACAD MED, V73, P688, DOI 10.1097/00001888-199806000-00016; Litzelman DK, 1998, ACAD MED, V73, P324, DOI 10.1097/00001888-199803000-00022; Marriott DJ, 1998, ACAD MED, V73, pS72, DOI 10.1097/00001888-199810000-00050; Morrison EH, 2003, ACAD MED, V78, P722, DOI 10.1097/00001888-200307000-00016; Morrison EH, 2002, ACAD MED, V77, pS29, DOI 10.1097/00001888-200210001-00010; Morrison EH, 2002, FAM MED, V34, P445; Morrison EH, 2001, ACAD MED, V76, pS1, DOI 10.1097/00001888-200110001-00002; Neher J O, 1992, J Am Board Fam Pract, V5, P419; Prislin MD, 1998, ACAD MED, V73, P1116, DOI 10.1097/00001888-199810000-00024; SCHWENK TL, 1993, RESIDENTS TEACHERS G; SKEFF KM, 1992, ARCH INTERN MED, V152, P1156, DOI 10.1001/archinte.1992.00400180028004; Snell L, 2000, MED EDUC, V34, P862, DOI 10.1046/j.1365-2923.2000.00754.x; Strauss A., 1998, BASICS QUALITATIVE R; WEINBERGER S, 2003, CLIN ED MED STUDENTS; Wilkerson L, 1998, ACAD MED, V73, P387, DOI 10.1097/00001888-199804000-00011; Wipf JE, 1999, ACAD MED, V74, P938, DOI 10.1097/00001888-199908000-00021	28	68	71	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2004	141	4					257	263		10.7326/0003-4819-141-4-200408170-00005	http://dx.doi.org/10.7326/0003-4819-141-4-200408170-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846BX	15313741				2022-12-28	WOS:000223290900002
J	Arvidson, RE; Anderson, RC; Bartlett, P; Bell, JF; Blaney, D; Christensen, PR; Chu, P; Crumpler, L; Davis, K; Ehlmann, BL; Fergason, R; Golombek, MP; Gorevan, S; Grant, JA; Greeley, R; Guinness, EA; Haldemann, AFC; Herkenhoff, K; Johnson, J; Landis, G; Li, R; Lindemann, R; McSween, H; Ming, DW; Myrick, T; Richter, L; Seelos, FP; Squyres, SW; Sullivan, RJ; Wang, A; Wilson, J				Arvidson, RE; Anderson, RC; Bartlett, P; Bell, JF; Blaney, D; Christensen, PR; Chu, P; Crumpler, L; Davis, K; Ehlmann, BL; Fergason, R; Golombek, MP; Gorevan, S; Grant, JA; Greeley, R; Guinness, EA; Haldemann, AFC; Herkenhoff, K; Johnson, J; Landis, G; Li, R; Lindemann, R; McSween, H; Ming, DW; Myrick, T; Richter, L; Seelos, FP; Squyres, SW; Sullivan, RJ; Wang, A; Wilson, J			Localization and physical properties experiments conducted by Spirit at Gusev crater	SCIENCE			English	Article							PATHFINDER	The precise location and relative elevation of Spirit during its traverses from the Columbia Memorial station to Bonneville crater were determined with bundle-adjusted retrievals from rover wheel turns, suspension and tilt angles, and overlapping images. Physical properties experiments show a decrease of 0.2% per Mars solar day in solar cell output resulting from deposition of airborne dust, cohesive soil-like deposits in plains and hollows, bright and dark rock coatings, and relatively weak volcanic rocks of basaltic composition. Volcanic, impact, aeolian, and water-related processes produced the encountered landforms and materials.	Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Honeybee Robot, New York, NY 10012 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; US Geol Survey, Flagstaff, AZ 86001 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Deutsch Luft & Raumfahrt Inst Raumsimulat, D-51170 Cologne, Germany	Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University; Arizona State University; Arizona State University-Tempe; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; University System of Ohio; Ohio State University; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Arvidson, RE (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.		Haldemann, Albert F C/I-9224-2012; Seelos, Frank/C-7875-2016	Haldemann, Albert F C/0000-0003-3741-8841; Seelos, Frank/0000-0001-9721-941X				Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Landis GA, 2000, J GEOPHYS RES-PLANET, V105, P1855, DOI 10.1029/1999JE001029; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; Moore HJ, 1999, J GEOPHYS RES-PLANET, V104, P8729, DOI 10.1029/1998JE900005; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794	10	144	155	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					821	824		10.1126/science.1099922	http://dx.doi.org/10.1126/science.1099922			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297662				2022-12-28	WOS:000223104900035
J	Gellert, R; Rieder, R; Anderson, RC; Bruckner, J; Clark, BC; Dreibus, G; Economou, T; Klingelhofer, G; Lugmair, GW; Ming, DW; Squyres, SW; d'Uston, C; Wanke, H; Yen, A; Zipfel, J				Gellert, R; Rieder, R; Anderson, RC; Bruckner, J; Clark, BC; Dreibus, G; Economou, T; Klingelhofer, G; Lugmair, GW; Ming, DW; Squyres, SW; d'Uston, C; Wanke, H; Yen, A; Zipfel, J			Chemistry of rocks and soils in Gusev crater from the alpha particle x-ray spectrometer	SCIENCE			English	Article							CHEMICAL-COMPOSITION; PATHFINDER SITE; MARS; ROVER	The alpha particle x-ray spectrometer on the Spirit rover determined major and minor elements of soils and rocks in Gusev crater in order to unravel the crustal evolution of planet Mars. The composition of soils is similar to those at previous landing sites, as a result of global mixing and distribution by dust storms. Rocks ( fresh surfaces exposed by the rock abrasion tool) resemble volcanic rocks of primitive basaltic composition with low intrinsic potassium contents. High abundance of bromine ( up to 170 parts per million) in rocks may indicate the alteration of surfaces formed during a past period of aqueous activity in Gusev crater.	Max Planck Inst Chem, D-55128 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; Univ Chicago, Enrico Fermi Inst, Lab Atmospher & Space Res, Chicago, IL 60637 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France	Max Planck Society; Johannes Gutenberg University of Mainz; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Lockheed Martin; University of Chicago; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Cornell University	Gellert, R (corresponding author), Max Planck Inst Chem, JJ Becher Weg 27, D-55128 Mainz, Germany.	gellert@mpch-mainz.mpg.de						BANIN A., 2000, MARS, P594; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; CLARK BC, 1979, GEOPHYS RES LETT, V6, P811, DOI 10.1029/GL006i010p00811; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; DREIBUS G, UNPUB; Dreibus G., 2003, INT S EV SOL SYST MA, P19; Foley CN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002019; GOREVAN SP, 2003, J GEOPHYS RES-PLANET, V108; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Newsom HE, 1997, J GEOPHYS RES-PLANET, V102, P19345, DOI 10.1029/97JE01687; Rieder R, 1997, SCIENCE, V278, P1771, DOI 10.1126/science.278.5344.1771; Rieder R., 2003, Journal of Geophysical Research, V108, pROV7, DOI 10.1029/2003JE002150; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; SUTTON SR, 2002, LUNAR PLANET SCI, V33, P1278; WANKE H, 1994, PHILOS T R SOC A, V349, P285, DOI 10.1098/rsta.1994.0132; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645	17	244	247	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					829	832		10.1126/science.1099913	http://dx.doi.org/10.1126/science.1099913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297665				2022-12-28	WOS:000223104900038
J	Khakoo, SI; Thio, CL; Martin, MP; Brooks, CR; Gao, XJ; Astemborski, J; Cheng, J; Goedert, JJ; Vlahov, D; Hilgartner, M; Cox, S; Little, AM; Alexander, GJ; Cramp, ME; O'Brien, SJ; Rosenberg, WMC; Thomas, DL; Carrington, M				Khakoo, SI; Thio, CL; Martin, MP; Brooks, CR; Gao, XJ; Astemborski, J; Cheng, J; Goedert, JJ; Vlahov, D; Hilgartner, M; Cox, S; Little, AM; Alexander, GJ; Cramp, ME; O'Brien, SJ; Rosenberg, WMC; Thomas, DL; Carrington, M			HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection	SCIENCE			English	Article							RECOGNITION; CYTOMEGALOVIRUS; ACTIVATION; ARTHRITIS; DIVERSITY; LOCUS; BLOOD	Natural killer (NK) cells provide a central defense against viral infection by using inhibitory and activation receptors for major histocompatibility complex class I molecules as a means of controlling their activity. We show that genes encoding the inhibitory NK cell receptor KIR2DL3 and its human leukocyte antigen C group1 (HLA-C1) ligand directly influence resolution of hepatitis C virus (HCV) infection. This effect was observed in Caucasians and African Americans with expected low infectious doses of HCV but not in those with high-dose exposure, in whom the innate immune response is likely overwhelmed. The data strongly suggest that inhibitory NK cell interactions are important in determining antiviral immunity and that diminished inhibitory responses confer protection against HCV.	Univ Southampton, Div Infect Inflammat & Repair, Liver Grp, Southampton 5016 6YD, Hants, England; Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21231 USA; NCI Federick, Basic Res Program, Sci Applicat Int Corp Frederick Inc, Lab Gen Divers, Frederick, MD 21702 USA; NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; New York Acad Med, New York, NY 10029 USA; Cornell Med Ctr, New York Presbyterian Hosp, Dept Pediat, New York, NY 10021 USA; Royal Free Hosp, Anthony Nolan Res Inst, London NW3 2PF, England; Univ Cambridge, Dept Med, Cambridge CD2 2QQ, England; Derriford Hosp, Dept Gastroenterol, Plymouth PL6 8DH, Devon, England; NCI, Lab Gen Divers, Frederick, MD 21702 USA	University of Southampton; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York Academy of Medicine; Cornell University; NewYork-Presbyterian Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Cambridge; Derriford Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Carrington, M (corresponding author), Univ Southampton, Div Infect Inflammat & Repair, Liver Grp, Southampton 5016 6YD, Hants, England.	sik@soton.ac.uk; carringt@ncifcrf.gov	Yang, Chen/G-1379-2010; OBRIEN, STEPHEN/ABD-1346-2020; Cox, Steve Thomas/AAE-5408-2021; Rosenberg, William/ABA-1071-2021	Cox, Steve Thomas/0000-0003-0590-1281; Rosenberg, William/0000-0002-2732-2304; Brooks, Collin/0000-0002-3947-2246; Khakoo, Salim/0000-0002-4057-9091; OBRIEN, STEPHEN/0000-0001-7857-0757	NCI NIH HHS [N01-CP-01004, N01-CP-33002, N01-CO-12400] Funding Source: Medline; NICHD NIH HHS [N01-HD-4-3200] Funding Source: Medline; NIDA NIH HHS [DA00441, DA13324, DA04334] Funding Source: Medline; DIVISION OF BASIC SCIENCES - NCI [Z01BC010269] Funding Source: NIH RePORTER; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP001004, N01CP033002] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD043200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013324, R01DA004334, R56DA004334, R37DA004334] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adams EJ, 1999, IMMUNOGENETICS, V49, P865; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; Crotta S, 2002, J EXP MED, V195, P35, DOI 10.1084/jem.20011124; GUO ZP, 1995, TRANSFUSION, V35, P112, DOI 10.1046/j.1537-2995.1995.35295125732.x; Hershberger KL, 2001, J IMMUNOL, V166, P4380, DOI 10.4049/jimmunol.166.7.4380; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Khakoo SI, 2000, IMMUNITY, V12, P687, DOI 10.1016/S1074-7613(00)80219-8; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; Racanelli V, 2003, TRENDS IMMUNOL, V24, P456, DOI 10.1016/S1471-4906(03)00178-9; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; Shilling HG, 2002, J IMMUNOL, V169, P239, DOI 10.4049/jimmunol.169.1.239; SIMMONDS P, 1990, LANCET, V336, P1469, DOI 10.1016/0140-6736(90)93179-S; Thio CL, 2002, J VIROL, V76, P4792, DOI 10.1128/JVI.76.10.4792-4797.2002; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; Winter CC, 1998, J IMMUNOL, V161, P571; Yen JH, 2001, J EXP MED, V193, P1159, DOI 10.1084/jem.193.10.1159	23	912	957	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					872	874		10.1126/science.1097670	http://dx.doi.org/10.1126/science.1097670			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297676				2022-12-28	WOS:000223104900051
J	Powe, NR; Cooper, LA				Powe, NR; Cooper, LA			Diversifying the racial and ethnic composition of the physician workforce	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNDERSERVED POPULATIONS; AFFIRMATIVE-ACTION; CARE; RACE; MINORITY; OUTCOMES; PATIENT		Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Powe, NR (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-600, Baltimore, MD 21205 USA.	npowe@jhmi.edu						Amer College Physicians, 2004, ANN INTERN MED, V141, P226, DOI 10.7326/0003-4819-141-3-200408030-00015; Ashton CM, 2003, NEW ENGL J MED, V349, P1637, DOI 10.1056/NEJMsa003299; Brotherton SE, 2000, ARCH PEDIAT ADOL MED, V154, P912, DOI 10.1001/archpedi.154.9.912; Cantor JC, 1996, INQUIRY-J HEALTH CAR, V33, P167; Cooper LA, 2003, ANN INTERN MED, V139, P907, DOI 10.7326/0003-4819-139-11-200312020-00009; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; KEITH SN, 1985, NEW ENGL J MED, V313, P1519, DOI 10.1056/NEJM198512123132406; Komaromy M, 1996, NEW ENGL J MED, V334, P1305, DOI 10.1056/NEJM199605163342006; Lee LJ, 2002, J GEN INTERN MED, V17, P640, DOI 10.1046/j.1525-1497.2002.10742.x; MOY E, 1995, JAMA-J AM MED ASSOC, V273, P1515, DOI 10.1001/jama.273.19.1515; Perez-Stable EJ, 1997, MED CARE, V35, P1212, DOI 10.1097/00005650-199712000-00005; U.S. Census Bureau, 2004, US INT PROJ AG SEX R; Xu G, 1997, AM J PUBLIC HEALTH, V87, P817, DOI 10.2105/AJPH.87.5.817	14	34	35	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2004	141	3					223	224		10.7326/0003-4819-141-3-200408030-00013	http://dx.doi.org/10.7326/0003-4819-141-3-200408030-00013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HG	15289221				2022-12-28	WOS:000223068600008
J	Ansermino, M; Hemsley, C				Ansermino, M; Hemsley, C			ABC of burns - Intensive care management and control of infection	BRITISH MEDICAL JOURNAL			English	Review							THERAPY		British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada; John Radcliffe Hosp, Oxford OX3 9DU, England	BC Childrens Hospital; University of British Columbia; University of Oxford	Ansermino, M (corresponding author), British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada.			Ansermino, J Mark/0000-0001-8427-2035				Desai MH, 1998, J BURN CARE REHABIL, V19, P210, DOI 10.1097/00004630-199805000-00004; MONAFO WW, 1990, DRUGS, V40, P364, DOI 10.2165/00003495-199040030-00004; Pruitt BA, 1998, WORLD J SURG, V22, P135; Still JM, 2000, CLIN PLAST SURG, V27, P23; Warren S, 1991, Curr Clin Top Infect Dis, V11, P206	5	42	47	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 24	2004	329	7459					220	223		10.1136/bmj.329.7459.220	http://dx.doi.org/10.1136/bmj.329.7459.220			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840NW	15271835	Green Published			2022-12-28	WOS:000222866900023
J	Marsh, JCW; Gordon-Smith, EC				Marsh, JCW; Gordon-Smith, EC			Insights into the autoimmune nature of aplastic anaemia	LANCET			English	Editorial Material							BONE-MARROW; IMMUNOSUPPRESSIVE THERAPY; PATHOGENESIS; REPERTOIRE; MECHANISMS; CELLS		St George Hosp, Sch Med, London SW17 0RE, England	St Georges University London	Marsh, JCW (corresponding author), St George Hosp, Sch Med, London SW17 0RE, England.	jmarsh@sghms.ac.uk						Bacigalupo A, 2000, SEMIN HEMATOL, V37, P69, DOI 10.1016/S0037-1963(00)90031-3; Hinterberger W, 1997, ANN INTERN MED, V126, P116, DOI 10.7326/0003-4819-126-2-199701150-00004; Hirano N, 2003, BLOOD, V102, P4567, DOI 10.1182/blood-2002-11-3409; Karadimitris A, 2001, LEUKEMIA, V15, P1148, DOI 10.1038/sj.leu.2402180; Karadimitris A, 2000, BLOOD, V96, P2613, DOI 10.1182/blood.V96.7.2613.h8002613_2613_2620; Killick SB, 2000, BRIT J HAEMATOL, V111, P1164, DOI 10.1046/j.1365-2141.2000.02485.x; Kook H, 2002, BLOOD, V99, P3668, DOI 10.1182/blood.V99.10.3668; MARSH JCW, 2000, APLASTIC ANAEMIA PAT, P3; MATHE G, 1970, BMJ-BRIT MED J, V2, P131, DOI 10.1136/bmj.2.5702.131; Risitano AM, 2002, BLOOD, V100, P178, DOI 10.1182/blood-2002-01-0236; Saunthararajah Y, 2002, BLOOD, V100, P1570, DOI 10.1182/blood.V100.5.1570.h81702001570_1570_1574; Sloand E, 2002, BLOOD, V100, P1185, DOI 10.1182/blood-2002-01-0035; Young NS, 1997, NEW ENGL J MED, V336, P1365, DOI 10.1056/NEJM199705083361906; Zeng WH, 2004, BLOOD, V103, P325, DOI 10.1182/blood-2003-02-0490	14	6	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					308	309		10.1016/S0140-6736(04)16736-6	http://dx.doi.org/10.1016/S0140-6736(04)16736-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276370				2022-12-28	WOS:000222853300005
J	Pitts, S; Kellermann, AL				Pitts, S; Kellermann, AL			Hyperventilation during cardiac arrest	LANCET			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION		Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA	Emory University	Kellermann, AL (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA.	akell01@emory.edu						ANDERSEN MN, 1966, ANN SURG, V163, P161, DOI 10.1097/00000658-196602000-00001; [Anonymous], 2000, CIRCULATION S, V102, P186; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Lurie KG, 2002, CIRCULATION, V105, P124, DOI 10.1161/hc0102.101391; Maheshwari A, 2002, EMERG MED CLIN N AM, V20, P759, DOI 10.1016/S0733-8627(02)00026-3; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; PARADIS NA, 1990, JAMA-J AM MED ASSOC, V263, P1106, DOI 10.1001/jama.263.8.1106; Sigurdsson Gardar, 2003, Curr Opin Crit Care, V9, P183, DOI 10.1097/00075198-200306000-00002	8	32	37	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					313	315		10.1016/S0140-6736(04)16740-8	http://dx.doi.org/10.1016/S0140-6736(04)16740-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276374				2022-12-28	WOS:000222853300009
J	Meeusen, S; McCaffery, JM; Nunnari, J				Meeusen, S; McCaffery, JM; Nunnari, J			Mitochondrial fusion intermediates revealed in vitro	SCIENCE			English	Article							DYNAMIN-RELATED GTPASE; DOMINANT OPTIC ATROPHY; OUTER-MEMBRANE; SACCHAROMYCES-CEREVISIAE; PROTEIN; FISSION; MGM1P; APOPTOSIS; FZO1P; YEAST	The events that occur during the fusion of double-membraned mitochondria are unknown. As an essential step toward determining the mechanism of mitochondria) fusion, we have captured this event in vitro. Mitochondrial outer and inner membrane fusion events were separable and mechanistically distinct, but both required guanosine 5'-triphosphate hydrolysis. Homotypic trans interactions of the ancient outer transmembrane guanosine triphosphatase, Fzo1, were required to promote the fusion of mitochondrial outer membranes, whereas electrical potential was also required for fusion of inner membranes. Our conclusions provide fundamental insights into the molecular events driving mitochondrial fusion and advance our understanding of the evolution of mitochondria) fusion in eukaryotic cells.	Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Integrated Imaging Ctr, Baltimore, MD 21218 USA	University of California System; University of California Davis; Johns Hopkins University; Johns Hopkins University	Nunnari, J (corresponding author), Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA.	jmnunnari@ucdavis.edu			NCRR NIH HHS [S10 RR019409-01] Funding Source: Medline; NIGMS NIH HHS [R01-GM62942A] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062942] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Belenkiy R, 2000, BBA-BIOMEMBRANES, V1467, P207, DOI 10.1016/S0005-2736(00)00222-4; Caldon CE, 2003, CURR OPIN MICROBIOL, V6, P135, DOI 10.1016/S1369-5274(03)00037-7; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fritz S, 2001, J CELL BIOL, V152, P683, DOI 10.1083/jcb.152.4.683; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; SIMON VR, 1995, J CELL BIOL, V130, P345, DOI 10.1083/jcb.130.2.345; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	23	329	351	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1747	1752		10.1126/science.1100612	http://dx.doi.org/10.1126/science.1100612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15297626	Bronze			2022-12-28	WOS:000224039500033
J	Chaudhuri, J; Khuong, C; Alt, FW				Chaudhuri, J; Khuong, C; Alt, FW			Replication protein A interacts with AID to promote deamination of somatic hypermutation targets	NATURE			English	Article							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; B-CELLS; IMMUNOGLOBULIN GENES; IN-VITRO; TRANSCRIPTION; SEQUENCES; MECHANISM; REGION	Activation-induced cytidine deaminase ( AID) is a single-stranded ( ss) DNA deaminase required for somatic hypermutation (SHM) and class switch recombination of immunoglobulin genes. Class switch recombination involves transcription through switch regions, which generates ssDNA within R loops. However, although transcription through immunoglobulin variable region exons is required for SHM, it does not generate stable ssDNA, which leaves the mechanism of AID targeting unresolved. Here we characterize the mechanism of AID targeting to in-vitro-transcribed substrates harbouring SHM motifs. We show that the targeting activity of AID is due to replication protein A (RPA), a ssDNA-binding protein involved in replication, recombination and repair. The 32-kDa subunit of RPA interacts specifically with AID from activated B cells in a manner that seems to be dependent on post-translational AID modification. Thus, our study implicates RPA as a novel factor involved in immunoglobulin diversification. We propose that B-cell-specific AID-RPA complexes preferentially bind to ssDNA of small transcription bubbles at SHM 'hotspots', leading to AID-mediated deamination and RPA-mediated recruitment of DNA repair proteins.	Childrens Hosp, Ctr Blood Res, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Alt, FW (corresponding author), Childrens Hosp, Ctr Blood Res, Howard Hughes Med Inst, 300 Longwood Ave, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu						Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; Matsunaga T, 1996, J BIOL CHEM, V271, P11047, DOI 10.1074/jbc.271.19.11047; Michael N, 2002, IMMUNITY, V16, P123, DOI 10.1016/S1074-7613(02)00261-3; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagelhus TA, 1997, J BIOL CHEM, V272, P6561, DOI 10.1074/jbc.272.10.6561; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Steitz TA, 2004, CURR OPIN STRUC BIOL, V14, P4, DOI 10.1016/j.sbi.2004.01.006; Storb U, 2002, CURR BIOL, V12, pR725, DOI 10.1016/S0960-9822(02)01247-2; Storb U, 1998, IMMUNOL REV, V162, P153; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; YELAMOS J, 1995, NATURE, V376, P225; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Yu KF, 2003, DNA REPAIR, V2, P1163, DOI 10.1016/j.dnarep.2003.08.010; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	50	299	309	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					992	998		10.1038/nature02821	http://dx.doi.org/10.1038/nature02821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15273694				2022-12-28	WOS:000223514900034
J	Lee, C; Hong, B; Choi, JM; Kim, Y; Watanabe, S; Ishimi, Y; Enomoto, T; Tada, S; Kim, YC; Cho, YJ				Lee, C; Hong, B; Choi, JM; Kim, Y; Watanabe, S; Ishimi, Y; Enomoto, T; Tada, S; Kim, YC; Cho, YJ			Structural basis for inhibition of the replication licensing factor Cdt1 by geminin	NATURE			English	Article							DNA-REPLICATION; BACILLUS-SUBTILIS; PROTEIN; RECOGNITION; BINDING; CDC6	To maintain chromosome stability in eukaryotic cells, replication origins must be licensed by loading mini-chromosome maintenance (MCM2-7) complexes once and only once per cell cycle(1-9). This licensing control is achieved through the activities of geminin(10-12) and cyclin-dependent kinases(9,13,14). Geminin binds tightly to Cdt1, an essential component of the replication licensing system(6,15-18), and prevents the inappropriate reinitiation of replication on an already fired origin. The inhibitory effect of geminin is thought to prevent the interaction between Cdt1 and the MCM helicase(19,20). Here we describe the crystal structure of the mouse geminin-Cdt1 complex using tGeminin (residues 79-157, truncated geminin) and tCdt1 (residues 172-368, truncated Cdt1). The amino-terminal region of a coiled-coil dimer of tGeminin interacts with both N-terminal and carboxy-terminal parts of tCdt1. The primary interface relies on the steric complementarity between the tGeminin dimer and the hydrophobic face of the two short N-terminal helices of tCdt1 and, in particular, Pro 181, Ala 182, Tyr 183, Phe 186 and Leu 189. The crystal structure, in conjunction with our biochemical data, indicates that the N-terminal region of tGeminin might be required to anchor tCdt1, and the C-terminal region of tGeminin prevents access of the MCM complex to tCdt1 through steric hindrance.	Pohang Univ Sci & Technol, Natl Creat Res Ctr Struct Biol, Pohang, Kyungbook, South Korea; Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Kyungbook, South Korea; Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; Mitsubishi Kagaku Inst Life Sci, Biomol & Technol Dept, Tokyo 1948511, Japan; Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Tohoku University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); United States Department of Energy (DOE); Argonne National Laboratory	Cho, YJ (corresponding author), Pohang Univ Sci & Technol, Natl Creat Res Ctr Struct Biol, Hyoja Dong,San 31, Pohang, Kyungbook, South Korea.	yunje@postech.ac.kr	Lee, Changwook/D-6010-2011	Kim, Youngchang/0000-0002-1610-4889; Choi, Jung Min/0000-0003-2450-3916				Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSSIERE DE, 1995, CELL, V80, P651; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Diffley JFX, 2001, CURR BIOL, V11, pR367, DOI 10.1016/S0960-9822(01)00196-8; Gautam A, 2001, J BIOL CHEM, V276, P23471, DOI 10.1074/jbc.M009537200; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Kearsey SE, 2003, MOL CELL, V12, P1067, DOI 10.1016/S1097-2765(03)00441-6; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Li A, 2004, NAT CELL BIOL, V6, P260, DOI 10.1038/ncb1100; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shreeram S, 2003, Prog Cell Cycle Res, V5, P287; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Whittaker AJ, 2000, GENE DEV, V14, P1765; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yamaguchi R, 2003, CELL, V113, P115, DOI 10.1016/S0092-8674(03)00200-9; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; You ZY, 1999, MOL CELL BIOL, V19, P8003	29	113	119	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					913	917		10.1038/nature02813	http://dx.doi.org/10.1038/nature02813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15286659				2022-12-28	WOS:000223369800047
J	Rowan, R				Rowan, R			Coral bleaching - Thermal adaptation in reef coral symbionts	NATURE			English	Editorial Material							CLIMATE-CHANGE; PHOTOINHIBITION; PHOTOSYNTHESIS		Univ Guam, Marine Lab, Mangilao, GU 96923 USA	University of Guam	Rowan, R (corresponding author), Univ Guam, Marine Lab, Mangilao, GU 96923 USA.	rrowan@uog9.uog.edu						Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Huner NPA, 1998, TRENDS PLANT SCI, V3, P224, DOI 10.1016/S1360-1385(98)01248-5; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; ROWAN R, UNPUB ECOLOGY; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Werner C, 2001, PLANT CELL ENVIRON, V24, P27, DOI 10.1046/j.1365-3040.2001.00651.x	12	468	492	3	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					742	742		10.1038/430742a	http://dx.doi.org/10.1038/430742a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306800	Bronze			2022-12-28	WOS:000223233600031
J	Sachs, JD				Sachs, JD			Seeking a global solution	NATURE			English	Editorial Material									Columbia Univ, Earth Inst, New York, NY 10027 USA	Columbia University	Sachs, JD (corresponding author), Columbia Univ, Earth Inst, 535 W 116th St, New York, NY 10027 USA.								0	11	11	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					725	726		10.1038/430725a	http://dx.doi.org/10.1038/430725a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306785				2022-12-28	WOS:000223233600017
J	Grimes, DA				Grimes, DA			When to deliver the stunted fetus?	LANCET			English	Editorial Material							TESTS; TRIAL		Family Hlth Int, Res Triangle Pk, NC 27709 USA		Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	dgrimes@fhi.org						[Anonymous], [No title captured]; Blix E, 2003, BJOG-INT J OBSTET GY, V110, P1; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Enkin M, 2000, KEIRSE CHALMERS; LILFORD R, 1994, BMJ-BRIT MED J, V308, P111, DOI 10.1136/bmj.308.6921.111; Malcus P, 2004, CURR OPIN OBSTET GYN, V16, P123, DOI 10.1097/00001703-200404000-00005; Neilson JP, 2000, COCHRANE DB SYST REV, V2; Parer JT, 2003, AM J OBSTET GYNECOL, V188, P1622, DOI 10.1067/mob.2003.394; Pattison N., 2000, COCHRANE DB SYST REV; THORNTON JG, 1993, BRIT J OBSTET GYNAEC, V100, P197, DOI 10.1111/j.1471-0528.1993.tb15229.x; Van Bulck B, 2003, BJOG-INT J OBSTET GY, V110, P27	11	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					483	484		10.1016/S0140-6736(04)16823-2	http://dx.doi.org/10.1016/S0140-6736(04)16823-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302175				2022-12-28	WOS:000223132700006
J							Amer College Physicians	Racial and ethnic disparities in health care - A position paper of the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							POOR	Disparities clearly exist in the health care of racial and ethnic minorities. This position paper of the American College of Physicians (ACP) provides ample evidence illustrating that minorities do not always receive the same quality of health care, do not have the same access to health care, are less represented in the health professions, and have poorer overall health status than nonminorities. The ACP finds this to be a major problem in our nation's health system that must be addressed. The ACP is dedicated to working toward eliminating all disparities in health care. This position paper sets forth specific positions for reducing these disparities and will be the foundation for public policy advocacy by ACP for eliminating racial and ethnic disparities in health care.	Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Amer College Physicians (corresponding author), Amer Coll Physicians, 190 Independence Mall W, Philadelphia, PA 19106 USA.							*AM COLL PHYS, 2002, ACH AFF HLTH INS COV; *AM COLL PHYS, 2000, NO HLTH INS ITS EN M; *AM HEART ASS, 2002, TOB IND TARG YOUTH M; [Anonymous], 2002, CULTURAL COMPETENCE; *ASS AM MED COLL, 2004, MIN ACC MED SCH WOUL; *ASS AM MED COLL, 2000, MIN GRAD US MED SCH; Barzansky B, 2002, JAMA-J AM MED ASSOC, V288, P1067, DOI 10.1001/jama.288.9.1067; Bierman AS, 2002, HEALTH AFFAIR, V21, P91, DOI 10.1377/hlthaff.21.3.91; Brach C, 2000, MED CARE RES REV, V57, P181, DOI 10.1177/107755800773743655; Brach Cindy, 2002, Qual Manag Health Care, V10, P15; Brotherton SE, 2000, ARCH PEDIAT ADOL MED, V154, P912, DOI 10.1001/archpedi.154.9.912; Caetano R, 1998, ALCOHOL HEALTH RES W, V22, P233; Cohen JJ, 2002, HEALTH AFFAIR, V21, P90, DOI 10.1377/hlthaff.21.5.90; Collins KS, 2002, FINDINGS COMMONWEALT; Collins KS, 1999, US MINORITY HLTH CHA; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; CROSS T, 1999, J BLACKS HIGH EDUC, V24, P74; Fang D, 2000, JAMA-J AM MED ASSOC, V284, P1085, DOI 10.1001/jama.284.9.1085; Ginsburg JA, 1998, ANN INTERN MED, V128, P236, DOI 10.7326/0003-4819-128-3-199802010-00012; GINZBERG E, 1994, JAMA-J AM MED ASSOC, V271, P464, DOI 10.1001/jama.271.6.464; HALEY JM, 2001, NATL SURVEY AM FAM B, V35; Institute of Medicine, 2001, COV MATT INS HLTH CA; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; *KAIS FAM FDN, 2004, KEY FACTS RAC ETHN M; KEPPEL KG, 2002, HLTH PEOPLE 2000 STA, V23, P1; KOHN LT, 1999, TO ERR IS HUMAN BUIL; Mills RJ, 2003, HLTH INSURANCE COVER; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; NERENZ DR, 2002, DEV HLTH PLAN REPORT; NEWMAN B, 2003, WALL STREET J   0109, P1; PEROT RT, 2001, RACIAL ETHNIC PRIMAR; REGULA R, 2002, COMMUNICATION   0829; US Department of Health and Human Services, 1998, TOB US US RAC ETHN M; *VIOL POL CTR, 2001, HISP FIR VIOL; WATSON S, 2001, P SOC MARK ADV SOC M, P12; 2004, KAISER PERMANENTE AN; 1998, MMWR MORB MORTAL WKL, V47, P193	37	169	171	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2004	141	3					226	232		10.7326/0003-4819-141-3-200408030-00015	http://dx.doi.org/10.7326/0003-4819-141-3-200408030-00015			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HG	15289223	Green Published			2022-12-28	WOS:000223068600010
J	Ash, AS; Carr, PL; Goldstein, R; Friedman, RH				Ash, AS; Carr, PL; Goldstein, R; Friedman, RH			Compensation and advancement of women in academic medicine: Is there equity?	ANNALS OF INTERNAL MEDICINE			English	Article							SEX-DIFFERENCES; FEMALE PHYSICIANS; INTERNAL MEDICINE; ROLE-MODELS; FACULTY; CAREER; MEN; PERCEPTIONS; HARASSMENT; INCOMES	Background: women have been entering academic medicine in numbers at least equal to their male colleagues for several decades. Most studies have found that women do not advance in academic rank as fast as men and that their salaries are not as great. These studies, however, have typically not had the data to examine equity, that is, do women receive similar rewards for similar achievement? Objective: To examine equity in promotion and salary for female versus male medical school faculty nationally. Design: Mailed survey questionnaire. Setting: 24 randomly selected medical schools in the contiguous United States. Participants: 1814 full-time U.S. medical school faculty in 1995-1996, stratified by sex, specialty, and graduation cohort. Measurements: Promotion and compensation of academic medical faculty. Results: Among the 1814 faculty respondents (response rate, 60%), female faculty were less likely to be full professors than were men with similar professional roles and achievement. For example, 66% of men but only 47% of women (P < 0.01) with 15 to 19 years of seniority were full professors. Large deficits in rank for senior faculty women were confirmed in logistic models that accounted for a wide range of other professional characteristics and achievements, including total career publications, years of seniority, hours worked per week, department type, minority status, medical versus nonmedical final degree, and school. Similar multivariable modeling also confirmed gender inequity in compensation. Although base salaries of nonphysician faculty are gender comparable, female physician faculty have a noticeable deficit (-$11691; P = 0.01). Furthermore, both physician and nonphysician women with greater seniority have larger salary deficits (-$485 per year of seniority; P = 0.01). Limitations: This is a cross-sectional study of a longitudinal phenomenon. No data are available for faculty who are no longer working full-time in academic medicine, and all data are self-reported. Conclusions: Female medical school faculty neither advance as rapidly nor are compensated as well as professionally similar male colleagues. Deficits for female physicians are greater than those for nonphysician female faculty, and for both physicians and nonphysicians, women's deficits are greater for faculty with more seniority.	Boston Univ, Sch Med, Off Student Affairs, Boston, MA 02118 USA	Boston University	Carr, PL (corresponding author), Boston Univ, Sch Med, Off Student Affairs, 715 Albany St,L109, Boston, MA 02118 USA.	plcarr@bu.edu	Ash, Arlene/AAG-2914-2019	Ash, Arlene/0000-0002-8448-0253; Friedman, Robert/0000-0002-9440-2443				*ASS AM MED COLL, 1998, AAMC FAC ROST SYST U; Baker LC, 1996, NEW ENGL J MED, V334, P960, DOI 10.1056/NEJM199604113341506; BALDWIN DWC, 1991, WESTERN J MED, V155, P140; Barnett RC, 1998, ACAD MED, V73, P180, DOI 10.1097/00001888-199802000-00017; BEATY HN, 1986, ANN INTERN MED, V104, P90, DOI 10.7326/0003-4819-104-1-90; BICKEL J, 2000, WOMEN JUS ACAD STAT; Cain JM, 2001, ACAD MED, V76, P628, DOI 10.1097/00001888-200106000-00015; Carr PL, 2000, ANN INTERN MED, V132, P889, DOI 10.7326/0003-4819-132-11-200006060-00007; Carr PL, 1998, ANN INTERN MED, V129, P532, DOI 10.7326/0003-4819-129-7-199810010-00004; CARR PL, 1993, ANN INTERN MED, V119, P908, DOI 10.7326/0003-4819-119-9-199311010-00008; COLE JR, 1987, SCI AM, V256, P119, DOI 10.1038/scientificamerican0287-119; Cole JR, 1991, OUTER CIRCLE WOMEN S; DIAL TH, 1994, AM J PSYCHIAT, V151, P96; DIAL TH, 1989, ACAD MED, V64, P198, DOI 10.1097/00001888-198904000-00007; Etzkowitz H., 2000, ATHENA UNBOUND ADV W; Fried LP, 1996, JAMA-J AM MED ASSOC, V276, P898, DOI 10.1001/jama.276.11.898; Grant L, 1988, J Am Med Womens Assoc (1972), V43, P109; GRANT L, 1988, J AM MED WOMEN ASSOC, V43, P115; GRAVES PL, 1985, JAMA-J AM MED ASSOC, V254, P781, DOI 10.1001/jama.254.6.781; Kaplan SH, 1996, NEW ENGL J MED, V335, P1282, DOI 10.1056/NEJM199610243351706; KEHRER BH, 1976, J HUM RESOUR, V11, P526, DOI 10.2307/145430; KOMAROMY M, 1993, NEW ENGL J MED, V328, P322, DOI 10.1056/NEJM199302043280507; LANGWELL KM, 1982, J HUM RESOUR, V17, P261, DOI 10.2307/145472; LEVEY BA, 1990, ACAD MED, V65, P102, DOI 10.1097/00001888-199002000-00011; LEVINSON W, 1991, WESTERN J MED, V154, P423; LEVINSON W, 1989, NEW ENGL J MED, V321, P1511, DOI 10.1056/NEJM198911303212205; LONG JS, 1993, AM SOCIOL REV, V58, P703, DOI 10.2307/2096282; NEUMAYER L, 1993, ARCH SURG-CHICAGO, V128, P669; NICKERSON KG, 1990, JAMA-J AM MED ASSOC, V264, P1813, DOI 10.1001/jama.264.14.1813; Nonnemaker L, 2000, NEW ENGL J MED, V342, P399, DOI 10.1056/NEJM200002103420606; Ochberg R L, 1989, J Am Med Womens Assoc (1972), V44, P123; OHSFELDT RL, 1986, J HEALTH ECON, V5, P335, DOI 10.1016/0167-6296(86)90008-1; PAETZOLD RL, 1999, STAT DISCRIMINATION; Palepu A, 1998, ACAD MED, V73, P318, DOI 10.1097/00001888-199803000-00021; PETERSDORF RG, 1990, ACAD MED, V65, P663, DOI 10.1097/00001888-199011000-00001; TESCH BJ, 1995, JAMA-J AM MED ASSOC, V273, P1022, DOI 10.1001/jama.273.13.1022; Tosi LL, 1998, CLIN ORTHOP RELAT R, P254; Valian V, 1998, WHY SO SLOW ADVANCEM; WHITE LJ, 1991, ANN INTERN MED, V114, P63, DOI 10.7326/0003-4819-114-1-63; WILKINSON CJ, 1986, ANESTHESIOLOGY, V64, P496, DOI 10.1097/00000542-198604000-00014	40	274	275	1	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2004	141	3					205	212		10.7326/0003-4819-141-3-200408030-00009	http://dx.doi.org/10.7326/0003-4819-141-3-200408030-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HG	15289217				2022-12-28	WOS:000223068600005
J	Ely, E				Ely, E			Mind reading	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Ely, E (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.		Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					420	422		10.1056/NEJMp038237	http://dx.doi.org/10.1056/NEJMp038237			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282347				2022-12-28	WOS:000222939700003
J	Tsori, Y; Tournilhac, F; Leibler, L				Tsori, Y; Tournilhac, F; Leibler, L			Demixing in simple fluids induced by electric field gradients	NATURE			English	Article							CRITICAL-POINT; DIELECTRIC-CONSTANT	Phase separation in liquid mixtures is mainly controlled by temperature and pressure, but can also be influenced by gravitational, magnetic or electric fields. However, the weak coupling between such fields and concentration fluctuations limits this effect to extreme conditions(1-3). For example, mixing induced by uniform electric fields is detectable only at temperatures that are within a few hundredths of degree or less of the phase transition temperature of the system being studied(4-7). Here we predict and demonstrate that electric fields can control the phase separation behaviour of mixtures of simple liquids under more practical conditions, provided that the fields are non-uniform. By applying a voltage of 100 V across unevenly spaced electrodes about 50 mum apart, we can reversibly induce the demixing of paraffin and silicone oil at 1K above the phase transition temperature of the mixture; when the field gradients are turned off, the mixture becomes homogeneous again. This direct control over phase separation behaviour depends on field intensity, with the electrode geometry determining the length-scale of the effect. We expect that this phenomenon will find a number of nanotechnological applications, particularly as it benefits from field gradients near small conducting objects.	Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 167, Lab Mat Molle & Chim, F-75231 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Leibler, L (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 167, Lab Mat Molle & Chim, 10 Rue Vauquelin, F-75231 Paris 05, France.	Ludwik.leibler@espci.fr	Tsori, Yoav/F-1524-2012; Tsori, Yoav/B-7427-2014	Tsori, Yoav/0000-0003-3664-6498; Tsori, Yoav/0000-0003-3664-6498				AMUNDSON K, 1994, MACROMOLECULES, V27, P6559, DOI 10.1021/ma00100a047; Berge B, 2000, EUR PHYS J E, V3, P159, DOI 10.1007/s101890070029; Christen T, 2000, APPL PHYS LETT, V76, P230, DOI 10.1063/1.125711; Comiskey B, 1998, NATURE, V394, P253, DOI 10.1038/28349; De Gennes P.-G., 1979, SCALING CONCEPTS POL; DEBYE P, 1965, J CHEM PHYS, V42, P3155, DOI 10.1063/1.1696394; EARLY MD, 1992, J CHEM PHYS, V96, P641, DOI 10.1063/1.462447; GREER SC, 1975, PHYS REV LETT, V34, P250, DOI 10.1103/PhysRevLett.34.250; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Khusid B, 1996, PHYS REV E, V54, P5428, DOI 10.1103/PhysRevE.54.5428; Korda PT, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.128301; Kumar A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021402; Landau L. D., 1957, ELEKTRODINAMIKA SPLO; Lifshitz E. M., 1980, STAT PHYS; MELCHER JR, 1969, ANNU REV FLUID MECH, V1, P111, DOI 10.1146/annurev.fl.01.010169.000551; MOLDOVER MR, 1979, REV MOD PHYS, V51, P79, DOI 10.1103/RevModPhys.51.79; ONUKI A, 1995, EUROPHYS LETT, V29, P611, DOI 10.1209/0295-5075/29/8/004; Orzechowski K, 1999, CHEM PHYS, V240, P275, DOI 10.1016/S0301-0104(98)00386-3; Pohl H., 1978, DIELECTROPHORESIS; Pollack MG, 2000, APPL PHYS LETT, V77, P1725, DOI 10.1063/1.1308534; Rosensweig R. E., 1998, FERROHYDRODYNAMICS; Rowlinson J. S., 1982, LIQUIDS LIQUID MIXTU; Schaffer E, 2000, NATURE, V403, P874, DOI 10.1038/35002540; SENGERS JV, 1980, PHYSICA A, V104, P573, DOI 10.1016/0378-4371(80)90014-X; Tsori Y, 2002, MACROMOLECULES, V35, P5161, DOI 10.1021/ma0117716; WIRTZ D, 1993, PHYS REV LETT, V71, P2236, DOI 10.1103/PhysRevLett.71.2236	26	74	75	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					544	547		10.1038/nature02758	http://dx.doi.org/10.1038/nature02758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282601				2022-12-28	WOS:000222946100043
J	Vaccari, NE; Edgecombe, GD; Escudero, C				Vaccari, NE; Edgecombe, GD; Escudero, C			Cambrian origins and affinities of an enigmatic fossil group of arthropods	NATURE			English	Article							SCUTIGERA-COLEOPTRATA; HOUSE CENTIPEDE; EVOLUTION; SEQUENCES; PHYLOGENY; ARGENTINA	Euthycarcinoids are one of the most enigmatic arthropod groups, having been assigned to nearly all major clades of Arthropoda. Recent work has endorsed closest relationships with crustaceans(1) or a myriapod - hexapod assemblage(2), a basal position in the Euarthropoda(3), or a placement in the Hexapoda(4) or hexapod stem group(5). Euthycarcinoids are known from 13 species ranging in age from Late Ordovician or Early Silurian to Middle Triassic, all in freshwater or brackish water environments(6). Here we describe a euthycarcinoid from marine strata in Argentina dating from the latest Cambrian period, extending the group's record back as much as 50 million years. Despite its antiquity and marine occurrence, the Cambrian species demonstrates that morphological details were conserved in the transition to fresh water. Trackways in the same unit as the euthycarcinoid strengthen arguments that similar traces of subaerial origin from Cambro-Ordovician rocks were made by euthycarcinoids(7,8). Large mandibles in euthycarcinoids(6,9) are confirmed by the Cambrian species. A morphology-based phylogeny resolves euthycarcinoids as stem-group Mandibulata, sister to the Myriapoda and Crustacea plus Hexapoda.	Univ Nacl Jujuy, Inst Geol & Mineria, RA-4600 San Salvador De Jujuy, Argentina; Australian Museum, Sydney, NSW 2010, Australia; OHiggins & Zarate, RA-4612 San Salvador De Jujuy, Argentina	Australian Museum	Vaccari, NE (corresponding author), Univ Nacl Jujuy, Inst Geol & Mineria, Ave Bolivia 1661, RA-4600 San Salvador De Jujuy, Argentina.	evac@idgym.unju.edu.ar		Edgecombe, Gregory/0000-0002-9591-8011				Anderson LI, 2003, PALAEONTOLOGY, V46, P467, DOI 10.1111/1475-4983.00308; Bergstrom J., 1980, Abhandlungen des Naturwissenschaftlichen Vereins in Hamburg, V23, P7; Bitsch J, 2001, ANN SOC ENTOMOL FR, V37, P305; Buatois LA, 2003, J S AM EARTH SCI, V16, P343, DOI 10.1016/S0895-9811(03)00097-X; Edgecombe GD, 1999, ALCHERINGA, V23, P193, DOI 10.1080/03115519908619516; Edgecombe Gregory D., 2003, African Invertebrates, V44, P115; FARRIS JS, 1969, SYST ZOOL, V18, P374, DOI 10.2307/2412182; Gall J. C., 1964, Annales de Paleontologie Invertebres, V50, P1; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Kusche K, 2003, EUR J BIOCHEM, V270, P2860, DOI 10.1046/j.1432-1033.2003.03664.x; MacNaughton RB, 2002, GEOLOGY, V30, P391, DOI 10.1130/0091-7613(2002)030<0391:FSOLAT>2.0.CO;2; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; MCNAMARA KJ, 1993, PALAEONTOLOGY, V36, P319; Muller CHG, 2003, ZOOMORPHOLOGY, V122, P191, DOI 10.1007/s00435-003-0085-0; Negrisolo E, 2004, MOL BIOL EVOL, V21, P770, DOI 10.1093/molbev/msh078; Richter S, 2002, ORG DIVERS EVOL, V2, P217, DOI 10.1078/1439-6092-00048; SCHRAM F R, 1991, Memoirs of the Queensland Museum, V31, P1; SCHRAM FR, 1982, J PALEONTOL, V56, P1434; SCHULTKA S, 1991, Palaeontologische Zeitschrift, V65, P319; Tortello MF, 2003, AMEGHINIANA, V40, P323; TREWIN NH, 1994, PALAEONTOLOGY, V37, P811; TREWIN NH, 1995, T ROY SOC EDINBURGH, V85, P117; Wills MA, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P33; Wilson HM, 2001, PALAEONTOLOGY, V44, P143, DOI 10.1111/1475-4983.00174	24	30	32	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					554	557		10.1038/nature02705	http://dx.doi.org/10.1038/nature02705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282604				2022-12-28	WOS:000222946100046
J	Hardy, A				Hardy, A			Historical keywords - Vitamin	LANCET			English	Editorial Material												a.hardy@ucl.ac.uk							0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 24	2004	364	9431					323	323		10.1016/S0140-6736(04)16703-2	http://dx.doi.org/10.1016/S0140-6736(04)16703-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276376	Bronze			2022-12-28	WOS:000222853300013
J	Molyneux, DH				Molyneux, DH			"Neglected" diseases but unrecognised successes - challenges and opportunities for infectious disease control	LANCET			English	Editorial Material							LYMPHATIC FILARIASIS ELIMINATION; ONCHOCERCIASIS CONTROL; MALARIA; PROGRAMS; TARGETS; HEALTH		Univ Liverpool, Liverpool Sch Trop Med, Lymphat Filariasis Support Ctr, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Molyneux, DH (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Lymphat Filariasis Support Ctr, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	fahy@liv.ac.uk						Akhavan D., 2000, ANALISE CUSTO EFETIV; [Anonymous], TUB MAL; Aylward RB, 2003, LANCET, V362, P909, DOI 10.1016/S0140-6736(03)14337-1; Benton B, 1998, ANN TROP MED PARASIT, V92, pS33, DOI 10.1080/00034989859537; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Gwatkin DR, 1999, LANCET, V354, P586, DOI 10.1016/S0140-6736(99)02108-X; Hagmann R, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-15; Hopkins DR, 2002, AM J TROP MED HYG, V67, P415, DOI 10.4269/ajtmh.2002.67.415; Hopkins DR, 2002, AM J TROP MED HYG, V67, P266; Kim A, 1997, 1835 AFR HUM DEV DEP; Molyneux DH, 2004, BMJ-BRIT MED J, V328, P1129, DOI 10.1136/bmj.328.7448.1129; Molyneux DH, 2002, ANN TROP MED PARASIT, V96, pS15, DOI 10.1179/000349802125002374; Najera J. A., 2001, Parassitologia (Rome), V43, P1; Ottesen EA, 1999, PARASITOL TODAY, V15, P382, DOI 10.1016/S0169-4758(99)01486-6; Richards FO, 2001, TRENDS PARASITOL, V17, P558, DOI 10.1016/S1471-4922(01)02112-2; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; TAYLOR LE, 1998, ERADICATION INFECT D, P145; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Utzinger J, 2002, TROP MED INT HEALTH, V7, P657, DOI 10.1046/j.1365-3156.2002.00916.x; *WHO, WHOCDS200315; *WHO, 2003, LEPR EL PROJ STAT RE; *WHO, 2002, WHOCDSSTB200116; Widdus R, 2001, B WORLD HEALTH ORGAN, V79, P713	25	112	115	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					380	383		10.1016/S0140-6736(04)16728-7	http://dx.doi.org/10.1016/S0140-6736(04)16728-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276399				2022-12-28	WOS:000222853300038
J	Rawlins, MD; Culyer, AJ				Rawlins, MD; Culyer, AJ			National Institute for Clinical Excellence and its value judgments	BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; EUROQOL; EQUITY		Med Sch Newcastle Upon Tyne, Wolfson Unit Clin Pharmacol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England	Newcastle University - UK; University of York - UK	Rawlins, MD (corresponding author), Med Sch Newcastle Upon Tyne, Wolfson Unit Clin Pharmacol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.							Anderson RT, 1996, PHARMACOECONOMICS, V10, P336, DOI 10.2165/00019053-199610040-00004; BRAZIER J, 1993, QUAL LIFE RES, V2, P169, DOI 10.1007/BF00435221; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Culyer AJ, 1997, BRIT MED J, V314, P667, DOI 10.1136/bmj.314.7081.667; Culyer AJ, 2001, J MED ETHICS, V27, P275, DOI 10.1136/jme.27.4.275; CULYER AJ, 1995, SOC SCI MED, V40, P727, DOI 10.1016/0277-9536(94)00307-F; Culyer AJ, 2001, J MED ETHICS, V27, P217, DOI 10.1136/jme.27.4.217; Devlin N, 2002, COST EFFECTIVENESS T; Kind P, 1999, 172 CTR HLTH EC; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; *NAT I CLIN EXC, 2002, 50 NICE; *NAT I CLIN EXC, 2002, 29 NICE; *NAT I CLIN EXC, 2003, GUID NICE; *NAT I CLIN EXC, 2002, 32 NICE; *NAT I CLIN EXC, 2003, 72 NICE; National Institute for Clinical Excellence (Producer), 2004, SCI SOC VAL JUDG; *NICE CIT COUNC, 2003, REP AGE; *NICE CIT COUNC, 2003, 1 M DET CLIN NEED LO; Roset M, 1999, QUAL LIFE RES, V8, P539, DOI 10.1023/A:1008973731515; WEINSTEIN ML, 1995, VALUING HLTH	21	560	571	0	23	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 24	2004	329	7459					224	227		10.1136/bmj.329.7459.224	http://dx.doi.org/10.1136/bmj.329.7459.224			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840NW	15271836	Green Published, Green Accepted			2022-12-28	WOS:000222866900024
J	Stephenson, JM; Strange, V; Forrest, S; Oakley, A; Copas, A; Allen, E; Babiker, A; Black, S; Ali, M; Monteiro, H; Johnson, AM				Stephenson, JM; Strange, V; Forrest, S; Oakley, A; Copas, A; Allen, E; Babiker, A; Black, S; Ali, M; Monteiro, H; Johnson, AM		RIPPLE study team	Pupil-led sex education in England (RIPPLE study): cluster-randomised intervention trial	LANCET			English	Article							YOUNG-PEOPLE; PEER EDUCATION; HEALTH; ADOLESCENTS	Background Improvement of sex education in schools is a key part of the UK government's strategy to reduce teenage pregnancy in England. We examined the effectiveness of one form of peer-led sex education in a school-based randomised trial of over 8000 pupils. Methods 29 schools were randomised to either peer-led sex education (intervention) or to continue their usual teacher-led sex education (control). in intervention schools, peer educators aged 16-17 years delivered three sessions of sex education to 13-14 year-old pupils from the same schools. Primary outcome was unprotected (without condom) first heterosexual intercourse by age 16 years. Analysis was by intention to treat. Findings By age 16 years, significantly fewer girls reported intercourse in the peer-led arm than in the control arm, but proportions were similar for boys. The proportions of pupils reporting unprotected first sex did not differ for girls (8.4% intervention vs 8.3% control) or for boys (6.2% vs 4.7%). Stratified estimates of the difference between arms were -0.4% (95% CI -3.7% to 2.8%, p=0.79) for girls and -1.4% (-4.4% to 1.6%, p=0.36) for boys. At follow-up (mean age 16.0 years [SD 0.32]), girls in the intervention arm reported fewer unintended pregnancies, although the difference was borderline (2.3% vs 3.3%, p=0.07). Girls and boys were more satisfied with peer-led than teacher-led sex education, but 57% of girls and 32% of boys wanted sex education in single-sex groups. Interpretation Peer-led sex education was effective in some ways, but broader strategies are needed to improve young people's sexual health. The role of single-sex sessions should be investigated further.	Ctr Sexual Hlth & HIV Res, London WC1E 6AU, England; Royal Free & UCL, Ctr Infect Dis Epidemiol, London, England; Royal Free & UCL, Dept Primary Care & Populat Sci, London, England; Univ London, Inst Educ, Social Sci Res Unit, London WC1N 1AZ, England; MRC, Clin Trials Unit, London, England; WHO, Dept Reprod Hlth, CH-1211 Geneva, Switzerland	University of London; University College London; University of London; University College London; University of London; University College London; UCL Institute of Education; Medical Research Council Clinical Trials Unit; World Health Organization	Stephenson, JM (corresponding author), Ctr Sexual Hlth & HIV Res, Mortimer Market Ctr & Capper St, London WC1E 6AU, England.	Jstephen@gum.uct.ac.uk		Copas, Andrew/0000-0001-8968-5963; Johnson, Anne/0000-0003-1330-7100	MRC [G9626797] Funding Source: UKRI; Medical Research Council [G9626797] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 1999, TEEN PREGN, P1; Boheim R, 1999, RESIDENTIAL MOBILITY; *DEP ED SKILLS, 1998, SEC SCH PERF TABL; Department of Education and Science, 2003, 01162000 DFEE DEP ED, P1; DiCenso A, 2002, BMJ-BRIT MED J, V324, P1426, DOI 10.1136/bmj.324.7351.1426; Forrest S., 2002, SEX ED, V2, P195, DOI DOI 10.1080/1468181022000025776; Guyatt GH, 2000, J CLIN EPIDEMIOL, V53, P167, DOI 10.1016/S0895-4356(99)00160-2; Harden A, 2001, HLTH ED J, V60, P339, DOI DOI 10.1177/001789690106000406; Johnson BT, 2003, ARCH PEDIAT ADOL MED, V157, P381, DOI 10.1001/archpedi.157.4.381; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Milburn K, 1995, HEALTH EDUC RES, V10, P407, DOI 10.1093/her/10.4.407; Nicoll A, 1999, BRIT MED J, V318, P1321, DOI 10.1136/bmj.318.7194.1321; OAKLEY A, 1995, BRIT MED J, V310, P158, DOI 10.1136/bmj.310.6973.158; OAKLEY A, IN PRESS EVALUATION; Sciacca J, 1987, PEER FACILITATOR Q, V5, P4; Stephenson JM, 2003, CONTROL CLIN TRIALS, V24, P643, DOI 10.1016/S0197-2456(03)00070-9; Strange V, 2003, GENDER EDUC, V15, P201, DOI 10.1080/09540250303852; Strange V, 2002, HEALTH EDUC RES, V17, P327, DOI 10.1093/her/17.3.327; Strange V, 2002, HEALTH EDUC RES, V17, P339, DOI 10.1093/her/17.3.339; Strange V., 2001, RES MATTERS HLTH PRO, P138; *TEEN PREGN UN, 2003, TEEN PREGN STRAT EV; Wellings F, 2001, LANCET, V358, P1843, DOI 10.1016/S0140-6736(01)06885-4; WELLINGS K, 1990, NATURE, V348, P276, DOI 10.1038/348276a0; Wight D, 2002, BMJ-BRIT MED J, V324, P1430, DOI 10.1136/bmj.324.7351.1430	25	129	131	1	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					338	346		10.1016/S0140-6736(04)16722-6	http://dx.doi.org/10.1016/S0140-6736(04)16722-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276393				2022-12-28	WOS:000222853300032
J	HATSOPOULOS, N; GABBIANI, F; LAURENT, G				HATSOPOULOS, N; GABBIANI, F; LAURENT, G			ELEMENTARY COMPUTATION OF OBJECT APPROACH BY A WIDE-FIELD VISUAL NEURON	SCIENCE			English	Article							MOVEMENT DETECTOR SYSTEM; ORTHOPTERAN DCMD NEURON; SENSORY ANALYZER; MOVING-OBJECTS; FLOW-FIELD; REEVALUATION; COLLISION; RESPONSES; VISION; MOTION	An essential function of the brain is to detect threats, such as those posed by objects or predators on a collision course. A wide-field, movement-sensitive visual neuron in the brain of the locust was studied by presenting simulated approaching, receding, and translating objects. The neuron's responses could be described simply by multiplying the velocity of the image edge (d theta/dt) with an exponential function of the size of the object's image on the retina (e(-alpha theta)). Because this product peaks before the image reaches its maximum size during approach, this neuron can anticipate collision. The neuron's activity peaks approximately when the approaching object reaches a certain angular size. Because this neuron receives distinct inputs about image size and velocity, the dendritic tree of a single neuron may function as a biophysical device that can carry out a multiplication of two independent input signals.	CALTECH,DIV BIOL,PASADENA,CA 91125	California Institute of Technology			Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X				[Anonymous], 1989, ANALOG VLSI IMPLEMEN; BORST A, 1988, NATURWISSENSCHAFTEN, V75, P265, DOI 10.1007/BF00378023; Gibson J.J., 1986, ECOLOGICAL APPROACH; GIBSON JJ, 1957, PSYCHOL REV, V64, P288, DOI 10.1037/h0044277; HOLMQVIST MH, 1991, J COMP PHYSIOL A, V169, P451, DOI 10.1007/BF00197657; KOCH C, 1987, SYNAPTIC FUNCTION, P637; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1992, J COMP PHYSIOL A, V171, P563, DOI 10.1007/BF00194105; LEE DN, 1980, PHILOS T R SOC B, V290, P169, DOI 10.1098/rstb.1980.0089; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; OSHEA M, 1976, J EXP BIOL, V65, P289; OSHEA M, 1974, J COMP PHYSIOL, V91, P257, DOI 10.1007/BF00698057; PALKA J, 1967, J INSECT PHYSIOL, V13, P235, DOI 10.1016/0022-1910(67)90151-5; RIND FC, 1984, J EXP BIOL, V110, P143; RIND FC, 1992, J NEUROPHYSIOL, V68, P1654, DOI 10.1152/jn.1992.68.5.1654; RIND FC, 1987, J COMP PHYSIOL A, V161, P477, DOI 10.1007/BF00603973; ROWELL CHF, 1977, J EXP BIOL, V68, P157; SCHLOTTERER GR, 1977, CAN J ZOOL, V55, P1372, DOI 10.1139/z77-179; SIMMONS PJ, 1992, J NEUROPHYSIOL, V68, P1667, DOI 10.1152/jn.1992.68.5.1667; WAGNER H, 1982, NATURE, V297, P147, DOI 10.1038/297147a0; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0	21	197	199	0	22	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 10	1995	270	5238					1000	1003		10.1126/science.270.5238.1000	http://dx.doi.org/10.1126/science.270.5238.1000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD878	15290817				2022-12-28	WOS:A1995TD87800053
J	Miller, C; Thomsen, LE; Gaggero, C; Mosseri, R; Ingmer, H; Cohen, SN				Miller, C; Thomsen, LE; Gaggero, C; Mosseri, R; Ingmer, H; Cohen, SN			SOS response induction by beta-lactams and bacterial defense against antibiotic lethality	SCIENCE			English	Article							PENICILLIN-BINDING-PROTEINS; ESCHERICHIA-COLI PLASMIDS; CELL-DIVISION; GENE-EXPRESSION; MUTANTS; REPLICATION; INHERITANCE; CHROMOSOMES; INVOLVEMENT; PSC101	The SOS response aids bacterial propagation by inhibiting cell division during repair of DNA damage. We report that inactivation of the ftsl gene product, penicillin binding protein 3, by either beta-lactam antibiotics or genetic mutation induces SOS in Escherichia coli through the DpiBA two-component signal transduction system. This event, which requires the SOS-promoting recA and lexA genes as well as dpiA, transiently halts bacterial cell division, enabling survival to otherwise lethal antibiotic exposure. Our findings reveal defective cell wait synthesis as an unexpected initiator of the bacterial SOS response, indicate that beta-lactam antibiotics are extracellular stimuli of this response, and demonstrate a novel mechanism for mitigation of antimicrobial lethality.	Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Royal Vet & Agr Univ, Dept Vet Pathobiol, DK-1870 Frederiksberg C, Denmark	Stanford University; University of Copenhagen	Cohen, SN (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	sncohen@stanford.edu		Ingmer, Hanne/0000-0002-8350-5631; Thomsen, Line Elnif/0000-0001-5460-9178	NIAID NIH HHS [R01 AI08619] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI008619] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bacolla A, 2001, J BIOL CHEM, V276, P18597, DOI 10.1074/jbc.M100845200; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; BIEK DP, 1989, J BACTERIOL, V171, P2066, DOI 10.1128/jb.171.4.2066-2074.1989; BOTT M, 1995, MOL MICROBIOL, V18, P533, DOI 10.1111/j.1365-2958.1995.mmi_18030533.x; BOTTA GA, 1981, J BACTERIOL, V145, P333, DOI 10.1128/JB.145.1.333-340.1981; Chadwick D., 1997, ANTIBIOTIC RESISTANC; Chen J., COMMUNICATION; Denome SA, 1999, J BACTERIOL, V181, P3981, DOI 10.1128/JB.181.13.3981-3993.1999; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Hendricks EC, 2000, MOL MICROBIOL, V36, P973, DOI 10.1046/j.1365-2958.2000.01920.x; Hoch JA, 1995, 2 COMPONENT SIGNAL T; HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490; Ingmer H, 1998, MOL MICROBIOL, V29, P49, DOI 10.1046/j.1365-2958.1998.00895.x; Miller C, 2003, J BACTERIOL, V185, P6025, DOI 10.1128/JB.185.20.6025-6031.2003; Nguyen-Disteche M, 1998, CELL MOL LIFE SCI, V54, P309, DOI 10.1007/s000180050157; OHMORI H, 1995, J BACTERIOL, V177, P156, DOI 10.1128/jb.177.1.156-165.1995; Pogliano J, 1997, P NATL ACAD SCI USA, V94, P559, DOI 10.1073/pnas.94.2.559; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shaw KJ, 2003, J MOL MICROB BIOTECH, V5, P105, DOI 10.1159/000069981; Sleator RD, 2000, INT J FOOD MICROBIOL, V60, P261, DOI 10.1016/S0168-1605(00)00316-0; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; SPRATT BG, 1977, J BACTERIOL, V131, P293, DOI 10.1128/JB.131.1.293-305.1977; TOMASZ A, 1974, MODE ACTION ANTIBIOT, P439; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984	25	397	431	5	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1629	1631		10.1126/science.1101630	http://dx.doi.org/10.1126/science.1101630			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15308764				2022-12-28	WOS:000223891200046
J	Reddy, KC; Villeneuve, AM				Reddy, KC; Villeneuve, AM			C-elegans HIM-17 links chromatin modification and competence for initiation of meiotic recombination	CELL			English	Article							DOUBLE-STRAND BREAKS; CAENORHABDITIS-ELEGANS; CROSSING-OVER; HISTONE DEACETYLASE; DNA-REPLICATION; PROTEIN; MEIOSIS; GENE; PATHWAY; COMPLEX	Initiation of meiotic recombination by double-strand breaks (DSBs) must occur in a controlled fashion to avoid jeopardizing genome integrity. Here, we identify chromatin-associated protein HIM-17 as a link between chromatin state and DSB formation during C. elegans meiosis. Dependencies of several meiotic prophase events on HIM-17 parallel those seen for DSB-generating enzyme SPO-11: HIM-17 is essential for DSB formation but dispensable for homolog synapsis. Crossovers and chiasmata are eliminated in him-17 null mutants but are restored by artificially induced DSBs, indicating that all components required to convert DSBs into chiasmata are present. Unlike SPO-11, HIM-17 is also required for proper accumulation of histone H3 methylation at lysine 9 on meiotic prophase chromosomes. HIM-17 shares structural features with three proteins that interact genetically with LIN-35/Rb, a known component of chromatin-modifying complexes. Furthermore, DSB levels and incidence of chiasmata can be modulated by loss of LIN-35/Rb. These and other data suggest that chromatin state governs the timing of DSB competence.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Villeneuve, AM (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	villen@cmgm.stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053804, R01GM067268] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053804, R01 GM067268, R01GM67268, R01GM53804] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; ASHLEY T, 1995, CHROMOSOMA, V104, P19, DOI 10.1007/BF00352222; Barlow AL, 1997, EMBO J, V16, P5207, DOI 10.1093/emboj/16.17.5207; BARNES TM, 1995, GENETICS, V141, P159; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Boxem M, 2001, DEVELOPMENT, V128, P4349; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; BRENNER S, 1974, GENETICS, V77, P71; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Chin GM, 2001, GENE DEV, V15, P522, DOI 10.1101/gad.864101; CLARK SG, 1994, GENETICS, V137, P987; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Colaiacovo MP, 2002, GENETICS, V162, P113; Davis L, 2001, GENETICS, V157, P1179; DEMBURG AF, 1998, CELL, V94, P387; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Evans DH, 1997, GENETICS, V146, P1253; Fan QQ, 1996, MOL CELL BIOL, V16, P2037; Fay DS, 2003, DEVELOPMENT, V130, P3319, DOI 10.1242/dev.00561; FERGUSON EL, 1989, GENETICS, V123, P109; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Gardiner JM, 1997, GENETICS, V146, P1265; GOLDSTEIN P, 1982, CHROMOSOMA, V86, P577, DOI 10.1007/BF00330128; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiao K, 2003, MOL CELL BIOL, V23, P5928, DOI 10.1128/MCB.23.16.5928-5938.2003; JOHZUKA K, 1995, GENETICS, V139, P1521; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kee K, 2002, GENETICS, V160, P111; Kee K, 2004, EMBO J, V23, P1815, DOI 10.1038/sj.emboj.7600184; Keeney S, 1996, GENES CELLS, V1, P475, DOI 10.1046/j.1365-2443.1996.d01-257.x; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kelly KO, 2000, GENETICS, V156, P617; Kelly WG, 2002, DEVELOPMENT, V129, P479; KLECKNER N, 2004, IN PRESS P NATL ACAD; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee CC, 1998, EMBO J, V17, P4166, DOI 10.1093/emboj/17.14.4166; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ohta K, 1998, P NATL ACAD SCI USA, V95, P646, DOI 10.1073/pnas.95.2.646; OHTA K, 1994, EMBO J, V13, P5754, DOI 10.1002/j.1460-2075.1994.tb06913.x; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Praitis V, 2001, GENETICS, V157, P1217; Priess J. R., 1997, C ELEGANS 2; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rinaldo C, 2002, GENETICS, V160, P471; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; STOLAZZI A, 2003, GENE DEV, V17, P2675; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; Takanami T, 1998, DNA Res, V5, P373, DOI 10.1093/dnares/5.6.373; TERASAWA M, 1995, GENE DEV, V9, P925, DOI 10.1101/gad.9.8.925; Tesse S, 2003, P NATL ACAD SCI USA, V100, P12865, DOI 10.1073/pnas.2034282100; Thomas JH, 1999, DEVELOPMENT, V126, P3449; VILLENEUVE AM, 1994, GENETICS, V136, P887; Villeneuve AM, 2001, CELL, V106, P647, DOI 10.1016/S0092-8674(01)00500-1; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; WILLIAMS BD, 1992, GENETICS, V131, P609; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Yamada T, 2004, EMBO J, V23, P1792, DOI 10.1038/sj.emboj.7600138; Zalevsky J, 1999, GENETICS, V153, P1271; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258	76	119	129	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					439	452		10.1016/j.cell.2004.07.026	http://dx.doi.org/10.1016/j.cell.2004.07.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315757	Bronze			2022-12-28	WOS:000223650900007
J	Nijveldt, R; Serne, EH; Sepers, JM; Maassen, JA; Cornel, JH; Arnold, AER				Nijveldt, R; Serne, EH; Sepers, JM; Maassen, JA; Cornel, JH; Arnold, AER			A man with diabetes and heart failure	LANCET			English	Article									VU Univ Med Ctr, Dept Cardiol, NL-1081 HV Amsterdam, Netherlands; VU Univ Med Ctr, Dept Internal Med, NL-1081 HV Amsterdam, Netherlands; Med Ctr Alkmaar, Dept Internal Med, Alkmaar, Netherlands; Med Ctr Alkmaar, Dept Cardiol, Alkmaar, Netherlands; Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Medical Center Of Alkmaar; Medical Center Of Alkmaar; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Nijveldt, R (corresponding author), VU Univ Med Ctr, Dept Cardiol, NL-1081 HV Amsterdam, Netherlands.	r.nijveldt@vumc.nl	Nijveldt, Robin/N-8683-2017; cornel, jan hein/Y-7065-2019	Nijveldt, Robin/0000-0003-1530-6363; cornel, jan hein/0000-0002-1006-2112; Serne, Erik/0000-0003-0657-7225				Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008; Hargreaves IP, 2002, LANCET, V359, P711, DOI 10.1016/S0140-6736(02)07795-4; HART LM, 1994, DIABETOLOGIA, V37, P1169; Maassen JA, 2002, AM J MED GENET, V115, P66, DOI 10.1002/ajmg.10346; SATOH K, 1995, BRIT J PHARMACOL, V116, P1894, DOI 10.1111/j.1476-5381.1995.tb16679.x	5	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					636	636		10.1016/S0140-6736(04)16858-X	http://dx.doi.org/10.1016/S0140-6736(04)16858-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313366				2022-12-28	WOS:000223275100038
J	Popescu, G; Robert, A; Howe, JR; Auerbach, A				Popescu, G; Robert, A; Howe, JR; Auerbach, A			Reaction mechanism determines NMDA receptor response to repetitive stimulation	NATURE			English	Article							METHYL-D-ASPARTATE; GLUTAMATE; SYNAPSES; TRANSMITTER; CHANNELS; NEURONS; AMPA; NONSATURATION; KINETICS; SUBUNIT	At central excitatory synapses, N-methyl-D-aspartate (NMDA) receptors, which have a high affinity for glutamate(1), produce a slowly rising synaptic current in response to a single transmitter pulse and an additional current after a second, closely timed stimulus(2). Here we show, by examining the kinetics of transmitter binding and channel gating in single-channel currents from recombinant NR1/NR2A receptors, that the synaptic response to trains of impulses is determined by the molecular reaction mechanism of the receptor. The rate constants estimated for the activation reaction predict that, after binding neurotransmitter, receptors hesitate for similar to4 ms in a closed high-affinity conformation before they either proceed towards opening or release neurotransmitter, with about equal probabilities. Because only about half of the initially fully occupied receptors become active, repetitive stimulation elicits currents with distinct waveforms depending on pulse frequency. This high-affinity/low-efficiency activation mechanism might serve as a link between stimulation frequency and the directionality of the ensuing synaptic plasticity.	SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; SUNY Buffalo, Ctr Single Mol Biophys, Buffalo, NY 14214 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Yale University	Popescu, G (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA.	popescu@buffalo.edu	popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002	NIDA NIH HHS [F32 DA015164] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA015164] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anson LC, 1998, J NEUROSCI, V18, P581; Anson LC, 2000, J PHYSIOL-LONDON, V527, P225, DOI 10.1111/j.1469-7793.2000.00225.x; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen NS, 2001, MOL PHARMACOL, V59, P212, DOI 10.1124/mol.59.2.212; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Diamond JS, 1997, J NEUROSCI, V17, P4672; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; Frerking M, 1996, CURR OPIN NEUROBIOL, V6, P395, DOI 10.1016/S0959-4388(96)80125-5; Ishikawa T, 2002, NEURON, V34, P613, DOI 10.1016/S0896-6273(02)00692-X; Magleby KL, 2004, TRENDS NEUROSCI, V27, P231, DOI 10.1016/j.tins.2004.03.001; MAGLEBY KL, 1983, J PHYSIOL-LONDON, V344, P605, DOI 10.1113/jphysiol.1983.sp014958; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Popescu G, 2004, NEUROSCIENTIST, V10, P192, DOI 10.1177/1073858404263483; Popescu G, 2003, NAT NEUROSCI, V6, P476, DOI 10.1038/nn1044; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781	29	102	105	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					790	793		10.1038/nature02775	http://dx.doi.org/10.1038/nature02775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306812				2022-12-28	WOS:000223233600044
J	Kotloff, KL; Corretti, M; Palmer, K; Campbell, JD; Reddish, MA; Hu, MC; Wasserman, SS; Dale, JB				Kotloff, KL; Corretti, M; Palmer, K; Campbell, JD; Reddish, MA; Hu, MC; Wasserman, SS; Dale, JB			Safety and immunogenicity of a recombinant multivalent group A streptococcal vaccine in healthy adults - Phase 1 trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							M-PROTEIN VACCINE; RHEUMATIC-FEVER; EPIDEMIOLOGIC ANALYSIS; UNITED-STATES; HEART-DISEASE; EPITOPES; IMMUNIZATION; INFECTIONS; VOLUNTEERS; CHALLENGE	Context Group A streptococcal infections and their sequelae represent a global health problem. Recent advances have allowed previous obstacles associated with group A streptococcal vaccine development to be overcome. Objective To preliminarily evaluate the safety and immunogenicity of ascending doses of a recombinant fusion peptide group A streptococcal vaccine containing N-terminal M protein fragments from serotypes 1, 3, 5, 6, 19, and 24 in healthy volunteers. Design, Setting, and Participants An open-label, uncontrolled, dose-ascending phase 1 vaccine trial of 28 healthy adult volunteers aged 18 to 50 years recruited from the metropolitan area of Baltimore, Md, between October 5, 1999, and February 26, 2003, using newspaper advertisements and posted fliers, and evaluated in the outpatient facility of the Center for Vaccine Development. Interventions Each volunteer received 3 spaced intramuscular injections of 50 mug (n=8), 100 mug (n=10), or 200 mug (n=10) of hexavalent group A streptococcal vaccine formulated with aluminum hydroxide into the deltoid muscle of alternating arms. Main Outcome Measures Assessments of clinical safety, including elicitation of antibodies that cross-react with host tissues, and immunogenicity as measured by enzyme-linked immunosorbent assay (ELISA) and assays of opsonophagocytic- and bactericidal-antibody responses. Results One year of intensive follow-up revealed the vaccine to be well tolerated. There was no evidence of tissue cross-reactive antibodies or immunological complications. At the highest (200 mug) dose, vaccination elicited significant increases in geometric mean antibody levels to all 6 component M antigens by ELISA (all P<.01) and to 5 of 6 M types in the opsonophagocytosis assay (all P<.05). In addition, postvaccination increases in serum bactericidal activity of at least 30% were observed in 31 (55%) of 56 assays. Conclusion These results provide the first evidence in humans that a hybrid fusion protein is a feasible strategy for evoking type-specific opsonic antibodies against multiple serotypes of group A streptococcus without eliciting antibodies that cross-react with host tissues, which represents a critical step in the development of a vaccine.	Univ Maryland, Sch Med, Ctr Vaccine Dev, Dept Pediat, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Vaccine Dev, Dept Med, Baltimore, MD 21201 USA; ID Biomed Corp, Bothell, WA USA; Univ Tennessee, Memphis, TN USA; Dept Vet Affairs Med Ctr, Memphis, TN USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Kotloff, KL (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Dept Pediat, 685 W Baltimore St,HSF 480, Baltimore, MD 21201 USA.	kkotloff@medicine.umaryland.edu	kotloff, karen l/E-7768-2012; Campbell, James D/AFN-5982-2022	kotloff, karen l/0000-0003-1808-6431; Dale, James/0000-0001-9860-9233	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI010085, N01AI045251] Funding Source: NIH RePORTER; NIAID NIH HHS [N01-AI-45251, R37-AI-10085] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAIRD RW, 1991, J IMMUNOL, V146, P3132; BEACHEY EH, 1986, J IMMUNOL, V136, P2287; BEACHEY EH, 1977, J EXP MED, V145, P1469, DOI 10.1084/jem.145.6.1469; BEACHEY EH, 1987, J EXP MED, V166, P647, DOI 10.1084/jem.166.3.647; BEACHEY EH, 1988, VACCINE, V6, P192, DOI 10.1016/S0264-410X(88)80027-6; BEACHEY EH, 1979, J EXP MED, V150, P862, DOI 10.1084/jem.150.4.862; Bisno A.L., 1980, STREPTOCOCCAL DISEAS, P789; Black S, 2001, CLIN INFECT DIS, V33, pS323, DOI 10.1086/322568; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; BRONZE MS, 1993, J IMMUNOL, V151, P2820; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dale JB, 1999, VACCINE, V17, P193, DOI 10.1016/S0264-410X(98)00150-9; DALE JB, 1985, J EXP MED, V161, P113, DOI 10.1084/jem.161.1.113; Dale JB, 1999, INFECT DIS CLIN N AM, V13, P227, DOI 10.1016/S0891-5520(05)70052-0; DALE JB, 1983, J EXP MED, V158, P1727, DOI 10.1084/jem.158.5.1727; DALESSANDRI R, 1978, J INFECT DIS, V138, P712, DOI 10.1093/infdis/138.6.712; Espinosa LE, 2003, J CLIN MICROBIOL, V41, P373, DOI 10.1128/JCM.41.1.373-378.2003; FOX EN, 1973, J CLIN INVEST, V52, P1885, DOI 10.1172/JCI107372; Galvin JE, 2000, J CLIN INVEST, V106, P217, DOI 10.1172/JCI7132; Haddy TB, 1999, J LAB CLIN MED, V133, P15, DOI 10.1053/lc.1999.v133.a94931; Hauknes HA, 2002, J INFECT DIS, V185, P915, DOI 10.1086/339407; Ho PL, 2003, J CLIN MICROBIOL, V41, P937, DOI 10.1128/JCM.41.3.937-942.2003; Hu MC, 2002, INFECT IMMUN, V70, P2171, DOI 10.1128/IAI.70.4.2171-2177.2002; JOHNSON DR, 1992, J INFECT DIS, V166, P374, DOI 10.1093/infdis/166.2.374; JONES KF, 1988, J EXP MED, V167, P1114, DOI 10.1084/jem.167.3.1114; Kaplan EL, 2001, LANCET, V358, P1334, DOI 10.1016/S0140-6736(01)06415-7; LANCEFIELD RC, 1959, J EXP MED, V110, P271, DOI 10.1084/jem.110.2.271; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; MASSELL BF, 1969, J AMER MED ASSOC, V207, P1115, DOI 10.1001/jama.207.6.1115; MASSELL BF, 1968, APPL MICROBIOL, V16, P509, DOI 10.1128/AEM.16.3.509-518.1968; Nakashima K, 1997, CLIN INFECT DIS, V25, P260, DOI 10.1086/514543; NORDET P, 1992, B WORLD HEALTH ORGAN, V70, P213; O'Brien KL, 2002, CLIN INFECT DIS, V35, P268, DOI 10.1086/341409; Pelton SI, 2003, VACCINE, V21, P1562, DOI 10.1016/S0264-410X(02)00681-3; POLLY SM, 1975, J INFECT DIS, V131, P217, DOI 10.1093/infdis/131.3.217; SARGENT SJ, 1987, J IMMUNOL, V139, P1285; STOLLERMAN GH, 1967, ARTHRITIS RHEUM-US, V10, P245, DOI 10.1002/art.1780100311; Stollerman GH, 1997, LANCET, V349, P935, DOI 10.1016/S0140-6736(96)06364-7; STRATTON KR, 2001, VACCINES 21 CENTURY, P299; TOMAI M, 1990, J EXP MED, V172, P359, DOI 10.1084/jem.172.1.359; 2003, MMWR MORB MORTAL WKL, V52, P106	42	108	114	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					709	715		10.1001/jama.292.6.709	http://dx.doi.org/10.1001/jama.292.6.709			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304468	Bronze			2022-12-28	WOS:000223177300025
J	Shapiro, D				Shapiro, D			For the obscure researcher	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												shapiro@u.arizona.edu		Shapiro, Daniel/0000-0002-7166-7705				Hodgkin, 1832, Med Chir Trans, V17, P68	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					665	665		10.1001/jama.292.6.665	http://dx.doi.org/10.1001/jama.292.6.665			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304446				2022-12-28	WOS:000223177300001
J	Gregori, L; McCombie, N; Palmer, D; Birch, P; Sowemimo-Coker, S; Giulivi, A; Rohwer, RG				Gregori, L; McCombie, N; Palmer, D; Birch, P; Sowemimo-Coker, S; Giulivi, A; Rohwer, RG			Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; COMPONENTS	In 1999, the UK implemented universal leucoreduction as a precaution against transmission of variant Creutzfeldt-Jakob disease by transfusion of domestic blood or red blood cells. We aimed to assess how effectively leucoreduction reduced infectivity of transmissible spongiform encephalopathies (TSEs) in blood. 450 mL of whole blood collected and pooled from scrapie-infected hamsters was leucoreduced with a commercial filter. Blood cell concentrations were quantified, and infectivity titres measured. Blood cell recovery and white blood cell removal complied with American Association of Blood Banks standards. Leucofiltration removed 42% (SD 12) of the total TSE infectivity in endogenously infected blood. Leucoreduction is necessary for the removal of white-cell-associated TSE infectivity from blood; however, it is not, by itself, sufficient to remove all blood-borne TSE infectivity.	Univ Maryland, Vet Affairs Med Ctr, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA; Hlth Canada, Ctr Infect Dis Prevent & Control, Ottawa, ON K1A 0L2, Canada; Canadian Blood Serv, Ottawa, ON, Canada; Pall Corp, Port Washington, NY USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Health Canada; Canadian Blood Services; Pall Corporation	Rohwer, RG (corresponding author), Univ Maryland, Vet Affairs Med Ctr, Vet Affairs Maryland Hlth Care Syst, 10 N Greene St, Baltimore, MD 21201 USA.	rrohwer@umaryland.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063930] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-63930] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Holada K, 2002, J VIROL, V76, P4649, DOI 10.1128/JVI.76.9.4649-4650.2002; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Prowse CV, 2000, VOX SANG, V79, P248, DOI 10.1046/j.1423-0410.2000.7940248.x; Williamson LM, 2000, BRIT J HAEMATOL, V110, P256, DOI 10.1046/j.1365-2141.2000.02062.x; 1998, AABB BLOOD BANK OPER, P24	7	154	156	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					529	531		10.1016/S0140-6736(04)16812-8	http://dx.doi.org/10.1016/S0140-6736(04)16812-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302197				2022-12-28	WOS:000223132700033
J	Howe, A; Campion, P; Searle, J; Smith, H				Howe, A; Campion, P; Searle, J; Smith, H			New perspectives - approaches to medical education at four new UK medical schools	BRITISH MEDICAL JOURNAL			English	Article							EXPERIENCE; CURRICULUM		Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; Univ York, Hull York Med Sch, Commun Off, York YO10 5DD, N Yorkshire, England; Peninsula Med Sch, Plymouth PL6 8BX, Devon, England; Brighton & Sussex Med Sch, Brighton BN1 9PH, E Sussex, England	University of East Anglia; University of Hull; University of York - UK; University of Plymouth; University of Brighton; University of Sussex	Howe, A (corresponding author), Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England.	amanda.howe@uea.ac.uk	Smith, Helen E/M-2449-2016	Smith, Helen E/0000-0003-1883-6124				Asch E, 1998, Acad Med, V73, P575, DOI 10.1097/00001888-199805000-00034; *AUSTR COUNC ED RE, 2002, GRAD AUSTR MED SCH A; David T., 1999, PROBLEM BASED LEARNI; Department for Education and Skills, 2003, FUT HIGH ED; *GEN MED COUNC, 2003, TOM DOCT; Hafferty F.W., 1991, VALLEY DEATH SOCIALI; Harden RM, 1999, MED TEACH, V21, P141, DOI 10.1080/01421599979752; Harden RM, 1999, MED TEACH, V21, P546, DOI 10.1080/01421599978951; *HIGH ED FUND COUN, 2001, 0131 HEFCE; Holmes D, 2002, MED EDUC, V36, P979, DOI 10.1046/j.1365-2923.2002.01269.x; Prideaux D, 2002, MED EDUC, V36, P1114, DOI 10.1046/j.1365-2923.2002.01411.x; SILVERMAN J, 1998, SKILLS COMMUNICATING; SINCLAIR S., 1997, MAKING DOCTORS I APP; SMITH T, 2001, SURVEY CLIN ACAD STA; Universities UK, 2002, SOC CLASS PART GOOD; USHERWOOD T, 1991, MED EDUC, V25, P421, DOI 10.1111/j.1365-2923.1991.tb00090.x; vanderVleuten CPM, 1996, MED TEACH, V18, P103	17	74	75	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 7	2004	329	7461					327	331		10.1136/bmj.329.7461.327	http://dx.doi.org/10.1136/bmj.329.7461.327			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846FF	15297339	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000223300300022
J	Botvinick, M				Botvinick, M			Probing the neural basis of body ownership	SCIENCE			English	Editorial Material							SELF		Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 15104 USA	University of Pennsylvania; Pennsylvania Medicine	Botvinick, M (corresponding author), Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 15104 USA.	mmb@mail.med.upenn.edu						BOISSON D, 2004, ANN MED-PSYCHOL, V162, P55, DOI DOI 10.1016/j.amp.2003.12.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brewer B., 1995, BODY SELF; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Farne A, 2000, BRAIN, V123, P2350, DOI 10.1093/brain/123.11.2350; GRAZIANO MS, 2002, COMMON MECH PERCEPTI, V19; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Iriki A, 2001, NEUROSCI RES, V40, P163, DOI 10.1016/S0168-0102(01)00225-5; RADEAU M, 1994, CAH PSYCHOL COGN, V13, P3; Rochat P, 2000, INFANT BEHAV DEV, V23, P513, DOI 10.1016/S0163-6383(01)00055-8; Rochat P., 1995, SELF INFANCY THEORY; SACHS O, 1993, LEG STAND ON; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2; Wegner DM, 2002, BRADFORD BOOKS, P1	14	112	113	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					782	783		10.1126/science.1101836	http://dx.doi.org/10.1126/science.1101836			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297651				2022-12-28	WOS:000223104900025
J	Paul, BJ; Barker, MM; Ross, W; Schneider, DA; Webb, C; Foster, JW; Gourse, RL				Paul, BJ; Barker, MM; Ross, W; Schneider, DA; Webb, C; Foster, JW; Gourse, RL			DksA: A critical component of the transcription initiation machinery that potentiates the regulation of rRNA promoters by ppGpp and the initiating NTP	CELL			English	Article							RATE-DEPENDENT CONTROL; ESCHERICHIA-COLI; GROWTH-RATE; SALMONELLA-TYPHIMURIUM; NUCLEOSIDE TRIPHOSPHATE; IN-VITRO; MUTANTS; 5'-DIPHOSPHATE; POLYMERASE; PROTEASE	Ribosomal RNA (rRNA) transcription is regulated primarily at the level of initiation from rRNA promoters. The unusual kinetic properties of these promoters result in their specific regulation by two small molecule signals, ppGpp and the initiating NTP, that bind to RNA polymerase (RNAP) at all promoters. We show here that DksA, a protein previously unsuspected as a transcription factor, is absolutely required for rRNA regulation. InDeltadksA mutants, rRNA promoters are unresponsive to changes in amino acid availability, growth rate, or growth phase. In vitro, DksA binds to RNAP, reduces open complex lifetime, inhibits rRNA promoter activity, and amplifies effects of ppGpp and the initiating NTP on rRNA transcription, explaining the dksA requirement in vivo. These results expand our molecular understanding of rRNA transcription regulation, may explain previously described pleiotropic effects of dksA, and illustrate how transcription factors that do not bind DNA can nevertheless potentiate RNAP for regulation.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA	University of Wisconsin System; University of Wisconsin Madison; University of South Alabama	Gourse, RL (corresponding author), Univ Wisconsin, Dept Bacteriol, 420 Henry Mall, Madison, WI 53706 USA.	rgourse@bact.wisc.edu		Schneider, David/0000-0003-0635-5091	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037048, R01GM037048] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM37048, R37 GM037048] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afflerbach H, 1998, MOL MICROBIOL, V28, P641, DOI 10.1046/j.1365-2958.1998.00829.x; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Barker MM, 2001, J BACTERIOL, V183, P6315, DOI 10.1128/JB.183.21.6315-6323.2001; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; Bartlett MS, 1998, J MOL BIOL, V279, P331, DOI 10.1006/jmbi.1998.1779; BARTLETT MS, 1994, J BACTERIOL, V176, P5560, DOI 10.1128/JB.176.17.5560-5564.1994; Bass S, 1996, J BACTERIOL, V178, P1154, DOI 10.1128/jb.178.4.1154-1161.1996; BOKAL AJ, 1995, J MOL BIOL, V245, P197, DOI 10.1006/jmbi.1994.0016; Branny P, 2001, J BACTERIOL, V183, P1531, DOI 10.1128/JB.183.5.1531-1539.2001; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Choy HE, 2000, J BIOL CHEM, V275, P6783, DOI 10.1074/jbc.275.10.6783; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; GAAL T, 1990, P NATL ACAD SCI USA, V87, P5533, DOI 10.1073/pnas.87.14.5533; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; GOURSE RL, 1988, NUCLEIC ACIDS RES, V16, P9789, DOI 10.1093/nar/16.20.9789; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Hirsch M, 2002, J BACTERIOL, V184, P5077, DOI 10.1128/JB.184.18.5077-5087.2002; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Ishii Y, 2000, BIOSCI BIOTECH BIOCH, V64, P799, DOI 10.1271/bbb.64.799; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Murray HD, 2004, MOL MICROBIOL, V52, P1375, DOI 10.1111/j.1365-2958.2004.04060.x; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; Murray HD, 2003, J BACTERIOL, V185, P28, DOI 10.1128/JB.185.1.28-34.2003; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; SANDS MK, 1952, J BACTERIOL, V63, P505, DOI 10.1128/JB.63.4.505-511.1952; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Schneider DA, 2003, METHOD ENZYMOL, V370, P606; Schneider DA, 2003, J BACTERIOL, V185, P6185, DOI 10.1128/JB.185.20.6185-6191.2003; Schneider DA, 2003, CURR OPIN MICROBIOL, V6, P151, DOI 10.1016/S1369-5274(03)00038-9; Schneider DA, 2002, P NATL ACAD SCI USA, V99, P8602, DOI 10.1073/pnas.132285199; STEPHENS JC, 1975, P NATL ACAD SCI USA, V72, P4389, DOI 10.1073/pnas.72.11.4389; Turner AK, 1998, INFECT IMMUN, V66, P2099, DOI 10.1128/IAI.66.5.2099-2106.1998; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; XIAO H, 1991, J BIOL CHEM, V266, P5980; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908	39	368	378	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					311	322		10.1016/j.cell.2004.07.009	http://dx.doi.org/10.1016/j.cell.2004.07.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294157	Bronze			2022-12-28	WOS:000223353100008
J	Denver, DR; Morris, K; Lynch, M; Thomas, WK				Denver, DR; Morris, K; Lynch, M; Thomas, WK			High mutation rate and predominance of insertions in the Caenorhabditis elegans nuclear genome	NATURE			English	Article							DROSOPHILA-MELANOGASTER; DNA-SEQUENCES; EVOLUTION; SELECTION; NUCLEOTIDE; GENES	Mutations have pivotal functions in the onset of genetic diseases and are the fundamental substrate for evolution. However, present estimates of the spontaneous mutation rate and spectrum are derived from indirect and biased measurements. For instance, mutation rate estimates for Caenorhabditis elegans are extrapolated from observations on a few genetic loci with visible phenotypes and vary over an order of magnitude(1). Alternative approaches in mammals, relying on phylogenetic comparisons of pseudogene loci(2) and fourfold degenerate codon positions(3), suffer from uncertainties in the actual number of generations separating the compared species and the inability to exclude biases associated with natural selection. Here we provide a direct and unbiased estimate of the nuclear mutation rate and its molecular spectrum with a set of C. elegans mutation-accumulation lines that reveal a mutation rate about tenfold higher than previous indirect estimates and an excess of insertions over deletions. Because deletions dominate patterns of C. elegans pseudogene variation(4,5), our observations indicate that natural selection might be significant in promoting small genome size, and challenge the prevalent assumption that pseudogene divergence accurately reflects the spontaneous mutation spectrum.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA	Indiana University System; Indiana University Bloomington; University System Of New Hampshire; University of New Hampshire	Denver, DR (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	ddenver@bio.indiana.edu						Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Charlesworth B, 1996, NATURE, V384, P315, DOI 10.1038/384315a0; Davies EK, 1999, SCIENCE, V285, P1748, DOI 10.1126/science.285.5434.1748; Denver DR, 2004, J MOL EVOL, V58, P584, DOI 10.1007/s00239-004-2580-4; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; Drake JW, 1998, GENETICS, V148, P1667; Gunsalus KC, 2004, NUCLEIC ACIDS RES, V32, pD406, DOI 10.1093/nar/gkh110; Hahn MW, 2003, MOL BIOL EVOL, V20, P901, DOI 10.1093/molbev/msg096; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hill F, 2000, EMBO REP, V1, P29, DOI 10.1093/embo-reports/kvd015; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Keightley PD, 1998, GENETICS, V148, P753; KONDRASHOV AS, 1994, P ROY SOC B-BIOL SCI, V258, P221, DOI 10.1098/rspb.1994.0166; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; LANGLEY CH, 1976, MUTAT RES, V36, P385, DOI 10.1016/0027-5107(76)90248-7; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Marais G, 2001, P NATL ACAD SCI USA, V98, P5688, DOI 10.1073/pnas.091427698; Nachman MW, 2000, GENETICS, V156, P297; NACLERIO G, 1992, J MOL BIOL, V226, P159, DOI 10.1016/0022-2836(92)90131-3; Ochman H, 2003, MOL BIOL EVOL, V20, P2091, DOI 10.1093/molbev/msg229; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Petrov DA, 2000, J HERED, V91, P221, DOI 10.1093/jhered/91.3.221; Richterich P, 1998, GENOME RES, V8, P251, DOI 10.1101/gr.8.3.251; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; SEIN LD, 2003, PLOS BIOL, V1, P166; Vassilieva LL, 2000, EVOLUTION, V54, P1234, DOI 10.1111/j.0014-3820.2000.tb00557.x; Witherspoon DJ, 2003, J MOL EVOL, V56, P751, DOI 10.1007/s00239-002-2450-x; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305	29	266	275	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					679	682		10.1038/nature02697	http://dx.doi.org/10.1038/nature02697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295601				2022-12-28	WOS:000223085400046
J	McMurray, JJV; O'Meara, E				McMurray, JJV; O'Meara, E			Treatment of heart failure with spironolactone - Trial and tribulations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow	McMurray, JJV (corresponding author), Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland.		mcmurray, John/B-2467-2013	mcmurray, John/0000-0002-6317-3975				Pitt B, 1996, AM J CARDIOL, V78, P902; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001	2	51	144	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					526	528		10.1056/NEJMp048144	http://dx.doi.org/10.1056/NEJMp048144			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295043				2022-12-28	WOS:000223069900003
J	Wolfraim, LA; Fernandez, TM; Mamura, M; Fuller, WL; Kumar, R; Cole, DE; Byfield, S; Felici, A; Flanders, KC; Walz, TM; Roberts, AB; Aplan, PD; Balis, FM; Letterio, JJ				Wolfraim, LA; Fernandez, TM; Mamura, M; Fuller, WL; Kumar, R; Cole, DE; Byfield, S; Felici, A; Flanders, KC; Walz, TM; Roberts, AB; Aplan, PD; Balis, FM; Letterio, JJ			Loss of Smad3 in acute T-cell lymphoblastic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TGF-BETA; P27(KIP1); EXPRESSION; INHIBITOR; LYMPHOMAS; GROWTH; MICE	BACKGROUND: The receptors for transforming growth factor (beta) (TGF-(beta)) and their signaling intermediates make up an important tumor-suppressor pathway. The role of one of these intermediates -- Smad3 -- in the pathogenesis of lymphoid neoplasia is unknown. METHODS: We measured Smad3 messenger RNA (mRNA) and protein in leukemia cells obtained at diagnosis from 19 children with acute leukemia, including 10 with T-cell acute lymphoblastic leukemia (ALL), 7 with pre-B-cell ALL, and 2 with acute nonlymphoblastic leukemia (ANLL). All nine exons of the SMAD3 gene (MADH3) were sequenced. Mice in which one or both alleles of Smad3 were inactivated were used to evaluate the role of Smad3 in the response of normal T cells to TGF-(beta) and in the susceptibility to spontaneous leukemogenesis in mice in which both alleles of the tumor suppressor p27(sup Kip1) were deleted. RESULTS: Smad3 protein was absent in T-cell ALL but present in pre-B-cell ALL and ANLL. No mutations were found in the MADH3 gene in T-cell ALL, and Smad3 mRNA was present in T-cell ALL and normal T cells at similar levels. In mice, the loss of one allele for Smad3 impairs the inhibitory effect of TGF-(beta) on the proliferation of normal T cells and works in tandem with the homozygous inactivation of p27(sup Kip1) to promote T-cell leukemogenesis. CONCLUSIONS: Loss of Smad3 protein is a specific feature of pediatric T-cell ALL. A reduction in Smad3 expression and the loss of p27(sup Kip1) work synergistically to promote T-cell leukemogenesis in mice.	NCI, LCRC, CCR, NIH, Bethesda, MD 20892 USA; NCI, Pediat Oncol Branch, CCR, NIH, Bethesda, MD 20892 USA; NCI, Genet Branch, CCR, NIH, Bethesda, MD 20892 USA; Linkoping Univ Hosp, Fac Hlth Sci, Div Oncol, Dept Biomed & Surg, S-58185 Linkoping, Sweden	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Linkoping University	Letterio, JJ (corresponding author), NCI, LCRC, CCR, NIH, Bldg 41,Rm C629,41 Lib Dr, Bethesda, MD 20892 USA.	letterij@mail.nih.gov	Aplan, Peter D/K-9064-2016	Balis, Frank/0000-0002-8117-6926; Mamura, Mizuko/0000-0003-4531-0144	DIVISION OF BASIC SCIENCES - NCI [Z01BC005051, Z01BC010049] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01SC006880, ZIASC010378, Z01SC010378, ZIASC006880] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chervinsky DS, 1999, MOL CELL BIOL, V19, P5025; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 2001, NAT GENET, V29, P351; Flanders KC, 2001, DEV DYNAM, V220, P141, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1096>3.0.CO;2-4; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Komuro Hiroaki, 1999, Neoplasia (New York), V1, P253, DOI 10.1038/sj.neo.7900033; Lin ZS, 2003, BRIT J HAEMATOL, V121, P739, DOI 10.1046/j.1365-2141.2003.04354.x; Margolin J.F., 2002, PRINCIPLES PRACTICE, P489; MOROSETTI R, 1995, BLOOD, V86, P1924, DOI 10.1182/blood.V86.5.1924.bloodjournal8651924; Piekarz RL, 2001, BLOOD, V98, P2865, DOI 10.1182/blood.V98.9.2865; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280	13	121	130	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					552	559		10.1056/NEJMoa031197	http://dx.doi.org/10.1056/NEJMoa031197			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295048				2022-12-28	WOS:000223069900008
J	Zeitlin, P				Zeitlin, P			Can curcumin cure cystic fibrosis?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CFTR FUNCTION		Johns Hopkins Univ, Sch Med, Div Pediat Resp Sci, Baltimore, MD 21205 USA	Johns Hopkins University	Zeitlin, P (corresponding author), Johns Hopkins Univ, Sch Med, Div Pediat Resp Sci, Baltimore, MD 21205 USA.			Zeitlin, Pamela/0000-0002-2719-1834				Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Illek B, 1999, AM J PHYSIOL-CELL PH, V277, pC833, DOI 10.1152/ajpcell.1999.277.4.C833; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Yerxa BR, 2002, J PHARMACOL EXP THER, V302, P871, DOI 10.1124/jpet.102.035485; Zeitlin PL, 2002, MOL THER, V6, P119, DOI 10.1006/mthe.2002.0639	5	32	34	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					606	608		10.1056/NEJMcibr041584	http://dx.doi.org/10.1056/NEJMcibr041584			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295056				2022-12-28	WOS:000223069900017
J	Srivastava, R				Srivastava, R			Soul (re)searching	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dranu@hotmail.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2004	292	5					543	544		10.1001/jama.292.5.543	http://dx.doi.org/10.1001/jama.292.5.543			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843AE	15292072				2022-12-28	WOS:000223045500001
J	Rouse, GW; Goffredi, SK; Vrijenhoek, RC				Rouse, GW; Goffredi, SK; Vrijenhoek, RC			Osedax: Bone-eating marine worms with dwarf males	SCIENCE			English	Article							MOLECULAR EVIDENCE; VESTIMENTIFERA; POGONOPHORANS; WHALES; VENT	We describe a new genus, Osedax, and two new species of annelids with females that consume the bones of dead whales via ramifying roots. Molecular and morphological evidence revealed that Osedax belongs to the Siboglinidae, which includes pogonophoran and vestimentiferan worms from deep-sea vents, seeps, and anoxic basins. Osedax has skewed sex ratios with numerous dwarf (paedomorphic) males that live in the tubes of females. DNA sequences reveal that the two Osedax species diverged about 42 million years ago and currently maintain large populations ranging from 10(5) to 10(6) adult females.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; S Australian Museum, Adelaide, SA 5000, Australia; Univ Adelaide, Adelaide, SA 5005, Australia	Monterey Bay Aquarium Research Institute; University of Adelaide	Vrijenhoek, RC (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	vrijen@mbari.org	Rouse, Greg W/F-2611-2010; Rouse, Gregory/AAW-1494-2021	Rouse, Greg W/0000-0001-9036-9263; Rouse, Gregory/0000-0001-9036-9263				Chevaldonne P, 2002, CAH BIOL MAR, V43, P367; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; GOFFREDI SK, UNPUB; GOFFREDI SK, IN PRESS DEEP SEA RE, V1; Halanych KM, 2001, BIOL BULL, V201, P65, DOI 10.2307/1543527; JONES ML, 1981, SCIENCE, V213, P333, DOI 10.1126/science.213.4505.333; Julian D, 1999, J EXP BIOL, V202, P2245; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Pilger J., 1978, P103; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Rouse GW, 2001, ZOOL J LINN SOC-LOND, V132, P55, DOI 10.1111/j.1096-3642.2001.tb02271.x; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Southward EC, 1999, HYDROBIOLOGIA, V402, P185, DOI 10.1023/A:1003796626851; Southward Eve C., 1993, P327; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VANDOVER CL, 2000, ECOLOGY DEEP SEA HYD, P411	17	245	251	2	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					668	671		10.1126/science.1098650	http://dx.doi.org/10.1126/science.1098650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286372	Green Submitted			2022-12-28	WOS:000222992100048
J	Walker, FO; Raymond, LA				Walker, FO; Raymond, LA			Targeting energy metabolism in Huntington's disease	LANCET			English	Editorial Material							DIETARY RESTRICTION; MUTANT MICE; MOUSE MODEL; PROGRESSION		Wake Forest Univ, Bowman Gray Sch Med, Dept Neurol, Winston Salem, NC 27157 USA; Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada	Wake Forest University; Wake Forest Baptist Medical Center; University of British Columbia	Walker, FO (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Neurol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	fwalker@wfubmc.edu	Raymond, Lynn A/A-6664-2010; Raymond, Lynn A./R-6707-2016; Longo, Kenneth A/A-5631-2010	Raymond, Lynn A/0000-0002-8610-1042; Raymond, Lynn A./0000-0002-8610-1042; Walker, Francis/0000-0002-7817-9421				Duan WZ, 2004, ANN NEUROL, V55, P590, DOI 10.1002/ana.20075; Duan WZ, 2003, ENDOCRINOLOGY, V144, P2446, DOI 10.1210/en.2002-0113; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Hickey MA, 2003, CYTOGENET GENOME RES, V100, P276, DOI 10.1159/000072863; Kieburtz K, 2001, NEUROLOGY, V57, P397; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Zeron MM, 2004, MOL CELL NEUROSCI, V25, P469, DOI 10.1016/j.mcn.2003.11.014	7	12	12	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 24	2004	364	9431					312	313		10.1016/S0140-6736(04)16739-1	http://dx.doi.org/10.1016/S0140-6736(04)16739-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276373				2022-12-28	WOS:000222853300008
J	Dambisya, YM				Dambisya, YM			The fate and career destinations of doctors who qualified at Uganda's Makerere Medical School in 1984: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ North, Sch Hlth Sci, Pharm Programme, ZA-0727 Sovenga, South Africa	University of Limpopo	Dambisya, YM (corresponding author), Univ North, Sch Hlth Sci, Pharm Programme, Private Bag X1106, ZA-0727 Sovenga, South Africa.	yoswad@unorth.ac.za						Dovlo D, BRAIN DRAIN RETENTIO; Lambert TW, 1996, BRIT MED J, V313, P19, DOI 10.1136/bmj.313.7048.19; Padarath A., 2003, 3 EQUINET; Weiner R, 1998, S AFR J SCI, V94, P59; WOODWARD CA, 1982, CAN MED ASSOC J, V127, P477	5	26	26	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2004	329	7466					600	601		10.1136/bmj.38134.524387.AE	http://dx.doi.org/10.1136/bmj.38134.524387.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854SK	15297304	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000223923400016
J	Alanen, A				Alanen, A			Commentary: Does screening reduce preterm births?	BRITISH MEDICAL JOURNAL			English	Editorial Material							BACTERIAL VAGINOSIS; DELIVERY; WOMEN		Univ Turku, Dept Obstet & Gynaecol, FIN-20520 Turku, Finland	University of Turku	Alanen, A (corresponding author), Univ Turku, Dept Obstet & Gynaecol, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland.	anna.alanen@utu.fi						Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; HOENST H, 2004, BJOG, V111, P409; Kiss H, 2004, BMJ-BRIT MED J, V329, P371, DOI 10.1136/bmj.38169.519653.EB; MCDONALD H, 2003, COCHRANE DB SYST REV; Ugwumadu A, 2003, LANCET, V361, P983, DOI 10.1016/S0140-6736(03)12823-1	5	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 14	2004	329	7462					374	374		10.1136/bmj.329.7462.374	http://dx.doi.org/10.1136/bmj.329.7462.374			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YI	15310607	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000223433600015
J	Martin, J; Ilani, S; Verdene, B; Smet, J; Umansky, V; Mahalu, D; Schuh, D; Abstreiter, G; Yacoby, A				Martin, J; Ilani, S; Verdene, B; Smet, J; Umansky, V; Mahalu, D; Schuh, D; Abstreiter, G; Yacoby, A			Localization of fractionally charged quasi-particles	SCIENCE			English	Article							METAL-INSULATOR-TRANSITION; QUANTUM HALL REGIME; COMPRESSIBILITY; TRANSPORT; BEHAVIOR; STATES; FIELD	An outstanding question pertaining to the microscopic properties of the fractional quantum Hall effect is understanding the nature of the particles that participate in the localization but that do not contribute to electronic transport. By using a scanning single electron transistor, we imaged the individual localized states in the fractional quantum Hall regime and determined the charge of the localizing particles. Highlighting the symmetry between filling factors 1/3 and 2/3, our measurements show that quasi-particles with fractional charge e* = e/3 localize in space to submicrometer dimensions, where e is the electron charge.	Weizmann Inst Sci, IL-76100 Rehovot, Israel; Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; Tech Univ Munich, Walter Schottky Inst, D-85748 Garching, Germany	Weizmann Institute of Science; Max Planck Society; Technical University of Munich	Martin, J (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.	jens.martin@weizmann.ac.il	Martin, Jens/H-9029-2013; ILANI, SHAHAL/K-1377-2012; Umansky, Vladimir/P-1334-2019	ILANI, SHAHAL/0000-0001-8589-7723; Umansky, Vladimir/0000-0001-5727-2064				CHKLOVSKII DB, 1993, PHYS REV B, V48, P18060, DOI 10.1103/PhysRevB.48.18060; COOPER NR, 1993, PHYS REV B, V48, P4530, DOI 10.1103/PhysRevB.48.4530; dePicciotto R, 1997, NATURE, V389, P162, DOI 10.1038/38241; EFROS AL, 1988, SOLID STATE COMMUN, V67, P1019, DOI 10.1016/0038-1098(88)91177-5; Franklin JDF, 1996, SURF SCI, V361, P17, DOI 10.1016/0039-6028(96)00320-2; GOLDMAN VJ, 1995, SCIENCE, V267, P1010, DOI 10.1126/science.267.5200.1010; HUCKESTEIN B, 1995, REV MOD PHYS, V67, P357, DOI 10.1103/RevModPhys.67.357; Ilani S, 2004, NATURE, V427, P328, DOI 10.1038/nature02230; Ilani S, 2000, PHYS REV LETT, V84, P3133, DOI 10.1103/PhysRevLett.84.3133; Ilani S, 2001, SCIENCE, V292, P1354, DOI 10.1126/science.1058645; KIVELSON S, 1992, PHYS REV B, V46, P2223, DOI 10.1103/PhysRevB.46.2223; LAUGHLIN RB, 1983, PHYS REV LETT, V50, P1359; PRANGE RE, 1990, QUANTUM HALL EFFECT, pCH1; Reznikov M, 1999, NATURE, V399, P238, DOI 10.1038/20384; Ruzin IM, 1996, PHYS REV B, V53, P1558, DOI 10.1103/PhysRevB.53.1558; Saminadayar L, 1997, PHYS REV LETT, V79, P2526, DOI 10.1103/PhysRevLett.79.2526; Yacoby A, 1999, SOLID STATE COMMUN, V111, P1, DOI 10.1016/S0038-1098(99)00139-8; Yoo MJ, 1997, SCIENCE, V276, P579, DOI 10.1126/science.276.5312.579; Zhitenev NB, 2000, NATURE, V404, P473, DOI 10.1038/35006591	21	103	103	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					980	983		10.1126/science.1099950	http://dx.doi.org/10.1126/science.1099950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310895				2022-12-28	WOS:000223250700040
J	Paz-y-Mino, G; Bond, AB; Kamil, AC; Balda, RP				Paz-y-Mino, G; Bond, AB; Kamil, AC; Balda, RP			Pinyon jays use transitive inference to predict social dominance	NATURE			English	Article							VOCAL RECOGNITION; INFORMATION; EVOLUTION	Living in large, stable social groups is often considered to favour the evolution of enhanced cognitive abilities, such as recognizing group members, tracking their social status and inferring relationships among them(1-4). An individual's place in the social order can be learned through direct interactions with others, but conflicts can be time-consuming and even injurious. Because the number of possible pairwise interactions increases rapidly with group size, members of large social groups will benefit if they can make judgments about relationships on the basis of indirect evidence(5). Transitive reasoning should therefore be particularly important for social individuals, allowing assessment of relationships from observations of interactions among others. Although a variety of studies have suggested that transitive inference may be used in social settings(6-10), the phenomenon has not been demonstrated under controlled conditions in animals. Here we show that highly social pinyon jays (Gymnorhinus cyanocephalus) draw sophisticated inferences about their own dominance status relative to that of strangers that they have observed interacting with known individuals. These results directly demonstrate that animals use transitive inference in social settings and imply that such cognitive capabilities are widespread among social species.	Univ Nebraska, Sch Biol Sci, Ctr Avian Cognit, Lincoln, NE 68588 USA; Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Northern Arizona University	Bond, AB (corresponding author), Univ Nebraska, Sch Biol Sci, Ctr Avian Cognit, Lincoln, NE 68588 USA.	abond@unl.edu; akamil@unl.edu		Paz-y-Mino-C, Guillermo/0000-0003-4040-140X				Balda Russell P., 1996, Current Ornithology, V13, P33; Balda Russell P., 2002, Birds of North America, V605, P1; Bergman TJ, 2003, SCIENCE, V302, P1234, DOI 10.1126/science.1087513; Bond AB, 2003, ANIM BEHAV, V65, P479, DOI 10.1006/anbe.2003.2101; CHASE ID, 1994, ANIM BEHAV, V48, P393, DOI 10.1006/anbe.1994.1253; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; De Waal FBM, 2003, ANIMAL SOCIAL COMPLEXITY, P230; Hogue ME, 1996, BEHAV PROCESS, V38, P241, DOI 10.1016/S0376-6357(96)00035-6; Holekamp KE, 1999, ANIM BEHAV, V58, P383, DOI 10.1006/anbe.1999.1157; Humphrey NK., 1976, GROWING POINTS ETHOL, P303; Huntingford F.A., 1987, ANIMAL CONFLICT; JOLLY A, 1966, SCIENCE, V153, P501, DOI 10.1126/science.153.3735.501; Kummer H., 1997, HUMAN NATURE BIOL SO, P157; Marzluff J. M., 1992, PINYON JAY; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Peake TM, 2002, P ROY SOC B-BIOL SCI, V269, P1925, DOI 10.1098/rspb.2002.2112; ROHWER S, 1982, AM ZOOL, V22, P531; *SAS I INC, 2000, SAS V8; Seyfarth RM, 2003, ANIMAL SOCIAL COMPLEXITY, P207; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522	20	230	236	4	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					778	781		10.1038/nature02723	http://dx.doi.org/10.1038/nature02723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306809	Green Published			2022-12-28	WOS:000223233600041
J	Gonczy, P				Gonczy, P			Myosin assembly: The power of multiubiquitylation	CELL			English	Editorial Material							CHAPERONE; UNC-45; CHIP		Swiss Inst Expt Canc Res, ISREC, CH-1066 Epalinges, Switzerland	Swiss Institute Experimental Cancer Research	Gonczy, P (corresponding author), Swiss Inst Expt Canc Res, ISREC, 155,Ch Boveresses, CH-1066 Epalinges, Switzerland.			Gonczy, Pierre/0000-0002-6305-6883				Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Mahoney JA, 2002, BIOCHEM J, V361, P587, DOI 10.1042/0264-6021:3610587; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2	9	1	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					272	274		10.1016/j.cell.2004.07.020	http://dx.doi.org/10.1016/j.cell.2004.07.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294151	Bronze			2022-12-28	WOS:000223353100002
J	Roy, E; Haley, N; Leclerc, P; Sochanski, B; Boudreau, JF; Boivin, JF				Roy, E; Haley, N; Leclerc, P; Sochanski, B; Boudreau, JF; Boivin, JF			Mortality in a cohort of street youth in Montreal	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-YORK-CITY; SEXUAL RISK BEHAVIOR; HOMELESS ADOLESCENTS; VIRUS-INFECTION; HIV SEROPREVALENCE; HEROIN OVERDOSE; SUBSTANCE USE; RUNAWAY; PREVALENCE; INJECTION	Context Many studies have shown a high prevalence of sexually transmitted diseases, human immunodeficiency virus (HIV) infection, viral hepatitis, drug dependence, and mental health problems among street youth. However, data on mortality among these youth are sparse. Objectives To estimate mortality rate among street youth in Montreal and to identify causes of death and factors increasing the risk of death. Design, Setting, and Population From January 1995 to September 2000, 1013 street youth 14 to 25 years of age were recruited in a prospective cohort with semiannual follow-ups. Original study objectives were to determine the incidence and risk factors for HIV infection in that population; however, several participants died during the first months of follow-up, prompting investigators to add mortality to the study objectives. Mortality data were obtained from the coroner's office and the Institut de la Statisticlue du Quebec. Main Outcome Measures Mortality rate among participants and factors increasing the risk of death. Results Twenty-six youth died during follow-up for a mortality rate of 921 per 100000 person-years (95% confidence interval [CI], 602-1350); this represented a standardized mortality ratio of 11.4. The observed causes of death were as follows: suicide (13), overdose (8), unintentional injury (2), fulminant hepatitis A (1), heart disease (1); 1 was unidentified. In multivariate Cox regression analyses, HIV infection (adjusted hazard ratio [AHR]=5.6; 95% Cl, 1.9-16.8), daily alcohol use in the last month (AHR=3.2; 95% Cl, 1.3-7.7), homelessness in the last 6 months (AHR=3.0; 95% Cl, 1.1-7.6), drug injection in the last 6 months (AHR=2.7; 95% Cl, 1.2-6.2), and male sex (AHR=2.6; 95% Cl, 0.9-7.7) were identified as independent predictors of mortality. Conclusions Current heavy substance use and homelessness were factors associated with death among street youth. HIV infection was also identified as an important predictor of mortality; however, its role remains to be clarified. These findings should be taken into account when developing interventions to prevent mortality among street youth.	McGill Univ, Direct Sante Publ, Montreal, PQ, Canada; McGill Univ, Joint Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; McGill Univ, Dept Family Med, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Roy, E (corresponding author), 1301 Sherbrooke St E, Montreal, PQ H2L 1M3, Canada.	eroy@santepub-mtl.qc.ca						ALSTROM CH, 1975, BRIT J ADDICT, V70, P245; ANDERSON JE, 1994, FAM PLANN PERSPECT, V26, P22, DOI 10.2307/2136092; Bailey SL, 1998, J ADOLESCENT HEALTH, V23, P378, DOI 10.1016/S1054-139X(98)00033-0; Barrow SM, 1999, AM J PUBLIC HEALTH, V89, P529, DOI 10.2105/AJPH.89.4.529; Brent DA, 1999, J AM ACAD CHILD PSY, V38, P1497, DOI 10.1097/00004583-199912000-00010; Breslow N E, 1987, IARC Sci Publ, P1; *CAN FIR CTR, FIR CRIM CAN VS US; Cheung AM, 2004, CAN MED ASSOC J, V170, P1243, DOI 10.1503/cmaj.1031167; Clatts MC, 1998, CHILD WELFARE, V77, P195; Darke S, 2001, ADDICTION, V96, P1443, DOI 10.1046/j.1360-0443.2001.961014438.x; Dematteo D, 1999, J ADOLESCENT HEALTH, V25, P358, DOI 10.1016/S1054-139X(99)00059-2; Gleghorn AA, 1998, DRUG ALCOHOL DEPEN, V51, P219, DOI 10.1016/S0376-8716(98)00042-8; Greene JM, 1999, AM J PUBLIC HEALTH, V89, P1406, DOI 10.2105/AJPH.89.9.1406; Heale P, 2003, J URBAN HEALTH, V80, P230, DOI 10.1093/jurban/jtg026; HIBBS JR, 1994, NEW ENGL J MED, V331, P304, DOI 10.1056/NEJM199408043310506; Hwang SW, 2002, CAN J PUBLIC HEALTH, V93, P407, DOI 10.1007/BF03405026; Hwang SW, 1997, ANN INTERN MED, V126, P625, DOI 10.7326/0003-4819-126-8-199704150-00007; Hwang SW, 2000, JAMA-J AM MED ASSOC, V283, P2152, DOI 10.1001/jama.283.16.2152; Hwang SW, 1998, ARCH INTERN MED, V158, P1454, DOI 10.1001/archinte.158.13.1454; JANUS MD, 1995, CHILD ABUSE NEGLECT, V19, P433, DOI 10.1016/0145-2134(95)00007-U; KIPKE MD, 1995, ARCH PEDIAT ADOL MED, V149, P513, DOI 10.1001/archpedi.1995.02170180043006; Kipke MD, 1997, J ADOLESCENT HEALTH, V20, P360, DOI 10.1016/S1054-139X(97)00037-2; Kipke MD, 1997, ADOLESCENCE, V32, P655; Kral AH, 1997, INT J STD AIDS, V8, P109, DOI 10.1258/0956462971919651; KUFELDT K, 1987, CHILD ABUSE NEGLECT, V11, P531, DOI 10.1016/0145-2134(87)90079-2; Martinez TE, 1998, J PSYCHOACTIVE DRUGS, V30, P1; Noell J, 2001, CHILD ABUSE NEGLECT, V25, P137, DOI 10.1016/S0145-2134(00)00223-4; Nordentoft M, 2003, BRIT MED J, V327, P81, DOI 10.1136/bmj.327.7406.81; Ochnio JJ, 2001, CAN MED ASSOC J, V165, P293; Pfeifer RW, 1997, J ADOLESCENT HEALTH, V20, P339, DOI 10.1016/S1054-139X(97)00038-4; Rohde P, 2001, J ADOLESCENCE, V24, P447, DOI 10.1006/jado.2001.0382; Roy E, 2000, INT J STD AIDS, V11, P241, DOI 10.1258/0956462001915778; Roy E, 2003, AIDS, V17, P1071, DOI 10.1097/00002030-200305020-00017; Roy E, 2003, J URBAN HEALTH, V80, P92, DOI 10.1093/jurban/jtg092; Roy E, 2001, CAN MED ASSOC J, V165, P557; Roy E, 1999, CAN MED ASSOC J, V161, P689; Roy N, 1998, LANCET, V352, P32, DOI 10.1016/S0140-6736(05)79510-6; Shaw M, 1998, LANCET, V352, P743, DOI 10.1016/S0140-6736(05)60868-9; STRICOF RL, 1991, AM J PUBLIC HEALTH, V81, P50, DOI 10.2105/AJPH.81.Suppl.50; Weber AE, 2002, J URBAN HEALTH, V79, P525, DOI 10.1093/jurban/79.4.525; Whitbeck LB, 1997, J RES ADOLESCENCE, V7, P375, DOI 10.1207/s15327795jra0704_2	41	196	196	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2004	292	5					569	574		10.1001/jama.292.5.569	http://dx.doi.org/10.1001/jama.292.5.569			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843AE	15292082				2022-12-28	WOS:000223045500014
J	Tannen, T				Tannen, T			Thomas F Mancuso - Obituary	LANCET			English	Biographical-Item												ttannen@sbcglobal.net						MANCUSO TF, PUBLICATION LIST	1	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					410	410		10.1016/S0140-6736(04)16749-4	http://dx.doi.org/10.1016/S0140-6736(04)16749-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15290841				2022-12-28	WOS:000222998600015
J	Homes, CC; Dordevic, SV; Strongin, M; Bonn, DA; Liang, RX; Hardy, WN; Komiya, S; Ando, Y; Yu, G; Kaneko, N; Zhao, X; Greven, M; Basov, DN; Timusk, T				Homes, CC; Dordevic, SV; Strongin, M; Bonn, DA; Liang, RX; Hardy, WN; Komiya, S; Ando, Y; Yu, G; Kaneko, N; Zhao, X; Greven, M; Basov, DN; Timusk, T			A universal scaling relation in high-temperature superconductors	NATURE			English	Article							OPTICAL-PROPERTIES; PENETRATION DEPTH; C-AXIS; CUPRATE SUPERCONDUCTORS; GAP ANISOTROPY; CONDUCTIVITY; PSEUDOGAP; PLANE; TL2BA2CUO6+DELTA; LA2-XSRXCUO4	Since the discovery of superconductivity at elevated temperatures in the copper oxide materials(1) there has been a considerable effort to find universal trends and correlations amongst physical quantities, as a clue to the origin of the superconductivity. One of the earliest patterns that emerged was the linear scaling of the superfluid density (rho(s)) with the superconducting transition temperature (T-c), which marks the onset of phase coherence. This is referred to as the Uemura relation(2), and it works reasonably well for the underdoped materials. It does not, however, describe optimally doped ( where T-c is a maximum) or overdoped materials(3). Similarly, an attempt to scale the superfluid density with the d.c. conductivity (sigma(dc)) was only partially successful(4). Here we report a simple scaling relation (rho(s) proportional to proportional to(dc)T(c), with sigma(dc) measured at approximately T-c) that holds for all tested high-T-c materials. It holds regardless of doping level, nature of dopant ( electrons versus holes), crystal structure and type of disorder(5), and direction ( parallel or perpendicular to the copper oxygen planes).	Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA; Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 2A6, Canada; Cent Res Inst Elect Power Ind, Tokyo 2018511, Japan; Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	United States Department of Energy (DOE); Brookhaven National Laboratory; University of British Columbia; Central Research Institute of Electric Power Industry - Japan; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; University of California System; University of California San Diego; McMaster University	Homes, CC (corresponding author), Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA.	homes@bnl.gov	Kaneko, Nobu-Hisa/L-9421-2018; Hardy, Walter Newbold/AAN-7827-2020; Yu, Guichuan/K-4025-2014; Ando, Yoichi/B-8163-2013	Kaneko, Nobu-Hisa/0000-0003-3857-7940; Ando, Yoichi/0000-0002-3553-3355; Ando, Yukio/0000-0001-7115-9105				AMBEGAOKAR V, 1963, PHYS REV LETT, V10, P486, DOI 10.1103/PhysRevLett.10.486; Ando Y, 1996, PHYS REV LETT, V77, P2065, DOI 10.1103/PhysRevLett.77.2065; BASOV DN, 1995, PHYS REV LETT, V74, P598, DOI 10.1103/PhysRevLett.74.598; BASOV DN, 1994, PHYS REV B, V50, P3511, DOI 10.1103/PhysRevB.50.3511; Basov DN, 1999, SCIENCE, V283, P49, DOI 10.1126/science.283.5398.49; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; BULAEVSKII LN, 1973, ZH EKSP TEOR FIZ, V37, P1133; CHAKRAVARTY S, 1993, SCIENCE, V261, P337, DOI 10.1126/science.261.5119.337; Dordevic SV, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.134511; Eisaki H, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064512; HARDY WN, 1993, PHYS REV LETT, V70, P3999, DOI 10.1103/PhysRevLett.70.3999; Homes CC, 1999, PHYS REV B, V60, P9782, DOI 10.1103/PhysRevB.60.9782; HOMES CC, 1995, PHYSICA C, V254, P265, DOI 10.1016/0921-4534(95)00579-X; Homes CC, 1997, PHYS REV B, V56, P5525, DOI 10.1103/PhysRevB.56.5525; KLEIN O, 1994, PHYS REV B, V50, P6307, DOI 10.1103/PhysRevB.50.6307; LAWRENCE WE, 1971, P LT, V12, P361; Liu HL, 1999, J PHYS-CONDENS MAT, V11, P239, DOI 10.1088/0953-8984/11/1/020; NIEDERMAYER C, 1993, PHYS REV LETT, V71, P1764, DOI 10.1103/PhysRevLett.71.1764; ORENSTEIN J, 1990, PHYS REV B, V42, P6342, DOI 10.1103/PhysRevB.42.6342; Pimenov A, 1999, EUROPHYS LETT, V48, P73, DOI 10.1209/epl/i1999-00116-1; Pronin AV, 1998, PHYS REV B, V57, P14416, DOI 10.1103/PhysRevB.57.14416; PUCHKOV AV, 1995, PHYS REV B, V51, P3312, DOI 10.1103/PhysRevB.51.3312; SCHUTZMANN J, 1994, PHYS REV LETT, V73, P174, DOI 10.1103/PhysRevLett.73.174; SHEN ZX, 1993, PHYS REV LETT, V70, P1553, DOI 10.1103/PhysRevLett.70.1553; SHIBAUCHI T, 1994, PHYS REV LETT, V72, P2263, DOI 10.1103/PhysRevLett.72.2263; Singley EJ, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.224503; Startseva T, 1999, PHYS REV B, V59, P7184, DOI 10.1103/PhysRevB.59.7184; Tanner DB, 1998, PHYSICA B, V244, P1, DOI 10.1016/S0921-4526(97)00453-5; UEMURA YJ, 1989, PHYS REV LETT, V62, P2317, DOI 10.1103/PhysRevLett.62.2317	29	198	204	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 29	2004	430	6999					539	541		10.1038/nature02673	http://dx.doi.org/10.1038/nature02673			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282599	Green Submitted			2022-12-28	WOS:000222946100041
J	Lopez-Vaamonde, C; Koning, JW; Brown, RM; Jordan, WC; Bourke, AFG				Lopez-Vaamonde, C; Koning, JW; Brown, RM; Jordan, WC; Bourke, AFG			Social parasitism by male-producing reproductive workers in a eusocial insect	NATURE			English	Article							BOMBUS-TERRESTRIS HYMENOPTERA; BUMBLE BEES; MALE PARENTAGE; QUEEN CONFLICT; SEX-RATIOS; APIDAE; MICROSATELLITES; HYPNORUM; COLONIES; HONEYBEE	The evolution of extreme cooperation, as found in eusocial insects ( those with a worker caste), is potentially undermined by selfish reproduction among group members(1-3). In some eusocial Hymenoptera ( ants, bees and wasps), workers can produce male offspring from unfertilized eggs(4). Kin selection theory predicts levels of worker reproduction as a function of the relatedness structure of the workers' natal colony and the colony-level costs of worker reproduction(5,6). However, the theory has been only partially successful in explaining levels of worker reproduction(7-9). Here we show that workers of a eusocial bumble bee (Bombus terrestris) enter unrelated, conspecific colonies in which they then produce adult male offspring, and that such socially parasitic workers reproduce earlier and are significantly more reproductive and aggressive than resident workers that reproduce within their own colonies. Explaining levels of worker reproduction, and hence the potential of worker selfishness to undermine the evolution of cooperation, will therefore require more than simply a consideration of the kin-selected interests of resident workers. It will also require knowledge of the full set of reproductive options available to workers, including intraspecific social parasitism.	Zool Soc London, Inst Zool, London NW1 4RY, England	Zoological Society of London	Lopez-Vaamonde, C (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	carlos.lopez.vaamonde@ioz.ac.uk; andrew.bourke@ioz.ac.uk	Bourke, Andrew F. G./E-5271-2011; Vaamonde, Carlos Lopez/A-5548-2009	Vaamonde, Carlos Lopez/0000-0003-2278-2368; Koning, Will/0000-0002-9895-1140				AKRE R D, 1976, Journal of the Kansas Entomological Society, V49, P63; Bloch G, 1999, P ROY SOC B-BIOL SCI, V266, P2465, DOI 10.1098/rspb.1999.0947; BOURKE AFG, 1988, Q REV BIOL, V63, P291, DOI 10.1086/415930; Bourke AFG, 1997, PHILOS T ROY SOC B, V352, P1921, DOI 10.1098/rstb.1997.0179; Bourke AFG, 2001, P ROY SOC B-BIOL SCI, V268, P347, DOI 10.1098/rspb.2000.1381; Brown MJF, 2003, MOL ECOL, V12, P1599, DOI 10.1046/j.1365-294X.2003.01840.x; BULMER MG, 1981, J THEOR BIOL, V93, P239, DOI 10.1016/0022-5193(81)90068-0; Chapman RE, 2003, MOL ECOL, V12, P2801, DOI 10.1046/j.1365-294X.2003.01957.x; DUCHATEAU MJ, 1988, BEHAVIOUR, V107, P186, DOI 10.1163/156853988X00340; Duchateau MJ, 1996, P 20 INT C ENT FIR, P404; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; ESTOUP A, 1995, MOL ECOL, V4, P89, DOI 10.1111/j.1365-294X.1995.tb00195.x; Foster KR, 2000, NATURE, V407, P692, DOI 10.1038/35037665; GOULSON D, 2003, BUMBLEBEES THEIR BEH; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hammond RL, 2003, J EVOLUTION BIOL, V16, P446, DOI 10.1046/j.1420-9101.2003.00544.x; HARDER LD, 1986, HOLARCTIC ECOL, V9, P99; Holehouse KA, 2003, INSECT SOC, V50, P277, DOI 10.1007/s00040-003-0672-6; Keller L, 1999, LEVELS SELECTION EVO; Lopez-Vaamonde C, 2003, ANIM BEHAV, V66, P577, DOI 10.1006/anbe.2003.2205; Martin SJ, 2002, NATURE, V415, P163, DOI 10.1038/415163a; Moritz RFA, 2004, ANIM BEHAV, V67, P681, DOI 10.1016/j.anbehav.2003.08.004; OWEN RE, 1982, BEHAV ECOL SOCIOBIOL, V11, P91, DOI 10.1007/BF00300097; Paxton RJ, 2001, MOL ECOL, V10, P2489, DOI 10.1046/j.0962-1083 .2001.01377.x; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; RATNIEKS FLW, 1992, J THEOR BIOL, V158, P33, DOI 10.1016/S0022-5193(05)80647-2; Schmid-Hempel R, 2000, INSECT SOC, V47, P36, DOI 10.1007/s000400050006; Sundstrom L, 2001, HEREDITY, V86, P515, DOI 10.1046/j.1365-2540.2001.00884.x; Toth E, 2004, INSECT SOC, V51, P1, DOI 10.1007/s00040-003-0707-z; VANHONK CGJ, 1981, BEHAV ECOL SOCIOBIOL, V9, P9, DOI 10.1007/BF00299847	30	124	127	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					557	560		10.1038/nature02769	http://dx.doi.org/10.1038/nature02769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282605				2022-12-28	WOS:000222946100047
J	Wilson, SE				Wilson, SE			Use of lasers for vision correction of nearsightedness and farsightedness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-SITU KERATOMILEUSIS; PHOTOREFRACTIVE KERATECTOMY; MYOPIA; ASTIGMATISM; COMPLICATIONS; ABLATION; PRK		Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Wilson, SE (corresponding author), Cleveland Clin Fdn, Cole Eye Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wilsons4@ccf.org	Wilson, Steven E/C-6140-2018	Wilson, Steven E/0000-0001-8121-960X				Ambrosio R, 2001, J REFRACT SURG, V17, P350; Ambrosio Renato Jr, 2003, Semin Ophthalmol, V18, P2, DOI 10.1080/08820530390897738; Autrata R, 2003, J CATARACT REFR SURG, V29, P661, DOI 10.1016/S0886-3350(02)01897-7; El-Agha MSH, 2003, J CATARACT REFR SURG, V29, P900, DOI 10.1016/S0886-3350(02)02039-4; Hersh PS, 1997, OPHTHALMOLOGY, V104, P1535, DOI 10.1016/S0161-6420(97)30073-6; PALLIKARIS IG, 1994, J REFRACT CORNEAL S, V10, P498; Peyman GA, 1996, AM J OPHTHALMOL, V122, P284, DOI 10.1016/S0002-9394(14)72035-5; Phusitphoykai N, 2003, J REFRACT SURG, V19, pS217; Porter J, 2003, AM J OPHTHALMOL, V136, P327, DOI 10.1016/S0002-9394(03)00222-8; Rapuano CJ, 1999, OPHTHALMOLOGY, V106, P422; Stulting RD, 1999, OPHTHALMOLOGY, V106, P13, DOI 10.1016/S0161-6420(99)90000-3; Sugar A, 2002, OPHTHALMOLOGY, V109, P175, DOI 10.1016/S0161-6420(01)00966-6; Van Gelder RN, 2002, J CATARACT REFR SURG, V28, P462, DOI 10.1016/S0886-3350(01)01177-4; Vinciguerra P, 1998, J REFRACT SURG, V14, pS199; Vinciguerra P, 2002, J REFRACT SURG, V18, pS371; Vongthongsri A, 2002, J REFRACT SURG, V18, pS332; Walker MB, 2001, CORNEA, V20, P153, DOI 10.1097/00003226-200103000-00007	17	37	39	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					470	475		10.1056/NEJMcp033210	http://dx.doi.org/10.1056/NEJMcp033210			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282354				2022-12-28	WOS:000222939700010
J	Clark, BA				Clark, BA			A time to live or a time to die? Let those who have ears hear	BRITISH MEDICAL JOURNAL			English	Letter									Selly Oak Hosp, Birmingham B29 6JD, W Midlands, England		Clark, BA (corresponding author), Selly Oak Hosp, Birmingham B29 6JD, W Midlands, England.	barry.clark@uhb.nhs.uk						Drife JO, 2004, BRIT MED J, V328, P1445, DOI 10.1136/bmj.328.7453.1445-a	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 24	2004	329	7459					233	233		10.1136/bmj.329.7459.233-a	http://dx.doi.org/10.1136/bmj.329.7459.233-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840NW	15271849	Green Published			2022-12-28	WOS:000222866900039
J	Liu, JD; Carmell, MA; Rivas, FV; Marsden, CG; Thomson, JM; Song, JJ; Hammond, SM; Joshua-Tor, L; Hannon, GJ				Liu, JD; Carmell, MA; Rivas, FV; Marsden, CG; Thomson, JM; Song, JJ; Hammond, SM; Joshua-Tor, L; Hannon, GJ			Argonaute2 is the catalytic engine of mammalian RNAi	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; INTERFERING RNA; C-ELEGANS; DROSOPHILA; GENE; CLEAVAGE; MICRORNA; PIWI	Gene silencing through RNA interference (RNAi) is carried out by RISC, the RNA-induced silencing complex. RISC contains two signature components, small interfering RNAs (siRNAs) and Argonaute family proteins. Here, we show that the multiple Argonaute proteins present in mammals are both biologically and biochemically distinct, with a single mammalian family member, Argonaute2, being responsible for messenger RNA cleavage activity. This protein is essential for mouse development, and cells tacking Argonaute2 are unable to mount an experimental response to siRNAs. Mutations within a cryptic ribonuclease H domain within Argonaute2, as identified by comparison with the structure of an archeal. Argonaute protein, inactivate RISC. Thus, our evidence supports a model in which Argonaute contributes "Slicer" activity to RISC, providing the catalytic engine for RNAi.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of North Carolina; University of North Carolina Chapel Hill	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Song, Ji-Joon/C-1721-2011; Hannon, Gregory/AAB-3568-2019	Joshua-Tor, Leemor/0000-0001-8185-8049				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Chapados BR, 2001, J MOL BIOL, V307, P541, DOI 10.1006/jmbi.2001.4494; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	43	1921	2073	6	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1437	1441		10.1126/science.1102513	http://dx.doi.org/10.1126/science.1102513			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15284456	Bronze			2022-12-28	WOS:000223761900040
J	Casali, A; Struhl, G				Casali, A; Struhl, G			Reading the Hedgehog morphogen gradient by measuring the ratio of bound to unbound Patched protein	NATURE			English	Article							CUBITUS INTERRUPTUS; DROSOPHILA EMBRYOS; MEMBRANE-PROTEIN; SONIC HEDGEHOG; GENE ENCODES; POLARITY; RECEPTOR; PATTERN; SIGNAL; FORMS	Morphogens are 'form-generating' substances that spread from localized sites of production and specify distinct cellular outcomes at different concentrations. A cell's perception of morphogen concentration is thought to be determined by the number of active receptors, with inactive receptors making little if any contribution(1). Patched (Ptc)(2-5), the receptor for the morphogen Hedgehog (Hh)(6-12), is active in the absence of ligand and blocks the expression of target genes by inhibiting Smoothened (Smo), an essential transducer of the Hh signal(3,13-16). Hh binding to Ptc abrogates the ability of Ptc to inhibit Smo, thereby unleashing Smo activity and inducing target gene expression(2,3,12-16). Here, we show that a cell's measure of ambient Hh concentration is not determined solely by the number of active (unliganded) Ptc molecules. Instead, we find that Hh-bound Ptc can titrate the inhibitory action of unbound Ptc. Furthermore, we demonstrate that this effect is sufficient to allow normal reading of the Hh gradient in the presence of a form of Ptc that cannot bind the ligand(12) but retains its ability to inhibit Smo. These results support a model in which the ratio of bound to unbound Ptc molecules determines the cellular response to Hh.	Columbia Univ, Howard Hughes Med Inst, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Struhl, G (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Genet & Dev, New York, NY 10032 USA.	gs20@columbia.edu	Casali, Andreu/Z-5620-2019; Casali, Andreu/ABD-5226-2021	Casali, Andreu/0000-0003-1738-869X				Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Aza-Blanc P, 1999, TRENDS GENET, V15, P458, DOI 10.1016/S0168-9525(99)01869-7; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Greenwood S, 1997, DEVELOPMENT, V124, P4879; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hepker J, 1997, DEVELOPMENT, V124, P549; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; HOOPER JE, 1994, NATURE, V372, P461, DOI 10.1038/372461a0; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Mullor JL, 1997, DEVELOPMENT, V124, P1227; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strigini M, 1997, DEVELOPMENT, V124, P4697; Struhl G, 1997, DEVELOPMENT, V124, P2143; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1	30	94	95	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					76	80		10.1038/nature02835	http://dx.doi.org/10.1038/nature02835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15300262				2022-12-28	WOS:000223641500044
J	Keeley, EC; Grines, CL				Keeley, EC; Grines, CL			Primary percutaneous coronary intervention for every patient with ST-segment elevation myocardial infarction: What stands in the way?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONVENTIONAL BALLOON ANGIOPLASTY; PRACTICE GUIDELINES COMMITTEE; TISSUE-PLASMINOGEN ACTIVATOR; ASSOCIATION TASK-FORCE; SITE CARDIAC-SURGERY; HIGH-RISK PATIENTS; THROMBOLYTIC THERAPY; RANDOMIZED-TRIAL; IMMEDIATE THROMBOLYSIS; INTRAVENOUS STREPTOKINASE	According to data from randomized, controlled trials, primary percutaneous coronary intervention (PCI) is the treatment of choice for ST-segment elevation myocardial infarction (MI). In these trials, 1 life was saved and 2 other life-threatening complications, including stroke and reinfarction, were prevented for every 50 patients with ST-segment elevation MI treated with primary PCI rather than thrombolytic therapy. Only 1 major bleeding episode occurred. How can these superior results be realized outside the context of randomized trials? We anticipate 4 obstacles to instituting primary PCI as the universal treatment of ST-segment elevation MI: 1) lack of timely availability, 2) technical expertise of center and operator, 3) the need to address patient subgroups that are not studied in randomized trials, and 4) comparisons of primary PCI to newer pharmacologic regimens. We propose 3 strategies to increase the availability of this procedure: 1) perform primary PCI in qualified community hospitals without surgical back-up; 2) transfer patients from community hospitals without primary PCI capability to hospitals with primary PCI capability; and 3) develop a universal system in which ambulances directly transfer patients to a regional primary PC[ center, not necessarily to the closest hospital, similar to the system used for trauma patients, We contend that, in light of the superior clinical outcomes seen with primary PCI for treating ST-segment elevation MI, this procedure should be available to all patients with ST-segment elevation MI and efforts should be made to institute these measures.	Univ Texas, SW Med Ctr, Div Cardiol, Dallas, TX 75390 USA; William Beaumont Hosp, Royal Oak, MI 48072 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Beaumont Health	Keeley, EC (corresponding author), Univ Texas, SW Med Ctr, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ellen.keeley@utsouthwestern.edu						Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Antoniucci D, 1998, J AM COLL CARDIOL, V31, P1234, DOI 10.1016/S0735-1097(98)00097-7; Antoniucci D, 2002, AM J CARDIOL, V89, P1248, DOI 10.1016/S0002-9149(02)02320-2; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943; Berger AK, 1999, JAMA-J AM MED ASSOC, V282, P341, DOI 10.1001/jama.282.4.341; Bonnefoy E, 2002, LANCET, V360, P825, DOI 10.1016/S0140-6736(02)09963-4; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Brodie BR, 2003, AM HEART J, V145, P708, DOI 10.1067/mhj.2003.9; Brodie BR, 2001, AM J CARDIOL, V88, P1085, DOI 10.1016/S0002-9149(01)02039-2; Brodie BR, 1997, AM J CARDIOL, V79, P1586, DOI 10.1016/S0002-9149(97)00203-8; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; Canto JG, 2002, CIRCULATION, V106, P3018, DOI 10.1161/01.CIR.0000041246.20352.03; Dalby M, 2003, CIRCULATION, V108, P1809, DOI 10.1161/01.CIR.0000091088.63921.8C; de Boer MJ, 2002, J AM COLL CARDIOL, V39, P1723, DOI 10.1016/S0735-1097(02)01878-8; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; Gibson CM, 2003, J AM COLL CARDIOL, V42, P7, DOI 10.1016/S0735-1097(03)00506-0; Goldberg RJ, 1998, AM J CARDIOL, V82, P259, DOI 10.1016/S0002-9149(98)00342-7; Goldenberg I, 2003, AM HEART J, V145, P862, DOI 10.1016/S0002-8703(02)94709-5; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Grines CL, 2002, J AM COLL CARDIOL, V39, P1713, DOI 10.1016/S0735-1097(02)01870-3; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Grzybowski M, 2003, JAMA-J AM MED ASSOC, V290, P1891, DOI 10.1001/jama.290.14.1891; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; JACOBS AK, 2003, NEW ENGL J MED, V107, P2538; KAHN JK, 1990, AM J CARDIOL, V66, P1045, DOI 10.1016/0002-9149(90)90502-R; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Magid DJ, 2000, JAMA-J AM MED ASSOC, V284, P3131, DOI 10.1001/jama.284.24.3131; Maillard L, 2000, J AM COLL CARDIOL, V35, P1729, DOI 10.1016/S0735-1097(00)00612-4; Moreno R, 2002, J AM COLL CARDIOL, V39, P598, DOI 10.1016/S0735-1097(01)01796-X; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Nakatani D, 2003, AM J CARDIOL, V92, P785, DOI 10.1016/S0002-9149(03)00883-X; Nallamothu BK, 2003, AM J CARDIOL, V92, P824, DOI 10.1016/S0002-9149(03)00891-9; Newby LK, 1996, J AM COLL CARDIOL, V27, P1646; Nunn CM, 1999, J AM COLL CARDIOL, V33, P640, DOI 10.1016/S0735-1097(98)00622-6; ONEILL WW, 1992, CIRCULATION, V86, P1710, DOI 10.1161/01.CIR.86.6.1710; Rodriguez A, 1998, AM J CARDIOL, V81, P1286, DOI 10.1016/S0002-9149(98)00154-4; Rogers WJ, 2000, J AM COLL CARDIOL, V35, P371, DOI 10.1016/S0735-1097(99)00505-7; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Ross AM, 1999, J AM COLL CARDIOL, V34, P1954, DOI 10.1016/S0735-1097(99)00444-1; ROSS AM, 1993, NEW ENGL J MED, V329, P1615; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Saito S, 1999, CATHETER CARDIO INTE, V48, P262, DOI 10.1002/(SICI)1522-726X(199911)48:3<262::AID-CCD5>3.0.CO;2-4; Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602; Schomig A, 2003, CIRCULATION, V108, P1084, DOI 10.1161/01.CIR.0000086346.32856.9C; Singh M, 2002, J AM COLL CARDIOL, V39, P1881, DOI 10.1016/S0735-1097(02)01901-0; Smith SC, 2001, J AM COLL CARDIOL, V37, P2215, DOI 10.1016/S0735-1097(01)01344-4; Steg PG, 2003, CIRCULATION, V108, P2851, DOI 10.1161/01.CIR.0000103122.10021.F2; Steg PG, 1998, J AM COLL CARDIOL, V31, P776, DOI 10.1016/S0735-1097(98)00018-7; Stone GW, 2000, AM J CARDIOL, V85, P1292, DOI 10.1016/S0002-9149(00)00758-X; Straumann E, 1999, HEART, V82, P415, DOI 10.1136/hrt.82.4.415; Suryapranata H, 1998, CIRCULATION, V97, P2502, DOI 10.1161/01.CIR.97.25.2502; Vakili BA, 2001, CIRCULATION, V104, P2171, DOI 10.1161/hc3901.096668; Vermeer F, 1999, HEART, V82, P426, DOI 10.1136/hrt.82.4.426; WEAVER WD, 1993, CIRCULATION, V88, P2067, DOI 10.1161/01.CIR.88.5.2067; Wharton TP, 1999, J AM COLL CARDIOL, V33, P1257, DOI 10.1016/S0735-1097(99)00009-1; Widimsky P, 2000, EUR HEART J, V21, P823, DOI 10.1053/euhj.1999.1993; Widimsky P, 2003, EUR HEART J, V24, P94, DOI 10.1016/S0195-668X(02)00468-2; Williams DO, 2004, CIRCULATION, V109, P1806, DOI 10.1161/01.CIR.0000126892.17646.83; Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007; Yip HK, 2003, CHEST, V124, P565, DOI 10.1378/chest.124.2.565; Zeymer U, 1999, AM HEART J, V137, P34, DOI 10.1016/S0002-8703(99)70457-6; Zijistra F, 2002, EUR HEART J, V23, P550, DOI 10.1053/euhj.2001.2901; Zijlstra F, 1999, NEW ENGL J MED, V341, P1413, DOI 10.1056/NEJM199911043411901; ZIJLSTRA F, 1994, CORONARY ARTERY DIS, V5, P707, DOI 10.1097/00019501-199408000-00009; Zijlstra F, 1997, HEART, V78, P333, DOI 10.1136/hrt.78.4.333	68	35	38	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2004	141	4					298	304		10.7326/0003-4819-141-4-200408170-00010	http://dx.doi.org/10.7326/0003-4819-141-4-200408170-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846BX	15313746				2022-12-28	WOS:000223290900007
J	Eisenstein, JP				Eisenstein, JP			Half full or half empty?	SCIENCE			English	Editorial Material							SUPERCONDUCTIVITY; SYSTEMS		CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Eisenstein, JP (corresponding author), CALTECH, Pasadena, CA 91125 USA.	jpe@caltech.edu						BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BARDEEN J, 1957, PHYS REV, V106, P162, DOI 10.1103/PhysRev.106.162; Butov LV, 2003, SOLID STATE COMMUN, V127, P89, DOI 10.1016/S0038-1098(03)00312-0; FERTIG HA, 1989, PHYS REV B, V40, P1087, DOI 10.1103/PhysRevB.40.1087; KELDYSH LV, 1965, FIZ TVERD TELA+, V6, P2219; Kellogg M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036801; Lai CW, 2004, SCIENCE, V303, P503, DOI 10.1126/science.1092691; MACDONALD AH, 1990, PHYS REV B, V42, P3224, DOI 10.1103/PhysRevB.42.3224; Snoke D, 2002, SCIENCE, V298, P1368, DOI 10.1126/science.1078082; Spielman IB, 2000, PHYS REV LETT, V84, P5808, DOI 10.1103/PhysRevLett.84.5808; Tutuc E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036802; WEN XG, 1992, PHYS REV LETT, V69, P1811, DOI 10.1103/PhysRevLett.69.1811	12	25	25	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					950	951		10.1126/science.1099386	http://dx.doi.org/10.1126/science.1099386			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310880				2022-12-28	WOS:000223250700024
J	Isbister, GK				Isbister, GK			Necrotic arachnidism: the mythology of a modern plague	LANCET			English	Editorial Material							WHITE-TAILED SPIDER; DISGUST SENSITIVITY; CLINICAL TOXINOLOGY; LAMPONA-CYLINDRATA; MISS-MUFFET; BITE; ETIOLOGY; LOXOSCELES; DIAGNOSIS; PHOBIAS		Univ Newcastle, Newcastle Mater Misericordiae Hosp, Clin Envenoming Res Grp, Waratah, NSW 2298, Australia	Calvary Mater Newcastle Hospital; University of Newcastle	Isbister, GK (corresponding author), Univ Newcastle, Newcastle Mater Misericordiae Hosp, Clin Envenoming Res Grp, Waratah, NSW 2298, Australia.	gsbite@femtree.com	Isbister, Geoffrey K/G-8052-2015	Isbister, Geoffrey K/0000-0003-1519-7419				ATKINSON RK, 1991, COMP BIOCHEM PHYS C, V98, P441, DOI 10.1016/0742-8413(91)90230-Q; *AUSTR TRANSP SAF, 2002, ROAD CRASH DAT RAT A; Bettini S, 1978, ARTHROPOD VENOMS, P103; Davey G.C., 1991, ANXIETY RES, V4, P299, DOI [https://doi.org/10.1080/08917779208248798, DOI 10.1080/08917779208248798, 10.1080/08917779208248798]; DAVEY GCL, 1994, BRIT J PSYCHOL, V85, P541, DOI 10.1111/j.2044-8295.1994.tb02540.x; DAVEY GCL, 1994, SOC ANIM, V2, P17, DOI 10.1163/156853094X00045; DAVEY GCL, 1993, BEHAV RES THER, V31, P41, DOI 10.1016/0005-7967(93)90041-R; FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008; GRAY M, 1989, MED J AUSTRALIA, V151, P114, DOI 10.5694/j.1326-5377.1989.tb101182.x; Isbister GK, 2004, INTERN MED J, V34, P38, DOI 10.1111/j.1444-0903.2004.00506.x; Isbister GK, 2003, MED J AUSTRALIA, V179, P199, DOI 10.5694/j.1326-5377.2003.tb05499.x; Isbister GK, 2002, QJM-INT J MED, V95, P723, DOI 10.1093/qjmed/95.11.723; Isbister GK, 2002, J TOXICOL-CLIN TOXIC, V40, P231, DOI 10.1081/CLT-120005493; KEMP DR, 1990, MED J AUSTRALIA, V152, P669, DOI 10.5694/j.1326-5377.1990.tb125430.x; MARETIC Z, 1979, OTHER EUROPEAN ARANE, P172; MCGAIN F, 2000, BEE WASP STING RELAT; MENZIES RG, 1995, CLIN PSYCHOL REV, V15, P23, DOI 10.1016/0272-7358(94)00039-5; Merckelbach H, 1997, BEHAV RES THER, V35, P1031, DOI 10.1016/S0005-7967(97)00054-5; MORFORD MPO, CLASSICAL MYTHOLOGY, pCH8; RAVEN RJ, 1991, MED J AUSTRALIA, V154, P208; RIBEIRO LA, 1990, TOXICON, V28, P715, DOI 10.1016/0041-0101(90)90260-E; Sams HH, 2001, J AM ACAD DERMATOL, V44, P561, DOI 10.1067/mjd.2001.112385; Sezerino UM, 1998, T ROY SOC TROP MED H, V92, P546, DOI 10.1016/S0035-9203(98)90909-9; SOUTHCOTT RV, 1976, MED J AUSTRALIA, V1, P406, DOI 10.5694/j.1326-5377.1976.tb140704.x; SPRING WJ, 1987, MED J AUSTRALIA, V147, P605, DOI 10.5694/j.1326-5377.1987.tb133700.x; STGEORGE I, 1991, NEW ZEAL MED J, V104, P207; Sutherland S, 2001, AUSTR ANIMAL TOXINS; SUTHERLAND SK, 1987, MED J AUSTRALIA, V147, P531, DOI 10.5694/j.1326-5377.1987.tb133672.x; SUTHERLAND SK, 1982, TOXICON S1, V20, P59; VEST DK, 1987, TOXICON, V25, P175, DOI 10.1016/0041-0101(87)90239-X; Vetter RS, 2002, ANN EMERG MED, V39, P544, DOI 10.1067/mem.2002.123594; White J, 2003, MED J AUSTRALIA, V179, P180, DOI 10.5694/j.1326-5377.2003.tb05493.x; White J, 2003, J TOXICOL-CLIN TOXIC, V41, P263, DOI 10.1081/CLT-120021112; WHITE J, 1989, MED J AUSTRALIA, V150, P401, DOI 10.5694/j.1326-5377.1989.tb136536.x; 1996, ADVERSE DRUG REACT T, V15, P199	35	26	28	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					549	553		10.1016/S0140-6736(04)16816-5	http://dx.doi.org/10.1016/S0140-6736(04)16816-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302201				2022-12-28	WOS:000223132700037
J	Linstedt, AD				Linstedt, AD			Positioning the Golgi apparatus	CELL			English	Editorial Material							ORGANELLE; TRANSPORT; BINDING		Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Linstedt, AD (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA.							Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83; Rios RM, 2004, CELL, V118, P323; Schroer TA, 2000, TRAFFIC, V1, P3, DOI 10.1034/j.1600-0854.2000.010102.x; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029	8	21	22	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 6	2004	118	3					271	272		10.1016/j.cell.2004.07.015	http://dx.doi.org/10.1016/j.cell.2004.07.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294150	Bronze			2022-12-28	WOS:000223353100001
J	Reed, EJ; Soljacic, M; Ibanescu, M; Joannopoulos, JD				Reed, EJ; Soljacic, M; Ibanescu, M; Joannopoulos, JD			Comment on "Observation of the inverse Doppler effect"	SCIENCE			English	Editorial Material									MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Reed, EJ (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	evan@mit.edu	Soljacic, Marin/AAA-4868-2019; Joannopoulos, John D/E-6401-2013					Kittel C., 2018, INTRO SOLID STATE PH; Reed EJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.133901; Seddon N, 2003, SCIENCE, V302, P1537, DOI 10.1126/science.1089342	3	13	13	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685												2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297649				2022-12-28	WOS:000223104900021
J	Manoli, DS; Baker, BS				Manoli, DS; Baker, BS			Median bundle neurons coordinate behaviours during Drosophila male courtship	NATURE			English	Article							DETERMINATION GENE FRUITLESS; MALE SEXUAL-BEHAVIOR; EXPRESSION PATTERNS; MELANOGASTER; PROTEIN; MUTANT; ORIENTATION; ENCODES; DOMAIN; ROLES	Throughout the animal kingdom the innate nature of basic behaviour routines suggests that the underlying neuronal substrates necessary for their execution are genetically determined and developmentally programmed(1-2). Complex innate behaviours require proper timing and ordering of individual component behaviours. In Drosophila melanogaster, analyses of combinations of mutations of the fruitless (fru) gene have shown that male-specific isoforms (Fru(M)) of the Fru transcription factor are necessary for proper execution of all steps of the innate courtship ritual(3-9). Here, we eliminate Fru(M) expression in one group of about 60 neurons in the Drosophila central nervous system and observe severely contracted courtship behaviour, including rapid courtship initiation, absence of orienting and tapping, and the simultaneous occurrence of wing vibration, licking and attempted copulation. Our results identify a small group of median bundle neurons, that in wild-type Drosophila appropriately trigger the sequential execution of the component behaviours that constitute the Drosophila courtship ritual.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Baker, BS (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	bbaker@cmgm.stanford.edu		Manoli, Devanand/0000-0002-7238-2330				ALONSOPIMENTEL H, 1994, CELL TISSUE RES, V275, P467, DOI 10.1007/BF00318816; Anand A, 2001, GENETICS, V158, P1569; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Emmons SW, 2003, J NEUROBIOL, V54, P93, DOI 10.1002/neu.10163; Gaines P, 2000, GENETICS, V154, P1627; Goodwin SF, 2000, GENETICS, V154, P725; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; MANNING AUBREY, 1959, BEHAVIOUR, V15, P123; Melnattur K, 2002, GENESIS, V34, P29, DOI 10.1002/gene.10151; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; SHANBHAG SR, 1992, CELL TISSUE RES, V267, P273, DOI 10.1007/BF00302965; SPIETH HERMAN T., 1940, JOUR NEW YORK ENT SOC, V48, P379; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; STONE GN, 1995, ECOL ENTOMOL, V20, P169, DOI 10.1111/j.1365-2311.1995.tb00443.x; Villella A, 1997, GENETICS, V147, P1107; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18	25	62	64	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					564	569		10.1038/nature02713	http://dx.doi.org/10.1038/nature02713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282607				2022-12-28	WOS:000222946100049
J	Lew, DP; Waldvogel, FA				Lew, DP; Waldvogel, FA			Osteomyelitis	LANCET			English	Review							RESISTANT STAPHYLOCOCCUS-AUREUS; CHRONIC POSTTRAUMATIC OSTEOMYELITIS; PARENTERAL ANTIMICROBIAL THERAPY; ACUTE HEMATOGENOUS OSTEOMYELITIS; INFECTED ORTHOPEDIC IMPLANTS; RANDOMIZED CONTROLLED-TRIAL; FOREIGN-BODY INFECTION; SMALL-COLONY VARIANTS; SEPTIC ARTHRITIS; VERTEBRAL OSTEOMYELITIS	Bone and joint infections are painful for patients and frustrating for both them and their doctors. The high success rates of antimicrobial therapy in most infectious diseases have not yet been achieved in bone and joint infections owing to the physiological and anatomical characteristics of bone. The key to successful management is early diagnosis, including bone sampling for microbiological and pathological examination to allow targeted and long-lasting antimicrobial therapy. The various types of osteomyelitis require differing medical and surgical therapeutic strategies. These types include, in order of decreasing frequency: osteomyelitis secondary to a contiguous focus of infection (after trauma, surgery, or insertion of a joint prosthesis); that secondary to vascular insufficiency (in diabetic foot infections); or that of haematogenous origin. Chronic osteomyelitis is associated with avascular necrosis of bone and formation of sequestrum (dead bone), and surgical debridement is necessary for cure in addition to antibiotic therapy. By contrast, acute osteomyelitis can respond to antibiotics alone. Generally, a multidisciplinary approach is required for success, involving expertise in orthopaedic surgery, infectious diseases, and plastic surgery, as well as vascular surgery, particularly for complex cases with soft-tissue loss.	Univ Hosp Geneva, Infect Dis Serv, Dept Internal Med, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Serv Med 2, Dept Internal Med, CH-1211 Geneva 14, Switzerland	University of Geneva; University of Geneva	Lew, DP (corresponding author), Univ Hosp Geneva, Infect Dis Serv, Dept Internal Med, 24 Rue Micheli du Crest, CH-1211 Geneva 14, Switzerland.	Daniel.Lew@hcuge.ch	Thompson, Lester D. R./J-8404-2016; Groneberg, David/A-5132-2018; Shirtliff, Mark E/H-2563-2017	Thompson, Lester D. R./0000-0003-3714-1432; Groneberg, David/0000-0001-8551-6556; Shirtliff, Mark E/0000-0002-8913-3445				Abdul-Karim FW, 1998, MODERN PATHOL, V11, P427; Alonge T O, 2002, West Afr J Med, V21, P302; Alonge TO, 2002, INT J CLIN PRACT, V56, P353; Ariza J, 1999, LANCET, V353, P1587, DOI 10.1016/S0140-6736(99)01017-X; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baumert N, 2002, MICROB DRUG RESIST, V8, P253, DOI 10.1089/10766290260469507; Becker P, 2001, APPL ENVIRON MICROB, V67, P2958, DOI 10.1128/AEM.67.7.2958-2965.2001; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Bernard L, 2001, J CLIN PHARM THER, V26, P445, DOI 10.1046/j.1365-2710.2001.00380.x; Bernard L, 2004, J ANTIMICROB CHEMOTH, V53, P127, DOI 10.1093/jac/dkh033; BERNARD L, 2003, QUINOLONE ANTIMICROB, P251; Beronius M, 2001, SCAND J INFECT DIS, V33, P527, DOI 10.1080/00365540110026566; Birmingham MC, 2003, CLIN INFECT DIS, V36, P159, DOI 10.1086/345744; Biviji Ayaz A, 2002, J Am Acad Orthop Surg, V10, P312; Bonhoeffer J, 2001, SWISS MED WKLY, V131, P575; Boxma H, 1996, LANCET, V347, P1133, DOI 10.1016/S0140-6736(96)90606-6; Brandt CM, 1999, MAYO CLIN PROC, V74, P553, DOI 10.4065/74.6.553; Brook I, 1998, AM J EMERG MED, V16, P585, DOI 10.1016/S0735-6757(98)90225-X; CAPUTO GM, 1994, NEW ENGL J MED, V331, P854, DOI 10.1056/NEJM199409293311307; Charnley J, 1972, Clin Orthop Relat Res, V87, P167, DOI 10.1097/00003086-197209000-00020; CHUARD C, 1991, ANTIMICROB AGENTS CH, V35, P2611, DOI 10.1128/AAC.35.12.2611; CIERNY III G, 1985, CONT ORTHOP, V10, P17, DOI DOI 10.1097/01.BLO.0000088564.81746.62; CLASSEN DC, 1992, NEW ENGL J MED, V326, P281, DOI 10.1056/NEJM199201303260501; Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365; DAROUICHE RO, 1994, ARCH INTERN MED, V154, P753, DOI 10.1001/archinte.154.7.753; de Barros J W, 1992, Rev Soc Bras Med Trop, V25, P235; DRANCOURT M, 1993, ANTIMICROB AGENTS CH, V37, P1214, DOI 10.1128/AAC.37.6.1214; Drancourt M, 1997, J ANTIMICROB CHEMOTH, V39, P235, DOI 10.1093/jac/39.2.235; ECKARDT JJ, 1994, CLIN ORTHOP RELAT R, V298, P229; Eggink BH, 2003, PEDIATR INFECT DIS J, V22, P572, DOI 10.1097/00006454-200306000-00020; FALK A, 1967, AM REV RESPIR DIS, V95, P1; Fisman DN, 2001, CLIN INFECT DIS, V32, P419, DOI 10.1086/318502; Francois P, 2003, FEMS IMMUNOL MED MIC, V35, P135, DOI 10.1016/S0928-8244(02)00463-7; GOLD RH, 1991, AM J ROENTGENOL, V157, P365, DOI 10.2214/ajr.157.2.1853823; GORSE GJ, 1983, MEDICINE, V62, P178, DOI 10.1097/00005792-198305000-00005; Gosselin R A, 2004, Cochrane Database Syst Rev, pCD003764, DOI 10.1002/14651858.CD003764.pub2; GRAYSON ML, 1995, JAMA-J AM MED ASSOC, V273, P721, DOI 10.1001/jama.273.9.721; GREEN SA, 1991, ORTHOP CLIN N AM, V22, P515; HOWARD CB, 1994, J BONE JOINT SURG BR, V76B, P311, DOI 10.1302/0301-620X.76B2.8113300; Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075; Jaberi FM, 2002, J PEDIATR ORTHOPED, V22, P317; JACOBSON IV, 1987, S AFR MED J, V72, P476; Jauregui, 1995, DIAGNOSIS MANAGEMENT, P37; Kaim AH, 2002, EUR RADIOL, V12, P1193, DOI 10.1007/s00330-001-1141-0; KAISER S, 1994, PEDIATR RADIOL, V24, P336, DOI 10.1007/BF02012120; Klosterhalfen B, 1996, J TRAUMA, V40, P372, DOI 10.1097/00005373-199603000-00008; Komurcu M, 2003, MIL MED, V168, P694; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lew Daniel P., 1999, P937; Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406; Lew DP, 1999, DRUGS, V58, P85, DOI 10.2165/00003495-199958002-00017; Lew DP., 2004, HOSP EPIDEMIOLOGY IN, VThird ed, P1181; Lipsky BA, 2004, CLIN INFECT DIS, V38, P17, DOI 10.1086/380449; MACKOWIAK PA, 1978, JAMA-J AM MED ASSOC, V239, P2772, DOI 10.1001/jama.239.26.2772; Mader J.T., 2000, PRINCIPLES PRACTICE, P1182; MADER JT, 1992, CLIN INFECT DIS, V15, pS155, DOI 10.1093/clind/15.Supplement_1.S155; MAH ET, 1994, J BONE JOINT SURG BR, V76B, P969, DOI 10.1302/0301-620X.76B6.7983130; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; MATHES SJ, 1982, NEW ENGL J MED, V306, P294, DOI 10.1056/NEJM198202043060509; MUDUN A, 1995, CLIN NUCL MED, V20, P772, DOI 10.1097/00003072-199509000-00004; Narang A, 1998, Indian J Pediatr, V65, P461, DOI 10.1007/BF02761144; Nolla JM, 2002, SEMIN ARTHRITIS RHEU, V31, P271, DOI 10.1053/sarh.2002.29492; NORDEN C, 1992, CLIN INFECT DIS, V15, pS177, DOI 10.1093/clind/15.Supplement_1.S177; NORDEN CW, 1991, REV INFECT DIS, V13, pS842; Osmon DR, 2002, CLIN ORTHOP RELAT R, P80, DOI 10.1097/01.blo.0000030171.56585.1d; OYEN WJG, 1992, RADIOLOGY, V182, P195, DOI 10.1148/radiology.182.1.1727281; Parsch K, 1997, ORTHOPADE, V26, P838, DOI 10.1007/PL00003333; PATZAKIS MJ, 1991, CLIN ORTHOP RELAT R, V264, P178; Perry AC, 2003, CLIN ORTHOP RELAT R, P95, DOI 10.1097/01.blo.0000087322.60612.14; Peters AM, 1998, BRIT J RADIOL, V71, P252, DOI 10.1259/bjr.71.843.9616233; Pittet D, 1999, ARCH INTERN MED, V159, P851, DOI 10.1001/archinte.159.8.851; PROCTOR RA, 1995, CLIN INFECT DIS, V20, P95, DOI 10.1093/clinids/20.1.95; Rayner CR, 2004, INFECTION, V32, P8, DOI 10.1007/s15010-004-3029-9; REESE JH, 1995, DIAGNOSIS MANAGEMENT, P425; Restrepo CS, 2003, RHEUM DIS CLIN N AM, V29, P89, DOI 10.1016/S0889-857X(02)00078-9; Roberts ME, 2004, ANTIMICROB AGENTS CH, V48, P48, DOI 10.1128/AAC.48.1.48-52.2004; Robiller FC, 2000, EUR RADIOL, V10, P855, DOI 10.1007/s003300051019; Schmitz A, 2000, J SPINAL DISORD, V13, P541, DOI 10.1097/00002517-200012000-00016; Schwank S, 1998, ANTIMICROB AGENTS CH, V42, P895, DOI 10.1128/AAC.42.4.895; Shirtliff ME, 2002, CHEM BIOL, V9, P859, DOI 10.1016/S1074-5521(02)00198-9; Shuford JA, 2003, CURR OPIN INFECT DIS, V16, P515, DOI 10.1097/00001432-200312000-00001; Simpson AHRW, 2001, J BONE JOINT SURG BR, V83B, P403, DOI 10.1302/0301-620X.83B3.10727; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; STECKELBERG JM, 2000, INFECT ASS INDWELLIN, P173; STEIN A, 2000, INFECT ASS INDWELLIN, P211; Stengel D, 2001, Lancet Infect Dis, V1, P175, DOI 10.1016/S1473-3099(01)00094-9; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; SUGARMAN B, 1987, ARCH INTERN MED, V147, P553, DOI 10.1001/archinte.147.3.553; Tice AD, 2003, AM J MED, V114, P723, DOI 10.1016/S0002-9343(03)00231-6; TUMEH SS, 1991, RHEUM DIS CLIN N AM, V17, P559; UNKILAKALLIO L, 1994, PEDIATRICS, V93, P59; Vandecasteele SJ, 2003, J INFECT DIS, V188, P730, DOI 10.1086/377452; Vaudaux P., 2000, INFECT ASS INDWELLIN, P1; Vilain S, 2004, J PROTEOME RES, V3, P132, DOI 10.1021/pr034044t; Vinod MB, 2002, J PAEDIATR CHILD H, V38, P363, DOI 10.1046/j.1440-1754.2002.00007.x; WALDVOGEL FA, 1980, NEW ENGL J MED, V303, P360, DOI 10.1056/NEJM198008143030703; WALDVOGEL FA, 1970, NEW ENGL J MED, V282, P316, DOI 10.1056/NEJM197002052820606; WALLACE R, 1976, AM J MED, V61, P277, DOI 10.1016/0002-9343(76)90177-7; WIDMER AF, 1992, CLIN INFECT DIS, V14, P1251, DOI 10.1093/clinids/14.6.1251; Wong M, 1995, PEDIATR INFECT DIS J, V14, P1047, DOI 10.1097/00006454-199512000-00004; Yarwood JM, 2003, J CLIN INVEST, V112, P1620, DOI 10.1172/JCI200320442; Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537	103	1145	1218	13	205	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					369	379		10.1016/S0140-6736(04)16727-5	http://dx.doi.org/10.1016/S0140-6736(04)16727-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276398				2022-12-28	WOS:000222853300037
J	Santa Barbara, J; MacQueen, G				Santa Barbara, J; MacQueen, G			Peace through health: key concepts	LANCET			English	Editorial Material									McMaster Univ, Ctr Peace Studies, Hamilton, ON L8S 4M4, Canada	McMaster University	Santa Barbara, J (corresponding author), McMaster Univ, Ctr Peace Studies, Hamilton, ON L8S 4M4, Canada.	Joanna@web.ca						FOEGE W, 2000, WAR PUBLIC HLTH; *G WASH CTR INT HL, CAN HLTH SERV BRIDG; Garcia Ed, 1994, PILGRIM VOICES CITIZ; GARFIELD R, 2000, WAR PUBLIC HLTH; LEDERACH J, 1997, BUILDING PEACE SUSTA, P39; Medact, 2002, COLL DAM HLTH ENV CO; World Health Organization, 2002, WORLD REPORT VIOLENC; ZWI A, 1989, SOC SCI MED, V28, P633, DOI 10.1016/0277-9536(89)90210-4	8	28	28	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					384	386						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276400				2022-12-28	WOS:000222853300039
J	Strobel, P; Riedel, M; Ristein, J; Ley, L				Strobel, P; Riedel, M; Ristein, J; Ley, L			Surface transfer doping of diamond	NATURE			English	Article							ELECTRON-AFFINITY; DEPOSITED DIAMOND; HYDROGEN; CONDUCTIVITY; FILMS; MECHANISM; LAYER	The electronic properties of many materials can be controlled by introducing appropriate impurities into the bulk crystal lattice in a process known as doping. In this way, diamond (a well-known insulator) can be transformed into a semiconductor(1), and recent progress in thin-film diamond synthesis has sparked interest in the potential applications of semiconducting diamond(2,3). However, the high dopant activation energies (in excess of 0.36 eV) and the limitation of donor incorporation to (111) growth facets only have hampered the development of diamond-based devices. Here we report a doping mechanism for diamond, using a method that does not require the introduction of foreign atoms into the diamond lattice. Instead, C(60) molecules are evaporated onto the hydrogen-terminated diamond surface, where they induce a subsurface hole accumulation and a significant rise in two-dimensional conductivity. Our observations bear a resemblance to the so-called surface conductivity of diamond(4-8) seen when hydrogenated diamond surfaces are exposed to air, and support an electrochemical model in which the reduction of hydrated protons in an aqueous surface layer gives rise to a hole accumulation layer(6,7). We expect that transfer doping by C(60) will open a broad vista of possible semiconductor applications for diamond.	Univ Erlangen Nurnberg, Inst Tech Phys, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Ristein, J (corresponding author), Univ Erlangen Nurnberg, Inst Tech Phys, D-91054 Erlangen, Germany.	juergen.ristein@physik.uni-erlangen.de	Ristein, Juergen/E-1742-2013					BANDIS C, 1995, PHYS REV B, V52, P12056, DOI 10.1103/PhysRevB.52.12056; Cui JB, 1998, PHYS REV LETT, V81, P429, DOI 10.1103/PhysRevLett.81.429; Denisenko A, 2000, DIAM RELAT MATER, V9, P1138, DOI 10.1016/S0925-9635(99)00317-9; GI RS, 1995, JPN J APPL PHYS 1, V34, P5550, DOI 10.1143/JJAP.34.5550; GLUCHE P, 1997, IEEE ELECTR DEVICE L, V18; GOLDEN MS, 1995, J PHYS-CONDENS MAT, V7, P8219, DOI 10.1088/0953-8984/7/43/004; Gunnarsson O, 1997, REV MOD PHYS, V69, P575, DOI 10.1103/RevModPhys.69.575; HADDON RC, 1995, APPL PHYS LETT, V67, P121, DOI 10.1063/1.115503; Hayashi K, 1997, J APPL PHYS, V81, P744, DOI 10.1063/1.364299; Isberg J, 2002, SCIENCE, V297, P1670, DOI 10.1126/science.1074374; Kawarada H, 1996, SURF SCI REP, V26, P205, DOI 10.1016/S0167-5729(97)80002-7; Maier F, 2000, PHYS REV LETT, V85, P3472, DOI 10.1103/PhysRevLett.85.3472; Maier F, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.165411; NEBEL CE, 2003, MONOGR SER SEMICONDU, V76, P145; NEBEL CE, 2004, MONOGR SER SEMICONDU, V77, P97; Riedel M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.125338; Takeuchi D, 2002, DIAM RELAT MATER, V11, P355, DOI 10.1016/S0925-9635(01)00682-3; YANG SH, 1987, CHEM PHYS LETT, V139, P233, DOI 10.1016/0009-2614(87)80548-1	18	211	216	5	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					439	441		10.1038/nature02751	http://dx.doi.org/10.1038/nature02751			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269764				2022-12-28	WOS:000222801400038
J	Northrup, AB; MacMillan, DWC				Northrup, AB; MacMillan, DWC			Two-step synthesis of carbohydrates by selective aldol reactions	SCIENCE			English	Article							DIELS-ALDER REACTION; ASYMMETRIC-SYNTHESIS; ALDEHYDES; HEXOSES; SUGARS; ROUTE	Studies of carbohydrates have been hampered by the lack of chemical strategies for the expeditious construction and coupling of differentially protected monosaccharides. Here, a synthetic route based on aldol coupling of three aldehydes is presented for the de novo production of polyol differentiated hexoses in only two chemical steps. The dimerization of alpha-oxyaldehydes, catalyzed by L-proline, is then followed by a tandem Mukaiyama aldol addition-cyclization step catalyzed by a Lewis acid. Differentially protected glucose, allose, and mannose stereoisomers can each be selected, in high yield and stereochemical purity, simply by changing the solvent and Lewis acid used. The reaction sequence also efficiently produces C-13-labeled analogs, as well as structural variants such as 2-amino- and 2-thio-substituted derivatives.	CALTECH, Dept Chem, Pasadena, CA 91125 USA	California Institute of Technology	MacMillan, DWC (corresponding author), CALTECH, Dept Chem, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dmacmill@caltech.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066142] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM066142, R01 GM66142-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bataille C, 2002, J ORG CHEM, V67, P8054, DOI 10.1021/jo0204193; BOGER DL, 1988, J ORG CHEM, V53, P5793, DOI 10.1021/jo00259a040; DANISHEFSKY S, 1985, J AM CHEM SOC, V107, P7761, DOI 10.1021/ja00311a089; Davies SG, 2002, SYNLETT, P1637, DOI 10.1055/s-2002-34215; Denmark SE, 2001, ANGEW CHEM INT EDIT, V40, P4759, DOI 10.1002/1521-3773(20011217)40:24<4759::AID-ANIE4759>3.0.CO;2-G; EDER U, 1971, ANGEW CHEM INT EDIT, V10, P496, DOI 10.1002/anie.197104961; Ernst, 2000, CARBOHYD CHEM-SPR; HAJOS ZG, 1974, J ORG CHEM, V39, P1615, DOI 10.1021/jo00925a003; KO SY, 1983, SCIENCE, V220, P949, DOI 10.1126/science.220.4600.949; List B, 2002, TETRAHEDRON, V58, P5573, DOI 10.1016/S0040-4020(02)00516-1; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Movassaghi M, 2002, SCIENCE, V298, P1904, DOI 10.1126/science.1076547; Nicolaou K. C., 1999, BIOORGANIC CHEM CARB, P134; Northrup AB, 2004, ANGEW CHEM INT EDIT, V43, P2152, DOI 10.1002/anie.200453716; Northrup AB, 2002, J AM CHEM SOC, V124, P6798, DOI 10.1021/ja0262378; Takeuchi M, 1999, SYNTHESIS-STUTTGART, P341; TIETZE LF, 1994, SYNLETT, P509; Vogel P., 2001, GLYCOSCIENCE, V2, P1023	18	345	354	5	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1752	1755		10.1126/science.1101710	http://dx.doi.org/10.1126/science.1101710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	856IS	15308765				2022-12-28	WOS:000224039500034
J	Wilson, JF				Wilson, JF			Searching for epilepsy solutions	ANNALS OF INTERNAL MEDICINE			English	Editorial Material												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136					0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2004	141	4					329	332		10.7326/0003-4819-141-4-200408170-00032	http://dx.doi.org/10.7326/0003-4819-141-4-200408170-00032			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846BX	15313762				2022-12-28	WOS:000223290900025
J	Kahaleh, B				Kahaleh, B			Progress in research into systemic sclerosis	LANCET			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; SCLERODERMA; ANGIOGENESIS; PROGENITORS; FIBROSIS; DEFECT; SKIN		Med Coll Toledo, Div Rheumatol, Dept Med, Toledo, OH 43614 USA		Kahaleh, B (corresponding author), Med Coll Toledo, Div Rheumatol, Dept Med, Toledo, OH 43614 USA.	bkahaleh@mco.edu						CAMPBELL P M, 1975, Seminars in Arthritis and Rheumatism, V4, P351, DOI 10.1016/0049-0172(75)90017-7; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Harraz M, 2001, STEM CELLS, V19, P304, DOI 10.1634/stemcells.19-4-304; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; KOCH AE, 1992, CLIN IMMUNOL IMMUNOP, V64, P153, DOI 10.1016/0090-1229(92)90193-R; Konttinen YT, 2003, CLIN RHEUMATOL, V22, P196, DOI 10.1007/s10067-003-0698-1; LEROY EC, 1974, J CLIN INVEST, V54, P880, DOI 10.1172/JCI107827; Luttun A, 2002, TRENDS CARDIOVAS MED, V12, P88, DOI 10.1016/S1050-1738(01)00152-9; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Shi-Wen X, 2000, EXP CELL RES, V259, P213, DOI 10.1006/excr.2000.4972; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Varga J, 2002, ARTHRITIS RHEUM-US, V46, P1703, DOI 10.1002/art.10413	14	12	12	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					561	562		10.1016/S0140-6736(04)16864-5	http://dx.doi.org/10.1016/S0140-6736(04)16864-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313340				2022-12-28	WOS:000223275100006
J	Robinson, TE				Robinson, TE			Addicted rats	SCIENCE			English	Editorial Material							DRUG INTAKE		Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; Univ Michigan, Program Neurosci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Robinson, TE (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	ter@umich.edu						Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Arnold JM, 1997, PHARMACOL BIOCHEM BE, V57, P441, DOI 10.1016/S0091-3057(96)00445-5; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Kelley AE, 2002, J NEUROSCI, V22, P3306; Paterson NE, 2003, NEUROREPORT, V14, P2229, DOI 10.1097/00001756-200312020-00019; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; WEEKS JR, 1962, SCIENCE, V138, P143, DOI 10.1126/science.138.3537.143; WOLFFGRAMM J, 1995, BEHAV BRAIN RES, V70, P77, DOI 10.1016/0166-4328(95)00131-C; Yokel R. A., 1987, METHODS ASSESSING RE, P1, DOI DOI 10.1007/978-1-4612-4812-5_1	10	34	42	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					951	953		10.1126/science.1102496	http://dx.doi.org/10.1126/science.1102496			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310881				2022-12-28	WOS:000223250700025
J	Voets, T; Droogmans, G; Wissenbach, U; Janssens, A; Flockerzi, V; Nilius, B				Voets, T; Droogmans, G; Wissenbach, U; Janssens, A; Flockerzi, V; Nilius, B			The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels	NATURE			English	Article							CAPSAICIN-RECEPTOR; EVOKED ACTIVATION; ION-CHANNEL; VOLTAGE; MECHANISMS	The mammalian sensory system is capable of discriminating thermal stimuli ranging from noxious cold to noxious heat. Principal temperature sensors belong to the TRP cation channel family, but the mechanisms underlying the marked temperature sensitivity of opening and closing ('gating') of these channels are unknown. Here we show that temperature sensing is tightly linked to voltage-dependent gating in the cold-sensitive channel TRPM8 and the heat-sensitive channel TRPV1. Both channels are activated upon depolarization, and changes in temperature result in graded shifts of their voltage-dependent activation curves. The chemical agonists menthol ( TRPM8) and capsaicin ( TRPV1) function as gating modifiers, shifting activation curves towards physiological membrane potentials. Kinetic analysis of gating at different temperatures indicates that temperature sensitivity in TRPM8 and TRPV1 arises from a tenfold difference in the activation energies associated with voltage-dependent opening and closing. Our results suggest a simple unifying principle that explains both cold and heat sensitivity in TRP channels.	Katholieke Univ Leuven, Physiol Lab, B-3000 Louvain, Belgium; Univ Saarland, Fak Med, D-66421 Homburg, Germany	KU Leuven; Saarland University	Voets, T (corresponding author), Katholieke Univ Leuven, Physiol Lab, Campus Gasthuisberg, B-3000 Louvain, Belgium.	Thomas.Voets@med.kuleuven.ac.be	Voets, Thomas/AAD-4389-2019; Voets, Thomas/E-2466-2012	Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Janssens, Annelies/0000-0002-6735-8248				Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Guler AD, 2002, J NEUROSCI, V22, P6408; Gunthorpe MJ, 2000, J PHYSIOL-LONDON, V525, P747, DOI 10.1111/j.1469-7793.2000.t01-1-00747.x; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; MARSH D, 1991, CHEM PHYS LIPIDS, V57, P109, DOI 10.1016/0009-3084(91)90071-I; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tiwari JK, 1999, EUR BIOPHYS J BIOPHY, V28, P338, DOI 10.1007/s002490050216; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; VANLUNTEREN E, 1993, J PHYSIOL-LONDON, V466, P81; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2003, J MEMBRANE BIOL, V192, P1, DOI 10.1007/s00232-002-1059-8; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	31	728	776	2	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					748	754		10.1038/nature02732	http://dx.doi.org/10.1038/nature02732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306801	Green Published			2022-12-28	WOS:000223233600033
J	Haider, A; Shaw, JC				Haider, A; Shaw, JC			Treatment of acne vulgaris	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRETINOIN 0.025-PERCENT GEL; ERYTHROMYCIN-RESISTANT PROPIONIBACTERIA; PEROXIDE/CLINDAMYCIN TOPICAL GEL; RECALCITRANT NODULAR ACNE; POLYCYSTIC-OVARY-SYNDROME; PLACEBO-CONTROLLED TRIAL; 100 MU-G; DOUBLE-BLIND; CYPROTERONE-ACETATE; ETHINYL ESTRADIOL	Context Management of acne vulgaris by nondermatologists is increasing. Current understanding of the different presentations of acne allows for individualized treatments and improved outcomes. Objective To review the best evidence available for individualized treatment of acne. Data Sources Search of MEDLINE, EMBASE, and the Cochrane database to search for all English-language articles on acne treatment from 1966 to 2004. Study Selection Well-designed randomized controlled trials, meta-analyses, and other systematic reviews are the focus of this article. Data Extraction Acne literature is characterized by a lack of standardization with respect to outcome measures and methods used to grade disease severity. Data Synthesis Main outcome measures of 29 randomized double-blind trials that were evaluated included reductions in inflammatory, noninflammatory, and total acne lesion counts. Topical retinoids reduce the number of comedones and inflammatory lesions in the range of 40% to 70%. These agents are the mainstay of therapy in patients with comedones only. Other agents, including topical antimicrobials, oral antibiotics, hormonal therapy (in women), and isotretinoin all yield high response rates. Patients with mild to moderate severity inflammatory acne with papules and pustules should be treated with topical antibiotics combined with retinoids. Oral antibiotics are first-line therapy in patients with moderate to severe inflammatory acne while oral isotretinoin is indicated for severe nodular acne, treatment failures, scarring, frequent relapses, or in cases of severe psychological distress. Long-term topical or oral antibiotic therapy should be avoided when feasible to minimize occurrence of bacterial resistance. Isotretinoin is a powerful teratogen mandating strict precautions for use among women of childbearing age. Conclusions Acne responses to treatment vary considerably. Frequently more than 1 treatment modality is used concomitantly. Best results are seen when treatments are individualized on the basis of clinical presentation.	Univ Toronto, Div Dermatol, Toronto, ON, Canada	University of Toronto	Shaw, JC (corresponding author), Toronto Western Hosp, Univ Hlth Netwrok, 399 Bathurst St,E Wing 8-517, Toronto, ON M5T 2S8, Canada.	james.shaw@uhn.on.ca						Aktan S, 2000, INT J DERMATOL, V39, P354, DOI 10.1046/j.1365-4362.2000.00907.x; BARTH JH, 1993, BRIT J DERMATOL, V129, P704, DOI 10.1111/j.1365-2133.1993.tb03336.x; Bataille V, 2002, J INVEST DERMATOL, V119, P1317, DOI 10.1046/j.1523-1747.2002.19621.x; BECKER LE, 1981, ARCH DERMATOL, V117, P482, DOI 10.1001/archderm.117.8.482; Bershad S, 2002, ARCH DERMATOL, V138, P481, DOI 10.1001/archderm.138.4.481; Braathen L R, 1984, Scand J Infect Dis Suppl, V43, P71; CARLBORG L, 1986, ACTA OBSTET GYN SCAN, P29; Carmina E, 2002, CLIN ENDOCRINOL, V57, P231, DOI 10.1046/j.1365-2265.2002.01594.x; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Cibula D, 2000, BRIT J DERMATOL, V143, P399, DOI 10.1046/j.1365-2133.2000.03669.x; Cooper AJ, 1998, MED J AUSTRALIA, V169, P259, DOI 10.5694/j.1326-5377.1998.tb140250.x; Cordain L, 2002, ARCH DERMATOL, V138, P1584, DOI 10.1001/archderm.138.12.1584; Cunliffe WJ, 2003, J AM ACAD DERMATOL, V49, pS218, DOI 10.1067/S0190-9622(03)01153-8; Cunliffe WJ, 2002, EUR J DERMATOL, V12, P350; Cunliffe WJ, 2002, CLIN THER, V24, P1117, DOI 10.1016/S0149-2918(02)80023-6; Cunliffe WJ, 1998, BRIT J DERMATOL, V139, P48; CUSAN L, 1994, FERTIL STERIL, V61, P281; DOBSON RL, 1980, J AM ACAD DERMATOL, V3, P478, DOI 10.1016/S0190-9622(80)80113-7; Dreno B, 2001, DERMATOLOGY, V203, P135, DOI 10.1159/000051728; Eady AE, 2003, AM J CLIN DERMATOL, V4, P813, DOI 10.2165/00128071-200304120-00002; EADY EA, 1989, BRIT J DERMATOL, V121, P51, DOI 10.1111/j.1365-2133.1989.tb01399.x; EADY EA, 1993, BRIT J DERMATOL, V128, P556, DOI 10.1111/j.1365-2133.1993.tb00235.x; Egan N, 2001, Cutis, V68, P20; Elkayam O, 1999, SEMIN ARTHRITIS RHEU, V28, P392, DOI 10.1016/S0049-0172(99)80004-3; Ellis CN, 1998, BRIT J DERMATOL, V139, P41; Ellis CN, 2001, CUTIS, V67, P13; ESTERLY NB, 1978, J INVEST DERMATOL, V70, P51, DOI 10.1111/1523-1747.ep12543487; Falsetti L, 2001, HUM REPROD, V16, P36, DOI 10.1093/humrep/16.1.36; FARQUHAR C, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; GAMMON WR, 1986, J AM ACAD DERMATOL, V14, P183, DOI 10.1016/S0190-9622(86)70019-4; Garner SE, 2002, COCHRANE LIB; Gollnick H, 2003, J AM ACAD DERMATOL, V49, pS1, DOI 10.1067/mjd.2003.618; Golub L M, 1998, Adv Dent Res, V12, P12; GOODFELLOW A, 1984, BRIT J DERMATOL, V111, P209, DOI 10.1111/j.1365-2133.1984.tb04045.x; Goulden V, 1999, BRIT J DERMATOL, V141, P297; Graupe K, 1996, Cutis, V57, P20; HABBEMA L, 1989, BRIT J DERMATOL, V121, P497, DOI 10.1111/j.1365-2133.1989.tb15518.x; Hamilton JB, 1941, J CLIN ENDOCRINOL, V1, P570, DOI 10.1210/jcem-1-7-570; Hawley W, 1993, J Am Board Fam Pract, V6, P123; Hjorth N, 1989, Acta Derm Venereol Suppl (Stockh), V143, P45, DOI 10.2340/000155551434548; Hull PR, 2003, AM J CLIN DERMATOL, V4, P493, DOI 10.2165/00128071-200304070-00005; JONES DH, 1983, BRIT J DERMATOL, V108, P333, DOI 10.1111/j.1365-2133.1983.tb03973.x; JONES EL, 1981, ARCH DERMATOL, V117, P551, DOI 10.1001/archderm.117.9.551; Katsambas A, 1989, Acta Derm Venereol Suppl (Stockh), V143, P35, DOI 10.2340/000155551433539; Koren G, 2004, CAN MED ASSOC J, V170, P1567, DOI 10.1503/cmaj.1040317; KORTING HC, 1989, DRUG EXP CLIN RES, V15, P447; LAYTON AM, 1993, BRIT J DERMATOL, V129, P292, DOI 10.1111/j.1365-2133.1993.tb11849.x; Legro RS, 2001, MOL CELL ENDOCRINOL, V184, P87, DOI 10.1016/S0303-7207(01)00640-2; Lehmann HP, 2002, J AM ACAD DERMATOL, V47, P231, DOI 10.1067/mjd.2002.120912; LESHER JL, 1985, J AM ACAD DERMATOL, V12, P526, DOI 10.1016/S0190-9622(85)70074-6; Leyden J, 2002, J AM ACAD DERMATOL, V47, P399, DOI 10.1067/mjd.2002.122192; Leyden James J, 2002, Cutis, V69, P12; Leyden JJ, 2001, J CUTAN MED SURG, V5, P37, DOI 10.1007/s102270000008; Leyden JJ, 1996, J DERMATOL TREAT, V7, P223, DOI 10.3109/09546639609089553; Lidegaard Ojvind, 2003, J Obstet Gynaecol Can, V25, P575; Lin Alpha D Y, 2003, J Chin Med Assoc, V66, P735; Lookingbill DP, 1997, J AM ACAD DERMATOL, V37, P590, DOI 10.1016/S0190-9622(97)70177-4; LOOKINGBILL DP, 1985, J AM ACAD DERMATOL, V12, P481, DOI 10.1016/S0190-9622(85)70067-9; Lucky A, 2001, Cutis, V68, P34; Lucky AW, 1997, J AM ACAD DERMATOL, V37, P746, DOI 10.1016/S0190-9622(97)70112-9; MILLS OH, 1978, ACTA DERM-VENEREOL, V58, P555; MUHLEMANN MF, 1986, BRIT J DERMATOL, V115, P227, DOI 10.1111/j.1365-2133.1986.tb05722.x; PECK GL, 1979, NEW ENGL J MED, V300, P329, DOI 10.1056/NEJM197902153000701; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; POCHI PE, 1962, J INVEST DERMATOL, V39, P475, DOI 10.1038/jid.1962.146; Redmond GP, 1997, OBSTET GYNECOL, V89, P615, DOI 10.1016/S0029-7844(97)00059-8; Richter JR, 1998, J DERMATOL TREAT, V9, P81, DOI 10.3109/09546639809161377; Richter JR, 1998, J EUR ACAD DERMATOL, V11, P227, DOI 10.1016/S0926-9959(98)00071-3; RIETSCHEL RL, 1983, INT J DERMATOL, V22, P41, DOI 10.1111/j.1365-4362.1983.tb02113.x; Ross JI, 2003, BRIT J DERMATOL, V148, P467, DOI 10.1046/j.1365-2133.2003.05067.x; RUDIGER T, 1995, LANCET, V345, P452, DOI 10.1016/S0140-6736(95)90434-4; Schroder FH, 2004, EUR UROL, V45, P457, DOI 10.1016/j.eururo.2003.11.016; Seukeran DC, 1999, BRIT J DERMATOL, V141, P307; Shalita AR, 1999, CUTIS, V63, P349; Shaw JC, 2000, J AM ACAD DERMATOL, V43, P498, DOI 10.1067/mjd.2000.105557; Shaw JC, 2002, J CUTAN MED SURG, V6, P541, DOI 10.1007/s10227-001-0152-4; Skidmore R, 2003, ARCH DERMATOL, V139, P459, DOI 10.1001/archderm.139.4.459; Stern RS, 1996, ARCH DERMATOL, V132, P776, DOI 10.1001/archderm.132.7.776; Stewart FH, 2001, JAMA-J AM MED ASSOC, V285, P2232, DOI 10.1001/jama.285.17.2232; STRAUSS JS, 1984, J AM ACAD DERMATOL, V10, P490, DOI 10.1016/S0190-9622(84)80100-0; Strauss JS, 2001, J AM ACAD DERMATOL, V45, P196, DOI 10.1067/mjd.2001.115966; Strauss JS, 2001, J AM ACAD DERMATOL, V45, P187, DOI 10.1067/mjd.2001.115965; Sturkenboom MCJM, 1999, ARCH INTERN MED, V159, P493, DOI 10.1001/archinte.159.5.493; Tan HH, 2003, AM J CLIN DERMATOL, V4, P307, DOI 10.2165/00128071-200304050-00002; Thiboutot D, 2003, DERMATOLOGY, V206, P57, DOI 10.1159/000067823; Thiboutot D, 2001, Cutis, V68, P10; Thiboutot D, 2001, FERTIL STERIL, V76, P461, DOI 10.1016/S0015-0282(01)01938-0; Thiboutot D, 1999, ARCH DERMATOL, V135, P1041, DOI 10.1001/archderm.135.9.1041; van Vloten Willem A, 2002, Cutis, V69, P2; VANWAYJEN RGA, 1995, EXP CLIN ENDOCR DIAB, V103, P241, DOI 10.1055/s-0029-1211357; Vartiainen M, 2001, EUR J CONTRACEP REPR, V6, P46, DOI 10.1080/713604178; Vessey M, 2003, LANCET, V362, P185, DOI 10.1016/S0140-6736(03)13907-4; VOWELS BR, 1995, INFECT IMMUN, V63, P3158, DOI 10.1128/IAI.63.8.3158-3165.1995; Webster G F, 2001, Cutis, V67, P4; WEBSTER GF, 1981, BRIT J DERMATOL, V104, P453, DOI 10.1111/j.1365-2133.1981.tb15317.x; Webster Guy F, 2002, Cutis, V69, P4; White GM, 1998, ARCH DERMATOL, V134, P376, DOI 10.1001/archderm.134.3.376; Wolf JE, 2003, J AM ACAD DERMATOL, V49, pS211, DOI 10.1067/S0190-9622(03)01152-6; Worret I, 2001, DERMATOLOGY, V203, P38, DOI 10.1159/000051701	100	167	180	2	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					726	735		10.1001/jama.292.6.726	http://dx.doi.org/10.1001/jama.292.6.726			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304471				2022-12-28	WOS:000223177300028
J	Seward, JF; Zhang, JX; Maupin, TJ; Mascola, L; Jumaan, AO				Seward, JF; Zhang, JX; Maupin, TJ; Mascola, L; Jumaan, AO			Contagiousness of varicella in vaccinated cases - A household contact study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; FAMILY CONTACTS; OUTBREAK; CHILDREN; SCHOOL; POSTLICENSURE; INFECTIONS; CHICKENPOX; AGE	Context Limited data are available on the contagiousness of vaccinated varicella cases Objectives To describe secondary attack rates within households according to disease history and vaccination status of the primary case and household contacts and to estimate varicella vaccine effectiveness. Design, Setting, and Patients Population-based, active varicella surveillance project in a community of approximately 320000 in Los Angeles County, California, during 1997 and 2001. Varicella cases were reported by child care centers, private and public schools, and health care clinicians and were investigated to collect demographic, clinical, medical, and vaccination data. Information on household contacts' age, varicella history, and vaccination status was collected. Main Outcome Measures Varicella secondary attack rate among household contacts; vaccine effectiveness using secondary attack rates in unvaccinated and vaccinated children and adolescents. Results A total of 6316 varicella cases were reported. Among children and adolescents aged 1 to 14 years, secondary attack rates varied according to age and by disease and vaccination status of the primary case and exposed household contacts. Among contacts aged 1 to 14 years exposed to unvaccinated cases, the secondary attack rate was 71.5% if they were unvaccinated and 15.1% if they were vaccinated (risk ratio [RR], 0.21; 95% confidence interval [CI], 0.15-0.30). Overall, vaccinated cases were half as contagious as unvaccinated cases. However, vaccinated cases with 50 lesions or more were similarly contagious as unvaccinated cases whereas those with fewer than 50 lesions were only one third as contagious (secondary attack rate, 23.4%; RR, 0.32 [95% CI, 0.19-0.53]). Vaccine effectiveness for prevention of all disease was 78.9% (95% CI, 69.7%-85.3%); moderate disease, 92% (50-500 lesions) and 100% (clinician visit); and severe disease, 100%. Conclusions Under conditions of intense exposure, varicella vaccine was highly effective in preventing moderate and severe disease and about 80% effective in preventing all disease. Breakthrough varicella cases in household settings were half as contagious as unvaccinated persons with varicella, although contagiousness varied with numbers of lesions.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA	Seward, JF (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-62, Atlanta, GA 30333 USA.	jseward@cdc.gov						ARBETER AM, 1986, PEDIATRICS, V78, P748; ASANO Y, 1977, PEDIATRICS, V59, P3; BALFOUR HH, 1990, J PEDIATR-US, V116, P633, DOI 10.1016/S0022-3476(05)81618-X; BERNSTEIN HH, 1993, PEDIATRICS, V92, P833; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P545; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P884; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; Dworkin MS, 2002, CLIN INFECT DIS, V35, P102, DOI 10.1086/340868; Galil K, 2002, J INFECT DIS, V186, P102, DOI 10.1086/341089; Galil K, 2002, NEW ENGL J MED, V347, P1909, DOI 10.1056/NEJMoa021662; Galil K, 2002, PEDIATR INFECT DIS J, V21, P931, DOI 10.1097/00006454-200210000-00009; Gershon AA, 2002, NEW ENGL J MED, V347, P1962, DOI 10.1056/NEJMe020138; Hall S, 2002, PEDIATRICS, V109, P1068, DOI 10.1542/peds.109.6.1068; HOBBS F, 2002, CENSUS 2000 SPECIAL; HOPESIMPSON RE, 1952, LANCET, V2, P549, DOI DOI 10.1016/S0140-6736(52)91357-3; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; JUNKER AK, 1991, PEDIATR INFECT DIS J, V10, P569, DOI 10.1097/00006454-199108000-00004; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Kuter B, 2004, PEDIATR INFECT DIS J, V23, P132, DOI 10.1097/01.inf.0000109287.97518.67; Lieu TA, 1998, PEDIATR INFECT DIS J, V17, P120, DOI 10.1097/00006454-199802000-00008; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; ROSS AH, 1962, NEW ENGL J MED, V267, P369, DOI 10.1056/NEJM196208232670801; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; Tugwell BD, 2004, PEDIATRICS, V113, P455, DOI 10.1542/peds.113.3.455; Vazquez M, 2004, JAMA-J AM MED ASSOC, V291, P851, DOI 10.1001/jama.291.7.851; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; WATSON BM, 1993, PEDIATRICS, V91, P17; Wharton M, 1996, INFECT DIS CLIN N AM, V10, P571, DOI 10.1016/S0891-5520(05)70313-5	30	124	138	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					704	708		10.1001/jama.292.6.704	http://dx.doi.org/10.1001/jama.292.6.704			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304467	Bronze			2022-12-28	WOS:000223177300024
J	Mejillano, MR; Kojima, S; Applewhite, DA; Gertler, FB; Svitkina, TM; Borisy, GG				Mejillano, MR; Kojima, S; Applewhite, DA; Gertler, FB; Svitkina, TM; Borisy, GG			Lamellipodial versus filopodial mode of the actin nanomachinery: Pivotal role of the filament barbed end	CELL			English	Article							CAPPING PROTEIN; ARP2/3 COMPLEX; ENA/VASP PROTEINS; IN-VITRO; MOTILITY; DYNAMICS; GELSOLIN; CYTOSKELETON; POLYMERIZATION; LOCALIZATION	Understanding how a particular cell type expresses the lamellipodial or filopodial form of the actin machinery is essential to understanding a cell's functional interactions. To determine how a cell "chooses" among these alternative modes of "molecular hardware," we tested the role of key proteins that affect actin filament barbed ends. Depletion of capping protein (CP) by short hairpin RNA (shRNA) caused loss of lamellipodia and explosive formation of filopodia. The knockdown phenotype was rescued by a CP mutant refractory to shRNA, but not by another barbed-end capper, gelsolin, demonstrating that the phenotype was specific for CID. In EnaNASP deficient cells, CP depletion resulted in ruffling instead of filopodia. We propose a model for selection of lamellipodial versus filopodial organization in which CP is a negative regulator of filopodia formation and EnaNASP has recruiting/activating functions downstream of actin filament elongation in addition to its previously suggested anticapping and antibranching activities.	Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Northwestern University; Feinberg School of Medicine; Massachusetts Institute of Technology (MIT); University of Pennsylvania	Borisy, GG (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	g-borisy@northwestern.edu	Applewhite, Derek/AAU-9458-2020	Applewhite, Derek/0000-0002-2431-0316; Borisy, Gary/0000-0002-0266-8018	NIGMS NIH HHS [GM62431, GM58801] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058801, R01GM062431] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9; AMATRUDA JF, 1990, NATURE, V344, P352, DOI 10.1038/344352a0; AMATRUDA JF, 1992, J CELL BIOL, V119, P1151, DOI 10.1083/jcb.119.5.1151; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; Ballestrem C, 1998, J CELL SCI, V111, P1649; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carlier MF, 1998, CURR OPIN CELL BIOL, V10, P45, DOI 10.1016/S0955-0674(98)80085-9; Chou J, 2002, INT J BIOCHEM CELL B, V34, P776, DOI 10.1016/S1357-2725(01)00177-7; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; COOPER JA, 1999, GUIDEBOOK CYTOSKELET; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Grevengoed EE, 2003, J CELL BIOL, V163, P1267, DOI 10.1083/jcb.200307026; Han YH, 2002, J BIOL CHEM, V277, P49877, DOI 10.1074/jbc.M209107200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Hopmann R, 1996, J CELL BIOL, V133, P1293, DOI 10.1083/jcb.133.6.1293; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Jacinto A, 2001, CURR BIOL, V11, pR634, DOI 10.1016/S0960-9822(01)00378-5; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; Katoh K, 1999, MOL BIOL CELL, V10, P197, DOI 10.1091/mbc.10.1.197; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Kwiatkowski DJ, 1999, CURR OPIN CELL BIOL, V11, P103, DOI 10.1016/S0955-0674(99)80012-X; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Loureiro JJ, 2002, MOL BIOL CELL, V13, P2533, DOI 10.1091/mbc.E01-10-0102; Lu M, 1997, J CELL BIOL, V138, P1279, DOI 10.1083/jcb.138.6.1279; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Remmert K, 2004, J BIOL CHEM, V279, P3068, DOI 10.1074/jbc.M308829200; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rorth P, 2003, CELL, V112, P595, DOI 10.1016/S0092-8674(03)00156-9; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; SCHAFER DA, 1994, J CELL BIOL, V127, P453, DOI 10.1083/jcb.127.2.453; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SCHAFER DA, 1992, J CELL BIOL, V118, P335, DOI 10.1083/jcb.118.2.335; Schafer DA, 1998, J CELL BIOL, V143, P1919, DOI 10.1083/jcb.143.7.1919; Sizonenko GI, 1996, MOL BIOL CELL, V7, P1; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1998, METHOD ENZYMOL, V298, P570, DOI 10.1016/S0076-6879(98)98045-4; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; vonBulow M, 1997, EXP CELL RES, V233, P216, DOI 10.1006/excr.1997.3564; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	54	325	327	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					363	373		10.1016/j.cell.2004.07.019	http://dx.doi.org/10.1016/j.cell.2004.07.019			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294161	Green Published, Bronze			2022-12-28	WOS:000223353100012
J	Kroenke, K; Logio, L				Kroenke, K; Logio, L			Update in General Internal Medicine	ANNALS OF INTERNAL MEDICINE			English	Review							VIRTUAL COLONOSCOPY; MANAGEMENT; INHIBITORS; DISEASE; TRIALS		Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA; Indiana Univ, Indianapolis, IN 46204 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University-Purdue University Indianapolis	Kroenke, K (corresponding author), Regenstrief Inst Hlth Care, 1050 Wishard Blvd, Indianapolis, IN 46202 USA.	kkroenke@regenstrief.org		Kroenke, Kurt/0000-0002-0114-4669				Berg AO, 2003, ANN INTERN MED, V139, P51, DOI 10.7326/0003-4819-139-1-200307010-00013; Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; Cotton PB, 2004, JAMA-J AM MED ASSOC, V291, P1713, DOI 10.1001/jama.291.14.1713; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; Larson EB, 2004, J GEN INTERN MED, V19, P69, DOI 10.1111/j.1525-1497.2004.31337.x; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Ransohoff DF, 2004, JAMA-J AM MED ASSOC, V291, P1772, DOI 10.1001/jama.291.14.1772; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Spiegel BMR, 2003, ANN INTERN MED, V138, P795, DOI 10.7326/0003-4819-138-10-200305200-00007	11	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2004	141	3					213	220		10.7326/0003-4819-141-3-200408030-00010	http://dx.doi.org/10.7326/0003-4819-141-3-200408030-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HG	15289218				2022-12-28	WOS:000223068600006
J	von Both, U; Baehr, A; Kontny, U; Kromeier, J; Batsford, S; Berner, R				von Both, U; Baehr, A; Kontny, U; Kromeier, J; Batsford, S; Berner, R			A boy with a mediastinal mass	LANCET			English	Editorial Material									Univ Hosp Freiburg, Dept Pediat, D-79104 Freiburg, Germany; Univ Hosp Freiburg, Dept Pediat Radiol, D-79104 Freiburg, Germany; Inst Med Microbiol, Dept Immunol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Berner, R (corresponding author), Univ Hosp Freiburg, Dept Pediat, D-79104 Freiburg, Germany.	berner@kikli.ukl.uni-freiburg.de	Berner, Reinhard/P-7351-2017; von Both, Ulrich/HCI-1318-2022	Berner, Reinhard/0000-0002-6216-9173; von Both, Ulrich/0000-0001-8411-1071				Bhargava A, 2001, AM FAM PHYSICIAN, V64, P1237; Callister MEJ, 2001, SCAND J INFECT DIS, V33, P771, DOI 10.1080/003655401317074608; CORSTEN MJ, 1997, THORAX, V52, P792; ENQUIST RW, 1976, JAMA-J AM MED ASSOC, V236, P1048, DOI 10.1001/jama.236.9.1048; UPP ME, 1995, PRINCIPLES PRACTICE, P813	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					474	474						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288748				2022-12-28	WOS:000222998600040
J	De Pontieu, B; Erdelyi, R; James, SP				De Pontieu, B; Erdelyi, R; James, SP			Solar chromospheric spicules from the leakage of photospheric oscillations and flows	NATURE			English	Article							REBOUND SHOCK MODEL; TRANSITION REGION; INTENSITY OSCILLATIONS; CORONAL EXPLORER; ATMOSPHERE; SUN; PROPAGATION; SIMULATIONS	Spicules are dynamic jets propelled upwards ( at speeds of similar to20 km s(-1)) from the solar 'surface' (photosphere) into the magnetized low atmosphere of the Sun(1-3). They carry a mass flux of 100 times that of the solar wind into the low solar corona(4). With diameters close to observational limits (< 500 km), spicules have been largely unexplained(3) since their discovery in 1877(5): none of the existing models(3) can account simultaneously for their ubiquity, evolution, energetics and recently discovered periodicity(6). Here we report a synthesis of modelling and high-spatial-resolution observations in which numerical simulations driven by observed photospheric velocities directly reproduce the observed occurrence and properties of individual spicules. Photospheric velocities are dominated by convective granulation ( which has been considered before for spicule formation(7-11)) and by p-modes ( which are solar global resonant acoustic oscillations visible in the photosphere as quasi-sinusoidal velocity and intensity pulsations). We show that the previously ignored p-modes are crucial: on inclined magnetic flux tubes, the p-modes leak sufficient energy from the global resonant cavity into the chromosphere to power shocks that drive upward flows and form spicules.	Lockheed Martin Solar & Asrophys Lab, Palo Alto, CA 94304 USA; Univ Sheffield, Dept Appl Math, Solar Phys & Upper Atmosphere Res Ctr, Sheffield S3 7RH, S Yorkshire, England	University of Sheffield	De Pontieu, B (corresponding author), Lockheed Martin Solar & Asrophys Lab, 3251 Hanover St,Org ADBS,Bldg 252, Palo Alto, CA 94304 USA.	bdp@lmsal.com		erdelyi, robertus/0000-0003-3439-4127				Beckers J. M., 1968, SOL PHYS, V3, P367, DOI DOI 10.1007/BF00171614; BECKERS JM, 1972, ANNU REV ASTRON ASTR, V10, P73, DOI 10.1146/annurev.aa.10.090172.000445; CARLSSON M, 1995, ASTROPHYS J, V440, pL29, DOI 10.1086/187753; Cheng QQ, 1996, ASTRON ASTROPHYS, V313, P971; CHRISTENSENDALSGAARD J, 1985, SCIENCE, V229, P923, DOI 10.1126/science.229.4717.923; De Moortel I, 2002, SOL PHYS, V209, P61, DOI 10.1023/A:1020956421063; De Pontieu B, 2003, ASTROPHYS J, V595, pL63, DOI 10.1086/378843; De Pontieu B, 2003, ASTROPHYS J, V590, P502, DOI 10.1086/374928; FOUKAL P, 1990, SOLAR ASTROPHYSICS, P10; Handy BN, 1999, SOL PHYS, V187, P229, DOI 10.1023/A:1005166902804; HOLLWEG JV, 1982, ASTROPHYS J, V257, P345, DOI 10.1086/159993; James SP, 2003, ASTRON ASTROPHYS, V406, P715, DOI 10.1051/0004-6361:20030685; LINDSEY C, 1992, NATURE, V358, P308, DOI 10.1038/358308a0; Musielak ZE, 2003, ASTRON ASTROPHYS, V400, P1057, DOI 10.1051/0004-6361:20030023; RAE IC, 1982, ASTROPHYS J, V256, P761, DOI 10.1086/159948; ROBERTS B, 1979, SOL PHYS, V61, P23, DOI 10.1007/BF00155443; Scharmer GB, 2003, P SOC PHOTO-OPT INS, V4853, P341, DOI 10.1117/12.460377; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429; Schrijver CJ, 2003, ASTROPHYS J, V597, pL165, DOI 10.1086/379870; SCHRIJVER CJ, 1994, SOL PHYS, V150, P1, DOI 10.1007/BF00712873; Schrijver CJ, 1999, SOL PHYS, V187, P261, DOI 10.1023/A:1005194519642; SPRUIT HC, 1983, NATURE, V304, P401, DOI 10.1038/304401a0; STERLING AC, 1990, ASTROPHYS J, V349, P647, DOI 10.1086/168352; STERLING AC, 1989, ASTROPHYS J, V343, P985, DOI 10.1086/167767; STERLING AC, 1988, ASTROPHYS J, V327, P950, DOI 10.1086/166252; Sterling AC, 2000, SOL PHYS, V196, P79, DOI 10.1023/A:1005213923962; SUEMATSU Y, 1995, ASTROPHYS J, V450, P411, DOI 10.1086/176151; SUTMANN G, 1995, ASTRON ASTROPHYS, V294, P241; VERNAZZA JE, 1981, ASTROPHYS J SUPPL S, V45, P635, DOI 10.1086/190731; WITHBROE GL, 1983, ASTROPHYS J, V267, P825, DOI 10.1086/160917	30	350	352	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					536	539		10.1038/nature02749	http://dx.doi.org/10.1038/nature02749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282598				2022-12-28	WOS:000222946100040
J	Bondi, H				Bondi, H			Thomas Gold (1920-2004) - Obituary	NATURE			English	Biographical-Item									Univ Cambridge Churchhill Coll, Cambridge CB3 0DS, England	University of Cambridge	Bondi, H (corresponding author), Univ Cambridge Churchhill Coll, Cambridge CB3 0DS, England.							GOLD T, PUBLICATION LIST	1	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					415	415		10.1038/430415a	http://dx.doi.org/10.1038/430415a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269755	Bronze			2022-12-28	WOS:000222801400029
J	Dodek, P; Keenan, S; Cook, D; Heyland, D; Jacka, M; Hand, L; Muscedere, J; Foster, D; Mehta, N; Hall, R; Brun-Buisson, C				Dodek, P; Keenan, S; Cook, D; Heyland, D; Jacka, M; Hand, L; Muscedere, J; Foster, D; Mehta, N; Hall, R; Brun-Buisson, C		Canadian Critical Care Trials Grp	Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia	ANNALS OF INTERNAL MEDICINE			English	Review							INTENSIVE-CARE-UNIT; NOSOCOMIAL MAXILLARY SINUSITIS; RESPIRATORY-TRACT INFECTIONS; ILL ADULT PATIENTS; MOISTURE EXCHANGERS; RISK-FACTORS; SELECTIVE DECONTAMINATION; MECHANICAL VENTILATION; DIGESTIVE-TRACT; SUBGLOTTIC SECRETIONS	Background: Ventilator-associated pneumonia (VAP) is an important patient safety issue in critically ill patients. Purpose: To develop an evidence-based guideline for the prevention of VAP. Data Sources: MEDLINE, EMBASE, and the Cochrane Database of Systematic Reviews. Study Selection: The authors systematically searched for relevant randomized, controlled trials and systematic reviews that involved mechanically ventilated adults and were published before 1 April 2003. Data Extraction: Physical, positional, and pharmacologic interventions that may influence the development of VAP were considered. Independently and in duplicate, the authors scored the validity of trials; the effect size and confidence intervals; the homogeneity of results; and safety, feasibility, and economic issues. Data Synthesis: Recommended. The orotracheal route of intubation, changes of ventilator circuits only for each new patient and if the circuits are soiled, use of closed endotracheal suction systems that are changed for each new patient and as clinically indicated, heat and moisture exchangers in the absence of contraindications, weekly changes of heat and moisture exchangers, and semi-recumbent positioning in the absence of contraindications. Consider subglottic secretion drainage and kinetic beds. Not recommended: Sucralfate to prevent VAP in patients at high risk for gastrointestinal bleeding and topical antibiotics to prevent VAP. Because of insufficient or conflicting evidence, no recommendations were made about systematically searching for maxillary sinusitis, chest physiotherapy, the timing of tracheostomy, prone positioning, prophylactic intravenous antibiotics, or intravenous plus topical antibiotics. Limitations: No formal economic analysis was performed, and patient perspectives were not considered. Conclusion: if effectively implemented, this guideline may decrease the morbidity, mortality, and costs of VAP in mechanically ventilated patients.	Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Queens Univ, Kingston, ON K7L 3N6, Canada; McMaster Univ, Hamilton, ON L8S 4L8, Canada; Hotel Dieu Grace Hosp, Windsor, CT USA; Univ Toronto, Toronto, ON, Canada; Sudbury Reg Hosp, Sudbury, ON, Canada; Univ Alberta Hosp, Edmonton, AB T6G 2B7, Canada; Dalhousie Univ, Halifax, NS, Canada; Univ Paris 12, Hop Henri Mondor, F-94010 Creteil, France	University of British Columbia; Queens University - Canada; McMaster University; University of Toronto; Health Sciences North; University of Alberta; Dalhousie University; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Dodek, P (corresponding author), St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	pedodek@interchange.ubc.ca	Mehta, Neil/AAL-9824-2020; Muscedere, John/AAH-9291-2021					AERDTS SJA, 1993, BRIT MED J, V307, P525; BACH A, 1992, ANAESTHESIA, V47, P335, DOI 10.1111/j.1365-2044.1992.tb02177.x; Baker AM, 1996, AM J RESP CRIT CARE, V153, P343, DOI 10.1164/ajrccm.153.1.8542141; BENMENACHEM T, 1994, ANN INTERN MED, V121, P568, DOI 10.7326/0003-4819-121-8-199410150-00003; Beuret P, 2002, INTENS CARE MED, V28, P564, DOI 10.1007/s00134-002-1266-x; Black N, 1999, J Health Serv Res Policy, V4, P236; Boots RJ, 1997, CRIT CARE MED, V25, P1707, DOI 10.1097/00003246-199710000-00021; BUENOCAVANILLAS A, 1994, CRIT CARE MED, V22, P55, DOI 10.1097/00003246-199401000-00013; Campbell GD, 1996, AM J RESP CRIT CARE, V153, P1711; CELIS R, 1988, CHEST, V93, P318, DOI 10.1378/chest.93.2.318; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Cluzeau FA, 1999, INT J QUAL HEALTH C, V11, P21, DOI 10.1093/intqhc/11.1.21; Combes P, 2000, INTENS CARE MED, V26, P878, DOI 10.1007/s001340051276; Cook D, 2000, CRIT CARE MED, V28, P3547, DOI 10.1097/00003246-200010000-00034; Cook DJ, 1997, ANN INTERN MED, V127, P210, DOI 10.7326/0003-4819-127-3-199708010-00006; Cook DJ, 1998, JAMA-J AM MED ASSOC, V279, P1605, DOI 10.1001/jama.279.20.1605; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; Cook DJ, 2002, CRIT CARE MED, V30, P1472, DOI 10.1097/00003246-200207000-00012; Cook DJ, 1997, ANN INTERN MED, V126, P376, DOI 10.7326/0003-4819-126-5-199703010-00006; CRAIG CP, 1984, AM J INFECT CONTROL, V12, P233, DOI 10.1016/0196-6553(84)90114-7; CRAVEN DE, 1988, ARCH INTERN MED, V148, P1161, DOI 10.1001/archinte.148.5.1161; Cunnion KM, 1996, AM J RESP CRIT CARE, V153, P158, DOI 10.1164/ajrccm.153.1.8542110; D'Amico R, 1998, BMJ-BRIT MED J, V316, P1275, DOI 10.1136/bmj.316.7140.1275; Davis K, 2000, CRIT CARE MED, V28, P1412, DOI 10.1097/00003246-200005000-00026; DEBOISBLANC BP, 1993, CHEST, V103, P1543, DOI 10.1378/chest.103.5.1543; DECLERCQ J, 1983, ACTA ANAESTH BELG, V34, P179; DEMAREST GB, 1989, WESTERN J MED, V150, P35; DEPPE SA, 1990, CRIT CARE MED, V18, P1389, DOI 10.1097/00003246-199012000-00016; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; DREYFUSS D, 1995, AM J RESP CRIT CARE, V151, P986; DREYFUSS D, 1991, AM REV RESPIR DIS, V143, P738, DOI 10.1164/ajrccm/143.4_Pt_1.738; DUNHAM CM, 1984, J TRAUMA, V24, P120, DOI 10.1097/00005373-198402000-00005; EDDLESTON JM, 1994, CRIT CARE MED, V22, P1949; Fagon JY, 1996, JAMA-J AM MED ASSOC, V275, P866, DOI 10.1001/jama.275.11.866; FAGON JY, 1993, AM J MED, V94, P281, DOI 10.1016/0002-9343(93)90060-3; Feder G, 1999, BRIT MED J, V318, P728; FINK MP, 1990, CHEST, V97, P132, DOI 10.1378/chest.97.1.132; GENTILELLO L, 1988, CRIT CARE MED, V16, P783, DOI 10.1097/00003246-198808000-00010; George JN, 1997, ANN INTERN MED, V126, P319; Girou E, 1998, AM J RESP CRIT CARE, V157, P1151, DOI 10.1164/ajrccm.157.4.9701129; Graham ID, 2001, CAN MED ASSOC J, V165, P157; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; GRIMSHAW JM, 2001, MED CARE S, V39, P112; Grol R, 1999, Jt Comm J Qual Improv, V25, P503; GUYATT GH, 1994, JAMA-J AM MED ASSOC, V271, P59, DOI 10.1001/jama.271.1.59; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; Hayward R S, 1993, Ann Intern Med, V118, P731; Hayward RSA, 1997, CAN MED ASSOC J, V156, P1715; HEYLAND DK, 1994, CHEST, V105, P1221, DOI 10.1378/chest.105.4.1221; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; Heyland DK, 1999, CRIT CARE MED, V27, P1195, DOI 10.1097/00003246-199906000-00052; HOLZAPFEL L, 1993, CRIT CARE MED, V21, P1132, DOI 10.1097/00003246-199308000-00010; Holzapfel L, 1999, AM J RESP CRIT CARE, V159, P695, DOI 10.1164/ajrccm.159.3.9712076; HURLEY JC, 1995, ANTIMICROB AGENTS CH, V39, P941, DOI 10.1128/AAC.39.4.941; JIMENEZ P, 1989, CRIT CARE MED, V17, P882, DOI 10.1097/00003246-198909000-00007; JOHNSON KL, 1994, CRIT CARE MED, V22, P658, DOI 10.1097/00003246-199404000-00023; KAPPSTEIN I, 1992, EUR J CLIN MICROBIOL, V11, P504, DOI 10.1007/BF01960804; KERVER AJH, 1987, INTENS CARE MED, V13, P347; Kirschenbaum L, 2002, CRIT CARE MED, V30, P1983, DOI 10.1097/00003246-200209000-00006; Kirton OC, 1997, CHEST, V112, P1055, DOI 10.1378/chest.112.4.1055; KOLLEF MH, 1994, CHEST, V105, P1101, DOI 10.1378/chest.105.4.1101; Kollef MH, 1999, CHEST, V116, P1339, DOI 10.1378/chest.116.5.1339; Kollef MH, 1998, CHEST, V113, P759, DOI 10.1378/chest.113.3.759; KOLLEF MH, 1995, ANN INTERN MED, V123, P168, DOI 10.7326/0003-4819-123-3-199508010-00002; LIBERATI A, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000022.PUB2; Long MN, 1996, INFECT CONT HOSP EP, V17, P14; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; MAHUL P, 1992, INTENS CARE MED, V18, P20, DOI 10.1007/BF01706421; MARTIN C, 1990, CHEST, V97, P144, DOI 10.1378/chest.97.1.144; McMullin JP, 2002, INTENS CARE MED, V28, P304, DOI 10.1007/s00134-002-1225-6; Memish ZA, 2001, AM J INFECT CONTROL, V29, P301, DOI 10.1067/mic.2001.115404; Metz C., 1998, CLIN INTENSIVE CARE, V9, P20, DOI [10.3109/tcic.9.1.20.24, DOI 10.3109/TCIC.9.1.20.24]; MICHELSON A, 1991, ANAESTHESIST, V40, P100; MULROW CD, 1987, ANN INTERN MED, V106, P485, DOI 10.7326/0003-4819-106-3-485; Nathens AB, 1999, ARCH SURG-CHICAGO, V134, P170, DOI 10.1001/archsurg.134.2.170; Ntoumenopoulos G, 2002, INTENS CARE MED, V28, P850, DOI 10.1007/s00134-002-1342-2; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; Papazian L, 1996, AM J RESP CRIT CARE, V154, P91, DOI 10.1164/ajrccm.154.1.8680705; POTGIETER PD, 1987, CRIT CARE MED, V15, P495, DOI 10.1097/00003246-198705000-00008; RELLO J, 1991, CHEST, V100, P439, DOI 10.1378/chest.100.2.439; RODRIGUEZ JL, 1990, SURGERY, V108, P655; ROUBY JJ, 1994, AM J RESP CRIT CARE, V150, P776, DOI 10.1164/ajrccm.150.3.8087352; ROUSTAN JP, 1992, INTENS CARE MED, V18, P97, DOI 10.1007/BF01705040; SALORD F, 1990, INTENS CARE MED, V16, P390, DOI 10.1007/BF01735177; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; Shekelle P, 2001, BMJ-BRIT MED J, V323, P155, DOI 10.1136/bmj.323.7305.155; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Shiffman RN, 2003, ANN INTERN MED, V139, P493, DOI 10.7326/0003-4819-139-6-200309160-00013; Shorr AF, 2001, CHEST, V119, P228, DOI 10.1378/chest.119.1.228; Smulders K, 2002, CHEST, V121, P858, DOI 10.1378/chest.121.3.858; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; SUMMER WR, 1989, J CRIT CARE, V4, P45, DOI 10.1016/0883-9441(89)90091-9; TABLAN OC, 1994, AM J INFECT CONTROL, V22, P247; Thomachot L, 2002, CRIT CARE MED, V30, P232, DOI 10.1097/00003246-200201000-00033; Tonnesen E K, 1999, Ugeskr Laeger, V161, P15; TRAVER GA, 1995, J CRIT CARE, V10, P97, DOI 10.1016/0883-9441(95)90000-4; TUNIS SR, 1994, ANN INTERN MED, V120, P956, DOI 10.7326/0003-4819-120-11-199406010-00008; VALLES J, 1995, ANN INTERN MED, V122, P179, DOI 10.7326/0003-4819-122-3-199502010-00004; van Nieuwenhoven CA, 2001, JAMA-J AM MED ASSOC, V286, P335, DOI 10.1001/jama.286.3.335; VANDENBROUCKEGRAULS CMJE, 1991, LANCET, V338, P859, DOI 10.1016/0140-6736(91)91510-2; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Whiteman K, 1995, Am J Crit Care, V4, P133; WOOLF SH, 1990, J CLIN EPIDEMIOL, V43, P891, DOI 10.1016/0895-4356(90)90073-X; Zeitoun S S, 2001, Rev Lat Am Enfermagem, V9, P46	105	306	343	0	42	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2004	141	4					305	313		10.7326/0003-4819-141-4-200408170-00011	http://dx.doi.org/10.7326/0003-4819-141-4-200408170-00011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846BX	15313747				2022-12-28	WOS:000223290900008
J	Barnes, PJ; Kleinert, S				Barnes, PJ; Kleinert, S			COPD - a neglected disease	LANCET			English	Editorial Material							BURDEN		Natl Heart & Lung Inst, Imperial Coll Sch Med, London SW3 6LY, England	Imperial College London	Barnes, PJ (corresponding author), Natl Heart & Lung Inst, Imperial Coll Sch Med, Dovehouse St, London SW3 6LY, England.	p.j.barnes@imperial.ac.uk		Barnes, Peter/0000-0002-5122-4018				Ait-Khaled N, 2001, B WORLD HEALTH ORGAN, V79, P971; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; European Commission, 2003, EFSA J, P1; *GOLD GLOB IN CHRO, 2003, NHLBI WHO WORKSH REP; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; MURRAY CJL, 2001, 36 WHO	6	48	48	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2004	364	9434					564	565		10.1016/S0140-6736(04)16866-9	http://dx.doi.org/10.1016/S0140-6736(04)16866-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313342				2022-12-28	WOS:000223275100008
J	Hansen, B; Osterhus, S; Quadfasel, D; Turrell, W				Hansen, B; Osterhus, S; Quadfasel, D; Turrell, W			Already the day after tomorrow?	SCIENCE			English	Editorial Material							ATLANTIC-OCEAN; NORDIC SEAS; CIRCULATION; WATER		Bjerknes Ctr, NO-5007 Bergen, Norway; Marine Lab, Aberdeen AB11 9DB, Scotland; Inst Meereskunde, D-20146 Hamburg, Germany	Bjerknes Centre for Climate Research		bogihan@frs.fo	Turrell, William R/A-4185-2011	Osterhus, Svein/0000-0001-9915-2685; Turrell, William/0000-0002-1889-1468				Blindheim J, 2000, DEEP-SEA RES PT I, V47, P655, DOI 10.1016/S0967-0637(99)00070-9; Curry R, 2003, NATURE, V426, P826, DOI 10.1038/nature02206; Dickson B, 2002, NATURE, V416, P832, DOI 10.1038/416832a; DICKSON RR, 1994, J GEOPHYS RES-OCEANS, V99, P12319, DOI 10.1029/94JC00530; DICKSON RR, COMMUNICATION; Ganachaud A, 2000, NATURE, V408, P453, DOI 10.1038/35044048; Hansen B, 2000, PROG OCEANOGR, V45, P109, DOI 10.1016/S0079-6611(99)00052-X; Hansen B, 2001, NATURE, V411, P927, DOI 10.1038/35082034; Latif M, 2000, J CLIMATE, V13, P1809, DOI 10.1175/1520-0442(2000)013<1809:L>2.0.CO;2; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; Rahmstorf S, 1999, NATURE, V399, P523, DOI 10.1038/21066; Seager R, 2002, Q J ROY METEOR SOC, V128, P2563, DOI 10.1256/qj.01.128; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Wunsch C, 2002, SCIENCE, V298, P1179, DOI 10.1126/science.1079329	14	61	66	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					953	954		10.1126/science.1100085	http://dx.doi.org/10.1126/science.1100085			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310882				2022-12-28	WOS:000223250700026
J	Kohli, P; Harrell, CC; Cao, ZH; Gasparac, R; Tan, WH; Martin, CR				Kohli, P; Harrell, CC; Cao, ZH; Gasparac, R; Tan, WH; Martin, CR			DNA-functionalized nanotube membranes with single-base mismatch selectivity	SCIENCE			English	Article							TRANSPORT	We describe synthetic membranes in which the molecular recognition chemistry used to accomplish selective permeation is DNA hybridization. These membranes contain template-synthesized gold nanotubes with inside diameters of 12 nanometers, and a "transporter" DNA-hairpin molecule is attached to the inside walls of these nanotubes. These DNA-functionalized nanotube membranes selectively recognize and transport the DNA strand that is complementary to the transporter strand, relative to DNA strands that are not complementary to the transporter. Under optimal conditions, single-base mismatch transport selectivity can be obtained.	Univ Florida, Dept Chem, Gainesville, FL 32611 USA; Univ Florida, Ctr Res Bionano Interface, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Martin, CR (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	crmartin@chern.ufl.edu	Martin, Charles/AAA-1040-2019; Tan, Weihong/AAA-4536-2020					Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Bonnet G, 1999, P NATL ACAD SCI USA, V96, P6171, DOI 10.1073/pnas.96.11.6171; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Hall MC, 2001, J MOL BIOL, V312, P637, DOI 10.1006/jmbi.2001.4958; Hill, 2001, ION CHANNELS EXCITAB, P441; Howorka S, 2001, NAT BIOTECHNOL, V19, P636, DOI 10.1038/90236; Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655; Lakshmi BB, 1997, NATURE, V388, P758, DOI 10.1038/41978; Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396; MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961; Martin CR, 2001, J PHYS CHEM B, V105, P1925, DOI 10.1021/jp003486e; MULDER M, 1996, BASIC PRINCIPLES MEM, P342; OSADA Y, 1992, MEMBRANE SCI TECHNOL, P377	15	283	294	2	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					984	986		10.1126/science.1100024	http://dx.doi.org/10.1126/science.1100024			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310896				2022-12-28	WOS:000223250700041
J	Uchic, MD; Dimiduk, DM; Florando, JN; Nix, WD				Uchic, MD; Dimiduk, DM; Florando, JN; Nix, WD			Sample dimensions influence strength and crystal plasticity	SCIENCE			English	Article							THIN-FILMS; DEFORMATION; SIZE; GRADIENT; COPPER; STRESS	When a crystal deforms plastically, phenomena such as dislocation storage, multiplication, motion, pinning, and nucleation occur over the submicron-to-nanometer scale. Here we report measurements of plastic yielding for single crystals of micrometer-sized dimensions for three different types of metals. We find that within the tests, the overall sample dimensions artificially limit the length scales available for plastic processes. The results show dramatic size effects at surprisingly large sample dimensions. These results emphasize that at the micrometer scale, one must de. ne both the external geometry and internal structure to characterize the strength of a material.	USAF, Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA	United States Department of Defense; United States Air Force; US Air Force Research Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Stanford University	Uchic, MD (corresponding author), USAF, Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA.	michael.uchic@wpafb.af.mil		Florando, Jeffrey/0000-0002-1592-5503				ASHBY MF, 1970, PHILOS MAG, V21, P399, DOI 10.1080/14786437008238426; BAZINSKI SJ, 1979, DISLOCATIONS SOLIDS, V4, P261; BRENNER SS, 1956, J APPL PHYS, V27, P1484, DOI 10.1063/1.1722294; BRENNER SS, 1957, J APPL PHYS, V28, P1023, DOI 10.1063/1.1722900; BRENNER SS, 1959, GROWTH PERFECTION CR, P157; Espinosa HD, 2004, J MECH PHYS SOLIDS, V52, P667, DOI 10.1016/j.jmps.2003.07.001; Espinosa HD, 2003, J MECH PHYS SOLIDS, V51, P47, DOI 10.1016/S0022-5096(02)00062-5; FLECK NA, 1994, ACTA METALL MATER, V42, P475, DOI 10.1016/0956-7151(94)90502-9; FOURIE JT, 1968, PHILOS MAG, V17, P735, DOI 10.1080/14786436808223026; GilSevillano J., 1993, MAT SCI FORUM, V113, P19, DOI [10.4028/www.scientific.net/MSF.113-115.19, DOI 10.4028/WWW.SCIENTIFIC.NET/MSF.113-115.19]; HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303; Haque MA, 2002, SENSOR ACTUAT A-PHYS, V97-8, P239, DOI 10.1016/S0924-4247(01)00861-5; HIRSCH PB, 1992, PHILOS MAG A, V65, P569, DOI 10.1080/01418619208201539; MA Q, 1995, J MATER RES, V10, P853, DOI 10.1557/JMR.1995.0853; MILLS MJ, 1989, MATER RES SOC SYMP P, V133, P203; Nix WD, 1998, J MECH PHYS SOLIDS, V46, P411, DOI 10.1016/S0022-5096(97)00086-0; NYE JF, 1953, ACTA METALL MATER, V1, P153, DOI 10.1016/0001-6160(53)90054-6; PETCH NJ, 1953, J IRON STEEL I, V174, P25; Sharpe WN, 2001, J MICROELECTROMECH S, V10, P317, DOI 10.1109/84.946774; SHI XL, 1995, PHIL MAG LETT, V71, P1, DOI 10.1080/09500839508240507; Stolken JS, 1998, ACTA MATER, V46, P5109, DOI 10.1016/S1359-6454(98)00153-0; SUZUKI H, 1956, J PHYS SOC JPN, V11, P382, DOI 10.1143/JPSJ.11.382; Uchic MD, 2003, MATER RES SOC SYMP P, V753, P27; Veyssiere P., 1996, DISLOCATIONS SOLIDS, V10, P253; Yip S, 1998, NATURE, V391, P532, DOI 10.1038/35254	25	1780	1821	19	713	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					986	989		10.1126/science.1098993	http://dx.doi.org/10.1126/science.1098993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310897				2022-12-28	WOS:000223250700042
J	Somorjai, GA				Somorjai, GA			On the move	NATURE			English	Editorial Material									Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Somorjai, GA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.		Anderson, David G/E-6125-2014	Anderson, David G/0000-0002-9624-5867				Somorjai G.A., 2010, INTRO SURFACE CHEM C; Thomas J. M., 1997, PRINCIPLES PRACTICE; TSOU CL, 1993, SCIENCE, V262, P380, DOI 10.1126/science.8211158	3	33	33	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					730	730		10.1038/430730a	http://dx.doi.org/10.1038/430730a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306789				2022-12-28	WOS:000223233600022
J	Melese, M; Chidambaram, JD; Alemayelm, W; Lee, DC; Yi, EH; Cevallos, V; Zhou, ZX; Donnellan, C; Saidel, M; Whitcher, JP; Gaynor, BD; Lietman, TM				Melese, M; Chidambaram, JD; Alemayelm, W; Lee, DC; Yi, EH; Cevallos, V; Zhou, ZX; Donnellan, C; Saidel, M; Whitcher, JP; Gaynor, BD; Lietman, TM			Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST-SAVING STRATEGY; URINE SPECIMENS; AZITHROMYCIN; INFECTION; DISEASE; NEPAL; BLINDNESS; PROGRAMS; AREAS; PCR	Context Mass antibiotic administrations for ocular chlamydial infection play a key role in the World Health Organization's trachoma control program. Mathematical models suggest that it is possible to eliminate trachoma locally with repeat mass treatment, depending on the coverage level of the population, frequency of mass treatments, and rate that infection returns into a community after each mass treatment. Precise estimates of this latter parameter have never been reported. Objective To determine the rate at which chlamydial infection returns to a population after mass treatment and to estimate the treatment frequency required for elimination of ocular chlamydia from a community. Design, Setting, and Participants Longitudinal cohort study of 24 randomly selected villages from the Gurage Zone in Ethiopia conducted February 2003 to October 2003. A total of 1332 children aged 1 to 5 years were monitored for prevalence of ocular chlamydial infection pretreatment and 2 and 6 months posttreatment. Interventions All individuals older than 1 year were eligible for single-dose oral azithromycin treatment. Pregnant women were offered tetracycline eye ointment. Main Outcome Measures Prevalence of ocular chlamydial infection, measured by polymerase chain reaction, in children aged 1 to 5 years, in each of 24 villages at each time point was used to estimate the rate of return of infection and the treatment frequency necessary for elimination. Results The prevalence of. infection was 56.3% pretreatment (95% confidence interval [CI], 47.5%-65.1%), 6.7% 2 months posttreatment (95% Cl, 4.2%-9.2%), and 11.0% 6 months posttreatment (95% CI, 7.3%-14.7%). Infection returned after treatment at an exponential rate of 12.3% per month (95% Cl, 4.6%-19.9% per month). The minimum treatment frequency necessary for elimination was calculated to be once every 11.6 months (95% Cl, 7.2-30.9 months), given a coverage level of 80%. Thus, biannual treatment, already being performed in some areas, was estimated to be more than frequent enough to eventually eliminate infection. Conclusion The rate at which ocular chlamydial infection returns to a community after mass treatment suggests that elimination of infection in a hyperendemic area is feasible with biannual mass antibiotic administrations and attainable coverage levels.	Univ Calif San Francisco, FI Proctor Fdn, WHO Collaborating Ctr, San Francisco, CA 94143 USA; ORBIS Int, Addis Ababa, Ethiopia; Univ Calif San Francisco, Inst Global Hlth, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Global Hlth, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; World Health Organization; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lietman, TM (corresponding author), Univ Calif San Francisco, FI Proctor Fdn, WHO Collaborating Ctr, Room 307,95 Kirkhan St, San Francisco, CA 94143 USA.	tml@itsa.ucsf.edu		Chidambaram, Jaya/0000-0001-5438-2858	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048789, R21AI055752] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI48789, R21 AI055752] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bird M, 2003, J INFECT DIS, V187, P1669, DOI 10.1086/374743; Chan K., 2000, SENSITIVITY ANAL; Diamant J, 2001, Ophthalmic Epidemiol, V8, P109, DOI 10.1076/opep.8.2.109.4156; Dolin PJ, 1997, LANCET, V349, P1511, DOI 10.1016/S0140-6736(97)01355-X; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Emerson PM, 2000, TROP MED INT HEALTH, V5, P515, DOI 10.1046/j.1365-3156.2000.00603.x; Farid M. A., 1980, World Health Forum, V1, P8; FRIEDERICH R, 1982, ANN OPHTHALMOL, V14, P38; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; Gaynor BD, 2003, EMERG INFECT DIS, V9, P596, DOI 10.3201/eid0905.020577; Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17; Hoechsmann A, 2001, Ophthalmic Epidemiol, V8, P145, DOI 10.1076/opep.8.2.145.4169; Holm SO, 2001, B WORLD HEALTH ORGAN, V79, P194; Jha H, 2002, CLIN INFECT DIS, V35, P765, DOI 10.1086/342298; JONES RB, 1990, J INFECT DIS, V162, P1309, DOI 10.1093/infdis/162.6.1309; Kacena KA, 1998, J CLIN MICROBIOL, V36, P481, DOI 10.1128/JCM.36.2.481-485.1998; KATZ J, 1993, INT J EPIDEMIOL, V22, P709, DOI 10.1093/ije/22.4.709; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; McOrist S, 2000, TRENDS MICROBIOL, V8, P483, DOI 10.1016/S0966-842X(00)01854-0; Morre SA, 2000, J CLIN MICROBIOL, V38, P1679; Murray DM, 1998, DESIGN ANAL GROUP RA; Peeling RW, 1998, SEX TRANSM INFECT, V74, P66, DOI 10.1136/sti.74.1.66; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; TAYLOR HR, 1990, SCIENCE, V250, P116, DOI 10.1126/science.2218502; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; World Health Organization, 1997, 1 M WHO ALL GLOB EL	27	97	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					721	725		10.1001/jama.292.6.721	http://dx.doi.org/10.1001/jama.292.6.721			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304470	Bronze, Green Accepted			2022-12-28	WOS:000223177300027
J	Lederman, L				Lederman, L			The pleasure of learning	NATURE			English	Editorial Material									Fermilab Natl Accelerator Lab, Batavia, IL 60510 USA	United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory	Lederman, L (corresponding author), Fermilab Natl Accelerator Lab, POB 500, Batavia, IL 60510 USA.								0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					617	617		10.1038/430617a	http://dx.doi.org/10.1038/430617a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295578				2022-12-28	WOS:000223085400025
J	Schulz, KG; Zondervan, I; Gerringa, LJA; Timmermans, KR; Veldhuis, MJW; Riebesell, U				Schulz, KG; Zondervan, I; Gerringa, LJA; Timmermans, KR; Veldhuis, MJW; Riebesell, U			Effect of trace metal availability on coccolithophorid calcification	NATURE			English	Article							SUB-ARCTIC PACIFIC; CADMIUM CONCENTRATIONS; MARINE-PHYTOPLANKTON; GREENLAND ICE; CARBONIC-ACID; ZINC; SEAWATER; IRON; DISSOCIATION; COMPLEXATION	The deposition of atmospheric dust into the ocean has varied considerably over geological time(1,2). Because some of the trace metals contained in dust are essential plant nutrients which can limit phytoplankton growth in parts of the ocean, it has been suggested that variations in dust supply to the surface ocean might influence primary production(3,4). Whereas the role of trace metal availability in photosynthetic carbon fixation has received considerable attention, its effect on biogenic calcification is virtually unknown. The production of both particulate organic carbon and calcium carbonate (CaCO3) drives the ocean's biological carbon pump. The ratio of particulate organic carbon to CaCO3 export, the so-called rain ratio, is one of the factors determining CO2 sequestration in the deep ocean. Here we investigate the influence of the essential trace metals iron and zinc on the prominent CaCO3-producing microalga Emiliania huxleyi. We show that whereas at low iron concentrations growth and calcification are equally reduced, low zinc concentrations result in a de-coupling of the two processes. Despite the reduced growth rate of zinc-limited cells, CaCO3 production rates per cell remain unaffected, thus leading to highly calcified cells. These results suggest that changes in dust deposition can affect biogenic calcification in oceanic regions characterized by trace metal limitation, with possible consequences for CO2 partitioning between the atmosphere and the ocean.	Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; Leibniz Inst Marine Sci IFM GEOMAR, D-24105 Kiel, Germany; Netherlands Inst Sea Res, NL-1790 AB Den Burg, Texel, Netherlands	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Schulz, KG (corresponding author), Alfred Wegener Inst Polar & Marine Res, POB 120161, D-27515 Bremerhaven, Germany.	kschulz@ifm-geomar.de	Riebesell, Ulf/AAC-9717-2020; Schulz, Kai/AEZ-9073-2022; Schulz, Kai G./Q-5608-2017	Schulz, Kai/0000-0002-8481-4639; Schulz, Kai G./0000-0002-8481-4639; timmermans, klaas/0000-0002-3214-4354; Riebesell, Ulf/0000-0002-9442-452X				Boyd P.W., 2000, CHANGING OCEAN CARBO, p[61, 107]; Broecker W.S., 1982, TRACERS SEA; Broecker WS, 1987, GLOBAL BIOGEOCHEM CY, V1, P15, DOI 10.1029/GB001i001p00015; BRULAND KW, 1989, LIMNOL OCEANOGR, V34, P269, DOI 10.4319/lo.1989.34.2.0269; CANDELONE JP, 1995, J GEOPHYS RES-ATMOS, V100, P16605, DOI 10.1029/95JD00989; COALE KH, 1991, LIMNOL OCEANOGR, V36, P1851, DOI 10.4319/lo.1991.36.8.1851; CONKRIGHT ME, 1994, 1 NOAA NESDIS US DEP, V1; Crawford DW, 2003, LIMNOL OCEANOGR, V48, P1583, DOI 10.4319/lo.2003.48.4.1583; Dickson A.G., 1994, HDB METHODS ANAL VAR; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; Ellwood MJ, 2001, MAR CHEM, V75, P33, DOI 10.1016/S0304-4203(01)00024-X; Hong SM, 1997, ATMOS ENVIRON, V31, P2235, DOI 10.1016/S1352-2310(97)00029-0; Hong SM, 1996, EARTH PLANET SC LETT, V143, P233, DOI 10.1016/0012-821X(96)00137-9; Kremling K, 2001, DEEP-SEA RES PT I, V48, P2541, DOI 10.1016/S0967-0637(01)00036-X; Liu XW, 2002, MAR CHEM, V77, P43, DOI 10.1016/S0304-4203(01)00074-3; Lohan MC, 2002, DEEP-SEA RES PT II, V49, P5793, DOI 10.1016/S0967-0645(02)00215-1; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Millero FJ, 1998, AQUAT GEOCHEM, V4, P153, DOI 10.1023/A:1009656023546; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; MOREL FMM, 1994, NATURE, V369, P740, DOI 10.1038/369740a0; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pettit L. D., 2001, IUPAC STABILITY CONS; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Stoll MHC, 2001, ANAL CHEM, V73, P4111, DOI 10.1021/ac010303r; Sunda W, 2003, MAR CHEM, V84, P35, DOI 10.1016/S0304-4203(03)00101-4; Sunda WG, 1995, LIMNOL OCEANOGR, V40, P1404, DOI 10.4319/lo.1995.40.8.1404; Zondervan I, 2002, J EXP MAR BIOL ECOL, V272, P55, DOI 10.1016/S0022-0981(02)00037-0	30	76	79	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					673	676		10.1038/nature02631	http://dx.doi.org/10.1038/nature02631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295599	Green Published			2022-12-28	WOS:000223085400044
J	Cardozo, BL; Bilukha, OO; Crawford, CAG; Shaikh, I; Wolfe, MI; Gerber, ML; Anderson, M				Cardozo, BL; Bilukha, OO; Crawford, CAG; Shaikh, I; Wolfe, MI; Gerber, ML; Anderson, M			Mental health, social functioning, and disability in postwar Afghanistan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-RIGHTS; REFUGEES; TORTURE; TRAUMA; WAR; INSTRUMENT; ATTITUDES; KOSOVO; CAMPS	Context More than 2 decades of conflict have led to widespread human suffering and population displacement in Afghanistan. In 2002, the Centers for Disease Control and Prevention and other collaborating partners performed a national population-based mental health survey in Afghanistan. Objective To provide national estimates of mental health status of the disabled (any restriction or lack of ability to perform an activity in the manner considered normal for a human being) and nondisabled Afghan population aged at least 15 years. Design, Setting, and Participants A national multistage, cluster, population-based mental health survey of 799 adult household members (699 nondisabled and 100 disabled respondents) aged 15 years or older conducted from July to September 2002. Fifty district-level clusters were selected based on probability proportional to size sampling. One village was randomly selected in each cluster and 15 households were randomly selected in each village, yielding 750 households. Main Outcome Measures Demographics, social functioning as measured by selected questions from the Medical Outcomes Study 36-Item Short-Form Health Survey, depressive symptoms measured by the Hopkins Symptoms Checklist-25, trauma events and symptoms of posttraumatic stress disorder (PTSD) measured by the Harvard Trauma Questionnaire, and culture-specific symptoms of mental illness and coping mechanisms. Results A total of 407 respondents (62.0%) reported experiencing at least 4 trauma events during the previous 10 years. The most common trauma events experienced by the respondents were lack of food and water (56.1%) for nondisabled persons and lack of shelter (69.7%) for disabled persons. The prevalence of respondents with symptoms of depression was 67.7% (95% confidence interval [CI], 54.6%-80.7%) and 71.7% (95% Cl, 65.0%-78.4%), and symptoms of anxiety 72.2% (95% Cl, 63.8%-80.7%) and 84.6% (95% Cl, 74.1%-95.0%) for nondisabled and disabled respondents, respectively. The prevalence of symptoms of PTSD was similar for both groups (nondisabled, 42.1%; 95% Cl, 34.2%-50.1%; and disabled, 42.2% - 95% Cl, 29.2%-55.2%). Women had significantly poorer mental health status than men did. Respondents who were disabled had significantly lower social functioning and poorer mental health status than those who were nondisabled. Feelings of hatred were high (84% of nondisabled and 81% of disabled respondents). Coping mechanisms included religious and spiritual practices; focusing on basic needs, such as higher income, better housing, and more food; and seeking medical assistance. Conclusions In this nationally representative survey of Afghans, prevalence rates of symptoms of depression, anxiety, and PTSD were high. These data underscore the need for donors and health care planners to address the current lack of mental health care resources, facilities, and trained mental health care professionals in Afghanistan.	Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Branch, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Environm Hazards & Hlth Effects, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; Vietnam Vet Amer Fdn, Washington, DC USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Cardozo, BL (corresponding author), Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Branch, Natl Ctr Environm Hlth, 1600 Clifton Rd NE,Mailstop E-97, Atlanta, GA 30333 USA.	bhc8@cdc.gov	Bilukha, Oleg/ABC-5095-2020					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Amowitz LL, 2003, J WOMEN HEALTH GEN-B, V12, P577, DOI 10.1089/154099903768248285; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Cardozo BL, 2003, J TRAUMA STRESS, V16, P351, DOI 10.1023/A:1024413918346; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Gandek, 1997, SF 36 HLTH SURVEY MA; GOBAR AH, 1976, B NARCOTICS, V28, P1; Goodhand J, 2000, DISASTERS, V24, P87, DOI 10.1111/1467-7717.00135; Holtz TH, 1998, J NERV MENT DIS, V186, P24, DOI 10.1097/00005053-199801000-00005; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Mollica RF, 2002, J NERV MENT DIS, V190, P158, DOI 10.1097/00005053-200203000-00004; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; *PHYS HUM RIGHTS, PHYS HUM RIGHTS REP; Rasekh Z, 1998, JAMA-J AM MED ASSOC, V280, P449, DOI 10.1001/jama.280.5.449; Saraceno B., 2001, Eastern Mediterranean Health Journal, V7, P332; Shrestha NM, 1998, JAMA-J AM MED ASSOC, V280, P443, DOI 10.1001/jama.280.5.443; *UNHCR, 2002, UNHCR AFGH HUM UPD 6; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; *WHO, WORLD HLTH DAY 2001; World Health Organization, 1980, INT CLASS IMP DIS HA; WORLD FACT BOOK AFGH	23	216	221	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2004	292	5					575	584		10.1001/jama.292.5.575	http://dx.doi.org/10.1001/jama.292.5.575			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843AE	15292083				2022-12-28	WOS:000223045500015
J	Meredith, S				Meredith, S			Commentary: Better support for investigators is essential	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									MRC, Clin Trials Unit, London NW1 2DA, England	Medical Research Council Clinical Trials Unit	Meredith, S (corresponding author), MRC, Clin Trials Unit, London NW1 2DA, England.	sm@ctu.mrc.ac.uk						*DEP HLTH, RES PAT BEN WORK PAR; *MED RES COUNC DEP, JOINT PROJ CLIN TRIA; Wald DS, 2004, BRIT MED J, V329, P282, DOI 10.1136/bmj.329.7460.282	3	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2004	329	7460					285	285		10.1136/bmj.329.7460.285	http://dx.doi.org/10.1136/bmj.329.7460.285			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284158	Green Published			2022-12-28	WOS:000223133300027
J	Boyd, OS; Jones, CH; Sheehan, AF				Boyd, OS; Jones, CH; Sheehan, AF			Foundering lithosphere imaged beneath the Southern Sierra Nevada, California, USA	SCIENCE			English	Article							MANTLE; DELAMINATION; ANELASTICITY; VOLCANISM; ORIGIN; CRUST	Seismic tomography reveals garnet-rich crust and mantle lithosphere descending into the upper mantle beneath the southeastern Sierra Nevada. The descending lithosphere consists of two layers: an iron-rich eclogite above a magnesium-rich garnet peridotite. These results place descending eclogite above and east of high P wave speed material previously imaged beneath the southern Great Valley, suggesting a previously unsuspected coherence in the lithospheric removal process.	Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Boyd, OS (corresponding author), Univ Colorado, Dept Geol Sci, 2200 Colorado Ave, Boulder, CO 80309 USA.	oliver.boyd@colorado.edu	Jones, Craig H/K-2224-2017; Sheehan, Anne F/B-3954-2014	Jones, Craig H/0000-0002-1698-0408; Sheehan, Anne F/0000-0002-9629-1687; Boyd, Oliver/0000-0001-9457-0407				ALKHATIB HH, 1991, J GEOPHYS RES-SOL EA, V96, P18129, DOI 10.1029/91JB01660; BOYD OS, IN PRESS GEOPHYS MON; CHRISTENSEN NI, 1995, J GEOPHYS RES-SOL EA, V100, P9761, DOI 10.1029/95JB00259; Christensen NI, 1996, J GEOPHYS RES-SOL EA, V101, P3139, DOI 10.1029/95JB03446; COLEMAN RG, 1965, GEOL SOC AM BULL, V76, P483, DOI 10.1130/0016-7606(1965)76[483:EAETDA]2.0.CO;2; DODGE FCW, 1988, GEOL SOC AM BULL, V100, P938, DOI 10.1130/0016-7606(1988)100<0938:FOTMAC>2.3.CO;2; Ducea MN, 2000, GEOPHYS RES LETT, V27, P2405, DOI 10.1029/2000GL011565; Ducea MN, 1996, J GEOPHYS RES-SOL EA, V101, P8229, DOI 10.1029/95JB03452; Ducea MN, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000643; Ducea MN, 1998, CONTRIB MINERAL PETR, V133, P169, DOI 10.1007/s004100050445; Farmer GL, 2002, GEOL SOC AM BULL, V114, P754; Fliedner MM, 1996, GEOLOGY, V24, P367, DOI 10.1130/0091-7613(1996)024<0367:TDCSOT>2.3.CO;2; Hacker BR, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000614; Houseman GA, 1997, GEOPHYS J INT, V128, P125, DOI 10.1111/j.1365-246X.1997.tb04075.x; JACKSON I, 1993, ANNU REV EARTH PL SC, V21, P375, DOI 10.1146/annurev.ea.21.050193.002111; Jones C, 1999, J LIBR INF SCI, V31, P7, DOI 10.1177/096100069903100102; JONES CH, 1994, J GEOPHYS RES-SOL EA, V99, P4567, DOI 10.1029/93JB01232; Jull M, 2001, J GEOPHYS RES-SOL EA, V106, P6423, DOI 10.1029/2000JB900357; KARATO S, 1993, GEOPHYS RES LETT, V20, P1623, DOI 10.1029/93GL01767; Manley CR, 2000, GEOLOGY, V28, P811, DOI 10.1130/0091-7613(2000)28<811:TOVITS>2.0.CO;2; Polet J, 2002, GEOPHYS J INT, V149, P313, DOI 10.1046/j.1365-246X.2002.01630.x; Saleeby J, 2003, TECTONICS, V22, DOI 10.1029/2002TC001374; SHEEHAN AF, 1992, J GEOPHYS RES-SOL EA, V97, P15339, DOI 10.1029/92JB01093; WATT JP, 1976, REV GEOPHYS, V14, P541, DOI 10.1029/RG014i004p00541; Wernicke B, 1996, SCIENCE, V271, P190, DOI 10.1126/science.271.5246.190; WILSHIRE HG, 1988, US GEOL SURV PROF PA, V1443, P179; Zandt G, 2003, INT GEOL REV, V45, P213, DOI 10.2747/0020-6814.45.3.213	27	98	103	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					660	662		10.1126/science.1099181	http://dx.doi.org/10.1126/science.1099181			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286370				2022-12-28	WOS:000222992100045
J	Veugelers, M; Bressan, M; McDermott, DA; Weremowicz, S; Morton, CC; Mabry, CC; Lefaivre, JF; Zunamon, A; Destree, A; Chaudron, JM; Basson, CT				Veugelers, M; Bressan, M; McDermott, DA; Weremowicz, S; Morton, CC; Mabry, CC; Lefaivre, JF; Zunamon, A; Destree, A; Chaudron, JM; Basson, CT			Mutation of perinatal myosin heavy chain associated with a Carney complex variant	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FAMILIAL CARDIAC MYXOMAS; HOLT-ORAM-SYNDROME; SKELETAL-MUSCLE; DUTCH-KENTUCKY; EXPRESSION; GENE; TRISMUS; HEART; PHOSPHORYLATION; IDENTIFICATION	BACKGROUND: Familial cardiac myxomas occur in the hereditary syndrome Carney complex. Although PRKAR1A mutations can cause the Carney complex, the disorder is genetically heterogeneous. To identify the cause of a Carney complex variant associated with distal arthrogryposis (the trismus-pseudocamptodactyly syndrome), we performed clinical and genetic studies. METHODS: A large family with familial cardiac myxomas and the trismus-pseudocamptodactyly syndrome (Family 1) was identified and clinically evaluated along with two families with trismus and pseudocamptodactyly. Genetic linkage analyses were performed with the use of microsatellite polymorphisms to determine a locus for this Carney complex variant. Positional cloning and mutational analyses of candidate genes were performed to identify the genetic cause of disease in the family with the Carney complex as well as in the families with the trismus-pseudocamptodactyly syndrome. RESULTS: Clinical evaluations demonstrated that the Carney complex cosegregated with the trismus-pseudocamptodactyly syndrome in Family 1, and genetic analyses demonstrated linkage of the disease to chromosome 17p12-p13.1 (maximum multipoint lod score, 4.39). Sequence analysis revealed a missense mutation (Arg674Gln) in the perinatal myosin heavy-chain gene (MYH8). The same mutation was also found in the two families with the trismus-pseudocamptodactyly syndrome. Arg674 is highly conserved evolutionarily, localizes to the actin-binding domain of the perinatal myosin head, and is close to the ATP-binding site. We identified nonsynonymous MYH8 polymorphisms in patients with cardiac myxoma syndromes but without arthrogryposis. CONCLUSIONS: We describe a novel heart-hand syndrome involving familial cardiac myxomas and distal arthrogryposis and demonstrate that these disorders are caused by a founder mutation in the MYH8 gene. Our findings demonstrate novel roles for perinatal myosin in both the development of skeletal muscle and cardiac tumorigenesis.	Cornell Univ, Weill Med Coll, Dept Med, Greenberg Cardiol Div,Mol Cardiol Lab, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Univ Kentucky, Coll Med, Dept Pediat, Div Endocrinol & Metab, Lexington, KY USA; Univ S Carolina, Sch Med, Dept Surg, Div Plast Surg, Columbia, SC USA; Evanston NW Healthcare, Div Cardiol, Evanston, IL USA; Inst Pathol & Genet, Ctr Genet Humaine, Loverval, Belgium; Jolimont Hosp, Dept Cardiol, Jolimont, Belgium	Cornell University; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Kentucky; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; NorthShore University Health System; Groupe Jolimont	Basson, CT (corresponding author), Cornell Univ, Weill Med Coll, Dept Med, Greenberg Cardiol Div,Mol Cardiol Lab, 525 E 68th St, New York, NY 10021 USA.	ctbasson@med.cornell.edu	Brown, Matthew A/E-5749-2010	Brown, Matthew A/0000-0003-0538-8211	NCI NIH HHS [CA78895] Funding Source: Medline; NHLBI NIH HHS [R01-HL61785] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078895] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061785] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAKOU S, 2001, BASIC APPL MYOL, V11, P13; BANDMAN E, 1985, SCIENCE, V227, P780, DOI 10.1126/science.3969567; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; CARNEY JA, 1985, MEDICINE, V64, P270, DOI 10.1097/00005792-198507000-00007; Casey M, 2001, J CLIN INVEST, V107, P235, DOI 10.1172/JCI10841C1; Casey M, 1998, CIRCULATION, V98, P2560, DOI 10.1161/01.CIR.98.23.2560; Casey M, 2000, J CLIN INVEST, V106, pR31, DOI 10.1172/JCI10841; CHAUDRON JM, 1992, EUR HEART J, V13, P569, DOI 10.1093/oxfordjournals.eurheartj.a060216; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; FEGHALI R, 1989, J CELL BIOL, V108, P1791, DOI 10.1083/jcb.108.5.1791; HALL JG, 1982, AM J MED GENET, V11, P185, DOI 10.1002/ajmg.1320110208; He J, 2004, AM J MED GENET A, V126A, P93, DOI 10.1002/ajmg.a.20487; HECHT F, 1969, Birth Defects Original Article Series, V5, P96; *HUM GEN PROJ, 2004, UCSC GEN BROWS; KARSCHMIZRACHI I, 1990, GENE, V89, P289, DOI 10.1016/0378-1119(90)90020-R; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lefaivre JF, 2003, ANN PLAS SURG, V50, P310, DOI 10.1097/01.SAP.0000046787.17899.83; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; MABRY CC, 1974, J PEDIATR-US, V85, P503, DOI 10.1016/S0022-3476(74)80453-1; Machida S, 2000, DEV DYNAM, V217, P37, DOI 10.1002/(SICI)1097-0177(200001)217:1<37::AID-DVDY4>3.0.CO;2-3; Martinsson T, 2000, P NATL ACAD SCI USA, V97, P14614, DOI 10.1073/pnas.250289597; Mayer DCG, 1997, J CELL BIOL, V139, P1477, DOI 10.1083/jcb.139.6.1477; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; REYNEN K, 1995, NEW ENGL J MED, V333, P1610, DOI 10.1056/NEJM199512143332407; Rombouts J J, 1992, Ann Chir Main Memb Super, V11, P333, DOI 10.1016/S0753-9053(05)80481-8; Sacks LD, 2003, DEVELOPMENT, V130, P3391, DOI 10.1242/dev.00541; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Stratakis CA, 2001, J CLIN ENDOCR METAB, V86, P4041, DOI 10.1210/jc.86.9.4041; Stratakis CA, 1996, J CLIN INVEST, V97, P699, DOI 10.1172/JCI118467; Sung SS, 2003, AM J HUM GENET, V73, P212, DOI 10.1086/376418; Sung SS, 2003, AM J HUM GENET, V72, P681, DOI 10.1086/368294; VAGHADIA H, 1988, CAN J ANAESTH, V35, P80, DOI 10.1007/BF03010551; VEUGELERS M, 2002, GENETIC BASIS HUMAN, P635; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; WILSON R V, 1969, Birth Defects Original Article Series, V5, P99; Xiao QX, 2002, AM J PHYSIOL-HEART C, V283, pH213, DOI 10.1152/ajpheart.01085.2001; Zhao F, 2001, AM J HUM GENET, V69, P695, DOI 10.1086/323410	40	87	89	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					460	469		10.1056/NEJMoa040584	http://dx.doi.org/10.1056/NEJMoa040584			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282353	Bronze			2022-12-28	WOS:000222939700009
J	Kumarasamy, M; Desai, SP				Kumarasamy, M; Desai, SP			Drug points - Anterior uveitis is associated with travoprost	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LATANOPROST; EDEMA		Doncaster Royal Infirm, Dept Ophthalmol, Doncaster DN2 5LT, England		Desai, SP (corresponding author), Doncaster Royal Infirm, Dept Ophthalmol, Doncaster DN2 5LT, England.	desaisp@hotmail.com						*BRIT MED ASS ROYA, 2003, BRIT NAT FORM, V515; Faulkner WJ, 2003, ARCH OPHTHALMOL-CHIC, V121, P1054, DOI 10.1001/archopht.121.7.1054; Fechtner RD, 1998, AM J OPHTHALMOL, V126, P37, DOI 10.1016/S0002-9394(98)00071-3; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Warwar RE, 1998, OPHTHALMOLOGY, V105, P263, DOI 10.1016/S0161-6420(98)92977-3	5	11	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2004	329	7459					205	205		10.1136/bmj.329.7459.205	http://dx.doi.org/10.1136/bmj.329.7459.205			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840NW	15271831	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000222866900018
J	Horn, K				Horn, K			Physics - Charging atoms, one by one	SCIENCE			English	Editorial Material							SCANNING TUNNELING MICROSCOPE		Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany	Max Planck Society; Fritz Haber Institute of the Max Planck Society	Horn, K (corresponding author), Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany.	horn@fhi-berlin.mpg.de						Abbet S, 2001, PHYS REV LETT, V86, P5950, DOI 10.1103/PhysRevLett.86.5950; Bennewitz R, 2002, NANOTECHNOLOGY, V13, P499, DOI 10.1088/0957-4484/13/4/312; BINNIG G, 1982, APPL PHYS LETT, V40, P178, DOI 10.1063/1.92999; EIGLER DM, 1991, NATURE, V352, P600, DOI 10.1038/352600a0; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Feynman R.P., 1992, J MICROELECTROMECH S, V1, P60, DOI 10.1109/84.128057; Repp J, 2004, SCIENCE, V305, P493, DOI 10.1126/science.1099557	7	14	15	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					483	484		10.1126/science.1101350	http://dx.doi.org/10.1126/science.1101350			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273383				2022-12-28	WOS:000222828900027
J	Treasure, T				Treasure, T			Commentary: The learning curve	BRITISH MEDICAL JOURNAL			English	Editorial Material									Guys & St Thomas Hosp, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Treasure, T (corresponding author), Guys & St Thomas Hosp, London SE1 9RT, England.	tom.treasure@ukgateway.net						ANDERSON RG, 1996, FEDERAL RESERVE BANK, V0078; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Bridgewater B, 2004, BMJ-BRIT MED J, V329, P421, DOI 10.1136/bmj.38173.577697.55; Gawande A., 2002, NEW YORKER, V77, P52; Gogbashian A, 2004, EUR J CARDIO-THORAC, V25, P695, DOI 10.1016/j.ejcts.2004.02.022; JACKSON B, BRISTOL INQUIRY REPO; ONeill Onora., 2002, TELEGRAPH	7	14	14	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 21	2004	329	7463					424	424		10.1136/bmj.38176.444745.63	http://dx.doi.org/10.1136/bmj.38176.444745.63			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849EA	15298880	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000223520300014
J	Kuwana, M; Okazaki, Y; Yasuoka, H; Kawakami, Y; Ikeda, Y				Kuwana, M; Okazaki, Y; Yasuoka, H; Kawakami, Y; Ikeda, Y			Defective vasculogenesis in systemic sclerosis	LANCET			English	Article							ENDOTHELIAL PROGENITOR CELLS; GROWTH-FACTOR; HUMAN CYTOMEGALOVIRUS; RHEUMATOID-ARTHRITIS; ANGIOGENESIS; MOBILIZATION; SCLERODERMA; EXPRESSION; APOPTOSIS; ANTIBODY	Background Typical vascular features of systemic sclerosis include low capillary density and vascular obliteration. The formation and repair of blood vessels in adults involve vasculogenesis, which is mediated through the recruitment of bone-marrow-derived circulating endothelial precursors (CEP). We investigated whether vasculogenesis is impaired in patients with systemic sclerosis. Methods Peripheral blood was obtained from 11 patients with systemic sclerosis, 11 with rheumatoid arthritis, and 11 healthy controls. Factors potentially affecting the CEP number were matched among the three groups. CEP (identified as circulating cells positive for CD34, CD133, and the type 2 receptor for vascular endothelial growth factor) were quantified by cell sorting and three-colour flow cytometry. The circulating concentrations of angiogenic factors were measured by ELISA. The potential of CEP to differentiate into endothelial cells was assessed by the upregulation of von Willebrand factor after in-vitro maturation treatment. Findings The absolute number of CEP was much lower in patients with systemic sclerosis than in patients with rheumatoid arthritis or healthy controls (median 274 [IQR 178-395] vs 1154 [653-1524] and 1074 [713-1186] per 20 mL peripheral blood, respectively; p<0.0001 by Kruskal-Wallis test. Paradoxically, circulating concentrations of most angiogenic factors were significantly higher in patients with systemic sclerosis than in healthy controls. The proportion of CEP that differentiated into endothelial cells was significantly lower in patients with systemic sclerosis than in healthy controls (p<0.0001, Mann-Whitney test). Interpretation Insufficient vascular repair machinery due to defective vasculogenesis might contribute to vasculopathy in systemic sclerosis. Relevance to practice As well as providing an important insight into the pathogenesis of this disorder, these findings suggest that dysregulated vasculogenesis might be important in other disorders with abnormalities in vascular formation, including those with excessive formation of new vessels such as cancer and those with deficient vessel formation such as atherosclerosis. Circulating endothelial precursors could be a novel target for therapeutic strategies for ischaemic complications in patients with systemic sclerosis.	Keio Univ, Sch Med, Inst Adv Med Res, Shinjuku Ku, Tokyo 1608582, Japan; Keio Univ, Sch Med, Dept Internal Med, Tokyo 1608582, Japan	Keio University; Keio University	Kuwana, M (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kuwanam@sc.itc.keio.ac.jp	Kuwana, Masataka/L-2918-2013; Yasuoka, Hidekata/AAC-6277-2019; Kawakami, Yutaka/E-7429-2013; Yasuoka, Hidekata/L-3041-2013	Kawakami, Yutaka/0000-0003-4836-2855; 				[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bhattacharya V, 2000, BLOOD, V95, P581, DOI 10.1182/blood.V95.2.581; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; CHEN ZY, 1984, AM J MED, V77, P812, DOI 10.1016/0002-9343(84)90517-5; Clements PJ, 1996, SYSTEMIC SCLEROSIS, P389; Distler O, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar596; Freedman SB, 2002, ANN INTERN MED, V136, P54, DOI 10.7326/0003-4819-136-1-200201010-00011; Gehling UM, 2000, BLOOD, V95, P3106; Gill M, 2001, CIRC RES, V88, P167; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Kawaguchi Y, 1999, J RHEUMATOL, V26, P1012; LeRoy EC, 1996, RHEUM DIS CLIN N AM, V22, P675, DOI 10.1016/S0889-857X(05)70295-7; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; Mackiewicz Z, 2002, CLIN EXP RHEUMATOL, V20, P641; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Murayama T, 2002, EXP HEMATOL, V30, P967, DOI 10.1016/S0301-472X(02)00867-6; Pandey JP, 1998, ARTHRITIS RHEUM, V41, P10, DOI 10.1002/1529-0131(199801)41:1<10::AID-ART2>3.0.CO;2-P; Papadaki HA, 2002, BLOOD, V99, P1610, DOI 10.1182/blood.V99.5.1610; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Rajagopalan S, 2003, AM HEART J, V145, P1114, DOI 10.1016/S0002-8703(03)00102-9; Schachna L, 2002, CURR OPIN RHEUMATOL, V14, P686, DOI 10.1097/00002281-200211000-00010; Sgonc R, 2000, ARTHRITIS RHEUM-US, V43, P2550, DOI 10.1002/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Weber AJ, 2000, JOINT BONE SPINE, V67, P366	31	211	222	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2004	364	9434					603	610		10.1016/S0140-6736(04)16853-0	http://dx.doi.org/10.1016/S0140-6736(04)16853-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313361				2022-12-28	WOS:000223275100033
J	Vain, NE; Szyld, EG; Prudent, LM; Wiswell, TE; Aguilar, AM; Vivas, NI				Vain, NE; Szyld, EG; Prudent, LM; Wiswell, TE; Aguilar, AM; Vivas, NI		Meconium Study Network	Oropharyngeal and nasopharyngeal suctioning of meconium-stained neonates before delivery of their shoulders: multicentre, randomnised controlled trial	LANCET			English	Article							ASPIRATION SYNDROME; AMNIOTIC-FLUID; AIRWAY MANAGEMENT; NULL HYPOTHESIS; APPROPRIATE	Background Meconium aspiration syndrome (MAS) is a life-threatening respiratory disorder in infants born through meconium-stained amniotic fluid (MSAF). Although anecdotal data concerning the efficacy of intrapartum oropharyngeal and nasopharyngeal suctioning of MSAF are conflicting, the procedure is widely used. We aimed to assess the effectiveness of intrapartum suctioning for the prevention of MAS. Methods We designed a randomised controlled trial in 11 hospitals in Argentina and one in the USA. 2514 patients with MSAF of any consistency, gestational age at least 37 weeks, and cephalic presentation were randomly assigned to suctioning of the oropharynx and nasopharynx (including the hypopharynx) before delivery of the shoulders (n=1263), or no suctioning before delivery (n=1251). Postnatal delivery-room management followed Neonatal Resuscitation Program guidelines. The primary outcome was incidence of MAS. Clinicians diagnosing the syndrome and designating other study outcomes were masked to group assignment. An informed consent waiver was used. Analysis was by intention to treat. Findings 18 infants in the suction group and 15 in the no suction group did not meet entry criteria after random assignment. 87 in the suction group were not suctioned, and 26 in the no suction group were suctioned. No significant difference between treatment groups was seen in the incidence of MAS (52 [4%] suction vs 47 [4%] no suction; relative risk 0.9, 95% CI 0.6-1.3), need for mechanical ventilation for MAS (24 [2%] vs 18 [1%]; 0.8, 0.4-1.4), mortality (9 [1%] vs 4 [0.3%]; 0.4, 0.1-1.5), or in the duration of ventilation, oxygen treatment, and hospital care. Interpretation Routine intrapartum oropharyngeal and nasopharyngeal suctioning of term-gestation infants born through MSAF does not prevent MAS. Consideration should be given to revision of present recommendations.	Sanat Trinidad Hosp, Buenos Aires, DF, Argentina; Diego Paroissien Hosp, Buenos Aires, DF, Argentina; Otamendi Hosp, Buenos Aires, DF, Argentina; Suizo Argentina Hosp, Buenos Aires, DF, Argentina; SUNY Stony Brook, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Vain, NE (corresponding author), Chenaut 1831, RA-1426 Buenos Aires, DF, Argentina.	vain@fibertel.com.ar						American Academy of Pediatrics and the American College of Obstetricians and Gynecologists, 1997, GUID PER CAR, P117; BLACKWELDER WC, 1984, CONTROL CLIN TRIALS, V5, P97, DOI 10.1016/0197-2456(84)90116-8; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; BROWN BL, 1981, OBSTET GYNECOL, V57, P26; CARSON BS, 1976, AM J OBSTET GYNECOL, V126, P712, DOI 10.1016/0002-9378(76)90525-1; Cleary GM, 1998, PEDIATR CLIN N AM, V45, P511, DOI 10.1016/S0031-3955(05)70025-0; DAVIS RO, 1985, AM J OBSTET GYNECOL, V151, P731, DOI 10.1016/0002-9378(85)90506-X; FALCIGLIA HS, 1992, AM J OBSTET GYNECOL, V167, P1243, DOI 10.1016/S0002-9378(11)91695-0; FALCIGLIA HS, 1988, OBSTET GYNECOL, V71, P349; Ghidini A, 2001, AM J OBSTET GYNECOL, V185, P931, DOI 10.1067/mob.2001.116828; GREENOUGH A, 1995, EARLY HUM DEV, V41, P183, DOI 10.1016/0378-3782(95)01625-D; HALLIDAY HL, 2003, COCHRANE LIB; HOULIHAN CM, 1994, J REPROD MED, V39, P888; JOVANOVIC R, 1989, OBSTET GYNECOL, V73, P652; Kattwinkel J, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e56; KATTWINKEL J, 2000, NEONATAL RESUSCITATI; KATZ VL, 1992, AM J OBSTET GYNECOL, V166, P171, DOI 10.1016/0002-9378(92)91856-6; MANNING FA, 1978, AM J OBSTET GYNECOL, V132, P111, DOI 10.1016/0002-9378(78)90810-4; RICHMOND S, 2001, RESUSCITATION BIRTH, P36; Thureen PJ, 1997, AM J OBSTET GYNECOL, V176, P967, DOI 10.1016/S0002-9378(97)70387-9; US Department of Health and Human Services, GEN REQ INF CONS; VALENCIA P, 1993, CLIN RES, V41, pA736; Wiswell TE, 2000, PEDIATRICS, V105, P1, DOI 10.1542/peds.105.1.1; WISWELL TE, 1990, PEDIATRICS, V85, P715; WISWELL TE, 1993, PEDIATR CLIN N AM, V40, P955; YODER BA, 1994, OBSTET GYNECOL, V83, P77; Yoder BA, 2002, OBSTET GYNECOL, V99, P731, DOI 10.1016/S0029-7844(02)01942-7	27	193	201	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					597	602		10.1016/S0140-6736(04)16852-9	http://dx.doi.org/10.1016/S0140-6736(04)16852-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313360				2022-12-28	WOS:000223275100032
J	Anderson, JD; Schubert, G; Jacobson, RA; Lau, EL; Moore, WB; Palguta, JL				Anderson, JD; Schubert, G; Jacobson, RA; Lau, EL; Moore, WB; Palguta, JL			Discovery of mass anomalies on Ganymede	SCIENCE			English	Article								We present the discovery of mass anomalies on Ganymede, Jupiter's third and largest Galilean satellite. This discovery is surprising for such a large icy satellite. We used the radio Doppler data generated with the Galileo spacecraft during its second encounter with Ganymede on 6 September 1996 to model the mass anomalies. Two surface mass anomalies, one a positive mass at high latitude and the other a negative mass at low latitude, can explain the data. There are no obvious geological features that can be identified with the anomalies.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles	Anderson, JD (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	john.d.anderson@jpl.nasa.gov						Anderson J. D., 2001, B AM ASTRON SOC, V33, P1101; Kaula W.M., 1966, THEORY SATELLITE GEO; MOHR BJ, 2002, PHYS TODAY, V55, DOI UNSP BG6; MULLER PM, 1968, SCIENCE, V161, P680, DOI 10.1126/science.161.3842.680; SCHUBERT G, 2004, JUPITER PLANET SATEL, pCH13; THOLEN DJ, 2000, ALLENS ASTROPHYSICAL, P302	6	16	16	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					989	991		10.1126/science.1099050	http://dx.doi.org/10.1126/science.1099050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310898				2022-12-28	WOS:000223250700043
J	Zhang, YL; Blattman, JN; Kennedy, NJ; Duong, J; Nguyen, T; Wang, Y; Davis, RJ; Greenberg, PD; Flavell, RA; Dong, C				Zhang, YL; Blattman, JN; Kennedy, NJ; Duong, J; Nguyen, T; Wang, Y; Davis, RJ; Greenberg, PD; Flavell, RA; Dong, C			Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5	NATURE			English	Article							RECOGNITION; FAMILY; JNK	Mitogen-activated protein ( MAP) kinases are essential regulators in immune responses(1), and their activities are modulated by kinases and phosphatases. MAP kinase phosphatase (MKP) is a family of dual-specificity phosphatases whose function is evolutionarily conserved(2,3). A number of mammalian MKPs have been identified so far(2,3), but their specific physiological functions in negative regulation of MAP kinases have not been genetically defined. Here we examine innate and adaptive immune responses in the absence of MKP5. JNK activity was selectively increased in Mkp5 ( also known as Dusp10)-deficient mouse cells. Mkp5-deficient cells produced greatly enhanced levels of pro-inflammatory cytokines during innate immune responses and exhibited greater T-cell activation than their wild-type counterparts. However, Mkp5-deficient T cells proliferated poorly upon activation, which resulted in increased resistance to experimental autoimmune encephalomyelitis. By contrast, Mkp5-deficient CD4(+) and CD8(+) effector T cells produced significantly increased levels of cytokines compared with wild-type cells, which led to much more robust and rapidly fatal immune responses to secondary infection with lymphocytic choriomeningitis virus. Therefore, MKP5 has a principal function in both innate and adaptive immune responses, and represents a novel target for therapeutic intervention of immune diseases.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Massachusetts, Howard Hughes Med Inst, Worcester, MA 01605 USA; Yale Univ, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	richard.flavell@yale.edu; cdong@mdanderson.org	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Rincon Mercedes, 1997, Genes and Function, V1, P51; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; Theodosiou A, 2002, GENOME BIOL, V3	13	186	192	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					793	797		10.1038/nature02764	http://dx.doi.org/10.1038/nature02764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306813				2022-12-28	WOS:000223233600045
J	Burke, GW; Ciancio, G				Burke, GW; Ciancio, G			Show me the money - immunosuppression in kidney transplantation	LANCET			English	Editorial Material							LONG-TERM TRIAL; MYCOPHENOLATE-MOFETIL; RENAL-TRANSPLANTATION; RANDOMIZED-TRIAL; CYCLOSPORINE; TACROLIMUS; SURVIVAL; WITHDRAWAL; AZATHIOPRINE; REJECTION		Univ Miami, Sch Med, Dept Surg, Div Transplantat, Miami, FL 33136 USA	University of Miami	Burke, GW (corresponding author), Univ Miami, Sch Med, Dept Surg, Div Transplantat, Miami, FL 33136 USA.	gburke@med.miami.edu						Ahsan N, 1999, TRANSPLANTATION, V68, P1865; Cianci G, 2004, TRANSPLANTATION, V77, P252, DOI 10.1097/01.TP.0000101495.22734.07; Ciancio G, 2004, TRANSPLANTATION, V77, P244, DOI 10.1097/01.TP.0000101290.20629.DC; Ciancio G, 2002, TRANSPLANTATION, V73, P1100, DOI 10.1097/00007890-200204150-00015; Flechner SM, 2002, TRANSPLANTATION, V74, P1070, DOI 10.1097/00007890-200210270-00002; Gonwa T, 2003, TRANSPLANTATION, V75, P2048, DOI 10.1097/01.TP.0000069831.76067.22; Halloran P, 1997, TRANSPLANTATION, V63, P618; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Kasiske BL, 2000, J AM SOC NEPHROL, V11, P1910, DOI 10.1681/ASN.V11101910; Khwaja K, 2004, AM J TRANSPLANT, V4, P980, DOI 10.1111/j.1600-6143.2004.00443.x; KILBERD BA, 2004, AM J TRANSPLANT, V4, P1079; Lachenbruch PA, 2004, AM J TRANSPLANT, V4, P451, DOI 10.1111/j.1600-6143.2004.00386.x; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Meier-Kriesche HU, 2003, TRANSPLANTATION, V75, P1341, DOI 10.1097/01.TP.0000062833.14843.4B; Meier-Kriesche HU, 2003, TRANSPLANTATION, V75, P1291, DOI 10.1097/01.TP.0000061602.03327.E2; Meier-Kriesche HU, 2003, AM J TRANSPLANT, V3, P68, DOI 10.1034/j.1600-6143.2003.30112.x; Ojo AO, 2000, KIDNEY INT, V57, P307, DOI 10.1046/j.1523-1755.2000.00816.x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Suwelack B, 2004, AM J TRANSPLANT, V4, P655, DOI 10.1111/j.1600-6143.2004.00404.x; ter Meulen CG, 2004, AM J TRANSPLANT, V4, P803, DOI 10.1111/j.1600-6143.2004.00419.x; Terasaki PI, 2004, AM J TRANSPLANT, V4, P438, DOI 10.1111/j.1600-6143.2004.00360.x; Weimer R, 2003, TRANSPLANTATION, V75, P2090, DOI 10.1097/01.TP.0000058808.37349.23	22	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					481	483		10.1016/S0140-6736(04)16822-0	http://dx.doi.org/10.1016/S0140-6736(04)16822-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302174				2022-12-28	WOS:000223132700005
J	Burns, JC; Glode, MP				Burns, JC; Glode, MP			Kawasaki syndrome	LANCET			English	Review							INTRAVENOUS GAMMA-GLOBULIN; CORONARY-ARTERY LESIONS; TUMOR-NECROSIS-FACTOR; LYMPH-NODE SYNDROME; ENDOTHELIAL GROWTH-FACTOR; LONG-TERM CONSEQUENCES; PERIPHERAL-BLOOD MONOCYTES; RISK-FACTORS; YOUNG-ADULTS; SERUM-LEVELS	Kawasaki syndrome is an acute, self-limited vasculitis that occurs in children of all ages and presents a challenge for the clinician: the disorder can be difficult to recognise; there is no diagnostic laboratory test; there is an extremely effective therapy; and there is a 25% chance of serious cardiovascular damage if the treatment is not given early in the course of the disease. This review includes discussion of the history of the syndrome, the diagnostic challenges, epidemiology, aetiology, pathology, immunopathogenesis, therapy, genetic influences, and the long-term cardiovascular sequelae.	Univ Calif San Diego, Sch Med, Dept Pediat, Div Allergy Immunol & Rheumatol, La Jolla, CA 92093 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Childrens Hosp, Dept Pediat, Denver, CO 80218 USA	University of California System; University of California San Diego; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado	Burns, JC (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, Div Allergy Immunol & Rheumatol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jcburns@ucsd.edu	Burns, Jane C/J-6167-2015; Ogden, Graham/U-6774-2019	Ogden, Graham/0000-0003-3394-4537	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069413] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL69413] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akagi T, 2000, J PEDIATR-US, V137, P181, DOI 10.1067/mpd.2000.107164; AKAGI T, 1990, AM HEART J, V120, P366, DOI 10.1016/0002-8703(90)90081-8; Albisetti M, 2003, BLOOD COAGUL FIBRIN, V14, P181, DOI 10.1097/00001721-200302000-00010; *AM AC PED, 2003, RED BOOK 2003 REP CO, P392; APRIL MM, 1989, ARCH OTOLARYNGOL, V115, P512; Ariga S, 2001, PATHOL INT, V51, P257, DOI 10.1046/j.1440-1827.2001.01202.x; Asai T, 1983, Nihon Rinsho, V41, P2080; Asano T, 2000, CLIN EXP IMMUNOL, V122, P514, DOI 10.1046/j.1365-2249.2000.01395.x; Barone SR, 2000, ARCH PEDIAT ADOL MED, V154, P453, DOI 10.1001/archpedi.154.5.453; BASTIAN JF, 2002, PEDIATR RES, V53, pA34; Beiser AS, 1998, AM J CARDIOL, V81, P1116, DOI 10.1016/S0002-9149(98)00116-7; Biezeveld MH, 2003, LANCET, V361, P1268, DOI 10.1016/S0140-6736(03)12985-6; Brogan PA, 2002, ARCH DIS CHILD, V86, P286, DOI 10.1136/adc.86.4.286; Bruckheimer E, 1998, CIRCULATION, V97, P410; BURNS JC, 1991, J PEDIATR-US, V118, P680, DOI 10.1016/S0022-3476(05)80026-5; Burns JC, 1996, J AM COLL CARDIOL, V28, P253, DOI 10.1016/0735-1097(96)00099-X; Burns JC, 2002, PEDIATR INFECT DIS J, V21, P993, DOI 10.1097/00006454-200211000-00002; Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009; Burns JC, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.2.e27; BURNS JC, 1986, J PEDIATR-US, V109, P759, DOI 10.1016/S0022-3476(86)80689-8; BURNS JC, 2003, PEDIATR RES, V53, pA1857; CAPANNARI TE, 1986, J AM COLL CARDIOL, V7, P355, DOI 10.1016/S0735-1097(86)80505-8; Checchia PA, 2001, PEDIATR CARDIOL, V22, P102, DOI 10.1007/s002460010170; Checchia PA, 1997, PEDIATRICS, V100, P695, DOI 10.1542/peds.100.4.695; DADLANI GH, 2003, PEDIATR RES, V53, pA161; DANIELS SR, 1991, J PEDIATR-US, V118, P485, DOI 10.1016/S0022-3476(05)82173-0; DAVIS RL, 1995, ARCH PEDIAT ADOL MED, V149, P66, DOI 10.1001/archpedi.1995.02170130068016; Dengler LD, 1998, PEDIATR INFECT DIS J, V17, P478, DOI 10.1097/00006454-199806000-00008; DESOUZA VR, 1995, EUR J IMMUNOL, V25, P1267, DOI 10.1002/eji.1830250521; Dhillon R, 1996, CIRCULATION, V94, P2103, DOI 10.1161/01.CIR.94.9.2103; DURONGPISITKUL K, 1995, PEDIATRICS, V96, P1057; EBERHARD BA, 1995, PEDIATR INFECT DIS J, V14, P199, DOI 10.1097/00006454-199503000-00006; FINBERG RW, 1992, J PEDIATR-US, V120, P376, DOI 10.1016/S0022-3476(05)80900-X; Freeman AF, 2003, PEDIATR PULM, V36, P102, DOI 10.1002/ppul.10333; FUJIWARA H, 1978, PEDIATRICS, V61, P100; FUKAZAWA M, 1993, PEDIATR CARDIOL, V14, P67, DOI 10.1007/BF00796982; Fukuda T, 1998, AM HEART J, V135, P482, DOI 10.1016/S0002-8703(98)70325-4; FUKUSHIGE J, 1994, ACTA PAEDIATR, V83, P1057, DOI 10.1111/j.1651-2227.1994.tb12985.x; FURUKAWA S, 1988, CLIN IMMUNOL IMMUNOP, V48, P247, DOI 10.1016/0090-1229(88)90088-8; FURUSHO K, 1984, LANCET, V2, P1055; GAVIN PJ, 2003, SYSTEMIC ARTERIAL EX, V23, P576; Greil GF, 2002, CIRCULATION, V105, P908, DOI 10.1161/hc0802.105563; Harada Kensuke, 1991, Acta Paediatrica Japonica, V33, P805; Harnden A, 2002, BRIT MED J, V324, P1424, DOI 10.1136/bmj.324.7351.1424; Hiraishi S, 2002, J AM COLL CARDIOL, V40, P1816, DOI 10.1016/S0735-1097(02)02479-8; Hiraishi S, 2000, HEART, V83, P400, DOI 10.1136/heart.83.4.400; Hirata S, 2002, ARCH PEDIAT ADOL MED, V156, P77, DOI 10.1001/archpedi.156.1.77; Hirata S, 2001, ACTA PAEDIATR, V90, P40, DOI 10.1080/080352501750064851; Holman RC, 2003, PEDIATRICS, V112, P495, DOI 10.1542/peds.112.3.495; Honkanen VEA, 2003, PEDIATR CARDIOL, V24, P122, DOI 10.1007/s00246-002-0063-1; Huang FY, 2000, EXP CLIN IMMUNOGENET, V17, P130, DOI 10.1159/000019132; Iemura M, 2000, HEART, V83, P307, DOI 10.1136/heart.83.3.307; Ishii M, 2001, PEDIATR INT, V43, P558, DOI 10.1046/j.1442-200X.2001.01464.x; JEANETTE JC, 2003, CLEVELAND CHIN J MED, V69; JEANETTE JC, 2002, PEDIATR RES, V53, pA94; Jibiki T, 2001, ARTHRITIS RHEUM, V44, P2211, DOI 10.1002/1529-0131(200109)44:9<2211::AID-ART375>3.0.CO;2-A; JOFFE A, 1995, WESTERN J MED, V162, P322; Kamizono S, 1999, PEDIATR INT, V41, P341, DOI 10.1046/j.1442-200x.1999.01085.x; Kaneko K, 1999, ACTA PAEDIATR, V88, P791, DOI 10.1080/08035259950169152; Katayama K, 2000, CLIN EXP IMMUNOL, V121, P566, DOI 10.1046/j.1365-2249.2000.01321.x; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; KATO H, 1992, LANCET, V340, P1127, DOI 10.1016/0140-6736(92)93152-D; KAWASAKI T, 1974, PEDIATRICS, V54, P271; KAWASAKI T, 1967, JAP J ALLERG, V16, P178, DOI DOI 10.4070/KCJ.2018.0214; Kitamura S, 2002, CORONARY ARTERY DIS, V13, P437, DOI 10.1097/00019501-200212000-00009; Koga M, 1998, PATHOL INT, V48, P512, DOI 10.1111/j.1440-1827.1998.tb03942.x; KOREN G, 1986, J PEDIATR-US, V108, P388, DOI 10.1016/S0022-3476(86)80878-2; Kosaki F, 1971, SHONIKA RINSHO, V24, P2545; Kuijpers TW, 2003, PEDIATRICS, V112, P986, DOI 10.1542/peds.112.4.986; Kuramochi Y, 2000, PEDIATR INT, V42, P470, DOI 10.1046/j.1442-200x.2000.01270.x; Kushner HI, 2003, PERSPECT BIOL MED, V46, P216, DOI 10.1353/pbm.2003.0024; LANDING BH, 1977, PEDIATRICS, V59, P651; LAWRENCE SM, 2003, PEDIATR RES, V53, pA1929; Leung DYM, 2002, J PEDIATR-US, V140, P742, DOI 10.1067/mpd.2002.123664; Maeno N, 1998, PEDIATR RES, V44, P596, DOI 10.1203/00006450-199810000-00021; MARASINI M, 1991, AM J CARDIOL, V68, P796, DOI 10.1016/0002-9149(91)90658-8; MATSUBARA T, 1990, CLIN IMMUNOL IMMUNOP, V56, P29, DOI 10.1016/0090-1229(90)90166-N; MAURY CPJ, 1988, NEW ENGL J MED, V319, P1670; Meissner HC, 2000, PEDIATR INFECT DIS J, V19, P91, DOI 10.1097/00006454-200002000-00001; MELISH M, 1992, Pediatric Research, V31, p170A; MELISH ME, 1974, PEDIATR RES, V8, P427, DOI 10.1203/00006450-197404000-00521; MELISH ME, 1976, AM J DIS CHILD, V130, P599, DOI 10.1001/archpedi.1976.02120070025006; Mitani Y, 1997, CIRCULATION, V96, P454; Momenah T, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e7; Mori M, 2000, J PEDIATR-US, V137, P177, DOI 10.1067/mpd.2000.107890; Mori M, 1995, Nihon Rinsho Meneki Gakkai Kaishi, V18, P282; Mori M, 2001, J PEDIATR-US, V139, P754, DOI 10.1067/mpd.2001.118426; MORIKAWA Y, 2000, PEDIATR INT, V43, P363; Morikawa Yoshiyuki, 1994, Acta Paediatrica Japonica, V36, P347; Muzik O, 1996, J AM COLL CARDIOL, V28, P757, DOI 10.1016/0735-1097(96)00199-4; Nakamura Y, 1998, ACTA PAEDIATR JAPON, V40, P419; Newburger Jane W, 2003, Pediatr Res, V53, P153, DOI 10.1203/00006450-200301000-00026; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; Newburger JW, 2000, J PEDIATR-US, V137, P149, DOI 10.1067/mpd.2000.109025; NEWBURGER JW, 1989, CIRCULATION, V79, P1237, DOI 10.1161/01.CIR.79.6.1237; Nishimura S, 2003, J PEDIATR-US, V143, P357, DOI 10.1067/S0022-3476(03)00330-5; Noto N, 2001, PEDIATRICS, V107, P1095, DOI 10.1542/peds.107.5.1095; O'Brien M, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.5.e64; Ouchi K, 2003, J INFECT DIS, V187, P326, DOI 10.1086/345878; PARIDON SM, 1995, J AM COLL CARDIOL, V25, P1420, DOI 10.1016/0735-1097(95)00003-M; PATRIARCA PA, 1982, LANCET, V2, P578; Quasney MW, 2001, PEDIATR RES, V49, P686, DOI 10.1203/00006450-200105000-00013; RAUCH AM, 1988, AM J DIS CHILD, V142, P441, DOI 10.1001/archpedi.1988.02150040095027; Ravekes WJ, 2001, AM J CARDIOL, V87, P919, DOI 10.1016/S0002-9149(00)01541-1; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; ROSENFELD EA, 1995, J PEDIATR-US, V126, P524, DOI 10.1016/S0022-3476(95)70344-6; Rowley AH, 2000, J INFECT DIS, V182, P1183, DOI 10.1086/315832; ROWLEY AH, 1994, PEDIATR RES, V36, P567, DOI 10.1203/00006450-199411000-00003; Rowley AH, 1997, J IMMUNOL, V159, P5946; Rowley AH, 2001, J IMMUNOL, V166, P1334, DOI 10.4049/jimmunol.166.2.1334; ROWLEY AH, 1987, J PEDIATR-US, V110, P409, DOI 10.1016/S0022-3476(87)80503-6; ROWLEY AH, 2003, PEDIATR RES, V53, pA1757; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Segawa M, 1995, INT CONGR SER, V1093, P101; Senzaki H, 2001, CIRCULATION, V104, P860, DOI 10.1161/hc3301.095286; Shibuya N, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e17; SHULMAN ST, 1993, J PEDIATR-US, V122, P84, DOI 10.1016/S0022-3476(05)83493-6; Silva AAEE, 2001, J PEDIATR-US, V138, P400, DOI 10.1067/mpd.2001.111430; SMITH LBH, 1989, PEDIATR INFECT DIS J, V8, P116; Sohn MH, 2001, GENES IMMUN, V2, P357, DOI 10.1038/sj.gene.6363785; Stapp J, 2000, SOUTHERN MED J, V93, P44; Stockheim JA, 2000, J PEDIATR-US, V137, P250, DOI 10.1067/mpd.2000.105150; SUGAWARA T, 1987, KAWASAKI DIS, P185; Sundel RP, 2003, J PEDIATR-US, V142, P611, DOI 10.1067/mpd.2003.191; SUZUKI A, 1986, PEDIATR CARDIOL, V7, P3, DOI 10.1007/BF02315475; Suzuki A, 1996, J AM COLL CARDIOL, V27, P291, DOI 10.1016/0735-1097(95)00447-5; Takahashi K, 2001, PEDIATR CARDIOL, V22, P138, DOI 10.1007/s002460010180; TAKAHASHI M, 1989, CIRCULATION, V79, P1398, DOI 10.1161/01.CIR.79.6.1398; Takeuchi K, 1997, EUR J PEDIATR, V156, P266, DOI 10.1007/s004310050597; Tashiro N, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e77; Terai M, 1999, AM J CARDIOL, V83, P337, DOI 10.1016/S0002-9149(98)00864-9; Terai M, 1997, J PEDIATR-US, V131, P888, DOI 10.1016/S0022-3476(97)70038-6; Terai M, 2002, PEDIATR INFECT DIS J, V21, P777, DOI 10.1097/00006454-200208000-00015; Ting EC, 1998, PEDIATR INFECT DIS J, V17, P431, DOI 10.1097/00006454-199805000-00020; Treadwell TA, 2002, PEDIATR INFECT DIS J, V21, P976, DOI 10.1097/00006454-200210000-00018; Tse SML, 2002, J PEDIATR-US, V140, P450, DOI 10.1067/mpd.2002.122469; Tsukahara H, 2000, PEDIATR INT, V42, P236, DOI 10.1046/j.1442-200x.2000.01229.x; Uehara R, 2003, ACTA PAEDIATR, V92, P694, DOI 10.1080/08035320310002768; UENO Y, 1989, CLIN EXP IMMUNOL, V76, P337; Wallace CA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e78; Williams RV, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e4; Witt MT, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e10; WITT S, 2003, J AM COLL CARDIOL, V41, P1070; Wright DA, 1996, J PEDIATR-US, V128, P146, DOI 10.1016/S0022-3476(96)70447-X; Xu C, 1998, AM J PATHOL, V153, P1257, DOI 10.1016/S0002-9440(10)65670-2; Yasukawa K, 2002, CIRCULATION, V105, P766, DOI 10.1161/hc0602.103396; YOSHIKAWA J, 1979, CIRCULATION, V59, P133, DOI 10.1161/01.CIR.59.1.133; YUTANI C, 1981, ARCH PATHOL LAB MED, V105, P470; Zhang T, 2002, ACTA PAEDIATR, V91, P517, DOI 10.1080/080352502753711623; Zilberman MV, 2003, PEDIATR CARDIOL, V24, P338, DOI 10.1007/s00246-002-0327-9	151	639	690	1	52	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					533	544		10.1016/S0140-6736(04)16814-1	http://dx.doi.org/10.1016/S0140-6736(04)16814-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302199				2022-12-28	WOS:000223132700035
J	Haj, M; Dasani, H; Kundu, S; Mohite, U; Collins, PW				Haj, M; Dasani, H; Kundu, S; Mohite, U; Collins, PW			Acquired haemophilia A may be associated with clopidogrel	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Wales Hosp, Dept Haematol, Cardiff CF14 4XN, S Glam, Wales	Cardiff University	Collins, PW (corresponding author), Univ Wales Hosp, Dept Haematol, Cardiff CF14 4XN, S Glam, Wales.	peter.collins@cardiffandvale.wales.nhs.uk						Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Elmi F, 2000, J INVASIVE CARDIOL, V12, P532; GREEN D, 1981, THROMB HAEMOSTASIS, V45, P200; Hay CRM, 1998, BAILLIERE CLIN HAEM, V11, P287, DOI 10.1016/S0950-3536(98)80049-8; MORRISON AE, 1995, BRIT J HAEMATOL, V89, P231, DOI 10.1111/j.1365-2141.1995.tb03294.x	5	16	24	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2004	329	7461					323	323		10.1136/bmj.329.7461.323	http://dx.doi.org/10.1136/bmj.329.7461.323			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846FF	15297338	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000223300300017
J	Jagsi, R; Lehmann, S				Jagsi, R; Lehmann, S			The ethics of medical education	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LEGAL IMPLICATIONS; INFORMED CONSENT; STUDENT DOCTOR; CARE; RESIDENTS; ATTITUDES; PATIENT		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lehmann, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA.	llehmann1@partners.org		Jagsi, Reshma/0000-0001-6562-1228				ANNAS GJ, 1980, B NEW YORK ACAD MED, V56, P403; BASSON MD, 1982, HASTINGS CENT REP, V12, P27; BEATTY ME, 1995, ACAD MED, V70, P175, DOI 10.1097/00001888-199503000-00002; Brody BA, 1998, ETHICS BIOMEDICAL RE; Butters JM, 1996, ACAD MED, V71, P583, DOI 10.1097/00001888-199606000-00008; COHEN DL, 1987, J MED EDUC, V62, P789; COHEN DL, 1988, J MED EDUC, V63, P821; Coldicott Y, 2003, BRIT MED J, V326, P97, DOI 10.1136/bmj.326.7380.97; Diekema DS, 1996, AM J EMERG MED, V14, P6, DOI 10.1016/S0735-6757(96)90002-9; Doyal L, 2001, BRIT MED J, V322, P685, DOI 10.1136/bmj.322.7288.685; Frank SH, 1997, JAMA-J AM MED ASSOC, V278, P712, DOI 10.1001/jama.278.9.712; Hicks LK, 2001, BRIT MED J, V322, P709, DOI 10.1136/bmj.322.7288.709; KAPP MB, 1983, J MED EDUC, V58, P293; KING D, 1992, MED EDUC, V26, P360, DOI 10.1111/j.1365-2923.1992.tb00186.x; Magrane D, 1996, OBSTET GYNECOL, V88, P298, DOI 10.1016/0029-7844(96)00191-3; Marracino RK, 1998, J GEN INTERN MED, V13, P266, DOI 10.1046/j.1525-1497.1998.00078.x; RICH EC, 1990, JAMA-J AM MED ASSOC, V263, P953; Vinicky J K, 1991, J Clin Ethics, V2, P35; WILLIG C, 1992, J COMMUNITY APPL SOC, V2, P217, DOI 10.1002/casp.2450020306	19	29	31	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2004	329	7461					332	334		10.1136/bmj.329.7461.332	http://dx.doi.org/10.1136/bmj.329.7461.332			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	846FF	15297341	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000223300300024
J	Bach, PB; Pham, HH; Schrag, D; Tate, RC; Hargraves, JL				Bach, PB; Pham, HH; Schrag, D; Tate, RC; Hargraves, JL			Primary care physicians who treat blacks and whites	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE; RACIAL-DIFFERENCES; RACE; MEDICARE; DISPARITIES; QUALITY; SATISFACTION; MORTALITY; OUTCOMES; CERTIFICATION	BACKGROUND: In the United States, black patients generally receive lower-quality health care than white patients. Black patients may receive their care from a subgroup of physicians whose qualifications or resources are inferior to those of the physicians who treat white patients. METHODS: We performed a cross-sectional analysis of 150,391 visits by black Medicare beneficiaries and white Medicare beneficiaries 65 years of age or older for medical ``evaluation and management'' who were seen by 4355 primary care physicians who participated in a biannual telephone survey, the 2000-2001 Community Tracking Study Physician Survey. RESULTS: Most visits by black patients were with a small group of physicians (80 percent of visits were accounted for by 22 percent of physicians) who provided only a small percentage of care to white patients. In a comparison of visits by white patients and black patients, we found that the physicians whom the black patients visited were less likely to be board certified (77.4 percent) than were the physicians visited by the white patients (86.1 percent, P=0.02) and also more likely to report that they were unable to provide high-quality care to all their patients (27.8 percent vs. 19.3 percent, P=0.005). The physicians treating black patients also reported facing greater difficulties in obtaining access for their patients to high-quality subspecialists, high-quality diagnostic imaging, and nonemergency admission to the hospital. CONCLUSIONS: Black patients and white patients are to a large extent treated by different physicians. The physicians treating black patients may be less well trained clinically and may have less access to important clinical resources than physicians treating white patients. Further research should be conducted to address the extent to which these differences may be responsible for disparities in health care.	Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, New York, NY 10021 USA; Ctr Studying Hlth Syst Change, Washington, DC USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, 1275 York Ave,Box 221, New York, NY 10021 USA.			Schrag, Deborah/0000-0002-4334-5717	NATIONAL CANCER INSTITUTE [R01CA090226, K23CA086968] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA090226, K23CA86968] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aaron KF, 2003, JAMA-J AM MED ASSOC, V289, P1033, DOI 10.1001/jama.289.8.1033; *AM MED ASS, 1999, PHYS CURR PROC TERM; Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Ashford A, 2000, AM J PREV MED, V19, P59, DOI 10.1016/S0749-3797(00)00152-5; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Bach PB, 2002, MED CARE, V40, P19; Baldwin LM, 2002, MED CARE, V40, P82; Best A E, 1999, J Med Syst, V23, P175, DOI 10.1023/A:1020515419714; BLUMENTHAL D, 1995, HEALTH SERV RES, V30, P253; Blustein J, 1998, J HEALTH CARE POOR U, V9, P153; Canto JG, 2000, NEW ENGL J MED, V342, P1094, DOI 10.1056/NEJM200004133421505; Chandra A, 2003, W9513 NBER; Cohen JJ, 2002, HEALTH AFFAIR, V21, P90, DOI 10.1377/hlthaff.21.5.90; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; *CTR MED MED SERV, 2002, 2002 DAT COMP; Department of Health Human Services Washington DC. Healthy People 2010 (Group) and United States Government Printing Office., 2000, HLTH PEOPL 2010; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Gemson D H, 1988, J Community Health, V13, P53, DOI 10.1007/BF01321480; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; HESLIN K, 2003, AC HLTH 20 ANN RES M; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Kemper P, 1996, INQUIRY-J HEALTH CAR, V33, P195; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; Komaromy M, 1996, NEW ENGL J MED, V334, P1305, DOI 10.1056/NEJM199605163342006; Landon BE, 2001, MED CARE, V39, P889, DOI 10.1097/00005650-200108000-00014; Landon BE, 2003, JAMA-J AM MED ASSOC, V289, P442, DOI 10.1001/jama.289.4.442; Lauderdale DS, 1996, AM J PUBLIC HEALTH, V86, P712, DOI 10.2105/AJPH.86.5.712; LaVeist TA, 2002, J NATL MED ASSOC, V94, P937; Laveist TA, 2002, J HEALTH SOC BEHAV, V43, P296, DOI 10.2307/3090205; Lurie N, 2002, NEW ENGL J MED, V347, P1709, DOI 10.1056/NEJMe020126; Meyers DG, 1997, AM J PREV MED, V13, P45, DOI 10.1016/S0749-3797(18)30224-1; MOY E, 1995, JAMA-J AM MED ASSOC, V273, P1515, DOI 10.1001/jama.273.19.1515; Mukamel DB, 2000, AM J PUBLIC HEALTH, V90, P1774, DOI 10.2105/AJPH.90.11.1774; Norcini JJ, 2002, MED EDUC, V36, P853, DOI 10.1046/j.1365-2923.2002.01293.x; RAMSEY PG, 1989, ANN INTERN MED, V110, P719, DOI 10.7326/0003-4819-110-9-719; Saha S, 2000, HEALTH AFFAIR, V19, P76, DOI 10.1377/hlthaff.19.4.76; Saha S, 1999, ARCH INTERN MED, V159, P997, DOI 10.1001/archinte.159.9.997; Schneider EC, 2002, JAMA-J AM MED ASSOC, V287, P1288, DOI 10.1001/jama.287.10.1288; Shah BV, 1996, SUDAAN USERS MANUAL; Sharp LK, 2002, ACAD MED, V77, P534, DOI 10.1097/00001888-200206000-00011; Shi L, 2002, HEALTH SERV RES, V37, P529, DOI 10.1111/1475-6773.t01-1-00036; Shi LY, 2003, STROKE, V34, P1958, DOI 10.1161/01.STR.0000082380.80444.A9; Skinner J, 2003, NEW ENGL J MED, V349, P1350, DOI 10.1056/NEJMsa021569; St Peter RF, 1999, NEW ENGL J MED, V341, P1980, DOI 10.1056/NEJM199912233412606; Tamblyn R, 2002, JAMA-J AM MED ASSOC, V288, P3019, DOI 10.1001/jama.288.23.3019; van Ryn M, 2002, MED CARE, V40, P140; Williams RL, 2001, MED CARE, V39, P1260, DOI 10.1097/00005650-200111000-00012; Xu G, 1997, AM J PUBLIC HEALTH, V87, P817, DOI 10.2105/AJPH.87.5.817	49	754	756	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					575	584		10.1056/NEJMsa040609	http://dx.doi.org/10.1056/NEJMsa040609			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	843HS	15295050	Bronze			2022-12-28	WOS:000223069900010
J	Xiong, Y; Steitz, TA				Xiong, Y; Steitz, TA			Mechanism of transfer RNA maturation by CCA-adding enzyme without using an oligonucleotide template	NATURE			English	Article							DNA-POLYMERASE-BETA; NUCLEOTIDYLTRANSFERASE SUPERFAMILY; POLYMERIZATION; COMPLEXES; ATP	Transfer RNA nucleotidyltransferases (CCA-adding enzymes) are responsible for the maturation or repair of the functional 30 end of tRNAs by means of the addition of the essential nucleotides CCA. However, it is unclear how tRNA nucleotidyltransferases polymerize CCA onto the 30 terminus of immature tRNAs without using a nucleic acid template. Here we describe the crystal structure of the Archaeoglobus fulgidus tRNA nucleotidyltransferase in complex with tRNA. We also present ternary complexes of this enzyme with both RNA duplex mimics of the tRNA acceptor stem that terminate with the nucleotides C74 or C75, as well as the appropriate incoming nucleoside 5'-triphosphates. A single nucleotide-binding pocket exists whose specificity for both CTP and ATP is determined by the protein side chain of Arg 224 and backbone phosphates of the tRNA, which are non-complementary to and thus exclude UTP and GTP. Discrimination between CTP or ATP at a given addition step and at termination arises from changes in the size and shape of the nucleotide binding site that is progressively altered by the elongating 30 end of the tRNA.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009					AEBI M, 1990, J BIOL CHEM, V265, P16216; Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DEUTSCHER MP, 1972, J BIOL CHEM, V247, P459; DEUTSCHER MP, 1982, ENZYMES, V15, P183, DOI DOI 10.1016/S1874-6047(08)60279-6; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Okabe M, 2003, EMBO J, V22, P5918, DOI 10.1093/emboj/cdg563; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Shi PY, 1998, RNA, V4, P276; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tomari Y, 2000, GENES CELLS, V5, P689, DOI 10.1046/j.1365-2443.2000.00360.x; Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4; Yue DX, 1996, RNA, V2, P895; ZHU LQ, 1987, EMBO J, V6, P2473, DOI 10.1002/j.1460-2075.1987.tb02528.x	26	97	103	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					640	645		10.1038/nature02711	http://dx.doi.org/10.1038/nature02711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295590				2022-12-28	WOS:000223085400035
J	Johnson, CF				Johnson, CF			Child sexual abuse	LANCET			English	Review							PHYSICAL ABUSE; RISK-FACTORS; BAUSERMAN (1998)/; SOUTH-AFRICA; WOMEN; PREVALENCE; ADOLESCENTS; DISORDER; HISTORY; HEALTH	Child sexual abuse is a worldwide concern. It is an insidious, persistent, and serious problem that, depending on the population studied and definition used, affects 2-62% of women and 3-16% of men as victims. Pain and tissue injury from child sexual abuse can completely heal in time, but psychological and medical consequences can persist through adulthood. Associated sexually transmitted diseases (such as HIV) and suicide attempts can be fatal. All physicians who treat children should be aware of the manifestations and consequences of child sexual abuse, and should be familiar with normal and abnormal genital and anal anatomy of children. This aim is best accomplished through training and routine examination of the anus and genitalia of children. Because as many as 96% of children assessed for suspected sexual abuse will have normal genital and anal examinations, a forensic interview by a trained professional must be relied on to document suspicion of abuse.	Ohio State Univ, Childrens Hosp, Coll Med, Child Abuse Program, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Johnson, CF (corresponding author), Ohio State Univ, Childrens Hosp, Coll Med, Child Abuse Program, 700 Childrens Dr, Columbus, OH 43205 USA.	Cjohnson@chi.osu.edu						Acebes-Escobal BC, 2002, INT J GYNECOL OBSTET, V76, P213, DOI 10.1016/S0020-7292(01)00551-3; Adams J A, 2001, J Pediatr Adolesc Gynecol, V14, P175, DOI 10.1016/S1083-3188(01)00126-7; Adams J A, 2001, Child Maltreat, V6, P31, DOI 10.1177/1077559501006001003; Ameh EA, 2001, ANN TROP PAEDIATR, V21, P273, DOI 10.1080/02724930120077871; Amowitz LL, 2002, JAMA-J AM MED ASSOC, V287, P513, DOI 10.1001/jama.287.4.513; Anda RF, 2002, OBSTET GYNECOL, V100, P37, DOI 10.1016/S0029-7844(02)02063-X; Andrews G, 2002, MED J AUSTRALIA, V176, P458, DOI 10.5694/j.1326-5377.2002.tb04515.x; Balogh R, 2001, J INTELL DISABIL RES, V45, P194, DOI 10.1046/j.1365-2788.2001.00293.x; BAYS J, 2001, CHILD ABUSE MED DIAG, P287; Benbenishty R, 2002, CHILD ABUSE NEGLECT, V26, P763, DOI 10.1016/S0145-2134(02)00350-2; Bentovim A, 2002, CHILD ABUSE NEGLECT, V26, P661, DOI 10.1016/S0145-2134(02)00340-X; Berenson AB, 2002, J PEDIATR-US, V140, P600, DOI 10.1067/mpd.2002.123101; Berenson AB, 2002, PEDIATRICS, V109, P228, DOI 10.1542/peds.109.2.228; Bifulco A, 2002, B MENNINGER CLIN, V66, P241, DOI 10.1521/bumc.66.3.241.23366; Brady S, 2002, AIDS PATIENT CARE ST, V16, P121, DOI 10.1089/108729102317330463; Brems C, 2002, SUBST USE MISUSE, V37, P473, DOI 10.1081/JA-120002806; Breslau Naomi, 2002, Semin Clin Neuropsychiatry, V7, P80, DOI 10.1053/scnp.2002.31780; BUDIN LE, 1989, CHILD ABUSE NEGLECT, V13, P77, DOI 10.1016/0145-2134(89)90031-8; BUSSEN S, 2002, ZENTRALBL GYNAKOL, V123, P562; Carlstedt A, 2001, ARCH SEX BEHAV, V30, P483, DOI 10.1023/A:1010287100679; Chadwick DL, 2002, CHILD ABUSE NEGLECT, V26, P887, DOI 10.1016/S0145-2134(02)00357-5; Collings SJ, 2002, PSYCHOL REP, V91, P28, DOI 10.2466/PR0.91.5.28-28; Craissati Jackie, 2002, Sex Abuse, V14, P225, DOI 10.1177/107906320201400303; Curtis Tine, 2002, Int J Circumpolar Health, V61, P110; Dallam SJ, 2001, PSYCHOL BULL, V127, P715, DOI 10.1037//0033-2909.127.6.715; Deirmenjian JM, 2002, J FORENSIC SCI, V47, P1090; Diaz-Olavarrieta C, 2002, SOC SCI MED, V55, P1589, DOI 10.1016/S0277-9536(01)00293-3; Drach KM, 2001, CHILD ABUSE NEGLECT, V25, P489, DOI 10.1016/S0145-2134(01)00222-8; ELLIOTT M, 1995, CHILD ABUSE NEGLECT, V19, P579, DOI 10.1016/0145-2134(95)00017-3; Estes LS, 2002, FAM PRACT, V19, P36, DOI 10.1093/fampra/19.1.36; Fagan PJ, 2002, JAMA-J AM MED ASSOC, V288, P2458, DOI 10.1001/jama.288.19.2458; Fallon Moira A, 2002, J Pediatr Nurs, V17, P363, DOI 10.1053/jpdn.2002.129054; Farley M, 2001, PSYCHOL REP, V89, P595, DOI 10.2466/PR0.89.7.595-606; Farley MS, 2002, J FAM PRACTICE, V51, P827; Feldman KW, 2001, CHILD ABUSE NEGLECT, V25, P1555, DOI 10.1016/S0145-2134(01)00294-0; FINKEL MA, 2001, CHILD ABUSE MED DIAG, P207; Franz H B, 2001, Kongressbd Dtsch Ges Chir Kongr, V118, P632; FRENCH GM, 1994, CLIN PEDIATR, V33, P38, DOI 10.1177/000992289403300106; Friedman S, 2002, J ANXIETY DISORD, V16, P259, DOI 10.1016/S0887-6185(02)00097-X; Fuselier Daniel A, 2002, Sex Abuse, V14, P271, DOI 10.1023/A:1015374526142; Ghetti S, 2002, CHILD ABUSE NEGLECT, V26, P977, DOI 10.1016/S0145-2134(02)00367-8; GIARDINO AP, 1992, PRACTICAL GUIDE EVAL; Glasser M, 2001, BRIT J PSYCHIAT, V179, P482, DOI 10.1192/bjp.179.6.482; GLAZERROSOFF KE, 1997, DISS ABSTR INT, V58, P2121; Gosset Didier, 2002, Rev Prat, V52, P734; Haj-Yahia MM, 2001, CHILD ABUSE NEGLECT, V25, P1303, DOI 10.1016/S0145-2134(01)00277-0; Hall DK, 2002, CHILD ABUSE NEGLECT, V26, P289, DOI 10.1016/S0145-2134(01)00326-X; Hanson RF, 2001, AM J ORTHOPSYCHIAT, V71, P108, DOI 10.1037/0002-9432.71.1.108; Hebert M, 2001, CHILD ABUSE NEGLECT, V25, P505, DOI 10.1016/S0145-2134(01)00223-X; HEGER AH, 2000, EVALUATION SEXUALLY; HELEPIN DS, 1996, BRIT MED J, V312, P1326; HERBERT M, 2002, VIOLENCE VICTIMS, V17, P355; Hershkowitz I, 2001, CHILD ABUSE NEGLECT, V25, P1397, DOI 10.1016/S0145-2134(01)00274-5; Hobbis ICA, 2002, SCAND J GASTROENTERO, V37, P423, DOI 10.1080/003655202317316051; Ilnyckyj A, 2002, CAN J GASTROENTEROL, V16, P801, DOI 10.1155/2002/245256; Ingram DM, 2001, CHILD ABUSE NEGLECT, V25, P1109, DOI 10.1016/S0145-2134(01)00259-9; Jankowski MK, 2002, J TRAUMA STRESS, V15, P235, DOI 10.1023/A:1015259412746; JENNY C, 1998, VISUAL DIAGNOSIS CHI; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; Johnson C.F., 1999, CHILD MALTREATMENT, V4, P228; Johnson C. F., 2001, NELSON TXB PEDIAT; Johnson C.F., 1990, PEDIATR EMERG CARE, V15, P84; Johnson CF, 2002, PEDIATR INT, V44, P554; JOHNSON CF, 1995, PSYCHIAT DISORDERS C; Johnson PJ, 2002, PUBLIC HEALTH REP, V117, P148, DOI 10.1093/phr/117.2.148; Johnson PJ, 2002, PERSPECT SEX REPRO H, V34, P62, DOI 10.2307/3030208; Jones LM, 2002, CHILD ABUSE NEGLECT, V26, P889, DOI 10.1016/S0145-2134(02)00358-7; Jones LM, 2001, CHILD ABUSE NEGLECT, V25, P1139, DOI 10.1016/S0145-2134(01)00263-0; Kaplan R, 2001, COMPR PSYCHIAT, V42, P342, DOI 10.1053/comp.2001.24588; KAUFMAN KL, 1995, J INTERPERS VIOLENCE, V10, P322, DOI 10.1177/088626095010003006; Kellogg ND, 2000, CHILD ABUSE NEGLECT, V24, P1601, DOI 10.1016/S0145-2134(00)00204-0; KELLOGG ND, 2003, SECT CHILD ABUSE NEG, P1; Kelly RJ, 2002, CHILD ABUSE NEGLECT, V26, P425, DOI 10.1016/S0145-2134(02)00317-4; King JA, 2001, PSYCHIAT CLIN NEUROS, V55, P71, DOI 10.1046/j.1440-1819.2001.00787.x; Klit H, 2002, UGESKRIFT LAEGER, V164, P3771; Koplin B, 2002, CURR OPIN PEDIATR, V14, P713, DOI 10.1097/00008480-200212000-00013; Korbin JE, 2002, CHILD ABUSE NEGLECT, V26, P637, DOI 10.1016/S0145-2134(02)00338-1; LADSON S, 1987, AM J DIS CHILD, V141, P411, DOI 10.1001/archpedi.1987.04460040069016; Lampe A, 2000, OBSTET GYNECOL, V96, P929, DOI 10.1016/S0029-7844(00)01072-3; Lampe A, 2002, Z PSYCHOSOM MED PSYC, V48, P370; Lauritsen AK, 2001, UGESKRIFT LAEGER, V163, P2485; Lee JKP, 2002, CHILD ABUSE NEGLECT, V26, P73, DOI 10.1016/S0145-2134(01)00304-0; Lentsch K A, 2000, Child Maltreat, V5, P72, DOI 10.1177/1077559500005001009; Lesser J, 2000, J Pediatr Nurs, V15, P378, DOI 10.1053/jpdn.2000.16714; Leverich GS, 2002, BIOL PSYCHIAT, V51, P288, DOI 10.1016/S0006-3223(01)01239-2; Liebschutz J, 2002, J SUBST ABUSE TREAT, V22, P121, DOI 10.1016/S0740-5472(02)00220-9; Macfie J, 2001, CHILD ABUSE NEGLECT, V25, P1253, DOI 10.1016/S0145-2134(01)00266-6; Madu SN, 2001, ARCH SEX BEHAV, V30, P311, DOI 10.1023/A:1002704331364; Makoroff KL, 2002, CHILD ABUSE NEGLECT, V26, P1235, DOI 10.1016/S0145-2134(02)00419-2; Mazza D, 2001, MED J AUSTRALIA, V175, P199, DOI 10.5694/j.1326-5377.2001.tb143095.x; MCCANN J, 1999, ANATOMY CHILD ADOLES; McNally RJ, 2000, J CONSULT CLIN PSYCH, V68, P1033, DOI 10.1037/0022-006X.68.6.1033; Messman-Moore Terri L, 2002, Violence Vict, V17, P319, DOI 10.1891/vivi.17.3.319.33662; Meyerson LA, 2002, CHILD ABUSE NEGLECT, V26, P387, DOI 10.1016/S0145-2134(02)00315-0; Molnar BE, 2001, AM J PUBLIC HEALTH, V91, P753, DOI 10.2105/AJPH.91.5.753; Monpoux F, 2002, ARCH PEDIATRIE, V9, P232, DOI 10.1016/S0929-693X(01)00758-8; MORRIS JL, 1985, AM J DIS CHILD, V139, P194, DOI 10.1001/archpedi.1985.02140040096037; Moszynski P, 2002, BRIT MED J, V325, P732; Myhre AK, 2001, ACTA PAEDIATR, V90, P1321; Nelson EC, 2002, ARCH GEN PSYCHIAT, V59, P139, DOI 10.1001/archpsyc.59.2.139; Nemets Boris, 2002, Harefuah, V141, P726; Nhundu TJ, 2001, CHILD ABUSE NEGLECT, V25, P1517, DOI 10.1016/S0145-2134(01)00288-5; Niederberger JM, 2002, CHILD ABUSE NEGLECT, V26, P55, DOI 10.1016/S0145-2134(01)00303-9; Nolan M, 2002, CHILD ABUSE NEGLECT, V26, P333, DOI 10.1016/S0145-2134(02)00312-5; Olsson A, 2000, CHILD ABUSE NEGLECT, V24, P1579, DOI 10.1016/S0145-2134(00)00215-5; Ondersma SJ, 2001, PSYCHOL BULL, V127, P707, DOI 10.1037//0033-2909.127.6.707; Palusci VJ, 2001, CHILD ABUSE NEGLECT, V25, P1535, DOI 10.1016/S0145-2134(01)00287-3; Patel V, 2001, NATL MED J INDIA, V14, P263; Peters DF, 2001, CHILD ABUSE NEGLECT, V25, P149; Pillai M, 2002, MED SCI LAW, V42, P149, DOI 10.1177/002580240204200206; Pillay AL, 2001, PSYCHOL REP, V88, P727, DOI 10.2466/PR0.88.3.727-733; Powell J, 2001, J AM ACAD DERMATOL, V44, P803, DOI 10.1067/mjd.2001.113474; Price L, 2002, ARCH DIS CHILD, V86, P164, DOI 10.1136/adc.86.3.164; Rew L, 2001, Issues Compr Pediatr Nurs, V24, P225; Rind B, 1998, PSYCHOL BULL, V124, P22, DOI 10.1037/0033-2909.124.1.22; Rind B, 2001, PSYCHOL BULL, V127, P734, DOI 10.1037//0033-2909.127.6.734; Roelofs K, 2002, AM J PSYCHIAT, V159, P1908, DOI 10.1176/appi.ajp.159.11.1908; Romans S, 2002, PSYCHOTHER PSYCHOSOM, V71, P141, DOI 10.1159/000056281; Rumstein-McKean O, 2001, CLIN PSYCHOL REV, V21, P471, DOI 10.1016/S0272-7358(99)00069-0; Runtz Marsha G, 2002, Child Maltreat, V7, P241, DOI 10.1177/1077559502007003006; Russell D E, 1983, Child Abuse Negl, V7, P133, DOI 10.1016/0145-2134(83)90065-0; Salmon K, 2001, CLIN PSYCHOL REV, V21, P267, DOI 10.1016/S0272-7358(99)00048-3; Shaw JA, 2001, CHILD ABUSE NEGLECT, V25, P1363, DOI 10.1016/S0145-2134(01)00272-1; Silovsky Jane F, 2002, Child Maltreat, V7, P187, DOI 10.1177/1077559502007003002; Stoffels H, 2002, NERVENARZT, V73, P445, DOI 10.1007/s00115-002-1327-y; Striegel-Moore RH, 2002, AM J PSYCHIAT, V159, P1902, DOI 10.1176/appi.ajp.159.11.1902; Svedin CG, 2002, NORD J PSYCHIAT, V56, P355, DOI 10.1080/080394802760322123; Tang CSK, 2002, CHILD ABUSE NEGLECT, V26, P23, DOI 10.1016/S0145-2134(01)00306-4; TIEMAN J, 2002, MOD HEALTHCARE, V32, P6; Trivits LC, 2002, AM PSYCHOL, V57, P690, DOI 10.1037/0003-066X.57.9.690; *US DEP HHS, 2002, 11 YEARS REP CHILD M; Vogeltanz ND, 1999, CHILD ABUSE NEGLECT, V23, P579, DOI 10.1016/S0145-2134(99)00026-5; von Heyden B, 2001, PSYCHOSOM MED, V63, P505, DOI 10.1097/00006842-200105000-00022; Walker Karen Elizabeth, 2002, J Child Health Care, V6, P182; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; Willis BM, 2002, LANCET, V359, P1417, DOI 10.1016/S0140-6736(02)08355-1; Wilsnack SC, 2002, CHILD ABUSE NEGLECT, V26, P139, DOI 10.1016/S0145-2134(01)00313-1; YIMIN C, 2002, CONTRACEPTION, V64, P77	138	159	169	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					462	470		10.1016/S0140-6736(04)16771-8	http://dx.doi.org/10.1016/S0140-6736(04)16771-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	842IX	15288746				2022-12-28	WOS:000222998600038
J	Lieb, K; Zanarini, MC; Schmahl, C; Linehan, MM; Bohus, M				Lieb, K; Zanarini, MC; Schmahl, C; Linehan, MM; Bohus, M			Borderline personality disorder	LANCET			English	Editorial Material							DIALECTICAL BEHAVIOR-THERAPY; POSITRON-EMISSION-TOMOGRAPHY; DOUBLE-BLIND; FOLLOW-UP; FEMALE-PATIENTS; AXIS-I; PARTIAL HOSPITALIZATION; CHILDHOOD EXPERIENCES; IMPULSIVE AGGRESSION; DIVALPROEX SODIUM	Borderline personality disorder is characterised by a pervasive pattern of instability in affect regulation, impulse control, interpersonal relationships, and self-image. Clinical signs of the disorder include emotional dysregulation, impulsive aggression, repeated self-injury, and chronic suicidal tendencies, which make these patients frequent users of mental-health resources. Causal factors are only partly known, but genetic factors and adverse events during childhood, such as physical and sexual abuse, contribute to the development of the disorder. Dialectical behaviour therapy and psychodynamic partial hospital programmes are effective treatments for out-of-control patients, and drug therapy can reduce depression, anxiety, and impulsive aggression. More research is needed for the understanding and management of this disabling clinical condition. Current strategies are focusing on the neurobiological underpinnings of the disorder and the development and dissemination of better and more cost-effective treatments to clinicians.	Univ Freiburg, Sch Med, Dept Psychiat & Psychotherapy, D-79104 Freiburg, Germany; McLean Hosp, Belmont, MA 02178 USA; Harvard Univ, Sch Med, Belmont, MA 02178 USA; Heidelberg Univ, Cent Inst Mental Hlth, Dept Psychosomat & Psychotherapeut Med, D-6800 Mannheim, Germany; Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Freiburg; Harvard University; McLean Hospital; Harvard University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Washington; University of Washington Seattle	Lieb, K (corresponding author), Univ Freiburg, Sch Med, Dept Psychiat & Psychotherapy, Hauptstr 5, D-79104 Freiburg, Germany.	klaus-lieb@psyallg.ukl.uni-freiburg.de	Schmahl, Christian/E-8760-2012	Schmahl, Christian/0000-0003-0141-0821	NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH047588, R01MH062169, R01MH034486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014997] Funding Source: NIH RePORTER; NIDA NIH HHS [DA014997] Funding Source: Medline; NIMH NIH HHS [MH47588, MH34486, MH62169] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*AM PSYCH ASS, 2001, AM J PSYCHIAT, V158, P2; [Anonymous], 2008, INT HDB SUICIDE ATTE; BARLEY WD, 1993, J PERS DISORD, V7, P232, DOI 10.1521/pedi.1993.7.3.232; Bateman A, 1999, AM J PSYCHIAT, V156, P1563, DOI 10.1176/ajp.156.10.1563; Bateman A, 2001, AM J PSYCHIAT, V158, P36, DOI 10.1176/appi.ajp.158.1.36; Bender DS, 2001, AM J PSYCHIAT, V158, P295, DOI 10.1176/appi.ajp.158.2.295; BERNSTEIN DP, 1993, AM J PSYCHIAT, V150, P1237; Bohus M, 2000, BEHAV RES THER, V38, P875, DOI 10.1016/S0005-7967(99)00103-5; Bohus M, 2004, BEHAV RES THER, V42, P487, DOI 10.1016/S0005-7967(03)00174-8; Bohus MJ, 1999, J CLIN PSYCHIAT, V60, P598, DOI 10.4088/JCP.v60n0906; Chengappa KNR, 1999, J CLIN PSYCHIAT, V60, P477, DOI 10.4088/JCP.v60n0710; Clarkin JF, 2001, J PERS DISORD, V15, P487, DOI 10.1521/pedi.15.6.487.19190; Coccaro EF, 1997, ARCH GEN PSYCHIAT, V54, P1081; CORNELIUS JR, 1993, PSYCHOPHARMACOL BULL, V29, P333; CORNELIUS JR, 1993, AM J PSYCHIAT, V150, P1843; CORYELL W, 1995, J AFFECT DISORDERS, V33, P201, DOI 10.1016/0165-0327(94)00091-M; COWDRY RW, 1988, ARCH GEN PSYCHIAT, V45, P111; DELAFUENTE JM, 1994, EUR NEUROPSYCHOPHARM, V4, P479, DOI 10.1016/0924-977X(94)90296-8; DeLaFuente JM, 1997, J PSYCHIATR RES, V31, P531, DOI 10.1016/S0022-3956(97)00001-0; Donegan NH, 2003, BIOL PSYCHIAT, V54, P1284, DOI 10.1016/S0006-3223(03)00636-X; Driessen M, 2000, ARCH GEN PSYCHIAT, V57, P1115, DOI 10.1001/archpsyc.57.12.1115; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Frankenburg FR, 2002, J CLIN PSYCHIAT, V63, P442, DOI 10.4088/JCP.v63n0511; FRANKENBURG FR, 1993, COMPR PSYCHIAT, V34, P402, DOI 10.1016/0010-440X(93)90065-C; GELLER JL, 1986, HOSP COMMUNITY PSYCH, V37, P386; GOLDBERG SC, 1986, ARCH GEN PSYCHIAT, V43, P680; Gunderson JG, 1996, AM J PSYCHIAT, V153, P752; HERMAN JL, 1989, AM J PSYCHIAT, V146, P490; Herpertz SC, 2001, BIOL PSYCHIAT, V50, P292, DOI 10.1016/S0006-3223(01)01075-7; Hollander E, 2001, J CLIN PSYCHIAT, V62, P199, DOI 10.4088/JCP.v62n0311; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P1186, DOI 10.1038/sj.npp.1300153; Juengling FD, 2003, J PSYCHIAT RES, V37, P109, DOI 10.1016/S0022-3956(02)00084-5; Koenigsberg HW, 2002, AM J PSYCHIAT, V159, P784, DOI 10.1176/appi.ajp.159.5.784; Koons CR, 2001, BEHAV THER, V32, P371, DOI 10.1016/S0005-7894(01)80009-5; Leyton M, 2001, AM J PSYCHIAT, V158, P775, DOI 10.1176/appi.ajp.158.5.775; Linehan MM, 1999, AM J ADDICTION, V8, P279; Linehan MM, 1997, ANN NY ACAD SCI, V836, P302, DOI 10.1111/j.1749-6632.1997.tb52367.x; LINEHAN MM, 1994, AM J PSYCHIAT, V151, P1771; LINEHAN MM, 1993, ARCH GEN PSYCHIAT, V50, P157; LINEHAN MM, 1993, ARCH GEN PSYCHIAT, V50, P971; Linehan MM, 2002, DRUG ALCOHOL DEPEN, V67, P13, DOI 10.1016/S0376-8716(02)00011-X; LINEHAN MM, 1991, ARCH GEN PSYCHIAT, V48, P1060; LINEHAN MM, 2002, S PRES ASS ADV BEH T; LINKS PS, 1988, CAN J PSYCHIAT, V33, P336, DOI 10.1177/070674378803300504; Livesley WJ, 1998, ARCH GEN PSYCHIAT, V55, P941, DOI 10.1001/archpsyc.55.10.941; Lyoo IK, 1998, J AFFECT DISORDERS, V50, P235, DOI 10.1016/S0165-0327(98)00104-9; Markovitz PJ, 1995, IMPULSIVITY AGGRESSI, P263; McCann RA, 2000, COGN BEHAV PRACT, V7, P447, DOI 10.1016/S1077-7229(00)80056-5; McGlashan TH, 2000, ACTA PSYCHIAT SCAND, V102, P256, DOI 10.1034/j.1600-0447.2000.102004256.x; MCGLASHAN TH, 1985, BORDERLINE CURRENT E, P61; New AS, 2003, BIOL PSYCHIAT, V53, p104S; OGATA SN, 1990, AM J PSYCHIAT, V147, P1008; OLDHAM JM, 1995, AM J PSYCHIAT, V152, P571; PARIS J, 1994, COMPR PSYCHIAT, V35, P301, DOI 10.1016/0010-440X(94)90023-X; PARIS J, 1994, J NERV MENT DIS, V182, P375, DOI 10.1097/00005053-199407000-00002; Paris J, 2001, COMPR PSYCHIAT, V42, P482, DOI 10.1053/comp.2001.26271; PARIS J, 1987, COMPR PSYCHIAT, V28, P530, DOI 10.1016/0010-440X(87)90019-8; PARIS J, 1988, COMPR PSYCHIAT, V29, P147, DOI 10.1016/0010-440X(88)90007-7; Perry J. C., 1985, BORDERLINE CURRENT E, P21; PERRY JC, 1990, PSYCHIAT ANN, V20, P33, DOI 10.3928/0048-5713-19900101-08; PHILIPSEN A, IN PRESS J CLIN PSYC; Pinto OC, 1998, J AFFECT DISORDERS, V51, P333, DOI 10.1016/S0165-0327(99)00007-5; PLAKUN EM, 1991, J PERS DISORD, V5, P93, DOI 10.1521/pedi.1991.5.2.93; POPE HG, 1985, AM J PSYCHIAT, V142, P1285; RASCATI JN, 1990, PSYCHIATRY, V53, P124; Rathus JH, 2002, SUICIDE LIFE-THREAT, V32, P146, DOI 10.1521/suli.32.2.146.24399; Rinne T, 2002, BIOL PSYCHIAT, V52, P1102, DOI 10.1016/S0006-3223(02)01395-1; Rinne T, 2002, AM J PSYCHIAT, V159, P2048, DOI 10.1176/appi.ajp.159.12.2048; Rocca P, 2002, J CLIN PSYCHIAT, V63, P241, DOI 10.4088/JCP.v63n0311; SALZMAN C, 1995, J CLIN PSYCHOPHARM, V15, P23, DOI 10.1097/00004714-199502000-00005; Schmahl C, 2001, FORTSCHR NEUROL PSYC, V69, P310, DOI 10.1055/s-2001-15305; Schmahl CG, 2004, BIOL PSYCHIAT, V55, P759, DOI 10.1016/j.biopsych.2003.11.007; Schmahl CG, 2003, BIOL PSYCHIAT, V54, P142, DOI 10.1016/S0006-3223(02)01720-1; Schmahl CG, 2003, PSYCHIAT RES-NEUROIM, V122, P193, DOI 10.1016/S0925-4927(03)00023-4; Schulz SC, 1999, BIOL PSYCHIAT, V46, P1429, DOI 10.1016/S0006-3223(99)00128-6; Shaffer D, 2001, J AM ACAD CHILD PSY, V40, p24S, DOI 10.1097/00004583-200107001-00003; Shea MT, 2002, AM J PSYCHIAT, V159, P2036, DOI 10.1176/appi.ajp.159.12.2036; SHEARER SL, 1990, AM J PSYCHIAT, V147, P214; Siever LJ, 2002, BIOL PSYCHIAT, V51, P964, DOI 10.1016/S0006-3223(02)01326-4; SILK KR, 1995, AM J PSYCHIAT, V152, P1059; Skodol AE, 2002, AM J PSYCHIAT, V159, P276, DOI 10.1176/appi.ajp.159.2.276; Skodol AE, 2002, BIOL PSYCHIAT, V51, P936, DOI 10.1016/S0006-3223(02)01324-0; Skodol AE, 2002, BIOL PSYCHIAT, V51, P951, DOI 10.1016/S0006-3223(02)01325-2; SKODOL AE, 1983, J NERV MENT DIS, V171, P405, DOI 10.1097/00005053-198307000-00003; SOLOFF PH, 1989, J CLIN PSYCHOPHARM, V9, P238, DOI 10.1097/00004714-198908000-00002; Soloff PH, 2000, BIOL PSYCHIAT, V47, P540, DOI 10.1016/S0006-3223(99)00202-4; Soloff PH, 2003, PSYCHIAT RES-NEUROIM, V123, P153, DOI 10.1016/S0925-4927(03)00064-7; Soloff PH, 2003, PSYCHIAT RES, V119, P11, DOI 10.1016/S0165-1781(03)00100-8; SOLOFF PH, 1986, ARCH GEN PSYCHIAT, V43, P691; SOLOFF PH, 1993, ARCH GEN PSYCHIAT, V50, P377; Soloff PH, 2000, PSYCHIAT CLIN N AM, V23, P169, DOI 10.1016/S0193-953X(05)70150-7; STANLEY B, 1998, 32 ANN CONV ASS ADV; Stiglmayr CE, 2001, J PSYCHIAT RES, V35, P111, DOI 10.1016/S0022-3956(01)00012-7; Stone M. H, 1990, FATE BORDERLINE PATI; SURBER RW, 1987, HOSP COMMUNITY PSYCH, V38, P1112; SWARTZ M, 1990, J PERSONALITY DISORD, V0004; Swenson CR, 2002, PSYCHIATR SERV, V53, P171, DOI 10.1176/appi.ps.53.2.171; Swigar M E, 1991, Int J Soc Psychiatry, V37, P259, DOI 10.1177/002076409103700405; Tohen M, 2000, AM J PSYCHIAT, V157, P220, DOI 10.1176/appi.ajp.157.2.220; Torgersen S, 2000, COMPR PSYCHIAT, V41, P416, DOI 10.1053/comp.2000.16560; Torgersen S, 2001, ARCH GEN PSYCHIAT, V58, P590, DOI 10.1001/archpsyc.58.6.590; TUCKER L, 1987, AM J PSYCHIAT, V144, P1443; Turner RM, 2000, COGN BEHAV PRACT, V7, P413, DOI 10.1016/S1077-7229(00)80052-8; van den Bosch LMC, 2002, ADDICT BEHAV, V27, P911, DOI 10.1016/S0306-4603(02)00293-9; van Elst LT, 2001, J NEUROPSYCH CLIN N, V13, P511, DOI 10.1176/appi.neuropsych.13.4.511; van Elst LT, 2003, BIOL PSYCHIAT, V54, P163, DOI 10.1016/S0006-3223(03)01743-2; Verheul R, 2003, BRIT J PSYCHIAT, V182, P135, DOI 10.1192/bjp.182.2.135; WEST M, 1993, CAN J PSYCHIAT, V38, pS16; WESTEN D, 1990, AM J ORTHOPSYCHIAT, V60, P55, DOI 10.1037/h0079175; WIDIGER TA, 1991, HOSP COMMUNITY PSYCH, V42, P1015; WOOGH CM, 1986, CAN J PSYCHIAT, V31, P214, DOI 10.1177/070674378603100306; Zanarini MC, 1998, COMPR PSYCHIAT, V39, P296, DOI 10.1016/S0010-440X(98)90038-4; Zanarini MC, 2002, J NERV MENT DIS, V190, P381, DOI 10.1097/00005053-200206000-00006; Zanarini MC, 2004, J CLIN PSYCHIAT, V65, P28, DOI 10.4088/jcp.v65n0105; Zanarini MC, 1997, AM J PSYCHIAT, V154, P1101; Zanarini MC, 2003, AM J PSYCHIAT, V160, P167, DOI 10.1176/appi.ajp.160.1.167; Zanarini MC, 2003, AM J PSYCHIAT, V160, P274, DOI 10.1176/appi.ajp.160.2.274; Zanarini MC, 1998, AM J PSYCHIAT, V155, P1733, DOI 10.1176/ajp.155.12.1733; ZANARINI MC, 1990, AM J PSYCHIAT, V147, P57; ZANARINI MC, 1990, AM J PSYCHIAT, V147, P161; ZANARINI MC, 1989, COMPR PSYCHIAT, V30, P18, DOI 10.1016/0010-440X(89)90114-4; Zanarini MC, 2001, COMPR PSYCHIAT, V42, P144, DOI 10.1053/comp.2001.19749; Zanarini MC, 2001, J CLIN PSYCHIAT, V62, P849, DOI 10.4088/JCP.v62n1103; Zanarini MC, 1998, HARVARD REV PSYCHIAT, V6, P201, DOI 10.3109/10673229809000330; Zimmerman M, 1999, COMPR PSYCHIAT, V40, P245, DOI 10.1016/S0010-440X(99)90123-2; ZIMMERMAN M, 1994, ARCH GEN PSYCHIAT, V51, P225	126	742	753	8	287	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					453	461		10.1016/S0140-6736(04)16770-6	http://dx.doi.org/10.1016/S0140-6736(04)16770-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	842IX	15288745				2022-12-28	WOS:000222998600037
J	Kriege, M; Brekelmans, CTM; Boetes, C; Besnard, PE; Zonderland, HM; Obdeijn, IM; Manoliu, RA; Kok, T; Peterse, H; Tilanus-Linthorst, MMA; Muller, SH; Meijer, S; Oosterwijk, JC; Beex, LVAM; Tollenaar, RAEM; de Koning, HJ; Rutgers, EJT; Klijn, JGM				Kriege, M; Brekelmans, CTM; Boetes, C; Besnard, PE; Zonderland, HM; Obdeijn, IM; Manoliu, RA; Kok, T; Peterse, H; Tilanus-Linthorst, MMA; Muller, SH; Meijer, S; Oosterwijk, JC; Beex, LVAM; Tollenaar, RAEM; de Koning, HJ; Rutgers, EJT; Klijn, JGM		Magnetic Resonance Imaging Screeni	Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MUTATION CARRIERS; BRCA2 MUTATION; HIGH-RISK; HISTORY; TRIALS; SURVEILLANCE; OOPHORECTOMY; MASTECTOMY; MORTALITY; DENSITY	BACKGROUND: The value of regular surveillance for breast cancer in women with a genetic or familial predisposition to breast cancer is currently unproven. We compared the efficacy of magnetic resonance imaging (MRI) with that of mammography for screening in this group of high-risk women. METHODS: Women who had a cumulative lifetime risk of breast cancer of 15 percent or more were screened every six months with a clinical breast examination and once a year by mammography and MRI, with independent readings. The characteristics of the cancers that were detected were compared with the characteristics of those in two different age-matched control groups. RESULTS: We screened 1909 eligible women, including 358 carriers of germ-line mutations. Within a median follow-up period of 2.9 years, 51 tumors (44 invasive cancers, 6 ductal carcinomas in situ, and 1 lymphoma) and 1 lobular carcinoma in situ were detected. The sensitivity of clinical breast examination, mammography, and MRI for detecting invasive breast cancer was 17.9 percent, 33.3 percent, and 79.5 percent, respectively, and the specificity was 98.1 percent, 95.0 percent, and 89.8 percent, respectively. The overall discriminating capacity of MRI was significantly better than that of mammography (P<0.05). The proportion of invasive tumors that were 10 mm or less in diameter was significantly greater in our surveillance group (43.2 percent) than in either control group (14.0 percent [P<0.001] and 12.5 percent [P=0.04], respectively). The combined incidence of positive axillary nodes and micrometastases in invasive cancers in our study was 21.4 percent, as compared with 52.4 percent (P<0.001) and 56.4 percent (P=0.001) in the two control groups. CONCLUSIONS: MRI appears to be more sensitive than mammography in detecting tumors in women with an inherited susceptibility to breast cancer.	Erasmus MC, Dr Daniel den Hoed Canc Ctr, Dept Med Oncol, Rotterdam Family Canc Clin, NL-3075 EA Rotterdam, Netherlands; Erasmus MC, Dr Daniel den Hoed Canc Ctr, Dept Radiol, NL-3075 EA Rotterdam, Netherlands; Erasmus MC, Dr Daniel den Hoed Canc Ctr, Dept Surg, NL-3075 EA Rotterdam, Netherlands; Univ Med Ctr Nijmegen, Dept Radiol, Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Med Oncol, Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Family Canc Clin, Nijmegen, Netherlands; Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands; Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Radiol, Amsterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Surg, Amsterdam, Netherlands; Univ Groningen Hosp, Dept Radiol, Groningen, Netherlands; Univ Groningen Hosp, Dept Clin Genet, Groningen, Netherlands; Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC	Klijn, JGM (corresponding author), Erasmus MC, Dr Daniel den Hoed Canc Ctr, Dept Med Oncol, Rotterdam Family Canc Clin, Groene Hilledijk 301, NL-3075 EA Rotterdam, Netherlands.	j.g.m.klijn@erasmusmc.nl	Rutgers, Emiel J T/C-5934-2015; Oosterwijk, Jan C./G-5770-2011; de+Koning, Harry/AAF-9062-2019	de+Koning, Harry/0000-0003-4682-3646				Adem C, 2003, CANCER, V97, P1, DOI 10.1002/cncr.11048; American College of Radiology, 1998, ILL BREAST IM REP DA; Boetes C, 2001, Magn Reson Imaging Clin N Am, V9, P357; Brekelmans CTM, 2001, J CLIN ONCOL, V19, P924, DOI 10.1200/JCO.2001.19.4.924; Chart PL, 1997, CAN MED ASSOC J, V157, P1235; CLAUS EB, 1994, CANCER, V73, P643, DOI 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; DEKONING HJ, 1995, JNCI-J NATL CANCER I, V87, P1217; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Huo ZM, 2002, RADIOLOGY, V225, P519, DOI 10.1148/radiol.2252010845; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Klijn JGM, 2003, EJC SUPPL, V1, P13, DOI 10.1016/S1359-6349(03)00005-3; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Kollias J, 1998, EUR J CANCER, V34, P878, DOI 10.1016/S0959-8049(97)00365-1; Kriege M, 2001, Fam Cancer, V1, P163, DOI 10.1023/A:1021135809870; Kuhl CK, 2000, RADIOLOGY, V215, P267, DOI 10.1148/radiology.215.1.r00ap01267; Lalloo F, 1998, EUR J CANCER, V34, P937, DOI 10.1016/S0959-8049(98)00005-7; Liberman L, 2003, CANCER-AM CANCER SOC, V98, P377, DOI 10.1002/cncr.11491; Liberman L, 2002, RADIOL CLIN N AM, V40, P409, DOI 10.1016/S0033-8389(01)00017-3; Macmillan RD, 2000, EUR J SURG ONCOL, V26, P149, DOI 10.1053/ejso.1999.0759; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Morris EA, 2001, SEMIN ROENTGENOL, V36, P226, DOI 10.1053/sroe.2001.25123; Nystrom L, 2002, LANCET, V360, P724; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Orel SG, 2001, RADIOLOGY, V220, P13, DOI 10.1148/radiology.220.1.r01jl3113; Otto SJ, 2003, LANCET, V361, P1411, DOI 10.1016/S0140-6736(03)13132-7; Podo F, 2002, J EXP CLIN CANC RES, V21, P115; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.2002.20.5.1260; Stoutjesdijk MJ, 2001, JNCI-J NATL CANCER I, V93, P1095, DOI 10.1093/jnci/93.14.1095; Tabar L, 1996, INT J CANCER, V68, P693; Tilanus-Linthorst M, 2002, INT J CANCER, V102, P665, DOI 10.1002/ijc.10838; Tilanus-Linthorst M, 2002, INT J CANCER, V102, P91, DOI 10.1002/ijc.10666; Tilanus-Linthorst MMA, 2000, BREAST CANCER RES TR, V63, P53, DOI 10.1023/A:1006480106487; van Asperen CJ, 2003, EUR J HUM GENET, V11, P633, DOI 10.1038/sj.ejhg.5201021; Visser O, 2002, INCIDENCE CANC NETHE; Warner E, 2001, J CLIN ONCOL, V19, P3524, DOI 10.1200/JCO.2001.19.15.3524	41	1178	1208	2	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					427	437		10.1056/NEJMoa031759	http://dx.doi.org/10.1056/NEJMoa031759			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282350	Green Published			2022-12-28	WOS:000222939700006
J	Saadlla, H				Saadlla, H			Images in clinical medicine: Electrocardiographic changes in extreme hypothermia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Prince Georges Gen Hosp & Med Ctr, Cheverly, MD 20785 USA		Saadlla, H (corresponding author), Prince Georges Gen Hosp & Med Ctr, Cheverly, MD 20785 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					E4	E4		10.1056/ENEJMicm030346	http://dx.doi.org/10.1056/ENEJMicm030346			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282365				2022-12-28	WOS:000222939700013
J	Delbaldo, C; Michiels, S; Syz, N; Soria, JC; Le Chevalier, T; Pignon, JP				Delbaldo, C; Michiels, S; Syz, N; Soria, JC; Le Chevalier, T; Pignon, JP			Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PHASE-III TRIAL; HIGH-DOSE CISPLATIN; VINDESINE PLUS CISPLATIN; INDIVIDUAL PATIENT DATA; RANDOMIZED-TRIAL; COMBINATION CHEMOTHERAPY; VINORELBINE-CISPLATIN; COMPARING CISPLATIN; ELDERLY-PATIENTS; ONCOLOGY-GROUP	Context Randomized trials have demonstrated that adding a drug to a single-agent or to a 2-agent regimen increased the tumor response rate in patients with advanced non-small-cell lung cancer (NSCLC), although its impact on survival remains controversial. Objective To evaluate the clinical benefit of adding a drug to a single-agent or 2-agent chemotherapy regimen in terms of tumor response rate, survival, and toxicity in patients with advanced NSCLC. Data Sources and Study Selection Data from all randomized controlled trials performed between 1980 and 2001 (published between January 1980 and October 2003) comparing a doublet regimen with a single-agent regimen or comparing a triplet regimen with a doublet regimen in patients with advanced NSCLC. There were no language restrictions. Searches of MEDLINE and EMBASE were performed using the search terms non-small-cell lung carcinoma/drug therapy, adenocarcinoma, large-cell carcinoma, squamous-cell carcinoma, lung, neoplasms, clinical trial phase III, and randomized trial. Manual searches were also performed to find conference proceedings published between January 1982 and October 2003. Data Extraction Two independent investigators reviewed the publications and extracted the data. Pooled odds ratios (ORs) for the objective tumor response rate, 1-year survival rate, and toxicity rate were calculated using the fixed-effect model. Pooled median ratios (MRS) for median survival also were calculated using the fixed-effect model. ORs and MRS lower than unity (<1.0) indicate a benefit of a doublet regimen compared with a single-agent regimen (or a triplet regimen compared with a doublet regimen). Data Synthesis Sixty-five trials (13601 patients) were eligible. In the trials comparing a doublet regimen with a single-agent regimen, a significant increase was observed in tumor response (OR, 0.42; 95% confidence interval [CI], 0.37-0.47; P<.001) and 1-year survival (OR, 0.80; 95% Cl, 0.70-0.91; P<.001) in favor of the doublet regimen. The median survival ratio was 0.83 (95% Cl, 0.79-0.89; P<.001). An increase also was observed in the tumor response rate (OR, 0.66; 95% Cl, 0.58-0.75; P<.001) in favor of the triplet regimen, but not for 1-year survival (OR, 1.01; 95% Cl, 0.85-1.21; P=.88). The median survival ratio was 1.00 (95% Cl, 0.94-1.06; P=.97). Conclusion Adding a second drug improved tumor response and survival rate. Adding a third drug had a weaker effect on, tumor response and no effect on survival.	Inst Gustave Roussy, Dept Biostat & Epidemiol, F-94805 Villejuif, France; Inst Gustave Roussy, Dept Med, F-94805 Villejuif, France	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy	Pignon, JP (corresponding author), Inst Gustave Roussy, Dept Biostat & Epidemiol, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	jppignon@igr.fr	Michiels, Stefan/L-1516-2013; Soria, Jean-Charles/F-3619-2014	Michiels, Stefan/0000-0002-6963-2968; PIGNON, Jean-Pierre/0000-0003-2047-1582				AGGSTROM MQ, 2003, P AN M AM SOC CLIN, V22, P624; ALBAIN KS, 1991, J CLIN ONCOL, V9, P1618, DOI 10.1200/JCO.1991.9.9.1618; Alberola V, 2003, J CLIN ONCOL, V21, P3207, DOI 10.1200/JCO.2003.12.038; ALBERTI W, 1995, BRIT MED J, V311, P899; ARECO A, 1989, P AN M AM SOC CLIN, V8, P240; Baggstrom MQ, 2002, P AN M AM SOC CLIN, V21, p306a; Bando H, 1986, Gan To Kagaku Ryoho, V13, P2094; BERARDI R, 2001, P AN M AM SOC CLIN, V20, pA347; BISSETT D, 2002, P AN M AM SOC CLIN, V21, pA296; BONOMI PD, 1989, J CLIN ONCOL, V7, P1602, DOI 10.1200/JCO.1989.7.11.1602; Breathnach OS, 2001, J CLIN ONCOL, V19, P1734, DOI 10.1200/JCO.2001.19.6.1734; BREAU JL, 1988, P AN M AM SOC CLIN, V7, P212; Bunn PA, 1998, CLIN CANCER RES, V4, P1087; Bunn PA, 2002, J CLIN ONCOL, V20, P3565, DOI 10.1200/JCO.2002.20.17.3565; Bunn PA, 2000, CHEST, V117, p138S, DOI 10.1378/chest.117.4_suppl_1.138S; Comella P, 2000, J CLIN ONCOL, V18, P1451, DOI 10.1200/JCO.2000.18.7.1451; CRINO L, 1990, CANCER CHEMOTH PHARM, V26, P52, DOI 10.1007/BF02940294; Crino L, 2002, SEMIN ONCOL, V29, P9, DOI 10.1053/sonc.2002.34266; DENKMAYR M, 1991, LUNG CANCER S, V7, P130; DEPIERRE A, 1994, ANN ONCOL, V5, P37, DOI 10.1093/oxfordjournals.annonc.a058687; DEZA EG, 1996, P AN M AM SOC CLIN, V15, P394; DHINGRA HM, 1985, J CLIN ONCOL, V3, P176, DOI 10.1200/JCO.1985.3.2.176; Edelman MJ, 2001, CANCER CHEMOTH PHARM, V48, P141, DOI 10.1007/s002800000273; EINHORN LH, 1986, J CLIN ONCOL, V4, P1037, DOI 10.1200/JCO.1986.4.7.1037; ELLIOTT JA, 1984, EUR J CANCER CLIN ON, V20, P1025, DOI 10.1016/0277-5379(84)90104-4; ERKISI M, 1995, LUNG CANCER, V12, P237, DOI 10.1016/0169-5002(95)00447-9; Frasci G, 2000, J CLIN ONCOL, V18, P2529, DOI 10.1200/JCO.2000.18.13.2529; FUKUOKA M, 1991, J CLIN ONCOL, V9, P606, DOI 10.1200/JCO.1991.9.4.606; GANDARA DR, 1993, J CLIN ONCOL, V11, P873, DOI 10.1200/JCO.1993.11.5.873; Gatzemeier U, 2000, J CLIN ONCOL, V18, P3390, DOI 10.1200/JCO.2000.18.19.3390; GATZEMEIER U, 2002, P AN M AM SOC CLIN, V21, pA297; GEORGOULIAS G, 2003, CLIN LUNG CANCER, V4, P288; GIACCONE G, 2004, J CLIN ONCOL, V22, P759; GOROSPE A, 2000, LUNG CANCER, V29, P70; GRALLA RJ, 1994, P AN M AM SOC CLIN, V13, P347; Greco FA, 2002, CANCER, V95, P1279, DOI 10.1002/cncr.10810; Gridelli C, 2003, JNCI-J NATL CANCER I, V95, P362, DOI 10.1093/jnci/95.5.362; GRILLI R, 1993, J CLIN ONCOL, V11, P1866, DOI 10.1200/JCO.1993.11.10.1866; HAINSWORTH JD, 1989, AM J CLIN ONCOL-CANC, V12, P345, DOI 10.1097/00000421-198908000-00014; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; HIRAKI S, 1991, LUNG CANCER S, V7, P111; HOFFMAN PC, 1985, P AN M AM SOC CLIN, V4, P185; HUSSEIN A, 2000, P AN M AM SOC CLIN, V19, pA504; IHDE DC, 1992, NEW ENGL J MED, V327, P1434; IHDE DC, 1991, CURR PROB CANCER, V15, P61; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; JENSEN NV, 2002, P AN M AM SOC CLIN, V21, pA322; Jeremic B, 1997, LUNG CANCER, V18, P179, DOI 10.1016/S0169-5002(97)00063-9; Juretic A, 1999, ANN ONCOL, V10, P93, DOI 10.1023/A:1008385731605; KAWAHARA M, 1991, CANCER, V68, P714, DOI 10.1002/1097-0142(19910815)68:4<714::AID-CNCR2820680408>3.0.CO;2-J; KLASTERSKY J, 1989, J CLIN ONCOL, V7, P1087, DOI 10.1200/JCO.1989.7.8.1087; Klastersky J, 2001, LUNG CANCER-J IASLC, V34, pS95; Kodani T, 2002, LUNG CANCER, V36, P313, DOI 10.1016/S0169-5002(02)00008-9; KOSMIDIS P, 1994, ANN ONCOL, V5, P159, DOI 10.1093/oxfordjournals.annonc.a058769; Laack E, 2002, ANN ONCOL, V13, P1550, DOI 10.1093/annonc/mdf270; Langer CJ, 2003, P AN M AM SOC CLIN, V22, P639; LECHEVALIER T, 1994, J CLIN ONCOL, V12, P360, DOI 10.1200/JCO.1994.12.2.360; Lilenbaum RC, 1998, CANCER, V82, P116, DOI 10.1002/(SICI)1097-0142(19980101)82:1<116::AID-CNCR14>3.0.CO;2-5; LILENBAUM RC, 2002, P AN M AM SOC CLIN, V21, P2; LORUSSO V, 1995, INT J ONCOL, V6, P65; LUEDKE DW, 1990, J CLIN ONCOL, V8, P886, DOI 10.1200/JCO.1990.8.5.886; MARINO P, 1994, CHEST, V106, P861, DOI 10.1378/chest.106.3.861; Masutani M, 1996, Respirology, V1, P49, DOI 10.1111/j.1440-1843.1996.tb00010.x; Mencoboni M, 1997, ANTICANCER RES, V17, P2795; MICHIELS S, IN PRESS INT J TECHN; NAKABAYASHI T, 1986, LUNG CANCER, V2, P124; Natale RB, 1997, SEMIN ONCOL, V24, pS29; Negoro S, 2003, BRIT J CANCER, V88, P335, DOI 10.1038/sj.bjc.6600725; NEGORO S, 1988, LUNG CANCER S, V4, pA126; PACCAGNELLA A, 1990, CANCER, V65, P2631, DOI 10.1002/1097-0142(19900615)65:12<2631::AID-CNCR2820651205>3.0.CO;2-Y; Perol M, 2002, ANN ONCOL, V13, P742, DOI 10.1093/annonc/mdf128; RICHARDS F, 1991, CANCER, V67, P2974; RIVERO S, 1999, P AN M AM SOC CLIN, V18, P2010; Rosell R, 2002, ANN ONCOL, V13, P1539, DOI 10.1093/annonc/mdf332; ROSSO R, 1990, CANCER-AM CANCER SOC, V66, P130, DOI 10.1002/1097-0142(19900701)66:1<130::AID-CNCR2820660123>3.0.CO;2-P; Sandler AB, 2000, J CLIN ONCOL, V18, P122, DOI 10.1200/JCO.2000.18.1.122; Sederholm C, 2002, SEMIN ONCOL, V29, P50, DOI 10.1053/sonc.2002.34276; SHAH S, 1988, P AN M AM SOC CLIN, V7, P211; SHINKAI T, 1991, EUR J CANCER, V27, P571, DOI 10.1016/0277-5379(91)90220-8; SIMES RJ, 1987, STAT MED, V6, P11, DOI 10.1002/sim.4780060104; Somerfield MR, 1997, J CLIN ONCOL, V15, P2996; Soria JC, 2002, ANN ONCOL, V13, P1515, DOI 10.1093/annonc/mdf331; Soria JC, 2001, ANN ONCOL, V12, P1667, DOI 10.1023/A:1013574413217; SORIA JC, 1999, P AN M AM SOC CLIN, V18, pA491; SOUQUET PJ, 1993, LANCET, V342, P19; Souquet PJ, 2002, ANN ONCOL, V13, P1853, DOI 10.1093/annonc/mdf316; Splinter TAW, 1996, J CLIN ONCOL, V14, P127, DOI 10.1200/JCO.1996.14.1.127; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Sweeney CJ, 2001, CANCER, V92, P2639, DOI 10.1002/1097-0142(20011115)92:10<2639::AID-CNCR1617>3.0.CO;2-8; TSURUTA M, 1986, LUNG CANCER, V2, P113; von Pawel J, 2000, J CLIN ONCOL, V18, P1351, DOI 10.1200/JCO.2000.18.6.1351; Waters JS, 2002, BRIT J CANCER, V87, P481, DOI 10.1038/sj.bjc.6600491; Williamson PR, 2000, J EVAL CLIN PRACT, V6, P205, DOI 10.1046/j.1365-2753.2000.00236.x; Wozniak AJ, 1998, J CLIN ONCOL, V16, P2459, DOI 10.1200/JCO.1998.16.7.2459; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zoli W, 1999, BRIT J CANCER, V81, P609, DOI 10.1038/sj.bjc.6690737	96	254	269	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2004	292	4					470	484		10.1001/jama.292.4.470	http://dx.doi.org/10.1001/jama.292.4.470			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841AA	15280345				2022-12-28	WOS:000222900500024
J	Reusser, LJ; Bierman, PR; Pavich, MJ; Zen, EA; Larsen, J; Finkel, R				Reusser, LJ; Bierman, PR; Pavich, MJ; Zen, EA; Larsen, J; Finkel, R			Rapid late Pleistocene incision of Atlantic passive-margin river gorges	SCIENCE			English	Article							BEDROCK INCISION; UPLIFT; BE-10; LEVEL; AL-26	The direct and secondary effects of rapidly changing climate caused large rivers draining the Atlantic passive margin to incise quickly into bedrock beginning about 35,000 years ago. Measured in samples from bedrock fluvial terraces, 10-beryllium shows that both the Susquehanna and Potomac Rivers incised 10- to 20-meter-deep gorges along steep, convex lower reaches during the last glacial cycle. This short-lived pulse of unusually rapid down-cutting ended by 13,000 to 14,000 years ago. The timing and rate of downcutting are similar on the glaciated Susquehanna and unglaciated Potomac Rivers, indicating that regional changes, not simply glacial meltwater, initiated incision.	Univ Vermont, Dept Geol, Burlington, VT 05401 USA; Univ Vermont, Sch Nat Resources, Burlington, VT 05401 USA; US Geol Survey, Natl Ctr, Reston, VA 20192 USA; Univ Maryland, Dept Geol, College Pk, MD 20742 USA; Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA	University of Vermont; University of Vermont; United States Department of the Interior; United States Geological Survey; University System of Maryland; University of Maryland College Park; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Reusser, LJ (corresponding author), Univ Vermont, Dept Geol, Burlington, VT 05401 USA.	lreusser@uvm.edu	Bierman, Paul/AAA-9466-2020	Bierman, Paul/0000-0001-9627-4601				Bierman PR, 2002, REV MINERAL GEOCHEM, V50, P147, DOI 10.2138/rmg.2002.50.4; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; BRAUN D, 1988, 53 ANN FIELD C PENNS, P3; BRAUN DE, 1994, 948 US NAV HLTH RES, P1; Burbank DW, 1996, NATURE, V379, P505, DOI 10.1038/379505a0; Clark DH, 1995, QUATERNARY RES, V44, P367, DOI 10.1006/qres.1995.1081; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; Douglas BC, 2002, PHYS TODAY, V55, P35, DOI 10.1063/1.1472392; Granger DE, 1997, GEOLOGY, V25, P107, DOI 10.1130/0091-7613(1997)025<0107:QDROTN>2.3.CO;2; GRIMM E, 2003, 16 INQUA C REN NV 23; Hancock GS, 2002, GEOL SOC AM BULL, V114, P1131; Hartshorn K, 2002, SCIENCE, V297, P2036, DOI 10.1126/science.1075078; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Leland J, 1998, EARTH PLANET SC LETT, V154, P93, DOI 10.1016/S0012-821X(97)00171-4; LITWIN R, 2004, NE SE GEOL SOC AM RE; Mayewski PA, 1997, J GEOPHYS RES-OCEANS, V102, P26345, DOI 10.1029/96JC03365; MERRITTS DJ, 1994, J GEOPHYS RES-SOL EA, V99, P14031, DOI 10.1029/94JB00857; Noren AJ, 2002, NATURE, V419, P821, DOI 10.1038/nature01132; PAZZAGLIA FJ, 1993, GEOMORPHOLOGY, V8, P83, DOI 10.1016/0169-555X(93)90031-V; PELLETIER J, COMMUNICATION; REED J, 1980, RIVER ROCKS GEOLOGIC, P75; REED JC, 1981, GEOLOGY, V9, P445, DOI 10.1130/0091-7613(1981)9<445:DPOTPR>2.0.CO;2; SHACKLETON NJ, 1987, QUATERNARY SCI REV, V6, P183, DOI 10.1016/0277-3791(87)90003-5; Sklar LS, 2001, GEOLOGY, V29, P1087, DOI 10.1130/0091-7613(2001)029<1087:SARSCO>2.0.CO;2; Snyder NP, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002649; Tinkler K.J., 1998, RIVERS ROCK FLUVIAL, DOI [10.1029/GM107, DOI 10.1029/GM107]; Tucker GE, 2004, EARTH SURF PROC LAND, V29, P185, DOI 10.1002/esp.1020; *USGS, 01646500 USGS; *USGS, 01576000 USGS; Whipple KX, 2000, GEOL SOC AM BULL, V112, P490, DOI 10.1130/0016-7606(2000)112<0490:RIIBMA>2.3.CO;2; Winograd IJ, 2001, QUATERNARY RES, V56, P299, DOI 10.1006/qres.2001.2272; ZEN E, 1997, 9760 US GEOL SURV; ZEN E, 1997, 97480 US GEOL SURV	33	69	70	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2004	305	5683					499	502		10.1126/science.1097780	http://dx.doi.org/10.1126/science.1097780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273389				2022-12-28	WOS:000222828900034
J	Ramchandani, P				Ramchandani, P			A question of balance	NATURE			English	Editorial Material							MAJOR DEPRESSION; CONTROLLED TRIAL; ADOLESCENTS; CHILDREN; EFFICACY		Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England	University of Oxford	Ramchandani, P (corresponding author), Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England.		Ramchandani, Paul/O-5340-2014	Ramchandani, Paul/0000-0003-3646-2410				Aynsley-Green A, 2000, BRIT MED J, V321, P229, DOI 10.1136/bmj.321.7255.229; Brent DA, 2004, J AM ACAD CHILD PSY, V43, P379, DOI 10.1097/01.chi.0000120018.48166.57; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Pich J, 2003, LANCET, V361, P1015, DOI 10.1016/S0140-6736(03)12799-7; Wagner KD, 2004, AM J PSYCHIAT, V161, P1079, DOI 10.1176/appi.ajp.161.6.1079; Wagner KD, 2003, JAMA-J AM MED ASSOC, V290, P1033, DOI 10.1001/jama.290.8.1033; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	8	10	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					401	402		10.1038/430401a	http://dx.doi.org/10.1038/430401a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269742				2022-12-28	WOS:000222801400018
J	Silbergeld, E; Lerman, S; Hushka, L				Silbergeld, E; Lerman, S; Hushka, L			Human health research ethics	SCIENCE			English	Editorial Material									ExxonMobil Biomed Sci Inc, Annandale, NJ 08801 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; ExxonMobil Corp, Houston, TX 77079 USA	Exxon Mobil Corporation; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Exxon Mobil Corporation	Lerman, S (corresponding author), ExxonMobil Biomed Sci Inc, Annandale, NJ 08801 USA.	steven.e.lerman@exxonmobil.com						*CIOMS, 2002, INT ETH GUID BIOM RE; *EPA FIFRA SCI ADV, 2000, EPASABEC00017 FIFRA; *NRC, 2002, US 3 PART TOX RES HU; *WORLD MED ASS, 2000, DECL HELS ETH PRINC; [No title captured]; 1996, ICH TOPIC E, V6; 2003, FED REG, V68, P24410	7	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					949	949		10.1126/science.1096862	http://dx.doi.org/10.1126/science.1096862			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310879				2022-12-28	WOS:000223250700023
J	Baker, AC; Starger, CJ; McClanahan, TR; Glynn, PW				Baker, AC; Starger, CJ; McClanahan, TR; Glynn, PW			Corals' adaptive response to climate change	NATURE			English	Editorial Material							REEF CORALS; FLEXIBILITY; HYPOTHESIS; MORTALITY; DIVERSITY; PATTERNS; ECOLOGY		Wildlife Conservat Soc, Marine Program, Bronx, NY 10460 USA; Columbia Univ, Ctr Environm Res & Conservat, New York, NY 10027 USA; Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	Wildlife Conservation Society; Columbia University; Columbia University; University of Miami	Baker, AC (corresponding author), Wildlife Conservat Soc, Marine Program, Bronx, NY 10460 USA.	abaker@wcs.org	McClanahan, Tim/K-4998-2019	McClanahan, Timothy/0000-0001-5821-3584; Baker, Andrew/0000-0002-7866-2587; Starger, Craig/0000-0003-2444-6632				Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Glynn PW, 2001, B MAR SCI, V69, P79; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Ware JR, 1996, ECOL MODEL, V84, P199, DOI 10.1016/0304-3800(94)00132-4; WILKINSON C, 2002, STATUS CORAL REEFS W	13	566	593	4	290	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					741	741		10.1038/430741a	http://dx.doi.org/10.1038/430741a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306799	Bronze			2022-12-28	WOS:000223233600030
J	Lerner, BH				Lerner, BH			Sins of omission - Cancer research without informed consent	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Med Ctr, Dept Med, New York, NY 10027 USA; Columbia Univ, Med Ctr, Mailman Sch Publ Hlth, New York, NY USA	Columbia University; Columbia University	Lerner, BH (corresponding author), Columbia Univ, Med Ctr, Dept Med, New York, NY 10027 USA.							BEECHER HK, 1966, NEW ENGL J MED, V274, P1354, DOI 10.1056/NEJM196606162742405; Drazen JM, 2000, NEW ENGL J MED, V343, P1643, DOI 10.1056/NEJM200011303432212; KATZ J, 1972, EXPT HUMAN BEINGS, P9; Langer E, 1964, SCIENCE, V143, P551; Preminger Beth Aviva, 2002, Pharos Alpha Omega Alpha Honor Med Soc, V65, P4	5	24	26	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					628	630		10.1056/NEJMp048108	http://dx.doi.org/10.1056/NEJMp048108			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306661				2022-12-28	WOS:000223225500002
J	Whitcomb, ME; Cohen, JJ				Whitcomb, ME; Cohen, JJ			The future of primary care medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Assoc Amer Med Coll, Washington, DC 20037 USA	Association of American Medical Colleges	Whitcomb, ME (corresponding author), Assoc Amer Med Coll, Washington, DC 20037 USA.							Grumbach K, 2002, JAMA-J AM MED ASSOC, V288, P889, DOI 10.1001/jama.288.7.889; Showstack J, 2003, ANN INTERN MED, V138, P268, DOI 10.7326/0003-4819-138-3-200302040-00036; Wiest FC, 2002, JAMA-J AM MED ASSOC, V288, P2609, DOI 10.1001/jama.288.20.2609	3	73	75	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					710	712		10.1056/NEJMsb045003	http://dx.doi.org/10.1056/NEJMsb045003			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306674				2022-12-28	WOS:000223225500016
J	Bertelsen, P; Goetz, W; Madsen, MB; Kinch, KM; Hviid, SF; Knudsen, JM; Gunnlaugsson, HP; Merrison, J; Nornberg, P; Squyres, SW; Bell, JF; Herkenhoff, KE; Gorevan, S; Yen, AS; Myrick, T; Klingelhofer, G; Rieder, R; Gellert, R				Bertelsen, P; Goetz, W; Madsen, MB; Kinch, KM; Hviid, SF; Knudsen, JM; Gunnlaugsson, HP; Merrison, J; Nornberg, P; Squyres, SW; Bell, JF; Herkenhoff, KE; Gorevan, S; Yen, AS; Myrick, T; Klingelhofer, G; Rieder, R; Gellert, R			Magnetic Properties Experiments on the Mars exploration Rover Spirit at Gusev crater	SCIENCE			English	Article							IRON-OXIDES; MOSSBAUER; SPECTROMETER; SOILS; ROCKS	The magnetic properties experiments are designed to help identify the magnetic minerals in the dust and rocks on Mars-and to determine whether liquid water was involved in the formation and alteration of these magnetic minerals. Almost all of the dust particles suspended in the martian atmosphere must contain ferrimagnetic minerals (such as maghemite or magnetite) in an amount of similar to2% by weight. The most magnetic fraction of the dust appears darker than the average dust. Magnetite was detected in the first two rocks ground by Spirit.	Univ Copenhagen, Danish Space Res Inst, Ctr Planetary Sci, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Niels Bohr Inst Astron Phys & Geophys, DK-2100 Copenhagen, Denmark; Univ Aarhus, Dept Phys & Astron, DK-8000 Aarhus, Denmark; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Univ Aarhus, Dept Earth Sci, DK-8000 Aarhus, Denmark; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; US Geol Survey, Branch Astrogeol, Flagstaff, AZ 86001 USA; Honeybee Robot Ltd, New York, NY 10012 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Johannes Gutenberg Univ Mainz, Inst Inorgan & Analyt Chem, D-55099 Mainz, Germany; Max Planck Inst Chem, D-55020 Mainz, Germany	Technical University of Denmark; University of Copenhagen; University of Copenhagen; Niels Bohr Institute; Aarhus University; Max Planck Society; Aarhus University; Cornell University; United States Department of the Interior; United States Geological Survey; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johannes Gutenberg University of Mainz; Max Planck Society	Bertelsen, P (corresponding author), Univ Copenhagen, Danish Space Res Inst, Ctr Planetary Sci, DK-2100 Copenhagen, Denmark.	preben@fys.ku.dk	Kinch, Kjartan Bergeron/C-5742-2015; Madsen, Morten Bo/D-2082-2011; Nornberg, Per/A-6228-2012; merrison, jonathan p/L-6524-2018; Gunnlaugsson, Haraldur/L-6535-2016	Kinch, Kjartan Bergeron/0000-0002-4629-8880; Madsen, Morten Bo/0000-0001-8909-5111; merrison, jonathan p/0000-0003-4362-6356; Gunnlaugsson, Haraldur/0000-0002-8958-0245				ASHWAL LD, 1977, J GEOPHYS RES, V82, P1315, DOI 10.1029/JB082i008p01315; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; BELL JF, 1990, J GEOPHYS RES-SOLID, V95, P14447, DOI 10.1029/JB095iB09p14447; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; Madsen MB, 1999, J GEOPHYS RES-PLANET, V104, P8761, DOI 10.1029/1998JE900006; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; MORRIS RV, 1989, J GEOPHYS RES-SOLID, V94, P2760, DOI 10.1029/JB094iB03p02760; MORRIS RV, 1993, GEOCHIM COSMOCHIM AC, V57, P4597, DOI 10.1016/0016-7037(93)90185-Y; Rieder R, 1997, SCIENCE, V278, P1771, DOI 10.1126/science.278.5344.1771; Smith PH, 1997, J GEOPHYS RES-PLANET, V102, P4003, DOI 10.1029/96JE03568; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121	13	69	72	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					827	829		10.1126/science.1100112	http://dx.doi.org/10.1126/science.1100112			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297664				2022-12-28	WOS:000223104900037
J	Acinas, SG; Klepac-Ceraj, V; Hunt, DE; Pharino, C; Ceraj, I; Distel, DL; Polz, MF				Acinas, SG; Klepac-Ceraj, V; Hunt, DE; Pharino, C; Ceraj, I; Distel, DL; Polz, MF			Fine-scale phylogenetic architecture of a complex bacterial community	NATURE			English	Article							GENOMIC ANALYSIS; DIVERSITY; SEQUENCE; POPULATION; DIVERGENCE	Although molecular data have revealed the vast scope of microbial diversity(1), two fundamental questions remain unanswered even for well-defined natural microbial communities: how many bacterial types co-exist, and are such types naturally organized into phylogenetically discrete units of potential ecological significance? It has been argued that without such information, the environmental function, population biology and biogeography of microorganisms cannot be rigorously explored(2). Here we address these questions by comprehensive sampling of two large 16S ribosomal RNA clone libraries from a coastal bacterioplankton community. We show that compensation for artefacts generated by common library construction techniques reveals fine-scale patterns of community composition. At least 516 ribotypes ( unique rRNA sequences) were detected in the sample and, by statistical extrapolation, at least 1,633 co-existing ribotypes in the sampled population. More than 50% of the ribotypes fall into discrete clusters containing less than 1% sequence divergence. This pattern cannot be accounted for by interoperon variation, indicating a large predominance of closely related taxa in this community. We propose that such microdiverse clusters arise by selective sweeps and persist because competitive mechanisms are too weak to purge diversity from within them.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; Bugaco, Somerville, MA 02144 USA; Univ Maine, Dept Biochem Microbiol & Mol Biol, Orono, ME 04469 USA	Massachusetts Institute of Technology (MIT); University of Maine System; University of Maine Orono	Polz, MF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mpolz@mit.edu	chen, qi/C-8585-2011; Acinas, Silvia/F-7462-2016; Distel, Daniel/A-8047-2017; Polz, Martin/ABE-7199-2020; Hunt, Dana/A-2051-2012	Acinas, Silvia/0000-0002-3439-0428; Distel, Daniel/0000-0002-3860-194X; Hunt, Dana/0000-0002-8801-9624; /0000-0001-9296-3733; Klepac-Ceraj, Vanja/0000-0001-5387-5706; Polz, Martin/0000-0002-4975-2946				Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Beja O, 2002, APPL ENVIRON MICROB, V68, P335, DOI 10.1128/AEM.68.1.335-345.2002; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Daubin V, 2003, SCIENCE, V301, P829, DOI 10.1126/science.1086568; Field KG, 1997, APPL ENVIRON MICROB, V63, P63, DOI 10.1128/AEM.63.1.63-70.1997; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hugenholtz P, 2003, INT J SYST EVOL MICR, V53, P289, DOI 10.1099/ijs.0.02441-0; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klepac-Ceraj V, 2004, ENVIRON MICROBIOL, V6, P686, DOI 10.1111/j.1462-2920.2004.00600.x; Lan R, 2001, TRENDS MICROBIOL, V9, P419, DOI 10.1016/S0966-842X(01)02133-3; Lan RT, 2000, TRENDS MICROBIOL, V8, P396, DOI 10.1016/S0966-842X(00)01791-1; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Pybus OG, 2002, BIOINFORMATICS, V18, P1404, DOI 10.1093/bioinformatics/18.10.1404; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Schleper C, 1998, J BACTERIOL, V180, P5003, DOI 10.1128/JB.180.19.5003-5009.1998; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vergin KL, 1998, APPL ENVIRON MICROB, V64, P3075; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799	29	397	406	0	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					551	554		10.1038/nature02649	http://dx.doi.org/10.1038/nature02649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282603				2022-12-28	WOS:000222946100045
J	Torriani, FJ; Rodriguez-Torres, M; Rockstroh, JK; Lissen, E; Gonzalez-Garcia, J; Lazzarin, A; Carosi, G; Sasadeusz, J; Katlama, C; Montaner, J; Sette, HJ; Passe, S; De Pamphilis, J; Duff, F; Schrenk, UM; Dieterich, DT				Torriani, FJ; Rodriguez-Torres, M; Rockstroh, JK; Lissen, E; Gonzalez-Garcia, J; Lazzarin, A; Carosi, G; Sasadeusz, J; Katlama, C; Montaner, J; Sette, HJ; Passe, S; De Pamphilis, J; Duff, F; Schrenk, UM; Dieterich, DT		APRICOT Study Grp	Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THERAPY; TRIAL; HCV	BACKGROUND: Hepatitis C virus (HCV) infection is highly prevalent and is associated with substantial morbidity and mortality among persons infected with the human immunodeficiency virus (HIV). We compared the efficacy and safety of pegylated interferon alfa-2a (peginterferon alfa-2a) plus either ribavirin or placebo with those of interferon alfa-2a plus ribavirin for the treatment of chronic HCV INFECTION IN PATIENTS WHO WERE ALSO INFECTED WITH HIV. METHODS: A total of 868 persons who were infected with both HIV and HCV and who had not previously been treated with interferon or ribavirin were randomly assigned to receive one of three regimens: peginterferon alfa-2a (180 microg per week) plus ribavirin (800 mg per day), peginterferon alfa-2a plus placebo, or interferon alfa-2a (3 million IU three times a week) plus ribavirin. Patients were treated for 48 weeks and followed for an additional 24 weeks. The primary end point was a sustained virologic response (defined as a serum HCV RNA level below 50 IU per milliliter at the end of follow-up, at week 72). RESULTS: The overall rate of sustained virologic response was significantly higher among the recipients of peginterferon alfa-2a plus ribavirin than among those assigned to interferon alfa-2a plus ribavirin (40 percent vs. 12 percent, P<0.001), or peginterferon alfa-2a plus placebo (40 percent vs. 20 percent, P<0.001). Among patients infected with HCV genotype 1, the rates of sustained virologic response were 29 percent with peginterferon alfa-2a plus ribavirin, 14 percent with peginterferon alfa-2a plus placebo, and 7 percent with interferon alfa-2a plus ribavirin. The corresponding rates among patients infected with HCV genotype 2 or 3 were 62 percent, 36 percent, and 20 percent. Neutropenia and thrombocytopenia were more common among patients treated with regimens that contained peginterferon alfa-2a, and anemia was more common among patients treated with regimens containing ribavirin. CONCLUSIONS: Among patients infected with both HIV and HCV, the combination of peginterferon alfa-2a plus ribavirin was significantly more effective than either interferon alfa-2a plus ribavirin or peginterferon alfa-2a monotherapy.	Univ Calif San Diego, AntiViral Res Ctr, Dept Med, Div Infect Dis, San Diego, CA 92103 USA; Fdn Invest Diego, Santurce, PR USA; Univ Bonn, D-5300 Bonn, Germany; Virgen Rocio Univ Hosp, Seville, Spain; Hosp Univ La Paz, Unidad Virus Immunodeficiencia Humana, Madrid, Spain; San Raffaele Vita Salute Univ, Ist Ricovero & Cura Carattere Sci, Milan, Italy; Univ Brescia, Dept Infect & Trop Dis, Brescia, Italy; Alfred Hosp, Melbourne, Vic, Australia; Grp Hosp Pitie Salpetriere, F-75634 Paris, France; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Inst Infectol Emilio Ribas, Sao Paulo, Brazil; Roche, Nutley, NJ USA; Roche, Basel, Switzerland; CUNY Mt Sinai Sch Med, New York, NY 10029 USA	University of California System; University of California San Diego; University of Bonn; Virgen del Rocio University Hospital; Hospital Universitario La Paz; IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; University of Brescia; Florey Institute of Neuroscience & Mental Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of British Columbia; Roche Holding; Roche Holding; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Torriani, FJ (corresponding author), Univ Calif San Diego, AntiViral Res Ctr, Dept Med, Div Infect Dis, 150 W Washington St,Suite 100, San Diego, CA 92103 USA.	ftorriani@ucsd.edu	Torriani, Francesca/HGE-5175-2022; Montaner, Julio/K-7621-2012; LAZZARIN, Adriano/K-3607-2018	LAZZARIN, Adriano/0000-0003-2551-7754; Gonzalez-Garcia, Juan/0000-0002-3652-002X				[Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Brau N, 2003, AIDS, V17, P2279, DOI [10.1097/00002030-200311070-00002, 10.1097/01.aids.0000088176.01779.19]; CHUNG R, 2004, 11 C RETR OPP INF SA, P116; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Herrmann E, 2003, HEPATOLOGY, V37, P1351, DOI 10.1053/jhep.2003.50218; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655; MAUSS S, 2004, IN PRESS AIDS; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Perez-Olmeda M, 2003, AIDS, V17, P1023, DOI 10.1097/00002030-200305020-00011; PERRONNE C, 2004, 11 C RETR OPP INF SA, P119; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Soriano V, 2002, AIDS, V16, P813, DOI 10.1097/00002030-200204120-00001; Torriani FJ, 2003, J INFECT DIS, V188, P1498, DOI 10.1086/379255	17	1010	1060	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					438	450		10.1056/NEJMoa040842	http://dx.doi.org/10.1056/NEJMoa040842			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282351				2022-12-28	WOS:000222939700007
J	Rogstad, KE				Rogstad, KE			Sex, sun, sea, and STEs: sexually transmitted infections acquired on holiday	BRITISH MEDICAL JOURNAL			English	Review							INTERNATIONAL TRAVELERS; RISK BEHAVIOR; HEALTH-PROMOTION; HIV; DISEASE		Royal Hallamshire Hosp, Dept Genitourinary Med, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Rogstad, KE (corresponding author), Royal Hallamshire Hosp, Dept Genitourinary Med, Sheffield S10 2JF, S Yorkshire, England.	Karen.Rogstad@sth.nhs.uk						Batalla-Duran E, 2003, FAM PRACT, V20, P493, DOI 10.1093/fampra/cmg431; Carter S, 1997, INT J STD AIDS, V8, P336, DOI 10.1258/0956462971920055; *DEP TRANSP, 1994, TRANSP STAT GREAT BR; *DEP TRANSP, 2003, TRANSP STAT GREAT BR; Finney H, 2003, FAM PRACT, V20, P93, DOI 10.1093/fampra/20.1.93; GILLIES P, 1992, AIDS, V6, P339, DOI 10.1097/00002030-199203000-00020; *GON RES ANT SURV, 2003, GON RES ANT SURV PRO; HART GJ, 2000, TOURISM SEX CULTURE; HAWKES S, 1994, AIDS, V8, P247, DOI 10.1097/00002030-199402000-00013; HAWKES S, 1995, GENITOURIN MED, V71, P351; *HLTH PROT AG, 2003, REN FOC HIV OTH SEX; Hook Er., 1999, SEX TRANSM DIS; Ison CA, 1998, ANTIMICROB AGENTS CH, V42, P2919, DOI 10.1128/AAC.42.11.2919; Mulhall BP, 1996, INT J STD AIDS, V7, P455, DOI 10.1258/0956462961918419; OMAHONY C, 2003, SEX TRANSM INFECT, V79, P261; Rogstad KE, 2003, SEX TRANSM INFECT, V79, P243, DOI 10.1136/sti.79.3.243; SCHMID GP, 1987, JAMA-J AM MED ASSOC, V258, P3265, DOI 10.1001/jama.258.22.3265; Shickle D, 1998, Commun Dis Public Health, V1, P41; Stephenson J, 2003, JAMA-J AM MED ASSOC, V289, P287, DOI 10.1001/jama.289.3.287; *UNAIDS WHO, 2003, AIDS EP UPD DEC 2003; Wellings K, 1999, J ROY SOC MED, V92, P60, DOI 10.1177/014107689909200204; 2003, COMPANY          NOV	22	62	62	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 24	2004	329	7459					214	217		10.1136/bmj.329.7459.214	http://dx.doi.org/10.1136/bmj.329.7459.214			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840NW	15271833	Green Published			2022-12-28	WOS:000222866900021
J	Verez-Bencomo, V; Fernandez-Santana, V; Hardy, E; Toledo, ME; Rodriguez, MC; Heynngnezz, L; Rodriguez, A; Baly, A; Herrera, L; Izquierdo, M; Villar, A; Valdes, Y; Cosme, K; Deler, ML; Montane, M; Garcia, E; Ramos, A; Aguilar, A; Medina, E; Torano, G; Sosa, I; Hernandez, I; Martinez, R; Muzachio, A; Carmenates, A; Costa, L; Cardoso, F; Campa, C; Diaz, M; Roy, R				Verez-Bencomo, V; Fernandez-Santana, V; Hardy, E; Toledo, ME; Rodriguez, MC; Heynngnezz, L; Rodriguez, A; Baly, A; Herrera, L; Izquierdo, M; Villar, A; Valdes, Y; Cosme, K; Deler, ML; Montane, M; Garcia, E; Ramos, A; Aguilar, A; Medina, E; Torano, G; Sosa, I; Hernandez, I; Martinez, R; Muzachio, A; Carmenates, A; Costa, L; Cardoso, F; Campa, C; Diaz, M; Roy, R			A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b	SCIENCE			English	Article							CAPSULAR POLYSACCHARIDE; HEMOPHILUS-INFLUENZAE; ANTIBODY-RESPONSES; PROTEIN; IMMUNOGENICITY; PREVENTION; INFECTIONS; FRAGMENTS; EFFICACY	Glycoconjugate vaccines provide effective prophylaxis against bacterial infections. To date, however, no commercial vaccine has been available in which the key carbohydrate antigens are produced synthetically. We describe the large-scale synthesis, pharmaceutical development, and clinical evaluation of a conjugate vaccine composed of a synthetic capsular polysaccharide antigen of Haemophilus influenzae type b (Hib). The vaccine was evaluated in clinical trials in Cuba and showed long-term protective antibody titers that compared favorably to licensed products prepared with the Hib polysaccharide extracted from bacteria. This demonstrates that access to synthetic complex carbohydrate - based vaccines is feasible and provides a basis for further development of similar approaches for other human pathogens.	Univ La Habana, Fac Quim, Ctr Study Synthet Antigens, Havana 10400, Cuba; Inst Trop Med Pedro Kouri, Havana 11300, Cuba; Prov Ctr Hyg & Epidemiol, Camaguey, Cuba; Finlay Inst, Havana 11600, Cuba; Univ Quebec, Dept Chem, Montreal, PQ H3C 3P8, Canada; Ctr Genet Engn & Biotechnol, Havana 10600, Cuba	Universidad de la Habana; University of Quebec; University of Quebec Montreal; Centro de Ingenieria Genetica y Biotecnologia	Verez-Bencomo, V (corresponding author), Univ La Habana, Fac Quim, Ctr Study Synthet Antigens, Havana 10400, Cuba.	vicente@fq.uh.cu; violeta@fq.uh.cu; eugenio.hardy@cigb.edu.cu; mariaeugenia@ipk.sld.cu; roy.rene@uqam.ca	Herrera, Luis/GOV-3311-2022; CAMPA, Claudine/C-9241-2015	Musacchio Lasa, Alexis/0000-0001-6598-6067				AMIR J, 1990, PEDIATR RES, V27, P358, DOI 10.1203/00006450-199004000-00008; ANDERSON P, 1983, INFECT IMMUN, V39, P233, DOI 10.1128/IAI.39.1.233-238.1983; ANDERSON P, 1972, J CLIN INVEST, V51, P39, DOI 10.1172/JCI106794; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; CHIUMACHADO I, 1995, J CARBOHYD CHEM, V14, P551, DOI 10.1080/07328309508005357; Chong P, 1997, INFECT IMMUN, V65, P4918, DOI 10.1128/IAI.65.12.4918-4925.1997; CHU CY, 1983, INFECT IMMUN, V40, P245, DOI 10.1128/IAI.40.1.245-256.1983; COCHI SL, 1988, PEDIATRICS, V81, P166; CONSTANTINO P, 1999, VACCINE, V17, P1251; Farrington P, 2003, METH MOLEC MED, V87, P335; Fernandez-Santana V, 1998, GLYCOCONJUGATE J, V15, P549, DOI 10.1023/A:1006903524007; FERNANDEZSANTAN.V, UNPUB; HOLMES SJ, 1993, AM J DIS CHILD, V147, P832, DOI 10.1001/archpedi.1993.02160320034015; HOOGERHOUT P, 1987, TETRAHEDRON LETT, V28, P1553, DOI 10.1016/S0040-4039(01)81040-6; JENNINGS HJ, 1996, POLYSACCHARIDES MED, P443; KANDIL AA, 1992, SYNLETT, P555; KAYHTY H, 1983, J INFECT DIS, V147, P1100; MARBURG S, 1986, J AM CHEM SOC, V108, P5282, DOI 10.1021/ja00277a037; NIKOLAEV AV, 1995, CARBOHYD RES, V272, P179, DOI 10.1016/0008-6215(95)00067-4; NILSSON S, 1992, J CARBOHYD CHEM, V11, P265, DOI 10.1080/07328309208017993; PEETERS CCAM, 1992, INFECT IMMUN, V60, P1826, DOI 10.1128/IAI.60.5.1826-1833.1992; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; PELTOLA H, 1984, NEW ENGL J MED, V310, P1561, DOI 10.1056/NEJM198406143102404; PHIPPS DC, 1990, J IMMUNOL METHODS, V135, P121, DOI 10.1016/0022-1759(90)90264-V; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; RANOFF DM, 1991, VACCINE S, V9, pS30; Robbins JB, 1996, JAMA-J AM MED ASSOC, V276, P1181, DOI 10.1001/jama.276.14.1181; Robbins JB, 1996, VACCINIA, VACCINATION, VACCINOLOGY, P135; RODRIGUES LP, 1971, J IMMUNOL, V107, P1071; Romero-Steiner S, 2001, CLIN DIAGN LAB IMMUN, V8, P1115, DOI 10.1128/CDLI.8.6.1115-1119.2001; SCHLESINGER Y, 1992, JAMA-J AM MED ASSOC, V267, P1489, DOI 10.1001/jama.267.11.1489; SCHNEERSON R, 1980, J EXP MED, V152, P361, DOI 10.1084/jem.152.2.361	32	358	382	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2004	305	5683					522	525		10.1126/science.1095209	http://dx.doi.org/10.1126/science.1095209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273395				2022-12-28	WOS:000222828900041
J	Bateson, P; Barker, D; Clutton-Brock, T; Deb, D; D'Udine, B; Foley, RA; Gluckman, P; Godfrey, K; Kirkwood, T; Lahr, MM; McNamara, J; Metcalfe, NB; Monaghan, P; Spencer, HG; Sultan, SE				Bateson, P; Barker, D; Clutton-Brock, T; Deb, D; D'Udine, B; Foley, RA; Gluckman, P; Godfrey, K; Kirkwood, T; Lahr, MM; McNamara, J; Metcalfe, NB; Monaghan, P; Spencer, HG; Sultan, SE			Developmental plasticity and human health	NATURE			English	Article							CATCH-UP GROWTH; HYPOTHESIS; ORIGINS; DISEASE; OBESITY; NUMBER; BIRTH	Many plants and animals are capable of developing In a variety of ways, forming characteristics that are well adapted to the environments In which they are likely to live. In adverse circumstances, for example, small size and slow metabolism can facilitate survival, whereas larger size and more rapid metabolism have advantages for reproductive success when resources are more abundant Often these characteristics are induced In early life or are even set by cues to which their parents or grandparents were exposed. Individuals developmentally adapted to one environment may, however, he at risk when exposed to another when they are older, The biological evidence may be relevant to the understanding of human development and susceptibility to disease. As the nutritional state of many human mothers has improved around the world, the characteristics of their offspring-such as body size and metabolism-have also changed, Responsiveness to their mothers' condition before birth may generally prepare individuals so that they are best suited to the environment forecast by cues available in early life. Paradoxically, however, rapid improvements in nutrition and other environmental Conditions may have damaging effects on the health of those people whose parents and grandparents lived In impoverished conditions. A fuller understanding of patterns of human plasticity in response to early nutrition and other environmental factors will have implications for the administration of public health.	Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England; Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Ctr Interdisciplinary Studies, Kolkata 700123, India; Univ Udine, Dept Pisiol Vegetale, I-33100 Udine, Italy; Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 3DZ, England; Univ Auckland, Liggins Inst, Auckland 1, New Zealand; Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand; Univ Newcastle, Sch Clin Med Sci Gerontol, Henry Wellcome Lab Biogerontol Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England; Univ Glasgow, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; Univ Otago, Dept Zool, Dunedin, New Zealand; Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA	University of Cambridge; University of Southampton; University of Cambridge; University of Udine; University of Cambridge; University of Auckland; University of Auckland; Newcastle University - UK; University of Bristol; University of Glasgow; University of Otago; Wesleyan University	Bateson, P (corresponding author), Univ Cambridge, Subdept Anim Behav, High St, Cambridge CB3 8AA, England.	ppgb@cam.ac.uk	Metcalfe, Neil B./C-5997-2009; Spencer, Hamish G/B-9637-2008; Monaghan, Pat/A-4271-2008; Monaghan, Pat/E-6810-2015; Barker, David JP/A-5671-2013	Metcalfe, Neil B./0000-0002-1970-9349; Spencer, Hamish G/0000-0001-7531-597X; Deb, Debal/0000-0002-7230-659X; Mirazon Lahr, Marta/0000-0001-5752-5770; Godfrey, Keith/0000-0002-4643-0618	Biotechnology and Biological Sciences Research Council [BEP17042] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ALBON SD, 1987, J ANIM ECOL, V56, P69, DOI 10.2307/4800; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 1998, MOTHERS BABIES HLTH; Bateson P, 2001, J BIOSCIENCES, V26, P561, DOI 10.1007/BF02704754; Bateson P., 1999, DESIGN LIFE BEHAV DE; Chali D, 1998, ETHIOPIAN MED J, V36, P227; Chapman C, 2000, J NUTR, V130, P146, DOI 10.1093/jn/130.2.146; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Gilbert SF, 2001, DEV BIOL, V233, P1, DOI 10.1006/dbio.2001.0210; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Godfrey KM, 1997, BRIT J OBSTET GYNAEC, V104, P663, DOI 10.1111/j.1471-0528.1997.tb11975.x; Hales CN, 1997, DIABETIC MED, V14, P189; HINCHLIFFE SA, 1992, BRIT J OBSTET GYNAEC, V99, P296, DOI 10.1111/j.1471-0528.1992.tb13726.x; HUCK UW, 1987, BIOL REPROD, V37, P612, DOI 10.1095/biolreprod37.3.612; JONES AP, 1982, SCIENCE, V215, P1518, DOI 10.1126/science.7063860; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MACKENZIE HS, 1995, AM J KIDNEY DIS, V26, P91, DOI 10.1016/0272-6386(95)90161-2; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; NEEL JV, 1962, AM J HUM GENET, V14, P353; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Pener MP, 1998, J INSECT PHYSIOL, V44, P365, DOI 10.1016/S0022-1910(97)00169-8; Pigliucci M., 2001, SYN ECO EVO; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Schmitt J, 1995, AM NAT, V146, P937, DOI 10.1086/285832; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Sultan SE, 2003, J EXP ZOOL PART B, V296B, P1, DOI 10.1002/jez.b.00010; Tollrian R, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P177; Tufto J, 2000, AM NAT, V156, P121, DOI 10.1086/303381; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vitzthum VJ, 2003, HUM BIOL, V75, P539, DOI 10.1353/hub.2003.0064; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; West-Eberhard Mary Jane, 2003, pi; WIDDOWSON EM, 1972, ARCH DIS CHILD, V47, P652, DOI 10.1136/adc.47.254.652	40	1141	1179	2	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					419	421		10.1038/nature02725	http://dx.doi.org/10.1038/nature02725			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269759				2022-12-28	WOS:000222801400033
J	Gingerich, O				Gingerich, O			A radical reorientation	NATURE			English	Editorial Material									Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Gingerich, O (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.								0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					407	407		10.1038/430407a	http://dx.doi.org/10.1038/430407a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269748	Bronze			2022-12-28	WOS:000222801400023
J	Solomon, T				Solomon, T			Current concepts - Flavivirus encephalitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							WEST-NILE-VIRUS; ST-LOUIS ENCEPHALITIS; JAPANESE ENCEPHALITIS; UNITED-STATES; CLINICAL-FEATURES; CEREBROSPINAL-FLUID; MOVEMENT-DISORDERS; FLACCID PARALYSIS; SUBSTANTIA-NIGRA; GENOME SEQUENCES		Univ Liverpool, Walton Ctr Neurol & Neurosurg, Dept Neurol Sci, Liverpool L9 7LJ, Merseyside, England; Univ Liverpool, Dept Med Microbiol, Liverpool L9 7LJ, Merseyside, England	University of Liverpool; Walton Centre; University of Liverpool	Solomon, T (corresponding author), Univ Liverpool, Walton Ctr Neurol & Neurosurg, Dept Neurol Sci, Liverpool L9 7LJ, Merseyside, England.	tsolomon@liv.ac.uk		Solomon, Tom/0000-0001-7266-6547				Agrawal AG, 2003, J INFECT DIS, V188, P1, DOI 10.1086/376871; Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; [Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P1135; APRK M, 2003, J NEUROL NEUROSUR PS, V74, P823; Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; BENNETT NMK, 1976, MED J AUSTRALIA, V2, P446, DOI 10.5694/j.1326-5377.1976.tb130324.x; BOND JO, 1970, AM J EPIDEMIOL, V92, P321, DOI 10.1093/oxfordjournals.aje.a121213; Bosanko CM, 2003, ARCH NEUROL-CHICAGO, V60, P1448, DOI 10.1001/archneur.60.10.1448; Breinl A., 1918, MED J AUSTRALIA, V1, P209; Breinl A., 1918, MED J AUSTRALIA, V1, P229; BRINKER KR, 1980, LOUIS ENCEPHALITIS, P503; BURKE DS, 1985, AM J TROP MED HYG, V34, P1203, DOI 10.4269/ajtmh.1985.34.1203; BURKE DS, 1985, J INFECT DIS, V151, P1093, DOI 10.1093/infdis/151.6.1093; Burke DSMT, 2001, FLAVIVIRUSES FIELDS, V1, P1043; Burrow JNC, 1998, AUST NZ J MED, V28, P590, DOI 10.1111/j.1445-5994.1998.tb00653.x; *CDCP, W NIL VIR UPD CURR C; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P769; Cerna F, 1999, AM J NEURORADIOL, V20, P1281; CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712; CHEN WR, 1990, J GEN VIROL, V71, P2915, DOI 10.1099/0022-1317-71-12-2915; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; Desai A, 1997, EPIDEMIOL INFECT, V118, P165, DOI 10.1017/S0950268896007327; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; GADOTH N, 1979, ARCH NEUROL-CHICAGO, V36, P172, DOI 10.1001/archneur.1979.00500390090012; Gandelman-Marton R, 2003, CLIN INFECT DIS, V37, P1573, DOI 10.1086/379516; GEORGE S, 1987, INDIAN J MED RES, V86, P131; GROSSMAN RA, 1973, AM J EPIDEMIOL, V98, P133, DOI 10.1093/oxfordjournals.aje.a121538; Haley M, 2003, CLIN INFECT DIS, V37, pE88, DOI 10.1086/377172; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; HARINASUTA C, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P332; HAWKES RA, 1995, EXOTIC VIRAL INFECT, P175; Huang CN, 2002, EMERG INFECT DIS, V8, P1367, DOI 10.3201/eid0812.020532; IGARASHI A, 1994, MICROBIOL IMMUNOL, V38, P827, DOI 10.1111/j.1348-0421.1994.tb01866.x; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; Jeha LE, 2003, NEUROLOGY, V61, P55, DOI 10.1212/01.WNL.0000073617.08185.0A; Johnson CT, 2002, CURR CLIN TOPICS INF, V22, P52; JOHNSON RT, 1985, ANN NEUROL, V18, P567, DOI 10.1002/ana.410180510; Kelley TW, 2003, NEW ENGL J MED, V348, P564, DOI 10.1056/NEJM200302063480618; Kienzle N, 2003, Australas Radiol, V47, P61, DOI 10.1046/j.1440-1673.2003.01105.x; Kumar P, 2004, J INFECT DIS, V189, P880, DOI 10.1086/381768; KUMAR R, 1990, INDIAN J MED RES-A, V91, P321; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Leis AA, 2002, NEW ENGL J MED, V347, P1279, DOI 10.1056/NEJM2002c021587; Li J, 2003, ANN NEUROL, V53, P703, DOI 10.1002/ana.10575; Libraty DH, 2002, T ROY SOC TROP MED H, V96, P173, DOI 10.1016/S0035-9203(02)90294-4; Martin DA, 2002, CLIN DIAGN LAB IMMUN, V9, P544, DOI 10.1128/CDLI.9.3.544-549.2002; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; McCordock HA, 1934, J AMER MED ASSOC, V103, P0822, DOI 10.1001/jama.1934.02750370026006; Misra UK, 1997, ACTA NEUROL SCAND, V96, P114; Misra UK, 1997, J NEUROL, V244, P299, DOI 10.1007/s004150050090; Monath Thomas P., 2002, P1097; Monath TP, 2002, CURR TOP MICROBIOL, V267, P105; Monath TP, 2001, ANN NY ACAD SCI, V951, P1; MONATH TP, 1980, LOUIS ENCEPHALITIS, P239; Mostashari F, 2003, EMERG INFECT DIS, V9, P641; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; NEWMAN W, 1954, CANCER, V7, P106, DOI 10.1002/1097-0142(195401)7:1<106::AID-CNCR2820070112>3.0.CO;2-L; Ni HL, 1996, J GEN VIROL, V77, P1449, DOI 10.1099/0022-1317-77-7-1449; O'Leary DR, 2004, VECTOR-BORNE ZOONOT, V4, P61, DOI 10.1089/153036604773083004; Pepperell C, 2003, CAN MED ASSOC J, V168, P1399; Perelygin AA, 2002, P NATL ACAD SCI USA, V99, P9322, DOI 10.1073/pnas.142287799; Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009; Petersen LR, 2002, NEW ENGL J MED, V347, P1225, DOI 10.1056/NEJMo020128; RAHAL J, 2002, 40 M INF DIS SOC AM, P823; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P1318; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788, DOI 10.3201/eid0907.030129; Shimoni Z, 2001, EMERG INFECT DIS, V7, P759; Shlim DR, 2002, CLIN INFECT DIS, V35, P183, DOI 10.1086/341247; Solomon T, 1998, J CLIN MICROBIOL, V36, P2030, DOI 10.1128/JCM.36.7.2030-2034.1998; Solomon T, 2003, CLIN INFECT DIS, V36, pE140, DOI 10.1086/374936; Solomon T, 2003, BMJ-BRIT MED J, V326, P865, DOI 10.1136/bmj.326.7394.865; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Solomon T, 2002, CURR TOP MICROBIOL, V267, P171; Solomon T, 2002, BRAIN, V125, P1084, DOI 10.1093/brain/awf116; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0; Solomon T, 2003, LANCET, V361, P821, DOI 10.1016/S0140-6736(03)12709-2; Solomon T, 2004, TRAVELERS VACCINES, pp219; SOUTHERN PM, 1969, ANN INTERN MED, V71, P681, DOI 10.7326/0003-4819-71-4-681; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087; Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524; Wasay M, 2000, ARCH NEUROL-CHICAGO, V57, P114, DOI 10.1001/archneur.57.1.114; Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409; Whitley RJ, 2002, LANCET, V359, P507, DOI 10.1016/S0140-6736(02)07681-X; ZIMMERMAN HM, 1946, AM J PATHOL, V22, P965; 2004, MMWR MORB MORTAL WKL, V53, P154	94	235	251	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2004	351	4					370	378		10.1056/NEJMra030476	http://dx.doi.org/10.1056/NEJMra030476			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839RC	15269317	Green Submitted, Bronze			2022-12-28	WOS:000222801200011
J	Chin, C; Bartenstein, M; Altmeyer, A; Riedl, S; Jochim, S; Denschlag, JH; Grimm, R				Chin, C; Bartenstein, M; Altmeyer, A; Riedl, S; Jochim, S; Denschlag, JH; Grimm, R			Observation of the pairing gap in a strongly interacting Fermi gas	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATE; ATOMS; SUPERCONDUCTIVITY; MOLECULES	We studied fermionic pairing in an ultracold two-component gas of (6)Li atoms by observing an energy gap in the radio-frequency excitation spectra. With control of the two-body interactions through a Feshbach resonance, we demonstrated the dependence of the pairing gap on coupling strength, temperature, and Fermi energy. The appearance of an energy gap with moderate evaporative cooling suggests that our full evaporation brought the strongly interacting system deep into a superfluid state.	Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria	University of Innsbruck; Austrian Academy of Sciences	Grimm, R (corresponding author), Univ Innsbruck, Inst Expt Phys, Technikerstr 25, A-6020 Innsbruck, Austria.	rudolf.grimm@uibk.ac.at	Denschlag, Johannes P Hecker/B-6047-2008; Grimm, Rudolf/D-2864-2009; Jochim, Selim/G-1287-2011	Denschlag, Johannes P Hecker/0000-0003-1984-4994; Grimm, Rudolf/0000-0003-1085-5558; Jochim, Selim/0000-0001-6049-2658				Bartenstein M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120401; Bourdel T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.050401; BUCHLER HP, UNPUB; BULGAC A, UNPUB; Carr LD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.150404; Chen Q., UNPUB; Cho A, 2003, SCIENCE, V301, P750; DIENER RB, UNPUB; EAGLES DM, 1969, PHYS REV, V186, P456, DOI 10.1103/PhysRev.186.456; Greiner M, 2003, NATURE, V426, P537, DOI 10.1038/nature02199; Gupta S, 2003, SCIENCE, V300, P1723, DOI 10.1126/science.1085335; Heiselberg H, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.043606; Ho TL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.090402; Holland M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.120406; HULET R, 2004, KAUL I THEOR PHYS C; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; Jochim S, 2003, SCIENCE, V302, P2101, DOI 10.1126/science.1093280; Kinast J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.150402; Kinnunen J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.230403; Kinnunen J, 2004, SCIENCE, V305, P1131, DOI 10.1126/science.1100782; Leggett A. J., 1980, Modern Trends in the Theory of Condensed Matter. Proceedings of the XVIth Karpacz Winter School of Theoretical Physics, P13; NOZIERES P, 1985, J LOW TEMP PHYS, V59, P195, DOI 10.1007/BF00683774; O'Hara KM, 2002, SCIENCE, V298, P2179, DOI 10.1126/science.1079107; Ohashi Y, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.130402; Perali A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220404; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Regal CA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.230404; Regal CA, 2003, NATURE, V424, P47, DOI 10.1038/nature01738; Stajic J, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.063610; Timmermans E, 2001, PHYS LETT A, V285, P228, DOI 10.1016/S0375-9601(01)00346-2; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; Torma P, 2000, PHYS REV LETT, V85, P487, DOI 10.1103/PhysRevLett.85.487; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403; Zwierlein MW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250401	34	701	712	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2004	305	5687					1128	1130		10.1126/science.1100818	http://dx.doi.org/10.1126/science.1100818			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15272125	Green Submitted			2022-12-28	WOS:000223557400039
J	Ramiro, AR; Jankovic, M; Eisenreich, T; Difilippantonio, S; Chen-Kiang, S; Muramatsu, M; Hongo, T; Nussenzweig, A; Nussenzweig, MC				Ramiro, AR; Jankovic, M; Eisenreich, T; Difilippantonio, S; Chen-Kiang, S; Muramatsu, M; Hongo, T; Nussenzweig, A; Nussenzweig, MC			AID is required for c-myc/IgH chromosome translocations in vivo	CELL			English	Article							CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; DOUBLE-STRAND BREAKS; MYC ONCOGENE; SOMATIC HYPERMUTATION; B-CELLS; BURKITT-LYMPHOMA; CIRCULAR DNA; NEOPLASTIC DEVELOPMENT; MURINE PLASMACYTOMAS	Chromosome translocations between c-myc and immunoglobulin (Ig) are associated with Burkitt's lymphoma in humans and with pristane- and IL6-induced plasmacytomas in mice. These translocations frequently involve Ig switch regions, suggesting that they might be the result of aberrant Ig class switch recombination (CSR). However, a direct link between CSR and chromosome translocations has not been established. We have examined c-myc/IgH translocations in IL6 transgenic mice that are mutant for activation induced cytidine deaminase (AID), the enzyme that initiates CSR. Her a we report that AID is essential for the c-myc/IgH chromosome translocations induced by IL6.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA; Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University; Kyoto University	Ramiro, AR (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	nussen@mail.rockefeller.edu	Muramatsu, Masamichi/C-4339-2015; Nussenzweig, Michel/AAE-7292-2019; Ramiro, Almudena R/H-6037-2015	Muramatsu, Masamichi/0000-0002-0153-3533; Ramiro, Almudena R/0000-0002-7539-3844	NATIONAL CANCER INSTITUTE [Z01BC010283, ZIABC010283] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1982, P NATL ACAD SCI-BIOL, V79, P6966, DOI 10.1073/pnas.79.22.6966; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; ARMITAGE JO, 2001, HARRISONS PRINCIPLES, P715; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; CREWS S, 1982, SCIENCE, V218, P1319, DOI 10.1126/science.7146913; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820; GAUWERKY CE, 1993, SEMIN CANCER BIOL, V4, P333; HAMLYN PH, 1983, NATURE, V304, P135, DOI 10.1038/304135a0; HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; Kim N, 1999, J EXP MED, V190, P21, DOI 10.1084/jem.190.1.21; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kovalchuk AL, 2000, LEUKEMIA, V14, P1127, DOI 10.1038/sj.leu.2401767; Kovalchuk AL, 1997, ONCOGENE, V15, P2369, DOI 10.1038/sj.onc.1201409; Kovalchuk AL, 2000, LEUKEMIA, V14, P909, DOI 10.1038/sj.leu.2401676; Kovalchuk AL, 2002, P NATL ACAD SCI USA, V99, P1509, DOI 10.1073/pnas.022643999; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; ROTH DB, 1992, CELL, V69, P41, DOI 10.1016/0092-8674(92)90117-U; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Schrader CE, 2002, J EXP MED, V195, P367, DOI 10.1084/jem.20011877; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; SUEMATSU S, 1992, P NATL ACAD SCI USA, V89, P232, DOI 10.1073/pnas.89.1.232; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	59	350	360	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					431	438		10.1016/j.cell.2004.08.006	http://dx.doi.org/10.1016/j.cell.2004.08.006			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315756	Bronze			2022-12-28	WOS:000223650900006
J	Steven, AC				Steven, AC			Signal transduction at a protein synapse	CELL			English	Editorial Material							BACTERIOPHAGE-T4	Contraction of the bacteriophage T4 tail in the act of host cell penetration represents a massive structural change powered by conformational free energy. A paper in this issue of Cell by Leiman et al. (2004) compares cryo-electron microscopic reconstructions of the initial and final states and reveals that the basic underlying mechanism is concerted rigid-body movements of the constituent protein subunits, akin to the tumbling of gears in a lock.	NIAMS, Struct Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Steven, AC (corresponding author), NIAMS, Struct Biol Lab, Bldg 50,Room 1517,50 South Dr MSC 8025, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR027002, ZIAAR027002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Coombs David H., 1994, P259; JACOB F, 1988, STATUE, P224; KING J, 1997, STRUCTURAL BIOL VIRU, P288; Kostyuchenko VA, 2003, NAT STRUCT BIOL, V10, P688, DOI 10.1038/nsb970; Leiman PG, 2003, CELL MOL LIFE SCI, V60, P2356, DOI 10.1007/s00018-003-3072-1; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; MONOD J, 1971, CHANCE NECESSITY, P85; van Raaij MJ, 2001, J MOL BIOL, V314, P1137, DOI 10.1006/jmbi.2000.5204	9	0	0	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 20	2004	118	4					403	404		10.1016/j.cell.2004.08.004	http://dx.doi.org/10.1016/j.cell.2004.08.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315751	Bronze			2022-12-28	WOS:000223650900001
J	Emanuel, EJ; Wood, A; Fleischman, A; Bowen, A; Getz, KA; Grady, C; Levine, C; Hammerschmidt, DE; Faden, R; Eckenwiler, L; Muse, CT; Sugarman, J				Emanuel, EJ; Wood, A; Fleischman, A; Bowen, A; Getz, KA; Grady, C; Levine, C; Hammerschmidt, DE; Faden, R; Eckenwiler, L; Muse, CT; Sugarman, J			Oversight of human participants research: Identifying problems to evaluate reform proposals	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONFLICTS-OF-INTEREST; POLICIES; TRIALS; BOARD	The oversight of research involving human participants is widely believed to be inadequate. The U.S. Congress, national commissions, the Department of Health and Human Services, the Institute of Medicine, numerous professional societies, and others are proposing remedies based on the assumption that the main problems are researchers' conflict of interest, lack of institutional review board ORB) resources, and the volume and complexity of clinical research. Developing appropriate reform proposals requires carefully delineating the problems of the current system to know what reforms are needed. To stimulate a more informed and meaningful debate, we delineate 15 current problems into 3 broad categories. First, structural problems encompass 8 specific problems related to the way the research oversight system is organized. Second, procedural problems constitute 5 specific problems related to the operations of IRB review. Finally, performance assessment problems include 2 problems related to absence of systematic assessment of the outcomes of the oversight system. We critically assess proposed reforms, such as accreditation and central IRBs, according I to how well they address these 15 problems. None of the reforms addresses all 15 problems. Indeed, most focus on the procedural problems, failing to address either the structure or the performance assessment problems. Finally, on the basis of the delineation of problems, we outline components of a more effective reform proposal, including bringing all research under federal oversight, a permanent advisory committee to address recurrent ethical issues in clinical research, mandatory single-time review for multicenter research protocols, additional financial support for IRB functions, and a standardized system for collecting and disseminating data on both adverse events and the performance assessment of IRBs.	Warren G Magnuson Clin Ctr, Dept Clin Bioeth, NIH, Bethesda, MD 20892 USA; New York Acad Med, New York, NY USA; Western IRB, Olympia, WA USA; Thomson Ctr Watch, Boston, MA USA; United Hosp Fund, New York, NY USA; Univ Minnesota, Minneapolis, MN USA; Johns Hopkins Univ, Phoebe R Berman Bioeth Inst, Baltimore, MD USA; Old Dominion Univ, Norfolk, VA USA; Duke Univ, Ctr Med, Durham, NC USA	National Institutes of Health (NIH) - USA; New York Academy of Medicine; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Old Dominion University; Duke University	Emanuel, EJ (corresponding author), Warren G Magnuson Clin Ctr, Dept Clin Bioeth, NIH, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	eemanuel@nih.gov		Sugarman, Jeremy/0000-0001-7022-8332				ANNAS GJ, 1991, HASTINGS CENT REP, V21, P18, DOI 10.2307/3563317; [Anonymous], 1986, HIST THEORY INFORM C; *APP RES ETH NAT A, ARENAS OBJ; *APPL RES ETH NAT, CERTIFICATION OVERV; *ASS ACCR HUM RES, AAHRPP ACCR 10 ORG; *ASS ACCR HUM RES, FINAL STAND; *ASS AM MED COLL, 2002, TASK FORC FIN CONFL; BELL J, 1998, EVALUATION NIH IMPLE; *CFR, 1991, 45 CFR; Chen J, 2003, HEALTH AFFAIR, V22, P243, DOI 10.1377/hlthaff.22.2.243; Cho MK, 2000, JAMA-J AM MED ASSOC, V284, P2203, DOI 10.1001/jama.284.17.2203; Christian MC, 2002, NEW ENGL J MED, V346, P1405, DOI 10.1056/NEJM200205023461814; *COMM WEALTH FUN T, 1999, BENCH BEDS PRES RES; Department of Agriculture Department of Energy National Aeronautics and Space Administration Department of Commerce Consumer Product Safety Commission International Development Cooperation Agency Agency for International Development Department of Housing and Urban Development Department of Justice Department of Defense Department of Education Department of Veterans Affairs Environmental Protection Agency Department of Health and Human Services National Science Foundation and Department of Transportation, 1991, FED REGISTER, V56, P28003; FRANCIS L, 1996, CONFLICTS INTEREST C, P418; *GEN ACC OFF, 1996, SCI RES CONT VIG CRI; *GEN ACC OFF, 2001, HHS DIR NEED ADDR FI; HENDERSON L, 1999, CENTRALIZED AMCS GRO, V6, P21; Holt E, 2002, KENNEDY INST ETHIC J, V12, P215, DOI 10.1353/ken.2002.0010; *HUM REV BOARDS, 2002, HUM SUBJECT RES; *I MED, 2002, RESP RES SYST APPR P; *I MED, 2002, PRES PUBL TRUST ACCR; Kelch RP, 2002, NEW ENGL J MED, V346, P285, DOI 10.1056/NEJM200201243460413; Lo B, 2000, NEW ENGL J MED, V343, P1616, DOI 10.1056/NEJM200011303432206; McCrary SV, 2000, NEW ENGL J MED, V343, P1621, DOI 10.1056/NEJM200011303432207; MCNEILLPM, 1993, ETHICS POLITICS HUMA; *NAT COMM QUAL ASS, NCQA REL VERS 2 0 VA; *NAT COMM QUAL ASS, NAT LEAD HLTH CAR EV; National Bioethics Advisory Commission, 2001, ETH POL ISS RES INV; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1979, BELM REP ETH PRINC; *NCI, ADV EV EXP REP SYST; *NIH, 2004, COMP BAS TRAIN NIH I; *NIH, MENT SCI DEV AW RES; *NIH, REQ ED PROT HUM RES; *OFF EXTR RES, OER PEER REV POL ISS; *OFF HUM RES PROT, FIN REL INT RES INV; *OFF HUM RES PROT, QUALITY IMPR PROGR; *OFF HUM RES PROT, IRB KNOW LOC RES CON; *OFF HUM RES PROT, OHRP COMPL ACT COMM; *OFF INSP GEN, 2000, RECR HUM SUBJ SAMPL; *OFF INSP GEN, 1998, DHHS PUBL; *OFF INSP GEN, 1998, I REV BOARDS TIME RE; *OFF INSP GEN, 1998, LOW VOL INST REV BOR; *OFF INSP GEN, 2000, FDA OV CLIN INV; Office of Inspector General, 2000, DHHS PUBL; OTTO M, 2002, ACCR NCQA HALTS VA P; Powell K, 2002, NATURE, V419, P546, DOI 10.1038/419546b; Prentice Ernest D, 1997, IRB, V19, P1, DOI 10.2307/3564433; *PRES COMM STUD ET, 1982, COMP RES INJ ETH LEG; *PUBL RESP MED RES, PRIM R IRB PROF CERT; Randal J, 2003, J NATL CANCER I, V95, P636, DOI 10.1093/jnci/95.9.636; Steinbrook R, 2002, NEW ENGL J MED, V346, P716, DOI 10.1056/NEJM200202283460924; Sugarman J, 2000, ACAD MED, V75, P687, DOI 10.1097/00001888-200007000-00009; 1991, PROTECTION HUMAN SUB, V21; 1997, CENTERWATCH NEWSLETT, V4, P6; 2002, INVESTIGATIONAL 812, V21; 2003, INVESTIGATIONAL 312, V21; 1991, CFR 46, V45	58	121	123	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2004	141	4					282	291		10.7326/0003-4819-141-4-200408170-00008	http://dx.doi.org/10.7326/0003-4819-141-4-200408170-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846BX	15313744				2022-12-28	WOS:000223290900005
J	Erickson, GM; Makovicky, PJ; Currie, PJ; Norell, MA; Yerby, SA; Brochu, CA				Erickson, GM; Makovicky, PJ; Currie, PJ; Norell, MA; Yerby, SA; Brochu, CA			Gigantism and comparative life-history parameters of tyrannosaurid dinosaurs	NATURE			English	Article							GROWTH; EVOLUTION; AGE; REX	How evolutionary changes in body size are brought about by variance in developmental timing and/or growth rates ( also known as heterochrony) is a topic of considerable interest in evolutionary biology(1). In particular, extreme size change leading to gigantism occurred within the dinosaurs on multiple occasions(2). Whether this change was brought about by accelerated growth, delayed maturity or a combination of both processes is unknown. A better understanding of relationships between non-avian dinosaur groups and the newfound capacity to reconstruct their growth curves make it possible to address these questions quantitatively(3). Here we study growth patterns within the Tyrannosauridae, the best known group of large carnivorous dinosaurs, and determine the developmental means by which Tyrannosaurus rex, weighing 5,000 kg and more, grew to be one of the most enormous terrestrial carnivorous animals ever. T. rex had a maximal growth rate of 2.1 kg d(-1), reached skeletal maturity in two decades and lived for up to 28 years. T. rex's great stature was primarily attained by accelerating growth rates beyond that of its closest relatives.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; Field Museum, Dept Geol, Chicago, IL 60605 USA; Royal Tyrrell Museum Paleontol, Drumheller, AB T0J 0Y0, Canada; Stanford Univ, Dept Biomech Engn, Stanford, CA 94305 USA; Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA	State University System of Florida; Florida State University; American Museum of Natural History (AMNH); Field Museum of Natural History (Chicago); Stanford University; University of Iowa	Erickson, GM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	gerickson@bio.fsu.edu	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161				ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; BROCHU CA, 2003, J VERT PALEONTOL, V20, P1; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; CARRANO MT, IN PRESS AMNIOTE PAL; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; CASTANET J, 1974, ZOOL SCR, V3, P201, DOI 10.1111/j.1463-6409.1974.tb00817.x; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Currie Philip J., 2000, Gaia (Lisboa), V15, P271; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P227; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; De Buffrenil V, 2000, J HERPETOL, V34, P414, DOI 10.2307/1565365; Erickson GM, 2003, J VERTEBR PALEONTOL, V23, P966, DOI 10.1671/23; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 1999, SCI AM, V281, P42, DOI 10.1038/scientificamerican0999-42; Francillon-Vieillot H., 1990, P471; GOULD SJ, 1977, ONTOGENY PHYLOENY; Holtz Thomas R. Jr, 2001, P64; Horner J.R, 1993, COMPLETE T REX; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Maddison WP, 1992, MACCLADE VERSION 3 A; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sussman M., 1964, GROWTH DEV; Weishampel David B., 1994, P229; [No title captured]	30	232	238	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					772	775		10.1038/nature02699	http://dx.doi.org/10.1038/nature02699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306807	Green Published			2022-12-28	WOS:000223233600039
J	Berwick, DM; Kotagal, M				Berwick, DM; Kotagal, M			Restricted visiting hours in ICUs - Time to change	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Inst Healthcare Improvement, Boston, MA 02215 USA	Institute for Healthcare Improvement	Berwick, DM (corresponding author), Inst Healthcare Improvement, 375 Longwood Ave,4th Floor, Boston, MA 02215 USA.	dberwick@ihi.org						Gurley M J, 1995, Medsurg Nurs, V4, P40; Krapohl G L, 1995, Dimens Crit Care Nurs, V14, P245, DOI 10.1097/00003465-199509000-00004; MARFELL JA, 1995, NURS CLIN N AM, V30, P87; Rosenberg Charles E., 1987, CARE STRANGERS RISE; Simon S K, 1997, Am J Crit Care, V6, P210	5	123	133	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					736	737		10.1001/jama.292.6.736	http://dx.doi.org/10.1001/jama.292.6.736			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844RM	15304472				2022-12-28	WOS:000223177300029
J	Peden, AH; Head, MW; Ritchie, DL; Bell, JE; Ironside, JW				Peden, AH; Head, MW; Ritchie, DL; Bell, JE; Ironside, JW			Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN; ACCUMULATION	We report a case of preclinical variant Creutzfeldt-Jakob disease (vCJD) in a patient who died from a nonneurological disorder 5 years after receiving a blood transfusion from a donor who subsequently developed vCJD. Protease-resistant prion protein (PrPres) was detected by western blot, paraffin-embedded tissue blot, and immunohistochemistry in the spleen, but not in the brain. Immunohistochemistry for prion protein was also positive in a cervical lymph node. The patient was a heterozygote at codon 129 of PRNP, suggesting that susceptibility to vCJD infection is not confined to the methionine homozygous PRNP genotype. These findings have major implications for future estimates and surveillance of vCJD in the UK.	Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Ironside, JW (corresponding author), Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	james.ironside@ed.ac.uk		Head, Mark/0000-0003-2034-8613; Ironside, James/0000-0001-5869-2108				Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X	5	674	695	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					527	529		10.1016/S0140-6736(04)16811-6	http://dx.doi.org/10.1016/S0140-6736(04)16811-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302196				2022-12-28	WOS:000223132700032
J	Pollard, AJ; Savulescu, J				Pollard, AJ; Savulescu, J			Ethics in practice - Eligibility of overseas visitors and people of uncertain residential status for NHS treatment	BRITISH MEDICAL JOURNAL			English	Article									Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; Univ Oxford, Oxford Uehiro Ctr Pract Eth, Oxford OX1 1PT, England	University of Oxford; University of Oxford	Pollard, AJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.	andrew.pollard@paediatrics.oxford.ac.uk						BLOTT M, 2001, GUIDELINES MANAGEMEN; *DEP HLTH, 2003, PROP AM NAT HLTH SER; *DEP HLTH, NHS TRUSTS PRIM CAR; *DEP HLTHH REF COU, 2003, CAR DISP AS SEEK RES; Department of Health, 2004, PROP EXCL OV VIS EL; HEATH T, 2002, ASYLUM STAT UK; *HLTH PROT AG, 2002, HIV OTH SEX TRANSM I; Ioannidis JPA, 2001, J INFECT DIS, V183, P539, DOI 10.1086/318530; *MED FDN AIDS SEX, 2002, REC SAND NHS HIV SER; Rawls J., 1972, SOCIAL JUSTICE LIBER; Singer P., 1993, PRACTICAL ETHICS; United Nations High Commissioner for Refugees, 1996, CONV PROT REL STAT R	12	21	21	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 7	2004	329	7461					346	349		10.1136/bmj.329.7461.346	http://dx.doi.org/10.1136/bmj.329.7461.346			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846FF	15297347	Green Submitted, Green Published			2022-12-28	WOS:000223300300029
J	Greten, FR; Eckmann, L; Greten, TF; Park, JM; Li, ZW; Egan, LJ; Kagnoff, MF; Karin, M				Greten, FR; Eckmann, L; Greten, TF; Park, JM; Li, ZW; Egan, LJ; Kagnoff, MF; Karin, M			IKK beta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer	CELL			English	Article							NF-KAPPA-B; COLORECTAL-CANCER; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; ACTIVATION; APOPTOSIS; INHIBITION; EXPRESSION; KINASE; PREVENTION	A link between inflammation and cancer has long been suspected, but its molecular nature remained ill defined. A key player in inflammation is transcription factor NF-kappaB whose activity is triggered in response to infectious agents and proinflammatory cytokines via the IkappaB kinase (IKK) complex. Using a colitis-associated cancer model, we show that although deletion of IKKbeta in intestinal epithelial cells does not decrease inflammation, it leads to a dramatic decrease in tumor incidence without affecting tumor size. This is linked to increased epithelial apoptosis during tumor promotion. Deleting IKKbeta in myeloid cells, however, results in a significant decrease in tumor size. This deletion diminishes expression of proinflammatory cytokines that may serve as tumor growth factors, without affecting apoptosis. Thus, specific inactivation of the IKK/NF-kappaB pathway in two different cell types can attenuate formation of inflammation-associated tumors. In addition to suppressing apoptosis in advanced tumors, IKKbeta may link inflammation to cancer.	Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30655 Hannover, Germany; H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Mayo Clin, Gastroenterol Res Unit, Rochester, MN 55905 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Hannover Medical School; H Lee Moffitt Cancer Center & Research Institute; Mayo Clinic	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Greten, Tim F/B-3127-2015; Greten, Florian R/AAF-5196-2020	Greten, Tim F/0000-0002-0806-2535; Greten, Florian R/0000-0002-3928-6080	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477, R01AI056075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43477, AI56075] Funding Source: Medline; NIDDK NIH HHS [DK35108] Funding Source: Medline; NIEHS NIH HHS [ES10337] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amit S, 2003, SEMIN CANCER BIOL, V13, P15, DOI 10.1016/S1044-579X(02)00096-2; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Chung DC, 2000, GASTROENTEROLOGY, V119, P854, DOI 10.1053/gast.2000.16507; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DRISCOLL KE, 1995, J LEUKOCYTE BIOL, V58, P359, DOI 10.1002/jlb.58.3.359; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eaden J, 2000, ALIMENT PHARM THERAP, V14, P145; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Egan LJ, 2004, P NATL ACAD SCI USA, V101, P2452, DOI 10.1073/pnas.0306734101; Ekbom A, 1998, J Gastrointest Surg, V2, P312, DOI 10.1016/S1091-255X(98)80067-X; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 1999, ONCOGENE, V18, P6925, DOI 10.1038/sj.onc.1203222; Girnun GD, 2002, P NATL ACAD SCI USA, V99, P13771, DOI 10.1073/pnas.162480299; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hacker H, 2002, CANCER CELL, V2, P431, DOI 10.1016/S1535-6108(02)00213-1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardwick JCH, 2001, ONCOGENE, V20, P819, DOI 10.1038/sj.onc.1204162; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Iwamoto M, 1996, J PATHOL, V180, P152; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; MacMaster JF, 2003, INFLAMM RES, V52, P508, DOI 10.1007/s00011-003-1206-4; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; Murano M, 2000, CLIN EXP IMMUNOL, V120, P51, DOI 10.1046/j.1365-2249.2000.01183.x; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; SELTZ CS, 1998, P NATL ACAD SCI USA, V95, P2307; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Toft NJ, 1999, P NATL ACAD SCI USA, V96, P3911, DOI 10.1073/pnas.96.7.3911; van Hogerlinden M, 1999, CANCER RES, V59, P3299; van Hogerlinden M, 2002, ONCOGENE, V21, P4969, DOI 10.1038/sj.onc.1205620; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; Yamamoto Y, 1999, J BIOL CHEM, V274, P27307, DOI 10.1074/jbc.274.38.27307; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yu HG, 2003, ONCOLOGY-BASEL, V65, P37, DOI 10.1159/000071203; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	65	1960	2082	8	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					285	296		10.1016/j.cell.2004.07.013	http://dx.doi.org/10.1016/j.cell.2004.07.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294155	Bronze			2022-12-28	WOS:000223353100006
J	Junge, HJ; Rhee, JS; Jahn, O; Varoqueaux, F; Spiess, J; Waxham, MN; Rosenmund, C; Brose, N				Junge, HJ; Rhee, JS; Jahn, O; Varoqueaux, F; Spiess, J; Waxham, MN; Rosenmund, C; Brose, N			Calmodulin and Munc13 form a Ca2+ sensor/effector complex that controls short-term synaptic plasticity	CELL			English	Article							CORTICOTROPIN-RELEASING FACTOR; READILY RELEASABLE POOL; TRANSMITTER RELEASE; BINDING-PROTEIN; DEPRESSION; VESICLES; CALCIUM; UNC-13; TRANSMISSION; FACILITATION	The efficacy of synaptic transmission between neurons can be altered transiently during neuronal network activity. This phenomenon of short-term plasticity is a key determinant of network properties; is involved in many physiological processes such as motor control, sound localization, or sensory adaptation; and is critically dependent on cytosolic [Call]. However, the underlying molecular mechanisms and the identity of the Ca2+ sensor/effector complexes involved are unclear. We now identify a conserved calmodulin binding site in UNC-13/Munc13s, which are essential regulators of synaptic vesicle priming and synaptic efficacy. Ca2+ sensor/effector complexes consisting of calmodulin and Munc13s regulate synaptic vesicle priming and synaptic efficacy in response to a residual [Ca2+] signal and thus shape short-term plasticity characteristics during periods of sustained synaptic activity.	Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; Max Planck Inst Expt Med, Dept Mol Neuroendocrinol, D-37075 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA	Max Planck Society; Max Planck Society; Max Planck Society; University of Texas System	Brose, N (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	brose@em.mpg.de	Rosenmund, Christian/AAC-3596-2020; Varoqueaux, Frederique/AAC-1834-2021; Jahn, Olaf/AAD-8212-2020	Rosenmund, Christian/0000-0002-3905-2444; Varoqueaux, Frederique/0000-0002-3614-3121; Jahn, Olaf/0000-0002-3397-8924; Waxham, M. Neal/0000-0003-4801-1190; JUNGE, HARALD/0000-0003-2458-6010				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dittman JS, 2000, J NEUROSCI, V20, P1374; Eccles JC, 1941, J NEUROPHYSIOL, V4, P362, DOI 10.1152/jn.1941.4.5.362; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; FENG TP, 1941, CHIN J PHYSL, V13, P79; Jahn O, 2002, P NATL ACAD SCI USA, V99, P12055, DOI 10.1073/pnas.192449299; Jahn O, 2001, PEPTIDES, V22, P47, DOI 10.1016/S0196-9781(00)00356-9; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Nadim F, 2000, CURR OPIN NEUROBIOL, V10, P683, DOI 10.1016/S0959-4388(00)00159-8; ONEIL KT, 1989, PROTEINS, V6, P284, DOI 10.1002/prot.340060311; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Xu XZS, 1998, J BIOL CHEM, V273, P31297, DOI 10.1074/jbc.273.47.31297; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	35	177	182	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					389	401		10.1016/j.cell.2004.06.029	http://dx.doi.org/10.1016/j.cell.2004.06.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294163	Green Published, Bronze			2022-12-28	WOS:000223353100014
J	Lodahl, P; van Driel, AF; Nikolaev, IS; Irman, A; Overgaag, K; Vanmaekelbergh, D; Vos, WL				Lodahl, P; van Driel, AF; Nikolaev, IS; Irman, A; Overgaag, K; Vanmaekelbergh, D; Vos, WL			Controlling the dynamics of spontaneous emission from quantum dots by photonic crystals	NATURE			English	Article							BAND-GAP; TURNSTILE DEVICE; LASER; MICROCAVITIES	Control of spontaneously emitted light lies at the heart of quantum optics. It is essential for diverse applications ranging from miniature lasers and light-emitting diodes(1-5), to single-photon sources for quantum information(6-8), and to solar energy harvesting(9). To explore such new quantum optics applications, a suitably tailored dielectric environment is required in which the vacuum fluctuations that control spontaneous emission can be manipulated(10,11). Photonic crystals provide such an environment: they strongly modify the vacuum fluctuations, causing the decay of emitted light to be accelerated or slowed down(12,13), to reveal unusual statistics(14), or to be completely inhibited in the ideal case of a photonic bandgap(1,15). Here we study spontaneous emission from semiconductor quantum dots embedded in inverse opal photonic crystals(16). We show that the spectral distribution and time-dependent decay of light emitted from excitons confined in the quantum dots are controlled by the host photonic crystal. Modified emission is observed over large frequency bandwidths of 10%, orders of magnitude larger than reported for resonant optical microcavities(17). Both inhibited and enhanced decay rates are observed depending on the optical emission frequency, and they are controlled by the crystals' lattice parameter. Our experimental results provide a basis for all-solid-state dynamic control of optical quantum systems(18).	Univ Twente, Dept Sci & Technol, NL-7500 AE Enschede, Netherlands; Univ Twente, MESA Res Inst, NL-7500 AE Enschede, Netherlands; Univ Utrecht, Debye Inst, NL-3508 TA Utrecht, Netherlands	University of Twente; University of Twente; Utrecht University	Lodahl, P (corresponding author), Univ Twente, Dept Sci & Technol, POB 217, NL-7500 AE Enschede, Netherlands.	p.lodahl@utwente.nl	Vanmaekelbergh, Daniël/G-2104-2010; Lodahl, Peter/P-6297-2014; Vos, Willem L./B-7489-2012	Lodahl, Peter/0000-0002-9348-9591; Vos, Willem L./0000-0003-3066-859X				Bayer M, 2001, PHYS REV LETT, V86, P3168, DOI 10.1103/PhysRevLett.86.3168; Busch K, 1998, PHYS REV E, V58, P3896, DOI 10.1103/PhysRevE.58.3896; Bykov V. P., 1975, Soviet Journal of Quantum Electronics, V4, P861, DOI 10.1070/QE1975v004n07ABEH009654; Colombelli R, 2003, SCIENCE, V302, P1374, DOI 10.1126/science.1090561; Crooker SA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.186802; Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y; Fisher BR, 2004, J PHYS CHEM B, V108, P143, DOI 10.1021/jp035756+; Gerard JM, 1998, PHYS REV LETT, V81, P1110, DOI 10.1103/PhysRevLett.81.1110; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Hood CJ, 1998, PHYS REV LETT, V80, P4157, DOI 10.1103/PhysRevLett.80.4157; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Kim J, 1999, NATURE, V397, P500, DOI 10.1038/17295; Koenderink AF, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.213902; Koenderink AF, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.143903; Kuhn A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067901; Lambropoulos P, 2000, REP PROG PHYS, V63, P455, DOI 10.1088/0034-4885/63/4/201; Li ZY, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125106; Loudon R., 2000, QUANTUM THEORY LIGHT; Mabuchi H, 2002, SCIENCE, V298, P1372, DOI 10.1126/science.1078446; Michler P, 2000, SCIENCE, V290, P2282, DOI 10.1126/science.290.5500.2282; Noda S, 2001, SCIENCE, V293, P1123, DOI 10.1126/science.1061738; Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819; Scully M.O., 1997, QUANTUM OPT; Smith CJM, 1999, ELECTRON LETT, V35, P228, DOI 10.1049/el:19990157; Sprik R, 1996, EUROPHYS LETT, V35, P265, DOI 10.1209/epl/i1996-00564-y; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Wang RZ, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.155114; Wijnhoven JEGJ, 1998, SCIENCE, V281, P802, DOI 10.1126/science.281.5378.802; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059	30	1001	1017	12	409	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					654	657		10.1038/nature02772	http://dx.doi.org/10.1038/nature02772			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295594	Green Published			2022-12-28	WOS:000223085400039
J	Chen, XY; Duanmu, H; Wan, LY; Zhao, FZ; Wang, LX; Tu, DH; Du, X; Kim, SJ; Watt, C; Williams, B; Chin, D; Dye, C				Chen, XY; Duanmu, H; Wan, LY; Zhao, FZ; Wang, LX; Tu, DH; Du, X; Kim, SJ; Watt, C; Williams, B; Chin, D; Dye, C		China Tuberculosis Control Collabo	The effect of tuberculosis control in China	LANCET			English	Article							IMPACT	Background China has 1 . 4 million new cases of tuberculosis every year, more than any country except India. A new tuberculosis control project based on short-course chemotherapy was introduced in half the country in 1991, after a national survey of tuberculosis prevalence in 1990. Another survey was done in 2000 to re-evaluate the national tuberculosis burden, providing the opportunity to assess the effect of the control project. Methods The survey in 2000 identified 375 599 eligible individuals at 257 investigation points chosen from all 31 mainland provinces by stratified random sampling. Children (aged 0-14 years) were suspected of having tuberculosis if they had an induration of 10 mm or greater after a tuberculin skin test, and an abnormal fluorograph. Adults were suspected if they had a persistent cough, abnormal fluorograph, or both. Tuberculosis was diagnosed by chest radiograph, sputum-smear microscopy, and culture. Findings 365 097 people were examined (97% of those eligible). Prevalences of pulmonary, culture-positive, and smear-positive tuberculosis in 2000 were 367 (95% CI 340-397), 160 (144-177), and 122 (110-137) per 100 000 population, respectively. Between 1990 and 2000, prevalences of these three forms of the disease had fallen, respectively, by 32% (5-68), 37% (7-66), and 32% (9-51) more in areas in which the project was implemented than in non-project areas. For culture-positive disease, a 30% (9-48) reduction was directly attributable to the project. Interpretation Between 1991 and 2000, prevalence of tuberculosis was reduced significantly in areas of China by use of short-course chemotherapy following WHO guidelines. We estimate that in 2000, in a population of more than half a billion, there were 382 000 fewer prevalent culture-positive cases and 280 000 fewer prevalent smear-positive cases than there would otherwise have been.	WHO, CH-1211 Geneva 27, Switzerland; Minist Hlth, Dept Dis Control, Beijing, Peoples R China; Korean Inst TB, Seoul, South Korea	World Health Organization	Chen, XY (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.		Dye, Christopher/AIC-4659-2022					Cauthen GM, 2002, B WORLD HEALTH ORGAN, V80, P503; Chen XY, 2002, B WORLD HEALTH ORGAN, V80, P430; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Davison AC, 1997, BOOTSTRAP METHODS TH; Dye C, 2002, B WORLD HEALTH ORGAN, V80, P437; Dye C, 2000, INT J EPIDEMIOL, V29, P558, DOI 10.1093/ije/29.3.558; *MIN HLTH PEOPL RE, 2000, REP NAT RAND SURV EP; *MIN PUBL HLTH PEO, 1990, NAT RAND SURV EP TUB; Styblo K., 1985, B INT UNION TUBERC, V60, P117; *UN STAT DIV, MILL IND DAT; *WHO, WHOCDSTB2002, V297, P1; World Health Organization, 2002, WHO TRADITIONAL MED, P1; Zhang LX, 2000, INT J TUBERC LUNG D, V4, P904; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1	14	148	151	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					417	422						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288739				2022-12-28	WOS:000222998600031
J	Keroack, MD; Peralta, R; Abramson, SD; Misdraji, J; Harris, NL				Keroack, MD; Peralta, R; Abramson, SD; Misdraji, J; Harris, NL			A man with recurrent gastrointestinal bleeding - Inverted Meckel's diverticulum with ulceration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CAPSULE ENDOSCOPY; DIAGNOSIS; HEMORRHAGE; THERAPY; TRIAL		Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Keroack, MD (corresponding author), Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA.		Misdraji, Joseph/AGX-4779-2022; Misdraji, Joseph/AAD-4588-2019	Peralta, Ruben/0000-0003-2817-0194				Appleyard M, 2001, NEW ENGL J MED, V344, P232, DOI 10.1056/NEJM200101183440316; Arnold JF, 1997, AM SURGEON, V63, P354; BOLDERO JL, 1978, BRIT J RADIOL, V51, P829, DOI 10.1259/0007-1285-51-610-829; Costamagna G, 2002, GASTROENTEROLOGY, V123, P999, DOI 10.1053/gast.2002.35988; DAYAL Y, 1978, GASTROENTEROLOGY, V75, P655; Douard R, 2000, AM J SURG, V180, P181, DOI 10.1016/S0002-9610(00)00447-5; FARTHING MG, 1981, BRIT J SURG, V68, P176, DOI 10.1002/bjs.1800680311; Gill SS, 2001, J CLIN GASTROENTEROL, V33, P267, DOI 10.1097/00004836-200110000-00004; Higaki S, 2001, HEPATO-GASTROENTEROL, V48, P1628; Hori K, 2003, SURGERY, V133, P116, DOI 10.1067/msy.2003.89; Junquera F, 2001, GASTROENTEROLOGY, V121, P1073, DOI 10.1053/gast.2001.28650; Kovacs TOG, 2002, MED CLIN N AM, V86, P1319, DOI 10.1016/S0025-7125(02)00079-2; Lefkovitz Z, 2002, MED CLIN N AM, V86, P1357, DOI 10.1016/S0025-7125(02)00080-9; Lewis BS, 2002, GASTROINTEST ENDOSC, V56, P349, DOI 10.1067/mge.2002.126906; Lewis BS, 2000, GASTROENTEROL CLIN N, V29, P67, DOI 10.1016/S0889-8553(05)70108-4; Mylonaki M, 2002, ENDOSCOPY, V34, P1018, DOI 10.1055/s-2002-35850; SILVER B, 1983, J CAN ASSOC RADIOL, V34, P314; SOLTERO MJ, 1976, AM J SURG, V132, P168, DOI 10.1016/0002-9610(76)90043-X; Steinwald PM, 1996, AM SURGEON, V62, P889; STVIL D, 1991, J PEDIATR SURG, V26, P1289, DOI 10.1016/0022-3468(91)90601-O; THOMAS WEG, 1981, BRIT J SURG, V68, P521; Waye JD, 2001, ENDOSCOPY, V33, P24, DOI 10.1055/s-2001-11184; WONG TY, 1990, AM J GASTROENTEROL, V85, P195	23	8	8	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					488	495		10.1056/NEJMcpc049015	http://dx.doi.org/10.1056/NEJMcpc049015			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282357				2022-12-28	WOS:000222939700014
J	Taylor, SR				Taylor, SR			Why can't planets be like stars?	NATURE			English	Article									Australian Natl Univ, Dept Earth & Marine Sci, Canberra, ACT 0200, Australia	Australian National University	Taylor, SR (corresponding author), Australian Natl Univ, Dept Earth & Marine Sci, Canberra, ACT 0200, Australia.							BRUSH SG, 1996, HIST MODERN PLANETAR, V3; Stevenson DJ, 2004, PHYS TODAY, V57, P43, DOI 10.1063/1.1752421; TAYLOR SR, 2000, DESTINY CHANCE OUR S	3	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 29	2004	430	6999					509	509		10.1038/430509a	http://dx.doi.org/10.1038/430509a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282586	Bronze			2022-12-28	WOS:000222946100022
J	Wright, P				Wright, P			Sir Gordon Wolstenholme - Obituary	LANCET			English	Biographical-Item												pearce.wright@dial.pipex.com							0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 24	2004	364	9431					324	324		10.1016/S0140-6736(04)16704-4	http://dx.doi.org/10.1016/S0140-6736(04)16704-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15314832				2022-12-28	WOS:000222853300015
J	Elzerman, JM; Hanson, R; van Beveren, LHW; Witkamp, B; Vandersypen, LMK; Kouwenhoven, LP				Elzerman, JM; Hanson, R; van Beveren, LHW; Witkamp, B; Vandersypen, LMK; Kouwenhoven, LP			Single-shot read-out of an individual electron spin in a quantum dot	NATURE			English	Article							STATE	Spin is a fundamental property of all elementary particles. Classically it can be viewed as a tiny magnetic moment, but a measurement of an electron spin along the direction of an external magnetic field can have only two outcomes(1): parallel or anti-parallel to the field. This discreteness reflects the quantum mechanical nature of spin. Ensembles of many spins have found diverse applications ranging from magnetic resonance imaging(2) to magneto-electronic devices(3), while individual spins are considered as carriers for quantum information. Read-out of single spin states has been achieved using optical techniques(4), and is within reach of magnetic resonance force microscopy(5). However, electrical read-out of single spins(6-13) has so far remained elusive. Here we demonstrate electrical single-shot measurement of the state of an individual electron spin in a semiconductor quantum dot(14). We use spin-to-charge conversion of a single electron confined in the dot, and detect the single-electron charge using a quantum point contact; the spin measurement visibility is similar to65%. Furthermore, we observe very long single-spin energy relaxation times (up to similar to0.85 ms at a magnetic field of 8 T), which are encouraging for the use of electron spins as carriers of quantum information.	Delft Univ Technol, Kavli Inst Nanosci Delft, NL-2600 GA Delft, Netherlands; Delft Univ Technol, ERATO, Mesoscop Correlat Project, NL-2600 GA Delft, Netherlands	Delft University of Technology; Delft University of Technology	Vandersypen, LMK (corresponding author), Delft Univ Technol, Kavli Inst Nanosci Delft, POB 5046, NL-2600 GA Delft, Netherlands.	lieven@qt.tn.tudelft.nl	Hanson, Ronald/B-9555-2008; van Beveren, Laurens Willems/B-4301-2008; Elzerman, Jeroen M/J-3551-2012	van Beveren, Laurens Willems/0000-0002-4404-0042; Elzerman, Jeroen M/0000-0002-4596-8483				Blatt R., 1988, European Journal of Physics, V9, P250, DOI 10.1088/0143-0807/9/4/002; Ciorga M, 2001, PHYSICA E, V11, P35, DOI 10.1016/S1386-9477(01)00153-9; Elzerman JM, 2004, APPL PHYS LETT, V84, P4617, DOI 10.1063/1.1757023; Elzerman JM, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.161308; ENGEL H, IN PRESS PHYS REV LE; Erlingsson SI, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.155327; FIELD M, 1993, PHYS REV LETT, V70, P1311, DOI 10.1103/PhysRevLett.70.1311; Folk JA, 2003, SCIENCE, V299, P679, DOI 10.1126/science.1078419; Friesen M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.037901; Fujisawa T, 2004, APPL PHYS LETT, V84, P2343, DOI 10.1063/1.1691491; Fujisawa T, 2002, NATURE, V419, P278, DOI 10.1038/nature00976; GOLOVACH VN, 2003, PHONON INDUCED DECAY; GREENTREE AD, 2004, ELECT READOUT SPIN Q; Hanson R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.196802; HANSON R, 2003, SEMICONDUCTOR FEW EL; IONICIOU R, 2003, SINGLE SPIN MEASUREM; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Khaetskii AV, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.125316; Kouwenhoven LP, 1997, SCIENCE, V278, P1788, DOI 10.1126/science.278.5344.1788; Kouwenhoven LP, 2001, REP PROG PHYS, V64, P701, DOI 10.1088/0034-4885/64/6/201; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; VANDERSYPEN LMK, 2003, QUANTUM COMPUTING QU, P201; WEHRLI FW, 1992, PHYS TODAY, V45, P34, DOI 10.1063/1.881310; WEIS J, 1994, SURF SCI, V305, P664, DOI 10.1016/0039-6028(94)90974-1; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Woods LM, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.161318; Xiao M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.078301	30	1279	1319	7	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					431	435		10.1038/nature02693	http://dx.doi.org/10.1038/nature02693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269762	Green Submitted			2022-12-28	WOS:000222801400036
J	Serebrov, V; Pyle, AM				Serebrov, V; Pyle, AM			Periodic cycles of RNA unwinding and pausing by hepatitis C virus NS3 helicase	NATURE			English	Article							STEP-SIZE; NONSTRUCTURAL PROTEINS; CRYSTAL-STRUCTURE; RECBCD HELICASE; DNA HELICASE; NPH-II; TRANSLOCATION; MECHANISM; ENZYME; MODULATION	The NS3 helicase is essential for cytoplasmic RNA replication by the hepatitis C virus(1-4), and it is a representative member of helicase superfamily 2 (SF2). NS3 is an important model system for understanding unwinding activities of DExH/D proteins(5-7), and it has been the subject of extensive structural and mutational analyses(8-11). Despite intense interest in NS3, the molecular and kinetic mechanisms for RNA unwinding by this helicase have remained obscure. We have developed a combinatorial, time-resolved approach for monitoring the microscopic behaviour of a helicase at each nucleotide of a duplex substrate. By applying this analysis to NS3, we have independently established the 'physical' and 'kinetic' step size for unwinding of RNA (18 base pairs, in each case), which we relate to the stoichiometry of the functional, translocating species. Having obtained microscopic unwinding rate constants at each position along the duplex, we demonstrate that NS3 unwinds RNA through a highly coordinated cycle of fast ripping and local pausing that occurs with regular spacing along the duplex substrate, much like the stepping behaviour of cytoskeletal motor proteins(12).	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	anna.pyle@yale.edu		Serebrov, Victor/0000-0002-5800-3103				Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Bartenschlager R, 1999, J VIRAL HEPATITIS, V6, P165, DOI 10.1046/j.1365-2893.1999.00152.x; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bianco PR, 2000, NATURE, V405, P368, DOI 10.1038/35012652; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cho HS, 1998, J BIOL CHEM, V273, P15045, DOI 10.1074/jbc.273.24.15045; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; ESSINGES MN, 2004, P NATL ACAD SCI USA, V101, P6439; Gallinari P, 1999, BIOCHEMISTRY-US, V38, P5620, DOI 10.1021/bi982892+; Gallinari P, 1998, J VIROL, V72, P6758, DOI 10.1128/JVI.72.8.6758-6769.1998; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Kawaoka J, 2004, NAT STRUCT MOL BIOL, V11, P526, DOI 10.1038/nsmb771; Kim DW, 1997, J VIROL, V71, P9400, DOI 10.1128/JVI.71.12.9400-9409.1997; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korolev S, 1998, PROTEIN SCI, V7, P605, DOI 10.1002/pro.5560070309; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Locatelli GA, 2002, BIOCHEMISTRY-US, V41, P10332, DOI 10.1021/bi026082g; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Paolini C, 2000, J GEN VIROL, V81, P1335, DOI 10.1099/0022-1317-81-5-1335; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88	30	109	112	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					476	480		10.1038/nature02704	http://dx.doi.org/10.1038/nature02704			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269774				2022-12-28	WOS:000222801400049
J	Oransky, I				Oransky, I			Charles Kelman - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com						KELMAN C, PUBLICATION LIST	1	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 10	2004	364	9429					134	134		10.1016/S0140-6736(04)16646-4	http://dx.doi.org/10.1016/S0140-6736(04)16646-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837EV	15281216				2022-12-28	WOS:000222612200012
J	Maleki, S; Keeney, S				Maleki, S; Keeney, S			Modifying histories and initiating meiotic recombination: New answers to an old question	CELL			English	Editorial Material							HISTONE	It is well documented that the formation of the DNA double-strand breaks (DSBs) that initiate meiotic recombination is influenced by chromatin and larger scale chromosome organization, but the molecular nature of this influence has remained elusive. Several recent studies, including Reddy and Villeneuve (2004, this issue of Cell), shed light on this issue by revealing roles for posttranslational histone modifications in promoting DSB formation.	Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Maleki, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave,Box 97, New York, NY 10021 USA.		Keeney, Scott/GVR-8515-2022	Keeney, Scott/0000-0002-1283-6417				Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; KLECKNER N, 2004, IN PRESS P NATL ACAD; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Reddy KC, 2004, CELL, V118, P439, DOI 10.1016/j.cell.2004.07.026; Sollier J, 2004, EMBO J, V23, P1957, DOI 10.1038/sj.emboj.7600204; Yamada T, 2004, EMBO J, V23, P1792, DOI 10.1038/sj.emboj.7600138; Yamashita K, 2004, P NATL ACAD SCI USA, V101, P11380, DOI 10.1073/pnas.0400078101	10	10	13	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 20	2004	118	4					404	406		10.1016/j.cell.2004.08.008	http://dx.doi.org/10.1016/j.cell.2004.08.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315752	Bronze			2022-12-28	WOS:000223650900002
J	Babapulle, MN; Joseph, L; Belisle, P; Brophy, JM; Eisenberg, MJ				Babapulle, MN; Joseph, L; Belisle, P; Brophy, JM; Eisenberg, MJ			A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents	LANCET			English	Article							INTRAVASCULAR ULTRASOUND ANALYSIS; BALLOON-EXPANDABLE-STENT; ANGIOGRAPHIC FOLLOW-UP; NOVO CORONARY LESIONS; SLOW-RELEASE; DOUBLE-BLIND; LONG-TERM; IMPLANTATION; RESTENOSIS; ARTERIES	Background Drug-eluting stents (DES) are associated with lower restenosis rates than bare-metal stents (BMS), but the benefits and safety of the new devices have not been systematically quantified across different trials. We undertook a meta-analysis of randomised trials comparing BMS and stents eluting sirolimus or paclitaxel. Methods A systematic literature search aimed to identify all randomised clinical trials with 6-12 months of clinical follow-up. Results were pooled by a hierarchical Bayesian random-effects model with prespecified stratification for drug and the presence of carrier polymer. The primary outcomes examined were rates of death, myocardial infarction, target-lesion revascularisation, major adverse cardiac events (death, myocardial infarction, and target-vessel revascularisation), and angiographic restenosis. Findings We identified 11 eligible trials involving 5103 patients. The pooled mortality rates were low for both DES and BMS with no evidence of any difference between them (odds ratio 1.11 [95% credible interval 0.61-2.06]). Pooled rates of myocardial infarction showed no between-group difference (0.92 [0.65-1.25]). The rate of major adverse cardiac events was 7.8% with DES and 16.4% with BMS (0.42 [0.32-0.53]), and the angiographic restenosis rates were also lower for DES (8.9% vs 29.3%; 0.18 [0.06-0.40]). The pooled rates of major adverse cardiac events for each DES type and the respective BMS were: for sirolimus, 6.8% versus 21.0% (0.28 [0.17-0.41]); for polymer-based paclitaxel 8.7% versus 16.7% (0.47 [0.25-0.71]); and for non-polymer-based paclitaxel 7.7% versus 9.5% (0.64 [0.42-1.00]). We did not observe higher rates of edge restenosis, stent thrombosis, or late incomplete stent apposition with DES, although the credible intervals were wide. Interpretation Sirolimus-eluting and polymeric paclitaxel-eluting stents are effective at decreasing rates of angiographic restenosis and major adverse cardiac events compared with BMS. However, there is no evidence that they affect mortality or myocardial-infarction rates. They also appear to be safe in the short to medium term, although definitive conclusions are not possible. Larger studies with longer follow-up are needed to define better the role of these new devices.	McGill Univ, Jewish Gen Hosp, Div Cardiol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Jewish Gen Hosp, Div Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Cardiol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Montreal Gen Hosp, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada	McGill University; McGill University; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University	Eisenberg, MJ (corresponding author), McGill Univ, Jewish Gen Hosp, Div Cardiol, 3755 Cote Str Catherine Rd,Suite A-118, Montreal, PQ H3T 1E2, Canada.	marke@epid.jgh.mcgill.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875				Albiero R, 2000, CIRCULATION, V101, P2454, DOI 10.1161/01.CIR.101.21.2454; Babapulle MN, 2002, CIRCULATION, V106, P2859, DOI 10.1161/01.CIR.0000038984.30279.89; Brophy JM, 2003, ANN INTERN MED, V138, P777, DOI 10.7326/0003-4819-138-10-200305200-00005; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; Degertekin M, 2003, CIRCULATION, V108, P2747, DOI 10.1161/01.CIR.0000103666.25660.77; Degertekin M, 2002, CIRCULATION, V106, P1610, DOI 10.1161/01.CIR.0000034447.02535.D5; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Gershlick A, 2004, CIRCULATION, V109, P487, DOI 10.1161/01.CIR.0000109694.58299.A0; Grube E, 2004, CIRCULATION, V109, P2168, DOI 10.1161/01.CIR.0000128850.84227.FD; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; GRUBE E, 2003, TRANSC CARD THER ANN; HELDMAN A, 2002, TRANSC CARD THER ANN; Hoffmann R, 2000, EUR HEART J, V21, P1739, DOI 10.1053/euhj.2000.2153; Hoffmann R, 1996, CIRCULATION, V94, P1247, DOI 10.1161/01.CIR.94.6.1247; Hong MK, 2003, CIRCULATION, V107, P517, DOI 10.1161/01.CIR.0000054163.42072.D4; Jeremias A, 2004, CIRCULATION, V109, P1930, DOI 10.1161/01.CIR.0000127105.99982.21; Kay IP, 2001, CIRCULATION, V103, P14; KNOPF W, 2003, TRANSC CARD THER ANN; Lansky AJ, 2004, CIRCULATION, V109, P1948, DOI 10.1161/01.CIR.0000127129.94129.6F; LEON MB, 2002, SIRIUS TRIAL, V2; MANN TT, 2003, TRANSC CARD THER ANN; Mintz GS, 2003, CIRCULATION, V107, P2660, DOI 10.1161/01.CIR.0000074778.46065.24; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Okura H, 2003, AM J CARDIOL, V92, P587, DOI 10.1016/S0002-9149(03)00728-8; ONEILL WW, 2003, AM COLL CARD SCI SES; Orlic D, 2004, J AM COLL CARDIOL, V43, P1154, DOI 10.1016/j.jacc.2003.10.052; Park SJ, 2003, NEW ENGL J MED, V348, P1537, DOI 10.1056/NEJMoa021007; Ruygrok PN, 1999, J AM COLL CARDIOL, V34, P1507, DOI 10.1016/S0735-1097(99)00380-0; Schampaert E, 2004, J AM COLL CARDIOL, V43, P1110, DOI 10.1016/j.jacc.2004.01.024; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Serruys PW, 2004, CIRCULATION, V109, P627, DOI 10.1161/01.CIR.0000112566.87022.32; Serruys PW, 2002, CIRCULATION, V106, P798, DOI 10.1161/01.CIR.0000025585.63486.59; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; SERRUYS PW, TRANSC CARD THER ANN; Sousa JE, 2003, CIRCULATION, V107, P24, DOI 10.1161/01.CIR.0000047063.22006.41; Sousa JE, 2003, CIRCULATION, V107, P2274, DOI 10.1161/01.CIR.0000069330.41022.90; Sousa JE, 2003, CIRCULATION, V107, P381, DOI 10.1161/01.CIR.0000051720.59095.6D; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; STONE GW, 2002, AM COLL CARD SCI SES; Tanabe K, 2003, CIRCULATION, V107, P559, DOI 10.1161/01.CIR.0000048184.96491.8A; Teirstein PS, 2001, CIRCULATION, V104, P1996, DOI 10.1161/circ.104.17.1996; TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333; *US FDA, FDA PUBL HLTH WEB NO; Virmani R, 2003, HEART, V89, P133, DOI 10.1136/heart.89.2.133; Virmani R, 2002, CIRCULATION, V106, P2649, DOI 10.1161/01.CIR.0000041632.02514.14; Wardeh AJ, 2001, EUR HEART J, V22, P669, DOI 10.1053/euhj.2000.2283	51	499	560	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2004	364	9434					583	591		10.1016/S0140-6736(04)16850-5	http://dx.doi.org/10.1016/S0140-6736(04)16850-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313358				2022-12-28	WOS:000223275100030
J	Kiss, H; Petricevic, L; Husslein, P				Kiss, H; Petricevic, L; Husslein, P			Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BIRTH-WEIGHT; BACTERIAL VAGINOSIS; GENITAL-TRACT; GESTATIONAL-AGE; PREMATURE BIRTH; WOMEN; COLONIZATION; CLINDAMYCIN; PREDICTION; PREGNANCY	Objective To evaluate whether a screening strategy pregnancy lowers the rate of preterm delivery in a general population of pregnant women. Design Multicentre, prospective, randomised controlled trial. Setting Non-hospital based antenatal clinics. Participants 4429 pregnant women presenting for their routine prenatal visits early in the second trimester were screened by Gram stain for asymptomatic vaginal infection. In the intervention group, the women's obstetricians received the test results and women received standard treatment and follow up for any detected infection. In the control group, the results of the vaginal smears were not revealed to the caregivers. Main outcome measures The primary outcome variable was preterm delivery at less than 37 weeks. Secondary outcome variables were preterm delivery at less than 37 weeks combined with different birth weight categories equal to or below 2500 g and the rate of late miscarriage. Results Outcome data were available for 2058 women in the intervention group and 2097 women in the control group. In the intervention group, the number of preterm births was significantly lower than in the control group (3.0% v 5.3%,95% confidence interval 1.2 to 3.6; P = 0.0001). Preterm births were also significantly reduced in lower weight categories at less than 37 weeks and less than or equal to2500 g. Eight late miscarriages occurred in the intervention group and 15 in the control group. Conclusion Integrating a simple infection screening programme into routine antenatal care leads to a significant reduction in preterm births and reduces the rate of late miscarriage in a general population of pregnant women.	Univ Vienna, Sch Med, Dept Obstet & Gynaecol, A-1090 Vienna, Austria	University of Vienna	Kiss, H (corresponding author), Univ Vienna, Sch Med, Dept Obstet & Gynaecol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	herber.kiss@akh-wien.ac.at						Ahner R, 2000, GEBURTSH FRAUENHEILK, V60, P20; Brocklehurst P, 2000, COCHRANE DB SYST REV; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Cotch MF, 1998, AM J OBSTET GYNECOL, V178, P374, DOI 10.1016/S0002-9378(98)80028-8; Elgen I, 2002, ARCH DIS CHILD-FETAL, V87, pF128, DOI 10.1136/fn.87.2.F128; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Goldenberg RL, 2002, OBSTET GYNECOL, V100, P1020, DOI 10.1016/S0029-7844(02)02212-3; GRAVETT MG, 1986, JAMA-J AM MED ASSOC, V256, P1899; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Hoyme UB, 2002, GEBURTSH FRAUENHEILK, V62, P257, DOI 10.1055/s-2002-25221; Lamont RF, 2003, OBSTET GYNECOL, V101, P516, DOI 10.1016/S0029-7844(02)03054-5; Leitich H, 2003, AM J OBSTET GYNECOL, V188, P752, DOI 10.1067/mob.2003.167; MATTISON DR, 2001, PAEDIAT PERINATAL S2, V15; MCGREGOR JA, 1995, AM J OBSTET GYNECOL, V173, P157, DOI 10.1016/0002-9378(95)90184-1; McGregor JA, 2000, OBSTET GYNECOL SURV, V55, pS1; MEIS PJ, 1995, AM J OBSTET GYNECOL, V173, P1231, DOI 10.1016/0002-9378(95)91360-2; Mercer BM, 1999, AM J OBSTET GYNECOL, V181, P1216, DOI 10.1016/S0002-9378(99)70111-0; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Petrou S, 2001, CHILD CARE HLTH DEV, V27, P97, DOI 10.1046/j.1365-2214.2001.00203.x; SCHAAF VM, 1990, ARCH INTERN MED, V150, P1929, DOI 10.1001/archinte.150.9.1929; St John EB, 2000, AM J OBSTET GYNECOL, V182, P170, DOI 10.1016/S0002-9378(00)70509-6; Ugwumadu A, 2003, LANCET, V361, P983, DOI 10.1016/S0140-6736(03)12823-1; Xu BZ, 1998, EPIDEMIOLOGY, V9, P662, DOI 10.1097/00001648-199811000-00017	24	158	167	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2004	329	7462					371	374		10.1136/bmj.38169.519653.EB	http://dx.doi.org/10.1136/bmj.38169.519653.EB			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YI	15294856	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000223433600014
J	Munro, AJ				Munro, AJ			Oesophageal cancer: a view over overviews	LANCET			English	Editorial Material									Univ Dundee, Dept Surg & Mol Oncol, Dundee, Scotland	University of Dundee	Munro, AJ (corresponding author), Univ Dundee, Dept Surg & Mol Oncol, Dundee, Scotland.	a.j.munro@dundee.ac.uk						ARNOTT SJ, 2004, COCHRANE LIB; BEDENNE L, 2002, AM SOC CLINL ONCOL P, V519; Fiorica F, 2004, GUT, V53, P925, DOI 10.1136/gut.2003.025080; *IARC, 2000, GLOBOCAN; MALTHANER R, 2004, COCHRANE LIB; *SCOTT AUD GASTR C, 2002, SCOTT AUD GASTR CANC; Sur RK, 2002, INT J RADIAT ONCOL, V53, P127, DOI 10.1016/S0360-3016(02)02702-5; Wong R, 2004, COCHRANE LIB	8	18	20	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					566	568		10.1016/S0140-6736(04)16868-2	http://dx.doi.org/10.1016/S0140-6736(04)16868-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313344				2022-12-28	WOS:000223275100010
J	Meehl, GA; Tebaldi, C				Meehl, GA; Tebaldi, C			More intense, more frequent, and longer lasting heat waves in the 21st century	SCIENCE			English	Article							GLOBAL CLIMATE; IMPACTS; 20TH-CENTURY; WEATHER; MODEL	A global coupled climate model shows that there is a distinct geographic pattern to future changes in heat waves. Model results for areas of Europe and North America, associated with the severe heat waves in Chicago in 1995 and Paris in 2003, show that future heat waves in these areas will become more intense, more frequent, and longer lasting in the second half of the 21st century. Observations and the model show that present-day heat waves over Europe and North America coincide with a specific atmospheric circulation pattern that is intensified by ongoing increases in greenhouse gases, indicating that it will produce more severe heat waves in those regions in the future.	Natl Ctr Atmospher Res, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Meehl, GA (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	meehl@ncar.ucar.edu	tebaldi, claudia/E-3089-2013	tebaldi, claudia/0000-0001-9233-8903				Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Dai A, 2001, J CLIMATE, V14, P485, DOI 10.1175/1520-0442(2001)014<0485:COTTAT>2.0.CO;2; Dai A, 2001, GEOPHYS RES LETT, V28, P4511, DOI 10.1029/2001GL013359; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Huth R, 2000, CLIMATIC CHANGE, V46, P29, DOI 10.1023/A:1005633925903; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Karl TR, 1997, B AM METEOROL SOC, V78, P1107, DOI 10.1175/1520-0477(1997)078<1107:TCHWHL>2.0.CO;2; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kunkel KE, 1996, B AM METEOROL SOC, V77, P1507, DOI 10.1175/1520-0477(1996)077<1507:TJHWIT>2.0.CO;2; Leggett J., 1992, CLIMATE CHANGE 1992, P69; Meehl GA, 2003, J CLIMATE, V16, P426, DOI [10.1175/1520-0442(2003)016<0426:SAGGFA>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;0426:SAGGFA&gt;2.0.CO;2]; MEEHL GA, IN PRESS J CLIM; MEEHL GA, IN PRESS CLIM DYN; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Palecki MA, 2001, B AM METEOROL SOC, V82, P1353, DOI 10.1175/1520-0477(2001)082<1353:TNAIOT>2.3.CO;2; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Santer BD, 2003, SCIENCE, V301, P479, DOI 10.1126/science.1084123; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; World Health Organization, 2003, HLTH IMP 2003 SUMM H	20	2552	2664	65	574	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					994	997		10.1126/science.1098704	http://dx.doi.org/10.1126/science.1098704			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310900				2022-12-28	WOS:000223250700045
J	Pratt, JS; Kaplan, LM; Cummings, S; Vineberg, DA; Graeme-Cook, F; Fernandez-del Castillo, C; Vacanti, J				Pratt, JS; Kaplan, LM; Cummings, S; Vineberg, DA; Graeme-Cook, F; Fernandez-del Castillo, C; Vacanti, J			Case 25-2004: A 49-year-old woman with severe obesity, diabetes, and hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							Y GASTRIC BYPASS; QUALITY-OF-LIFE; BARIATRIC SURGERY; DEPRESSION; OUTCOMES		Massachusetts Gen Hosp, Weight Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Psychiat, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Pratt, JS (corresponding author), Massachusetts Gen Hosp, Weight Ctr, Boston, MA 02114 USA.		Castillo, Carlos Fenandez-del/AAO-2602-2020	Pratt, Janey/0000-0002-6850-3427				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Averbukh Y, 2003, OBES SURG, V13, P833, DOI 10.1381/096089203322618605; Balsiger BM, 2000, MED CLIN N AM, V84, P477, DOI 10.1016/S0025-7125(05)70232-7; Beck A., 1987, MANUAL REVISED BECK; BLACKBURN GL, 1978, INT J OBESITY, V2, P133; Brolin RE, 1996, NUTRITION, V12, P403, DOI 10.1016/S0899-9007(96)00154-2; Brolin RE, 2002, JAMA-J AM MED ASSOC, V288, P2793, DOI 10.1001/jama.288.22.2793; Dymek MP, 2001, OBES SURG, V11, P32, DOI 10.1381/096089201321454088; Harris JA., 1919, BIOMETRIC STUDY BASA; Jones KB, 2004, INT SURG, V89, P51; Kaplan LA, 2003, J GASTROINTEST SURG, V7, P443, DOI 10.1016/S1091-255X(03)00047-7; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; McCullough AJ, 2002, J CLIN GASTROENTEROL, V34, P255, DOI 10.1097/00004836-200203000-00013; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; NEUSCHWANDERTET.BA, 2003, HEPATOLOGY, V38, P536; Nguyen NT, 2001, ANN SURG, V234, P279, DOI 10.1097/00000658-200109000-00002; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Podnos YD, 2003, ARCH SURG-CHICAGO, V138, P957, DOI 10.1001/archsurg.138.9.957; Ren CJ, 2002, AM J SURG, V184, p46S, DOI 10.1016/S0002-9610(02)01180-7; Roberts RE, 2003, INT J OBESITY, V27, P514, DOI 10.1038/sj.ijo.0802204; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Schauer PR, 2000, ANN SURG, V232, P515, DOI 10.1097/00000658-200010000-00007; Sugerman HJ, 2003, J GASTROINTEST SURG, V7, P102, DOI 10.1016/S1091-255X(02)00125-7; 1998, OBES RES, V6, P464	24	15	17	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					696	705		10.1056/NEJMcpc049017	http://dx.doi.org/10.1056/NEJMcpc049017			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306672				2022-12-28	WOS:000223225500014
J	Singer, M; De Santis, V; Vitale, D; Jeffcoate, W				Singer, M; De Santis, V; Vitale, D; Jeffcoate, W			Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation	LANCET			English	Article							NITRIC-OXIDE SYNTHASE; SEPTIC SHOCK; OXYGEN-CONSUMPTION; MITOCHONDRIAL DYSFUNCTION; SKELETAL-MUSCLE; SEPSIS; RAT; HYPERGLYCEMIA; VASOPRESSIN; INHIBITION	Sepsis and other critical illnesses produce a biphasic inflammatory, immune, hormonal, and metabolic response. The acute phase is marked by an abrupt rise in the secretion of so-called stress hormones with an associated increase in mitochondrial and metabolic activity. The combination of severe inflammation and secondary changes in endocrine profile diminish energy production, metabolic rate, and normal cellular processes, leading to multiple organ dysfunction. This perceived failure of organs might instead be a potentially protective mechanism, because reduced cellular metabolism could increase the chances of survival of cells, and thus organs, in the face of an overwhelming insult. We propose that, first, multiple organ failure induced by critical illness is primarily a functional, rather than structural, abnormality. Indeed, it may not be failure as such, but a potentially protective, reactive mechanism. Second, the decline in organ function is triggered by a decrease in mitochondrial activity and oxidative phosphorylation, leading to reduced cellular metabolism. Third, this effect on mitochondria might be the consequence of acute-phase changes in hormones and inflammatory mediators.	UCL, Wolfson Inst Biomed Res, Bloomsbury Inst Intens Care Med, London WC1E 6BT, England; UCL, Dept Med, London WC1E 6BT, England; Univ Roma La Sapienza, Dept Anaesthesia, Rome, Italy; City Hosp, Dept Endocrinol & Diabet, Nottingham NG5 1PB, England	University of London; University College London; University of London; University College London; Sapienza University Rome; University of Nottingham	Singer, M (corresponding author), UCL, Wolfson Inst Biomed Res, Bloomsbury Inst Intens Care Med, Gower St, London WC1E 6BT, England.	m.singer@ucl.ac.uk	Singer, Mervyn/J-4425-2012; Singer, Mervyn/Q-6142-2019; De Santis, Vincenzo/AAM-7960-2020	Singer, Mervyn/0000-0002-1042-6350; Singer, Mervyn/0000-0002-1042-6350; De Santis, Vincenzo/0000-0002-5105-7969				Acker CG, 2000, KIDNEY INT, V57, P293, DOI 10.1046/j.1523-1755.2000.00827.x; Agwunobi AO, 2000, J CLIN ENDOCR METAB, V85, P3770, DOI 10.1210/jc.85.10.3770; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; BOEKSTEGERS P, 1991, INFECTION, V19, P317, DOI 10.1007/BF01645355; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; Boulos M, 2003, CRIT CARE MED, V31, P353, DOI 10.1097/01.CCM.0000050074.82486.B2; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Costamagna ME, 1998, THYROID, V8, P1127, DOI 10.1089/thy.1998.8.1127; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; Duclos M, 2001, PFLUG ARCH EUR J PHY, V443, P218, DOI 10.1007/s004240100675; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; King CJ, 1999, CRIT CARE MED, V27, P2518, DOI 10.1097/00003246-199911000-00032; KREYMANN G, 1993, CRIT CARE MED, V21, P1012, DOI 10.1097/00003246-199307000-00015; Lee S, 1999, J NEUROSCI, V19, P7640, DOI 10.1523/JNEUROSCI.19-17-07640.1999; Ligtenberg JJM, 2001, INTENS CARE MED, V27, P1567, DOI 10.1007/s001340101050; Noble JS, 2001, ANAESTHESIA, V56, P124, DOI 10.1046/j.1365-2044.2001.01841.x; Nogueira V, 2002, J BIOENERG BIOMEMBR, V34, P55, DOI 10.1023/A:1013822820840; PALAZZO MG, 1991, INTENS CARE MED, V17, P325, DOI 10.1007/BF01716190; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; RIVIER C, 1994, J NEUROSCI, V14, P1985; Robb SJ, 2002, INTENS CARE MED, V28, pS64; ROTHWELL PM, 1995, CRIT CARE MED, V23, P78, DOI 10.1097/00003246-199501000-00015; Scheller K, 2003, INT REV CYTOL, V222, P1; Short KR, 2001, AM J PHYSIOL-ENDOC M, V280, pE761, DOI 10.1152/ajpendo.2001.280.5.E761; Singer M, 1999, BIOCHEM SOC SYMP, V66, P149, DOI 10.1042/bss0660149; Sugita H, 2002, AM J PHYSIOL-ENDOC M, V282, pE386, DOI 10.1152/ajpendo.00087.2001; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Tsai AG, 2003, AM J PHYSIOL-HEART C, V285, pH1537, DOI 10.1152/ajpheart.00176.2003; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; Venditti P, 2003, ARCH BIOCHEM BIOPHYS, V411, P121, DOI 10.1016/S0003-9861(02)00720-8; WANG XM, 1993, BURNS, V19, P110, DOI 10.1016/0305-4179(93)90030-C; Weekers F, 2003, ENDOCRINOLOGY, V144, P5329, DOI 10.1210/en.2003-0697; Zell R, 1997, MOL CELL BIOCHEM, V177, P61, DOI 10.1023/A:1006896832582	35	334	366	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					545	548		10.1016/S0140-6736(04)16815-3	http://dx.doi.org/10.1016/S0140-6736(04)16815-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302200				2022-12-28	WOS:000223132700036
J	Hofbauer, LC; Schoppet, M				Hofbauer, LC; Schoppet, M			Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							KAPPA-B LIGAND; SOLUBLE RECEPTOR ACTIVATOR; SERUM OSTEOPROTEGERIN; MULTIPLE-MYELOMA; OSTEOCLAST DIFFERENTIATION; RANK LIGAND; HUMORAL HYPERCALCEMIA; SURVIVAL FACTOR; CELLS; EXPRESSION	Bone resorption by osteoclasts is coupled with bone formation by osteoblasts, and this balanced process continuously remodels and adapts the skeleton. The receptor activator of nuclear factor kappaB ligand (RANKL) has been identified as an essential cytokine for the formation and activation of osteoclasts. The effects of RANKL are physiologically counterbalanced by the decoy receptor osteoprotegerin (OPG). Estrogen deficiency, glucocorticoid exposure, T-cell activation (eg, rheumatoid arthritis), and skeletal malignancies (eg, myeloma, metastases) enhance the ratio of RANKL to OPG and, thus, promote osteoclastogenesis, accelerate bone resorption, and induce bone loss. Moreover, alterations of the OPG/RANKL/RANK system have been implicated in vascular diseases. RANKL blockade (using OPG or RANK fusion proteins or RANKL antibodies) has prevented bone loss caused by osteoporosis, chronic inflammatory disorders, and malignant tumors in animal models and may emerge as a therapy in humans based on studies in postmenopausal osteoporosis, myeloma bone disease, and osteolytic metastases. This review summarizes the clinical implications of the OPG/RANKL/RANK system for bone and vascular diseases.	Univ Marburg, Dept Gastroenterol Endocrinol & Metab, D-35033 Marburg, Germany; Univ Marburg, Dept Cardiol, D-35033 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Hofbauer, LC (corresponding author), Univ Marburg, Dept Gastroenterol Endocrinol & Metab, Baldingerstr, D-35033 Marburg, Germany.	hofbauer@post.med.uni-marburg.de	Hofbauer, Lorenz C/G-2490-2010	Hofbauer, Lorenz C/0000-0002-8691-8423				Bekker PJ, 2001, J BONE MINER RES, V16, P348, DOI 10.1359/jbmr.2001.16.2.348; Bekker PJ, 2004, J BONE MINER RES, V19, P1059, DOI 10.1359/JBMR.040305; Body JJ, 2003, CANCER-AM CANCER SOC, V97, P887, DOI 10.1002/cncr.11138; Brown JM, 2001, CLIN CANCER RES, V7, P2977; Browner WS, 2001, J CLIN ENDOCR METAB, V86, P631, DOI 10.1210/jc.86.2.631; Cheng X, 2004, J BIOL CHEM, V279, P8269, DOI 10.1074/jbc.M309690200; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Fahrleitner A, 2003, BONE, V32, P96, DOI 10.1016/S8756-3282(02)00926-2; Giuliani N, 2001, BLOOD, V98, P3527, DOI 10.1182/blood.V98.13.3527; Heider U, 2003, CLIN CANCER RES, V9, P1436; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4382, DOI 10.1210/en.140.10.4382; Hofbauer LC, 2001, BIOCHEM BIOPH RES CO, V280, P334, DOI 10.1006/bbrc.2000.4130; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4367, DOI 10.1210/en.140.9.4367; Holen I, 2002, CANCER RES, V62, P1619; Honore P, 2000, NAT MED, V6, P521, DOI 10.1038/74999; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Jono S, 2002, CIRCULATION, V106, P1192, DOI 10.1161/01.CIR.0000031524.49139.29; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; Kobayashi Y, 2000, J BONE MINER RES, V15, P1924, DOI 10.1359/jbmr.2000.15.10.1924; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Locklin RM, 2003, J CELL BIOCHEM, V89, P180, DOI 10.1002/jcb.10490; Lubberts E, 2003, J IMMUNOL, V170, P2655, DOI 10.4049/jimmunol.170.5.2655; Malyankar UM, 2000, J BIOL CHEM, V275, P20959, DOI 10.1074/jbc.C000290200; Menaa C, 2000, J CLIN INVEST, V105, P1833, DOI 10.1172/JCI9133; Michigami T, 2001, CANCER RES, V61, P1637; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Nagai M, 2000, BIOCHEM BIOPH RES CO, V269, P532, DOI 10.1006/bbrc.2000.2314; Onyia JE, 2004, J PHARMACOL EXP THER, V309, P369, DOI 10.1124/jpet.103.057893; Oyajobi BO, 2001, CANCER RES, V61, P2572; Price PA, 2001, ARTERIOSCL THROM VAS, V21, P1610, DOI 10.1161/hq1001.097102; Rogers A, 2002, J CLIN ENDOCR METAB, V87, P4470, DOI 10.1210/jc.2002-020396; Sasaki N, 2001, NEPHROL DIAL TRANSPL, V16, P479, DOI 10.1093/ndt/16.3.479; Schett G, 2004, JAMA-J AM MED ASSOC, V291, P1108, DOI 10.1001/jama.291.9.1108; Schoppet M, 2003, J CLIN ENDOCR METAB, V88, P1024, DOI 10.1210/jc.2002-020775; Seidel C, 2001, BLOOD, V98, P2269, DOI 10.1182/blood.V98.7.2269; Sezer O, 2003, BLOOD, V101, P2094, DOI 10.1182/blood-2002-09-2684; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Standal T, 2002, BLOOD, V100, P3002, DOI 10.1182/blood-2002-04-1190; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teng YTA, 2000, J CLIN INVEST, V106, pR59, DOI 10.1172/JCI10763; Terpos E, 2003, BLOOD, V102, P1064, DOI 10.1182/blood-2003-02-0380; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Viereck V, 2003, J CLIN ENDOCR METAB, V88, P4206, DOI 10.1210/jc.2002-021877; Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096; Whyte MP, 2002, J BONE MINER RES, V17, P26, DOI 10.1359/jbmr.2002.17.1.26; Yano K, 1999, J BONE MINER RES, V14, P518, DOI 10.1359/jbmr.1999.14.4.518; Ziolkowska M, 2002, ARTHRITIS RHEUM-US, V46, P1744, DOI 10.1002/art.10388; Zwerina J, 2004, ARTHRITIS RHEUM, V50, P277, DOI 10.1002/art.11487	51	707	744	1	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2004	292	4					490	495		10.1001/jama.292.4.490	http://dx.doi.org/10.1001/jama.292.4.490			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841AA	15280347				2022-12-28	WOS:000222900500026
J	Raimer, BG; Stobo, JD				Raimer, BG; Stobo, JD			Health care delivery in the Texas prison system - The role of academic medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEWLY INCARCERATED INMATES; CORRECTIONAL SYSTEM; SEROPREVALENCE	Faced with explosive growth in its prison population and a legal mandate to improve medical care for incarcerated offenders, the state of Texas implemented a novel correctional managed health care program in 1994. The organizational structure of the program is based on a series of contractual relationships between the state prison system, 2 of the state's academic medical centers, and a separate governing body composed of 9 appointed members, which include 5 physicians. All medical, dental, and psychiatric care for more than 145000 offenders, incarcerated under the jurisdiction of the Texas Department of Criminal Justice, is provided by the University of Texas Medical Branch and Texas Tech University Health Sciences Center. The health delivery system is composed of several levels of care, including primary ambulatory care clinics in each prison unit, 16 infirmaries at strategic locations throughout the state, several regional medical facilities, and a dedicated prison hospital with a full range of services. Specialized treatment programs have been established at various units for patients with chronic conditions, such as hypertension, diabetes mellitus, major psychiatric disorders, hepatitis, and human immunodeficiency virus infection. Significant improvements in health outcomes have occurred since the managed care program was established.	Univ Texas, Med Branch, Off Community Outreach, Galveston, TX 77555 USA; Univ Texas, Med Branch, Off President, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Raimer, BG (corresponding author), Univ Texas, Med Branch, Off Community Outreach, 301 Univ Blvd, Galveston, TX 77555 USA.	bgraimer@utmb.edu						Anno B J, 1980, Eval Health Prof, V3, P365; ANNO BJ, 1982, JAMA-J AM MED ASSOC, V247, P2923; ANNO BJ, 2001, CORRECTIONAL HLTH CA; Baillargeon J, 2003, PUBLIC HEALTH, V117, P43, DOI 10.1016/S0033-3506(02)00009-4; Baillargeon J, 2000, ANN EPIDEMIOL, V10, P74, DOI 10.1016/S1047-2797(99)00033-2; BECK AJ, 1995, PRISONERS 1994; Beck Allen J., 2001, PRISONERS 2000; Brecht R M, 1996, Telemed J, V2, P25, DOI 10.1089/tmj.1.1996.2.25; BROWN JM, 1966, CORRECTIONAL POPULAT; Centers for Disease Control and Prevention (CDC), 2003, HIV AIDS SURVEILLANC, V9, P1; Hoyert D L, 1999, Natl Vital Stat Rep, V47, P1; Hoyert D L, 2001, Natl Vital Stat Rep, V49, P1; *JAILS PRIS TASK F, 1976, STAND HLTH SERV CORR; Minino Arialdi M, 2002, Natl Vital Stat Rep, V50, P1; Murphy S L, 2000, Natl Vital Stat Rep, V48, P1; Pastore Ann L., 1994, SOURCEBOOK CRIMINAL; Peters K D, 1998, Natl Vital Stat Rep, V47, P1; PUGH M, 1986, PRISON J, V66, P39; Robbins IP, 1999, J CRIM LAW CRIM, V90, P195, DOI 10.2307/1144165; Rold WJ, 1998, CLINICAL PRACTICE IN CORRECTIONAL MEDICINE, P344; *TEX CRIM JUST POL, ELD IN AG 55 OLD PRI; *TEX DEP CRIM JUST, 2003, TEX DEP CRIM JUST FI; *TEX DEP HLTH, BUR VIT STAT TABL 18; *TEX PERF REV, 1993, GRAIN HIGH QUAL LOW, V2; Thorburn KM, 1995, WESTERN J MED, V163, P560; TINSTMAN TC, 1995, TEX J RURAL HLTH, V14, P70; *U TEX MED BRANCH, NAT GUID CLEAR; WEINER J, 1992, ANN INTERN MED, V117, P71, DOI 10.7326/0003-4819-117-1-71; Wu ZH, 2001, ANN EPIDEMIOL, V11, P342, DOI 10.1016/S1047-2797(01)00210-1	29	45	49	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2004	292	4					485	489		10.1001/jama.292.4.485	http://dx.doi.org/10.1001/jama.292.4.485			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841AA	15280346				2022-12-28	WOS:000222900500025
J	Bennett, DLH; Webster, GJM; Molyneux, P; Descamps, MJL; Plant, GT; Pereira, SP; Reilly, MM				Bennett, DLH; Webster, GJM; Molyneux, P; Descamps, MJL; Plant, GT; Pereira, SP; Reilly, MM			The world through tinted glasses	LANCET			English	Editorial Material									Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Univ Coll Hosp NHS Trust, Dept Gastroenterol, Middlesex Hosp, London, England; W Suffolk Hosp NHS Trust, Dept Neurol, Bury St Edmunds, Suffolk, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London	Bennett, DLH (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	dlhbennett@talk21.com	Pereira, Stephen P/C-5639-2009	Pereira, Stephen P/0000-0003-0821-1809; Bennett, David/0000-0002-7996-2696; Reilly, Mary/0000-0003-0686-905X				BATES CJ, 1995, LANCET, V345, P31, DOI 10.1016/S0140-6736(95)91157-X; Nakamura T, 1996, ACTA GASTRO-ENT BELG, V59, P10; SMITH JP, 2000, INCREASING INCOME IN, P83	3	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 24	2004	364	9431					388	388		10.1016/S0140-6736(04)16731-7	http://dx.doi.org/10.1016/S0140-6736(04)16731-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276402				2022-12-28	WOS:000222853300041
J	Risitano, AM; Maciejewski, JP; Green, S; Plasilova, M; Zeng, WH; Young, NS				Risitano, AM; Maciejewski, JP; Green, S; Plasilova, M; Zeng, WH; Young, NS			In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing	LANCET			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; MYELODYSPLASTIC-SYNDROME; INTERFERON-GAMMA; STRUCTURAL BASIS; RECEPTOR; REPERTOIRE; EXPANSIONS; ANTIGEN; EPITOPE; CYTOTOXICITY	Background Aplastic anaemia is a bone-marrow-failure syndrome characterised by low blood-cell counts and fatty bone marrow. in most cases, no obvious aetiological factor can be identified. However, clinical responses to immunosuppression strongly suggest an immune pathophysiology. Methods To test the hypothesis that aplastic anaemia results from antigen-specific lymphocyte attack against haemopoietic tissue, we analysed effector immunity, seeking especially dominant specific T-cell responses. Blood samples from 54 patients with aplastic anaemia were subjected to flow cytometry to define T-cell-receptor Vbeta-chain usage and expansion of particular Vbeta subsets. We measured the size distribution of the complementarity-determining region 3 (CDR3) for expanded Vbeta subsets, then cloned and sequenced skewed, oligoclonal, or monoclonal peaks. Findings Expanded Vbeta subsets were identified in almost all the patients. Over-represented Vbeta subsets from CD8-positive cells showed oligoclonal or monoclonal CDR3 size patterns. The CDR3 sequence repertoire in aplastic anaemia showed much redundancy compared with healthy donors. We identified patient-specific putative pathogenetic clonotypes that were not detectable in controls. in selected patients who were assessed longitudinally, these clonotypes were quantitatively related to disease activity. Selective killing of autologous haemopoietic progenitors by the Vbeta-specific lymphocyte population was shown in one patient. These apparently pathogenetic CDR3 sequences showed homology between individuals, suggesting a role for a "semi-public" immune response in the pathophysiology of aplastic anaemia. Interpretation In-vivo dominant clonal immune response can be identified in many patients with aplastic anaemia, which is evidence for an underlying antigen-driven immune process. Longitudinal tracking by molecular techniques could inform individual clinical decisions and the development of new treatments in autoimmune diseases. Relevance to practice Although the target of the aberrant immune response is the haemopoietic stem cell, the triggering antigens remain unknown. We combined cell phenotypic, molecular biology, and functional analyses to study the effector arm of immunity in an attempt to establish an immune pathophysiology. Clinical application of such a model could broadly extend to other autoimmune diseases.	NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; Cleveland Clin Fdn, Expt Hematol & Hematopoiesis Sect, Taussig Canc Ctr, Cleveland, OH 44195 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Cleveland Clinic Foundation	Risitano, AM (corresponding author), Univ Naples Federico II, Div Hematol, Via Pansini 5, I-80131 Naples, Italy.	amrisita@unina.it			NHLBI NIH HHS [HL73429] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL002315, R01HL073429] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; Cohen GB, 2002, VIROLOGY, V304, P474, DOI 10.1006/viro.2002.1743; Dunn DE, 1999, ANN INTERN MED, V131, P401, DOI 10.7326/0003-4819-131-6-199909210-00002; Epperson DE, 2001, LEUKEMIA RES, V25, P1075, DOI 10.1016/S0145-2126(01)00083-2; EVEN J, 1995, RES IMMUNOL, V146, P65, DOI 10.1016/0923-2494(96)80240-9; Feng XM, 2003, BLOOD, V102, p206A; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; HEIMPEL H, 1987, BLOOD, V70, P1718; Hirano N, 2003, BLOOD, V102, P4567, DOI 10.1182/blood-2002-11-3409; Hofbauer M, 2003, P NATL ACAD SCI USA, V100, P4090, DOI 10.1073/pnas.0236183100; Hong J, 1999, J IMMUNOL, V163, P3530; Karadimitris A, 2000, BLOOD, V96, P2613, DOI 10.1182/blood.V96.7.2613.h8002613_2613_2620; Kochenderfer JN, 2002, BLOOD, V100, P3639, DOI 10.1182/blood-2002-01-0155; Kook H, 2002, BLOOD, V99, P3668, DOI 10.1182/blood.V99.10.3668; KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.iy.04.040186.002525; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Lim A, 2000, J IMMUNOL, V165, P2001, DOI 10.4049/jimmunol.165.4.2001; Liu LZ, 2002, NAT MED, V8, P185, DOI 10.1038/nm0202-185; MACIEJEWSKI JP, 1995, BRIT J HAEMATOL, V91, P245, DOI 10.1111/j.1365-2141.1995.tb05277.x; Maciejewski JP, 2001, BLOOD, V98, P3513, DOI 10.1182/blood.V98.13.3513; Michalek J, 2003, LANCET, V361, P1183, DOI 10.1016/S0140-6736(03)12917-0; Michalek J, 2003, P NATL ACAD SCI USA, V100, P1180, DOI 10.1073/pnas.0337543100; Muraro PA, 2003, BRAIN, V126, P20, DOI 10.1093/brain/awg021; Nakao S, 1997, BLOOD, V89, P3691, DOI 10.1182/blood.V89.10.3691.3691_3691_3699; O'Keefe CL, 2004, J IMMUNOL, V172, P1960, DOI 10.4049/jimmunol.172.3.1960; Plasilova Magdalena, 2003, Hematology, V8, P173, DOI 10.1080/1024533031000107505; Risitano AM, 2002, BLOOD, V100, P178, DOI 10.1182/blood-2002-01-0236; ROSENFELD SJ, 1995, BLOOD, V85, P3058, DOI 10.1182/blood.V85.11.3058.bloodjournal85113058; Scotet E, 1999, EUR J IMMUNOL, V29, P973, DOI 10.1002/(SICI)1521-4141(199903)29:03<973::AID-IMMU973>3.3.CO;2-G; Selleri C, 1996, BLOOD, V87, P4149, DOI 10.1182/blood.V87.10.4149.bloodjournal87104149; Sloand E, 2002, BLOOD, V100, P1185, DOI 10.1182/blood-2002-01-0035; Sospedra M, 2003, METHODS, V29, P236, DOI 10.1016/S1046-2023(02)00346-8; van den Beemd R, 2000, CYTOMETRY, V40, P336, DOI 10.1002/1097-0320(20000801)40:4<336::AID-CYTO9>3.0.CO;2-0; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Young N. S., 2000, BONE MARROW FAILURE, P1; Young NS, 2000, SEMIN HEMATOL, V37, P3, DOI 10.1016/S0037-1963(00)90026-X; Young NS, 1997, NEW ENGL J MED, V336, P1365, DOI 10.1056/NEJM199705083361906; Zeng WH, 2001, J CLIN INVEST, V108, P765, DOI 10.1172/JCI12687; ZOUMBOS NC, 1985, NEW ENGL J MED, V312, P257, DOI 10.1056/NEJM198501313120501	40	193	230	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					355	364		10.1016/S0140-6736(04)16724-X	http://dx.doi.org/10.1016/S0140-6736(04)16724-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276395				2022-12-28	WOS:000222853300034
J	Ruhl, HA; Smith, KL				Ruhl, HA; Smith, KL			Shifts in deep-sea community structure linked to climate and food supply	SCIENCE			English	Article							PORCUPINE ABYSSAL-PLAIN; BENTHIC BOUNDARY-LAYER; TIME-SERIES STATION; CALIFORNIA CURRENT; NORTH PACIFIC; NE PACIFIC; ONEIROPHANTA-MUTABILIS; EPIBENTHIC MEGAFAUNA; REPRODUCTIVE-BIOLOGY; ORGANIC-MATTER	A major change in the community structure of the dominant epibenthic megafauna was observed at 4100 meters depth in the northeast Pacific and was synchronous to a major El Nino/ La Nina event that occurred between 1997 and 1999. Photographic abundance estimates of epibenthic megafauna from 1989 to 2002 show that two taxa decreased in abundance after 1998 by 2 to 3 orders of magnitude, whereas several other species increased in abundance by 1 to 2 orders of magnitude. These faunal changes are correlated to climate fluctuations dominated by El Nino/La Nina. Megafauna even in remote marine areas appear to be affected by contemporary climatic fluctuations. Such faunal changes highlight the importance of an adequate temporal perspective in describing biodiversity, ecology, and anthropogenic impacts in deep-sea communities.	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Ruhl, HA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	hruhl@ucsd.edu						Baldwin RJ, 1998, DEEP-SEA RES PT II, V45, P643, DOI 10.1016/S0967-0645(97)00097-0; Beaulieu SE, 1998, DEEP-SEA RES PT II, V45, P781, DOI 10.1016/S0967-0645(98)00003-4; Bett BJ, 2001, PROG OCEANOGR, V50, P349, DOI 10.1016/S0079-6611(01)00066-0; Billett D.S.M., 1988, P421; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; Billett DSM, 2001, PROG OCEANOGR, V50, P325, DOI 10.1016/S0079-6611(01)00060-X; Bograd SJ, 2003, DEEP-SEA RES PT II, V50, P2355, DOI 10.1016/S0967-0645(03)00131-0; Brinton E, 2003, DEEP-SEA RES PT II, V50, P2449, DOI 10.1016/S0967-0645(03)00126-7; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI DOI 10.5670/0CEAN0G.1991.07; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; GOODAY AJ, 1988, NATURE, V332, P70, DOI 10.1038/332070a0; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hudson IR, 2003, PROG OCEANOGR, V59, P381, DOI 10.1016/j.pocean.2003.11.002; Iken K, 2001, PROG OCEANOGR, V50, P383, DOI 10.1016/S0079-6611(01)00062-3; Kahru M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014963; Lampitt RS, 2001, PROG OCEANOGR, V50, P27, DOI 10.1016/S0079-6611(01)00047-7; Lauerman LML, 1996, DEEP-SEA RES PT I, V43, P1075, DOI 10.1016/0967-0637(96)00045-3; Lauerman LML, 1998, DEEP-SEA RES PT II, V45, P817, DOI 10.1016/S0967-0645(98)00004-6; Lauerman LML, 1997, LIMNOL OCEANOGR, V42, P589, DOI 10.4319/lo.1997.42.3.0589; Lavaniegos BE, 2003, DEEP-SEA RES PT II, V50, P2473, DOI 10.1016/S0967-0645(03)00132-2; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Miller AJ, 2000, PROG OCEANOGR, V47, P355, DOI 10.1016/S0079-6611(00)00044-6; PFANNKUCHE O, 1993, DEEP-SEA RES PT I, V40, P727, DOI 10.1016/0967-0637(93)90068-E; Roberts D, 2001, PROG OCEANOGR, V50, P443, DOI 10.1016/S0079-6611(01)00065-9; Roberts D, 1997, BIODIVERS CONSERV, V6, P1487, DOI 10.1023/A:1018362319053; Smallwood BJ, 1999, NATURWISSENSCHAFTEN, V86, P320, DOI 10.1007/s001140050624; Smith CR, 2000, DEEP-SEA RES PT II, V47, P227, DOI 10.1016/S0967-0645(99)00108-3; Smith KL, 1999, SCIENCE, V284, P1174, DOI 10.1126/science.284.5417.1174; SMITH KL, 1993, DEEP-SEA RES PT I, V40, P2307, DOI 10.1016/0967-0637(93)90106-D; Uthicke S, 1999, J EXP MAR BIOL ECOL, V236, P69, DOI 10.1016/S0022-0981(98)00190-7; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wigham BD, 2003, J MAR BIOL ASSOC UK, V83, P175, DOI 10.1017/S0025315403006957h; Witbaard R, 2001, PROG OCEANOGR, V50, P423, DOI 10.1016/S0079-6611(01)00064-7	33	197	202	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					513	515		10.1126/science.1099759	http://dx.doi.org/10.1126/science.1099759			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273392				2022-12-28	WOS:000222828900038
J	Kinnunen, J; Rodriguez, M; Torma, P				Kinnunen, J; Rodriguez, M; Torma, P			Pairing gap and in-gap excitations in trapped fermionic superfluids	SCIENCE			English	Article							CONDENSATION	We consider trapped atomic Fermi gases with Feshbach-resonance enhanced interactions in pseudogap and superfluid temperatures. We calculate the spectrum of radio-frequency (or laser) excitations for transitions that transfer atoms out of the superfluid state. The spectrum displays the pairing gap and also the contribution of unpaired atoms, that is, in-gap excitations. The results support the conclusion that a superfluid, in which pairing is a many-body effect, was observed in recent experiments on radio-frequency spectroscopy of the pairing gap.	Univ Jyvaskyla, Dept Phys, NanoSci Ctr, FIN-40014 Jyvaskyla, Finland	University of Jyvaskyla	Torma, P (corresponding author), Univ Jyvaskyla, Dept Phys, NanoSci Ctr, POB 35, FIN-40014 Jyvaskyla, Finland.	paivi.torma@phys.jyu.fi	Törmä, Päivi/E-7359-2012; Kinnunen, Jami J/J-9809-2013	Törmä, Päivi/0000-0003-0979-9894; Kinnunen, Jami J/0000-0001-7155-1262				Baranov MA, 1999, JETP LETT+, V70, P396, DOI 10.1134/1.568187; Bartenstein M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.203201; Bartenstein M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120401; Bruun GM, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.033609; Carr LD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.150404; Chin C, 2004, SCIENCE, V305, P1128, DOI 10.1126/science.1100818; Chiofalo ML, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.090402; Gupta S, 2003, SCIENCE, V300, P1723, DOI 10.1126/science.1085335; Holland M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.120406; Kinast J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.150402; Kinnunen J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.230403; Leggett A. J., 1980, Modern Trends in the Theory of Condensed Matter. Proceedings of the XVIth Karpacz Winter School of Theoretical Physics, P13; NOZIERES P, 1985, J LOW TEMP PHYS, V59, P195, DOI 10.1007/BF00683774; Ohashi Y, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.130402; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Regal CA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.230404; Stajic J, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.063610; Timmermans E, 2001, PHYS LETT A, V285, P228, DOI 10.1016/S0375-9601(01)00346-2; Torma P, 2000, PHYS REV LETT, V85, P487, DOI 10.1103/PhysRevLett.85.487; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403	20	116	119	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1131	1133		10.1126/science.1100782	http://dx.doi.org/10.1126/science.1100782			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15272124	Green Submitted			2022-12-28	WOS:000223557400040
J	Natoli, G				Natoli, G			Little things that count in transcriptional regulation	CELL			English	Editorial Material							DNA; RECOGNITION	Although the NF-kappaB transcription factor tolerates significant sequence variations in its DNA binding site, NF-kappaB sites show remarkable evolutionary stability. In this issue of Cell, Leung et al. (2004) demonstrate that a single nucleotide change in an NF-kappaB binding site changes the dependence of the promoter on a specific coactivator without affecting NF-kappaB binding. These data suggest that binding sites may impart a specific configuration to bound transcription factors.	Inst Biomed Res, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana	Natoli, G (corresponding author), Inst Biomed Res, Via Vela 6, CH-6500 Bellinzona, Switzerland.		Natoli, gioacchino/J-2100-2018; Natoli, gioacchino/ABB-8679-2020	Natoli, Gioacchino/0000-0003-0711-2411				Brenner SE, 2001, NAT REV GENET, V2, P801, DOI 10.1038/35093574; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Lukens AK, 2000, NUCLEIC ACIDS RES, V28, P3853, DOI 10.1093/nar/28.20.3853; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127	7	14	14	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 20	2004	118	4					406	408		10.1016/j.cell.2004.08.003	http://dx.doi.org/10.1016/j.cell.2004.08.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315753	Bronze			2022-12-28	WOS:000223650900003
J	Lapsley, P				Lapsley, P			Commentary: Patients in medical education and research	BRITISH MEDICAL JOURNAL			English	Editorial Material									Skin Care Campaign, London N19 5NA, England		Lapsley, P (corresponding author), Skin Care Campaign, Hill House, London N19 5NA, England.	plapsley@eczema.org						Jagsi R, 2004, BMJ-BRIT MED J, V329, P332, DOI 10.1136/bmj.329.7461.332	1	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 7	2004	329	7461					334	334		10.1136/bmj.329.7461.334	http://dx.doi.org/10.1136/bmj.329.7461.334			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846FF	15297342	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000223300300025
J	Sekhar, M				Sekhar, M			Mean times in transfusion - carrots and sticks for practice in England	LANCET			English	Editorial Material							SURGERY		W Middlesex Univ Hosp, Dept Haematol, Isleworth TW7 6AF, Middx, England	Imperial College London	Sekhar, M (corresponding author), W Middlesex Univ Hosp, Dept Haematol, Isleworth TW7 6AF, Middx, England.	mallika.sekhar@wmuh-tr.nthames.nhs.uk		Sekhar, Mallika/0000-0002-5783-1855				*HLTH SERV CIRC, 2002, 2002009 HSC DEP HLTH; JAMES V, 2004, NATL BLOOD CONSERVAT; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; PENNY S, 2004, EMERGENCY PLANNING D; PRIOR G, 2002, HLTH SURVEY ENGLAND; Rosencher N, 2003, TRANSFUSION, V43, P459, DOI 10.1046/j.1537-2995.2003.00348.x; SIRCHIA G, 1994, TRANSFUSION MED, V4, P251	7	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 7	2004	364	9433					479	481		10.1016/S0140-6736(04)16821-9	http://dx.doi.org/10.1016/S0140-6736(04)16821-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302173				2022-12-28	WOS:000223132700004
J	Lawn, JE; Cousens, S; Bhutta, ZA; Darmstadt, GL; Martines, J; Paul, V; Knippenberg, R; Fogstadt, H; Shetty, P; Horton, R				Lawn, JE; Cousens, S; Bhutta, ZA; Darmstadt, GL; Martines, J; Paul, V; Knippenberg, R; Fogstadt, H; Shetty, P; Horton, R			Why are 4 million newborn babies dying each year?	LANCET			English	Editorial Material							CHILD SURVIVAL; HEALTH; CHALLENGE; MORTALITY		Inst Child Hlth, Int Perinatal Unit, London WC1N 1EH, England; London Sch Hyg & Trop Med, London WC1, England; Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; WHO, Dept Child & Adolescent Hlth & Dev & Reprod Hlth, CH-1211 Geneva, Switzerland; Saving Newborn Lives, New Delhi, India; UNICEF, New York, NY USA; The Lancet, London, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Aga Khan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; UNICEF	Lawn, JE (corresponding author), Inst Child Hlth, Int Perinatal Unit, 30 Guilford St, London WC1N 1EH, England.	joylawn@yahoo.co.uk	Darmstadt, Gary/AAU-7488-2020; Lawn, Joy/ABE-6382-2020	Lawn, Joy/0000-0002-4573-1443				Bhutta ZA, 2004, ARCH DIS CHILD, V89, P483, DOI 10.1136/adc.2003.045732; Bhutta ZA, 2004, BMJ-BRIT MED J, V328, P816, DOI 10.1136/bmj.328.7443.816; BHUTTA ZA, 2003, SHAPING POLICY MATER, P5; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Lee JW, 2003, LANCET, V362, P262, DOI 10.1016/S0140-6736(03)14006-8; MACFARLANE A, 2001, TXB NEONATOLOGY, P3; Saving Newborn Lives, 2001, SAV NEWB LIV STAT WO, P1; Venis S, 2003, LANCET, V361, P2172, DOI 10.1016/S0140-6736(03)13787-7; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; 2004, LANCET, V363, P1745	13	115	117	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					399	401		10.1016/S0140-6736(04)16783-4	http://dx.doi.org/10.1016/S0140-6736(04)16783-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288723				2022-12-28	WOS:000222998600009
J	Roberts, TG; Chabner, BA				Roberts, TG; Chabner, BA			Sounding board: Beyond fast track for drug approvals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELL LUNG-CANCER; GEFITINIB; MUTATIONS; THERAPY; TRIAL		Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; MIT, Program Pharmaceut Ind, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Roberts, TG (corresponding author), Massachusetts Gen Hosp, Div Hematol Oncol, Cox 640,100 Blossom St, Boston, MA 02114 USA.	troberts@partners.org			NATIONAL CANCER INSTITUTE [R25CA092203] Funding Source: NIH RePORTER; NCI NIH HHS [R25T CA 92203, R25 CA092203] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson L F, 1989, J Natl Cancer Inst, V81, P829; Castro M, 2002, J CLIN ONCOL, V20, P4606, DOI 10.1200/JCO.2002.99.183; Danzon P, 2000, J Health Serv Res Policy, V5, P253; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; *FDA, 2002, ONC DRUGS ADV COMM 7; *FDA, STAT REV IR; *FDA, 1998, GUID IND FAST TRACK; Gelijns AC, 1998, NEW ENGL J MED, V339, P693, DOI 10.1056/NEJM199809033391010; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mitka M, 2003, JAMA-J AM MED ASSOC, V289, P3227, DOI 10.1001/jama.289.24.3227; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Roberts TG, 2003, J CLIN ONCOL, V21, P3683, DOI 10.1200/JCO.2003.01.204; 2002, WALL STREET J   0924, pA18	14	42	46	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					501	505		10.1056/NEJMsb040064	http://dx.doi.org/10.1056/NEJMsb040064			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282359				2022-12-28	WOS:000222939700016
J	Tardiff, JC				Tardiff, JC			Myosin at the heart of the problem	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Tardiff, JC (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					424	426		10.1056/NEJMp048142	http://dx.doi.org/10.1056/NEJMp048142			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282349				2022-12-28	WOS:000222939700005
J	Gaunt, A; Heard, G; McKain, ES; Stephenson, BM				Gaunt, A; Heard, G; McKain, ES; Stephenson, BM			Caesarean scar endometrioma	LANCET			English	Editorial Material									Royal Gwent Hosp, Dept Surg, Newport NP20 2UB, Gwent, Wales	Royal Gwent Hospital	Stephenson, BM (corresponding author), Royal Gwent Hosp, Dept Surg, Newport NP20 2UB, Gwent, Wales.	brian.stephenson@gwent.wales.nhs.uk		Gaunt, Anne/0000-0002-6328-5651					0	19	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					368	368		10.1016/S0140-6736(04)16726-3	http://dx.doi.org/10.1016/S0140-6736(04)16726-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276397				2022-12-28	WOS:000222853300036
J	Offit, PA; Peter, G				Offit, PA; Peter, G			Meningococcal conjugate vaccine in the UK: an update	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; NEISSERIA-MENINGITIDIS; IMMUNOLOGICAL MEMORY; GROUP-A; IMMUNOGENICITY; INDUCTION; INFANTS; SAFETY		Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Rhode Isl Hosp, Div Pediat Infect Dis, Providence, RI USA; Brown Med Sch, Dept Pediat, Providence, RI USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Offit, PA (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA.	offit@email.chop.edu						*CDCP, 2002, MMWR-MORBID MORTAL W, V51, P234; Dagan R, 1998, INFECT IMMUN, V66, P2093, DOI 10.1128/IAI.66.5.2093-2098.1998; JENNINGS HJ, 1981, J IMMUNOL, V127, P1011; Lieberman JM, 1996, JAMA-J AM MED ASSOC, V275, P1499, DOI 10.1001/jama.275.19.1499; MacDonald NE, 1998, JAMA-J AM MED ASSOC, V280, P1685, DOI 10.1001/jama.280.19.1685; MacLennan JM, 2000, JAMA-J AM MED ASSOC, V283, P2795, DOI 10.1001/jama.283.21.2795; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; Zhang Q, 2001, INFECT IMMUN, V69, P4337, DOI 10.1128/IAI.69.7.4337-4341.2001; 1999, CDR WEEKLY, V9, P261	9	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 24	2004	364	9431					309	310		10.1016/S0140-6736(04)16737-8	http://dx.doi.org/10.1016/S0140-6736(04)16737-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276371				2022-12-28	WOS:000222853300006
J	Sebat, J; Lakshmi, B; Troge, J; Alexander, J; Young, J; Lundin, P; Maner, S; Massa, H; Walker, M; Chi, MY; Navin, N; Lucito, R; Healy, J; Hicks, J; Ye, K; Reiner, A; Gilliam, TC; Trask, B; Patterson, N; Zetterberg, A; Wigler, M				Sebat, J; Lakshmi, B; Troge, J; Alexander, J; Young, J; Lundin, P; Maner, S; Massa, H; Walker, M; Chi, MY; Navin, N; Lucito, R; Healy, J; Hicks, J; Ye, K; Reiner, A; Gilliam, TC; Trask, B; Patterson, N; Zetterberg, A; Wigler, M			Large-scale copy number polymorphism in the human genome	SCIENCE			English	Article							SEGMENTAL DUPLICATIONS; MICROARRAY ANALYSIS; GENE; HYBRIDIZATION; DELETIONS; CLONING; DISEASE	The extent to which large duplications and deletions contribute to human genetic variation and diversity is unknown. Here, we show that large-scale copy number polymorphisms (CNPs) ( about 100 kilobases and greater) contribute substantially to genomic variation between normal humans. Representational oligonucleotide microarray analysis of 20 individuals revealed a total of 221 copy number differences representing 76 unique CNPs. On average, individuals differed by 11 CNPs, and the average length of a CNP interval was 465 kilobases. We observed copy number variation of 70 different genes within CNP intervals, including genes involved in neurological function, regulation of cell growth, regulation of metabolism, and several genes known to be associated with disease.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Karolinska Inst, SE-17176 Stockholm, Sweden; SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Broad Inst, Cambridge, MA 02139 USA	Cold Spring Harbor Laboratory; Fred Hutchinson Cancer Center; Karolinska Institutet; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Wigler, M (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	wigler@cshl.edu	Maestrini, Elena/K-7508-2012; Ye, Kenny/U-2341-2019; Lucito, Robert/AID-7159-2022; Ye, Kenny/GSM-7731-2022	Maestrini, Elena/0000-0001-5924-3179; Ye, Kenny/0000-0002-1466-855X; Wigler, Michael/0000-0003-4396-1971; Sebat, Jonathan/0000-0002-9087-526X	NATIONAL CANCER INSTITUTE [R21CA081674, R01CA078544, R33CA081674] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG002606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER; NCI NIH HHS [5T32 CA069311, CA078544, CA81674] Funding Source: Medline; NHGRI NIH HHS [HG02606] Funding Source: Medline; NIDCD NIH HHS [DC004209] Funding Source: Medline; NIGMS NIH HHS [GM057070] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; BLUNT T, 1994, ANN HUM GENET, V58, P19, DOI 10.1111/j.1469-1809.1994.tb00722.x; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Frazer KA, 2003, GENOME RES, V13, P341, DOI 10.1101/gr.554603; Gilles F, 2000, GENOMICS, V70, P364, DOI 10.1006/geno.2000.6388; Healy J, 2003, GENOME RES, V13, P2306, DOI 10.1101/gr.1350803; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Imai Y, 1998, BIOCHEM BIOPH RES CO, V252, P582, DOI 10.1006/bbrc.1998.9705; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McLellan RA, 1997, PHARMACOGENETICS, V7, P187, DOI 10.1097/00008571-199706000-00003; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Sainsbury A, 2002, GENE DEV, V16, P1077, DOI 10.1101/gad.979102; Shan JD, 2000, GENE, V257, P67, DOI 10.1016/S0378-1119(00)00395-4; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D	25	1799	1991	2	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2004	305	5683					525	528		10.1126/science.1098918	http://dx.doi.org/10.1126/science.1098918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273396				2022-12-28	WOS:000222828900042
J	Leendertz, FH; Ellerbrok, H; Boesch, C; Couacy-Hymann, E; Matz-Rensing, K; Hakenbeck, R; Bergmann, C; Abaza, P; Junglen, S; Moebius, Y; Vigilant, L; Formenty, P; Pauli, G				Leendertz, FH; Ellerbrok, H; Boesch, C; Couacy-Hymann, E; Matz-Rensing, K; Hakenbeck, R; Bergmann, C; Abaza, P; Junglen, S; Moebius, Y; Vigilant, L; Formenty, P; Pauli, G			Anthrax kills wild chimpanzees in a tropical rainforest	NATURE			English	Article							BACILLUS-ANTHRACIS; NATIONAL-PARK; VIRUS; IDENTIFICATION; STRAINS; DECLINE; EBOLA; PCR	Infectious disease has joined habitat loss and hunting as threats to the survival of the remaining wild populations of great apes. Nevertheless, relatively little is known about the causative agents(1-3). We investigated an unusually high number of sudden deaths observed over nine months in three communities of wild chimpanzees (Pan troglodytes verus) in the Tai National Park, Ivory Coast. Here we report combined pathological, cytological and molecular investigations that identified Bacillus anthracis as the cause of death for at least six individuals. We show that anthrax can be found in wild non-human primates living in a tropical rainforest, a habitat not previously known to harbour B. anthracis. Anthrax is an acute disease that infects ruminants(4,5), but other mammals, including humans, can be infected through contacting or inhaling high doses of spores or by consuming meat from infected animals(6). Respiratory and gastrointestinal anthrax are characterized by rapid onset, fever, septicaemia and a high fatality rate without early antibiotic treatment(6,7). Our results suggest that epidemic diseases represent substantial threats to wild ape populations, and through bushmeat consumption also pose a hazard to human health.	Robert Koch Inst, Zentrum Biol Sicherheit, D-13353 Berlin, Germany; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Free Univ Berlin, Inst Parasitol & Int Anim Hlth, D-14163 Berlin, Germany; Lanada, Lcpa, Bingerville, Cote Ivoire; German Primate Ctr, D-37077 Gottingen, Germany; Univ Kaiserslautern, Dept Microbiol, D-67663 Kaiserslautern, Germany; WHO, Ebola Tai Forest Project, WHO Off, Abidjan, Cote Ivoire	Robert Koch Institute; Max Planck Society; Free University of Berlin; Deutsches Primatenzentrum (DPZ); University of Kaiserslautern; World Health Organization	Ellerbrok, H (corresponding author), Robert Koch Inst, Zentrum Biol Sicherheit, Nordufer 20, D-13353 Berlin, Germany.	ellerbrokh@rki.de	Leendertz, Fabian Hubertus/H-8902-2019; Junglen, Sandra/I-3033-2012	Junglen, Sandra/0000-0002-3799-6011				Andersen GL, 1996, J BACTERIOL, V178, P377, DOI 10.1128/jb.178.2.377-384.1996; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Beatty ME, 2003, ARCH INTERN MED, V163, P2527, DOI 10.1001/archinte.163.20.2527; Boesch C, 2000, CHIMPANZEES TAI FORE; Boutin J P, 1985, Med Trop (Mars), V45, P79; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Ellerbrok H, 2002, FEMS MICROBIOL LETT, V214, P51, DOI 10.1016/S0378-1097(02)00837-6; Ferber D, 2000, SCIENCE, V289, P1277, DOI 10.1126/science.289.5483.1277; Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Jackson PJ, 1997, APPL ENVIRON MICROB, V63, P1400, DOI 10.1128/AEM.63.4.1400-1405.1997; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Leendertz FH, 2004, J VIROL, V78, P4352, DOI 10.1128/JVI.78.8.4352-4356.2004; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Sirisanthana T, 2002, EMERG INFECT DIS, V8, P649, DOI 10.3201/eid0807.020062; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; TURNBULL PCB, 1992, EPIDEMIOL INFECT, V108, P299, DOI 10.1017/S0950268800049773; Vasconcelos D, 2003, LAB INVEST, V83, P1201, DOI 10.1097/01.LAB.0000080599.43791.01; Vigilant L, 2001, P NATL ACAD SCI USA, V98, P12890, DOI 10.1073/pnas.231320498; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Wolfe ND, 1998, EMERG INFECT DIS, V4, P149, DOI 10.3201/eid0402.980202	22	127	131	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					451	452		10.1038/nature02722	http://dx.doi.org/10.1038/nature02722			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269768				2022-12-28	WOS:000222801400042
J	Strupp, M; Zingler, VC; Arbusow, V; Niklas, D; Maag, KP; Dieterich, M; Bense, S; Theil, D; Jahn, K; Brandt, T				Strupp, M; Zingler, VC; Arbusow, V; Niklas, D; Maag, KP; Dieterich, M; Bense, S; Theil, D; Jahn, K; Brandt, T			Methylprednisolone, valacyclovir, or the combination for vestibular neuritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HERPES-SIMPLEX ENCEPHALITIS; ACADEMY-OF-NEUROLOGY; BELLS-PALSY; ACYCLOVIR; GANGLIA; COMPENSATION; SUBCOMMITTEE; GENICULATE; INFECTION; PARAMETER	Background: Vestibular neuritis is the second most common cause of peripheral vestibular vertigo. Its assumed cause is a reactivation of herpes simplex virus type 1 infection. Therefore, corticosteroids, antiviral agents, or a combination of the two might improve the outcome in patients with vestibular neuritis. Methods: We performed a prospective, randomized, double-blind, two-by-two factorial trial in which patients with acute vestibular neuritis were randomly assigned to treatment with placebo, methylprednisolone, valacyclovir, or methylprednisolone plus valacyclovir. Vestibular function was determined by caloric irrigation, with the use of the vestibular paresis formula (to measure the extent of unilateral caloric paresis) within 3 days after the onset of symptoms and 12 months afterward. Results: Of a total of 141 patients who underwent randomization, 38 received placebo, 35 methylprednisolone, 33 valacyclovir, and 35 methylprednisolone plus valacyclovir. At the onset of symptoms there was no difference among the groups in the severity of vestibular paresis. The mean (+/-SD) improvement in peripheral vestibular function at the 12-month follow-up was 39.6+/-28.1 percentage points in the placebo group, 62.4+/-16.9 percentage points in the methylprednisolone group, 36.0+/-26.7 percentage points in the valacyclovir group, and 59.2+/-24.1 percentage points in the methylprednisolone-plus-valacyclovir group. Analysis of variance showed a significant effect of methylprednisolone (P<0.001) but not of valacyclovir (P=0.43). The combination of methylprednisolone and valacyclovir was not superior to corticosteroid monotherapy. Conclusions: Methylprednisolone significantly improves the recovery of peripheral vestibular function in patients with vestibular neuritis, whereas valacyclovir does not.	Univ Munich, Dept Neurol, D-8000 Munich, Germany; Univ Munich, Dept Epidemiol & Biometr, Munich, Germany; Johannes Gutenberg Univ Mainz, Dept Neurol, D-6500 Mainz, Germany	University of Munich; University of Munich; Johannes Gutenberg University of Mainz	Strupp, M (corresponding author), Univ Munich, Klinikum Grosshadern, Dept Neurol, Marchioninistr 15, D-81377 Munich, Germany.	mstrupp@nefo.med.uni-muenchen.de	Jahn, Klaus/F-9902-2010; Jahn, Klaus/AAC-4969-2021	Jahn, Klaus/0000-0002-1669-3652; 				Adour KK, 1996, ANN OTO RHINOL LARYN, V105, P371, DOI 10.1177/000348949610500508; Arbusow V, 1999, ANN NEUROL, V46, P416, DOI 10.1002/1531-8249(199909)46:3<416::AID-ANA20>3.0.CO;2-W; ARIYASU L, 1990, ARCH OTOLARYNGOL, V116, P700; Baloh RW, 2003, NEW ENGL J MED, V348, P1027, DOI 10.1056/NEJMcp021154; Bohmer A, 1995, J Vestib Res, V5, P35; Borello-France D, 1994, VESTIBULAR REHABILIT, P247; Brandt T., 1999, VERTIGO ITS MULTISEN; Cameron SA, 1999, J PHYSIOL-LONDON, V518, P151, DOI 10.1111/j.1469-7793.1999.0151r.x; Curthoys I S, 1995, J Vestib Res, V5, P67, DOI 10.1016/0957-4271(94)00026-X; CURTHOYS IS, 1991, EXP BRAIN RES, V85, P218; DIX MR, 1952, P ROY SOC MED, V45, P341, DOI 10.1177/003591575204500604; Fife TD, 2000, NEUROLOGY, V55, P1431, DOI 10.1212/WNL.55.10.1431; FURUTA Y, 1993, ACTA OTO-LARYNGOL, P85; Grogan PM, 2001, NEUROLOGY, V56, P830, DOI 10.1212/WNL.56.7.830; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Hardman J. G., 1996, GOODMAN GILMANS PHAR; HONRUBIA V, 1994, VESTIBULAR REHABILIT, P113; JONGKEES L B, 1962, Pract Otorhinolaryngol (Basel), V24, P65; Lindsay J R, 1956, ANN OTO RHINOL LARYN, V65, P692; McGrath N, 1997, J NEUROL NEUROSUR PS, V63, P321, DOI 10.1136/jnnp.63.3.321; Murakami S, 1996, ANN INTERN MED, V124, P27, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00005; NADOL JB, 1995, OTOLARYNG HEAD NECK, V112, P162, DOI 10.1016/S0194-5998(95)70316-0; NAHMIAS AJ, 1973, NEW ENGL J MED, V289, P719, DOI 10.1056/NEJM197310042891404; Nylen C.O., 1924, ACTA OTO-LARYNGOL, V6, P106; OHBAYASHI S, 1993, ACTA OTO-LARYNGOL, P31; OKINAKA Y, 1993, ACTA OTO-LARYNGOL, P18; Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405; Ruttin E., 1909, OHRENHEILKUNDE, V57, P327; SCHUKNECHT HF, 1981, ANN OTO RHINOL LARYN, V90, P1; SEKITANI T, 1993, ACTA OTO-LARYNGOL, P9; SIPE J, 2001, COCHRANE DB SYST REV, V2, P1869; Strupp M, 1998, NEUROLOGY, V51, P838, DOI 10.1212/WNL.51.3.838; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Theil D, 2001, BRAIN PATHOL, V11, P408, DOI 10.1111/j.1750-3639.2001.tb00408.x	34	242	266	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2004	351	4					354	361		10.1056/NEJMoa033280	http://dx.doi.org/10.1056/NEJMoa033280			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839RC	15269315				2022-12-28	WOS:000222801200009
J	Daley, GQ				Daley, GQ			Missed opportunities in embryonic stem-cell research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Daley, GQ (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.							COOK G, 2004, BOSTON GLOBE    0523, pA14; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330	2	27	30	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					627	628		10.1056/NEJMp048200	http://dx.doi.org/10.1056/NEJMp048200			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15302910				2022-12-28	WOS:000223225500001
J	Haeni, JH; Irvin, P; Chang, W; Uecker, R; Reiche, P; Li, YL; Choudhury, S; Tian, W; Hawley, ME; Craigo, B; Tagantsev, AK; Pan, XQ; Streiffer, SK; Chen, LQ; Kirchoefer, SW; Levy, J; Schlom, DG				Haeni, JH; Irvin, P; Chang, W; Uecker, R; Reiche, P; Li, YL; Choudhury, S; Tian, W; Hawley, ME; Craigo, B; Tagantsev, AK; Pan, XQ; Streiffer, SK; Chen, LQ; Kirchoefer, SW; Levy, J; Schlom, DG			Room-temperature ferroelectricity in strained SrTiO3	NATURE			English	Article							THIN-FILMS; MICROWAVE DEVICES; TRANSITION	Systems with a ferroelectric to paraelectric transition in the vicinity of room temperature are useful for devices. Adjusting the ferroelectric transition temperature (T-c) is traditionally accomplished by chemical substitution - as in BaxSr1-xTiO3, the material widely investigated for microwave devices in which the dielectric constant (epsilon(r)) at GHz frequencies is tuned by applying a quasi-static electric field(1,2). Heterogeneity associated with chemical substitution in such films, however, can broaden this phase transition by hundreds of degrees(3), which is detrimental to tunability and microwave device performance. An alternative way to adjust Tc in ferroelectric films is strain(4-8). Here we show that epitaxial strain from a newly developed substrate can be harnessed to increase Tc by hundreds of degrees and produce room-temperature ferroelectricity in strontium titanate, a material that is not normally ferroelectric at any temperature. This strain-induced enhancement in T-c is the largest ever reported. Spatially resolved images of the local polarization state reveal a uniformity that far exceeds films tailored by chemical substitution. The high er at room temperature in these films ( nearly 7,000 at 10 GHz) and its sharp dependence on electric field are promising for device applications(1,2).	Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; USN, Res Lab, Washington, DC 20375 USA; Inst Crystal Growth, D-12489 Berlin, Germany; Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; Los Alamos Natl Lab, Mat Sci & Technol Div MST8, Los Alamos, NM 87545 USA; Motorola Labs, Tempe, AZ 85284 USA; Ecole Polytech Fed Lausanne, Lab Ceram, CH-1015 Lausanne, Switzerland; Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Defense; United States Navy; Naval Research Laboratory; Leibniz Institut fur Kristallzuchtung (IKZ); University of Michigan System; University of Michigan; United States Department of Energy (DOE); Los Alamos National Laboratory; Legend Holdings; Lenovo; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; United States Department of Energy (DOE); Argonne National Laboratory	Schlom, DG (corresponding author), Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.	schlom@ems.psu.edu	Chen, LongQing/I-7536-2012; Streiffer, Stephen K/A-1756-2009; Choudhury, Samrat/B-4115-2009; Tagantsev, Alexander K/E-3707-2010; Levy, Jeremy/A-2081-2009; Pan, Xiaoqing/ABF-4088-2020; Schlom, Darrell G/J-2412-2013; Irvin, Patrick/E-2159-2012; Li, Yulan/F-8929-2018	Chen, LongQing/0000-0003-3359-3781; Tagantsev, Alexander K/0000-0002-7547-3078; Levy, Jeremy/0000-0002-5700-2977; Pan, Xiaoqing/0000-0002-0965-8568; Schlom, Darrell G/0000-0003-2493-6113; Irvin, Patrick/0000-0002-0248-2758; Li, Yulan/0000-0002-2431-5408				Abe K, 1998, INTEGR FERROELECTR, V21, P197, DOI 10.1080/10584589808202063; BEACH RS, 1993, PHYS REV LETT, V70, P3502, DOI 10.1103/PhysRevLett.70.3502; BEDNORZ JG, 1984, PHYS REV LETT, V52, P2289, DOI 10.1103/PhysRevLett.52.2289; Bozovic I, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.107001; Canedy CL, 2000, APPL PHYS LETT, V77, P1695, DOI 10.1063/1.1308531; Chakoumakos BC, 1998, J APPL PHYS, V83, P1979, DOI 10.1063/1.366925; Chen A, 2000, J PHYS CHEM SOLIDS, V61, P191, DOI 10.1016/S0022-3697(99)00281-4; Christen HM, 1998, MAT SCI ENG B-SOLID, V56, P200, DOI 10.1016/S0921-5107(98)00237-2; DEVONSHIRE AF, 1954, ADV PHYS, V3, P85, DOI 10.1080/00018735400101173; Gan Q, 1998, APPL PHYS LETT, V72, P978, DOI 10.1063/1.120603; Gevorgian SS, 1996, IEEE T MICROW THEORY, V44, P896, DOI 10.1109/22.506449; Haeni JH, 2000, J ELECTROCERAM, V4, P385, DOI 10.1023/A:1009947517710; Hellwege A.M., 1979, LANDOLT BORNSTEIN NU, V11, P418; HELLWEGE KH, 1976, LANDOLTBORNSTEIN B1, V7, P26; HELLWEGE KH, 1976, LANDOLTBORNSTEIN N E, V7, P635; Hellwege KH, 1981, LANDOLTBORNSTEIN N A, V16, P59; Hubert C, 1999, REV SCI INSTRUM, V70, P3684, DOI 10.1063/1.1149978; Hubert C, 1997, APPL PHYS LETT, V71, P3353, DOI 10.1063/1.120335; Hubert C, 2000, PHYS REV LETT, V85, P1998, DOI 10.1103/PhysRevLett.85.1998; Itoh M, 1999, PHYS REV LETT, V82, P3540, DOI 10.1103/PhysRevLett.82.3540; *JCPDS INT CTR DIF, 1986, 27204 JCPDS INT CTR; Lancaster MJ, 1998, SUPERCOND SCI TECH, V11, P1323, DOI 10.1088/0953-2048/11/11/021; LEMANOV VV, 2002, FIZ TVERD TELA, V44, P1948; LOCK JM, 1951, PROC R SOC LON SER-A, V208, P391, DOI 10.1098/rspa.1951.0169; Pertsev NA, 1998, PHYS REV LETT, V80, P1988, DOI 10.1103/PhysRevLett.80.1988; Pertsev NA, 2000, PHYS REV B, V61, pR825, DOI 10.1103/PhysRevB.61.R825; Sato H, 1997, PHYSICA C, V274, P221, DOI 10.1016/S0921-4534(96)00675-2; Streiffer SK, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067601; Tidrow SC, 1997, IEEE T APPL SUPERCON, V7, P1766, DOI 10.1109/77.620924; UWE H, 1976, PHYS REV B, V13, P271, DOI 10.1103/PhysRevB.13.271; VENDIK OG, 1979, FERROELECTRICS MICRO	31	1677	1702	28	1014	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					758	761		10.1038/nature02773	http://dx.doi.org/10.1038/nature02773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306803	Green Published			2022-12-28	WOS:000223233600035
J	Hallstrom, AP; Ornato, JP; Weisfeldt, M; Travers, A; Christenson, J; McBurnie, MA; Zalenski, R; Becker, LB; Schron, EB; Proschan, M; Vijayaraghavan, K; Mattioni, T; Williams, C; Anton, AR; Jones, CD; Yahn, S; Rabel, D; O'Connor, RE; McGraw, P; Bollinger, M; Megargel, RE; Craven, RA; Bosken, LA; Burke, MP; Paulsen, J; Newton, G; Mahoney, BD; Knudson-Ballard, R; Vasquez, G; Groh, WJ; Cordes, D; Bondurant, SJ; Mann, NC; Shaum, B; Brown, K; Jacobsen, K; Aufderheide, TP; Pirrallo, RG; Conrad, CJ; Kitscha, DJ; Sparks, CW; von Briesen, C; Deja, KA; LeStarge, MM; Janisch, RW; Schmidt, SS; Parmenter, L; Grabowski, L; Ehrlich, S; Haynes, B; Asbury, L; Amaya, M; Richardson, LD; Ehlert, F; Freyberg, C; Richmond, N; Shields, C; Wilets, I; Holohan, J; Daya, M; Gunnels, MD; Hedges, JR; Jui, J; Schmidt, T; Wittwer, L; Brooks, H; Burke, C; Griffiths, D; Osur, M; MacGavin, B; Myrin, B; Weil, MH; Sehra, R; Cummins, RO; Doherty, A; Thompson, S; Wood, S; Christenson, J; Pennington, S; Holmes, A; Payne, H; Webb, R; Douglas, N; Lawson, P; Henry, MC; Johnson, S; Thode, H; Stapleton, ER; Reed, DB; Brown, LH; Evans, LM; Varghese, PJ; Lucas, R; Terndrup, TE; Stephens, S; Nafziger, S; Sanford, J; Travers, A; Panylyk, A; Irwin, K; Heisz, B; Becker, LB; Barry, A; Demertsidis, E; Van Zile, J; Grimmelsman, C; Nolting, L; Mosesso, VN; Slater, BK; Campbell, VJ; Hostler, D; Ornato, JP; Peberdy, MA; Overton, J; Schaffer, K; Zalenski, R; Compton, S; Dunne, R; Swor, R; Welch, R; Mango, LM; Bilicki, K; Weisfeldt, M; Sayre, MR; Schron, EB; Fleg, J; Domanski, MJ; Proschan, M; Rosenberg, Y; O'Neill, L; Simmons-Morton, D; Salive, ME; Nichol, G; Wells, G; Huszti, E; Rokosh, J; Morris, D; Kuntz, K; Feeny, D; Hallstrom, AP; Greene, HL; McBurnie, MA; Powell, J; Van Ottingham, L; Birnbaum, A; Ledingham, RB; Moore, R; Morris, M; Scholz, M; Kerr, A				Hallstrom, AP; Ornato, JP; Weisfeldt, M; Travers, A; Christenson, J; McBurnie, MA; Zalenski, R; Becker, LB; Schron, EB; Proschan, M; Vijayaraghavan, K; Mattioni, T; Williams, C; Anton, AR; Jones, CD; Yahn, S; Rabel, D; O'Connor, RE; McGraw, P; Bollinger, M; Megargel, RE; Craven, RA; Bosken, LA; Burke, MP; Paulsen, J; Newton, G; Mahoney, BD; Knudson-Ballard, R; Vasquez, G; Groh, WJ; Cordes, D; Bondurant, SJ; Mann, NC; Shaum, B; Brown, K; Jacobsen, K; Aufderheide, TP; Pirrallo, RG; Conrad, CJ; Kitscha, DJ; Sparks, CW; von Briesen, C; Deja, KA; LeStarge, MM; Janisch, RW; Schmidt, SS; Parmenter, L; Grabowski, L; Ehrlich, S; Haynes, B; Asbury, L; Amaya, M; Richardson, LD; Ehlert, F; Freyberg, C; Richmond, N; Shields, C; Wilets, I; Holohan, J; Daya, M; Gunnels, MD; Hedges, JR; Jui, J; Schmidt, T; Wittwer, L; Brooks, H; Burke, C; Griffiths, D; Osur, M; MacGavin, B; Myrin, B; Weil, MH; Sehra, R; Cummins, RO; Doherty, A; Thompson, S; Wood, S; Christenson, J; Pennington, S; Holmes, A; Payne, H; Webb, R; Douglas, N; Lawson, P; Henry, MC; Johnson, S; Thode, H; Stapleton, ER; Reed, DB; Brown, LH; Evans, LM; Varghese, PJ; Lucas, R; Terndrup, TE; Stephens, S; Nafziger, S; Sanford, J; Travers, A; Panylyk, A; Irwin, K; Heisz, B; Becker, LB; Barry, A; Demertsidis, E; Van Zile, J; Grimmelsman, C; Nolting, L; Mosesso, VN; Slater, BK; Campbell, VJ; Hostler, D; Ornato, JP; Peberdy, MA; Overton, J; Schaffer, K; Zalenski, R; Compton, S; Dunne, R; Swor, R; Welch, R; Mango, LM; Bilicki, K; Weisfeldt, M; Sayre, MR; Schron, EB; Fleg, J; Domanski, MJ; Proschan, M; Rosenberg, Y; O'Neill, L; Simmons-Morton, D; Salive, ME; Nichol, G; Wells, G; Huszti, E; Rokosh, J; Morris, D; Kuntz, K; Feeny, D; Hallstrom, AP; Greene, HL; McBurnie, MA; Powell, J; Van Ottingham, L; Birnbaum, A; Ledingham, RB; Moore, R; Morris, M; Scholz, M; Kerr, A		PAD Trial	Public-access defibrillation and survival after out-of-hospital cardiac arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; PAD TRIAL; POLICE; EXPERIENCE; RATIONALE; OFFICERS; IMPACT; DESIGN	Background: The rate of survival after out-of-hospital cardiac arrest is low. It is not known whether this rate will increase if laypersons are trained to attempt defibrillation with the use of automated external defibrillators (AEDs). Methods: We conducted a prospective, community-based, multicenter clinical trial in which we randomly assigned community units (e.g., shopping malls and apartment complexes) to a structured and monitored emergency-response system involving lay volunteers trained in cardiopulmonary resuscitation (CPR) alone or in CPR and the use of AEDs. The primary outcome was survival to hospital discharge. Results: More than 19,000 volunteer responders from 993 community units in 24 North American regions participated. The two study groups had similar unit and volunteer characteristics. Patients with treated out-of-hospital cardiac arrest in the two groups were similar in age (mean, 69.8 years), proportion of men (67 percent), rate of cardiac arrest in a public location (70 percent), and rate of witnessed cardiac arrest (72 percent). No inappropriate shocks were delivered. There were more survivors to hospital discharge in the units assigned to have volunteers trained in CPR plus the use of AEDs (30 survivors among 128 arrests) than there were in the units assigned to have volunteers trained only in CPR (15 among 107; P=0.03; relative risk, 2.0; 95 percent confidence interval, 1.07 to 3.77); there were only 2 survivors in residential complexes. Functional status at hospital discharge did not differ between the two groups. Conclusions: Training and equipping volunteers to attempt early defibrillation within a structured response system can increase the number of survivors to hospital discharge after out-of-hospital cardiac arrest in public locations. Trained laypersons can use AEDs safely and effectively.	Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Publ Access Defibrillat Clin Trial Ctr, Seattle, WA 98105 USA; Virginia Commonwealth Univ, Richmond, VA 23284 USA	University of Washington; University of Washington Seattle; Virginia Commonwealth University	Hallstrom, AP (corresponding author), Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Publ Access Defibrillat Clin Trial Ctr, 1107 NE 45th St,Room 505, Seattle, WA 98105 USA.	padctc@u.washington.edu	Nichol, Graham/Z-4996-2019; Daya, Mohamud R/A-9322-2012; Compton, Scott/AAF-5657-2020; Hedges, Jerris/AAC-1847-2021	Brown, Lawrence/0000-0002-5940-1840	NHLBI NIH HHS [N01-HC-95177] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095177] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Becker L, 1998, CIRCULATION, V97, P2106, DOI 10.1161/01.CIR.97.21.2106; BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P123; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; EPSTEIN AE, 1995, AM J CARDIOL, V75, P470; Mosesso VN, 2004, RESUSCITATION, V61, P29, DOI 10.1016/j.resuscitation.2003.11.016; Mosesso VN, 1998, ANN EMERG MED, V32, P200, DOI 10.1016/S0196-0644(98)70137-4; Myerburg RJ, 2002, CIRCULATION, V106, P1058, DOI 10.1161/01.CIR.0000028147.92190.A7; Ornato JP, 2003, RESUSCITATION, V56, P135, DOI 10.1016/S0300-9572(02)00442-2; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Pell JP, 2002, BRIT MED J, V325, P515, DOI 10.1136/bmj.325.7363.515; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Sayre MR, 2004, RESUSCITATION, V62, P25, DOI 10.1016/j.resuscitation.2004.02.007; Stiell IG, 1999, JAMA-J AM MED ASSOC, V281, P1175, DOI 10.1001/jama.281.13.1175; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Valenzuela TD, 1997, CIRCULATION, V96, P3308; White RD, 1998, RESUSCITATION, V39, P145, DOI 10.1016/S0300-9572(98)00135-X; 2000, CIRCULATION S1, V102, P60	19	785	806	3	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					637	646						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306665				2022-12-28	WOS:000223225500006
J	Hedwig, B; Poulet, JFA				Hedwig, B; Poulet, JFA			Complex auditory behaviour emerges from simple reactive steering	NATURE			English	Article							PATTERN-RECOGNITION; TEMPORAL PATTERN; FEMALE CRICKETS; CALLING SONG; ACOUSTIC COMMUNICATION; PHONOTACTIC BEHAVIOR; GRYLLUS-BIMACULATUS; FLYING CRICKETS; GRYLLIDAE; SYSTEM	The recognition and localization of sound signals is fundamental to acoustic communication(1,2). Complex neural mechanisms are thought to underlie the processing of species-specific sound patterns even in animals with simple auditory pathways(3,4). In female crickets, which orient towards the male's calling song, current models propose pattern recognition mechanisms based on the temporal structure of the song(5-7). Furthermore, it is thought that localization is achieved by comparing the output of the left and right recognition networks, which then directs the female to the pattern that most closely resembles the species-specific song(8-10). Here we show, using a highly sensitive method for measuring the movements of female crickets, that when walking and flying each sound pulse of the communication signal releases a rapid steering response. Thus auditory orientation emerges from reactive motor responses to individual sound pulses. Although the reactive motor responses are not based on the song structure, a pattern recognition process may modulate the gain of the responses on a longer timescale. These findings are relevant to concepts of insect auditory behaviour and to the development of biologically inspired robots performing cricket-like auditory orientation(11-13).	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Hedwig, B (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	bh202@cam.ac.uk; jfap2@cam.ac.uk		Poulet, James/0000-0003-0296-5415	Biotechnology and Biological Sciences Research Council [S19133] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ARKIN RC, 1998, BEHAV BASED ROBOTICS, P24302; Balakrishnan R, 2001, J COMP PHYSIOL A, V187, P255, DOI 10.1007/s003590100197; CADE WH, 1979, CAN ENTOMOL, V111, P741, DOI 10.4039/Ent111741-6; DOHERTY JA, 1985, J EXP BIOL, V114, P17; DOHERTY JA, 1991, J COMP PHYSIOL A, V168, P213, DOI 10.1007/BF00218413; GERHARD HC, 2002, ACOUSTIC COMMUNICATI, P24302; Hedwig B, 2000, J NEUROSCI METH, V100, P165, DOI 10.1016/S0165-0270(00)00255-7; Hennig RM, 2003, J COMP PHYSIOL A, V189, P589, DOI 10.1007/s00359-003-0438-7; HOY RR, 1978, FED PROC, V37, P2316; Huber F., 1990, Advances in the Study of Behavior, V19, P299, DOI 10.1016/S0065-3454(08)60206-5; MOISEFF A, 1978, P NATL ACAD SCI USA, V75, P4052, DOI 10.1073/pnas.75.8.4052; MURPHEY RK, 1972, J EXP BIOL, V56, P335; Nabatiyan A, 2003, J NEUROPHYSIOL, V90, P2484, DOI 10.1152/jn.00259.2003; Pollack G, 2000, CURR OPIN NEUROBIOL, V10, P763, DOI 10.1016/S0959-4388(00)00161-6; POLLACK GS, 1986, J COMP PHYSIOL A, V158, P549, DOI 10.1007/BF00603799; Pollack GS, 2001, CURR OPIN NEUROBIOL, V11, P734, DOI 10.1016/S0959-4388(01)00277-X; POLLACK GS, 1981, J INSECT PHYSIOL, V27, P41, DOI 10.1016/0022-1910(81)90030-5; POPOV AV, 1977, J COMP PHYSIOL, V119, P111, DOI 10.1007/BF00655876; Schildberger K., 1989, P423; SCHILDBERGER K, 1984, J COMP PHYSIOL, V155, P171, DOI 10.1007/BF00612635; SCHMITZ B, 1982, J COMP PHYSIOL, V148, P431, DOI 10.1007/BF00619782; STABEL J, 1989, J COMP PHYSIOL A, V165, P165, DOI 10.1007/BF00619191; ULAGARAJ SM, 1973, SCIENCE, V182, P1278, DOI 10.1126/science.182.4118.1278; VONHELVERSEN D, 1995, J COMP PHYSIOL A, V177, P767, DOI 10.1007/BF00187635; Webb B, 2002, NATURE, V417, P359, DOI 10.1038/417359a; Webb B, 2000, BIOL CYBERN, V82, P247, DOI 10.1007/s004220050024; WEBER T, 1988, J COMP PHYSIOL A, V163, P13, DOI 10.1007/BF00611992; WEBER T, 1981, J COMP PHYSIOL, V141, P215, DOI 10.1007/BF01342668; Weber T., 1989, P310; WEBSTER DB, 1992, EVOLUTIONARY BIOL HE, P24302	30	84	85	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					781	785		10.1038/nature02787	http://dx.doi.org/10.1038/nature02787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306810				2022-12-28	WOS:000223233600042
J	Roth, M; Johnson, PRA; Borger, P; Bihl, MP; Rudiger, JJ; King, GG; Ge, Q; Hostettler, K; Burgess, JK; Black, JL; Tamm, M				Roth, M; Johnson, PRA; Borger, P; Bihl, MP; Rudiger, JJ; King, GG; Ge, Q; Hostettler, K; Burgess, JK; Black, JL; Tamm, M			Dysfunctional interaction of C/EBP alpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HUMAN LUNG FIBROBLASTS; RAT HEPATOMA-CELLS; NF-KAPPA-B; EPITHELIAL-CELLS; BETA ISOFORMS; IN-VIVO; PROLIFERATION; EXPRESSION; INHIBITION	BACKGROUND: Increased proliferation of bronchial smooth-muscle cells may lead to increased muscle mass in the airways of patients with asthma. The antiproliferative effect of glucocorticoids in bronchial smooth-muscle cells in subjects without asthma is mediated by a complex of the glucocorticoid receptor and the CCAAT/enhancer binding protein (alpha) (C/EBP(alpha)). We examined the signaling pathway controlling the inhibitory effect of glucocorticoids on cell proliferation and interleukin-6 synthesis in bronchial smooth-muscle cells of subjects with asthma and those without asthma. METHODS: Lines of bronchial smooth-muscle cells were established from cells from 20 subjects with asthma, 8 subjects with emphysema, and 26 control subjects. Cell proliferation was determined by means of cell counts and [(sup 3)H]thymidine incorporation. Signal transduction was studied by means of an electrophoretic DNA mobility-shift assay, a supershift electrophoretic-mobility assay, immunoblotting, use of C/EBP(alpha) antisense oligonucleotides, and use of a human C/EBP(alpha) expression vector. Interleukin-6 release was determined by means of an enzyme-linked immunosorbent assay. RESULTS: Glucocorticoids activated the glucocorticoid receptor and inhibited serum-induced secretion of interleukin-6 in bronchial smooth-muscle cells from both subjects with asthma and those without asthma; however, glucocorticoids inhibited proliferation only in bronchial smooth-muscle cells from subjects without asthma. C/EBP(alpha) protein was detected by immunoblotting in all bronchial smooth-muscle cells from subjects without asthma but not in those with asthma, whereas the protein was expressed in lymphocytes from both groups of subjects. C/EBP(alpha) antisense oligonucleotides or the glucocorticoid-receptor inhibitor mifepristone reversed the antiproliferative effect of glucocorticoids in bronchial smooth-muscle cells from subjects without asthma. When bronchial smooth-muscle cells from subjects with asthma were transiently transfected with an expression vector for human C/EBP(alpha), two forms of the protein were expressed, and subsequent administration of glucocorticoids inhibited cell proliferation. CONCLUSIONS: We hypothesize that a cell-type-specific absence of C/EBP(alpha) is responsible for the enhanced proliferation of bronchial smooth-muscle cells derived from subjects with asthma and that it explains the failure of glucocorticoids to inhibit proliferation in vitro.	Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia; Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland	University of Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Basel; University of Basel	Roth, M (corresponding author), Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia.		Black, Judith L/C-6559-2008; Roth, Michael/H-8657-2019; Borger, Pieter (Peter)/HIR-2495-2022; Burgess, Janette/M-7117-2019; Ge, Qi/D-3988-2013; Burgess, Janette K/A-3597-2010	Roth, Michael/0000-0002-8139-2821; Burgess, Janette/0000-0001-9868-9966; Hostettler, Katrin/0000-0001-8118-7441				Adcock IM, 1996, AM J RESP CRIT CARE, V154, P771, DOI 10.1164/ajrccm.154.3.8810618; Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; Bellia V, 2003, CHEST, V123, P1066, DOI 10.1378/chest.123.4.1066; Biola A, 2000, FEBS LETT, V487, P229, DOI 10.1016/S0014-5793(00)02297-3; Cha HH, 1998, J BIOL CHEM, V273, P1998, DOI 10.1074/jbc.273.4.1998; CORRIGAN CJ, 1991, AM REV RESPIR DIS, V144, P1016, DOI 10.1164/ajrccm/144.5.1016; Cram EJ, 1998, J BIOL CHEM, V273, P2008, DOI 10.1074/jbc.273.4.2008; DEMOLY P, 1994, AM J RESP CRIT CARE, V150, P214, DOI 10.1164/ajrccm.150.1.7912988; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; EATON EM, 2002, J CELL PHYSL, V190, P131; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Fernandes D, 1999, AM J RESP CELL MOL, V21, P77, DOI 10.1165/ajrcmb.21.1.3396; Gagliardo R, 2000, AM J RESP CRIT CARE, V162, P7, DOI 10.1164/ajrccm.162.1.9911032; Gotoh T, 1997, J BIOL CHEM, V272, P3694, DOI 10.1074/jbc.272.6.3694; Gougat C, 2002, J MOL MED-JMM, V80, P309, DOI 10.1007/s00109-001-0302-6; Hirst SJ, 1998, AM J RESP CRIT CARE, V158, pS201, DOI 10.1164/ajrccm.158.supplement_2.13tac190; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; JEFFERY PK, 1994, AM J RESP CRIT CARE, V150, pS6, DOI 10.1164/ajrccm/150.5_Pt_2.S6; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Korn SH, 2001, EUR RESPIR J, V17, P1070, DOI 10.1183/09031936.01.00073301; LANE SJ, 1994, AM J RESP CELL MOL, V11, P42, DOI 10.1165/ajrcmb.11.1.8018337; O'Rourke JP, 1999, BIOCHEM BIOPH RES CO, V262, P696, DOI 10.1006/bbrc.1999.1256; Pang LH, 2000, AM J RESP CELL MOL, V23, P79, DOI 10.1165/ajrcmb.23.1.3985; Parkin SE, 2002, J BIOL CHEM, V277, P23563, DOI 10.1074/jbc.M202184200; Paschen W, 1998, MOL BRAIN RES, V60, P115, DOI 10.1016/S0169-328X(98)00180-6; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Ramos RA, 1999, FASEB J, V13, P169, DOI 10.1096/fasebj.13.1.169; Roth M, 2002, LANCET, V360, P1293, DOI 10.1016/S0140-6736(02)11319-5; Rudiger JJ, 2002, FASEB J, V16, P177, DOI 10.1096/fj.01-0226com; Sousa AR, 2000, J ALLERGY CLIN IMMUN, V105, P943, DOI 10.1067/mai.2000.106486; Stewart AG, 1995, BRIT J PHARMACOL, V116, P3219, DOI 10.1111/j.1476-5381.1995.tb15127.x; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Sutherland ER, 2003, J ALLERGY CLIN IMMUN, V112, P819, DOI 10.1016/S0091-6749(03)02011-6; TIMICHENKO NA, 1996, GENE DEV, V10, P804; TIMICHENKO NA, 1997, MOL CELL BIOL, V17, P7353; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; van der Velden VHJ, 1998, MEDIAT INFLAMM, V7, P229, DOI 10.1080/09629359890910; Wilson SJ, 2001, AM J RESP CRIT CARE, V164, P1047, DOI 10.1164/ajrccm.164.6.2010045; Zhang ZX, 1997, J BIOL CHEM, V272, P30607, DOI 10.1074/jbc.272.49.30607; ZITNIK RJ, 1994, AM J RESP CELL MOL, V10, P643, DOI 10.1165/ajrcmb.10.6.7516173	41	209	217	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					560	574		10.1056/NEJMoa021660	http://dx.doi.org/10.1056/NEJMoa021660			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295049				2022-12-28	WOS:000223069900009
J	Soderberg, AM; Kulkarni, SR; Berger, E; Fox, DW; Sako, M; Frail, DA; Gal-Yam, A; Moon, DS; Cenko, SB; Yost, SA; Phillips, MM; Persson, SE; Freedman, WL; Wyatt, P; Jayawardhana, R; Paulson, D				Soderberg, AM; Kulkarni, SR; Berger, E; Fox, DW; Sako, M; Frail, DA; Gal-Yam, A; Moon, DS; Cenko, SB; Yost, SA; Phillips, MM; Persson, SE; Freedman, WL; Wyatt, P; Jayawardhana, R; Paulson, D			The sub-energetic gamma-ray burst GRB 031203 as a cosmic analogue to the nearby GRB 980425	NATURE			English	Article							LIGHT-CURVE; UNUSUAL SUPERNOVA; 1998BW; JETS	Over the six years since the discovery(1) of the gamma-ray burst GRB 980425, which was associated(2) with the nearby ( distance similar to40 Mpc) supernova 1998bw, astronomers have debated fiercely the nature of this event. Relative to bursts located at cosmological distance ( redshift z approximate to 1), GRB 980425 was under-luminous in gamma-rays by three orders of magnitude. Radio calorimetry(3,4) showed that the explosion was sub-energetic by a factor of 10. Here we report observations of the radio and X-ray afterglow of the recent GRB 031203 ( refs 5 - 7), which has a redshift of z = 0.105. We demonstrate that it too is sub-energetic which, when taken together with the low gamma-ray luminosity(7), suggests that GRB 031203 is the first cosmic analogue to GRB 980425. We find no evidence that this event was a highly collimated explosion viewed off-axis. Like GRB 980425, GRB 031203 appears to be an intrinsically sub-energetic gamma-ray burst. Such sub-energetic events have faint afterglows. We expect intensive follow-up of faint bursts with smooth gamma-ray light curves(8,9) ( common to both GRB 031203 and 980425) to reveal a large population of such events.	CALTECH, Caltech Opt Observ 105 24, Pasadena, CA 91125 USA; Stanford Linear Accelerator Ctr, Menlo Pk, CA 94025 USA; Natl Radio Astron Observ, Socorro, NM 87801 USA; CALTECH, Space Radiat Lab 220 47, Pasadena, CA 91125 USA; Carnegie Observ, Pasadena, CA 91101 USA; Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA	California Institute of Technology; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; National Radio Astronomy Observatory (NRAO); California Institute of Technology; Carnegie Institution for Science; University of Michigan System; University of Michigan	Soderberg, AM (corresponding author), CALTECH, Caltech Opt Observ 105 24, Pasadena, CA 91125 USA.	ams@astro.caltech.edu		WYATT, PAMELA/0000-0002-2650-0850				Amati L, 2002, ASTRON ASTROPHYS, V390, P81, DOI 10.1051/0004-6361:20020722; Berger E, 2003, ASTROPHYS J, V590, P379, DOI 10.1086/374892; Berger E, 2003, ASTROPHYS J, V599, P408, DOI 10.1086/379214; Berger E, 2003, NATURE, V426, P154, DOI 10.1038/nature01998; Bloom JS, 2003, ASTROPHYS J, V594, P674, DOI 10.1086/377125; Bloom JS, 1998, ASTROPHYS J, V506, pL105, DOI 10.1086/311655; Frail DA, 2000, ASTROPHYS J, V537, P191, DOI 10.1086/309024; Frail DA, 2003, ASTRON J, V125, P2299, DOI 10.1086/374364; Frail DA, 2001, ASTROPHYS J, V562, pL55, DOI 10.1086/338119; Gal-Yam A, 2004, ASTROPHYS J, V609, pL59, DOI 10.1086/422841; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; GOTZ D, 2003, 2459 GRB; Granot J, 2002, ASTROPHYS J, V568, P820, DOI 10.1086/338966; Kulkarni SR, 1998, NATURE, V395, P663, DOI 10.1038/27139; Li ZY, 1999, ASTROPHYS J, V526, P716, DOI 10.1086/308031; Nakamura T, 2001, ASTROPHYS J, V550, P991, DOI 10.1086/319784; Norris JP, 2002, ASTROPHYS J, V579, P386, DOI 10.1086/342747; PAIN E, 2000, ASTROPHYS J, V536, P778; Panaitescu A, 2002, ASTROPHYS J, V571, P779, DOI 10.1086/340094; PROCHASKA JX, UNPUB ASTROPHYS J; RODRIGUEZPASCUA.P, 2003, 2474 GRB; SANTOSLLEO M, 2003, 2464 GRB; Sari R, 1998, ASTROPHYS J, V497, pL17, DOI 10.1086/311269; Soderberg AM, 2004, ASTROPHYS J, V607, pL13, DOI 10.1086/421722; Soderberg AM, 2004, ASTROPHYS J, V606, P994, DOI 10.1086/383082; VANDERSPEK R, 2004, ASTROPH0401311; Watson D, 2004, ASTROPHYS J, V605, pL101, DOI 10.1086/420844; Waxman E, 2004, ASTROPHYS J, V602, P886, DOI 10.1086/381230	28	177	178	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					648	650		10.1038/nature02757	http://dx.doi.org/10.1038/nature02757			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295592	Green Accepted			2022-12-28	WOS:000223085400037
J	Raine, R; Sanderson, C; Hutchings, A; Carter, S; Larkin, K; Black, N				Raine, R; Sanderson, C; Hutchings, A; Carter, S; Larkin, K; Black, N			An experimental study of determinants of group judgments in clinical guideline development	LANCET			English	Article							CORONARY REVASCULARIZATION; PHYSICIAN RATINGS; APPROPRIATENESS; PANEL; CONSENSUS; RECOMMENDATIONS; ANGIOGRAPHY; SPECIALTY; CARE	Background Clinical guidelines for improving the quality of care are a familiar part of clinical practice. Formal consensus methods such as the nominal group technique are often used as part of guideline development, but little is known about factors that affect the statements produced by nominal groups, and on their consistency with the research evidence. Methods Cognitive behavioural therapy, behavioural therapy, brief psychodynamic interpersonal therapy, and antidepressants for irritable bowel syndrome, chronic fatigue syndrome, and chronic back pain were selected for study. 16 nominal groups in a factorial design allowed comparison of GP-only with mixed groups of GPs and specialists, provision of a literature review with no provision, and ratings made in the context of realistic or ideal levels of healthcare resources. Participants rated appropriateness independently, and again after a facilitated meeting. Audiotapes of four group discussions were analysed. Findings There was agreement with the research evidence for 51% of 192 scenarios. Agreement was more likely if the group was GP-only, if a literature review was provided, or if the evidence was in accordance with clinicians' beliefs. Assumptions about the level of resources available had no impact. Clinical and social cues had mixed effects, irrespective of the research evidence. Qualitative analysis showed the modifying effect of clinical experience and beliefs about research evidence. Interpretation Guidelines cannot be based on data alone; judgment is unavoidable. The nominal group technique is a method of eliciting and aggregating judgments in a transparent and structured way. It can provide important information on levels of agreement between experts. However, conclusions can be at odds with the published literature. If they are, reasons need to be explicit.	Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Raine, R (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, Keppel St, London WC1E 7HT, England.	rosalind.raine@lshtm.ac.uk	Sanderson, Colin F/O-9877-2014	Sanderson, Colin/0000-0002-4838-6112; Carter, Simon/0000-0003-1838-3479; Hutchings, Andrew/0000-0003-0215-9923				Ayanian JZ, 1998, NEW ENGL J MED, V338, P1896, DOI 10.1056/NEJM199806253382608; Bernstein SJ, 2001, MED CARE, V39, P513, DOI 10.1097/00005650-200105000-00011; Burgers JS, 2003, INT J QUAL HEALTH C, V15, P31, DOI 10.1093/intqhc/15.1.31; Campbell SM, 1999, MED CARE, V37, P964, DOI 10.1097/00005650-199909000-00012; CHASSIN M, 1989, APPROPRIATE INVESTIG, P21; DELBECQ AL, 1971, J APPL BEHAV SCI, V7, P466, DOI 10.1177/002188637100700404; Ferlie E, 2000, J Health Serv Res Policy, V5, P96; Fitch K, 1999, EUR J PUBLIC HEALTH, V9, P181, DOI 10.1093/eurpub/9.3.181; Fitzgerald L, 2003, HEALTH SOC CARE COMM, V11, P219, DOI 10.1046/j.1365-2524.2003.00426.x; Glasier A, 2003, CONTRACEPTION, V68, P327, DOI 10.1016/j.contraception.2003.07.007; Green J, 1998, BMJ-BRIT MED J, V316, P1064; Green J, 1999, BRIT MED J, V319, P421; Herrin J, 1997, HEALTH POLICY, V42, P67, DOI 10.1016/S0168-8510(97)00055-9; Landrum MB, 1999, J CLIN EPIDEMIOL, V52, P309, DOI 10.1016/S0895-4356(98)00166-8; Mann T, 1996, CLIN GUID US CLIN GU; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; *NICE UK, 2003, PREOP TESTS US ROUT; Nicollier-Fahrni A, 2003, INT J QUAL HEALTH C, V15, P15, DOI 10.1093/intqhc/15.1.15; Pagliari C, 2002, J EVAL CLIN PRACT, V8, P145, DOI 10.1046/j.1365-2753.2002.00333.x; Raine R, 2002, BMJ-BRIT MED J, V325, P1082, DOI 10.1136/bmj.325.7372.1082; Reid S, 2000, BMJ-BRIT MED J, V320, P292, DOI 10.1136/bmj.320.7230.292; Sauerland S, 2000, SURG ENDOSC-ULTRAS, V14, P908, DOI 10.1007/s004640000283; *SPSS, 1999, SPSS BAS 10 0 WIND U; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; VLAEYEN JWS, 1995, BRIT J CLIN PSYCHOL, V34, P95, DOI 10.1111/j.2044-8260.1995.tb01443.x; Wood J, 1999, J Health Serv Res Policy, V4, P44; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; Wortman PM, 1998, INT J TECHNOL ASSESS, V14, P109, DOI 10.1017/S0266462300010564	29	106	107	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					429	437		10.1016/S0140-6736(04)16766-4	http://dx.doi.org/10.1016/S0140-6736(04)16766-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288741				2022-12-28	WOS:000222998600033
J	Black, BE; Foltz, DR; Chakravarthy, S; Luger, K; Woods, VL; Cleveland, DW				Black, BE; Foltz, DR; Chakravarthy, S; Luger, K; Woods, VL; Cleveland, DW			Structural determinants for generating centromeric chromatin	NATURE			English	Article							NUCLEOSOME CORE PARTICLE; CENP-A; PROTEIN; DNA; ORGANIZATION; NONDISJUNCTION; KINETOCHORES; CHROMOSOMES; ACTIVATION; DOMAIN	Mammalian centromeres are not defined by a consensus DNA sequence. In all eukaryotes a hallmark of functional centromeres - both normal ones and those formed aberrantly at atypical loci - is the accumulation of centromere protein A (CENP-A), a histone variant that replaces H3 in centromeric nucleosomes(1-7). Here we show using deuterium exchange/mass spectrometry coupled with hydrodynamic measures that CENP-A and histone H4 form sub-nucleosomal tetramers that are more compact and conformationally more rigid than the corresponding tetramers of histones H3 and H4. Substitution into histone H3 of the domain of CENP-A responsible for compaction is sufficient to direct it to centromeres. Thus, the centromere-targeting domain of CENP-A confers a unique structural rigidity to the nucleosomes into which it assembles, and is likely to have a role in maintaining centromere identity.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Colorado State University	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Foltz, Daniel/0000-0001-7423-6188; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331; Cleveland, Don/0000-0002-1934-3682				Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; duSart D, 1997, NAT GENET, V16, P144; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Glowczewski L, 2000, MOL CELL BIOL, V20, P5700, DOI 10.1128/MCB.20.15.5700-5711.2000; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Hamuro Y, 2003, J MOL BIOL, V327, P1065, DOI 10.1016/S0022-2836(03)00234-1; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; PALMER DK, 1985, MOL CELL BIOL, V5, P173, DOI 10.1128/MCB.5.1.173; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rudd MK, 2003, MOL CELL BIOL, V23, P7689, DOI 10.1128/MCB.23.21.7689-7697.2003; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002	30	322	340	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					578	582		10.1038/nature02766	http://dx.doi.org/10.1038/nature02766			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282608				2022-12-28	WOS:000222946100052
J	Green, MJ; Peterson, SK; Baker, MW; Harper, GR; Friedman, LC; Rubinstein, WS; Manger, DT				Green, MJ; Peterson, SK; Baker, MW; Harper, GR; Friedman, LC; Rubinstein, WS; Manger, DT			Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-CLINICAL-ONCOLOGY; OVARIAN-CANCER; FAMILY HISTORY; PHYSICIANS KNOWLEDGE; RISK PERCEPTION; BRCA1; EDUCATION; ATTITUDES; STATEMENT; MUTATION	Context As the availability of and demand for genetic testing for hereditary cancers increases in primary care and other clinical settings, alternative or adjunct educational methods to traditional genetic counseling will be needed. Objective To compare the effectiveness of a computer-based decision aid with standard genetic counseling for educating women about BRCA1 and BRCA2 genetic testing. Design Randomized controlled trial conducted from May 2000 to September 2002. Setting and Participants Outpatient clinics offering cancer genetic counseling at 6 US medical centers enrolled 211 women with personal or family histories of breast cancer. Interventions Standard one-on-one genetic counseling (n = 105) or education by a computer program followed by genetic counseling (n = 106). Main Outcome Measures Participants' knowledge, risk perception, intention to undergo genetic testing, decisional conflict, satisfaction with decision, anxiety, and satisfaction with the intervention. Counselor group measures were administered at baseline and after counseling. Computer group measures were administered at baseline, after computer use, and after counseling. Testing decisions were assessed at 1 and 6 months. Outcomes were analyzed by high vs low risk of carrying a BRCA1 or BRCA2 mutation. Results Both groups had comparable demographics, prior computer experience, medical literacy, and baseline knowledge of breast cancer and genetic testing, and both counseling and computer use were rated highly. Knowledge scores increased in both groups (P<.001) regardless of risk status, and change in knowledge was greater in the computer group compared with the counselor group (P=.03) among women at low risk of carrying a mutation. Perception of absolute risk of breast cancer decreased significantly after either intervention among all participants. Intention to undergo testing decreased significantly after either intervention among low-risk but not high-risk women. The counselor group had lower mean scores on a decisional conflict scale (P=.04) and, in low-risk women, higher mean scores on a satisfaction-with-decision scale (P=.001). Mean state anxiety scores were reduced by counseling but were within normal ranges for both groups at baseline and after either intervention, regardless of risk status. Conclusions An interactive computer program was more effective than standard genetic counseling for increasing knowledge of breast cancer and genetic testing among women at low risk of carrying a BRCA1 or BRCA2 mutation. However, genetic counseling was more effective than the computer at reducing women's anxiety and facilitating more accurate risk perceptions. These results suggest that this computer program has the potential to stand alone as an educational intervention for low-risk women but should be used as a supplement to genetic counseling for those at high risk.	Penn State Coll Med, Dept Humanities, Hershey, PA 17033 USA; Penn State Coll Med, Dept Med, Hershey, PA 17033 USA; Milton S Hershey Med Ctr, Penn State Canc Inst, Hershey, PA USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Lehigh Valley Hosp, Penn State Canc Inst, Allentown, PA USA; Baylor Coll Med, Houston, TX 77030 USA; Evanston NW Healthcare, Evanston, IL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Texas System; UTMD Anderson Cancer Center; Lehigh Valley Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Baylor College of Medicine; NorthShore University Health System	Green, MJ (corresponding author), Penn State Coll Med, Dept Humanities, Room C1743,500 Univ Dr, Hershey, PA 17033 USA.	mjg15@psu.edu	Green, Martin A/H-7567-2012	Green, Martin A/0000-0002-8860-396X; Green, Michael/0000-0002-4828-4749	NCI NIH HHS [R03CA70638, R01CA84770] Funding Source: Medline; NINR NIH HHS [R21 NR008539] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084770, R03CA070638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R21NR008539] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Armstrong K, 2002, PREV MED, V34, P590, DOI 10.1006/pmed.2002.1022; Barry MJ, 2002, ANN INTERN MED, V136, P127, DOI 10.7326/0003-4819-136-2-200201150-00010; Baty BJ, 1999, AM J MED GENET, V86, P93, DOI 10.1002/(SICI)1096-8628(19990903)86:1<93::AID-AJMG22>3.3.CO;2-M; Bernstein T, 1994, RADON RENTAL HOUSING; Berry DA, 2002, J CLIN ONCOL, V20, P2701, DOI 10.1200/JCO.2002.05.121; Berry DA, 1997, J NATL CANCER I, V89, P227, DOI 10.1093/jnci/89.3.227; Bleiker EMA, 2003, ACTA ONCOL, V42, P276, DOI 10.1080/02841860310004391; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Cooksey J.A., 2000, GENETIC COUNSELOR WO; Crowe JP, 1999, J WOMENS HEALTH, V8, P25, DOI 10.1089/jwh.1999.8.25; Croyle RT, 1997, CANCER, V80, P569, DOI 10.1002/(SICI)1097-0142(19970801)80:3+<569::AID-CNCR6>3.0.CO;2-4; Cull A, 1998, BRIT J CANCER, V77, P830, DOI 10.1038/bjc.1998.135; Dabney MK, 2000, GENET TEST, V4, P43, DOI 10.1089/109065700316453; Davis T C, 1993, Fam Med, V25, P391; ELIAS S, 1994, NEW ENGL J MED, V330, P1611, DOI 10.1056/NEJM199406023302213; Eng C, 2001, ANNU REV MED, V52, P371, DOI 10.1146/annurev.med.52.1.371; Escher M, 2000, ANN ONCOL, V11, P1131, DOI 10.1023/A:1008319114278; Euhus DM, 2002, J NATL CANCER I, V94, P844, DOI 10.1093/jnci/94.11.844; EVANS DGR, 1993, BRIT J CANCER, V67, P612, DOI 10.1038/bjc.1993.112; *FORCE, FAC OUR RISK CANC EM; Freedman AN, 2003, AM J MED GENET A, V120A, P63, DOI 10.1002/ajmg.a.10192; Friedman LC, 2003, J CANCER EDUC, V18, P91, DOI 10.1207/S15430154JCE1802_11; Fry A, 1999, FAM PRACT, V16, P468, DOI 10.1093/fampra/16.5.468; Geller G, 1997, JAMA-J AM MED ASSOC, V277, P1467, DOI 10.1001/jama.277.18.1467; Geller G, 1993, Arch Fam Med, V2, P1119, DOI 10.1001/archfami.2.11.1119; Green M J, 1997, J Cancer Educ, V12, P204; Green M J, 2000, J Genet Couns, V9, P359, DOI 10.1023/A:1009462314724; Green MJ, 1997, GENET TEST, V1, P131, DOI 10.1089/gte.1997.1.131; Green MJ, 2001, AM J MED GENET, V103, P16, DOI 10.1002/ajmg.1500; Green MJ, 2001, AM J MED GENET, V103, P24, DOI 10.1002/ajmg.1501; HOFMAN KJ, 1993, ACAD MED, V68, P625, DOI 10.1097/00001888-199308000-00013; HolmesRovner M, 1996, MED DECIS MAKING, V16, P58, DOI 10.1177/0272989X9601600114; Holtzman NA., 1998, PROMOTING SAFE EFFEC; Hopwood P, 2001, J MED GENET, V38, P139, DOI 10.1136/jmg.38.2.139; Hopwood P, 2000, BREAST CANCER RES, V2, P387, DOI 10.1186/bcr83; KAHN G, 1993, M D COMPUT, V10, P93; Klimberg VS, 1999, ANN SURG ONCOL, V6, P507, DOI 10.1007/s10434-999-0507-4; Lerman C, 1997, JNCI-J NATL CANCER I, V89, P148, DOI 10.1093/jnci/89.2.148; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; LERMAN C, 1994, ARCH INTERN MED, V154, P609, DOI 10.1001/archinte.154.6.609; Lerman C, 2002, J CONSULT CLIN PSYCH, V70, P784, DOI 10.1037//0022-006X.70.3.784; MCGEE G, 2003, GENETICS PUTTING POW, P96; MCGEE G, 1999, JAMA-J AM MED ASSOC, V281, P1652; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; *NAT ACT PLAN BREA, 1997, GEN TEST BREAST CANC; *NAT SOC GEN COUNS, 2003, NAT SOC GEN COUNS FA; *NCI, 1995, NIH PUBL; *NCI NAT ACT PLAN, GEN TEST BREAST CANC; O'Connor AM, 1999, MED DECIS MAKING, V19, P504, DOI 10.1177/0272989X9901900420; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Petersen GM, 2000, HEMATOL ONCOL CLIN N, V14, P939, DOI 10.1016/S0889-8588(05)70320-8; Schwartz MD, 2002, J CLIN ONCOL, V20, P514, DOI 10.1200/JCO.20.2.514; *SECR ADV COMM GEN, 2000, ENH OV GEN TESTS REC; Spielberger C. D., 1999, USE PSYCHOL TESTING, P993; SPIELBERGER CD, 1983, MANUAL STATE TRAIT A; Strecher V.J, 1999, J NATL CANCER INST M, V25, P134; TOUCHETTE N, 1997, 21 CENTURY INCORPORA; WEINSTEIN ND, 1987, J BEHAV MED, V10, P481, DOI 10.1007/BF00846146; Wilfond BS, 1997, J LAW MED ETHICS, V25, P243, DOI 10.1111/j.1748-720X.1997.tb01406.x; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	63	210	211	0	60	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2004	292	4					442	452		10.1001/jama.292.4.442	http://dx.doi.org/10.1001/jama.292.4.442			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841AA	15280342	Green Accepted, Bronze			2022-12-28	WOS:000222900500021
J	Veronin, MA; Youan, BBC				Veronin, MA; Youan, BBC			Medicine - Magic bullet gone astray: Medications and the Internet	SCIENCE			English	Editorial Material									Texas Tech Univ, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX 79106 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Veronin, MA (corresponding author), Texas Tech Univ, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX 79106 USA.	michael.veronin@ttuhsc.edu						ABDOU H. M., 2000, REMINGTON SCI PRACTI, P654; Gee Michael, 2002, J Manag Care Pharm, V8, P453; Gibson Liza, 2004, BMJ, V328, P486, DOI 10.1136/bmj.328.7438.486-c; Mudur Ganapati, 2003, BMJ, V327, P414, DOI 10.1136/bmj.327.7412.414-b; WALKER J, 2002, E PHARM GUIDE INTERN, P192; Young D, 2003, AM J HEALTH-SYST PH, V60, P729, DOI 10.1093/ajhp/60.8.729	6	36	36	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					481	481		10.1126/science.1097355	http://dx.doi.org/10.1126/science.1097355			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273381				2022-12-28	WOS:000222828900025
J	Clausen, J; Junge, W				Clausen, J; Junge, W			Detection of an intermediate of photosynthetic water oxidation	NATURE			English	Article							OXYGEN-EVOLVING COMPLEX; PHOTOSYSTEM-II; ELECTRON-TRANSFER; PROTON-TRANSFER; REDOX TRANSITIONS; CRYSTAL-STRUCTURE; SPLITTING ENZYME; MECHANISM; EVOLUTION; KINETICS	The oxygen that we breathe is produced by photosystem II of cyanobacteria and plants. The catalytic centre, a Mn4Ca cluster, accumulates four oxidizing equivalents before oxygen is formed, seemingly in a single reaction step1-8 2H(2)O(<--)(-->) O-2 = 4H(+) + 4e(-). The energy and cycling of this reaction derives solely from light. No intermediate oxidation product of water has been detected so far. Here, we shifted the equilibrium of the terminal reaction backward by increasing the oxygen pressure and monitoring ( by absorption transients in the near-ultraviolet spectrum) the electron transfer from bound water into the catalytic centre. A tenfold increase of ambient oxygen pressure (2.3 bar) half-suppressed the full progression to oxygen. The remaining electron transfer at saturating pressure ( 30 bar) was compatible with the formation of a stabilized intermediate. The abstraction of four electrons from water was probably split into at least two electron transfers: mildly endergonic from the centre's highest oxidation state to an intermediate, and exergonic from the intermediate to oxygen. There is little leeway for photosynthetic organisms to push the atmospheric oxygen concentration much above the present level.	Univ Osnabruck, Dept Biol Chem, Div Biophys, D-49069 Osnabruck, Germany	University Osnabruck	Junge, W (corresponding author), Univ Osnabruck, Dept Biol Chem, Div Biophys, D-49069 Osnabruck, Germany.	junge@uos.de						BABCOCK GT, 1976, FEBS LETT, V61, P286; Barber J, 2003, Q REV BIOPHYS, V36, P71, DOI 10.1017/S0033583502003839; BECK WF, 1985, BIOCHEMISTRY-US, V24, P3035, DOI 10.1021/bi00333a035; Clausen J, 2004, BBA-BIOENERGETICS, V1655, P184, DOI 10.1016/j.bbabio.2003.06.001; Clausen J, 2001, BBA-BIOENERGETICS, V1506, P224, DOI 10.1016/S0005-2728(01)00217-1; Dekker J. P., 1992, MANGANESE REDOX ENZY, P85; DEKKER JP, 1984, BIOCHIM BIOPHYS ACTA, V767, P176, DOI 10.1016/0005-2728(84)90093-8; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Haumann M, 1997, PHOTOSYNTH RES, V51, P193, DOI 10.1023/A:1005861917596; Haumann M, 1996, BBA-BIOENERGETICS, V1273, P237, DOI 10.1016/0005-2728(95)00152-2; Hendry G, 2003, BIOCHEMISTRY-US, V42, P6209, DOI 10.1021/bi034279i; Hillier W, 1998, BIOCHEMISTRY-US, V37, P16908, DOI 10.1021/bi980756z; Hundelt M, 1998, BIOCHEMISTRY-US, V37, P14450, DOI 10.1021/bi981164j; JAHNS P, 1991, BIOCHIM BIOPHYS ACTA, V1057, P313, DOI 10.1016/S0005-2728(05)80142-2; Junge W, 2002, PHILOS T ROY SOC B, V357, P1407, DOI 10.1098/rstb.2002.1137; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Karge M, 1997, BIOCHEMISTRY-US, V36, P8904, DOI 10.1021/bi962342g; KLIMOV VV, 1979, DOKL AKAD NAUK SSSR+, V249, P227; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; LAVERGNE J, 1991, BIOCHIM BIOPHYS ACTA, V1060, P175, DOI 10.1016/S0005-2728(09)91005-2; LAVERGNE J, 1993, PHOTOSYNTH RES, V38, P279, DOI 10.1007/BF00046752; RAPPAPORT F, 1994, BBA-BIOENERGETICS, V1184, P178, DOI 10.1016/0005-2728(94)90222-4; Rappaport F, 2001, BBA-BIOENERGETICS, V1503, P246, DOI 10.1016/S0005-2728(00)00228-0; RENGER G, 1986, BIOCHIM BIOPHYS ACTA, V850, P184, DOI 10.1016/0005-2728(86)90173-8; Renger G., 1978, Metzner, H. : Photosynthetic oxygen evolution., P229; Renger G, 2001, BBA-BIOENERGETICS, V1503, P210, DOI 10.1016/S0005-2728(00)00227-9; Robblee JH, 2001, BBA-BIOENERGETICS, V1503, P7, DOI 10.1016/S0005-2728(00)00217-6; RUTHERFORD AW, 1989, TRENDS BIOCHEM SCI, V14, P227, DOI 10.1016/0968-0004(89)90032-7; SAYGIN O, 1987, BIOCHIM BIOPHYS ACTA, V893, P452, DOI 10.1016/0005-2728(87)90097-1; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	30	105	106	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					480	483		10.1038/nature02676	http://dx.doi.org/10.1038/nature02676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269775				2022-12-28	WOS:000222801400050
J	Xiao, M; Martin, I; Yablonovitch, E; Jiang, HW				Xiao, M; Martin, I; Yablonovitch, E; Jiang, HW			Electrical detection of the spin resonance of a single electron in a silicon field-effect transistor	NATURE			English	Article							MAGNETIC-RESONANCE	The ability to manipulate and monitor a single-electron spin using electron spin resonance is a long-sought goal. Such control would be invaluable for nanoscopic spin electronics, quantum information processing using individual electron spin qubits and magnetic resonance imaging of single molecules. There have been several examples(1,2) of magnetic resonance detection of a single-electron spin in solids. Spin resonance of a nitrogen-vacancy defect centre in diamond has been detected optically(3), and spin precession of a localized electron spin on a surface was detected(4,5) using scanning tunnelling microscopy. Spins in semiconductors are particularly attractive for study because of their very long decoherence times(6). Here we demonstrate electrical sensing of the magnetic resonance spin-flips of a single electron paramagnetic spin centre, formed by a defect in the gate oxide of a standard silicon transistor. The spin orientation is converted to electric charge, which we measure as a change in the source/drain channel current. Our set-up may facilitate the direct study of the physics of spin decoherence, and has the practical advantage of being composed of test transistors in a conventional, commercial, silicon integrated circuit. It is well known from the rich literature of magnetic resonance studies that there sometimes exist structural paramagnetic defects(7) near the Si/SiO2 interface. For a small transistor, there might be only one isolated trap state that is within a tunnelling distance of the channel, and that has a charging energy close to the Fermi level.	Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Los Angeles	Jiang, HW (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	jiangh@physics.ucla.edu		Martin, Ivar/0000-0002-2010-6449				Durkan C, 2002, APPL PHYS LETT, V80, P458, DOI 10.1063/1.1434301; EATON SS, 1993, J MAGN RESON SER A, V102, P354, DOI 10.1006/jmra.1993.1116; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kato Y, 2003, SCIENCE, V299, P1201, DOI 10.1126/science.1080880; KIRTON MJ, 1989, ADV PHYS, V38, P367, DOI 10.1080/00018738900101122; KOHLER J, 1993, NATURE, V363, P242, DOI 10.1038/363242a0; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; MANASSEN Y, 1989, PHYS REV LETT, V62, P2531, DOI 10.1103/PhysRevLett.62.2531; Martin I, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.018301; Poindexter E. H., 1993, Semiconductor interfaces, microstructures and devices: properties and applications, P229; Tyryshkin AM, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.193207; Vrijen R, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.012306; WALLACE WJ, 1991, PHYS REV B, V44, P12964, DOI 10.1103/PhysRevB.44.12964; WRACHTRUP J, 1993, NATURE, V363, P244, DOI 10.1038/363244a0; Xiao M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.078301; Yablonovitch E, 2003, P IEEE, V91, P761, DOI 10.1109/JPROC.2003.811799	19	257	262	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					435	439		10.1038/nature02727	http://dx.doi.org/10.1038/nature02727			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269763				2022-12-28	WOS:000222801400037
J	Mysliwiec, PA; Brown, ML; Klabunde, CN; Ransohoff, DF				Mysliwiec, PA; Brown, ML; Klabunde, CN; Ransohoff, DF			Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER-SOCIETY GUIDELINES; SCREENING COLONOSCOPY; ASYMPTOMATIC ADULTS; CLINICAL GUIDELINES; PRACTICE PATTERNS; POLYP GUIDELINE; UNITED-STATES; RISK; UPDATE; CARE	Background: increasing use of colonoscopy for colorectal cancer screening and surveillance of colorectal adenomas after polypectomy has given rise to concerns about the availability of endoscopic resources in the United States. Guidelines recommend surveillance after polypectomy at 3 to 5 years for a small adenoma, and follow-up is not advised for hyperplastic polyps. The intensity of physicians' surveillance is largely unstudied. Objective: To survey practicing gastroenterologists and general surgeons about their perceived need for the frequency of surveillance after polypectomy, to compare survey responses to practice guidelines, and to identify factors influencing their recommendations for surveillance. Design: Survey study conducted by the National Cancer Institute. Setting: A nationally representative study of physicians in the United States. Participants: 349 gastroenterologists and 316 general surgeons. Measurements: Questionnaires mailed in 1999 and 2000 assessed physicians' recommendations for surveillance after polypectomy in asymptomatic, average-risk patients. Results: Response rates were 83%. Among gastroenterologists (317 of 349) and surgeons (125 of 316) who perform screening colonoscopy, 24% (95% Cl, 19.3% to 28.7%) of gastroenterologists and 54% (Cl, 44.9% to 62.5%) of surgeons recommend surveillance for a hyperplastic polyp. For a small adenoma, most physicians recommended surveillance colonoscopy and more than 50% recommended examinations every 3 years or more often. Physicians indicated that published evidence was very influential in their practice (83% [Cl, 78.8% to 87.2%] of gastroenterologists and 78% [Cl, 72.5% to 86.8%] of surgeons). By contrast, only half of respondents reported that guidelines were very influential. Limitations: The study was based on physicians' self-reported practice patterns. Results may overestimate or underestimate the performance of surveillance colonoscopy. Conclusions: Some surveillance colonoscopy seems to be inappropriately performed and in excess of guidelines, particularly for hyperplastic polyps and low-risk lesions such as a small adenoma. These results suggest unnecessary demand for endoscopic resources.	NCI, Bethesda, MD 20892 USA; Univ N Carolina, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill	Brown, ML (corresponding author), NCI, Executive Plaza N 4005,6130 Executive Blvd, Bethesda, MD 20892 USA.	mb53o@nih.gov			DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC085169] Funding Source: NIH RePORTER; NCI NIH HHS [N01-PC-85169] Funding Source: Medline	DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM SOC GASTR END, 1997, COL SCREEN SURV IND, V1030; *AM SOC GASTR END, 1997, COL SCREEN SURV IND; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; BOND JH, 1993, ANN INTERN MED, V119, P836, DOI 10.7326/0003-4819-119-8-199310150-00010; Bond JH, 2000, AM J GASTROENTEROL, V95, P3053; Brown ML, 2003, AM J MED, V115, P129, DOI 10.1016/S0002-9343(03)00297-3; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; CANNONALBRIGHT LA, 1994, AM J GASTROENTEROL, V89, P827; Cram P, 2003, ARCH INTERN MED, V163, P1601, DOI 10.1001/archinte.163.13.1601; Cruz-Correa M, 2001, ARCH INTERN MED, V161, P2588, DOI 10.1001/archinte.161.21.2588; *CTR MED MED SERV, MED INF RES; Eisenberg JM, 2002, MED CARE, V40, P1016, DOI 10.1097/00005650-200211000-00004; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Guyatt GH, 2000, BRIT MED J, V320, P954, DOI 10.1136/bmj.320.7240.954; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; HEDBERG CA, 2002, LETT HLTH INSURANCE; HILLMAN AL, 1991, HEALTH AFFAIR, V10, P138, DOI 10.1377/hlthaff.10.4.138; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; KODNER IJ, 1999, PRINCIPLES SURG, P1342; KOLATA G, 2003, NY TIMES        1208, pA23; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2000, GASTROENTEROLOGY, V118, P619, DOI 10.1016/S0016-5085(00)70269-1; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; MAGUIRE PO, 2002, ACP OBSERVER, V1, P16; MONTANO DE, 1995, AM J PUBLIC HEALTH, V85, P795, DOI 10.2105/AJPH.85.6.795; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; NEUGUT AI, 1995, GASTROENTEROLOGY, V108, P402, DOI 10.1016/0016-5085(95)90066-7; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; Prajapati DN, 2003, AM J GASTROENTEROL, V98, P194; Ransohoff DF, 2002, GASTROENTEROL CLIN N, V31, P1031, DOI 10.1016/S0889-8553(02)00059-6; Rex DK, 2001, GASTROINTEST ENDOSC, V54, P662, DOI 10.1067/mge.2001.117594; REX DK, 1991, GASTROENTEROLOGY, V100, P64, DOI 10.1016/0016-5085(91)90583-7; Rosson RS, 2003, ANN INTERN MED, V138, P356, DOI 10.7326/0003-4819-138-4-200302180-00022; Simmang CL, 1999, DIS COLON RECTUM, V42, P1123, DOI 10.1007/BF02238562; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; WAYE JD, 1982, ENDOSCOPY, V14, P79, DOI 10.1055/s-2007-1021585; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zauber AG, 2000, GASTROENTEROLOGY, V118, pA187, DOI 10.1016/S0016-5085(00)82821-8	45	262	266	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2004	141	4					264	271		10.7326/0003-4819-141-4-200408170-00006	http://dx.doi.org/10.7326/0003-4819-141-4-200408170-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846BX	15313742				2022-12-28	WOS:000223290900003
J	Hart, JT				Hart, JT			Further from Washington: can Celtic UK renew the NHS?	LANCET			English	Editorial Material							QUALITY-OF-CARE; FOR-PROFIT; HEALTH; COSTS		Univ Wales Swansea, Sch Clin, Dept Primary Care, Swansea, W Glam, Wales	Swansea University	Hart, JT (corresponding author), Gelli Deg, Swansea SA3 2HH, W Glam, Wales.	julian@tudorhart.freeserve.co.uk						[Anonymous], 1985, J Public Health Policy, V6, P435; BAUMOL WJ, 1993, P AM PHILOS SOC, V137, P612; BORGER J, 2003, GUARDIAN LONDON 1103; Chelala C, 1998, BRIT MED J, V316, P497; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; FRICK KD, 1999, NEW ENGL J MED, V341, P1961; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; Hart JT, 2001, INT J EPIDEMIOL, V30, P1263, DOI 10.1093/ije/30.6.1263; Hart JT, 1995, J PUBLIC HEALTH MED, V17, P383; Hart JT, 1997, J EPIDEMIOL COMMUN H, V51, P623, DOI 10.1136/jech.51.6.623; HART JT, 1992, LANCET, V340, P772, DOI 10.1016/0140-6736(92)92304-X; Himmelstein DU, 1999, JAMA-J AM MED ASSOC, V282, P159, DOI 10.1001/jama.282.2.159; Himmelstein DU, 2001, BLEEDING PATIENT CON; Howie J. G., 1997, 75 ROYAL COLL GEN PR; HUTT J, 2003, SOC HLTH ASS C CARD; KASSIRER JP, 1995, NEW ENGL J MED, V333, P50, DOI 10.1056/NEJM199507063330110; MAYNARD A, 1994, TAKING HLTH CLIN NAT; MCCORD C, 1990, NEW ENGL J MED, V322, P173, DOI 10.1056/NEJM199001183220306; MULVEY J, 1998, FINANCIAL TIMES 0714; Price D, 1999, LANCET, V354, P1889, DOI 10.1016/S0140-6736(99)11060-2; Sparrow M., 2000, LICENSE STEAL FRAUD; Terris M, 1998, J PUBLIC HEALTH POL, V19, P5, DOI 10.2307/3343085; Titmuss R. A, 1997, GIFT RELATIONSHIP HU; VICKERS G, 1958, LANCET, V1, P599; WOLINSKY H, 1995, LANCET, V345, P1499, DOI 10.1016/S0140-6736(95)91050-6; Woolhandler S, 1997, NEW ENGL J MED, V336, P769, DOI 10.1056/NEJM199703133361106; Woolhandler S, 1999, NEW ENGL J MED, V341, P444, DOI 10.1056/NEJM199908053410611; 1983, BMJ, V287, P1321	28	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2004	364	9434					633	635		10.1016/S0140-6736(04)16857-8	http://dx.doi.org/10.1016/S0140-6736(04)16857-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313365				2022-12-28	WOS:000223275100037
J	Orach, CG; De Brouwere, V				Orach, CG; De Brouwere, V			Postemergency health services for refugee and host populations in Uganda, 1999-2002	LANCET			English	Article								Since 1990, Uganda has hosted an estimated 200000 refugees in postemergency settlements interspersed within host communities. We investigated the extent to which obstetric needs were met in the refugee and host populations during 1999-2002. Between September and December, 2000, we retrospectively collected data from 1999 and 2000 on major obstetric interventions for absolute maternal indications from all five hospitals in Arua, Adjumani, and Moyo districts, Uganda. The same data were collected prospectively for 2001. We did community-based maternal mortality surveys on refugee and host populations in Adjumani district in 2002. Rates of major obstetric interventions were significantly higher for refugees than for the host population who live in the same rural areas as refugees (1.01% [95% CI 0.77-1.25] vs 0.45% [0.38-0.52]; p<0.0001). Rates of major obstetric interventions were also significantly higher for refugees than for the host population who live in rural areas without refugees (1.01% [0.77-1.25] vs 0.40% [0.36-0.441; p<0.0001). Maternal mortality was 2.5 times higher in the host population than in refugees in the Adjumani district (322 per 100000 births [247-396] vs 130 [81-179]. Refugees had better access to health services than did the rural host population in the northern Ugandan communities that we surveyed.	Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Free Univ Brussels, B-1050 Brussels, Belgium; Inst Trop Med, B-2000 Antwerp, Belgium	Makerere University; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institute of Tropical Medicine (ITM)	Orach, CG (corresponding author), Makerere Univ, Inst Publ Hlth, POB 7072, Kampala, Uganda.	cgorach@iph.ac.ug						CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; *GOU UNHCR, 1999, SELF REL REF HOST AR; Goyens P., 1996, Journal of Refugee Studies, V9, P268, DOI 10.1093/jrs/9.3.268; Hynes M, 2002, JAMA-J AM MED ASSOC, V288, P595, DOI 10.1001/jama.288.5.595; Van Damme W, 1998, LANCET, V351, P1609, DOI 10.1016/S0140-6736(97)10348-8	5	26	26	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					611	612		10.1016/S0140-6736(04)16854-2	http://dx.doi.org/10.1016/S0140-6736(04)16854-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313362				2022-12-28	WOS:000223275100034
J	Wynd, S; Durrheim, DN				Wynd, S; Durrheim, DN			Health-care provision and the path out of poverty	LANCET			English	Editorial Material							PUBLIC-HEALTH		James Cook Univ N Queensland, Sch Publ Hlth & Trop Med, Townsville, Qld 4811, Australia	James Cook University	Wynd, S (corresponding author), James Cook Univ N Queensland, Sch Publ Hlth & Trop Med, Townsville, Qld 4811, Australia.	Shona.Wynd@jcu.edu.au						Banatvala N, 2000, BMJ-BRIT MED J, V321, P101, DOI 10.1136/bmj.321.7253.101; CHOWDHURY M, 2004, INTERIM REPORT TASK; Chronic Poverty Research Centre, 2004, CHRON POV REP 2004 2; GELDOF B, 2004, GUARDIAN         FEB, P27; LAWSON D, 2003, 38 CPRC I DEV POL MA; SACHS J, 2004, ECONOMIST       0520; Spiegel PB, 2003, LANCET, V362, P72, DOI 10.1016/S0140-6736(03)13812-3; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283	8	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2004	364	9434					562	564		10.1016/S0140-6736(04)16865-7	http://dx.doi.org/10.1016/S0140-6736(04)16865-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313341				2022-12-28	WOS:000223275100007
J	Huisken, J; Swoger, J; Del Bene, F; Wittbrodt, J; Stelzer, EHK				Huisken, J; Swoger, J; Del Bene, F; Wittbrodt, J; Stelzer, EHK			Optical sectioning deep inside live embryos by selective plane illumination microscopy	SCIENCE			English	Article							GENE-EXPRESSION; FLUORESCENCE MICROSCOPY; THETA MICROSCOPY; CELL; AXIS; TOMOGRAPHY; RESOLUTION; SPECIMENS; MEDAKA; TOOL	Large, living biological specimens present challenges to existing optical imaging techniques because of their absorptive and scattering properties. We developed selective plane illumination microscopy (SPIM) to generate multidimensional images of samples up to a few millimeters in size. The system combines two-dimensional illumination with orthogonal camera-based detection to achieve high-resolution, optically sectioned imaging throughout the sample, with minimal photodamage and at speeds capable of capturing transient biological phenomena. We used SPIM to visualize all muscles in vivo in the transgenic Medaka line Arnie, which expresses green fluorescent protein in muscle tissue. We also demonstrate that SPIM can be applied to visualize the embryogenesis of the relatively opaque Drosophila melanogaster in vivo.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Huisken, J (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	huisken@embl.de; stelzer@embl.de	del bene, filippo/D-1245-2010; Stelzer, Ernst H K/A-7648-2011; Swoger, Jim/H-7651-2015; Huisken, Jan/B-2472-2009; Wittbrodt, Joachim/D-4735-2014	del bene, filippo/0000-0001-8551-2846; Stelzer, Ernst H K/0000-0003-1545-0736; Swoger, Jim/0000-0003-3805-0073; Huisken, Jan/0000-0001-7250-3756; Wittbrodt, Joachim/0000-0001-8550-7377				Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; IWAMATSU T, 1994, ZOOL SCI, V11, P825; Kikuchi S, 1997, OPT COMMUN, V138, P21, DOI 10.1016/S0030-4018(97)00054-0; Lindek S, 1999, J MOD OPTIC, V46, P843, DOI 10.1080/095003499149575; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; Pawley J, 1995, HDB BIOL CONFOCAL MI; Ruffins SW, 2002, CURR OPIN NEUROBIOL, V12, P580, DOI 10.1016/S0959-4388(02)00366-5; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; SHAW PJ, 1990, J MICROSC-OXFORD, V158, P165, DOI 10.1111/j.1365-2818.1990.tb02989.x; STELZER EHK, 1994, OPT COMMUN, V111, P536, DOI 10.1016/0030-4018(94)90533-9; STELZER EHK, 1995, J MICROSC-OXFORD, V179, P1, DOI 10.1111/j.1365-2818.1995.tb03608.x; Swoger J, 2003, OPT LETT, V28, P1654, DOI 10.1364/OL.28.001654; Webb DJ, 2003, NAT CELL BIOL, V5, P690, DOI 10.1038/ncb0803-690; Weninger WJ, 2002, NAT GENET, V30, P59, DOI 10.1038/ng785; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704	21	1509	1592	33	353	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1007	1009		10.1126/science.1100035	http://dx.doi.org/10.1126/science.1100035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310904				2022-12-28	WOS:000223250700049
J	Lincoff, AM; Kleiman, NS; Kereiakes, DJ; Feit, F; Bittl, JA; Jackman, JD; Sarembock, IJ; Cohen, DJ; Spriggs, D; Ebrahimi, R; Keren, G; Carr, J; Cohen, EA; Betriu, A; Desmet, W; Rutsch, W; Wilcox, RG; de Feyter, PJ; Vahanian, A; Topol, EJ				Lincoff, AM; Kleiman, NS; Kereiakes, DJ; Feit, F; Bittl, JA; Jackman, JD; Sarembock, IJ; Cohen, DJ; Spriggs, D; Ebrahimi, R; Keren, G; Carr, J; Cohen, EA; Betriu, A; Desmet, W; Rutsch, W; Wilcox, RG; de Feyter, PJ; Vahanian, A; Topol, EJ		REPLACE-2 Investigators	Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization - REPLACE-2 randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; ISCHEMIC EVENTS; RECEPTOR BLOCKADE; UNSTABLE ANGINA; ABCIXIMAB; INTERVENTION; ANGIOPLASTY; PREVENTION; COMPLICATIONS; EPTIFIBATIDE	Context In the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial, bivalirudin with provisional glycoprotein IIb/IIIa (Gp IIb/IIIa) inhibition was found to be noninferior to heparin plus planned Gp IIb/IIIa blockade in the prevention of acute ischemic end points and was associated with significantly less bleeding by 30 days after percutaneous coronary intervention (PCI). Objective To determine whether the efficacy of bivalirudin remains comparable with that of heparin plus Gp IIb/IIIa blockade over 6 months and 1 year. Design, Setting, and Participants Follow-up study to 1 year of a randomized, double-blind trial conducted among 6010 patients undergoing urgent or elective PCI at 233 community or referral hospitals in 9 countries from October 2001 through August 2002. Interventions Patients were randomly assigned to receive intravenously bivalirudin (0.75 mg/kg bolus, 1.75 mg/kg per hour for the duration of PCI), with provisional Gp IIb/IIIa inhibition, or to receive heparin (65 U/kg bolus), with planned Gp IIb/IIIa inhibition (abciximab or eptifibatide). Both groups received daily aspirin and a thienopyridine for at least 30 days after PCI. Main Outcome Measures incidence of death, myocardial infarction, or repeat revascularization by 6 months and death by 12 months after enrollment. Results At 6 months, death occurred in 1.4% of patients in the heparin plus Gp IIb/IIIa group and in 1.0% of patients in the bivalirudin group (hazard ratio [HR], 0.70; 95% confidence interval [CI], 0.43-1.14; P=.15). Myocardial infarction occurred in 7.4% and 8.2% of patients, respectively (HR, 1.12; 95% CI, 0.93-1.34; P=.24), and repeat revascularization was required in 11.4% and 12.1% of patients, respectively (HR, 1.06; 95% CI, 0.91-1.23; P=.45). By 1 year, death occurred in 2.46% of patients treated with heparin plus Gp IIb/IIIa blockade and in 1.89% of patients treated with bivalirudin (HR, 0.78; 95% CI, 0.55-1.11; P=.16). Nonsignificant trends toward lower 1-year mortality with bivalirudin were present in all patient subgroups analyzed and were of greatest magnitude among high-risk patients. Conclusion Long-term clinical outcome with bivalirudin and provisional Gp IIb/IIIa blockade is comparable with that of heparin plus planned Gp IIb/IIIa inhibition during contemporary PCI.	Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Baylor Coll Med, Houston, TX 77030 USA; Methodist Hosp, Houston, TX 77030 USA; Ohio Heart Hlth Ctr, Lindner Ctr, Cincinnati, OH USA; NYU, Sch Med, New York, NY USA; Ocala Heart Inst, Munroe Reg Med Ctr, Ocala, FL USA; Trinity Mother Frances Hosp, Tyler, TX USA; Univ Virginia Hlth Syst, Charlottesville, VA USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Clearwater Cardiovasc Consultants, Clearwater, FL USA; W Los Angeles VA, Los Angeles, CA USA; Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; E Texas Med Ctr, Tyler, TX USA; Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada; Univ Barcelona, Hosp Clin, Barcelona, Spain; Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; Univ Clin Charite Berlin, Berlin, Germany; Univ Nottingham Hosp, Nottingham NG7 2UH, England; Univ Hosp Dijkzigt, NL-3015 GD Rotterdam, Netherlands; Hop Bichat, F-75877 Paris, France	Cleveland Clinic Foundation; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; New York University; University of Virginia; Harvard University; Beth Israel Deaconess Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Barcelona; Hospital Clinic de Barcelona; KU Leuven; University Hospital Leuven; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Nottingham; Erasmus University Rotterdam; Erasmus MC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP	Lincoff, AM (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, Desk F25,9500 Euclid Ave, Cleveland, OH 44195 USA.	lincofa@ccf.org	; Carr, John/A-1938-2012	Topol, Eric/0000-0002-1478-4729; Carr, John/0000-0002-4398-8237				Abdelmeguid AE, 1996, AM HEART J, V131, P1097, DOI 10.1016/S0002-8703(96)90083-6; Anderson KM, 2001, J AM COLL CARDIOL, V37, P2059, DOI 10.1016/S0735-1097(01)01290-6; Antman EM, 2003, JAMA-J AM MED ASSOC, V289, P903, DOI 10.1001/jama.289.7.903; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Bittl JA, 2001, AM HEART J, V142, P952, DOI 10.1067/mhj.2001.119374; ELLIS SG, 1989, AM HEART J, V117, P777, DOI 10.1016/0002-8703(89)90612-1; FEIT F, 2004, ACUITY WEBCAST SERIE; Kereiakes DJ, 2002, AM J CARDIOL, V90, P628, DOI 10.1016/S0002-9149(02)02568-7; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Lincoff AM, 1997, J AM COLL CARDIOL, V30, P149, DOI 10.1016/S0735-1097(97)00110-1; Lincoff AM, 1999, CIRCULATION, V99, P1951, DOI 10.1161/01.CIR.99.15.1951; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Lincoff AM, 2002, AM HEART J, V143, P847, DOI 10.1067/mhj.2002.122173; Lincoff AM, 2000, J AM COLL CARDIOL, V35, P1103, DOI 10.1016/S0735-1097(00)00554-4; LINCOFF AM, IN PRESS AM J CARDIO; Tcheng JE, 2000, LANCET, V356, P2037; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 1999, LANCET, V354, P2019, DOI 10.1016/S0140-6736(99)10018-7; Topol EJ, 1997, JAMA-J AM MED ASSOC, V278, P479, DOI 10.1001/jama.278.6.479; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; Weitz Jeffrey I, 2003, Cardiovasc Toxicol, V3, P13, DOI 10.1385/CT:3:1:13; White HD, 2001, LANCET, V358, P1855	23	331	346	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					696	703		10.1001/jama.292.6.696	http://dx.doi.org/10.1001/jama.292.6.696			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304466	Bronze			2022-12-28	WOS:000223177300023
J	Proft, M; Struhl, K				Proft, M; Struhl, K			MAP kinase-mediated stress relief that precedes and regulates the timing of transcriptional induction	CELL			English	Article							ACTIVATED PROTEIN-KINASE; YEAST SACCHAROMYCES-CEREVISIAE; OSMOTIC-STRESS; SIGNAL-TRANSDUCTION; BUDDING YEAST; ENVIRONMENTAL-CHANGES; SALT STRESS; IN-VIVO; POL-II; HOG1	In yeast, hyperosmotic stress causes an immediate dissociation of most proteins from chromatin, presumably because cells are unprepared for, and initially unresponsive to, increased ion concentrations in the nucleus. Osmotic stress activates Hog1 MAP kinase which phosphorylates at least two proteins located at the plasma membrane, the Nha1 Na+/H+ antiporter and the Tok1 potassium channel. Hog1 phosphorylation stimulates Nha1 activity, and this is crucial for the rapid reassociation of proteins with their target sites in chromatin. This initial response to hyperosmolarity precedes and temporally regulates the activation of stress-response genes that depends on Hog1 phosphorylation of transcription factors in the nucleus. Thus, a single MAP kinase coordinates temporally, spatially, and mechanistically distinct responses to stress, thereby providing very rapid stress relief that facilitates subsequent changes in gene expression that permit long-term adaptation to harsh environmental conditions.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Struhl, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu	Proft, Markus/K-2323-2014	Proft, Markus/0000-0002-6788-5830	NIGMS NIH HHS [GM30186] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030186, R01GM030186] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; FERRANDO A, 1995, MOL CELL BIOL, V15, P5470; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Kamauchi S, 2002, J BIOCHEM, V131, P821, DOI 10.1093/oxfordjournals.jbchem.a003171; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kinclova O, 2001, MOL MICROBIOL, V40, P656, DOI 10.1046/j.1365-2958.2001.02412.x; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Marquez JA, 1996, FEBS LETT, V382, P89, DOI 10.1016/0014-5793(96)00157-3; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Pascual-Ahuir A, 2001, J BIOL CHEM, V276, P37373, DOI 10.1074/jbc.M105755200; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1998, CURR OPIN MICROBIOL, V1, P175, DOI 10.1016/S1369-5274(98)80008-8; Prior C, 1996, FEBS LETT, V387, P89, DOI 10.1016/0014-5793(96)00470-X; Proft M, 1999, MOL CELL BIOL, V19, P537; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MOL CELL BIOL, V19, P5474; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Teige M, 2001, P NATL ACAD SCI USA, V98, P5625, DOI 10.1073/pnas.091610798; Van Wuytswinkel O, 2000, MOL MICROBIOL, V37, P382, DOI 10.1046/j.1365-2958.2000.02002.x	36	162	168	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					351	361		10.1016/j.cell.2004.07.016	http://dx.doi.org/10.1016/j.cell.2004.07.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294160	Bronze			2022-12-28	WOS:000223353100011
J	Giron, D; Dunn, DW; Hardy, ICW; Strand, MR				Giron, D; Dunn, DW; Hardy, ICW; Strand, MR			Aggression by polyembryonic wasp soldiers correlates with kinship but not resource competition	NATURE			English	Article							COPIDOSOMA-FLORIDANUM; VISCOUS POPULATIONS; INCLUSIVE FITNESS; EVOLUTION; ALTRUISM; INVERTEBRATES; RELATEDNESS; ENVIRONMENT; ALLOCATION; RELATIVES	Kin selection theory predicts that individuals will show less aggression and more altruism towards relatives(1,2). However, recent theoretical developments suggest that with limited dispersal, competition between relatives can override the effects of relatedness(3-9). The predicted and opposing influences of relatedness and competition are difficult to approach experimentally because conditions that increase average relatedness among individuals also tend to increase competition. Polyembryonic wasps in the family Encyrtidae are parasites whose eggs undergo clonal division to produce large broods(10). These insects have also evolved a caste system: some embryos in a clone develop into reproductive larvae that mature into adults, whereas others develop into sterile soldier larvae that defend siblings from competitors(11-14). In a brood from a single egg, reproductive altruism by soldiers reflects clone-level allocation to defence at the cost of reproduction, with no conflict between individuals. When multiple eggs are laid into a host, inter-clone conflicts of interest arise. Here we report that soldier aggression in Copidosoma floridanum is inversely related to the genetic relatedness of competitors but shows no correlation with the level of resource competition.	Univ Georgia, Dept Entomol, Athens, GA 30602 USA; Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England	University System of Georgia; University of Georgia; University of Nottingham	Strand, MR (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	mrstrand@bugs.ent.uga.edu	Giron, David/B-9108-2013	Giron, David/0000-0001-8356-0983				Abbot P, 2001, P NATL ACAD SCI USA, V98, P12068, DOI 10.1073/pnas.201212698; Buss LW, 1987, EVOLUTION INDIVIDUAL, DOI DOI 10.1515/9781400858712; CROZIER RH, 1986, EVOLUTION, V40, P1100, DOI 10.1111/j.1558-5646.1986.tb00578.x; CRUZ YP, 1981, NATURE, V294, P446, DOI 10.1038/294446a0; DONNELL D, IN PRESS P NATL ACAD; GIRON D, 2004, P R SOC LOND S; Grafen A, 1984, BEHAV ECOLOGY EVOLUT, V2, P62; GRBIC M, 1992, NATURE, V360, P254, DOI 10.1038/360254a0; Grbic M, 1996, DEVELOPMENT, V122, P795; GROSBERG RK, 1988, Q REV BIOL, V63, P377, DOI 10.1086/416026; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Harvey JA, 2000, NATURE, V406, P183, DOI 10.1038/35018074; Ode PJ, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P218, DOI 10.1017/CBO9780511542053.011; ODE PJ, 1995, J ANIM ECOL, V64, P213, DOI 10.2307/5756; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; STRAND MR, 1989, ENTOMOL EXP APPL, V50, P37, DOI 10.1007/BF00190127; Strand MR, 1997, CURR TOP DEV BIOL, V35, P121, DOI 10.1016/S0070-2153(08)60258-6; STRAND MR, 1989, J INSECT BEHAV, V2, P355, DOI 10.1007/BF01068061; Strand MR, 2003, ENCY INSECTS, P928; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; West SA, 2001, NATURE, V409, P510, DOI 10.1038/35054057; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969	27	90	94	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					676	679		10.1038/nature02721	http://dx.doi.org/10.1038/nature02721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295600				2022-12-28	WOS:000223085400045
J	Shore, SA				Shore, SA			Airway smooth muscle in asthma - Not just more of the same	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Physiol Program, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Shore, SA (corresponding author), Harvard Univ, Sch Publ Hlth, Physiol Program, 665 Huntington Ave, Boston, MA 02115 USA.							Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380	2	21	47	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					531	532		10.1056/NEJMp048139	http://dx.doi.org/10.1056/NEJMp048139			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295045				2022-12-28	WOS:000223069900005
J	Wang, KY				Wang, KY			"Pseudoinfarction'' pattern due to hyperkalemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA	Hennepin County Medical Center	Wang, KY (corresponding author), Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA.								0	24	24	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					593	593		10.1056/NEJMicm970566	http://dx.doi.org/10.1056/NEJMicm970566			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295052				2022-12-28	WOS:000223069900012
J	Wilens, E; Faraone, SV; Biederman, J				Wilens, E; Faraone, SV; Biederman, J			Attention-deficit/hyperactivity disorder in adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEFICIT HYPERACTIVITY DISORDER; CHILDHOOD-ONSET; DOPAMINE TRANSPORTER; YOUNG-ADULTS; DOUBLE-BLIND; HUMAN BRAIN; METHYLPHENIDATE; ADHD; PERFORMANCE; CHILDREN		Massachusetts Gen Hosp, Pediat Psychopharmacol Unit, Clin Res Program Pediat Psychopharmacol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Wilens, E (corresponding author), Massachusetts Gen Hosp, Pediat Psychopharmacol Unit, Clin Res Program Pediat Psychopharmacol, ACC 725,15 Parkman St, Boston, MA 02114 USA.	twilens@partners.org	Faraone, Stephen V/O-7239-2018; Faraone, Stephen/AAE-7334-2019	Faraone, Stephen V/0000-0002-9217-3982; Faraone, Stephen/0000-0002-9217-3982	NIDA NIH HHS [R01 DA14419] Funding Source: Medline; NIMH NIH HHS [R01MH57934] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014419] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Achenbach TM, 1998, J AM ACAD CHILD PSY, V37, P718, DOI 10.1097/00004583-199807000-00011; Adler L, 2004, PSYCHIAT CLIN N AM, V27, P187, DOI 10.1016/j.psc.2003.12.003; Alpert JE, 1996, PSYCHIAT RES, V62, P213, DOI 10.1016/0165-1781(96)02912-5; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2002, J INT NEUROPSYCH SOC, V8, P655, DOI 10.1017/S1355617702801345; BIEDERMAN J, 1993, AM J PSYCHIAT, V150, P1792; BIEDERMAN J, 1995, AM J PSYCHIAT, V152, P431; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Cox DJ, 2000, J NERV MENT DIS, V188, P230, DOI 10.1097/00005053-200004000-00006; Epstein JN, 1997, NEUROPSYCHOLOGY, V11, P467, DOI 10.1037/0894-4105.11.4.467; Faraone S. V., 2002, NEUROPSYCHOPHARMACOL, P577; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Faraone SV, 2004, PSYCHIAT CLIN N AM, V27, P303, DOI 10.1016/S0193-953X(03)00090-X; FARAONE SV, 2002, AM J MED GENET, V114, P272; Fones CSL, 2000, J AFFECT DISORDERS, V58, P99, DOI 10.1016/S0165-0327(99)00065-8; Heiligenstein E, 1998, J AM COLL HEALTH, V46, P185, DOI 10.1080/07448489809595609; Heiligenstein E, 1998, J AM COLL HEALTH, V46, P213; HERVEY AS, IN PRESS NEUROPSYCHO; Hudziak JJ, 1998, J AM ACAD CHILD PSY, V37, P848, DOI 10.1097/00004583-199808000-00015; Johnson DE, 2001, ARCH CLIN NEUROPSYCH, V16, P587; Krause KH, 2000, NEUROSCI LETT, V285, P107, DOI 10.1016/S0304-3940(00)01040-5; Lanau F, 1997, J NEUROCHEM, V68, P804; Levin FR, 1998, DRUG ALCOHOL DEPEN, V52, P15, DOI 10.1016/S0376-8716(98)00049-0; Mannuzza S, 2002, AM J PSYCHIAT, V159, P1882, DOI 10.1176/appi.ajp.159.11.1882; McDermott S., 2000, ATTENTION DEFICIT DI, P569; Michelson D, 2003, BIOL PSYCHIAT, V53, P112, DOI 10.1016/S0006-3223(02)01671-2; Millstein R. B., 1997, J ATTEN DISORD, V2, P159, DOI [DOI 10.1177/108705479700200302, 10.1177/108705479700200302]; Murphy K., 1996, J ATTEN DISORD, V1, P147; Murphy P, 2000, AM J PSYCHIAT, V157, P1156, DOI 10.1176/appi.ajp.157.7.1156; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Schweitzer JB, 2000, AM J PSYCHIAT, V157, P278, DOI 10.1176/appi.ajp.157.2.278; Seidman LJ, 2004, PSYCHIAT CLIN N AM, V27, P323, DOI 10.1016/j.psc.2004.01.002; Solanto MV, 1998, BEHAV BRAIN RES, V94, P127, DOI 10.1016/S0166-4328(97)00175-7; Spencer T, 2001, ARCH GEN PSYCHIAT, V58, P775, DOI 10.1001/archpsyc.58.8.775; SPENCER T, 1995, ARCH GEN PSYCHIAT, V52, P434; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; WEISS G, 1985, J AM ACAD CHILD PSY, V24, P211, DOI 10.1016/S0002-7138(09)60450-7; WENDER PH, 1985, AM J PSYCHIAT, V142, P547; Wender PH, 1987, HYPERACTIVE CHILD AD; Wilens TE, 2003, PEDIATRICS, V111, P179, DOI 10.1542/peds.111.1.179; Wilens TE, 2003, DRUGS, V63, P2395, DOI 10.2165/00003495-200363220-00002; Wilens TE, 2001, AM J PSYCHIAT, V158, P282, DOI 10.1176/appi.ajp.158.2.282; ZAMETKIN AJ, 1990, NEW ENGL J MED, V323, P1361, DOI 10.1056/NEJM199011153232001	44	208	212	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2004	292	5					619	623		10.1001/jama.292.5.619	http://dx.doi.org/10.1001/jama.292.5.619			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	843AE	15292088				2022-12-28	WOS:000223045500020
J	Bach, RG; Cannon, CP; Weintraub, WS; DiBattiste, PM; Demopoulos, LA; Anderson, HV; DeLucca, PT; Mahoney, EM; Murphy, SA; Braunwald, E				Bach, RG; Cannon, CP; Weintraub, WS; DiBattiste, PM; Demopoulos, LA; Anderson, HV; DeLucca, PT; Mahoney, EM; Murphy, SA; Braunwald, E			The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes	ANNALS OF INTERNAL MEDICINE			English	Article							WAVE MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; CONSERVATIVE STRATEGIES; RANDOMIZED-TRIAL; COST-EFFECTIVENESS; TIROFIBAN; GUIDELINES; AGE	Background: Although increasing age is an important risk factor for adverse outcome among patients with acute coronary syndromes, elderly patients are more often managed conservatively. Objective: To examine outcome according to age and management strategy for patients with unstable angina and non-ST-segment elevation myocardial infarction (MI). Design: Randomized, controlled trial conducted from December 1997 to June 2000. Setting: 169 community and tertiary care hospitals in 9 countries. Patients: 2220 patients hospitalized with unstable angina and non-ST-segment elevation MI who were randomly assigned to an early invasive or conservative management strategy. Interventions: medical therapy and coronary angiography at 4 to 48 hours versus medical therapy and predischarge exercise testing. Measurements: Rates of 30-day and 6-month mortality, nonfatal MI, rehospitalization, stroke, and hemorrhagic complications. Results: Among patients 65 years of age and older, the early invasive strategy compared with the conservative strategy yielded an absolute reduction of 4.8 percentage points (8.8% vs. 13.6%; P = 0.018) and a relative reduction of 39% in death or MI at 6 months. Outcomes of the 2 strategies were similar, however, among patients younger than 65 years of age (6.1% vs. 6.5%; P > 0.2). Among patients older than 75 years of age, the early invasive strategy conferred an absolute reduction of 10.8 percentage points (10.8% vs. 21.6%; P = 0.016) and a relative reduction of 56% in death or MI at 6 months. The additional cost per death or MI prevented with the early invasive strategy was lower for elderly patients, but major bleeding rates were higher with this strategy in patients older than 75 years of age (16.6% vs. 6.5%; P = 0.009). Limitations: Because this study involved patients in the Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction (TACTICS-TIMI) 18 trial, its generalizability to elderly patients with excluded comorbid conditions is unknown. Conclusion: Despite an increased risk for major bleeding in patients older than 75 years of age, a routine early invasive strategy can significantly improve ischemic outcomes in elderly patients with unstable angina and non-ST-segment elevation MI.	Washington Univ, Sch Med, Div Cardiovasc, Med Ctr, St Louis, MO 63110 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Emory Univ, Atlanta, GA 30322 USA; Merck & Co Inc, West Point, PA USA; Univ Texas, Hlth Sci Ctr, Houston, TX USA; New England Res Inst, Watertown, MA 02172 USA	Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Emory University; Merck & Company; University of Texas System; University of Texas Health Science Center Houston; HealthCore, Inc	Bach, RG (corresponding author), Washington Univ, Sch Med, Div Cardiovasc, Med Ctr, 660 S Euclid Ave, St Louis, MO 63110 USA.	rbach@im.wustl.edu	Bach, Richard G/G-9764-2011; Bach, Richard/AAI-2515-2021					ANDERSON HV, 1995, J AM COLL CARDIOL, V26, P1643, DOI 10.1016/0735-1097(95)00404-1; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Bhatt DL, 2002, CIRCULATION, V106, P494; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Cannon CP, 1998, AM J CARDIOL, V82, P731, DOI 10.1016/S0002-9149(98)00540-2; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cannon CP, 2000, CIRCULATION, V102, P149, DOI 10.1161/01.CIR.102.2.149; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Giugliano RP, 1998, ARCH INTERN MED, V158, P1113, DOI 10.1001/archinte.158.10.1113; Hasdai D, 2000, AM HEART J, V139, P858, DOI 10.1016/S0002-8703(00)90018-8; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Mahoney EM, 2002, JAMA-J AM MED ASSOC, V288, P1851, DOI 10.1001/jama.288.15.1851; Michalis LK, 2000, EUR HEART J, V21, P1954, DOI 10.1053/euhj.2000.2397; *NAT CTR HLTH STAT, 1998, DIAGN HOSP PROC NAT; Spacek R, 2002, EUR HEART J, V23, P230, DOI 10.1053/euhj.2001.2735; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2; Weintraub WS, 1999, AM J CARDIOL, V83, P317, DOI 10.1016/S0002-9149(98)00860-1; Yusuf S, 1998, LANCET, V352, P507, DOI 10.1016/S0140-6736(97)11162-X	20	284	303	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2004	141	3					186	195		10.7326/0003-4819-141-3-200408030-00007	http://dx.doi.org/10.7326/0003-4819-141-3-200408030-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HG	15289215				2022-12-28	WOS:000223068600003
J	Nitta, R; Kikkawa, M; Okada, Y; Hirokawa, N				Nitta, R; Kikkawa, M; Okada, Y; Hirokawa, N			KIF1A alternately uses two loops to bind microtubules	SCIENCE			English	Article							KINESIN MOTOR; MECHANISM; PROCESSIVITY; ATPASE; MYOSIN; MODEL; DYNAMICS; ACTIN	The motor protein kinesin moves along microtubules, driven by adenosine triphosphate (ATP) hydrolysis. However, it remains unclear how kinesin converts the chemical energy into mechanical movement. We report crystal structures of monomeric kinesin KIF1A with three transition-state analogs: adenylyl imidodiphosphate (AMP-PNP), adenosine diphosphate (ADP)-vanadate, and ADP-AlFx (aluminofluoride complexes). These structures, together with known structures of the ADP-bound state and the adenylyl-(beta, gamma-methylene) diphosphate (AMP-PCP)-bound state, show that kinesin uses two microtubule-binding loops in an alternating manner to change its interaction with microtubules during the ATP hydrolysis cycle; loop L11 is extended in the AMP-PNP structure, whereas loop L12 is extended in the ADP structure. ADP-vanadate displays an intermediate structure in which a conformational change in two switch regions causes both loops to be raised from the microtubule, thus actively detaching kinesin.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Tokyo; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Okada, Yasushi/N-5067-2015; Nitta, Ryo/C-3727-2017; Kikkawa, Masahide/I-7958-2015	Okada, Yasushi/0000-0003-2601-3689; Nitta, Ryo/0000-0002-6537-9272; Kikkawa, Masahide/0000-0001-7656-8194				Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; Farrell CM, 2002, J BIOL CHEM, V277, P17079, DOI 10.1074/jbc.M108793200; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; GEEVES MA, 1991, BIOCHEM J, V274, P1; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; KORETZ JF, 1975, J BIOL CHEM, V250, P6344; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mackey AT, 2000, BIOCHEMISTRY-US, V39, P1346, DOI 10.1021/bi991918+; Matthies HJG, 2001, MOL BIOL CELL, V12, P4000, DOI 10.1091/mbc.12.12.4000; MIDELFORT CF, 1981, P NATL ACAD SCI-BIOL, V78, P2067, DOI 10.1073/pnas.78.4.2067; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 2003, NATURE, V424, P574, DOI 10.1038/nature01804; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Rosenfeld SS, 1996, J BIOL CHEM, V271, P9473, DOI 10.1074/jbc.271.16.9473; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; YOUNT RG, 1995, BIOPHYS J, V68, pS44; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611	30	143	152	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					678	683		10.1126/science.1096621	http://dx.doi.org/10.1126/science.1096621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286375				2022-12-28	WOS:000222992100052
J	Freed, AM; Burgmann, R				Freed, AM; Burgmann, R			Evidence of power-law flow in the Mojave desert mantle	NATURE			English	Article							1999 HECTOR-MINE; POSTSEISMIC DEFORMATION; GRAIN-SIZE; LANDERS; CALIFORNIA; EARTHQUAKE; RHEOLOGY; BENEATH; FAULT; SLIP	Studies of the Earth's response to large earthquakes can be viewed as large rock deformation experiments in which sudden stress changes induce viscous flow in the lower crust and upper mantle that lead to observable postseismic surface deformation(1). Laboratory experiments suggest that viscous flow of deforming hot lithospheric rocks is characterized by a power law in which strain rate is proportional to stress raised to a power, n ( refs 2, 3). Most geodynamic models of flow in the lower crust and upper mantle, however, resort to newtonian ( linear) stress - strain rate relations(4-10). Here we show that a power-law model of viscous flow in the mantle with n = 3.5 successfully explains the spatial and temporal evolution of transient surface deformation following the 1992 Landers(11) and 1999 Hector Mine(12) earthquakes in southern California. A power-law rheology implies that viscosity varies spatially with stress causing localization of strain, and varies temporally as stress evolves, rendering newtonian models untenable. Our findings are consistent with laboratory-derived flow law parameters for hot and wet olivine - the most abundant mineral in the upper mantle - and support the contention that, at least beneath the Mojave desert(5,6), the upper mantle is weaker than the lower crust.	Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Berkeley	Freed, AM (corresponding author), Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA.	freed@purdue.edu	Burgmann, Roland/AAE-5138-2022	Burgmann, Roland/0000-0002-3560-044X				CARTER NL, 1987, TECTONOPHYSICS, V136, P27, DOI 10.1016/0040-1951(87)90333-7; Deng JS, 1998, SCIENCE, V282, P1689, DOI 10.1126/science.282.5394.1689; FARMER GL, 1995, J GEOPHYS RES-SOL EA, V100, P8399, DOI 10.1029/95JB00070; Freed AM, 2002, GEOLOGY, V30, P571, DOI 10.1130/0091-7613(2002)030<0571:ASBOTS>2.0.CO;2; Freed AM, 2001, NATURE, V411, P180, DOI 10.1038/35075548; GOES S, 2002, J GEOPHYS RES, V107, DOI DOI 10.2000/JB000049; HANSEN FD, 1982, EOS T AGU, V63, P437; Hirth G, 2001, INT J EARTH SCI, V90, P77, DOI 10.1007/s005310000152; HIRTH G, 2004, SUBDUCTION FACTORY; Hudnut KW, 2002, B SEISMOL SOC AM, V92, P1403, DOI 10.1785/0120000912; JAOUL O, 1984, J GEOPHYS RES, V89, P4298, DOI 10.1029/JB089iB06p04298; KARATO SI, 1986, J GEOPHYS RES-SOLID, V91, P8151, DOI 10.1029/JB091iB08p08151; Kaverina A, 2002, B SEISMOL SOC AM, V92, P1266, DOI 10.1785/0120000907; Kenner SJ, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000189; KIRBY SH, 1987, REV GEOPHYS, V25, P1219, DOI 10.1029/RG025i006p01219; KRONENBERG AK, 1984, J GEOPHYS RES, V89, P4281, DOI 10.1029/JB089iB06p04281; Masterlark T, 2002, B SEISMOL SOC AM, V92, P1470, DOI 10.1785/0120000905; Melbourne T, 2001, GEOPHYS RES LETT, V28, P4003, DOI 10.1029/2001GL013167; NUR A, 1974, SCIENCE, V183, P204, DOI 10.1126/science.183.4121.204; Peltzer G, 1998, J GEOPHYS RES-SOL EA, V103, P30131, DOI 10.1029/98JB02302; Pollitz FF, 2001, SCIENCE, V293, P1814, DOI 10.1126/science.1061361; Pollitz FF, 2000, J GEOPHYS RES-SOL EA, V105, P8035, DOI 10.1029/1999JB900380; Pollitz FF, 2003, EARTH PLANET SC LETT, V215, P89, DOI 10.1016/S0012-821X(03)00432-1; Savage JC, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002330; Shelton G., 1981, EOS T AM GEOPHYS UN, V62, P396; Silver P.G., 1999, MANTLE PETROLOGY FIE, P79; THATCHER W, 1980, J GEOPHYS RES, V85, P6429, DOI 10.1029/JB085iB11p06429; WALD DJ, 1994, B SEISMOL SOC AM, V84, P668; Williams CF, 1996, GEOPHYS RES LETT, V23, P2029, DOI 10.1029/96GL02066	29	224	232	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					548	551		10.1038/nature02784	http://dx.doi.org/10.1038/nature02784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282602				2022-12-28	WOS:000222946100044
J	Anand, I; McMurray, J; Cohn, JN; Konstam, MA; Notter, T; Quitzau, K; Ruschitzka, F; Luscher, TF				Anand, I; McMurray, J; Cohn, JN; Konstam, MA; Notter, T; Quitzau, K; Ruschitzka, F; Luscher, TF		EARTH Investigators	Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin(A) Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial	LANCET			English	Article							PLASMA ENDOTHELIN; ETA; BLOCKADE; THERAPY	Background Endothelin-receptor blockade provides haemodynamic benefit in experimental and clinical heart failure. We aimed to measure the effects of long-term endothelin-blockade on left-ventricular (LV) remodelling and clinical outcomes in patients with chronic heart failure. Methods 642 patients with chronic heart failure were assigned the oral endothelin(A)-antagonist darusentan at 10, 25, 50, 100, or 300 mg daily or placebo for 24 weeks in addition to standard therapy in a randomised, double-blind, placebo-controlled trial. In the 50-300 mg groups, darusentan was uptitrated over 6 weeks. Primary endpoint was change in LV end-systolic volume (LVESV) at 24 weeks from baseline, measured by MRI. All patients for whom assessable MRI scans were available at baseline and follow-up were included in the analysis. Findings Darusentan was well tolerated. LVESV could be assessed in 485 (76%) patients with paired MRI data at baseline and 6 months. The change in LVESV was not significantly different from that with placebo at any dose (mean difference from placebo 1.27 mL [95% CI -9.9 to 12-4] with 10 mg dose, -1.84 mL [-13.0 to 9.3] with 25 mg, -5.68 mL [-16.9 to 5.6] with 50 mg, -4.05 mL [-15.5 to 7.4] with 100 mg, and -4.34 mL [-15.7 to 7.0] with 300 mg). Heart failure worsened in 71 (11.1%) patients, and 30 (4.7%) died during the study with no difference between groups. Interpretation Endothelin(A) blockade with darusentan did not improve cardiac remodelling or clinical symptoms or outcomes in patients with chronic heart failure receiving an angiotensin-converting-enzyme inhibitor, beta blocker, or aldosterone antagonist. Thus, endothelin(A) blockade is unlikely to be useful as an add-on treatment in such patients.	Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; Univ Minnesota, Vet Affairs Med Ctr, Minneapolis, MN USA; Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland; Univ Minnesota, Div Cardiovasc, Sch Med, Minneapolis, MN 55455 USA; Tufts Univ, New England Med Ctr, Div Cardiol, Boston, MA 02111 USA; Abbott, Ludwigshafen, Germany; Fdn Cardiovasc Res, Clin Res Ctr Intercornet, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Glasgow; University of Minnesota System; University of Minnesota Twin Cities; Tufts Medical Center; Tufts University	Luscher, TF (corresponding author), Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland.	cardiotfl@gmx.ch	mcmurray, John/B-2467-2013	mcmurray, John/0000-0002-6317-3975				Anand IS, 2002, J CARD FAIL, V8, pS452, DOI 10.1054/jcaf.2002.129286; Anand IS, 2003, J AM COLL CARDIOL, V41, p218A; Anand IS, 2002, J AM COLL CARDIOL, V39, P1414, DOI 10.1016/S0735-1097(02)01773-4; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Coletta A, 2002, EUR J HEART FAIL, V4, P381, DOI 10.1016/S1388-9842(02)00040-5; Coletta AP, 2001, EUR J HEART FAIL, V3, P747, DOI 10.1016/S1388-9842(01)00210-0; DOHERTY NE, 1992, J AM COLL CARDIOL, V19, P1294, DOI 10.1016/0735-1097(92)90337-M; Dubach P, 1997, CIRCULATION, V95, P2060, DOI 10.1161/01.CIR.95.8.2060; Dupuis J, 1996, CIRCULATION, V94, P1578, DOI 10.1161/01.CIR.94.7.1578; Fukuchi M, 1998, J CARDIOVASC PHARM, V31, pS421, DOI 10.1097/00005344-199800001-00120; HAYNES WG, 1994, LANCET, V344, P852, DOI 10.1016/S0140-6736(94)92827-4; HAYNES WG, 1993, CLIN SCI, V84, P427, DOI 10.1042/cs0840427; Hjalmarson A, 1999, LANCET, V353, P2001; KIOWSKI W, 1995, LANCET, V346, P732, DOI 10.1016/S0140-6736(95)91504-4; Koilpillai C, 1996, AM J CARDIOL, V77, P606, DOI 10.1016/S0002-9149(97)89315-0; Konstam MA, 2003, J CARD FAIL, V9, P350, DOI 10.1054/j.cardfail.2003.09.001; Love MP, 2000, CARDIOVASC RES, V47, P166, DOI 10.1016/S0008-6363(00)00081-X; Luscher TF, 2002, CIRCULATION, V106, P2666, DOI 10.1161/01.CIR.0000038497.80095.E1; Luscher Thomas F., 2001, HeartDrug, V1, P294, DOI 10.1159/000048978; MacCarthy PA, 2000, CIRCULATION, V101, P142, DOI 10.1161/01.CIR.101.2.142; MCMURRAY JJ, 1992, CIRCULATION, V85, P1374, DOI 10.1161/01.CIR.85.4.1374; Moreau P, 1997, CIRCULATION, V96, P1593, DOI 10.1161/01.CIR.96.5.1593; OMLAND T, 1994, CIRCULATION, V89, P1573, DOI 10.1161/01.CIR.89.4.1573; Packer M, 2001, J CARD FAIL, V7, P176, DOI 10.1054/jcaf.2001.25652; Packer M, 1998, CIRCULATION, V98, P3; Sakai S, 1996, NATURE, V384, P353, DOI 10.1038/384353a0; Sakai S, 1996, CIRCULATION, V93, P1214, DOI 10.1161/01.CIR.93.6.1214; SEO B, 1994, CIRCULATION, V89, P1203, DOI 10.1161/01.CIR.89.3.1203; Spieker LE, 2000, J AM COLL CARDIOL, V35, P1745, DOI 10.1016/S0735-1097(00)00649-5; STEWART DJ, 1992, CIRCULATION, V85, P510, DOI 10.1161/01.CIR.85.2.510; Sutsch G, 1998, CIRCULATION, V98, P2262, DOI 10.1161/01.CIR.98.21.2262; Wada A, 1997, J AM COLL CARDIOL, V30, P1385, DOI 10.1016/S0735-1097(97)00296-9; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yang ZH, 1999, CIRCULATION, V100, P5, DOI 10.1161/01.CIR.100.1.5; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	36	253	263	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					347	354		10.1016/S0140-6736(04)16723-8	http://dx.doi.org/10.1016/S0140-6736(04)16723-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276394				2022-12-28	WOS:000222853300033
J	Rothwell, PM				Rothwell, PM			Lessons from MATCH for future randomised trials in secondary prevention of stroke	LANCET			English	Editorial Material							CEREBRAL-ISCHEMIA; RISK-FACTORS; PROGNOSIS; ASPIRIN		Radcliffe Infirm, Univ Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford	Rothwell, PM (corresponding author), Radcliffe Infirm, Univ Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211				Algra A, 1999, J NEUROL NEUROSUR PS, V66, P255, DOI 10.1136/jnnp.66.2.255; Clark TG, 2003, J NEUROL NEUROSUR PS, V74, P577, DOI 10.1136/jnnp.74.5.577; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; COULL AJ, 2003, CEREBROVASC DIS, V16, P1; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Gorter JW, 1999, NEUROLOGY, V53, P1319, DOI 10.1212/WNL.53.6.1319; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Lovett JK, 2004, NEUROLOGY, V62, P569, DOI 10.1212/01.WNL.0000110311.09970.83; Nighoghossian N, 2002, STROKE, V33, P735, DOI 10.1161/hs0302.104615; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2001, LANCET, V357, P1612, DOI 10.1016/S0140-6736(00)04730-9; Rothwell PM, 2003, CEREBROVASC DIS, V16, P2, DOI 10.1159/000070271; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Yusuf S, 2001, NEW ENGL J MED, V345, P494; 2004, STROKE, V35, pE46	15	19	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2004	364	9431					305	307		10.1016/S0140-6736(04)16734-2	http://dx.doi.org/10.1016/S0140-6736(04)16734-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276368				2022-12-28	WOS:000222853300003
J	Day, C; Degenhardt, L; Gilmour, S; Hall, W				Day, C; Degenhardt, L; Gilmour, S; Hall, W			Effects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes	BRITISH MEDICAL JOURNAL			English	Article							AUSTRALIA		Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; Univ Queensland, Off Publ Policy & Eth, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of New South Wales Sydney; University of Queensland	Day, C (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.	carolyn.day@unsw.edu.au	Hall, Wayne D/A-3283-2008; Degenhardt, Louisa J/D-4515-2012	Hall, Wayne D/0000-0003-1984-0096; Degenhardt, Louisa J/0000-0002-8513-2218				Darke S, 2002, ADDICTION, V97, P179, DOI 10.1046/j.1360-0443.2002.00032.x; Degenhardt L., 2004, CAUSES COURSE CONSEQ; Law MG, 2003, INT J EPIDEMIOL, V32, P717, DOI 10.1093/ije/dyg101; *NAT CTR HIV EP CL, 2003, HIV AIDS VIR HEP SEX; TOPP L, 2002, AUSTR DRUG TRENDS 20	5	30	30	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 21	2004	329	7463					428	429		10.1136/bmj.38201.410255.55	http://dx.doi.org/10.1136/bmj.38201.410255.55			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849EA	15292056	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000223520300016
J	Leiman, PG; Chipman, PR; Kostyuchenko, VA; Mesyanzhinov, VV; Rossmann, MG				Leiman, PG; Chipman, PR; Kostyuchenko, VA; Mesyanzhinov, VV; Rossmann, MG			Three-dimensional rearrangement of proteins in the tail of bacteriophage T4 on infection of its host	CELL			English	Article							BASEPLATE MORPHOGENESIS; CONTRACTILE TAIL; GENETIC-CONTROL; ELECTRON MICROSCOPE; T4 BACTERIOPHAGES; ESCHERICHIA COLI; SHEATH PROTEIN; PRODUCT; DNA; EVOLUTION	The contractile tail of bacteriophage T4 undergoes major structural transitions when the virus attaches to the host cell surface. The baseplate at the distal end of the tail changes from a hexagonal to a star shape. This causes the sheath around the tail tube to contract and the tail tube to protrude from the baseplate and pierce the outer cell membrane and the cell wall before reaching the inner cell membrane for subsequent viral DNA injection. Analogously, the T4 tail can be contracted by treatment with 3 M urea. The structure of the T4 contracted tail, including the head-tail joining region, has been determined by cryo-electron microscopy to 17 Angstrom resolution. This 1200 Angstrom-long, 20 MDa structure has been interpreted in terms of multiple copies of its approximately 20 component proteins. A comparison with the metastable hexagonal baseplate of the mature virus shows that the baseplate proteins move as rigid bodies relative to each other during the structural change.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Mol Bioengn, Moscow 117997, Russia	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	mgr@indiana.bio.purdue.edu	Leiman, Petr G/E-5120-2010	Leiman, Petr G/0000-0002-9091-0918; Chipman, Paul/0000-0003-3652-4087; Kostyuchenko, Victor/0000-0001-9751-307X				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ABULADZE NK, 1994, VIROLOGY, V199, P301, DOI 10.1006/viro.1994.1128; Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; AMOS LA, 1975, J MOL BIOL, V99, P51, DOI 10.1016/S0022-2836(75)80158-6; Arisaka F, 1981, Prog Clin Biol Res, V64, P365; ARISAKA F, 1990, BIOCHEMISTRY-US, V29, P5057, DOI 10.1021/bi00473a009; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Black Lindsay W., 1994, P218; CASPAR DLD, 1980, BIOPHYS J, V32, P103, DOI 10.1016/S0006-3495(80)84929-0; Cerritelli ME, 1996, J MOL BIOL, V260, P767, DOI 10.1006/jmbi.1996.0436; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Coombs D, 1994, MOL BIOL BACTERIOPHA, P259; COOMBS DH, 1977, J MOL BIOL, V116, P375, DOI 10.1016/0022-2836(77)90076-6; CRAWFORD JT, 1980, J MOL BIOL, V139, P679, DOI 10.1016/0022-2836(80)90054-6; CROWTHER RA, 1977, J MOL BIOL, V116, P489, DOI 10.1016/0022-2836(77)90081-X; Desplats C, 2003, RES MICROBIOL, V154, P259, DOI 10.1016/S0923-2508(03)00069-X; DRIEDONKS RA, 1981, J MOL BIOL, V152, P641, DOI 10.1016/0022-2836(81)90121-2; DUDA RL, 1985, P NATL ACAD SCI USA, V82, P5550, DOI 10.1073/pnas.82.16.5550; Eiserling Frederick A., 1994, P209; FOKINE A, IN PRESS P NATL ACAD; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goldberg Edward, 1994, P347; Gowen B, 2003, J VIROL, V77, P7863, DOI 10.1128/JVI.77.14.7863-7871.2003; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kellenberger E, 1996, BIOPHYS CHEM, V59, P41, DOI 10.1016/0301-4622(95)00117-4; KIKUCHI Y, 1975, J MOL BIOL, V99, P695, DOI 10.1016/S0022-2836(75)80180-X; KIKUCHI Y, 1975, J SUPRAMOL STR CELL, V3, P24, DOI 10.1002/jss.400030104; KIKUCHI Y, 1975, J MOL BIOL, V99, P645, DOI 10.1016/S0022-2836(75)80178-1; KIKUCHI Y, 1975, J MOL BIOL, V99, P673, DOI 10.1016/S0022-2836(75)80179-3; KING J, 1971, J MOL BIOL, V58, P693, DOI 10.1016/0022-2836(71)90034-9; KING J, 1968, J MOL BIOL, V32, P231, DOI 10.1016/0022-2836(68)90007-7; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Kostyuchenko VA, 1999, STRUCTURE, V7, P1213, DOI 10.1016/S0969-2126(00)80055-6; Kostyuchenko VA, 2003, NAT STRUCT BIOL, V10, P688, DOI 10.1038/nsb970; Leiman PG, 2003, CELL MOL LIFE SCI, V60, P2356, DOI 10.1007/s00018-003-3072-1; Leiman PG, 2000, J MOL BIOL, V301, P975, DOI 10.1006/jmbi.2000.3989; Leiman PG, 2003, J MOL BIOL, V328, P821, DOI 10.1016/S0022-2836(03)00366-8; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Monod C, 1997, J MOL BIOL, V267, P237, DOI 10.1006/jmbi.1996.0867; MOODY MF, 1981, J MOL BIOL, V150, P217, DOI 10.1016/0022-2836(81)90450-2; MOODY MF, 1967, J MOL BIOL, V25, P167, DOI 10.1016/0022-2836(67)90136-2; MOODY MF, 1973, J MOL BIOL, V80, P613, DOI 10.1016/0022-2836(73)90200-3; Moore SD, 2002, CURR BIOL, V12, pR96, DOI 10.1016/S0960-9822(02)00670-X; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Orlova EV, 2003, EMBO J, V22, P1255, DOI 10.1093/emboj/cdg123; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; SIMON LD, 1967, VIROLOGY, V32, P298, DOI 10.1016/0042-6822(67)90278-4; SIMON LD, 1967, VIROLOGY, V32, P279, DOI 10.1016/0042-6822(67)90277-2; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; TAKEDA S, 1990, BIOCHEMISTRY-US, V29, P5050, DOI 10.1021/bi00473a008; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Thomassen E, 2003, J MOL BIOL, V331, P361, DOI 10.1016/s0022-2836(03)00755-1; Vianelli A, 2000, J BACTERIOL, V182, P680, DOI 10.1128/JB.182.3.680-688.2000; WATTS NR, 1990, J MOL BIOL, V216, P312; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Xu ZH, 1998, J STRUCT BIOL, V124, P129, DOI 10.1006/jsbi.1998.4060; Zhao L, 2003, J BACTERIOL, V185, P1693, DOI 10.1128/JB.185.5.1693-1700.2003	59	208	229	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					419	429		10.1016/j.cell.2004.07.022	http://dx.doi.org/10.1016/j.cell.2004.07.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315755	Bronze			2022-12-28	WOS:000223650900005
J	Demirdoven, N; Deutch, J				Demirdoven, N; Deutch, J			Hybrid cars now, fuel cell cars later	SCIENCE			English	Article								We compare the energy efficiency of hybrid and fuel cell vehicles as well as conventional internal combustion engines. Our analysis indicates that fuel cell vehicles using hydrogen from fossil fuels offer no significant energy efficiency advantage over hybrid vehicles operating in an urban drive cycle. We conclude that priority should be placed on hybrid vehicles by industry and government.	MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Engn Syst Div, Technol & Policy Program, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Deutch, J (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	jmd@mit.edu	Funde, Adinath M./D-8169-2012					AHLVI P, 2001, PUBLICATION VAGVERKE, V85; AN F, 2003, 2003010412 SAE; CUDDY MR, 1997, 970289 SAE; *DOE EN INF AG, CALC WEEKL DAT SUPPL; HOHLEIN B, 2003, HDB FUEL CELLS, V3, P245; Markel T, 2002, J POWER SOURCES, V110, P255, DOI 10.1016/S0378-7753(02)00189-1; *US DEP TRANSP BUR, 2002, BTS0208 US DEP TRANS; *US EPA, 2003, 430R03004 US EPA; Weiss M. A., 2000, 00003 MIT EL; WEISS MA, 2003, 2003001 MIT RP LAB E	10	126	130	5	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					974	976		10.1126/science.1093965	http://dx.doi.org/10.1126/science.1093965			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310893				2022-12-28	WOS:000223250700037
J	Turner, JA				Turner, JA			Sustainable hydrogen production	SCIENCE			English	Article								Identifying and building a sustainable energy system are perhaps two of the most critical issues that today's society must address. Replacing our current energy carrier mix with a sustainable fuel is one of the key pieces in that system. Hydrogen as an energy carrier, primarily derived from water, can address issues of sustainability, environmental emissions, and energy security. Issues relating to hydrogen production pathways are addressed here. Future energy systems require money and energy to build. Given that the United States has a finite supply of both, hard decisions must be made about the path forward, and this path must be followed with a sustained and focused effort.	Natl Renewable Energy Lab, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Turner, JA (corresponding author), Natl Renewable Energy Lab, Golden, CO 80401 USA.	jturner@nrel.gov	Funde, Adinath M./D-8169-2012; Dincer, Ibrahim/A-5379-2012					Bartlett AA, 2004, PHYS TODAY, V57, P53, DOI 10.1063/1.1784303; *EN INF ADM, 2004, UNPUB; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; GREGORY DP, 1973, SCI AM, V228, P13, DOI 10.1038/scientificamerican0173-13; Hoffmann P., 1981, FOREVER FUEL STORY H; IVY J, SUMMARY ELECTROLYTIC; Khaselev O, 1998, SCIENCE, V280, P425, DOI 10.1126/science.280.5362.425; Khaselev O, 2001, INT J HYDROGEN ENERG, V26, P127, DOI 10.1016/S0360-3199(00)00039-2; Lewis NS, 2001, NATURE, V414, P589, DOI 10.1038/414589a; MANN M, UNPUB; Melis A, 2002, INT J HYDROGEN ENERG, V27, P1217, DOI 10.1016/S0360-3199(02)00110-6; *ORG EC COOP DEV, 2003, 2 INF EXCH M ARG ILL; RICHARD G, 2002, ILEA LEAF        WIN; Steinfeld A, 2002, INT J HYDROGEN ENERG, V27, P611, DOI 10.1016/S0360-3199(01)00177-X; STEINFELD A, 2004, IN PRESS SOLAR ENERG; Turner J. A., 1999, SCIENCE, V285, P5428; Verne J., 1874, MYSTERIOUS ISLAND; Weisz PB, 2004, PHYS TODAY, V57, P47, DOI 10.1063/1.1784302	18	4086	4139	79	1355	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					972	974		10.1126/science.1103197	http://dx.doi.org/10.1126/science.1103197			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310892				2022-12-28	WOS:000223250700036
J	Clarke, MF				Clarke, MF			Chronic myelogenous leukemia - Identifying the hydra's heads	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA; Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Clarke, MF (corresponding author), Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA.							Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593	1	11	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					634	636		10.1056/NEJMp048120	http://dx.doi.org/10.1056/NEJMp048120			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306664				2022-12-28	WOS:000223225500005
J	Marbaix, E; Waignein, F; Camby, P; Escribano, ILD; Bernard, P; Sempoux, C				Marbaix, E; Waignein, F; Camby, P; Escribano, ILD; Bernard, P; Sempoux, C			Intranuclear biotin	LANCET			English	Editorial Material									Univ Catholique Louvain, Clin Univ St Luc, Dept Pathol, B-1200 Brussels, Belgium; Univ Catholique Louvain, Clin Univ St Luc, Dept Obstet, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Marbaix, E (corresponding author), Univ Catholique Louvain, Clin Univ St Luc, Dept Pathol, B-1200 Brussels, Belgium.			Sempoux, Christine/0000-0003-1375-3979					0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 7	2004	364	9433					532	532		10.1016/S0140-6736(04)16813-X	http://dx.doi.org/10.1016/S0140-6736(04)16813-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302198				2022-12-28	WOS:000223132700034
J	Downing, JR				Downing, JR			TGF-beta signaling, tumor suppression, and acute lymphoblastic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Downing, JR (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.		Downing, James R./N-8102-2018						0	16	18	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					528	530		10.1056/NEJMp048121	http://dx.doi.org/10.1056/NEJMp048121			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295044				2022-12-28	WOS:000223069900004
J	Price, RN; Uhlemann, AC; Brockman, A; McGready, R; Ashley, E; Phaipun, L; Patel, R; Laing, K; Looareesuwan, S; White, NJ; Nosten, F; Krishna, S				Price, RN; Uhlemann, AC; Brockman, A; McGready, R; Ashley, E; Phaipun, L; Patel, R; Laing, K; Looareesuwan, S; White, NJ; Nosten, F; Krishna, S			Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number	LANCET			English	Article							WESTERN BORDER; INCREASED SENSITIVITY; DRUG SUSCEPTIBILITY; ARTESUNATE; MALARIA; ANTIMALARIALS; POLYMORPHISMS; AMPLIFICATION; COMBINATION; POPULATION	Background The borders of Thailand harbour the world's most multidrug resistant Plasmodium falciparum parasites. In 1984 mefloquine was introduced as treatment for uncomplicated falciparum malaria, but substantial resistance developed within 6 years. A combination of artesunate with mefloquine now cures more than 95% of acute infections. For both treatment regimens, the underlying mechanisms of resistance are not known. Methods The relation between polymorphisms in the P falciparum multidrug resistant gene 1 (pfmdr1) and the in-vitro and in-vivo responses to mefloquine were assessed in 618 samples from patients with falciparum malaria studied prospectively over 12 years. pfmdr1 copy number was assessed by a robust real-time PCR assay. Single nucleotide polymorphisms of pfmdr1, P falciparum chloroquine resistance transporter gene (pfcrt) and P falciparum Ca2+ ATPase gene (pfATP6) were assessed by PCR-restriction fragment length polymorphism. Findings Increased copy number of pfmdr1 was the most important determinant of in-vitro and in-vivo resistance to mefloquine, and also to reduced artesunate sensitivity in vitro. In a Cox regression model with control for known confounders, increased pfmdr1 copy number was associated with an attributable hazard ratio (AHR) for treatment failure of 6.3 (95% CI 2.9-13.8, p<0.001) after mefloquine monotherapy and 5.4 (2.0-14.6, p=0.001) after artesunate-mefloquine therapy. Single nucleotide polymorphisms in pfmdr1 were associated with increased mefloquine susceptibility in vitro, but not in vivo. Interpretation Amplification in pfmdr1 is the main cause of resistance to mefloquine in falciparum malaria. Relevance to practice Multidrug resistant P falciparum malaria is common in southeast Asia, but difficult to identify and treat. Genes that encode parasite transport proteins maybe involved in export of drugs and so cause resistance. In this study we show that increase in copy number of pfmdr1, a gene encoding a parasite transport protein, is the best overall predictor of treatment failure with mefloquine. Increase in pfmdr1 copy number predicts failure even after chemotherapy with the highly effective combination of mefloquine and 3 days' artesunate. Monitoring of pfmdr1 copy number will be useful in epidemiological surveys of drug resistance in P falciparum, and potentially for predicting treatment failure in individual patients.	Univ London St Georges Hosp, Sch Med, Dept Cellular & Mol Med Infect Dis, London SW17 0RE, England; John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Vaccinol & Trop Med, Oxford OX3 9DU, England; Shoklo Malaria Res Unit, Mae Sot, Tak Province, Thailand; Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; Mahidol Univ, Fac Trop Med, Bangkok, Thailand	St Georges University London; University of Oxford; Mahidol University; Charles Darwin University; Menzies School of Health Research; Mahidol University	Krishna, S (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Cellular & Mol Med Infect Dis, London SW17 0RE, England.	s.krishna@sghms.ac.uk	White, Nick/AAC-6527-2019; Nosten, Francois/AAC-5509-2019; McGready, Rose/A-3290-2014; White, Nicholas J/I-4629-2012	White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; McGready, Rose/0000-0003-1621-3257; Krishna, Sanjeev/0000-0003-0066-0634; Price, Richard/0000-0003-2000-2874; Laing, Ken/0000-0003-1883-3433	Wellcome Trust [074637] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adagu IS, 2001, PARASITOLOGY, V123, P219, DOI 10.1017/S0031182001008344; BARNES DA, 1992, EMBO J, V11, P3067, DOI 10.1002/j.1460-2075.1992.tb05378.x; Basco LK, 1996, EXP PARASITOL, V82, P97, DOI 10.1006/expr.1996.0013; Basco LK, 1995, MOL BIOCHEM PARASIT, V74, P157, DOI 10.1016/0166-6851(95)02492-1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1994, ACTA TROP, V56, P157, DOI 10.1016/0001-706X(94)90061-2; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Krishna S, 2001, ANTIMICROB AGENTS CH, V45, P509, DOI 10.1128/AAC.45.2.509-516.2001; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Pickard AL, 2003, ANTIMICROB AGENTS CH, V47, P2418, DOI 10.1128/AAC.47.8.2418-2423.2003; Plowe CV, 2001, INFEC DIS S, P173; Price R, 1997, MOL BIOCHEM PARASIT, V85, P161, DOI 10.1016/S0166-6851(96)02822-8; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Simpson JA, 1999, CLIN PHARMACOL THER, V66, P472, DOI 10.1016/S0009-9236(99)70010-X; terKuile FO, 1995, T ROY SOC TROP MED H, V89, P660, DOI 10.1016/0035-9203(95)90435-2; Thomas SM, 2002, AM J TROP MED HYG, V66, P474, DOI 10.4269/ajtmh.2002.66.474; Vaidya AB, 2001, INFEC DIS S, P203; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; WILSON CM, 1993, MOL BIOCHEM PARASIT, V57, P151, DOI 10.1016/0166-6851(93)90252-S; Zalis MG, 1998, AM J TROP MED HYG, V58, P630, DOI 10.4269/ajtmh.1998.58.630	30	606	619	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					438	447		10.1016/S0140-6736(04)16767-6	http://dx.doi.org/10.1016/S0140-6736(04)16767-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288742	Green Accepted			2022-12-28	WOS:000222998600034
J	Marquis, RJ				Marquis, RJ			Herbivores rule	SCIENCE			English	Editorial Material							RECRUITMENT; FOREST		Univ Missouri, Dept Biol, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Marquis, RJ (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	robert_marquis@umsl.edu						CONNELL J H, 1971, P298; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; Dublin H., 1995, SERENGETI, V2, P71, DOI DOI 10.1029/2008JG000812; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Hyatt LA, 2003, OIKOS, V103, P590, DOI 10.1034/j.1600-0706.2003.12235.x; JANZEN D H, 1974, Biotropica, V6, P69, DOI 10.2307/2989823; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; King RT, 2003, BIOTROPICA, V35, P462, DOI 10.1111/j.1744-7429.2003.tb00603.x; LOUDA SM, 1982, ECOL MONOGR, V52, P25, DOI 10.2307/2937343; MARQUIS RJ, BIOTIC INTERACTIONS; SINCLAIR ARE, 1995, SERENGETI, V2	12	13	14	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2004	305	5684					619	621		10.1126/science.1101848	http://dx.doi.org/10.1126/science.1101848			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286352				2022-12-28	WOS:000222992100025
J	Ottino, JM; Wiggins, S				Ottino, JM; Wiggins, S			Applied physics - Designing optimal micromixers	SCIENCE			English	Editorial Material							LINKED TWIST MAPPINGS; MICROFLUIDICS; PROPERTY		Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA; Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; Univ Bristol, Sch Math, Bristol BS8 1TH, Avon, England	Northwestern University; Northwestern University; University of Bristol	Ottino, JM (corresponding author), Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.	jm-ottino@northwestern.edu; s.wiggins@bristol.ac.uk	Ottino, Julio/B-6682-2009	Wiggins, Stephen/0000-0002-0780-0911				Bottausci F, 2004, PHILOS T R SOC A, V362, P1001, DOI 10.1098/rsta.2003.1359; Bringer MR, 2004, PHILOS T R SOC A, V362, P1087, DOI 10.1098/rsta.2003.1364; Devaney R.L., 1980, LECT NOTES MATH, V819, P121; Kamholz AE, 2004, LAB CHIP, V4, p16N, DOI 10.1039/b400810n; PRZYTYCKI F, 1983, ANN SCI ECOLE NORM S, V16, P345; Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124; Stroock AD, 2002, SCIENCE, V295, P647, DOI 10.1126/science.1066238; *US DEP EN ADV SCI, MAY 10 11 2002 WORKS; Wiggins S, 2004, PHILOS T ROY SOC A, V362, P937, DOI 10.1098/rsta.2003.1356; WIGGINS S, 2004, PHILOS T R SOC LON A, V362; Wojtkowski M., 1980, ANN NY ACAD SCI, V357, P65, DOI 10.1111/j.1749-6632.1980.tb29676.x; [No title captured]	12	103	109	3	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					485	486		10.1126/science.1099343	http://dx.doi.org/10.1126/science.1099343			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273385				2022-12-28	WOS:000222828900029
J	Kaasik, K; Lee, CC				Kaasik, K; Lee, CC			Reciprocal regulation of haem biosynthesis and the circadian clock in mammals	NATURE			English	Article							SYNTHASE ACTIVITY; MELATONIN RHYTHM; NITRIC-OXIDE; IN-VIVO; VITAMIN-B-12; MPER1; TRANSCRIPTION; PROMOTERS; MECHANISM; PROTEINS	The circadian clock is the central timing system that controls numerous physiological processes. In mammals, one such process is haem biosynthesis, which the clock controls through regulation of the rate-limiting enzyme aminolevulinate synthase 1 (Alas1)(1,2). Several members of the core clock mechanism are PAS domain proteins, one of which, neuronal PAS 2 (NPAS2), has a haem-binding motif(3,4). Indeed, haem controls activity of the BMAL1-NPAS2 transcription complex in vitro by inhibiting DNA binding in response to carbon monoxide(3). Here we show that haem differentially modulates expression of the mammalian Period genes mPer1 and mPer2 in vivo by a mechanism involving NPAS2 and mPER2. Further experiments show that mPER2 positively stimulates activity of the BMAL1-NPAS2 transcription complex and, in turn, NPAS2 transcriptionally regulates Alas1. Vitamin B12 and haem compete for binding to NPAS2 and mPER2, but they have opposite effects on mPer2 and mPer1 expression in vivo. Our data show that the circadian clock and haem biosynthesis are reciprocally regulated and suggest that porphyrin-containing molecules are potential targets for therapy of circadian disorders.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, EE-51010 Tartu, Estonia	Baylor College of Medicine; University of Tartu	Lee, CC (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	cheng.c.lee@uth.tmc.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X				Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Artinian LR, 2001, EXP NEUROL, V171, P293, DOI 10.1006/exnr.2001.7781; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; FREEDMAN ML, 1974, J BIOL CHEM, V249, P7290; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gilles-Gonzalez MA, 2004, J APPL PHYSIOL, V96, P774, DOI 10.1152/japplphysiol.00941.2003; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hashimoto S, 1996, NEUROSCI LETT, V220, P129, DOI 10.1016/S0304-3940(96)13247-X; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Levitman M Kh, 2002, Radiats Biol Radioecol, V42, P511; Lincoln DW, 2000, INT J CANCER, V88, P479, DOI 10.1002/1097-0215(20001101)88:3<479::AID-IJC23>3.0.CO;2-Z; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McLEan GR, 1997, CANCER RES, V57, P4015; Nakamura T, 1997, CHRONOBIOL INT, V14, P549, DOI 10.3109/07420529709001446; Norman P, 2001, Curr Opin Investig Drugs, V2, P1611; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Rubio MF, 2003, NEUROSCI LETT, V353, P9, DOI 10.1016/j.neulet.2003.08.075; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Scagliotti GV, 2003, J CLIN ONCOL, V21, P1556, DOI 10.1200/JCO.2003.06.122; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; TSUTSUI K, 1982, ANAL BIOCHEM, V121, P244, DOI 10.1016/0003-2697(82)90475-4; Tunctan B, 2002, CHRONOBIOL INT, V19, P393, DOI 10.1081/CBI-120002915; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zhu YH, 2002, DNA CELL BIOL, V21, P333, DOI 10.1089/104454902753759744	29	278	288	4	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					467	471		10.1038/nature02724	http://dx.doi.org/10.1038/nature02724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269772				2022-12-28	WOS:000222801400047
J	Lippman, Z; Gendrel, AV; Black, M; Vaughn, MW; Dedhia, N; McCombie, WR; Lavine, K; Mittal, V; May, B; Kasschau, KD; Carrington, JC; Doerge, RW; Colot, V; Martienssen, R				Lippman, Z; Gendrel, AV; Black, M; Vaughn, MW; Dedhia, N; McCombie, WR; Lavine, K; Mittal, V; May, B; Kasschau, KD; Carrington, JC; Doerge, RW; Colot, V; Martienssen, R			Role of transposable elements in heterochromatin and epigenetic control	NATURE			English	Article							DNA METHYLATION; TANDEM REPEATS; RNAI; GENE; ARABIDOPSIS; DROSOPHILA; PLANTS; MAINTENANCE; INHERITANCE; PHENOTYPE	Heterochromatin has been defined as deeply staining chromosomal material that remains condensed in interphase, whereas euchromatin undergoes de-condensation(1). Heterochromatin is found near centromeres and telomeres, but interstitial sites of heterochromatin ( knobs) are common in plant genomes and were first described in maize(2). These regions are repetitive and late-replicating(3). In Drosophila, heterochromatin influences gene expression, a heterochromatin phenomenon called position effect variegation(4). Similarities between position effect variegation in Drosophila and gene silencing in maize mediated by "controlling elements" ( that is, transposable elements) led in part to the proposal that heterochromatin is composed of transposable elements, and that such elements scattered throughout the genome might regulate development(2). Using microarray analysis, we show that heterochromatin in Arabidopsis is determined by transposable elements and related tandem repeats, under the control of the chromatin remodelling ATPase DDM1 (Decrease in DNA Methylation 1). Small interfering RNAs (siRNAs) correspond to these sequences, suggesting a role in guiding DDM1. We also show that transposable elements can regulate genes epigenetically, but only when inserted within or very close to them. This probably accounts for the regulation by DDM1 and the DNA methyltransferase MET1 of the euchromatic, imprinted gene FWA, as its promoter is provided by transposable-element-derived tandem repeats that are associated with siRNAs.	Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; UEVE, CNRS, INRA, Unite Rech Genom Vegetale, F-91057 Evry, France; Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97330 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Oregon State University	Martienssen, R (corresponding author), Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	colot@evry.inra.fr; martiens@cshl.edu	Gendrel, Anne-Valerie/E-5584-2017; Carrington, James C/A-4656-2012; Black, Michael/F-1484-2010	Gendrel, Anne-Valerie/0000-0003-4510-0024; Carrington, James C/0000-0003-3572-129X; McCombie, W. Richard/0000-0003-1899-0682; Black, Michael/0000-0003-1174-6054; Lippman, Zachary/0000-0001-7668-9025; Vaughn, Matthew/0000-0002-1384-4283				Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; BARKAN A, 1991, P NATL ACAD SCI USA, V88, P3502, DOI 10.1073/pnas.88.8.3502; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Craig BA, 2003, J AGRIC BIOL ENVIR S, V8, P1, DOI 10.1198/1085711031256; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Heitz E., 1928, JAHRB WISS BOT, V69, P762; Hennig W, 1999, CHROMOSOMA, V108, P1, DOI 10.1007/s004120050346; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; McCombie WR, 2000, CELL, V100, P377, DOI 10.1016/S0092-8674(00)80673-X; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1784803; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Verbsky ML, 2001, CURR OPIN PLANT BIOL, V4, P494, DOI 10.1016/S1369-5266(00)00206-5; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Vermaak D, 2003, CURR OPIN CELL BIOL, V15, P266, DOI 10.1016/S0955-0674(03)00043-7; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	32	879	933	4	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					471	476		10.1038/nature02651	http://dx.doi.org/10.1038/nature02651			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269773				2022-12-28	WOS:000222801400048
J	Oransky, I				Oransky, I			William Ross Adey - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com						ADEY WR, PUBLICATION LIST	1	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 17	2004	364	9430					242	242		10.1016/S0140-6736(04)16699-3	http://dx.doi.org/10.1016/S0140-6736(04)16699-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839KV	15281218				2022-12-28	WOS:000222784900013
J	Leutgeb, S; Leutgeb, JK; Treves, A; Moser, MB; Moser, EI				Leutgeb, S; Leutgeb, JK; Treves, A; Moser, MB; Moser, EI			Distinct ensemble codes in hippocampal areas CA3 and CA1	SCIENCE			English	Article							SPATIAL FIRING PATTERNS; COMPLEX-SPIKE CELLS; PLACE CELLS; COMPUTATIONAL CONSTRAINTS; NMDA RECEPTORS; MEMORY; CONTEXT; ENVIRONMENT; RATS; REPRESENTATIONS	The hippocampus has differentiated into an extensively connected recurrent stage (CA3) followed by a feed-forward stage (CA1). We examined the function of this structural differentiation by determining how cell ensembles in rat CA3 and CA1 generate representations of rooms with common spatial elements. In CA3, distinct subsets of pyramidal cells were activated in each room, regardless of the similarity of the testing enclosure. In CA1, the activated populations overlapped, and the overlap increased in similar enclosures. After exposure to a novel room, ensemble activity developed slower in CA3 than CA1, suggesting that the representations emerged independently.	Scuola Int Super Studi Avanzati, Cognit Neurosci Sector, Trieste, Italy	International School for Advanced Studies (SISSA)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Med Tech Res Ctr, Ctr Biol Memory, N-7489 Trondheim, Norway.	edvard.moser@cbm.ntnu.no	Treves, Alessandro/B-2318-2009	TREVES, Alessandro/0000-0001-7246-5673; Leutgeb, Jill/0000-0002-2014-842X				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; BARNES CA, 1990, PROG BRAIN RES, V83, P287; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Freeman JH, 1996, J NEUROSCI, V16, P1538; Hebb Donald O., 1949, ORG BEHAV; HIRSH R, 1974, BEHAV BIOL, V12, P421, DOI 10.1016/S0091-6773(74)92231-7; JARRARD LE, 1975, J COMP PHYSIOL PSYCH, V89, P400, DOI 10.1037/h0077049; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb S, 2002, NEUROSCIENCE, V112, P655, DOI 10.1016/S0306-4522(02)00101-X; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; Sharp PE, 1997, BEHAV BRAIN RES, V85, P71, DOI 10.1016/S0166-4328(96)00165-9; Skaggs WE, 1998, J NEUROSCI, V18, P8455; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tanila H, 1999, HIPPOCAMPUS, V9, P235, DOI 10.1002/(SICI)1098-1063(1999)9:3<235::AID-HIPO4>3.0.CO;2-3; Treves A, 2004, HIPPOCAMPUS, V14, P539, DOI 10.1002/hipo.10187; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WINOCUR G, 1978, J COMP PHYSIOL PSYCH, V92, P312, DOI 10.1037/h0077468	33	509	516	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1295	1298		10.1126/science.1100265	http://dx.doi.org/10.1126/science.1100265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15272123				2022-12-28	WOS:000223624600043
J	Hiramatsu, K; Cui, LZ; Kuwahara-Arai, K				Hiramatsu, K; Cui, LZ; Kuwahara-Arai, K			Has vancomycin-resistant Staphylococcus aureus started going it alone?	LANCET			English	Editorial Material									Juntendo Univ, Postgrad Sch Med, Dept Microbiol & Infect Control Sci, Tokyo 1138421, Japan	Juntendo University	Hiramatsu, K (corresponding author), Juntendo Univ, Postgrad Sch Med, Dept Microbiol & Infect Control Sci, Tokyo 1138421, Japan.	hiram@med.juntendo.ac.jp		cui (Cui), long zhu (Longzhu)/0000-0002-8909-3885				ARTHUR M, 1992, J BACTERIOL, V174, P2582, DOI 10.1128/jb.174.8.2582-2591.1992; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; Fridkin SK, 2003, CLIN INFECT DIS, V36, P429, DOI 10.1086/346207; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; VOSS A, 1994, EUR J CLIN MICROBIOL, V13, P50, DOI 10.1007/BF02026127; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Whitener CJ, 2004, CLIN INFECT DIS, V38, P1049, DOI 10.1086/382357	9	12	12	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					565	566		10.1016/S0140-6736(04)16867-0	http://dx.doi.org/10.1016/S0140-6736(04)16867-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313343				2022-12-28	WOS:000223275100009
J	Deroche-Gamonet, V; Belin, D; Piazza, PV				Deroche-Gamonet, V; Belin, D; Piazza, PV			Evidence for addiction-like behavior in the rat	SCIENCE			English	Article							NUCLEUS-ACCUMBENS CORE; COCAINE-SEEKING; AMPHETAMINE; RELAPSE; PREDICT; VULNERABILITY; MODEL; BRAIN	Although the voluntary intake of drugs of abuse is a behavior largely preserved throughout phylogeny, it is currently unclear whether pathological drug use ("addiction") can be observed in species other than humans. Here, we report that behaviors that resemble three of the essential diagnostic criteria for addiction appear over time in rats trained to self-administer cocaine. As in humans, this addiction-like behavior is present only in a small proportion of subjects using cocaine and is highly predictive of relapse after withdrawal. These findings provide a new basis for developing a true understanding and treatment of addiction.	Univ Victor Segalen Bordeaux 2, Bordeaux Inst Neurosci, Lab Physiopathol Comportements, INSERM U588, F-33077 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Piazza, PV (corresponding author), Univ Victor Segalen Bordeaux 2, Bordeaux Inst Neurosci, Lab Physiopathol Comportements, INSERM U588, Rue Camille St Saens, F-33077 Bordeaux, France.	piazza@bordeaux.inserm.fr	Deroche-Gamonet, Véronique/E-5728-2010; Belin, David/E-1231-2014	Belin, David/0000-0002-7383-372X; Deroche-Gamonet, Veronique/0000-0002-9704-6624				Abramson CI, 2000, ALCOHOL CLIN EXP RES, V24, P1153, DOI 10.1111/j.1530-0277.2000.tb02078.x; *AM PSYCH ASS WASH, 2000, DIAGN STAT MAN MENT; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Crowley TJ, 1998, DRUG ALCOHOL DEPEN, V49, P225, DOI 10.1016/S0376-8716(98)00016-7; DEJONG W, 1994, INT J ADDICT, V29, P681, DOI 10.3109/10826089409047904; DEWIT H, 1986, DRUG ALCOHOL DEPEN, V16, P341, DOI 10.1016/0376-8716(86)90068-2; Enoch Mary-Anne, 2003, Am J Pharmacogenomics, V3, P217, DOI 10.2165/00129785-200303040-00001; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Fergusson DM, 2003, ARCH GEN PSYCHIAT, V60, P1033, DOI 10.1001/archpsyc.60.10.1033; GOLDBERG SR, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1306; Homberg JR, 2002, EUR J NEUROSCI, V15, P1542, DOI 10.1046/j.1460-9568.2002.01976.x; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kusayama T, 2000, NEUROREPORT, V11, P2511, DOI 10.1097/00001756-200008030-00033; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; OBrien Cp E.R., 1986, BEHAV ANAL DRUG DEPE, P329; Piazza PV, 2000, J NEUROSCI, V20, P4226; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; PICKENS R, 1968, PSYCHOPHARMACOLOGIA, V12, P158, DOI 10.1007/BF00401545; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SCHUSTER CR, 1969, ANNU REV PHARMACOLOG, V9, P483, DOI 10.1146/annurev.pa.09.040169.002411; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Spanagel R, 1995, PSYCHOPHARMACOLOGY, V122, P369, DOI 10.1007/BF02246268; WEEKS JR, 1962, SCIENCE, V138, P143, DOI 10.1126/science.138.3537.143; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0	29	791	808	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1014	1017		10.1126/science.1099020	http://dx.doi.org/10.1126/science.1099020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310906				2022-12-28	WOS:000223250700051
J	Stiell, IG; Wells, GA; Field, B; Spaite, DW; Nesbitt, LP; De Maio, VJ; Nichol, G; Cousineau, D; Blackburn, J; Munkley, D; Luinstra-Toohey, L; Campeau, T; Dagnone, E; Lyver, M				Stiell, IG; Wells, GA; Field, B; Spaite, DW; Nesbitt, LP; De Maio, VJ; Nichol, G; Cousineau, D; Blackburn, J; Munkley, D; Luinstra-Toohey, L; Campeau, T; Dagnone, E; Lyver, M		Ontario Prehospital Adv Life Suppo	Advanced cardiac life support in out-of-hospital cardiac arrest.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EMERGENCY MEDICAL-SERVICES; SURVIVAL; OPALS; CARE; RESUSCITATION; TECHNICIANS; PARAMEDICS; VICTIMS; PROGRAM; SYSTEM	Background: The Ontario Prehospital Advanced Life Support (OPALS) Study tested the incremental effect on the rate of survival after out-of-hospital cardiac arrest of adding a program of advanced life support to a program of rapid defibrillation. Methods: This multicenter, controlled clinical trial was conducted in 17 cities before and after advanced-life-support programs were instituted and enrolled 5638 patients who had had cardiac arrest outside the hospital. Of those patients, 1391 were enrolled during the rapid-defibrillation phase and 4247 during the subsequent advanced-life-support phase. Paramedics were trained in standard advanced life support, which includes endotracheal intubation and the administration of intravenous drugs. Results: From the rapid-defibrillation phase to the advanced-life-support phase, the rate of admission to a hospital increased significantly (10.9 percent vs. 14.6 percent, P<0.001), but the rate of survival to hospital discharge did not (5.0 percent vs. 5.1 percent, P=0.83). The multivariate odds ratio for survival after advanced life support was 1.1 (95 percent confidence interval, 0.8 to 1.5); after an arrest witnessed by a bystander, 4.4 (95 percent confidence interval, 3.1 to 6.4); after cardiopulmonary resuscitation administered by a bystander, 3.7 (95 percent confidence interval, 2.5 to 5.4); and after rapid defibrillation, 3.4 (95 percent confidence interval, 1.4 to 8.4). There was no improvement in the rate of survival with the use of advanced life support in any subgroup. Conclusions: The addition of advanced-life-support interventions did not improve the rate of survival after out-of-hospital cardiac arrest in a previously optimized emergency-medical-services system of rapid defibrillation. In order to save lives, health care planners should make cardiopulmonary resuscitation by citizens and rapid-defibrillation responses a priority for the resources of emergency-medical-services systems.	Univ Ottawa, Ottawa Hlth Res Inst, Dept Emergency Med, Ottawa, ON, Canada; Univ Ottawa, Ottawa Hlth Res Inst, Dept Epidemiol & Community Med, Ottawa, ON, Canada; Univ Ottawa, Ottawa Hlth Res Inst, Dept Med, Ottawa, ON, Canada; Univ Ottawa, Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; Interdev Technol, Toronto, ON, Canada; Univ Arizona, Dept Emergency Med, Tucson, AZ USA; Univ N Carolina, Dept Emergency Med, Chapel Hill, NC USA; Greater Niagara Base Hosp, Niagara Falls, ON, Canada; Ontario Minist Hlth & Long Term Care, Emergency Hlth Serv, Toronto, ON, Canada; Queens Univ, Dept Emergency Med, Kingston, ON, Canada; McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Arizona; University of North Carolina; University of North Carolina Chapel Hill; Queens University - Canada; McMaster University	Stiell, IG (corresponding author), Ottawa Hosp, Clin Epidemiol Unit, Ottawa Hlth Res Inst, Off F657, Civ Campus,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	istiell@ohri.ca	Nichol, Graham/Z-4996-2019	Spaite, Daniel/0000-0003-2601-6476; Stiell, Ian/0000-0002-2583-6408				Becker L, 1998, CIRCULATION, V97, P2106, DOI 10.1161/01.CIR.97.21.2106; BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; Boyle, 1998, 9811 MCMAST U CTR HL; CARVETH SW, 1974, ARCH SURG-CHICAGO, V108, P528; Cone DC, 2003, ANN EMERG MED, V42, P251, DOI 10.1067/mem.2003.267; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; De Maio VJ, 2003, ANN EMERG MED, V42, P242, DOI 10.1067/mem.2003.266; DEMAIO VJ, 2003, ACAD EMERG MED, V10, P504; DONOVAN PJ, 1989, ANN EMERG MED, V18, P495, DOI 10.1016/S0196-0644(89)80831-5; EISENBERG M, 1979, AM J PUBLIC HEALTH, V69, P30, DOI 10.2105/AJPH.69.1.30; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; EISENBERG MS, 1979, JAMA-J AM MED ASSOC, V241, P1905, DOI 10.1001/jama.241.18.1905; EISENBERG MS, 1980, JAMA-J AM MED ASSOC, V243, P1049, DOI 10.1001/jama.243.10.1049; Gratton M, 1999, Prehosp Emerg Care, V3, P303, DOI 10.1080/10903129908958958; GULY UM, 1995, BRIT MED J, V310, P1091, DOI 10.1136/bmj.310.6987.1091; KELSEY SF, 1991, CONTROL CLIN TRIALS, V12, P525; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; Mitchell RG, 1997, J ACCID EMERG MED, V14, P274; Nichol G, 1999, ANN EMERG MED, V34, P517, DOI 10.1016/S0196-0644(99)80054-7; Nichol G, 1996, ANN EMERG MED, V27, P700, DOI 10.1016/S0196-0644(96)70187-7; PANTRIDG.JF, 1967, LANCET, V2, P271; PEPE PE, 1994, ANN EMERG MED, V23, P1037, DOI 10.1016/S0196-0644(94)70100-8; Rainer TH, 1997, J ACCID EMERG MED, V14, P278; ROWLEY JM, 1987, BRIT MED J, V295, P1387, DOI 10.1136/bmj.295.6610.1387; Stiell I, 2003, CIRCULATION, V108, P1939, DOI 10.1161/01.CIR.0000095028.95929.B0; Stiell IG, 1998, ANN EMERG MED, V32, P180, DOI 10.1016/S0196-0644(98)70135-0; Stiell IG, 1999, JAMA-J AM MED ASSOC, V281, P1175, DOI 10.1001/jama.281.13.1175; Stiell IG, 1999, ANN EMERG MED, V33, P44, DOI 10.1016/S0196-0644(99)70415-4; VAILLANCOURT C, 2003, ACAD EMERG MED, V10, P466; VERTESI L, 1983, CAN MED ASSOC J, V128, P809; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	33	611	628	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					647	656		10.1056/NEJMoa040325	http://dx.doi.org/10.1056/NEJMoa040325			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306666				2022-12-28	WOS:000223225500007
J	Fichet, G; Comoy, E; Duval, C; Antloga, K; Dehen, C; Charbonnier, A; McDonnell, G; Brown, P; Lasmezas, CI; Deslys, JP				Fichet, G; Comoy, E; Duval, C; Antloga, K; Dehen, C; Charbonnier, A; McDonnell, G; Brown, P; Lasmezas, CI; Deslys, JP			Novel methods for disinfection of prion-contaminated medical devices	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; TISSUE DISTRIBUTION; SCRAPIE AGENT; TRANSMISSION; DECONTAMINATION; INACTIVATION; INFECTIVITY; PROTEIN; HEALTH	Background The unique resistance of prions to classic methods of decontamination, and evidence that prion diseases can be transmitted iatrogenically by medical devices pose a serious infection control challenge to healthcare facilities. In view of the widespread tissue distribution of the variant Creutzfeldt-Jakob disease agent in human beings, new practicable decontamination procedures are urgently needed. Methods We adapted an in-vivo method using stainless steel wires contaminated with prions to the hamster-adapted scrapie strain 263K. A new in-vitro protocol of surface contamination compatible with subsequent biochemical detection of PrPres (protease-resistant form of the prion protein) from the treated surface was developed to explore the mechanisms of action of methods of decontamination under test. These models were used to investigate the effectiveness of innovative physical and chemical methods of prion inactivation. Findings Standard chemical decontamination methods (NaOH IN, NaOCl 20 000 ppm) and autoclaving in water at 134degreesC reduced infectivity by >5.6 log(10) lethal doses; autoclaving without immersion was somewhat less effective (4-4.5 log reduction). Three milder treatments, including a phenolic disinfectant, an alkaline cleaner, and the combination of an enzymatic cleaner and vaporised hydrogen peroxide (VHP) were also effective. VHP alone, which can be compatible with electronic components, achieved an approximately 4.5 log reduction in infectivity (equivalent to autoclaving without water immersion). Interpretation New decontamination procedures are proposed to ensure the safety of medical and surgical instruments as well as surfaces that cannot withstand the currently recommended prion inactivation procedures.	CEA, DSV, DRM, Grp Innovat Diagnost & Therapeut Infect Prions, F-92265 Fontenay Aux Roses, France; Anjou Rech Veolia Water, F-94417 St Maurice, France; Steris, Basingstoke, Hants, England; EFS Nord France, F-59800 Lille, France	CEA; Veolia; Universite de Lille - ISITE; Universite de Lille	Comoy, E (corresponding author), CEA, DSV, DRM, Grp Innovat Diagnost & Therapeut Infect Prions, 18 Route Panorama, F-92265 Fontenay Aux Roses, France.	emmanuel.comoy@cea.fr		Jas, Christelle/0000-0001-6311-6017	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002957] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adjou KT, 1999, J GEN VIROL, V80, P1079, DOI 10.1099/0022-1317-80-4-1079; Antloga K, 2000, ASAIO J, V46, pS69, DOI 10.1097/00002480-200011000-00040; Barret A, 2003, J VIROL, V77, P8462, DOI 10.1128/JVI.77.15.8462-8469.2003; BROWN P, 1982, J INFECT DIS, V145, P683, DOI 10.1093/infdis/145.2.683; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BROWN P, 1984, NEW ENGL J MED, V310, P727; Deslys JP, 2001, NATURE, V409, P476, DOI 10.1038/35054134; ERNST DR, 1993, J VIROL METHODS, V41, P193, DOI 10.1016/0166-0934(93)90126-C; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; GIBBS CJ, 1994, J NEUROL NEUROSUR PS, V57, P757, DOI 10.1136/jnnp.57.6.757; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Kasermann F, 2003, J GEN VIROL, V84, P3173, DOI 10.1099/vir.0.19355-0; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; Krause J, 2001, CONTEMP TOP LAB ANIM, V40, P18; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DC, 2000, J VIROL METHODS, V84, P77, DOI 10.1016/S0166-0934(99)00135-4; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; McDonnell G, 2003, CLIN INFECT DIS, V36, P1152, DOI 10.1086/374668; Race RE, 2004, J VIROL, V78, P2164, DOI 10.1128/JVI.78.4.2164-2165.2004; REED L. J., 1938, AMER JOUR HYG, V27, P493; TAYLOR DM, 1994, ARCH VIROL, V139, P313, DOI 10.1007/BF01310794; Taylor DM, 1998, VET MICROBIOL, V64, P33, DOI 10.1016/S0378-1135(98)00257-0; TAYLOR DM, 1991, VET MICROBIOL, V27, P19, DOI 10.1016/0378-1135(91)90059-O; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; *WHO, 1999, WHOCDSCSRAPH2003; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	27	163	172	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					521	526		10.1016/S0140-6736(04)16810-4	http://dx.doi.org/10.1016/S0140-6736(04)16810-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302195				2022-12-28	WOS:000223132700031
J	Bertrand, G				Bertrand, G			The modest undressing of a silicon center	SCIENCE			English	Editorial Material							MAIN-GROUP ELEMENTS; SILYLIUM ION; CHEMISTRY		Univ Calif Riverside, Dept Chem, UCR CNRS Joint Res Chem Lab, UMR 2282, Riverside, CA 92521 USA	University of California System; University of California Riverside	Bertrand, G (corresponding author), Univ Calif Riverside, Dept Chem, UCR CNRS Joint Res Chem Lab, UMR 2282, Riverside, CA 92521 USA.	gbertran@mail.ucr.edu						Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; DENK M, 1994, J AM CHEM SOC, V116, P2691, DOI 10.1021/ja00085a088; Haaf M, 2000, ACCOUNTS CHEM RES, V33, P704, DOI 10.1021/ar950192g; IGAU A, 1988, J AM CHEM SOC, V110, P6466; Jutzi P, 2004, SCIENCE, V305, P849, DOI 10.1126/science.1099879; Jutzi P, 2003, PURE APPL CHEM, V75, P483, DOI 10.1351/pac200375040483; JUTZI P, 1986, ANGEW CHEM INT EDIT, V25, P164, DOI 10.1002/anie.198601641; Jutzi P, 1999, CHEM REV, V99, P969, DOI 10.1021/cr941099t; Kim KC, 2002, SCIENCE, V297, P825, DOI 10.1126/science.1073540; Kira M, 1999, J AM CHEM SOC, V121, P9722, DOI 10.1021/ja9925305; Kost D, 1998, CHEM FUNCT, V2, P1339, DOI 10.1002/0470857250.ch23; KUTZELNIGG W, 1984, ANGEW CHEM INT EDIT, V23, P272, DOI 10.1002/anie.198402721; Power PP, 1999, CHEM REV, V99, P3463, DOI 10.1021/cr9408989; Reed CA, 1998, ACCOUNTS CHEM RES, V31, P325, DOI 10.1021/ar960132q	14	23	23	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					783	785		10.1126/science.1102270	http://dx.doi.org/10.1126/science.1102270			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297652				2022-12-28	WOS:000223104900026
J	Nettles, JH; Li, HL; Cornett, B; Krahn, JM; Snyder, JP; Downing, KH				Nettles, JH; Li, HL; Cornett, B; Krahn, JM; Snyder, JP; Downing, KH			The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography	SCIENCE			English	Article							CONFORMATION-ACTIVITY RELATIONSHIPS; POLYKETIDE NATURAL-PRODUCTS; COMMON PHARMACOPHORE; BIOLOGICAL-ACTIVITY; BETA-TUBULIN; CHEMICAL-SYNTHESIS; PACLITAXEL; MUTATIONS; TAXOL; STABILITY	The structure of epothilone A, bound to alpha, beta-tubulin in zinc-stabilized sheets, was determined by a combination of electron crystallography at 2.89 angstrom resolution and nuclear magnetic resonance-based conformational analysis. The complex explains both the broad-based epothilone structure-activity relationship and the known mutational resistance pro. le. Comparison with Taxol shows that the longstanding expectation of a common pharmacophore is not met, because each ligand exploits the tubulin-binding pocket in a unique and independent manner.	Emory Univ, Dept Chem, Atlanta, GA 30322 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; NIEHS, Struct Biol Lab, Res Triangle Pk, NC 27709 USA; Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	Emory University; United States Department of Energy (DOE); Brookhaven National Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Snyder, JP (corresponding author), Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA.	snyder@euch4e.chem.emory.edu; khdowning@lbl.gov		Li, Huilin/0000-0001-8085-8928; Nettles, James/0000-0002-5683-8481				BOLLAG DM, 1995, CANCER RES, V55, P2325; Carlomagno T, 2003, ANGEW CHEM INT EDIT, V42, P2511, DOI 10.1002/anie.200351276; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Guastalla JP, 2003, BRIT J CANCER, V89, pS16, DOI 10.1038/sj.bjc.6601496; Hardt IH, 2001, J NAT PROD, V64, P847, DOI 10.1021/np000629f; He LF, 2000, BIOCHEMISTRY-US, V39, P3972, DOI 10.1021/bi992518p; He LF, 2001, MOL CANCER THER, V1, P3; HOFLE G, 1993, CHEM ABSTR 52841, V120; Jimenez-Barbero Jesus, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P91, DOI 10.2174/1568011023354416; Johnson J, 2000, ORG LETT, V2, P1537, DOI 10.1021/ol0058240; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Nagano S, 2003, J BIOL CHEM, V278, P44886, DOI 10.1074/jbc.M308115200; Nicolaou KC, 2000, CHEM BIOL, V7, P593, DOI 10.1016/S1074-5521(00)00006-5; Nicolaou KC, 1998, ANGEW CHEM INT EDIT, V37, P2015, DOI 10.1002/(SICI)1521-3773(19980817)37:15<2014::AID-ANIE2014>3.0.CO;2-2; Nicolaou KC, 2003, ANGEW CHEM INT EDIT, V42, P3515, DOI 10.1002/anie.200351819; Nicolaou KC, 2001, J AM CHEM SOC, V123, P9313, DOI 10.1021/ja011338b; Nicolaou KC, 2001, CHEM COMMUN, P1523, DOI 10.1039/b104949f; Ojima I, 1999, P NATL ACAD SCI USA, V96, P4256, DOI 10.1073/pnas.96.8.4256; Regueiro-Ren A, 2002, ORG LETT, V4, P3815, DOI 10.1021/ol026589j; Regueiro-Ren A, 2001, ORG LETT, V3, P2693, DOI 10.1021/ol016273w; Rivkin A, 2003, J AM CHEM SOC, V125, P2899, DOI 10.1021/ja029695p; Singla AK, 2002, INT J PHARMACEUT, V235, P179, DOI 10.1016/S0378-5173(01)00986-3; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Taylor RE, 2004, ORG BIOMOL CHEM, V2, P127, DOI 10.1039/b312213c; Taylor RE, 2003, J AM CHEM SOC, V125, P26, DOI 10.1021/ja028196l; Verrills NM, 2003, CHEM BIOL, V10, P597, DOI 10.1016/S1074-5521(03)00141-8; Wang MM, 2000, J ORG CHEM, V65, P1059, DOI 10.1021/jo9916075; Wang MM, 1999, ORG LETT, V1, P43, DOI 10.1021/ol990521v; Wartmann M., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P123, DOI 10.2174/1568011023354489	32	359	369	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					866	869		10.1126/science.1099190	http://dx.doi.org/10.1126/science.1099190			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297674				2022-12-28	WOS:000223104900049
J	Scholte, WF; Olff, M; Ventevogel, P; de Vries, GJ; Jansveld, E; Cardozo, BL; Crawford, CAG				Scholte, WF; Olff, M; Ventevogel, P; de Vries, GJ; Jansveld, E; Cardozo, BL; Crawford, CAG			Mental health symptoms following war and repression in eastern Afghanistan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HARVARD TRAUMA QUESTIONNAIRE; POSTCONFLICT SETTINGS; HUMAN-RIGHTS; REFUGEES; CHECKLIST-25; INSTRUMENT; ATTITUDES; TORTURE	Context Decades of armed conflict, suppression, and displacement resulted in a high prevalence of mental health symptoms throughout Afghanistan. Its Eastern province of Nangarhar is part of the region that originated the Taliban movement. This may have had a distinct impact on the living circumstances and mental health condition of the province's population. Objectives To determine the rate of exposure to traumatic events; estimate prevalence rates of symptoms of posttraumatic stress disorder (PTSD), depression, and anxiety; identify resources used for emotional support and risk factors for mental health symptoms; and assess the present coverage of basic needs in Nangarhar province, Afghanistan. Design, Setting, and Participants A cross-sectional multicluster sample survey of 1011 respondents aged 15 years or older, conducted in Nangarhar province during January and March 2003; 362 households were represented with a mean of 2.8 respondents per household (72% participation rate). Main Outcome Measures Posttraumatic stress disorder symptoms and traumatic events using the Harvard Trauma Questionnaire; depression and general anxiety symptoms using the Hopkins Symptom Checklist; and resources for emotional support through a locally informed questionnaire. Results During the past 10 years, 432 respondents (43.7%) experienced between 8 and 10 traumatic events; 141 respondents (14.1%) experienced 11 or more. High rates of symptoms of depression were reported by 391 respondents (38.5%); anxiety, 524 (51.8%); and PTSD, 207 (20.4%). Symptoms were more prevalent in women than in men (depression: odds ratio [OR], 7.3 [95% confidence interval {CI}, 5.4-9.8]; anxiety: OR, 12.8 [95% Cl, 9.0-18.1]; PTSD: OR, 5.8 (95% Cl, 3.8-8.9]). Higher rates of symptoms were associated with higher numbers of traumas experienced. The main resources for emotional support were religion and family. Medical care was reported to be insufficient by 228 respondents (22.6%). Conclusions In this survey of inhabitants of Nangarhar province, Afghanistan, prevalence rates of having experienced multiple traumatic events and having symptoms of anxiety, depression, and PTSD were high. These findings suggest that mental health symptoms in this region should be addressed at the population and primary health care level.	Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 BC Amsterdam, Netherlands; HealthNet Int, Amsterdam, Netherlands; War Child, Amsterdam, Netherlands; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Emergency & Environm Hlth Serv, Int Emergency & Environm Hlth Serv,Int Emergency, Atlanta, GA USA	University of Amsterdam; Academic Medical Center Amsterdam; Centers for Disease Control & Prevention - USA	Scholte, WF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Tafelbergweg 25, NL-1105 BC Amsterdam, Netherlands.	w.f.scholte@amc.uva.nl	Ventevogel, Peter/D-5831-2015; Scholte, Willem/R-1073-2018; Olff, Miranda/S-6235-2019; Scholte, Willem/AAJ-1088-2020	Ventevogel, Peter/0000-0002-3567-8861; de Vries, Giel-Jan/0000-0002-7333-6117	ODCDC CDC HHS [U50/CCU022475] Funding Source: Medline	ODCDC CDC HHS		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Amowitz LL, 2003, J WOMEN HEALTH GEN-B, V12, P577, DOI 10.1089/154099903768248285; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Cardozo BL, 2004, JAMA-J AM MED ASSOC, V292, P575, DOI 10.1001/jama.292.5.575; de Jong JTVM, 2003, LANCET, V361, P2128, DOI 10.1016/S0140-6736(03)13692-6; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Ford N, 2001, LANCET, V358, P1543, DOI 10.1016/S0140-6736(01)06588-6; Gernaat H B P E, 2002, Ned Tijdschr Geneeskd, V146, P1127; HILTON I, 2001, NEW YORKER      1203, P59; Kalafi Y, 2002, PSYCHOL REP, V90, P262, DOI 10.2466/PR0.90.1.262-266; Kleijn WC, 2001, PSYCHOL REP, V88, P527, DOI 10.2466/PR0.88.2.527-532; *MED FRONT, 1999, MENT HLTH ASS GHUR Z; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; Mollica RH, 2001, JAMA-J AM MED ASSOC, V286, P546, DOI 10.1001/jama.286.5.546; Rasekh Z, 1998, JAMA-J AM MED ASSOC, V280, P449, DOI 10.1001/jama.280.5.449; Rashid Ahmed., 2001, TALIBAN STORY AFGHAN; Shrestha NM, 1998, JAMA-J AM MED ASSOC, V280, P443, DOI 10.1001/jama.280.5.443; *UNICEF, 2002, UNICEF EXP PROGR IMM; *UNICEF, 1997, PSYCH ASS CHILDR EXP	22	171	177	0	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2004	292	5					585	593		10.1001/jama.292.5.585	http://dx.doi.org/10.1001/jama.292.5.585			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843AE	15292084	Bronze			2022-12-28	WOS:000223045500016
J	Birks, HJB; Birks, HH				Birks, HJB; Birks, HH			Paleoecology - The rise and fall of forests	SCIENCE			English	Editorial Material									Univ Bergen, Dept Biol, N-5007 Bergen, Norway; Bjerknes Ctr Climate Res, N-5007 Bergen, Norway	University of Bergen; Bjerknes Centre for Climate Research	Birks, HJB (corresponding author), Univ Bergen, Dept Biol, N-5007 Bergen, Norway.	john.birks@bio.uib.no; hilary.birks@bio.uib.no	Birks, John B/C-3103-2008; Birks, Hilary H/C-1859-2008	Birks, John B/0000-0002-5891-9859; 				Aaby B., 1983, DANMARKS GEOLOGISKE, V2, P114; Andersen ST, 1966, PALEOBOTANIST, V15, P117; Andersen ST, 1994, B GEOL SOC DENMARK, V41, P219; Birks H., 1986, HDB HOLOCENE PALAEOE; *BJERKN CTR CLIM R, PUBL BJERKN CTR CL A, V57; IVERSEN J., 1964, J ECOL, V52, P59; Iversen J., 1958, UPPSALA U ARSSKR, V6, P210; Last W.M., 2001, PHYS GEOCHEMICAL MET, V2; Last W. M., 2001, TRACKING ENV CHANGE, V1; Matthews JA., 1992, ECOLOGY RECENTLY DEG; Smol J.P., 2001, TERRESTRIAL ALGAL SI, V3; Smol JP, 2001, TRACKING ENV CHANGE, V4; STOCKMARR J, 1975, PALAEOHISTORIA, V17, P37; van der Hammen T, 1971, LATE CENOZOIC GLACIA, P391; Walker L.R., 2003, PRIMARY SUCCESSION E, DOI 10.1017/cbo9780511615078; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; Willis KJ, 1997, ECOLOGY, V78, P740, DOI 10.1890/0012-9658(1997)078[0740:DSCCVC]2.0.CO;2	17	79	81	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					484	485		10.1126/science.1101357	http://dx.doi.org/10.1126/science.1101357			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273384	Green Accepted			2022-12-28	WOS:000222828900028
J	Repp, J; Meyer, G; Olsson, FE; Persson, M				Repp, J; Meyer, G; Olsson, FE; Persson, M			Controlling the charge state of individual gold adatoms	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPE; DYNAMIC FORCE MICROSCOPY; METAL-SURFACES; FILMS; EXCITATION; RESOLUTION	The nature and control of individual metal atoms on insulators are of great importance in emerging atomic-scale technologies. Individual gold atoms on an ultrathin insulating sodium chloride film supported by a copper surface exhibit two different charge states, which are stabilized by the large ionic polarizability of the film. The charge state and associated physical and chemical properties such as diffusion can be controlled by adding or removing a single electron to or from the adatom with a scanning tunneling microscope tip. The simple physical mechanism behind the charge bistability in this case suggests that this is a common phenomenon for adsorbates on polar insulating films.	IBM Corp, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland; Chalmers Goteborg Univ, Dept Appl Phys, S-41296 Gothenburg, Sweden	International Business Machines (IBM); Chalmers University of Technology	Repp, J (corresponding author), IBM Corp, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland.	jre@zurich.ibm.com	Repp, Jascha/B-1843-2014; Persson, Mats O/A-7514-2011	Repp, Jascha/0000-0003-2883-7083; Persson, Mats O/0000-0002-1443-9490				Bennewitz R, 1999, SURF INTERFACE ANAL, V27, P462, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<462::AID-SIA543>3.0.CO;2-0; Bennewitz R, 1999, SURF SCI, V438, P289, DOI 10.1016/S0039-6028(99)00586-5; EIGLER DM, 1991, NATURE, V352, P600, DOI 10.1038/352600a0; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; GAO SW, 1992, SOLID STATE COMMUN, V84, P271, DOI 10.1016/0038-1098(92)90119-T; Hebenstreit W, 1999, SURF SCI, V424, pL321, DOI 10.1016/S0039-6028(99)00095-3; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Olsson FE, 2003, SURF SCI, V540, P172, DOI 10.1016/S0039-6028(03)00783-0; Olsson FE, 2002, J PHYS CHEM B, V106, P8161, DOI 10.1021/jp0257121; Pauling L., 1939, NATURE CHEM BOND; Repp J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.036803; Repp J, 2001, PHYS REV LETT, V86, P252, DOI 10.1103/PhysRevLett.86.252; SALAM GP, 1994, PHYS REV B, V49, P10655, DOI 10.1103/PhysRevB.49.10655; Sanchez A, 1999, J PHYS CHEM A, V103, P9573, DOI 10.1021/jp9935992; SHEN TC, 1995, SCIENCE, V268, P1590, DOI 10.1126/science.268.5217.1590; SHLUGER AL, 1993, J PHYS-CONDENS MAT, V5, P3049, DOI 10.1088/0953-8984/5/19/007; Stipe BC, 1997, PHYS REV LETT, V78, P4410, DOI 10.1103/PhysRevLett.78.4410; STONEHAM AM, 1985, J PHYS C SOLID STATE, V18, P543; TERSOFF J, 1983, PHYS REV LETT, V50, P1998, DOI 10.1103/PhysRevLett.50.1998	20	350	351	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2004	305	5683					493	495		10.1126/science.1099557	http://dx.doi.org/10.1126/science.1099557			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273388				2022-12-28	WOS:000222828900032
J	Tapley, BD; Bettadpur, S; Ries, JC; Thompson, PF; Watkins, MM				Tapley, BD; Bettadpur, S; Ries, JC; Thompson, PF; Watkins, MM			GRACE measurements of mass variability in the Earth system	SCIENCE			English	Article							SOIL-MOISTURE SIMULATIONS; TIME-VARIABLE GRAVITY; SATELLITE GRAVITY; FIELD; WATER; REDISTRIBUTION; PROJECT; LAGEOS	Monthly gravity field estimates made by the twin Gravity Recovery and Climate Experiment (GRACE) satellites have a geoid height accuracy of 2 to 3 millimeters at a spatial resolution as small as 400 kilometers. The annual cycle in the geoid variations, up to 10 millimeters in some regions, peaked predominantly in the spring and fall seasons. Geoid variations observed over South America that can be largely attributed to surface water and groundwater changes show a clear separation between the large Amazon watershed and the smaller watersheds to the north. Such observations will help hydrologists to connect processes at traditional length scales ( tens of kilometers or less) to those at regional and global scales.	Univ Texas, Ctr Space Res, Austin, TX 78712 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91125 USA	University of Texas System; University of Texas Austin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Ries, JC (corresponding author), Univ Texas, Ctr Space Res, Austin, TX 78712 USA.	ries@csr.utexas.edu	Bettadpur, Srinivas/M-3744-2014; Jiang, Wei/ABC-8398-2020	Tapley, Byron/0000-0003-3689-5750; Bettadpur, Srinivas/0000-0003-3885-2228				Alsdorf DE, 2003, SCIENCE, V301, P1491, DOI 10.1126/science.1089802; Cazenave A, 1999, EARTH PLANET SC LETT, V171, P549, DOI 10.1016/S0012-821X(99)00172-7; CHAO BF, 1995, GEOPHYS J INT, V122, P755, DOI 10.1111/j.1365-246X.1995.tb06834.x; CHAO BF, 1991, J GEOPHYS RES-SOLID, V96, P6569, DOI 10.1029/91JB00042; Cheng MK, 1999, J GEOPHYS RES-SOL EA, V104, P2667, DOI 10.1029/1998JB900036; Entekhabi D, 1996, J HYDROL, V184, P3, DOI 10.1016/0022-1694(95)02965-6; Entin JK, 1999, J METEOROL SOC JPN, V77, P183, DOI 10.2151/jmsj1965.77.1B_183; GRUBER T, 2003, 30 IERS, P157; Jayne SR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001619; Jekeli C., 1981, ALTERNATIVE METHODS; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kim J, 2002, J GUID CONTROL DYNAM, V25, P1100, DOI 10.2514/2.4989; *NAT RES COUNC, 1997, SAT GRAV GEOSPH; Nerem RS, 2000, GEOPHYS RES LETT, V27, P1783, DOI 10.1029/1999GL008440; Roads J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002583; Robock A, 1998, GLOBAL PLANET CHANGE, V19, P181, DOI 10.1016/S0921-8181(98)00047-2; Rodell M, 1999, WATER RESOUR RES, V35, P2705, DOI 10.1029/1999WR900141; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Swenson S, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000576; Tapley BD, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019920; TAPLEY BD, 2001, EOS T AGU S, V82, pG41; Thompson PF, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019285; Velicogna I, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001735; Wahr JM, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001274; Wu XP, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000543; YODER CF, 1983, NATURE, V303, P757, DOI 10.1038/303757a0	26	1568	1666	15	307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2004	305	5683					503	505		10.1126/science.1099192	http://dx.doi.org/10.1126/science.1099192			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273390				2022-12-28	WOS:000222828900035
J	Pauwels, RA; Rabe, KF				Pauwels, RA; Rabe, KF			Burden and clinical features of chronic obstructive pulmonary disease (COPD)	LANCET			English	Review							AIR-FLOW OBSTRUCTION; DYNAMIC HYPERINFLATION; GLOBAL BURDEN; LUNG-FUNCTION; EXPOSURE; HEALTH; DISABILITY; SMOKING; DYSPNEA; ASTHMA	Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and mortality and represents a substantial economic and social burden throughout the world. It is the fifth leading cause of death worldwide and further increases in its prevalence and mortality are expected in the coming decades. The substantial morbidity associated with COPD is often underestimated by health-care providers and patients; likewise, COPD is frequently underdiagnosed and undertreated. COPD develops earlier in life than is usually believed. Tobacco smoking is by far the major risk for COPD and the prevalence of the disease in different countries is related to rates of smoking and time of introduction of cigarette smoking. Contribution of occupational risk factors is quite small, but may vary depending on a country's level of economic development. Severe deficiency for alpha-l-antitrypsin is rare and the impact of other genetic factors on the prevalence of COPD has not been established. COPD should be considered in any patient presenting with cough, sputum production, or dyspnoea, especially if an exposure to risk factors for the disease has been present. Clinical diagnosis needs to be confirmed by standardised. spirometric tests in the presence of not-fully-reversible airflow limitation. COPD is generally a progressive disease. Continued exposure to noxious agents promotes a more rapid decline in lung function and increases the risk for repeated exacerbations. Smoking cessation is the only intervention shown to slow the decline. If exposure is stopped, the disease may still progress due to the decline in lung function that normally occurs with aging, and some persistence of the inflammatory response.	Ghent Univ Hosp, Dept Resp Dis, B-9000 Ghent, Belgium; Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands	Ghent University; Ghent University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Pauwels, RA (corresponding author), Ghent Univ Hosp, Dept Resp Dis, B-9000 Ghent, Belgium.	romain.pauwels@ugent.be	Rabe, Klaus F./AAW-6296-2021	Rabe, Klaus F./0000-0002-7020-1401				Amoli K, 1998, EUR RESPIR J, V11, P659; [Anonymous], 1965, LANCET, V1, P775; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; Antonelli-Incalzi R, 2003, EUR RESPIR J, V22, P444, DOI 10.1183/09031936.03.00101203; BADGETT RG, 1993, AM J MED, V94, P188, DOI 10.1016/0002-9343(93)90182-O; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; BURROWS B, 1965, AM REV RESPIR DIS, V91, P665; CALVERLEY PMA, 1982, AM REV RESPIR DIS, V125, P507, DOI 10.1164/arrd.1982.125.5.507; CALVERLEY PMA, 1998, CHRONIC OBSTRUCTIVE; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chen X, 1999, OPT EXPRESS, V5, P93, DOI 10.1364/OE.5.000093; Churg A, 2003, ENVIRON HEALTH PERSP, V111, P714, DOI 10.1289/ehp.6042; Coultas DB, 1998, THORAX, V53, P381, DOI 10.1136/thx.53.5.381; de Marco R, 2004, THORAX, V59, P120, DOI 10.1136/thorax.2003.011163; ELLIOTT MW, 1991, AM REV RESPIR DIS, V144, P826, DOI 10.1164/ajrccm/144.4.826; ERIKSSON S, 1965, ACTA MED SCAND, VS177, P5; Fabbri LM, 2003, AM J RESP CRIT CARE, V167, P418, DOI 10.1164/rccm.200203-183OC; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; GEORGOPOULOS D, 1991, CHRONIC OBSTRUCTIVE, P357; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Jacobson L, 2000, RESP MED, V94, P247, DOI 10.1053/rmed.1999.0733; JOHNSTON RN, 1960, BRIT MED J, V1, P592, DOI 10.1136/bmj.1.5173.592; Jones PW, 2001, THORAX, V56, P880, DOI 10.1136/thorax.56.11.880; KAUFFMANN F, 1982, BRIT J IND MED, V39, P221; KELLY CA, 1988, THORAX, V43, P335, DOI 10.1136/thx.43.4.335; KESTEN S, 1993, CHEST, V104, P254, DOI 10.1378/chest.104.1.254; LAL S, 1964, BRIT MED J, V1, P814, DOI 10.1136/bmj.1.5386.814; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; LOVERIDGE B, 1986, AM REV RESPIR DIS, V134, P930, DOI 10.1164/arrd.1986.134.5.930; Lundback B, 2003, RESP MED, V97, P115, DOI 10.1053/rmed.2003.1446; Marin JM, 2001, AM J RESP CRIT CARE, V163, P1395, DOI 10.1164/ajrccm.163.6.2003172; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; National Health Service Executive, 1996, BURD DIS DISC DOC; National Heart Lung and Blood Institute, 1998, MORB MORT CHARTB CAR; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; PANDEY MR, 1984, THORAX, V39, P337, DOI 10.1136/thx.39.5.337; Pena VS, 2000, CHEST, V118, P981, DOI 10.1378/chest.118.4.981; PerezPadilla R, 1996, AM J RESP CRIT CARE, V154, P701, DOI 10.1164/ajrccm.154.3.8810608; Peruzza S, 2003, RESP MED, V97, P612, DOI 10.1053/rmed.2003.1488; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Russi EW, 2002, SWISS MED WKLY, V132, P557; Rutgers SR, 2000, THORAX, V55, P12, DOI 10.1136/thorax.55.1.12; Sandford AJ, 2002, THORAX, V57, P736, DOI 10.1136/thorax.57.8.736; SCHOLS AMWJ, 1993, AM REV RESPIR DIS, V147, P1151, DOI 10.1164/ajrccm/147.5.1151; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; SIMON PM, 1990, AM REV RESPIR DIS, V142, P1009, DOI 10.1164/ajrccm/142.5.1009; SINGH GK, 1994, MONTHLY VITAL STAT R, V14; Smith KR, 2000, P NATL ACAD SCI USA, V97, P13286, DOI 10.1073/pnas.97.24.13286; Stoller JK, 1997, CHEST, V111, pS123, DOI 10.1378/chest.111.6_Supplement.123S; Strassels SA, 2001, CHEST, V119, P344, DOI 10.1378/chest.119.2.344; Swanney MP, 2000, AM J RESP CRIT CARE, V162, P917, DOI 10.1164/ajrccm.162.3.9907115; Vestbo J, 1996, AM J RESP CRIT CARE, V153, P1530, DOI 10.1164/ajrccm.153.5.8630597; Vestbo J, 2002, AM J RESP CRIT CARE, V166, P329, DOI 10.1164/rccm.2112048; Vogelzang PFJ, 1998, AM J RESP CRIT CARE, V157, P15, DOI 10.1164/ajrccm.157.1.9703087; World Health Organization, WORLD HLTH REP 2002	62	694	725	0	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2004	364	9434					613	620		10.1016/S0140-6736(04)16855-4	http://dx.doi.org/10.1016/S0140-6736(04)16855-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313363				2022-12-28	WOS:000223275100035
J	Tang, SM; Wolf, R; Xu, SP; Heisenberg, M				Tang, SM; Wolf, R; Xu, SP; Heisenberg, M			Visual pattern recognition in Drosophila is invariant for retinal position	SCIENCE			English	Article							FLIGHT ORIENTATION; FINE-STRUCTURE; YAW TORQUE; HONEYBEES; TEMPLATE; BEHAVIOR; VISION; MEMORY	Vision relies on constancy mechanisms. Yet, these are little understood, because they are difficult to investigate in freely moving organisms. One such mechanism, translation invariance, enables organisms to recognize visual patterns independent of the region of their visual field where they had originally seen them. Tethered flies ( Drosophila melanogaster) in a flight simulator can recognize visual patterns. Because their eyes are fixed in space and patterns can be displayed in defined parts of their visual field, they can be tested for translation invariance. Here, we show that flies recognize patterns at retinal positions where the patterns had not been presented before.	Acad Sinica, Inst Biophys, Beijing 100101, Peoples R China; Univ Wurzburg, Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Wurzburg	Tang, SM (corresponding author), Acad Sinica, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	tang-shm@sohu.com; heisenberg@biozentrum.uni-wuerzburg.de						[Anonymous], 1988, EYE BRAIN VISION; BAUSENWEIN B, 1986, J NEUROGENET, V3, P87, DOI 10.3109/01677068609106897; BUCHNER E, 1971, THESIS U TUBINGEN; DILL M, 1995, LEARN MEMORY, V2, P152, DOI 10.1101/lm.2.3-4.152; DILL M, 1995, PHILOS T ROY SOC B, V349, P143, DOI 10.1098/rstb.1995.0100; DILL M, 1993, NATURE, V365, P751, DOI 10.1038/365751a0; DILL M, 1992, THESIS U WURZBURG; Efler D, 2000, VISION RES, V40, P3391, DOI 10.1016/S0042-6989(00)00189-9; Ernst R, 1999, VISION RES, V39, P3920, DOI 10.1016/S0042-6989(99)00114-5; Heisenberg M, 2001, LEARN MEMORY, V8, P1, DOI 10.1101/lm.8.1.1; HEISENBERG M, 1979, J COMP PHYSIOL, V130, P113, DOI 10.1007/BF00611046; HEISENBERG M, 1995, CURR OPIN NEUROBIOL, V5, P475, DOI 10.1016/0959-4388(95)80008-5; Heisenberg M., 1984, STUDIES BRAIN FUNCTI, V12; HENGSTENBERG R, 1971, KYBERNETIK, V9, P56, DOI 10.1007/BF00270852; Horridge GA, 1998, J INSECT PHYSIOL, V44, P343, DOI 10.1016/S0022-1910(97)00116-9; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; SCHUSTER S, 1996, THESIS U TUBINGEN; SRINIVASAN MV, 1993, NATURE, V362, P539, DOI 10.1038/362539a0; SRINIVASAN MV, 1994, PHILOS T R SOC B, V343, P199, DOI 10.1098/rstb.1994.0021; TANG SJ, UNPUB, P95311; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; VANHATEREN JH, 1990, J COMP PHYSIOL A, V167, P649, DOI 10.1007/BF00192658; WEHNER R, 1985, NATURE, V315, P228, DOI 10.1038/315228a0; WEHNER R, 1967, NATURE, V215, P1244, DOI 10.1038/2151244a0; WEHNER R, 1966, Z VERGL PHYSIOL, V52, P290, DOI 10.1007/BF02427714; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; WOLF R, 1991, J COMP PHYSIOL A, V169, P699	28	68	68	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1020	1022		10.1126/science.1099839	http://dx.doi.org/10.1126/science.1099839			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310908				2022-12-28	WOS:000223250700053
J	Vanderschuren, LJMJ; Everitt, BJ				Vanderschuren, LJMJ; Everitt, BJ			Drug seeking becomes compulsive after prolonged cocaine self-administration	SCIENCE			English	Article							ADDICTION; BEHAVIOR; SUPPRESSION; STIMULI; CORTEX; ABUSE; RATS	Compulsive drug use in the face of adverse consequences is a hallmark feature of addiction, yet there is little preclinical evidence demonstrating the actual progression from casual to compulsive drug use. Presentation of an aversive conditioned stimulus suppressed drug seeking in rats with limited cocaine self-administration experience, but no longer did so after an extended cocaine-taking history. In contrast, after equivalent extended sucrose experience, sucrose seeking was still suppressed by an aversive conditioned stimulus. Persistent cocaine seeking in the presence of signals of environmental adversity after a prolonged cocaine-taking history was not due to impaired fear conditioning, nor to an increase in the incentive value of cocaine, and may reflect the establishment of compulsive behavior.	Univ Utrecht, Med Ctr, Dept Pharmacol & Anat, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	Utrecht University; Utrecht University Medical Center; University of Cambridge	Vanderschuren, LJMJ (corresponding author), Univ Utrecht, Med Ctr, Dept Pharmacol & Anat, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands.	l.j.m.j.vanderschuren@med.uu.nl	Vanderschuren, Louk/AAS-4391-2020	Everitt, Barry/0000-0003-4431-6536; Vanderschuren, Louk/0000-0002-5379-0363	MRC [G9537855] Funding Source: UKRI; Medical Research Council [G9537855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; *AM PSYCH ASS WASH, 1994, DIAGN STAT MAN MENT; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BOUTON ME, 1980, ANIM LEARN BEHAV, V8, P429, DOI 10.3758/BF03199629; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kalivas PW, 2003, PSYCHOPHARMACOLOGY, V168, P44, DOI 10.1007/s00213-003-1393-2; Kearns DN, 2002, DRUG ALCOHOL DEPEN, V65, P253, DOI 10.1016/S0376-8716(01)00167-3; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; LEDOUX JE, 1984, J NEUROSCI, V4, P683; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; OBrien CP, 1996, LANCET, V347, P237, DOI 10.1016/S0140-6736(96)90409-2; Olmstead MC, 2000, PSYCHOPHARMACOLOGY, V152, P123, DOI 10.1007/s002130000498; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rogers RD, 2001, CURR OPIN NEUROBIOL, V11, P250, DOI 10.1016/S0959-4388(00)00204-X; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	21	524	537	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					1017	1019		10.1126/science.1098975	http://dx.doi.org/10.1126/science.1098975			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310907				2022-12-28	WOS:000223250700052
J	Morley, M; Molony, CM; Weber, TM; Devlin, JL; Ewens, KG; Spielman, RS; Cheung, VG				Morley, M; Molony, CM; Weber, TM; Devlin, JL; Ewens, KG; Spielman, RS; Cheung, VG			Genetic analysis of genome-wide variation in human gene expression	NATURE			English	Article							QUANTITATIVE TRAIT; LINKAGE; DISSECTION; MAP	Natural variation in gene expression is extensive in humans and other organisms, and variation in the baseline expression level of many genes has a heritable component. To localize the genetic determinants of these quantitative traits ( expression phenotypes) in humans, we used microarrays to measure gene expression levels and performed genome-wide linkage analysis for expression levels of 3,554 genes in 14 large families. For approximately 1,000 expression phenotypes, there was significant evidence of linkage to specific chromosomal regions. Both cis- and trans-acting loci regulate variation in the expression levels of genes, although most act in trans. Many gene expression phenotypes are influenced by several genetic determinants. Furthermore, we found hotspots of transcriptional regulation where significant evidence of linkage for several expression phenotypes ( up to 31) coincides, and expression levels of many genes that share the same regulatory region are significantly correlated. The combination of microarray techniques for phenotyping and linkage analysis for quantitative traits allows the genetic mapping of determinants that contribute to variation in human gene expression.	Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Spielman, RS (corresponding author), Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA.	spielman@pobox.upenn.edu; vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081930] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM081930-08, R01 GM081930] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Cheung VG, 2003, COLD SPRING HARB SYM, V68, P403, DOI 10.1101/sqb.2003.68.403; Cheung VG, 2002, NAT GENET, V32, P522, DOI 10.1038/ng1036; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; McKenzie CA, 2001, HUM MOL GENET, V10, P1077, DOI 10.1093/hmg/10.10.1077; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Shete S, 2003, HUM HERED, V55, P79, DOI 10.1159/000072312; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; *STAT SOL LTD, 2003, SAGE STAT AN GEN EP; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	22	908	958	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					743	747		10.1038/nature02797	http://dx.doi.org/10.1038/nature02797			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15269782	Green Accepted			2022-12-28	WOS:000223233600032
J	Percec, V; Dulcey, AE; Balagurusamy, VSK; Miura, Y; Smidrkal, J; Peterca, M; Nummelin, S; Edlund, U; Hudson, SD; Heiney, PA; Hu, DA; Magonov, SN; Vinogradov, SA				Percec, V; Dulcey, AE; Balagurusamy, VSK; Miura, Y; Smidrkal, J; Peterca, M; Nummelin, S; Edlund, U; Hudson, SD; Heiney, PA; Hu, DA; Magonov, SN; Vinogradov, SA			Self-assembly of amphiphilic dendritic dipeptides into helical pores	NATURE			English	Article							DENDRIMERS; CONDUCTION; POLYMERS; CHANNEL; SHAPE	Natural pore-forming proteins act as viral helical coats(1) and transmembrane channels(2-4), exhibit antibacterial activity(5) and are used in synthetic systems, such as for reversible encapsulation(6) or stochastic sensing(7). These diverse functions are intimately linked to protein structure(1-4). The close link between protein structure and protein function makes the design of synthetic mimics a formidable challenge, given that structure formation needs to be carefully controlled on all hierarchy levels, in solution and in the bulk. In fact, with few exceptions(8,9), synthetic pore structures capable of assembling into periodically ordered assemblies that are stable in solution and in the solid state(10-13) have not yet been realized. In the case of dendrimers, covalent(14) and non- covalent(15) coating and assembly of a range of different structures(15-17) has only yielded closed columns(18). Here we describe a library of amphiphilic dendritic dipeptides that self-assemble in solution and in bulk through a complex recognition process into helical pores. We find that the molecular recognition and self-assembly process is sufficiently robust to tolerate a range of modifications to the amphiphile structure, while preliminary proton transport measurements establish that the pores are functional. We expect that this class of self-assembling dendrimers will allow the design of a variety of biologically inspired systems with functional properties arising from their porous structure.	Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA; Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA; Digital Instruments, Veeco Metrol Grp, Santa Barbara, CA 93110 USA; Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; National Institute of Standards & Technology (NIST) - USA; University of Pennsylvania	Percec, V (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA.	percec@sas.upenn.edu	Nummelin, Sami/P-4185-2019; Peterca, Mihai/C-9504-2009; Nummelin, Sami J/O-5741-2015; Hudson, Steven/W-3211-2019; Hudson, Steven/AAB-2909-2019; Miura, Yoshiko/AAD-1166-2020; Percec, Virgil/H-6316-2014	Nummelin, Sami/0000-0003-2195-4818; Peterca, Mihai/0000-0002-7247-4008; Nummelin, Sami J/0000-0003-2195-4818; Hudson, Steven/0000-0002-3203-4833; Miura, Yoshiko/0000-0001-8590-6079; Percec, Virgil/0000-0001-5926-0489; /0000-0002-1631-1781; Balagurusamy, Venkat/0000-0002-1994-2634				Balagurusamy VSK, 1997, J AM CHEM SOC, V119, P1539, DOI 10.1021/ja963295i; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.0.CO;2-N; Brunsveld L, 2000, J AM CHEM SOC, V122, P6175, DOI 10.1021/ja0005237; CHAN HS, 1995, PHILOS T R SOC B, V348, P61, DOI 10.1098/rstb.1995.0046; Cornelissen JJLM, 2001, SCIENCE, V293, P676, DOI 10.1126/science.1062224; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emrick T, 1999, CURR OPIN COLLOID IN, V4, P15, DOI 10.1016/S1359-0294(99)00008-4; Engelkamp H, 1999, SCIENCE, V284, P785, DOI 10.1126/science.284.5415.785; Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601; Finikova O, 2003, J AM CHEM SOC, V125, P4882, DOI 10.1021/ja0341687; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; GHADIRI MR, 1994, NATURE, V369, P301, DOI 10.1038/369301a0; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Hudson SD, 1997, SCIENCE, V278, P449, DOI 10.1126/science.278.5337.449; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Ishii D, 2003, NATURE, V423, P628, DOI 10.1038/nature01663; KLUG A, 1983, ANGEW CHEM INT EDIT, V22, P565, DOI 10.1002/anie.198305653; LEHN JM, 1995, SUPRAMOL CHEM, P118; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nelson JC, 1997, SCIENCE, V277, P1793, DOI 10.1126/science.277.5333.1793; Percec V, 1998, NATURE, V391, P161, DOI 10.1038/34384; Percec V, 2002, CHEM-EUR J, V8, P2011, DOI 10.1002/1521-3765(20020503)8:9<2011::AID-CHEM2011>3.0.CO;2-3; Percec V, 2001, J AM CHEM SOC, V123, P1302, DOI 10.1021/ja0037771; Percec V, 2002, NATURE, V419, P384, DOI 10.1038/nature01072; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Sakai N, 2003, CHEM COMMUN, P2514, DOI 10.1039/b303649a; Schmitt JL, 2003, HELV CHIM ACTA, V86, P1598, DOI 10.1002/hlca.200390137; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218	30	537	545	4	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					764	768		10.1038/nature02770	http://dx.doi.org/10.1038/nature02770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306805				2022-12-28	WOS:000223233600037
J	Bell, JF; Squyres, SW; Arvidson, RE; Arneson, HM; Bass, D; Blaney, D; Cabrol, N; Calvin, W; Farmer, J; Farrand, WH; Goetz, W; Golombek, M; Grant, JA; Greeley, R; Guinness, E; Hayes, AG; Hubbard, MYH; Herkenhoff, KE; Johnson, MJ; Johnson, JR; Joseph, J; Kinch, KM; Lemmon, MT; Li, R; Madsen, MB; Maki, JN; Malin, M; McCartney, E; McLennan, S; McSween, HY; Ming, DW; Moersch, JE; Morris, RV; Dobrea, EZN; Parker, TJ; Proton, J; Rice, JW; Seelos, F; Soderblom, J; Soderblom, LA; Sohl-Dickstein, JN; Sullivan, RJ; Wolff, MJ; Wang, A				Bell, JF; Squyres, SW; Arvidson, RE; Arneson, HM; Bass, D; Blaney, D; Cabrol, N; Calvin, W; Farmer, J; Farrand, WH; Goetz, W; Golombek, M; Grant, JA; Greeley, R; Guinness, E; Hayes, AG; Hubbard, MYH; Herkenhoff, KE; Johnson, MJ; Johnson, JR; Joseph, J; Kinch, KM; Lemmon, MT; Li, R; Madsen, MB; Maki, JN; Malin, M; McCartney, E; McLennan, S; McSween, HY; Ming, DW; Moersch, JE; Morris, RV; Dobrea, EZN; Parker, TJ; Proton, J; Rice, JW; Seelos, F; Soderblom, J; Soderblom, LA; Sohl-Dickstein, JN; Sullivan, RJ; Wolff, MJ; Wang, A			Pancam multispectral imaging results from the Spirit Rover at Gusev crater	SCIENCE			English	Article							PATHFINDER LANDING SITE; MARS; REFLECTANCE; MINERALOGY; ROCKS; DUST; MOSSBAUER; ABUNDANCE; SOILS	Panoramic Camera images at Gusev crater reveal a rock-strewn surface interspersed with high-to moderate-albedo fine-grained deposits occurring in part as drifts or in small circular swales or hollows. Optically thick coatings of fine-grained ferric iron-rich dust dominate most bright soil and rock surfaces. Spectra of some darker rock surfaces and rock regions exposed by brushing or grinding show near-infrared spectral signatures consistent with the presence of mafic silicates such as pyroxene or olivine. Atmospheric observations show a steady decline in dust opacity during the mission, and astronomical observations captured solar transits by the martian moons, Phobos and Deimos, as well as a view of Earth from the martian surface.	Cornell Univ, Ithaca, NY 14853 USA; Washington Univ, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Ames Res Ctr, Search Extraterr Intelligence Inst, Moffett Field, CA 94035 USA; Univ Nevada, Reno, NV 89501 USA; Arizona State Univ, Tempe, AZ 85287 USA; Space Sci Inst, Boulder, CO 80301 USA; Univ Copenhagen, DK-2100 Copenhagen O, Denmark; Smithsonian Inst, Natl Air & Space Museum, Washington, DC 20560 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Aarhus Univ, DK-8000 Aarhus C, Denmark; Texas A&M Univ, College Stn, TX 77843 USA; Ohio State Univ, Columbus, OH 43210 USA; Malin Space Sci Syst Inc, San Diego, CA 92191 USA; SUNY Stony Brook, Stony Brook, NY 11794 USA; Univ Tennessee, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Cornell University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Nevada System of Higher Education (NSHE); University of Nevada Reno; Arizona State University; Arizona State University-Tempe; University of Copenhagen; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; Aarhus University; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Bell, JF (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	jfb8@cornell.edu	Kinch, Kjartan Bergeron/C-5742-2015; Lemmon, Mark T/E-9983-2010; Farmer, Jack D/B-9343-2019; Madsen, Morten Bo/D-2082-2011; Moersch, Jeffrey E/F-7189-2010; Hayes, Alexander G/P-2024-2014; Seelos, Frank/C-7875-2016; Lemmon, Mark/X-2333-2019; Johnson, Jeffrey R/F-3972-2015	Kinch, Kjartan Bergeron/0000-0002-4629-8880; Lemmon, Mark T/0000-0002-4504-5136; Madsen, Morten Bo/0000-0001-8909-5111; Moersch, Jeffrey E/0000-0003-3433-9419; Hayes, Alexander G/0000-0001-6397-2630; Seelos, Frank/0000-0001-9721-941X; Lemmon, Mark/0000-0002-4504-5136; Johnson, Jeffrey R/0000-0002-5586-4901; Wang, Aimei/0000-0002-6575-4028; McLennan, Scott/0000-0003-4259-7178; Soderblom, Jason/0000-0003-3715-6407				ADAMS JB, 1974, J GEOPHYS RES, V79, P4829, DOI 10.1029/JB079i032p04829; Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; BELL J, 2004, 8298 IAU; BELL JA, UNPUB; Bell JF, 1997, J GEOPHYS RES-PLANET, V102, P9109, DOI 10.1029/96JE03990; Bell JF, 2000, J GEOPHYS RES-PLANET, V105, P1721, DOI 10.1029/1999JE001060; Bell JF, 2002, ICARUS, V158, P56, DOI 10.1006/icar.2002.6865; BELL JF, 2003, J GEOPHYS RES-PLANET, V108, DOI DOI 10.1029/2003JE002070; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Cabrol NA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002026; CLOUTIS EA, 1986, J GEOPHYS RES-SOLID, V91, P1641, DOI 10.1029/JB091iB11p11641; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002035; GOLOMBEK MP, 2004, LUNAR PLANET SCI, V35; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Hapke B., 1993, THEORY REFLECTANCE E; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Johnson JR, 2003, ICARUS, V163, P330, DOI 10.1016/S0019-1035(03)00084-8; Johnson JR, 1999, J GEOPHYS RES-PLANET, V104, P8809, DOI 10.1029/98JE02247; KLINGELHOFER G, 2004, LUNAR PLANET SCI, V35, P2184; LEMMON M, UNPUB; LEMMON MT, COMMUNICATION; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; Maki JN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002077; MCCORD TB, 1982, J GEOPHYS RES, V87, P3021, DOI 10.1029/JB087iB04p03021; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; McSween HY, 1999, J GEOPHYS RES-PLANET, V104, P8679, DOI 10.1029/98JE02551; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 1989, J GEOPHYS RES-SOLID, V94, P2760, DOI 10.1029/JB094iB03p02760; OckertBell ME, 1997, J GEOPHYS RES-PLANET, V102, P9039, DOI 10.1029/96JE03991; Selsis F, 2004, ASTRON ASTROPHYS, V416, P783, DOI 10.1051/0004-6361:20031724; Wolff MJ, 1999, J GEOPHYS RES-PLANET, V104, P9027, DOI 10.1029/98JE01967; WOLFF MJ, 2004, P LUN PLAN SCI 35	34	130	132	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					800	806		10.1126/science.1100175	http://dx.doi.org/10.1126/science.1100175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297658				2022-12-28	WOS:000223104900032
J	Hatsugai, N; Kuroyanagi, M; Yamada, K; Meshi, T; Tsuda, S; Kondo, M; Nishimura, M; Hara-Nishimura, I				Hatsugai, N; Kuroyanagi, M; Yamada, K; Meshi, T; Tsuda, S; Kondo, M; Nishimura, M; Hara-Nishimura, I			A plant vacuolar protease, VPE, mediates virus-induced hypersensitive cell death	SCIENCE			English	Article							PROCESSING ENZYME; PATHOGEN INTERACTIONS; STORAGE VACUOLES; LYTIC VACUOLES; APOPTOSIS; ENDOPEPTIDASE; PROTEINASE; PRECURSOR; CASPASES; REMOVAL	Programmed cell death (PCD) in animals depends on caspase protease activity. Plants also exhibit PCD, for example as a response to pathogens, although a plant caspase remains elusive. Here we show that vacuolar processing enzyme (VPE) is a protease essential for a virus-induced hypersensitive response that involves PCD. VPE deficiency prevented virus-induced hypersensitive cell death in tobacco plants. VPE is structurally unrelated to caspases, although VPE has a caspase-1 activity. Thus, plants have evolved a regulated cellular suicide strategy that, unlike PCD of animals, is mediated by VPE and the cellular vacuole.	Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; Natl Agr Res Ctr, Tsukuba, Ibaraki 3058602, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan	Hara-Nishimura, I (corresponding author), Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan.	ihnishi@gr.bot.kyoto-u.ac.jp	Yamada, Kenji/C-4336-2018; Hatsugai, Noriyuki/O-9156-2015	Yamada, Kenji/0000-0003-4872-3729; Hatsugai, Noriyuki/0000-0002-5708-4263; Kuroyanagi, Miwa/0000-0003-4362-8415; Nishimura, Mikio/0000-0001-7960-9721				Angell SM, 1999, PLANT J, V20, P357, DOI 10.1046/j.1365-313X.1999.t01-1-00597.x; BECKER C, 1995, EUR J BIOCHEM, V228, P456, DOI 10.1111/j.1432-1033.1995.tb20284.x; Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Goodman R.N., 1994, HYPERSENSITIVE REACT; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Greenberg JT, 1997, ANNU REV PLANT PHYS, V48, P525, DOI 10.1146/annurev.arplant.48.1.525; Hara-Nishimura I, 1998, J PLANT PHYSIOL, V152, P668, DOI 10.1016/S0176-1617(98)80028-X; Hara-Nishimura I, 1998, HDB PROTEOLYTIC ENZY, P746; HARANISHIMURA I, 1991, FEBS LETT, V294, P89, DOI 10.1016/0014-5793(91)81349-D; HARANISHIMURA I, 1993, PLANT CELL, V5, P1651, DOI 10.1105/tpc.5.11.1651; HARANISHIMURA I, 2000, VACUOLAR COMPARTMENT, P20; HATSUGAI N, UNPUB; Hiraiwa N, 1999, FEBS LETT, V447, P213, DOI 10.1016/S0014-5793(99)00286-0; Hoeberichts FA, 2003, PLANTA, V217, P517, DOI 10.1007/s00425-003-1049-9; Jones AM, 2001, PLANT PHYSIOL, V125, P94, DOI 10.1104/pp.125.1.94; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Kuroyanagi M, 2002, PLANT CELL PHYSIOL, V43, P143, DOI 10.1093/pcp/pcf035; Lam E, 2000, PLANT MOL BIOL, V44, P417, DOI 10.1023/A:1026509012695; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Mitsuhashi N, 2001, PLANT CELL, V13, P2361; Mittler R, 1997, J CELL SCI, V110, P1333; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Woltering EJ, 2002, PLANT PHYSIOL, V130, P1764, DOI 10.1104/pp.006338; Yamada K, 1999, J BIOL CHEM, V274, P2563, DOI 10.1074/jbc.274.4.2563	28	466	511	3	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					855	858		10.1126/science.1099859	http://dx.doi.org/10.1126/science.1099859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297671				2022-12-28	WOS:000223104900046
J	Carter, R				Carter, R			Ombudsman's eighth report	LANCET			English	Editorial Material							CONFLICTS-OF-INTEREST; LANCETS POLICY		The Lancet, London NW1 7BY, England		Carter, R (corresponding author), The Lancet, London NW1 7BY, England.							Horton R, 1996, LANCET, V348, P6, DOI 10.1016/S0140-6736(05)64352-8; James A, 2004, LANCET, V363, P2, DOI 10.1016/S0140-6736(03)15229-4; James A, 2003, LANCET, V361, P8, DOI 10.1016/S0140-6736(03)12184-8; McNamee D, 2001, LANCET, V357, P1819, DOI 10.1016/S0140-6736(00)05011-X; Sperschneider T, 2003, LANCET, V361, P1926, DOI 10.1016/S0140-6736(03)13602-1	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					402	402		10.1016/S0140-6736(04)16785-8	http://dx.doi.org/10.1016/S0140-6736(04)16785-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288725				2022-12-28	WOS:000222998600011
J	Horton, R				Horton, R			Why is Ian Kennedy's Healthcare Commission damaging NHS care?	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					401	402		10.1016/S0140-6736(04)16784-6	http://dx.doi.org/10.1016/S0140-6736(04)16784-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288724				2022-12-28	WOS:000222998600010
J	Chung, RT; Andersen, J; Volberding, P; Robbins, GK; Liu, T; Sherman, KE; Peters, MG; Koziel, MJ; Bhan, AK; Alston, B; Colquhoun, D; Nevin, T; Harb, G; van der Horst, C				Chung, RT; Andersen, J; Volberding, P; Robbins, GK; Liu, T; Sherman, KE; Peters, MG; Koziel, MJ; Bhan, AK; Alston, B; Colquhoun, D; Nevin, T; Harb, G; van der Horst, C		AIDS Clinical Trials Grp A5071 Stu	Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LIVER-DISEASE; COMBINATION THERAPY; INFECTION; REPLICATION; ANTAGONIZES; MORTALITY; EFFICACY; SAFETY; TRIAL	BACKGROUND: Chronic hepatitis C virus (HCV) infection is a cause of major complications in persons who are also infected with the human immunodeficiency virus (HIV). However, the treatment of HCV infection in such persons has been associated with a high rate of intolerance and a low rate of response. We conducted a multicenter, randomized trial comparing peginterferon plus ribavirin with interferon plus ribavirin for the treatment of chronic hepatitis C in persons coinfected with HIV. METHODS: A total of 66 subjects were randomly assigned to receive 180 microg of peginterferon alfa-2a weekly for 48 weeks, and 67 subjects were assigned to receive 6 million IU of interferon alfa-2a three times weekly for 12 weeks followed by 3 million IU three times weekly for 36 weeks. Both groups received ribavirin according to a dose-escalation schedule. At week 24, subjects who did not have a virologic response (those who had an HCV RNA level greater than or equal to 60 IU per milliliter) underwent liver biopsy, and medications were continued in subjects with either a virologic response or histologic improvement. RESULTS: Treatment with peginterferon and ribavirin was associated with a significantly higher rate of sustained virologic response (an HCV RNA level of less than 60 IU per milliliter 24 weeks after completion of therapy) than was treatment with interferon and ribavirin (27 percent vs. 12 percent, P=0.03). In the group given peginterferon and ribavirin, only 14 percent of subjects with HCV genotype 1 infection had a sustained virologic response (7 of 51), as compared with 73 percent of subjects with an HCV genotype other than 1 (11 of 15, P<0.001). Histologic responses were observed in 35 percent of subjects with no virologic response who underwent liver biopsy. CONCLUSIONS: In persons infected with HIV, the combination of peginterferon and ribavirin is superior to the combination of interferon and ribavirin in the treatment of chronic hepatitis C. These regimens may provide clinical benefit even in the absence of virologic clearance. The marked discrepancy in the rates of sustained virologic response between HCV genotypes indicates that strategies are needed to improve the outcome in persons infected with HCV genotype 1.	Massachusetts Gen Hosp, Gastrointestinal Unit, GRJ 825, Boston, MA 02114 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Cincinnati, Cincinnati, OH USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; NIAID, Bethesda, MD 20892 USA; Frontier Sci Technol & Res Fdn, Amherst, NY USA; Social & Sci Syst, Rockville, MD USA; Roche Labs, Nutley, NJ USA; Univ N Carolina, Chapel Hill, NC USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; University System of Ohio; University of Cincinnati; Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Frontier Science Foundation; Social & Scientific Systems; Roche Holding; University of North Carolina; University of North Carolina Chapel Hill	Chung, RT (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, GRJ 825, Boston, MA 02114 USA.	rtchung@partners.org	Robbins, Gregory/F-7988-2011	Robbins, Gregory/0000-0001-7545-5817	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096, M01RR000044, M01RR000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027675, U01AI069502, U01AI027661, U01AI025897, U01AI046370, P30AI027763, U01AI025868, UM1AI068636, U01AI046376, U01AI027659, U01AI027670, P30AI050410] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00096, RR00044, M01 RR000096, RR00046, M01 RR000046, M01 RR000044] Funding Source: Medline; NIAID NIH HHS [U01 AI027670, U01 AI025897, AI27661, AI25897, U01 AI046376, AI27670, U01 AI046370, AI046376, U01 AI027675, P30 AI027763, AI27659, U01 AI027659, AI50410, UM1 AI068636, P30 AI050410, U01 AI025868, P30-AI27763D, AI25868, AI27675, U01 AI027661, AI46370, U01 AI069502] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABA M, 1987, ANTIMICROB AGENTS CH, V31, P1613, DOI 10.1128/AAC.31.10.1613; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Chung RT, 2002, AIDS, V16, P1915, DOI 10.1097/00002030-200209270-00008; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Lafeuillade A, 2001, LANCET, V357, P280, DOI 10.1016/S0140-6736(00)03618-7; Landau A, 2000, AIDS, V14, P839, DOI 10.1097/00002030-200005050-00010; Lesens O, 1999, J INFECT DIS, V179, P1254, DOI 10.1086/314720; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; *NAT I ALL INF DIS, 1992, DIV AIDS TABL GRAD S; Shiffman ML, 1999, GASTROENTEROLOGY, V117, P1164, DOI 10.1016/S0016-5085(99)70402-6; VOGT MW, 1987, SCIENCE, V235, P1376, DOI 10.1126/science.2435003; Zylberberg H, 2000, GUT, V47, P694, DOI 10.1136/gut.47.5.694	15	697	733	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					451	459		10.1056/NEJMoa032653	http://dx.doi.org/10.1056/NEJMoa032653			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282352	Green Published, Green Accepted			2022-12-28	WOS:000222939700008
J	Gravett, MG; Novy, MJ; Rosenfeld, RG; Reddy, AP; Jacob, T; Turner, M; McCormack, A; Lapidus, JA; Hitti, J; Eschenbach, DA; Roberts, CT; Nagalla, SR				Gravett, MG; Novy, MJ; Rosenfeld, RG; Reddy, AP; Jacob, T; Turner, M; McCormack, A; Lapidus, JA; Hitti, J; Eschenbach, DA; Roberts, CT; Nagalla, SR			Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYMERASE-CHAIN-REACTION; AMNIOTIC-FLUID INFECTION; SELDI-TOF MS; INTRAUTERINE INFECTION; PRETERM DELIVERY; FETAL; CHORIOAMNIONITIS; ANTIBIOTICS; PROTEINS; INFANTS	Context Intra-amniotic infection (IAI) is commonly associated with preterm birth and adverse neonatal sequelae. Early diagnosis of IAI, however, has been hindered by insensitive or nonspecific tests. Objective To identify unique protein signatures in rhesus monkeys with experimental IAI, a proteomics-based analysis of amniotic fluid was used to develop diagnostic biomarkers for subclinical IN in amniotic fluid and blood of women with preterm labor. Design, Setting, and Participants Surface-enhanced laser desorption-ionization/time-of-flight mass spectrometry, gel electrophoresis, and tandem mass spectrometry were used to characterize amniotic fluid peptides in 19 chronically instrumented pregnant rhesus monkeys before and after experimental IAI. Candidate biomarkers were determined by liquid chromatography-tandem mass spectrometry. Polyclonal antibodies were generated from synthetic peptides for validation of biomarkers of IAI Amniotic fluid peptide profiles identified in experimental IN were subsequently tested in a cohort of 33 women admitted to Seattle, Wash, hospitals between June 25, 1991, and June 30, 1997, with preterm delivery at 35 weeks or earlier associated with subclinical IAI (n=11), preterm delivery at 35 weeks or earlier without IN (n = 11), and preterm contractions with subsequent term delivery at later than 35 weeks (n=11). Main Outcome Measures Identification of peptide biomarkers for occult IAI. Results Protein expression profiles in amniotic fluid showed unique signatures of overexpression of polypeptides in the 3- to 5-kDa and 10- to 12-kDa molecular weight ranges in all animals after infection and in no animal prior to infection. In women, the 10- to 12-kDa signature was identified in all 11 patients with subclinical IAI, in 2 of 11 with preterm delivery without IAI, and in 0 of 11 with preterm labor and term delivery without infection (P<.001). Peptide fragment analysis of the diagnostic peak in amniotic fluid identified calgranulin B and a unique fragment of insulinlike growth factor binding protein 1, which were also expressed in maternal serum. Mapping of other amniotic fluid proteins differentially expressed in IAI identified several immunoregulators not previously described in amniotic fluid. Conclusions This proteomics-based characterization of the differential expression of amniotic fluid proteins in IAI identified a distinct proteomic profile in an experimental primate chorioamnionitis model that detected subclinical IN in a human cohort with preterm labor. These diagnostic protein expression signatures, complemented by immunodetection of specific biomarkers in amniotic fluid and in maternal serum, might have application in the early detection of IAI.	Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; Oregon Natl Primate Res Ctr, Div Reprod Sci, Beaverton, OR USA; Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Div Biostat Publ Hlth & Prevent Med, Portland, OR 97201 USA; ProteoGenix Inc, Portland, OR USA; Lucile Packard Fdn Childrens Hlth, Palo Alto, CA USA; Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle	Gravett, MG (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	gravettm@oshu.edu	Roberts, Charles/K-6953-2017	Roberts, Charles/0000-0003-1756-5772	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD006159, R37HD006159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042490] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00163] Funding Source: Medline; NIAID NIH HHS [AI42490] Funding Source: Medline; NICHD NIH HHS [HD06159] Funding Source: Medline; NIDDK NIH HHS [1U24DK5870] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGERBERTH B, 1995, P NATL ACAD SCI USA, V92, P195, DOI 10.1073/pnas.92.1.195; BEJAR R, 1988, AM J OBSTET GYNECOL, V159, P357, DOI 10.1016/S0002-9378(88)80084-X; Courchesne PL, 1999, METH MOL B, V112, P487; DABIRI GA, 1992, J BIOL CHEM, V267, P16545; Gibbs RS, 1997, AM J OBSTET GYNECOL, V177, P375, DOI 10.1016/S0002-9378(97)70201-1; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gravett M, 2003, AM J OBSTET GYNECOL, V189, pS56, DOI 10.1016/j.ajog.2003.10.002; GRAVETT MG, 1994, AM J OBSTET GYNECOL, V171, P1660, DOI 10.1016/0002-9378(94)90418-9; Gravett MG, 2000, AM J OBSTET GYNECOL, V182, P1404, DOI 10.1067/mob.2000.106180; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; HILLIER SL, 1991, AM J OBSTET GYNECOL, V165, P955, DOI 10.1016/0002-9378(91)90447-Y; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Hills FA, 1996, EARLY HUM DEV, V44, P71, DOI 10.1016/0378-3782(95)01694-5; Hitti J, 1997, CLIN INFECT DIS, V24, P1228, DOI 10.1086/513669; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Issaq HJ, 2003, ANAL CHEM, V75, p148A, DOI 10.1021/ac031249c; MAILE L, 1999, IGF SYSTEM; Markenson GR, 1997, AM J OBSTET GYNECOL, V177, P1471, DOI 10.1016/S0002-9378(97)70093-0; Marvin L, 2000, RAPID COMMUN MASS SP, V14, P1287, DOI 10.1002/1097-0231(20000730)14:14<1287::AID-RCM27>3.0.CO;2-2; MIYASAKI KT, 1993, J DENT RES, V72, P517, DOI 10.1177/00220345930720020801; NEWTON ER, 1993, CLIN OBSTET GYNECOL, V36, P795, DOI 10.1097/00003081-199312000-00004; NOVY MJ, 1995, CLIN OBSTET GYNECOL, V38, P790, DOI 10.1097/00003081-199538040-00013; NOVY MJ, 2001, J SOC GYNECOL INVE S, V8, pA48; Page NM, 2002, REPRODUCTION, V123, P487, DOI 10.1530/reprod/123.4.487; PEREIRA HA, 1995, J LEUKOCYTE BIOL, V57, P805, DOI 10.1002/jlb.57.6.805; Prakobphol A, 2000, J BIOL CHEM, V275, P39860, DOI 10.1074/jbc.M006928200; ROMERO R, 1991, ANN NY ACAD SCI, V622, P355; SADOWSKY DW, 2002, J SOC GYNECOL INVEST, V9, pA206; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; Ventura S J, 2001, Natl Vital Stat Rep, V49, P1; WATTS DH, 1992, OBSTET GYNECOL, V79, P351; Yates Jr, 1999, METH MOL B, V112, P553; Yoon BH, 1998, AM J OBSTET GYNECOL, V179, P1254, DOI 10.1016/S0002-9378(98)70142-5	35	221	235	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2004	292	4					462	469		10.1001/jama.292.4.462	http://dx.doi.org/10.1001/jama.292.4.462			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841AA	15280344	Bronze			2022-12-28	WOS:000222900500023
J	Neufeld, V; Yusuf, S				Neufeld, V; Yusuf, S			The McMaster-Lancet health and peace conferences	LANCET			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Neufeld, V (corresponding author), 70 Chedoke Ave, Hamilton, ON L8P 4N9, Canada.	neufeld@mcmaster.ca		Yusuf, Salim/0000-0003-4776-5601				MacQueen G, 2001, LANCET, V357, P1460, DOI 10.1016/S0140-6736(00)04668-7; *MCM CTR PEAC STUD, AFGH PEAC ED PROGR; World Health Organization, HLTH BRIDG PEAC	3	7	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 24	2004	364	9431					311	312		10.1016/S0140-6736(04)16738-X	http://dx.doi.org/10.1016/S0140-6736(04)16738-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840IZ	15276372				2022-12-28	WOS:000222853300007
J	Rogers, ME; Ilg, T; Nikolaev, AV; Ferguson, MAJ; Bates, PA				Rogers, ME; Ilg, T; Nikolaev, AV; Ferguson, MAJ; Bates, PA			Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG	NATURE			English	Article							ACID-PHOSPHATASE; INFECTIVE STAGE; MEXICANA; LIPOPHOSPHOGLYCAN; PHOSPHOGLYCAN; PROMASTIGOTES; VECTOR; PROTEOPHOSPHOGLYCANS; MACROPHAGES; SALIVA	Sand flies are the exclusive vectors of the protozoan parasite Leishmania(1), but the mechanism of transmission by fly bite has not been determined nor incorporated into experimental models of infection. In sand flies with mature Leishmania infections the anterior midgut is blocked by a gel of parasite origin, the promastigote secretory gel(2,3). Here we analyse the inocula from Leishmania mexicana-infected Lutzomyia longipalpis sand flies. Analysis revealed the size of the infectious dose, the underlying mechanism of parasite delivery by regurgitation, and the novel contribution made to infection by filamentous proteophosphoglycan (fPPG), a component of promastigote secretory gel found to accompany the parasites during transmission. Collectively these results have important implications for understanding the relationship between the parasite and its vector, the pathology of cutaneous leishmaniasis in humans and also the development of effective vaccines and drugs. These findings emphasize that to fully understand transmission of vector-borne diseases the interaction between the parasite, its vector and the mammalian host must be considered together.	Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Max Planck Inst Biol, Abt Membranbiochem, D-72076 Tubingen, Germany; Univ Dundee, Wellcome Trust Bioctr, Sch Life Sci, Div Biol Chem & Mol Microbiol, Dundee DD1 5EH, Scotland	Liverpool School of Tropical Medicine; University of Liverpool; Max Planck Society; University of Dundee	Bates, PA (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	pbates@liv.ac.uk	Ferguson, Michael A. J./F-7829-2010	Ferguson, Michael A. J./0000-0003-1321-8714; Bates, Paul/0000-0001-6861-5421	Wellcome Trust [064945] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BATES PA, 1993, EXP PARASITOL, V76, P412, DOI 10.1006/expr.1993.1050; BATES PA, 1990, MOL BIOCHEM PARASIT, V39, P247, DOI 10.1016/0166-6851(90)90063-R; BEACH R, 1985, AM J TROP MED HYG, V34, P278, DOI 10.4269/ajtmh.1985.34.278; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Castro-Sousa F, 2001, MEM I OSWALDO CRUZ, V96, P997, DOI 10.1590/S0074-02762001000700019; Gopfert U, 1999, BIOCHEM J, V344, P787, DOI 10.1042/0264-6021:3440787; HERTIG M, 1963, EXP PARASITOL, V14, P92, DOI 10.1016/0014-4894(63)90014-6; Ilg T, 2000, PARASITOL TODAY, V16, P489, DOI 10.1016/S0169-4758(00)01791-9; ILG T, 1993, EUR J BIOCHEM, V217, P603, DOI 10.1111/j.1432-1033.1993.tb18283.x; Ilg T, 1996, J BIOL CHEM, V271, P21583, DOI 10.1074/jbc.271.35.21583; Ilg T, 2001, J BIOL CHEM, V276, P4988, DOI 10.1074/jbc.M008030200; Ilg T, 2000, EMBO J, V19, P1953, DOI 10.1093/emboj/19.9.1953; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; NIKOLAEV AV, 1995, CARBOHYD RES, V272, P179, DOI 10.1016/0008-6215(95)00067-4; PIMENTA PFP, 1992, SCIENCE, V256, P1812, DOI 10.1126/science.1615326; Rogers ME, 2002, PARASITOLOGY, V124, P495, DOI 10.1017/S0031182002001439; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Sacks DL, 2000, P NATL ACAD SCI USA, V97, P406, DOI 10.1073/pnas.97.1.406; SARAIVA EMB, 1995, PARASITOLOGY, V111, P275, DOI 10.1017/S003118200008183X; SCHLEIN Y, 1992, P NATL ACAD SCI USA, V89, P9944, DOI 10.1073/pnas.89.20.9944; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Spath GF, 2003, SCIENCE, V301, P1241, DOI 10.1126/science.1087499; Stierhof YD, 1999, EUR J CELL BIOL, V78, P675, DOI 10.1016/S0171-9335(99)80036-3; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; *UNDP WORLD BANK W, 2004, LEISHM; WARBURG A, 1986, AM J TROP MED HYG, V35, P926, DOI 10.4269/ajtmh.1986.35.926; WIESE M, 1995, EMBO J, V14, P1067, DOI 10.1002/j.1460-2075.1995.tb07089.x	28	189	199	1	35	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					463	467		10.1038/nature02675	http://dx.doi.org/10.1038/nature02675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269771	Green Accepted			2022-12-28	WOS:000222801400046
J	Vignal, C; Mathevon, N; Mottin, S				Vignal, C; Mathevon, N; Mottin, S			Audience drives male songbird response to partner's voice	NATURE			English	Article							TAENIOPYGIA-GUTTATA; SOCIAL-BEHAVIOR; RECOGNITION; CONTEXT; BUDGERIGARS; COURTSHIP; CHICKEN; CALLS; SEAL	According to the social intelligence hypothesis, social context represents an important force driving the selection of animal cognitive abilities such as the capacity to estimate the nature of the social relationships between other individuals(1-4). Despite this importance, the influence of this force has been assessed only in primates and never in other animals showing social interactions(5-7). In this way, avian communication generally takes place in a network of signallers and receivers, which represents an audience altering individual signalling behaviours(8,9). Indeed, vocal amplitude(10) and repertoire(11) are known to be socially regulated and the attitude towards the opposite sex may change depending on the audience(8,12,13). This 'audience effect'(8,14-16) provides support for the reality of social awareness in some bird species. However no evidence has yet been found to suggest that birds are able to estimate the characteristics of the social relationships between group-mates. Here we show that the male of a gregarious songbird species-the zebra finch (Taeniopygia guttata)-pays attention to the mating status of conspecific pairs, and uses this information to control its behaviour towards its female partner.	Univ Paris 11 Orsay, CNRS, UMR 8620, NAMC,Equipe Commun Acoust, F-42023 St Etienne 2, France; Univ St Etienne, CNRS, UMR 5516, TSI, F-42023 St Etienne 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Jean Monnet	Mathevon, N (corresponding author), Univ Paris 11 Orsay, CNRS, UMR 8620, NAMC,Equipe Commun Acoust, F-42023 St Etienne 2, France.	mathevon@univ-st-etienne.fr	MOTTIN, Stéphane/F-6850-2011	MOTTIN, Stéphane/0000-0002-7088-4353; Mathevon, Nicolas/0000-0003-0219-6601				Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; AUBIN T, 1994, BIOACOUSTICS, V6, P80; Baltz AP, 1997, ANIM BEHAV, V53, P1017, DOI 10.1006/anbe.1996.0354; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Butler A.B., 2005, COMP VERTEBRATE NEUR, DOI DOI 10.1017/CBO9780511525636.010; Byrne R., 1988, MACHIAVELLIAN INTELL; Charrier I, 2001, NATURE, V412, P873, DOI 10.1038/35091136; Cynx J, 2004, ANIM BEHAV, V67, P451, DOI 10.1016/j.anbehav.2003.04.008; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; EVANS CS, 1994, ANIM BEHAV, V47, P1159, DOI 10.1006/anbe.1994.1154; Evans CS, 1999, ANIM BEHAV, V58, P307, DOI 10.1006/anbe.1999.1143; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Insley SJ, 2000, NATURE, V406, P404, DOI 10.1038/35019064; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Johnstone RA, 2001, P NATL ACAD SCI USA, V98, P9177, DOI 10.1073/pnas.161058798; JOLLY A, 1966, SCIENCE, V153, P501, DOI 10.1126/science.153.3735.501; MARLER P, 1986, ANIM BEHAV, V34, P194, DOI 10.1016/0003-3472(86)90023-0; McGregor Peter K., 2000, P329; MILLER DB, 1979, ANIM BEHAV, V27, P376, DOI 10.1016/0003-3472(79)90172-6; Perry S, 2004, ANIM BEHAV, V67, P165, DOI 10.1016/j.anbehav.2003.04.005; ROBISSON P, 1993, ETHOLOGY, V94, P279; Sokal RR, 1995, BIOMETRY, P57; Striedter GF, 2003, ANIM BEHAV, V65, P875, DOI 10.1006/anbe.2003.2135; Tomasello M, 1997, PRIMATE COGNITION; [No title captured]	25	148	151	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					448	451		10.1038/nature02645	http://dx.doi.org/10.1038/nature02645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269767	Green Submitted			2022-12-28	WOS:000222801400041
J	Welschen, I; Kuyvenhoven, MM; Hoes, AW; Verheij, TJM				Welschen, I; Kuyvenhoven, MM; Hoes, AW; Verheij, TJM			Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; SORE THROAT; INFECTIONS; MANAGEMENT; STRATEGIES; RESISTANCE; GUIDELINES	Objectives To assess the effectiveness of a multiple intervention aimed at reducing antibiotic prescription rates for symptoms of the respiratory tract in primary care. Design Randomised controlled trial. Subjects Twelve peer review groups including 100 general practitioners with their collaborating pharmacists in the region of Utrecht, Netherlands. Intervention The intervention consisted of group education meetings, with a consensus procedure on indication for and type of antibiotics and with training in communication skills; monitoring and feedback on prescribing behaviour; group education for assistants of general practitioners and pharmacists; and educational material for patients. The control group did not receive any of these elements. Main outcome measures Antibiotic prescription rates for acute symptoms of the respiratory tract and patients' satisfaction. Results 89 general practitioners completed the study (89%). At baseline, prescription rates for antibiotics for respiratory tract symptoms did not differ between intervention and control group (27% v 29%, respectively). After nine months, the prescription rates in the intervention group fell to 23%, whereas the control group's rose to 37% (mean difference in change - 12%, 95% confidence interval - 18.9% to - 4.0%). Multilevel analysis confirmed the results of the unadjusted analysis (intervention effect - 10.7%, - 20.3% to - 1.0%). Patients' satisfaction was high and did not differ in the two groups at baseline or after the intervention. Conclusions A multiple intervention reduced prescribing rates of antibiotics for respiratory tract symptoms while maintaining a high degree of satisfaction among patients. Further research should focus on the sustainability and cost effectiveness of this intervention.	Univ Med Ctr utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Welschen, I (corresponding author), Univ Med Ctr utrecht, Julius Ctr Hlth Sci & Primary Care, POB 85060, NL-3508 AB Utrecht, Netherlands.	i.welschen@med.uu.nl						Appelman CLM, 1990, HUISARTS WET, V33, P242; ARNOLD SR, 2003, COCHRANE LIB; ARROLL B, 2000, COCHRANE DB SYST REV, V2; Arroll B., 2000, COCHRANE DB SYST REV; BECKER L, 2000, COCHRANE DB SYST REV, V2; Becker Y, 2002, VIRUS GENES, V24, P5, DOI 10.1023/A:1014021617345; Belongia EA, 1998, BRIT MED J, V317, P668, DOI 10.1136/bmj.317.7159.668; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; COENEN S, LANCET, V358, P1272; Dagnelie C, 1999, HUISARTS WET, V42, P271; Davey P, 2002, CLIN MICROBIOL INFEC, V8, P43, DOI 10.1046/j.1469-0691.8.s.2.6.x; de Bock GH, 1993, HUISARTS WET, V36, P255; de Melker R A, 1998, Ned Tijdschr Geneeskd, V142, P452; DELMAR CB, 2000, COCHRANE DATABASE SY; DEMELKER RA, 1994, J FAM PRACTICE, V38, P353; DEMEYERE M, 2001, INTERVENTIONS COMMUN, P38; Flottorp S, 2002, BMJ-BRIT MED J, V325, P367, DOI 10.1136/bmj.325.7360.367; GLASZIOU PP, 2003, COCHRANE DATABASE SY, DOI UNSP CD000243; Goldstein H., 1987, MULTILEVEL MODELS ED; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; Gross P., 2001, MED CARE S2, V39, P1155; Hox J. J., 1994, APPL MULTILEVEL ANAL; Kuyvenhoven MM, 2003, J ANTIMICROB CHEMOTH, V52, P675, DOI 10.1093/jac/dkg412; Lamberts H., 1987, ICPC INT CLASSIFICAT; Little P, 1997, BRIT MED J, V315, P350; Mainous AG, 1998, ARCH FAM MED, V7, P45, DOI 10.1001/archfami.7.1.45; Sanders S, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000219.PUB2; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; van Houwelingen J C, 1998, Ned Tijdschr Geneeskd, V142, P1662; Verheij T. J. M., 2003, HUISARTS WET, V46, P496; Wensing M, 1994, Int J Qual Health Care, V6, P115; *WHO COLL CTR DRUG, AN THER CHEM ATC CLA; Williams Jr JW, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000243; Zwar N, 1999, FAM PRACT, V16, P495, DOI 10.1093/fampra/16.5.495	35	120	121	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 21	2004	329	7463					431	433		10.1136/bmj.38182.591238.EB	http://dx.doi.org/10.1136/bmj.38182.591238.EB			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849EA	15297305	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000223520300019
J	Semenov, V; Dyadechkin, S; Punsly, B				Semenov, V; Dyadechkin, S; Punsly, B			Simulations of jets driven by black hole rotation	SCIENCE			English	Article							MAGNETOHYDRODYNAMIC SIMULATIONS; MAGNETICALLY DRIVEN; RADIO; ENERGY; FIELD; MODEL	The origin of jets emitted from black holes is not well understood; however, there are two possible energy sources: the accretion disk or the rotating black hole. Magnetohydrodynamic simulations show a well-defined jet that extracts energy from a black hole. If plasma near the black hole is threaded by large-scale magnetic flux, it will rotate with respect to asymptotic infinity, creating large magnetic stresses. These stresses are released as a relativistic jet at the expense of black hole rotational energy. The physics of the jet initiation in the simulations is described by the theory of black hole gravitohydromagnetics.	Boeing Space & Intelligence Syst, Boeing Electron Dynam Devices, Torrance, CA 90509 USA; St Petersburg State Univ, Inst Phys, St Petersburg 198504, Russia; Univ Roma La Sapienza, Int Ctr Relat Astrophys, I-00185 Rome, Italy	Boeing; Saint Petersburg State University; Sapienza University Rome	Punsly, B (corresponding author), Boeing Space & Intelligence Syst, Boeing Electron Dynam Devices, 3100 W Lomita Blvd,POB 2999, Torrance, CA 90509 USA.	brian.m.punsly@boeing.com	Semenov, Vladimir S/A-5530-2013	Semenov, Vladimir S/0000-0001-6592-056X				BARDEEN JM, 1970, NATURE, V226, P64, DOI 10.1038/226064a0; BEGELMAN MC, 1984, REV MOD PHYS, V56, P255, DOI 10.1103/RevModPhys.56.255; BENFORD G, 1978, MON NOT R ASTRON SOC, V183, P29, DOI 10.1093/mnras/183.1.29; Blundell KM, 2000, ASTRON J, V119, P1111, DOI 10.1086/301254; Casse F, 2004, ASTROPHYS J, V601, P90, DOI 10.1086/380441; Christensson M, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.063001; Eikenberry SS, 1998, ASTROPHYS J, V494, pL61, DOI 10.1086/311158; HARDEE PE, 1996, CYGNUS STUDY RADIO G, P113; HENRI G, 1991, ASTROPHYS J, V383, pL7, DOI 10.1086/186228; Hirose S, 2004, ASTROPHYS J, V606, P1083, DOI 10.1086/383184; Igumenshchev IV, 2003, ASTROPHYS J, V592, P1042, DOI 10.1086/375769; Jones TJ, 2000, ASTRON J, V120, P2920, DOI 10.1086/316880; Katz JI, 1997, ASTROPHYS J, V490, P633, DOI 10.1086/304896; Kellermann KI, 2004, ASTROPHYS J, V609, P539, DOI 10.1086/421289; Koide S, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.104010; Koide S, 2004, ASTROPHYS J, V606, pL45, DOI 10.1086/420976; Koide S, 2002, SCIENCE, V295, P1688, DOI 10.1126/science.1068240; Komissarov SS, 2004, MON NOT R ASTRON SOC, V350, P1431, DOI 10.1111/j.1365-2966.2004.07738.x; Lovelace RVE, 2003, ASTROPHYS J, V596, pL159, DOI 10.1086/379622; MacDonald D. A., 1986, BLACK HOLES MEMBRANE, P121; MCKINNEY J, IN PRESS ASTROPHYS J; Narayan R, 2003, PUBL ASTRON SOC JPN, V55, pL69, DOI 10.1093/pasj/55.6.L69; NEKTARIOS V, 2004, ASTROPHYS J, V605, P656; Punsly B, 1999, ASTROPHYS J, V527, P609, DOI 10.1086/308095; Punsly B., 2001, ASTR AST LI; REES MJ, 1982, NATURE, V295, P17, DOI 10.1038/295017a0; Semenov VS, 2002, PHYS SCRIPTA, V65, P13, DOI 10.1238/Physica.Regular.065a00013; Zheng W, 1997, ASTROPHYS J, V475, P469, DOI 10.1086/303560	28	67	67	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					978	980		10.1126/science.1100638	http://dx.doi.org/10.1126/science.1100638			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310894				2022-12-28	WOS:000223250700039
J	Grant, JA; Arvidson, R; Bell, JF; Cabrol, NA; Carr, MH; Christensen, P; Crumpler, L; Des Marais, DJ; Ehlmann, BL; Farmer, J; Golombek, M; Grant, FD; Greeley, R; Herkenhoff, K; Li, R; McSween, HY; Ming, DW; Moersch, J; Rice, JW; Ruff, S; Richter, L; Squyres, S; Sullivan, R; Weitz, C				Grant, JA; Arvidson, R; Bell, JF; Cabrol, NA; Carr, MH; Christensen, P; Crumpler, L; Des Marais, DJ; Ehlmann, BL; Farmer, J; Golombek, M; Grant, FD; Greeley, R; Herkenhoff, K; Li, R; McSween, HY; Ming, DW; Moersch, J; Rice, JW; Ruff, S; Richter, L; Squyres, S; Sullivan, R; Weitz, C			Surficial deposits at Gusev crater along Spirit Rover traverses	SCIENCE			English	Article							SIZE-FREQUENCY DISTRIBUTIONS; MAADIM-VALLIS; LANDING SITES; MARS; ROCKS; EROSION	The Mars Exploration Rover Spirit has traversed a fairly flat, rock-strewn terrain whose surface is shaped primarily by impact events, although some of the landscape has been altered by eolian processes. Impacts ejected basaltic rocks that probably were part of locally formed lava flows from at least 10 meters depth. Some rocks have been textured and/or partially buried by windblown sediments less than 2 millimeters in diameter that concentrate within shallow, partially filled, circular impact depressions referred to as hollows. The terrain traversed during the 90-sol (martian solar day) nominal mission shows no evidence for an ancient lake in Gusev crater.	Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; NASA, Ames Res Ctr, SETI Inst, Div Space Sci, Moffett Field, CA 94035 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; DLR, Inst Space Simulat, D-51170 Cologne, Germany; NASA Headquarters, Washington, DC 20560 USA	Smithsonian Institution; Washington University (WUSTL); Cornell University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; University System of Ohio; Ohio State University; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA)	Grant, JA (corresponding author), Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA.	grantj@nasm.si.edu	Moersch, Jeffrey E/F-7189-2010; Farmer, Jack D/B-9343-2019	Moersch, Jeffrey E/0000-0003-3433-9419; 				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Cabrol NA, 1996, ICARUS, V123, P269, DOI 10.1006/icar.1996.0157; Cabrol NA, 1998, ICARUS, V132, P362, DOI 10.1006/icar.1998.5903; Cabrol NA, 1998, ICARUS, V133, P98, DOI 10.1006/icar.1998.5914; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Folk R. L, 1980, PETROLOGY SEDIMENTAR; Golombek M, 1997, J GEOPHYS RES-PLANET, V102, P4117, DOI 10.1029/96JE03319; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002035; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; GOLOMBEK MP, 2004, LUNAR PLANET SCI; Grant JA, 2004, PLANET SPACE SCI, V52, P11, DOI 10.1016/j.pss.2003.08.011; GRANT JA, 1993, J GEOPHYS RES-PLANET, V98, P11025, DOI 10.1029/93JE00121; GRANT JA, 1993, J GEOPHYS RES-PLANET, V98, P15033, DOI 10.1029/93JE01580; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Hartmann WK, 1999, NATURE, V397, P586, DOI 10.1038/17545; Hartmann WK, 2001, ICARUS, V149, P37, DOI 10.1006/icar.2000.6532; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Horz F, 1999, SCIENCE, V285, P2105, DOI 10.1126/science.285.5436.2105; HURST M, 2004, LUNAR PLANET SCI; Irwin RP, 2002, SCIENCE, V296, P2209, DOI 10.1126/science.1071143; IRWIN RP, 2004, LUNAR PLANET SCI; Komatsu G, 1997, J GEOPHYS RES-PLANET, V102, P4151, DOI 10.1029/96JE02564; Leeder M.R, 1982, SEDIMENTOLOGY PROCES; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Melosh H.L, 1989, IMPACT CRATERING GEO; Milam KA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002023; RICE JW, 2003, LUNAR PLANET SCI; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794	30	66	66	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					807	810		10.1126/science.1099849	http://dx.doi.org/10.1126/science.1099849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297659				2022-12-28	WOS:000223104900033
J	Patrucco, E; Notte, A; Barberis, L; Selvetella, G; Maffei, A; Brancaccio, M; Marengo, S; Russo, G; Azzolino, O; Rybalkin, SD; Silengo, L; Altruda, F; Wetzker, R; Wymann, MP; Lembo, G; Hirsch, E				Patrucco, E; Notte, A; Barberis, L; Selvetella, G; Maffei, A; Brancaccio, M; Marengo, S; Russo, G; Azzolino, O; Rybalkin, SD; Silengo, L; Altruda, F; Wetzker, R; Wymann, MP; Lembo, G; Hirsch, E			PI3K gamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects	CELL			English	Article							PHOSPHOINOSITIDE 3-KINASE GAMMA; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; HEART-FAILURE; TRANSGENIC MICE; HYPERTROPHY; RECEPTOR; PROTEIN; ACTIVATION; PATHWAY; PHOSPHORYLATION	The G protein-coupled, receptor-activated phosphoinositide 3-kinase gamma (PI3Kgamma) mediates inflammatory responses and negatively controls cardiac contractility by reducing cAMP concentration. Here, we report that mice carrying a targeted mutation in the PI3Kgamma gene causing loss of kinase activity (PI3K-gamma(KD/KD)) display reduced inflammatory reactions but no alterations in cardiac contractility. We show that, in PI3K-gamma(KD/KD) hearts, cAMP levels are normal and that PI3Kgamma-deficient mice but not PI3Kgamma(KD/KD) mice develop dramatic myocardial damage after chronic pressure overload induced by transverse aortic constriction (TAC). Finally, our data indicate that PI3Kgamma is an essential component of a complex controlling PDE3B phosphodiesterase-mediated cAMP destruction. Thus, cardiac PI3Kgamma participates in two distinct signaling pathways: a kinase-dependent activity that controls PKB/Akt as well as MAPK phosphorylation and contributes to TAC-induced cardiac remodeling, and a kinase-independent activity that relies on protein interactions to regulate PDE3B activity and negatively modulates cardiac contractility.	San Giovanni Battista Hosp, Dept Genet Biol & Biochem, I-10126 Turin, Italy; San Giovanni Battista Hosp, Expt Med Res Ctr, I-10126 Turin, Italy; Neuromed Inst, Dept Neurocardiol, I-86077 Pozzilli, Isernia, Italy; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Hosp Jena, Res Unit Mol Cell Biol, D-07747 Jena, Germany; Univ Basel, Dept Clin & Biol Sci, CH-4301 Basel, Switzerland; Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; IRCCS Neuromed; University of Washington; University of Washington Seattle; Friedrich Schiller University of Jena; University of Basel; Sapienza University Rome	Lembo, G (corresponding author), San Giovanni Battista Hosp, Dept Genet Biol & Biochem, Via Santena 5Bis, I-10126 Turin, Italy.	lernbo@neuromed.it; hirsch@unito.it	Wymann, Matthias P/C-3227-2008; Selvetella, Giulio/J-4342-2012; Wetzker, Reinhard/AAD-8713-2019; Hirsch, Emilio/F-4848-2013; maffei, angelo/AAC-2219-2020; Lembo, Giuseppe/AAE-8096-2020	Wymann, Matthias P/0000-0003-3349-4281; Hirsch, Emilio/0000-0002-9073-6024; Lembo, Giuseppe/0000-0002-3510-223X; maffei, angelo/0000-0002-7491-0344; Patrucco, Enrico/0000-0001-8060-5058	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021723] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 21723] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alloatti G, 2003, CARDIOVASC RES, V60, P242, DOI 10.1016/j.cardiores.2003.08.008; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Asai K, 1999, J CLIN INVEST, V104, P551, DOI 10.1172/JCI7418; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Brede M, 2002, CIRCULATION, V106, P2491, DOI 10.1161/01.CIR.0000036600.39600.66; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Iwase M, 1996, CIRC RES, V78, P517, DOI 10.1161/01.RES.78.4.517; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; MOVSESIAN MA, 2002, BASIC RES CARDIOL S1, V97, P183; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Oudit GY, 2003, CIRCULATION, V108, P2147, DOI 10.1161/01.CIR.0000091403.62293.2B; Prasad SVN, 2000, J BIOL CHEM, V275, P4693, DOI 10.1074/jbc.275.7.4693; Prasad SVN, 2003, TRENDS CARDIOVAS MED, V13, P206, DOI 10.1016/S1050-1738(03)00080-X; Prasad SVN, 2002, J CELL BIOL, V158, P563, DOI 10.1083/jcb.200202113; Rapacciuolo A, 2001, J AM COLL CARDIOL, V38, P876, DOI 10.1016/S0735-1097(01)01433-4; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rondinone CM, 2000, J BIOL CHEM, V275, P10093, DOI 10.1074/jbc.275.14.10093; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P590; Stoyanova S, 1997, BIOCHEM J, V324, P489, DOI 10.1042/bj3240489; THOMPSON WJ, 1971, J BIOL CHEM, V246, P3145; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290	36	380	409	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					375	387		10.1016/j.cell.2004.07.017	http://dx.doi.org/10.1016/j.cell.2004.07.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294162	Bronze			2022-12-28	WOS:000223353100013
J	Vanhaesebroeck, B; Rohn, JL; Waterfield, MD				Vanhaesebroeck, B; Rohn, JL; Waterfield, MD			Gene targeting: Attention to detail	CELL			English	Editorial Material									Ludwig Inst Canc Res, London W1W 7BS, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England; Leiden Univ, Sylvius Lab, NL-2300 RA Leiden, Netherlands; Leadd BV, NL-2300 RA Leiden, Netherlands	Ludwig Institute for Cancer Research; University of London; University College London; Leiden University; Leiden University - Excl LUMC	Vanhaesebroeck, B (corresponding author), Ludwig Inst Canc Res, 91 Riding House St, London W1W 7BS, England.			Rohn, Jennifer/0000-0001-8766-6056				Barbier M, 2001, NATURE, V413, P796, DOI 10.1038/35101660; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Dekker LV, 2000, SCIENCE, V287, P982, DOI 10.1126/science.287.5455.982; Harris S, 2001, DRUG DISCOV TODAY, V6, P628, DOI 10.1016/S1359-6446(01)01794-9; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Prasad SVN, 2003, TRENDS CARDIOVAS MED, V13, P206, DOI 10.1016/S1050-1738(03)00080-X; Sasaki T, 2000, NATURE, V406, P897, DOI 10.1038/35022585; Sasaki T, 2003, NATURE, V426, P584, DOI 10.1038/nature02203; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535	9	29	29	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 6	2004	118	3					274	276		10.1016/j.cell.2004.07.018	http://dx.doi.org/10.1016/j.cell.2004.07.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294152	Bronze			2022-12-28	WOS:000223353100003
J	de Jager, CPC; Trof, RJ				de Jager, CPC; Trof, RJ			Gastrothorax simulating acute tension pneumothorax	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									VU Med Ctr, NL-1007 MB Amsterdam, Netherlands; Med Spectrum Twente, NL-7500 KA Enschede, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Medical Spectrum Twente	de Jager, CPC (corresponding author), VU Med Ctr, NL-1007 MB Amsterdam, Netherlands.								0	13	14	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					E5	E5		10.1056/NEJMicm030515	http://dx.doi.org/10.1056/NEJMicm030515			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295062				2022-12-28	WOS:000223069900013
J	Takeuchi, Y; Yoshizaki, G; Takeuchi, T				Takeuchi, Y; Yoshizaki, G; Takeuchi, T			Surrogate broodstock produces salmonids	NATURE			English	Editorial Material							PRIMORDIAL GERM-CELLS		Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Minato Ku, Tokyo 1088477, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo University of Marine Science & Technology; Japan Science & Technology Agency (JST)	Takeuchi, Y (corresponding author), Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Minato Ku, Tokyo 1088477, Japan.	goro@s.kaiyodai.ac.jp	Wei, Qiwei/B-6928-2014; YOSHIZAKI, Goro/O-1937-2014	Wei, Qiwei/0000-0002-6366-1020; Takeuchi, Yutaka/0000-0001-5450-4632				Bella DA, 2002, SCIENCE, V295, P1236; Kobayashi T, 2003, FISH PHYSIOL BIOCHEM, V28, P479, DOI 10.1023/B:FISH.0000030634.37486.fa; LAWRENCE PA, 1993, GENETICS, V134, P1145; McKay SJ, 1996, CAN J FISH AQUAT SCI, V53, P1165, DOI 10.1139/cjfas-53-5-1165; Ono T, 1996, EXP ANIM TOKYO, V45, P347, DOI 10.1538/expanim.45.347; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624; Takeuchi Y, 2002, BIOL REPROD, V67, P1087, DOI 10.1095/biolreprod67.4.1087; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7	8	130	144	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					629	630		10.1038/430629a	http://dx.doi.org/10.1038/430629a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295587				2022-12-28	WOS:000223085400032
J	Tomita, K; Fukai, S; Ishitani, R; Ueda, T; Takeuchi, N; Vassylyev, DG; Nureki, O				Tomita, K; Fukai, S; Ishitani, R; Ueda, T; Takeuchi, N; Vassylyev, DG; Nureki, O			Structural basis for template-independent RNA polymerization	NATURE			English	Article							CCA-ADDING ENZYME; DNA-POLYMERASE-BETA; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; NUCLEOTIDYLTRANSFERASE; COMPLEXES; SUBSTRATE; INSIGHTS; PRIMER; ATP	The 3'-terminal CCA nucleotide sequence ( positions 74 - 76) of transfer RNA is essential for amino acid attachment(1) and interaction with the ribosome(2-4) during protein synthesis. The CCA sequence is synthesized de novo and/or repaired by a template-independent RNA polymerase, 'CCA-adding enzyme', using CTP and ATP as substrates(5). Despite structural and biochemical studies(5-8), the mechanism by which the CCA-adding enzyme synthesizes the defined sequence without a nucleic acid template remains elusive. Here we present the crystal structure of Aquifex aeolicus CCA-adding enzyme, bound to a primer tRNA lacking the terminal adenosine and an incoming ATP analogue, at 2.8 Angstrom resolution. The enzyme enfolds the acceptor T helix of the tRNA molecule. In the catalytic pocket, C75 is adjacent to ATP, and their base moieties are stacked. The complementary pocket for recognizing C74-C75 of tRNA forms a 'protein template' for the penultimate two nucleotides, mimicking the nucleotide template used by template-dependent polymerases. These results are supported by systematic analyses of mutants. Our structure represents the 'pre-insertion' stage of selecting the incoming nucleotide and provides the structural basis for the mechanism underlying template-independent RNA polymerization.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058666, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; SPring 8, RIKEN Harima Inst, Cellular Signaling Lab, Mikazuki, Hyogo 6795148, Japan; JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; University of Tokyo; Japan Synchrotron Radiation Research Institute; RIKEN; Japan Science & Technology Agency (JST)	Nureki, O (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	onureki@bio.titech.ac.jp	Ueda, Takuya/K-5217-2014; Vassylyev, Dmitry/A-9005-2008; Tomita, Kozo/J-5746-2013; Fukai, Shuya/X-4838-2018; Tomita, Kozo/E-9390-2017	Ueda, Takuya/0000-0002-7760-8271; Fukai, Shuya/0000-0002-1241-1443; Tomita, Kozo/0000-0002-7374-3898				Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Deutscher M. P., 1983, ENZYMES NUCLEIC ACID, V2, P159; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; HEGG LA, 1990, NUCLEIC ACIDS RES, V18, P5975, DOI 10.1093/nar/18.20.5975; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Okabe M, 2003, EMBO J, V22, P5918, DOI 10.1093/emboj/cdg563; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Shi PY, 1998, RNA, V4, P276; Sprinzl M, 1979, Prog Nucleic Acid Res Mol Biol, V22, P1, DOI 10.1016/S0079-6603(08)60798-9; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tomita K, 2002, J BIOL CHEM, V277, P48192, DOI 10.1074/jbc.M207527200; Tomita K, 2001, SCIENCE, V294, P1334, DOI 10.1126/science.1063816; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yue DX, 1996, RNA, V2, P895	30	82	85	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					700	704		10.1038/nature02712	http://dx.doi.org/10.1038/nature02712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295603				2022-12-28	WOS:000223085400051
J	Staley, K				Staley, K			Neuroscience - Epileptic neurons go wireless	SCIENCE			English	Editorial Material							GRANULE CELLS; INHIBITION; DENDRITES; SYNAPSES		Univ Colorado, Hlth Sci Ctr, Dept Neurol & Pediat, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Staley, K (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Neurol & Pediat, 4200 E 9th Ave, Denver, CO 80262 USA.	kevin.staley@uchsc.edu						Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Lowe G, 2002, J NEUROPHYSIOL, V88, P64, DOI 10.1152/jn.2002.88.1.64; RIBAK CE, 1982, J NEUROSCI, V2, P1725; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Sutula Thomas, 2002, Epilepsy Curr, V2, P86, DOI 10.1046/j.1535-7597.2002.00032.x; Wuarin JP, 2001, J NEUROPHYSIOL, V85, P1067, DOI 10.1152/jn.2001.85.3.1067; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	12	4	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					482	483		10.1126/science.1101133	http://dx.doi.org/10.1126/science.1101133			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273382				2022-12-28	WOS:000222828900026
J	Liu, MC				Liu, MC			Substructure in the circumstellar disk around the young star AU Microscopii	SCIENCE			English	Article							BETA-PICTORIS; DUST; DEBRIS; RINGS; DETECTABILITY; EXPLANATION; ASYMMETRIES; SIGNATURES; TELESCOPE; ACCRETION	Keck adaptive optics imaging with a physical resolution of 0.4 astronomical units (AU) resolves the inner (15 to 80 AU) disk of AU Microscopii (AU Mic, GJ 803, HD 197481), the nearest known scattered light disk to Earth. The inner disk is asymmetric and possesses a sharp change in structure at 35 AU. The disk also shows spatially localized enhancements and deficits at 25- to 40-AU separations. The overall morphology points to the influence of unseen larger bodies and resembles structures expected from recent planet formation. AU Mic is coeval with the archetypical debris disk system beta Pictoris, and the similarities between their two disks point to synchronous disk evolution. Multiple indications of substructure appear to be common in circumstellar disks at an age of approximate to12 million years.	Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA	University of Hawaii System	Liu, MC (corresponding author), Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	mliu@ifa.hawaii.edu		Liu, Michael C/0000-0003-2232-7664				Artymowicz P, 1997, ANNU REV EARTH PL SC, V25, P175, DOI 10.1146/annurev.earth.25.1.175; Artymowicz P, 1997, ASTROPHYS J, V490, P863, DOI 10.1086/304889; Augereau JC, 2001, ASTRON ASTROPHYS, V370, P447, DOI 10.1051/0004-6361:20010199; Backman D. E., 1993, PROTOSTARS PLANETS, P1253; Brandeker A, 2004, ASTRON ASTROPHYS, V413, P681, DOI 10.1051/0004-6361:20034326; desEtangs AL, 1996, ASTRON ASTROPHYS, V307, P542; Dominik C, 2003, ASTROPHYS J, V598, P626, DOI 10.1086/379169; GOLIMOWSKI DA, 1993, ASTROPHYS J, V411, pL41, DOI 10.1086/186907; Greaves JS, 1998, ASTROPHYS J, V506, pL133, DOI 10.1086/311652; Heap SR, 2000, ASTROPHYS J, V539, P435, DOI 10.1086/309188; Holland WS, 1998, NATURE, V392, P788, DOI 10.1038/33874; Jewitt D. C., 2000, Protostars and planets 4, P1201; Jura M, 1998, ASTROPHYS J, V505, P897, DOI 10.1086/306184; Kalas P, 2004, SCIENCE, V303, P1990, DOI 10.1126/science.1093420; KALAS P, 1995, ASTRON J, V110, P794, DOI 10.1086/117565; Kalas P, 2000, ASTROPHYS J, V530, pL133, DOI 10.1086/312494; Kalas P, 1996, ASTRON J, V111, P1347, DOI 10.1086/117881; Kenyon SJ, 2004, ASTRON J, V127, P513, DOI 10.1086/379854; Kenyon SJ, 2002, ASTROPHYS J, V577, pL35, DOI 10.1086/344084; Lagrange A.-M., 2000, Protostars and planets 4, P639; Liou JC, 1999, ASTRON J, V118, P580, DOI 10.1086/300938; LISSAUER JJ, 1987, ICARUS, V69, P249, DOI 10.1016/0019-1035(87)90104-7; Liu MC, 2004, ASTROPHYS J, V608, P526, DOI 10.1086/392531; Mouillet D, 1997, MON NOT R ASTRON SOC, V292, P896, DOI 10.1093/mnras/292.4.896; Navascues DBY, 1999, ASTROPHYS J, V520, pL123, DOI 10.1086/312162; Ozernoy LM, 2000, ASTROPHYS J, V537, pL147, DOI 10.1086/312779; Perryman MAC, 1997, ASTRON ASTROPHYS, V323, pL49; Schneider G, 1999, ASTROPHYS J, V513, pL127, DOI 10.1086/311921; Schneider G, 2003, P SOC PHOTO-OPT INS, V4860, P1, DOI 10.1117/12.457840; Sheret I, 2004, MON NOT R ASTRON SOC, V348, P1282, DOI 10.1111/j.1365-2966.2004.07448.x; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; SMITH BA, 1992, ASTRON ASTROPHYS, V261, P499; Stern SA, 1997, ASTRON J, V114, P841, DOI 10.1086/118518; Thommes EW, 2003, ASTROPHYS J, V597, P566, DOI 10.1086/378317; Wahhaj Z, 2003, ASTROPHYS J, V584, pL27, DOI 10.1086/346123; Weinberger AJ, 2003, ASTROPHYS J, V584, pL33, DOI 10.1086/368065; WHITMIRE DP, 1988, ASTRON ASTROPHYS, V203, pL13; Wizinowich P, 2000, PUBL ASTRON SOC PAC, V112, P315, DOI 10.1086/316543; Zuckerman B, 2001, ASTROPHYS J, V562, pL87, DOI 10.1086/337968	40	124	124	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1442	1444		10.1126/science.1102929	http://dx.doi.org/10.1126/science.1102929			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15308766				2022-12-28	WOS:000223761900041
J	Valk-Lingbeek, ME; Bruggeman, SWM; Van Lohuizen, M				Valk-Lingbeek, ME; Bruggeman, SWM; Van Lohuizen, M			Stem colls and cancer: The polycomb connection	CELL			English	Review							H3 LYSINE-27 METHYLATION; ACUTE MYELOID-LEUKEMIA; MYC TRANSGENIC MICE; CELL SELF-RENEWAL; HISTONE H3; GROUP GENE; SONIC HEDGEHOG; BRAIN-TUMORS; IN-VIVO; METHYLTRANSFERASE ACTIVITY	Proteins from the Polycomb group (PcG) are epigenetic chromatin modifiers involved in cancer development and also in the maintenance of embryonic and adult stem cells, The therapeutic potential of stem cells and the growing conviction that tumors contain stem cells highlights the importance of understanding the extrinsic and intrinsic circuitry controlling stem cell fate and their connections to cancer.	Netherlands Canc Inst, Dept Mol Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Van Lohuizen, M (corresponding author), Netherlands Canc Inst, Dept Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	rn.v.lohuizen@nki.nl	Bruggeman, Sophia/N-4347-2018	Bruggeman, Sophia/0000-0002-2678-323X				Akasaka T, 1997, IMMUNITY, V7, P135, DOI 10.1016/S1074-7613(00)80516-6; Akasaka T, 2001, DEVELOPMENT, V128, P1587; Akasaka T, 2002, GENES CELLS, V7, P835, DOI 10.1046/j.1365-2443.2002.00565.x; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bea S, 2001, CANCER RES, V61, P2409; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; BJOMSSON JM, 2003, MOL CELL BIOL, V23, P3872; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Breiling A, 1999, MOL CELL BIOL, V19, P8451; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Core N, 1997, DEVELOPMENT, V124, P721; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Dyer MA, 2001, DEVELOPMENT, V128, P1717; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Fortunel NO, 2003, SCIENCE, V302, P393; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Guthrie S, 2004, CURR BIOL, V14, pR166, DOI 10.1016/j.cub.2004.01.050; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Imura T, 2003, J NEUROSCI, V23, P2824; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kajiume T, 2004, EXP HEMATOL, V32, P571, DOI 10.1016/j.exphem.2004.03.001; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Lewis JL, 2001, BLOOD, V97, P2604, DOI 10.1182/blood.V97.9.2604; Li L, 2003, CANCER RES, V63, P2733; Loring JF, 2001, RESTOR NEUROL NEUROS, V18, P81; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Miyazawa K, 2000, J NEUROSCI, V20, P5756, DOI 10.1523/JNEUROSCI.20-15-05756.2000; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morin-Kensicki Elizabeth M., 2001, Genesis The Journal of Genetics and Development, V31, P142, DOI 10.1002/gene.10017; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Neo SY, 2004, HEPATOLOGY, V39, P944, DOI 10.1002/hep.20105; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ohta H, 2002, J EXP MED, V195, P759, DOI 10.1084/jem.20011911; Owens BM, 2002, STEM CELLS, V20, P364, DOI 10.1634/stemcells.20-5-364; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Raaphorst FM, 2001, TRENDS IMMUNOL, V22, P682, DOI 10.1016/S1471-4906(01)02082-8; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Richie ER, 2002, ONCOGENE, V21, P299, DOI 10.1038/sj.onc.1205051; Rubin JB, 2002, CANCER CELL, V2, P7, DOI 10.1016/S1535-6108(02)00090-9; Santa-Olalla J, 2003, EUR J NEUROSCI, V18, P1073, DOI 10.1046/j.1460-9568.2003.02824.x; Schoorlemmer J, 1997, EMBO J, V16, P5930, DOI 10.1093/emboj/16.19.5930; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sewalt RGAB, 2002, MOL CELL BIOL, V22, P5539, DOI 10.1128/MCB.22.15.5539-5553.2002; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Singh SK, 2003, CANCER RES, V63, P5821; Smith KS, 2003, MOL CELL, V12, P393, DOI 10.1016/S1097-2765(03)00277-6; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Takihara Y, 1997, DEVELOPMENT, V124, P3673; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126	97	592	633	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					409	418		10.1016/j.cell.2004.08.005	http://dx.doi.org/10.1016/j.cell.2004.08.005			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315754	Bronze			2022-12-28	WOS:000223650900004
J	Prandoni, P; Lensing, AWA; Prins, MH; Frulla, M; Marchiori, A; Bernardi, E; Tormene, D; Mosena, L; Pagnan, A; Girolami, A				Prandoni, P; Lensing, AWA; Prins, MH; Frulla, M; Marchiori, A; Bernardi, E; Tormene, D; Mosena, L; Pagnan, A; Girolami, A			Below-knee elastic compression stockings to prevent the post-thrombotic syndrome - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP VENOUS THROMBOSIS; VEIN THROMBOSIS; POSTPHLEBITIC-SYNDROME; POPULATION	Background: Because only limited evidence suggests that elastic stockings prevent the post-thrombotic syndrome in patients with symptomatic deep venous thrombosis (DVT), these stockings are not widely used. Objective: To evaluate the efficacy of compression elastic stockings for prevention of the post-thrombotic syndrome in patients with proximal DVT. Design: Randomized, controlled clinical trial. Setting: University hospital. Patients: 180 consecutive patients with a first episode of symptomatic proximal DVT who received conventional anticoagulant treatment. Interventions: Before discharge, patients were randomly assigned to wear or not wear below-knee compression elastic stockings (30 to 40 mm Hg at the ankle) for 2 years. Follow-up was performed for up to 5 years. Measurements: The presence and severity of the post-thrombotic syndrome were scored by using a standardized scale. Results: Post-thrombotic sequelae developed in 44 of 90 controls (severe in 10) and in 23 of 90 patients wearing elastic stockings (severe in 3). All but 1 event developed in the first 2 years. The cumulative incidence of the post-thrombotic syndrome in the control group versus the elastic stockings group was 40.0% (95% Cl, 29.9% to 50.1%) versus 21.1% (Cl, 12.7% to 29.5%) after 6 months, 46.7% (Cl, 36.4% to 57.0%) versus 22.2% (Cl, 13.8% to 30.7%) after 1 year, and 49.1% (Cl, 38.7% to 59.4%) versus 24.5% (Cl, 15.6% to 33.4%) after 2 years. After adjustment for baseline characteristics, the hazard ratio for the post-thrombotic syndrome in the elastic stockings group compared with controls was 0.49 (Cl, 0.29 to 0.84; P = 0.011). Limitations: This study lacked a double-blind design. Conclusions: Post-thrombotic sequelae develop in almost half of patients with proximal DVT. Below-knee compression elastic stockings reduce this rate by approximately 50%.	Univ Padua, Div Internal Med 2, Dept Med & Surg Sci, I-35128 Padua, Italy; Acad Hosp Maastricht, Maastricht, Netherlands	University of Padua; Maastricht University; Maastricht University Medical Centre (MUMC)	Prandoni, P (corresponding author), Univ Padua, Div Internal Med 2, Dept Med & Surg Sci, Via Osped Civile 105, I-35128 Padua, Italy.	paoloprandoni@tin.it						[Anonymous], 1988, PHLEBOLOGIE; Bergqvist D, 1997, ANN INTERN MED, V126, P454, DOI 10.7326/0003-4819-126-6-199703150-00006; Bernardi E, 2000, Curr Opin Pulm Med, V6, P335, DOI 10.1097/00063198-200007000-00015; BEYTH RJ, 1995, ARCH INTERN MED, V155, P1031, DOI 10.1001/archinte.155.10.1031; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Evers EJ, 1999, VASA-J VASCULAR DIS, V28, P19, DOI 10.1024/0301-1526.28.1.19; Ginsberg JS, 2000, ARCH INTERN MED, V160, P669, DOI 10.1001/archinte.160.5.669; Ginsberg JS, 2001, ARCH INTERN MED, V161, P2105, DOI 10.1001/archinte.161.17.2105; IMMELMAN EJ, 1984, CLIN CHEST MED, V5, P537; Kahn SR, 2004, ARCH INTERN MED, V164, P17, DOI 10.1001/archinte.164.1.17; Kahn SR, 2003, J THROMB HAEMOST, V1, P500, DOI 10.1046/j.1538-7836.2003.00098.x; Kahn SR, 2002, ARCH INTERN MED, V162, P1144, DOI 10.1001/archinte.162.10.1144; LENSING AWA, 2000, HEMOSTASIS THROMBOSI, P1277; Mohr DN, 2000, MAYO CLIN PROC, V75, P1249, DOI 10.4065/75.12.1249; PIERSON S, 1983, JAMA-J AM MED ASSOC, V249, P242, DOI 10.1001/jama.249.2.242; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Prandoni P, 2002, THROMB HAEMOSTASIS, V88, P402; Prandoni Paolo, 1995, Haematologica, V80, P42; Saarinen J, 2000, J CARDIOVASC SURG, V41, P441; Simioni P, 1999, BEST PRACT RES CL HA, V12, P479, DOI 10.1053/beha.1999.0037; VANBECK EJ, 2000, HEMOSTASIS THROMBOSI, P1603; Villalta SBP, 1994, HAEMOSTASIS, V24, P157; Ziegler S, 2001, THROMB RES, V101, P23, DOI 10.1016/S0049-3848(00)00370-4	23	474	491	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2004	141	4					249	256		10.7326/0003-4819-141-4-200408170-00004	http://dx.doi.org/10.7326/0003-4819-141-4-200408170-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846BX	15313740				2022-12-28	WOS:000223290900001
J	Sprague, LD; Ferrigni, FJ				Sprague, LD; Ferrigni, FJ			Lung herniation after cardiopulmonary resuscitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									SSM St Joseph Hlth Ctr, St Charles, MO 63301 USA		Sprague, LD (corresponding author), SSM St Joseph Hlth Ctr, St Charles, MO 63301 USA.								0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					695	695		10.1056/NEJMicm030736	http://dx.doi.org/10.1056/NEJMicm030736			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306671				2022-12-28	WOS:000223225500012
J	Stone, SM; Alexander, JL				Stone, SM; Alexander, JL			Imperforate hymen with hematocolpometra	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Maine Med Ctr, Dept Emergency Med, Portland, ME 04102 USA	Maine Medical Center	Stone, SM (corresponding author), Maine Med Ctr, Dept Emergency Med, Portland, ME 04102 USA.								0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					E6	E6		10.1056/ENEJMicm020415	http://dx.doi.org/10.1056/ENEJMicm020415			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306680				2022-12-28	WOS:000223225500013
J	Perederina, A; Svetlov, V; Vassylyeva, MN; Tahirov, TH; Yokoyama, S; Artsimovitch, I; Vassylyev, DG				Perederina, A; Svetlov, V; Vassylyeva, MN; Tahirov, TH; Yokoyama, S; Artsimovitch, I; Vassylyev, DG			Regulation through the secondary channel-structural framework for ppGpp-DksA synergism during transcription	CELL			English	Article							CLEAVAGE FACTORS GREA; CRYSTAL-STRUCTURE; RIBONUCLEIC-ACID; RNA; ELONGATION; PROTEIN; RPOS; IDENTIFICATION; SUPPRESSORS; MECHANISM	Bacterial transcription is regulated by the alarmone ppGpp, which binds near the catalytic site of RNA polymerase (RNAP) and modulates its activity. We show that the DksA protein is a crucial component of ppGpp-dependent regulation. The 2.0 Angstrom resolution structure of Escherichia coli DksA reveals a globular domain and a coiled coil with two highly conserved Asp residues at its tip that is reminiscent of the transcript cleavage factor GreA. This structural similarity suggests that DksA coiled coil protrudes into the RNAP secondary channel to coordinate a ppGpp bound Mg2+ ion with the Asp residues, thereby stabilizing the ppGpp-RNAP complex. Biochemical analysis demonstrates that DksA affects transcript elongation, albeit differently from GreA; augments ppGpp effects on initiation; and binds directly to RNAP, positioning the Asp residues near the active site. Substitution of these residues eliminates the synergy between DksA and ppGpp. Thus, the secondary channel emerges as a common regulatory entrance for transcription factors.	RIKEN, Harima Inst SPring 8, Cellular Signaling Lab, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst SPring 8, Stucturome Res Grp, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst SPring 8, High Throughput Factory, Sayo, Hyogo 6795148, Japan; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; RIKEN; RIKEN; University System of Ohio; Ohio State University; RIKEN; University of Tokyo	Vassylyev, DG (corresponding author), RIKEN, Harima Inst SPring 8, Cellular Signaling Lab, 1-1-1 Kouto,Mikazuki Cho, Sayo, Hyogo 6795148, Japan.	dmitry@yumiyoshi.harima.riken.go.jp	Vassylyev, Dmitry/A-9005-2008; Artsimovitch, Irina/L-3467-2019; Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Tahirov, Tahir/0000-0002-1238-0069				ABOUD M, 1975, J BIOL CHEM, V250, P2189; Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bass S, 1996, J BACTERIOL, V178, P1154, DOI 10.1128/jb.178.4.1154-1161.1996; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; Choy HE, 2000, J BIOL CHEM, V275, P6783, DOI 10.1074/jbc.275.10.6783; Cramer P, 2004, CURR OPIN GENET DEV, V14, P218, DOI 10.1016/j.gde.2004.01.003; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; GALLANT J, 1967, J MOL BIOL, V25, P545, DOI 10.1016/0022-2836(67)90205-7; Hirsch M, 2002, J BACTERIOL, V184, P5077, DOI 10.1128/JB.184.18.5077-5087.2002; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jude F, 2003, J BACTERIOL, V185, P3558, DOI 10.1128/JB.185.12.3558-3566.2003; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Kulish D, 2000, J BIOL CHEM, V275, P12789, DOI 10.1074/jbc.275.17.12789; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mogull SA, 2001, INFECT IMMUN, V69, P5742, DOI 10.1128/IAI.69.9.5742-5751.2001; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Murphy H, 2003, METHOD ENZYMOL, V371, P596; Ohkubo S, 1997, J BACTERIOL, V179, P2089, DOI 10.1128/jb.179.6.2089-2091.1997; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; STEPHENS JC, 1975, P NATL ACAD SCI USA, V72, P4389, DOI 10.1073/pnas.72.11.4389; Takahashi K, 2004, P NATL ACAD SCI USA, V101, P4320, DOI 10.1073/pnas.0308555101; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; VASSYLYEVA MN, 2004, IN PRESS ACTA CRYSTA; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3	43	271	280	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					297	309		10.1016/j.cell.2004.06.030	http://dx.doi.org/10.1016/j.cell.2004.06.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294156	Bronze			2022-12-28	WOS:000223353100007
J	Mattson, MP				Mattson, MP			Pathways towards and away from Alzheimer's disease	NATURE			English	Review							AMYLOID PRECURSOR PROTEIN; PRESENILIN-1 TRANSGENIC MICE; CENTRAL-NERVOUS-SYSTEM; REVERSIBLE MEMORY LOSS; NECROSIS-FACTOR-ALPHA; A-BETA; SECRETASE CLEAVAGE; CELL-DEATH; NEURODEGENERATIVE DISORDERS; SYNAPTIC PLASTICITY	Slowly but surely, Alzheimer's disease ( AD) patients lose their memory and their cognitive abilities, and even their personalities may change dramatically. These changes are due to the progressive dysfunction and death of nerve cells that are responsible for the storage and processing of information. Although drugs can temporarily improve memory, at present there are no treatments that can stop or reverse the inexorable neurodegenerative process. But rapid progress towards understanding the cellular and molecular alterations that are responsible for the neuron's demise may soon help in developing effective preventative and therapeutic strategies.	NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Mattson, MP (corresponding author), NIA, Neurosci Lab, Intramural Res Program, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Mattson, Mark P/F-6038-2012		NATIONAL INSTITUTE ON AGING [Z01AG000314, Z01AG000317, Z01AG000312, Z01AG000313] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AG000312-07, Z01 AG000313-07, Z01 AG000317-07, Z01 AG000331-01, Z01 AG000314-07] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Blass JP, 2001, J NEUROSCI RES, V66, P851, DOI 10.1002/jnr.10087; Braak H, 1998, J NEURAL TRANSM-SUPP, P127; Buchner M, 2002, NEUROSCIENCE, V114, P285, DOI 10.1016/S0306-4522(02)00280-4; Bush AI, 2003, P NATL ACAD SCI USA, V100, P11193, DOI 10.1073/pnas.2135061100; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Chan SL, 2002, NEUROMOL MED, V2, P167, DOI 10.1385/NMM:2:2:167; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; CUMMINGS BJ, 1993, EXP NEUROL, V124, P315, DOI 10.1006/exnr.1993.1202; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dewachter I, 2002, LANCET NEUROL, V1, P409, DOI 10.1016/S1474-4422(02)00188-6; Dickson DW, 1997, NEUROBIOL AGING, V18, pS21, DOI 10.1016/S0197-4580(97)00065-1; Dodart JC, 1999, NEUROSCI LETT, V277, P49, DOI 10.1016/S0304-3940(99)00847-2; Eckert A, 2003, BIOCHEM PHARMACOL, V66, P1627, DOI 10.1016/S0006-2952(03)00534-3; Eckert A, 2001, NEUROBIOL DIS, V8, P331, DOI 10.1006/nbdi.2000.0378; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Farlow M, 2002, INT PSYCHOGERIATR, V14, P93, DOI 10.1017/S1041610203008688; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Hoozemans JJM, 2003, CURR DRUG TARGETS, V4, P461, DOI 10.2174/1389450033490902; Jantzen PT, 2002, J NEUROSCI, V22, P2246, DOI 10.1523/JNEUROSCI.22-06-02246.2002; John V, 2003, J MED CHEM, V46, P4625, DOI 10.1021/jm030247h; Kalmijn S, 2000, J Nutr Health Aging, V4, P202; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lazarov O, 2002, J NEUROSCI, V22, P9785; Le YY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0003.2001; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Mattson MP, 2003, ANN INTERN MED, V139, P441, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00012; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; McGeer PL, 2002, J NEUROVIROL, V8, P529, DOI 10.1080/13550280290100969; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; McPhie DL, 2003, J NEUROSCI, V23, P6914; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; OsterGranite ML, 1996, J NEUROSCI, V16, P6732; Pedersen WA, 2002, J NEUROSCI, V22, P404, DOI 10.1523/JNEUROSCI.22-02-00404.2002; Pope SK, 2003, ANNU REV PUBL HEALTH, V24, P111, DOI 10.1146/annurev.publhealth.24.100901.141015; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Resnick SM, 2002, JAMA-J AM MED ASSOC, V288, P2170, DOI 10.1001/jama.288.17.2170; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Roses AD, 1997, NEUROGENETICS, V1, P3, DOI 10.1007/s100480050001; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Song S, 2003, MOL CELL, V12, P553, DOI 10.1016/j.molcel.2003.08.005; Stahl R, 2003, RADIOLOGE, V43, P566, DOI 10.1007/s00117-003-0925-4; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; Wang HX, 2001, NEUROLOGY, V56, P1188, DOI 10.1212/WNL.56.9.1188; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Xu J, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-01-j0001.2001; Yang Y, 2004, NEUROSCIENCE, V124, P501, DOI 10.1016/j.neuroscience.2003.11.029; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yao PJ, 2004, TRENDS NEUROSCI, V27, P24, DOI 10.1016/j.tins.2003.10.012; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zandi PP, 2004, ARCH NEUROL-CHICAGO, V61, P82, DOI 10.1001/archneur.61.1.82	99	2294	2475	10	691	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					631	639		10.1038/nature02621	http://dx.doi.org/10.1038/nature02621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295589	Green Accepted			2022-12-28	WOS:000223085400034
J	Pham, PN; Weinstein, HM; Longman, T				Pham, PN; Weinstein, HM; Longman, T			Trauma and PTSD symptoms in Rwanda - Implications for attitudes toward justice and reconciliation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CHECKLIST	Context The 1994 genocide in Rwanda led to the loss of at least 10% of the country's 7.7 million inhabitants, the destruction of much of the country's infrastructure, and the displacement of nearly 4 million people. In seeking to rebuild societies such as Rwanda, it is important to understand how traumatic experience may shape the ability of individuals and groups to respond to judicial and other reconciliation initiatives. Objectives To assess the level of trauma exposure and the prevalence of posttraumatic stress disorder (PTSD) symptoms and their predictors among Rwandans and to determine how trauma exposure and PTSD symptoms are associated with Rwandans' attitudes toward justice and reconciliation. Design, Setting, and Participants Multistage, stratified cluster random survey of 2091 eligible adults in selected households in 4 communes in Rwanda in February 2002. Main Outcome Measures Rates of exposure to trauma and symptom criteria for PTSD using the PTSD Checklist-Civilian Version; attitudes toward judicial responses (Rwandan national and gacaca local trials and International Criminal Tribunal for Rwanda [ICTR]) and reconciliation (belief in community, nonviolence, social justice, and interdependence with other ethnic groups). Results Of 2074 respondents with data on exposure to trauma, 1563 (75.4%) were forced to flee their homes, 1526 (73.0%) had a close member of their family killed, and 1472 (70.9%) had property destroyed or lost. Among the 2091 total participants, 518 (24.8%) met symptom criteria for PTSD. The adjusted odds ratio (OR) of meeting PTSD symptom criteria for each additional traumatic event was 1.43 (95% Cl, 1.33-1.55). More respondents supported the local judicial responses (90.8% supported gacaca trials and 67.8% the Rwanda national trials) than the ICTR (42.1% in support). Respondents who met PTSD symptom criteria were less likely to have positive attitudes toward the Rwandan national trials (OR, 0.77; 95% Cl, 0.61-0.98), belief in community (OR, 0.76; 95% Cl, 0.60-0.97), and interdependence with other ethnic groups (OR, 0.71; 95% Cl, 0.56-0.90). Respondents with exposure to multiple trauma events were more likely to have positive attitudes toward the ICTR (OR, 1.10; 95% Cl, 1.04-1.17) and less likely to support the Rwandan national trials (OR, 0.90; 95% Cl, 0.84-0.96), the local gacaca trials (OR, 0.80; 95% Cl, 0.72-0.89), and 3 factors of openness to reconciliation: belief in nonviolence (OR, 0.92; 95% Cl, 0.87-0.97), belief in community (OR, 0.92; 95% Cl, 0.87-0.98), and interdependence with other ethnic groups (OR, 0.86; 95% Cl, 0.81-0.92). Other variables that were associated with attitudes toward judicial processes and openness to reconciliation were educational level, ethnicity, perception of change in poverty level and access to security compared with 1994, and ethnic distance. Conclusions This study demonstrates that traumatic exposure, PTSD symptoms, and other factors are associated with attitudes toward justice and reconciliation. Societal interventions following mass violence should consider the effects of trauma if reconciliation is to be realized.	Tulane Univ, Payson Ctr Int Dev & Technol Transfer, New Orleans, LA 70118 USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Vassar Coll, Poughkeepsie, NY USA	Tulane University; University of California System; University of California Berkeley; Vassar College	Pham, PN (corresponding author), Tulane Univ, Payson Ctr Int Dev & Technol Transfer, New Orleans, LA 70118 USA.	ppham1@tulane.edu		Pham, Phuong/0000-0002-5696-2933; Longman, Timothy/0000-0002-6852-8106				BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BIRO MW, IN PRESS MY NEIGHBOR; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Des Forges, 1999, LEAVE NONE TELL STOR; Fletcher LE, 2002, HUM RIGHTS QUART, V24, P573, DOI 10.1353/hrq.2002.0033; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Green BL, 2000, J TRAUMA STRESS, V13, P271, DOI 10.1023/A:1007758711939; KESSLER RC, 1988, ARCH GEN PSYCHIAT, V55, P626; LONGMAN T, IN PRESS MY NEIGHBOR; LONGMAN TP, 1997, CRITICAL JUNCTURE AF; Prunier G, 1995, RWANDA CRISIS HIST G	14	242	242	4	45	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2004	292	5					602	612		10.1001/jama.292.5.602	http://dx.doi.org/10.1001/jama.292.5.602			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843AE	15292086	Bronze			2022-12-28	WOS:000223045500018
J	Kyriacou, DN; Stein, AC; Yarnold, PR; Courtney, DM; Nelson, RR; Noskin, GA; Handler, JA; Frerichs, RR				Kyriacou, DN; Stein, AC; Yarnold, PR; Courtney, DM; Nelson, RR; Noskin, GA; Handler, JA; Frerichs, RR			Clinical predictors of bioterrorism-related inhalational anthrax	LANCET			English	Article							MANAGEMENT	Limitation of a bioterrorist anthrax attack will require rapid and accurate recognition of the earliest victims. To identify clinical characteristics of inhalational anthrax, we compared 47 historical cases (including 11 cases of bioterrorism-related anthrax) with 376 controls with community-acquired pneumonia or influenza-like illness. Nausea, vomiting, pallor or cyanosis, diaphoresis, altered mental status, and raised haematocrit were more frequently recorded in the inhalational anthrax cases than in either the community-acquired pneumonia or influenza-like illness controls. The most accurate predictor of anthrax was mediastinal widening or pleural effusion on a chest radiograph. This finding was 100% sensitive (95% CI 84.6-100.0) for inhalational anthrax, 71.8% specific (64.8-78.1) compared with community-acquired pneumonia, and 95.6% specific (90.0-98.5) compared with influenza-like illness. Our findings represent preliminary efforts toward identifying clinical predictors of inhalational anthrax.	Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles	Kyriacou, DN (corresponding author), 259 Erie St,Suite 100, Chicago, IL 60611 USA.	dkyriacou@aol.com		Handler, Jonathan/0000-0002-0304-7539; Yarnold, Paul/0000-0002-1648-739X				Centers for Disease Control and Prevention, 2001, MMWR-MORBID MORTAL W, V50, P984; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P941; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Hupert N, 2003, ANN INTERN MED, V139, P337, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00009; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Kuehnert MJ, 2003, CLIN INFECT DIS, V36, P328, DOI 10.1086/346035; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892	7	31	32	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					449	452		10.1016/S0140-6736(04)16769-X	http://dx.doi.org/10.1016/S0140-6736(04)16769-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288744				2022-12-28	WOS:000222998600036
J	Legname, G; Baskakov, IV; Nguyen, HOB; Riesner, D; Cohen, FE; DeArmond, SJ; Prusiner, SB				Legname, G; Baskakov, IV; Nguyen, HOB; Riesner, D; Cohen, FE; DeArmond, SJ; Prusiner, SB			Synthetic mammalian prions	SCIENCE			English	Article							TRANSGENIC MICE; IN-VITRO; ALZHEIMERS-DISEASE; STRAIN VARIATION; SCRAPIE PRIONS; PROTEIN; CONFORMATION; INFECTIVITY; NEURODEGENERATION; ENCEPHALOPATHY	Recombinant mouse prion protein (recMoPrP) produced in Escherichia coli was polymerized into amyloid fibrils that represent a subset of beta sheet-rich structures. Fibrils consisting of recMoPrP(89-230) were inoculated intracerebrally into transgenic (Tg) mice expressing MoPrP(89-231). The mice developed neurologic dysfunction between 380 and 660 days after inoculation. Brain extracts showed protease-resistant PrP by Western blotting; these extracts transmitted disease to wild-type FVB mice and Tg mice overexpressing PrP, with incubation times of 150 and 90 days, respectively. Neuropathological findings suggest that a novel prion strain was created. Our results provide compelling evidence that prions are infectious proteins.	Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Heinrich Heine University Dusseldorf	Prusiner, SB (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.	stanley@itsa.ucsf.edu	Legname, Giuseppe/C-1723-2012	Legname, Giuseppe/0000-0003-0716-4393	NIA NIH HHS [AG021601, AG10770, AG02132] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG002132, P01AG010770, P01AG021601] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GAJDUSEK DC, 1993, BRIT MED BULL, V49, P913, DOI 10.1093/oxfordjournals.bmb.a072653; Gambetti P, 1999, NEW ENGL J MED, V340, P1675, DOI 10.1056/NEJM199905273402111; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; LEGNAME G, UNPUB; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Mastrianni JA, 1999, NEW ENGL J MED, V340, P1630, DOI 10.1056/NEJM199905273402104; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Post K, 2000, ARCH VIROL, P265; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner Stanley B., 2004, VVolume 41, P187; Prusiner Stanley B., 2004, VVolume 41, P89; Supattapone S, 2001, J VIROL, V75, P1408, DOI 10.1128/JVI.75.3.1408-1413.2001; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Will Robert G., 2004, VVolume 41, P629; Wille H, 1996, J MOL BIOL, V259, P608, DOI 10.1006/jmbi.1996.0343; Wille H, 1999, BIOPHYS J, V76, P1048, DOI 10.1016/S0006-3495(99)77270-X	41	831	855	1	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					673	676		10.1126/science.1100195	http://dx.doi.org/10.1126/science.1100195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286374				2022-12-28	WOS:000222992100050
J	Korzhnev, DM; Salvatella, X; Vendruscolo, M; Di Nardo, AA; Davidson, AR; Dobson, CM; Kay, LE				Korzhnev, DM; Salvatella, X; Vendruscolo, M; Di Nardo, AA; Davidson, AR; Dobson, CM; Kay, LE			Low-populated folding intermediates of Fyn SH3 characterized by relaxation dispersion NMR	NATURE			English	Article							TRANSITION-STATE; PROTEIN; DOMAIN; KINETICS	Many biochemical processes proceed through the formation of functionally significant intermediates(1,2). Although the identification and characterization of such species can provide vital clues about the mechanisms of the reactions involved, it is challenging to obtain information of this type in cases where the intermediates are transient or present only at low population(1-4). One important example of such a situation involves the folding behaviour of small proteins that represents a model for the acquisition of functional structure in biology(1). Here we use relaxation dispersion nuclear magnetic resonance (NMR) spectroscopy to identify, for two mutational variants of one such protein, the SH3 domain from Fyn tyrosine kinase(5), a low-population folding intermediate in equilibrium with its unfolded and fully folded states. By performing the NMR experiments at different temperatures, this approach has enabled characterization of the kinetics and energetics of the folding process as well as providing structures of the intermediates. A general strategy emerges for an experimental determination of the energy landscape of a protein by applying this methodology to a series of mutants whose intermediates have differing degrees of native-like structure.	Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Prot Engn Network Ctr Excellence, Toronto, ON M5S 1A8, Canada; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Cambridge	Kay, LE (corresponding author), Univ Toronto, Dept Mol & Med Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	cmd44@cam.ac.uk; kay@pound.med.utoronto.ca	Di Nardo, Ariel A/P-4442-2017; Vendruscolo, Michele/F-5901-2012; Salvatella, Xavier/C-7337-2008	Di Nardo, Ariel A/0000-0003-2944-488X; Vendruscolo, Michele/0000-0002-3616-1610; Salvatella, Xavier/0000-0002-8371-4185				BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Di Nardo AA, 2004, P NATL ACAD SCI USA, V101, P7954, DOI 10.1073/pnas.0400550101; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Grantcharova VP, 2000, P NATL ACAD SCI USA, V97, P7084, DOI 10.1073/pnas.97.13.7084; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; KAHN F, 2003, J MOL BIOL, V333, P169; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; NOBLE MEM, 1993, EMBO J, V12, P2617, DOI 10.1002/j.1460-2075.1993.tb05922.x; Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748; Northey JGB, 2002, J MOL BIOL, V320, P389, DOI 10.1016/S0022-2836(02)00445-X; OLIVEBERG M, 1995, P NATL ACAD SCI USA, V92, P8926, DOI 10.1073/pnas.92.19.8926; Paci E, 2002, J MOL BIOL, V324, P151, DOI 10.1016/S0022-2836(02)00944-0; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Plaxco KW, 1998, BIOCHEMISTRY-US, V37, P2529, DOI 10.1021/bi972075u; Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Vetterling W.T., 1988, NUMERICAL RECIPES C; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xu XP, 2002, BIOPOLYMERS, V65, P408, DOI 10.1002/bip.10276	28	390	396	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					586	590		10.1038/nature02655	http://dx.doi.org/10.1038/nature02655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282609				2022-12-28	WOS:000222946100054
J	Maynard, A; Bloor, K; Freemantle, N				Maynard, A; Bloor, K; Freemantle, N			Challenges for the National Institute for Clinical Excellence	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FAIR INNINGS		Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of York - UK; University of Birmingham	Maynard, A (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	akm3@york.ac.uk		Bloor, Karen/0000-0003-4852-9854; Freemantle, Nick/0000-0001-5807-5740				*ASS BRIT PHARM IN, 1999, EXP PAT; Department of Health, 2003, PHARM PRIC REG SCHEM; Freemantle N, 2002, PHARMACOECONOMICS, V20, P389, DOI 10.2165/00019053-200220060-00003; Garattini S, 2002, BMJ-BRIT MED J, V325, P269, DOI 10.1136/bmj.325.7358.269; Hopkins Tanne Janice, 2003, BMJ, V327, P830, DOI 10.1136/bmj.327.7419.830-d; Maynard A, 1997, BRIT MED J, V315, P200, DOI 10.1136/bmj.315.7102.200; RAWLINS MD, 2004, BRIT MED J, V328, P224; Williams A, 1997, HEALTH ECON, V6, P117, DOI 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B	8	47	48	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2004	329	7459					227	229		10.1136/bmj.329.7459.227	http://dx.doi.org/10.1136/bmj.329.7459.227			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840NW	15271837	Green Published, Green Accepted			2022-12-28	WOS:000222866900025
J	Pewsner, D; Battaglia, M; Minder, C; Marx, A; Bucher, HC; Egger, M				Pewsner, D; Battaglia, M; Minder, C; Marx, A; Bucher, HC; Egger, M			Ruling a diagnosis in or out with "SpPIn" and "SnNOut": a note of caution	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OTTAWA ANKLE RULES; ALZHEIMERS-DISEASE; CLINICAL-DIAGNOSIS; DECISION RULES; HEART-FAILURE; ACCURACY; ASCITES		Univ Bern, Dept Social & Prevent Med, Div Epidemiol & Biostat, CH-3012 Bern, Switzerland; Univ Bern, Inselspital, Dept Gen Internal Med, CH-3010 Bern, Switzerland; Univ Hosp, Basel Inst Clin Epidemiol, Basel, Switzerland; Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol, Avon, England	University of Bern; University of Bern; University Hospital of Bern; University of Bristol	Egger, M (corresponding author), Univ Bern, Dept Social & Prevent Med, Div Epidemiol & Biostat, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	egger@ispm.unibe.ch		Egger, Matthias/0000-0001-7462-5132				Auleley GR, 1998, ANN EMERG MED, V32, P14, DOI 10.1016/S0196-0644(98)70093-9; Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Bakker AJ, 1999, DIABETES CARE, V22, P307, DOI 10.2337/diacare.22.2.307; Barry HC, 1997, ENDOCRIN METAB CLIN, V26, P45, DOI 10.1016/S0889-8529(05)70233-4; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; BUSH B, 1987, AM J MED, V82, P231, DOI 10.1016/0002-9343(87)90061-1; CHERPITEL CJ, 1995, ALCOHOL CLIN EXP RES, V19, P628, DOI 10.1111/j.1530-0277.1995.tb01559.x; Davie AP, 1997, QJM-MON J ASSOC PHYS, V90, P335, DOI 10.1093/qjmed/90.5.335; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; GUARINO JR, 1994, J GEN INTERN MED, V9, P71, DOI 10.1007/BF02600204; Horvath AR, 2004, CLIN CHIM ACTA, V342, P23, DOI 10.1016/j.cccn.2003.12.015; LEVIN BE, 1978, ARCH NEUROL-CHICAGO, V35, P37, DOI 10.1001/archneur.1978.00500250041009; MARANTZ PR, 1990, CHEST, V97, P776, DOI 10.1378/chest.97.4.776; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; *MOUNT SIN HOSP CT, SENS SPEC; *NAT EL LIB HLTH, FULL TEXT GUID COLL; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; SACKETT DL, 1992, CLIN EPIDEMIOLOGY BA; Schwartz A, 2003, BRIT MED J, V326, P536, DOI 10.1136/bmj.326.7388.536; SIMEL DL, 1988, J GEN INTERN MED, V3, P423, DOI 10.1007/BF02595917; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; *U OXF CTR EV BAS, SPPINS SNNOUTS; Varma AR, 1999, J NEUROL NEUROSUR PS, V66, P184, DOI 10.1136/jnnp.66.2.184; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; WILLIAMS JW, 1992, JAMA-J AM MED ASSOC, V267, P2645, DOI 10.1001/jama.267.19.2645	25	96	98	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2004	329	7459					209	213		10.1136/bmj.329.7459.209	http://dx.doi.org/10.1136/bmj.329.7459.209			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840NW	15271832	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000222866900020
J	Danchin, E; Giraldeau, LA; Valone, TJ; Wagner, RH				Danchin, E; Giraldeau, LA; Valone, TJ; Wagner, RH			Public information: From nosy neighbors to cultural evolution	SCIENCE			English	Review							BREEDING HABITAT SELECTION; MATE-CHOICE; DENSITY; PERSPECTIVE; STARLINGS; DIALECTS; SUCCESS; TRAITS; BIRDS; FISH	Psychologists, economists, and advertising moguls have long known that human decision-making is strongly influenced by the behavior of others. A rapidly accumulating body of evidence suggests that the same is true in animals. Individuals can use information arising from cues inadvertently produced by the behavior of other individuals with similar requirements. Many of these cues provide public information about the quality of alternatives. The use of public information is taxonomically widespread and can enhance fitness. Public information can lead to cultural evolution, which we suggest may then affect biological evolution.	UPMC, CNRS, UMR 7625, F-75252 Paris 05, France; Univ Quebec, Dept Sci Biol, Grp Rech Ecol Comportementale & Anim, Montreal, PQ H3C 3P8, Canada; St Louis Univ, Dept Biol, St Louis, MO 63103 USA; Austrian Acad Sci, Konrad Lorenz Inst, A-1160 Vienna, Austria	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Quebec; University of Quebec Montreal; Saint Louis University; Austrian Academy of Sciences	Danchin, E (corresponding author), UPMC, CNRS, UMR 7625, Bat A,7e Etage,Case 237,7 Quai St Bernard, F-75252 Paris 05, France.	edanchin@snv.jussieu.fr; giraldeau.luc-alain@uqam.ca; valone@slu.edu; r.wagner@klivv.oeaw.ac.at	Danchin, Etienne/AAB-2091-2021; Danchin, Etienne/A-2299-2009	Danchin, Etienne/0000-0002-5013-9612; Valone, Thomas/0000-0002-7657-3126				Andersson Malte, 1994; Blackmore S., 1999, MEME MACHINE; Boyd R., 1988, P29; Brooks R, 2001, EVOLUTION, V55, P1002, DOI 10.1554/0014-3820(2001)055[1002:DAISSA]2.0.CO;2; Buckley NJ, 1997, AM NAT, V149, P1091, DOI 10.1086/286040; CAVALLI-SFORZA L.L, 1981, CULTURAL TRANSMISSIO; Chilton G, 1996, CONDOR, V98, P567, DOI 10.2307/1369569; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Coolen I, 2003, P ROY SOC B-BIOL SCI, V270, P2413, DOI 10.1098/rspb.2003.2525; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Danchin Etienne, 2001, P243; DEUTSCH JC, 1992, NATURE, V356, P596, DOI 10.1038/356596a0; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Doligez B, 2004, J ANIM ECOL, V73, P75, DOI 10.1111/j.1365-2656.2004.00782.x; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Doutrelant C, 2001, BEHAV ECOL, V12, P283, DOI 10.1093/beheco/12.3.283; Doutrelant C, 2000, BEHAVIOUR, V137, P1655, DOI 10.1163/156853900502763; DUGATKIN LA, 1999, IMITATION FACTOR EVO; Emery NJ, 2001, NATURE, V414, P443, DOI 10.1038/35106560; Feldman MW, 1996, TRENDS ECOL EVOL, V11, P453, DOI 10.1016/0169-5347(96)10052-5; FELDMAN MW, 1984, P NATL ACAD SCI-BIOL, V81, P1604, DOI 10.1073/pnas.81.5.1604; GALEF BG, 1990, CAN J PSYCHOL, V44, P311, DOI 10.1037/h0084261; Gasparini J, 2001, P ROY SOC B-BIOL SCI, V268, P647, DOI 10.1098/rspb.2000.1411; Grant BR, 2002, BIOL J LINN SOC, V76, P545, DOI 10.1046/j.1095-8312.2002.00076.x; Hunt GR, 2001, NATURE, V414, P707, DOI 10.1038/414707a; Hunt GR, 2003, P ROY SOC B-BIOL SCI, V270, P867, DOI 10.1098/rspb.2002.2302; Iyengar VK, 2002, NATURE, V419, P830, DOI 10.1038/nature01027; Jablonka E, 1998, TRENDS ECOL EVOL, V13, P206, DOI 10.1016/S0169-5347(98)01344-5; Johnstone RA, 2001, P NATL ACAD SCI USA, V98, P9177, DOI 10.1073/pnas.161058798; Karban R, 2002, ECOLOGY, V83, P1209, DOI 10.1890/0012-9658(2002)083[1209:TFCOIE]2.0.CO;2; Laland KN, 2000, BEHAV BRAIN SCI, V23, P131, DOI 10.1017/S0140525X00002417; Lotem A, 1999, BEHAV ECOL, V10, P209, DOI 10.1093/beheco/10.2.209; MacDougall-Shackleton EA, 2001, EVOLUTION, V55, P2568, DOI 10.1111/j.0014-3820.2001.tb00769.x; McGregor Peter K., 2000, Acta Ethologica, V2, P71, DOI 10.1007/s102110000015; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Mesoudi A, 2004, EVOLUTION, V58, P1; NELSON DA, 1995, ANIM BEHAV, V50, P83, DOI 10.1006/anbe.1995.0223; Nordell SE, 1998, ECOL LETT, V1, P74; Oliveira RF, 2001, NATURE, V409, P475, DOI 10.1038/35054128; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; Part T, 2003, P ROY SOC B-BIOL SCI, V270, P1809, DOI 10.1098/rspb.2003.2419; Smith JW, 1999, BEHAV ECOL, V10, P54, DOI 10.1093/beheco/10.1.54; SOLTIS J, 1995, CURR ANTHROPOL, V36, P473, DOI 10.1086/204381; Templeton JJ, 1996, BEHAV ECOL SOCIOBIOL, V38, P105, DOI 10.1007/s002650050223; TEMPLETON JJ, 1995, BEHAV ECOL, V6, P65, DOI 10.1093/beheco/6.1.65; VALONE TJ, 1989, OIKOS, V56, P357, DOI 10.2307/3565621; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Veen J., 1977, BEHAVIOUR, V20, P1, DOI DOI 10.2307/30039178; WADE MJ, 1990, P NATL ACAD SCI USA, V87, P5749, DOI 10.1073/pnas.87.15.5749; Wagner RH, 2000, BEHAV ECOL, V11, P572, DOI 10.1093/beheco/11.5.572; Wagner RH, 2003, ANIM BEHAV, V65, P405, DOI 10.1006/anbe.2003.2037; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Warren PS, 2003, ANIM BEHAV, V65, P1169, DOI 10.1006/anbe.2003.2156; Whitehead H, 2004, J ANIM ECOL, V73, P190, DOI 10.1111/j.1365-2656.2004.00798.x; Wiens JJ, 2001, TRENDS ECOL EVOL, V16, P517, DOI 10.1016/S0169-5347(01)02217-0; Wilkinson GS, 1998, BEHAV ECOL, V9, P525, DOI 10.1093/beheco/9.5.525; Witte K, 2002, BEHAV ECOL SOCIOBIOL, V52, P194, DOI 10.1007/s00265-002-0503-1	59	1026	1042	7	313	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2004	305	5683					487	491		10.1126/science.1098254	http://dx.doi.org/10.1126/science.1098254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273386	Green Submitted			2022-12-28	WOS:000222828900030
J	True, HL; Berlin, I; Lindquist, SL				True, HL; Berlin, I; Lindquist, SL			Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST PRION; PHENOTYPIC PLASTICITY; TERMINATION CODONS; SPECIES BARRIER; SUP35 PROTEIN; EVOLUTION; READTHROUGH; MECHANISM; CAPACITOR	Phenotypic plasticity and the exposure of hidden genetic variation both affect the survival and evolution of new traits(1-3), but their contributing molecular mechanisms are largely unknown. A single factor, the yeast prion [PSI+], may exert a profound effect on both(4). [PSI+] is a conserved, protein-based genetic element that is formed by a change in the conformation and function of the translation termination factor Sup35p(5), and is transmitted from mother to progeny. Curing cells of [PSI+] alters their survival in different growth conditions and produces a spectrum of phenotypes in different genetic backgrounds(4). Here we show, by examining three plausible explanations for this phenotypic diversity, that all traits tested involved [PSI+]-mediated read-through of nonsense codons. Notably, the phenotypes analysed were genetically complex, and genetic re-assortment frequently converted [PSI+]-dependent phenotypes to stable traits that persisted in the absence of [PSI+]. Thus, [PSI+] provides a temporary survival advantage under diverse conditions, increasing the likelihood that new traits will become fixed by subsequent genetic change. As an epigenetic mechanism that globally affects the relationship between genotype and phenotype, [PSI+] expands the conceptual framework for phenotypic plasticity, provides a one-step mechanism for the acquisition of complex traits and affords a route to the genetic assimilation of initially transient epigenetic traits.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindquist, SL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	True, Heather/D-2979-2012					Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Behera N, 2004, J THEOR BIOL, V226, P177, DOI 10.1016/j.jtbi.2003.08.011; Bradley ME, 2003, YEAST, V20, P625, DOI 10.1002/yea.985; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 1996, P NATL ACAD SCI USA, V93, P2517, DOI 10.1073/pnas.93.6.2517; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; FIROOZAN M, 1991, YEAST, V7, P173, DOI 10.1002/yea.320070211; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Guthrie C, 1991, GUIDE YEAST GENETICS; Harrison P, 2002, J MOL BIOL, V316, P409, DOI 10.1006/jmbi.2001.5343; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; LUND PM, 1981, GENET RES, V37, P173, DOI 10.1017/S0016672300020140; Masel J, 2003, EVOLUTION, V57, P1498; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Namy O, 2003, NUCLEIC ACIDS RES, V31, P2289, DOI 10.1093/nar/gkg330; Namy O, 2002, MOL MICROBIOL, V43, P641, DOI 10.1046/j.1365-2958.2002.02770.x; Pigliucci M, 2003, EVOLUTION, V57, P1455; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603	30	262	280	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					184	187		10.1038/nature02885	http://dx.doi.org/10.1038/nature02885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15311209				2022-12-28	WOS:000223746000044
J	Annane, D; Bellissant, E; Bollaert, PE; Briegel, J; Keh, D; Kupfer, Y				Annane, D; Bellissant, E; Bollaert, PE; Briegel, J; Keh, D; Kupfer, Y			Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HIGH-DOSE METHYLPREDNISOLONE; DOUBLE-BLIND; CORTISOL RESPONSE; STEROID-THERAPY; HYDROCORTISONE; EPIDEMIOLOGY; MORTALITY; TRIAL	Objective To assess the effects of corticosteroids on mortality in patients with severe sepsis and septic shock. Data sources Randomised and quasi-randomised trials of corticosteroids versus placebo (or supportive treatment alone) retrieved from the Cochrane infectious diseases group's trials register, the Cochrane central register of controlled trials, Medline, Embase, and LILACS. Review method Two pairs of reviewers agreed on eligibility of trials. One reviewer entered data on to the computer and four reviewers checked them. We obtained some missing data from authors of trials and assessed methodological quality of trials. Results 16/23 trials (n=2063) were selected. Corticosteroids; did not change 28 day mortality (15 trials, n=2022; relative risk 0.92, 95% confidence interval 0.75 to 1.14) or hospital mortality (13 trials, n=1418; 0.89, 0.71 to 1.11). There was significant heterogeneity Subgroup analysis on long courses (greater than or equal to5 days) with low dose (less than or equal to300 mg hydrocortisone or equivalent) corticosteroids showed no more heterogeneity The relative risk for mortality was 0.80 at 28 days (five trials, n=465; 0.67 to 0.95) and 0.83 at hospital discharge (five trials, n=465, 0.71 to 0.97). Use of corticosteroids reduced mortality in intensive care units (four trials, n=425, 0.83, 0.70 to 0.97), increased shock reversal at 7 days (four trials, n=425; 1.60, 1.27 to 2.03) and 28 days (four trials, n=425, 1.26, 1.04 to 1.52) without inducing side effects. Conclusions For all trials, regardless of duration of, treatment and dose, use of corticosteroids did not significantly affect mortality. With long courses of low doses of corticosteroids, however, mortality at 28 days and hospital morality was reduced.	Univ Versailles, Assistance Publ Hop Paris, Hop Raymond Poincare, Crit Care Dept, F-92380 Garches, France; Univ Rennes 1, CHU, Hop Pontchaillou, INSERM,U0203,Clin Invest Ctr, F-35033 Rennes, France; Univ Nancy 1, CHU, Hop Cent, Crit Care Dept, F-54000 Nancy, France; Klinikum Univ Munchen, Inst Anaesthesiol, D-81366 Munich, Germany; Intens Care Unit, D-13353 Berlin, Germany; Maimonides Hosp, Div Pulm & Crit Care Med, Brooklyn, NY 11219 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU de Nancy; Universite de Lorraine; University of Munich; Maimonides Medical Center	Annane, D (corresponding author), Univ Versailles, Assistance Publ Hop Paris, Hop Raymond Poincare, Crit Care Dept, F-92380 Garches, France.	djillali.annane@rpc.ap-hop-paris.fr	Josef, Briegel/ABF-3522-2021; Briegel, Josef/AAG-3774-2019; Annane, Djillali/R-7947-2019	Briegel, Josef/0000-0003-2837-8008; 				Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2003, SHOCK, V20, P197, DOI 10.1097/01.shk.0000079423.72656.2f; Annane D., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002243.pub2, DOI 10.1002/14651858.CD002243.PUB2]; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Chawla K, 1999, CRIT CARE MED, V27, pA33, DOI 10.1097/00003246-199901001-00022; CLARKE M, 2003, COCHRANE LIB, V3; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; CRONIN L, 1995, CRIT CARE MED, V23, P1430, DOI 10.1097/00003246-199508000-00019; Group CS, 1963, JAMA-J AM MED ASSOC, V183, P462, DOI DOI 10.1001/JAMA.1963.63700060029012; HAHN EO, 1951, J CLIN INVEST, V30, P274, DOI 10.1172/JCI102441; HUGHES GS, 1984, LIFE SCI, V35, P2319, DOI 10.1016/0024-3205(84)90523-X; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; KLASTERSKY J, 1971, NEW ENGL J MED, V284, P1248, DOI 10.1056/NEJM197106032842206; LEFERING R, 1995, CRIT CARE MED, V23, P1294, DOI 10.1097/00003246-199507000-00021; LUCAS CE, 1984, ARCH SURG-CHICAGO, V119, P537; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; MCKEE JI, 1983, LANCET, V1, P484; Meduri GU, 1998, CHEST, V114, P355, DOI 10.1378/chest.114.2.355-a; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; PEDUZZI P, 1987, NEW ENGL J MED, V317, P659; Rangel-Frausto MS, 1998, CLIN INFECT DIS, V27, P185, DOI 10.1086/514630; ROGERS J, 1970, British Journal of Urology, V42, P742; ROTHWELL PM, 1991, LANCET, V337, P582, DOI 10.1016/0140-6736(91)91641-7; SCHUMER W, 1976, ANN SURG, V184, P333, DOI 10.1097/00000658-197609000-00011; Slusher T, 1996, PEDIATR INFECT DIS J, V15, P579, DOI 10.1097/00006454-199607000-00004; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; THOMPSON WL, 1976, CLIN RES, V24, pA258; WAGNER HN, 1956, B JOHNS HOPKINS HOSP, V98, P197; WEIGELT JA, 1985, ARCH SURG-CHICAGO, V120, P536; Yildiz O, 2002, CRIT CARE, V6, P251, DOI 10.1186/cc1498	37	311	332	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2004	329	7464					480	484		10.1136/bmj.38181.482222.55	http://dx.doi.org/10.1136/bmj.38181.482222.55			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KS	15289273	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000223684600012
J	Schofer, J; Schluter, M				Schofer, J; Schluter, M			Are drug-eluting stents a panacea for patients with coronary heart disease?	LANCET			English	Editorial Material							RESTENOSIS; IMPLANTATION; LESIONS		Ctr Cardiol & Vasc Intervent, D-22763 Hamburg, Germany		Schofer, J (corresponding author), Ctr Cardiol & Vasc Intervent, Othmarscher Kirchenweg 168, D-22763 Hamburg, Germany.	schofer@center-for-cardiology.de						ABIZAID A, REAL WORLD EVALUATIO; Colombo A, 2004, CIRCULATION, V109, P1244, DOI 10.1161/01.CIR.0000118474.71662.E3; Degertekin M, 2004, AM J CARDIOL, V93, P826, DOI 10.1016/j.amjcard.2003.12.018; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; Fujii K, 2004, CIRCULATION, V109, P1085, DOI 10.1161/01.CIR.0000121327.67756.19; Hoye A, 2004, J AM COLL CARDIOL, V43, P1954, DOI 10.1016/j.jacc.2004.01.045; Lemos PA, 2004, J AM COLL CARDIOL, V43, P704, DOI 10.1016/j.jacc.2003.12.022; MORICE MC, 3 YEAR FOLLOW UP RAV; Moussa I, 2004, CIRCULATION, V109, P2273, DOI 10.1161/01.CIR.0000129767.45513.71; Orlic D, 2004, J AM COLL CARDIOL, V43, P1154, DOI 10.1016/j.jacc.2003.10.052; SOUSA JE, LONG TERM FOLLOW UP; Tanabe K, 2003, CIRCULATION, V107, P559, DOI 10.1161/01.CIR.0000048184.96491.8A; URBAN P, EXPERIENCE BASED MED; Waksman R, 2004, CIRCULATION, V109, P340, DOI 10.1161/01.CIR.0000109488.62415.01	14	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					558	559		10.1016/S0140-6736(04)16862-1	http://dx.doi.org/10.1016/S0140-6736(04)16862-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313338				2022-12-28	WOS:000223275100004
J	Kuper, J; Llamas, A; Hecht, HJ; Mendel, RR; Schwarz, G				Kuper, J; Llamas, A; Hecht, HJ; Mendel, RR; Schwarz, G			Structure of the molybdopterin-bound Cnx1G domain links molybdenum and copper metabolism	NATURE			English	Article							ESCHERICHIA-COLI MOEA; CRYSTAL-STRUCTURE; SULFITE OXIDASE; NITRATE REDUCTASE; SULFUR METABOLISM; MOLECULAR-BASIS; PROTEIN; COFACTOR; INSIGHTS; ENZYMES	The molybdenum cofactor is part of the active site of all molybdenum-dependent enzymes(1), except nitrogenase. The molybdenum cofactor consists of molybdopterin, a phosphorylated pyranopterin(2), with an ene-dithiolate coordinating molybdenum. The same pyranopterin-based cofactor is involved in metal coordination of the homologous tungsten-containing enzymes found in archea(3). The molybdenum cofactor is synthesized by a highly conserved biosynthetic pathway(4). In plants, the multidomain protein Cnx1 catalyses the insertion of molybdenum into molybdopterin. The Cnx1 G domain (Cnx1G), whose crystal structure has been determined in its apo form, binds molybdopterin with high affinity and participates in the catalysis of molybdenum insertion. Here we present two high-resolution crystal structures of Cnx1G in complex with molybdopterin and with adenylated molybdopterin ( molybdopterin - AMP), a mechanistically important intermediate. Molybdopterin - AMP is the reaction product of Cnx1G and is subsequently processed in a magnesium-dependent reaction by the amino-terminal E domain of Cnx1 to yield active molybdenum cofactor. The unexpected identification of copper bound to the molybdopterin dithiolate sulphurs in both structures, coupled with the observed copper inhibition of Cnx1G activity, provides a molecular link between molybdenum and copper metabolism.	Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, D-38106 Braunschweig, Germany; German Res Ctr Biotechnol, D-38124 Braunschweig, Germany	Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Schwarz, G (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, Spielmannstr 7, D-38106 Braunschweig, Germany.	g.schwarz@tu-bs.de	Schwarz, Guenter/ABE-9643-2021; Llamas, Angel/L-1638-2014; Llamas, Angel/B-7104-2015	Schwarz, Guenter/0000-0002-2118-9338; Llamas, Angel/0000-0001-6042-9472; Llamas, Angel/0000-0001-6042-9472				Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; Enemark JH, 2002, MET IONS BIOL SYST, V39, P621; Guse A, 2003, J BIOL CHEM, V278, P25302, DOI 10.1074/jbc.M302639200; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; JOHNSON JL, 1980, P NATL ACAD SCI-BIOL, V77, P3715, DOI 10.1073/pnas.77.6.3715; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Kuper J, 2000, P NATL ACAD SCI USA, V97, P6475, DOI 10.1073/pnas.110568497; Kuper J, 2003, ARCH BIOCHEM BIOPHYS, V411, P36, DOI 10.1016/S0003-9861(02)00714-2; Kuper J, 2003, FEMS MICROBIOL LETT, V218, P187, DOI 10.1016/S0378-1097(02)01121-7; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; MASON J, 1986, TOXICOLOGY, V42, P99, DOI 10.1016/0300-483X(86)90001-6; Mendel RR, 1999, CRIT REV PLANT SCI, V18, P33, DOI 10.1016/S0735-2689(99)00386-X; Mendel RR, 2002, MET IONS BIOL SYST, V39, P317; Mercer JFB, 2001, TRENDS MOL MED, V7, P64, DOI 10.1016/S1471-4914(01)01920-7; Moorhead GBG, 2003, EUR J BIOCHEM, V270, P1356, DOI 10.1046/j.1432-1033.2003.03509.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; Santamaria-Araujo JA, 2004, J BIOL CHEM, V279, P15994, DOI 10.1074/jbc.M311815200; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; Schrag JD, 2001, J MOL BIOL, V310, P419, DOI 10.1006/jmbi.2001.4771; Schwarz G, 2000, PLANT CELL, V12, P2455, DOI 10.1105/tpc.12.12.2455; SHIH VE, 1977, NEW ENGL J MED, V297, P1022, DOI 10.1056/NEJM197711102971902; Stiefel EI, 1996, SCIENCE, V272, P1599, DOI 10.1126/science.272.5268.1599; Xiang S, 2001, STRUCTURE, V9, P299, DOI 10.1016/S0969-2126(01)00588-3	30	153	160	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					803	806		10.1038/nature02681	http://dx.doi.org/10.1038/nature02681			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306815				2022-12-28	WOS:000223233600047
J	Murphy, JM; Sexton, DMH; Barnett, DN; Jones, GS; Webb, MJ; Stainforth, DA				Murphy, JM; Sexton, DMH; Barnett, DN; Jones, GS; Webb, MJ; Stainforth, DA			Quantification of modelling uncertainties in a large ensemble of climate change simulations	NATURE			English	Article							PROBABILITY; RELIABILITY; SENSITIVITY; PROJECTIONS; CONSTRAINTS; PREDICTION; WEATHER	Comprehensive global climate models(1) are the only tools that account for the complex set of processes which will determine future climate change at both a global and regional level. Planners are typically faced with a wide range of predicted changes from different models of unknown relative quality(2,3), owing to large but unquantified uncertainties in the modelling process(4). Here we report a systematic attempt to determine the range of climate changes consistent with these uncertainties, based on a 53-member ensemble of model versions constructed by varying model parameters. We estimate a probability density function for the sensitivity of climate to a doubling of atmospheric carbon dioxide levels, and obtain a 5 - 95 per cent probability range of 2.4-5.4degreesC. Our probability density function is constrained by objective estimates of the relative reliability of different model versions, the choice of model parameters that are varied and their uncertainty ranges, specified on the basis of expert advice. Our ensemble produces a range of regional changes much wider than indicated by traditional methods based on scaling the response patterns of an individual simulation(5,6).	Hadley Ctr Climate Predict & Res, Met Off, Exeter EX1 3PB, Devon, England; Univ Oxford, Dept Phys, Oxford OX1 3PU, England	Met Office - UK; Hadley Centre; University of Oxford	Murphy, JM (corresponding author), Hadley Ctr Climate Predict & Res, Met Off, FitzRoy Rd, Exeter EX1 3PB, Devon, England.	james.murphy@metoffice.com	Jones, Gareth/H-8022-2013; Collins, Matthew/F-8473-2011	Collins, Matthew/0000-0003-3785-6008; Stainforth, David/0000-0001-6476-733X	Natural Environment Research Council [NER/J/S/2002/00737] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allen MR, 2000, NATURE, V407, P617, DOI 10.1038/35036559; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Anderson TL, 2003, SCIENCE, V300, P1103, DOI 10.1126/science.1084777; Andronova NG, 2001, J GEOPHYS RES-ATMOS, V106, P22605, DOI 10.1029/2000JD000259; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Boer GJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016549; CUBASCH U, 2001, CLIMATE CHANGE 2001, P527; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; Giorgi F, 2000, GEOPHYS RES LETT, V27, P1295, DOI 10.1029/1999GL011016; Giorgi F, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017130; Giorgi F, 2002, J CLIMATE, V15, P1141, DOI 10.1175/1520-0442(2002)015<1141:COAURA>2.0.CO;2; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Gregory JM, 2002, J CLIMATE, V15, P3117, DOI [10.1175/1520-0442(2002)015<3117:AOBEOT>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3117:AOBEOT&gt;2.0.CO;2]; Keen AB, 1997, CLIM DYNAM, V13, P847, DOI 10.1007/s003820050201; Knutti R, 2002, NATURE, V416, P719, DOI 10.1038/416719a; Leroy SS, 1998, J CLIMATE, V11, P640, DOI 10.1175/1520-0442(1998)011<0640:DCSSBA>2.0.CO;2; Mearns LO, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P739; Meehl GA, 2000, B AM METEOROL SOC, V81, P427, DOI 10.1175/1520-0477(2000)081<0427:TIEWAC>2.3.CO;2; Palmer TN, 2002, NATURE, V415, P512, DOI 10.1038/415512a; Palmer TN, 2001, Q J ROY METEOR SOC, V127, P279, DOI 10.1256/smsqj.57201; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; Randall DA, 1997, B AM METEOROL SOC, V78, P399, DOI 10.1175/1520-0477(1997)078<0399:MMOHIT>2.0.CO;2; Senior CA, 2000, GEOPHYS RES LETT, V27, P2685, DOI 10.1029/2000GL011373; STAINFORTH DA, UNPUB NATURE; Stocker TF, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P417; Stott PA, 2002, NATURE, V416, P723, DOI 10.1038/416723a; Stouffer RJ, 1999, J CLIMATE, V12, P2224, DOI 10.1175/1520-0442(1999)012<2224:ROACOA>2.0.CO;2; Watterson IG, 2000, J CLIMATE, V13, P202, DOI 10.1175/1520-0442(2000)013<0202:IOSGWU>2.0.CO;2; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604	29	1176	1208	6	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					768	772		10.1038/nature02771	http://dx.doi.org/10.1038/nature02771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306806				2022-12-28	WOS:000223233600038
J	Hultman, CM; Sparen, P				Hultman, CM; Sparen, P			Autism - prenatal insults or an epiphenomenon of a strongly genetic disorder?	LANCET			English	Editorial Material							PERINATAL RISK-FACTORS; SCHIZOPHRENIA		Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden	Karolinska Institutet	Hultman, CM (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden.	Christina.Hultman@meb.ki.se		Sparen, Par/0000-0002-5184-8971				Cnattingius S, 1999, ARCH GEN PSYCHIAT, V56, P634, DOI 10.1001/archpsyc.56.7.634; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; Hultman CM, 1999, BRIT MED J, V318, P421, DOI 10.1136/bmj.318.7181.421; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Nilsson E, 2002, SCHIZOPHR RES, V58, P221, DOI 10.1016/S0920-9964(01)00370-X; RODIER PM, 2004, CLIN MOL TERATOL, V70, P1	8	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					485	487		10.1016/S0140-6736(04)16825-6	http://dx.doi.org/10.1016/S0140-6736(04)16825-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302177				2022-12-28	WOS:000223132700008
J	Prideaux, D				Prideaux, D			Commentary: Promises and delivery - a research imperative for new approaches to medical education	BRITISH MEDICAL JOURNAL			English	Article									Flinders Univ S Australia, Dept Med Educ, Adelaide, SA 5001, Australia	Flinders University South Australia	Prideaux, D (corresponding author), Flinders Univ S Australia, Dept Med Educ, GPO Box 2100, Adelaide, SA 5001, Australia.	david.prideaux@flinders.edu.au		Prideaux, David/0000-0001-6695-2723				FRIEDMAN CP, 1990, ACAD MED, V65, P8, DOI 10.1097/00001888-199001000-00002; Hojat M, 1996, ED HLTH, V9, P99; Howe A, 2004, BRIT MED J, V329, P327, DOI 10.1136/bmj.329.7461.327; Murray E, 2002, MED EDUC, V36, P110, DOI 10.1046/j.1365-2923.2002.01155.x; Prideaux D, 2001, MED EDUC, V35, P495, DOI 10.1046/j.1365-2923.2001.00947.x	5	2	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 7	2004	329	7461					331	332		10.1136/bmj.329.7461.331	http://dx.doi.org/10.1136/bmj.329.7461.331			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846FF	15297340	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000223300300023
J	Wilson, K; Ricketts, MN				Wilson, K; Ricketts, MN			Transfusion transmission of vCJD: a crisis avoided?	LANCET			English	Editorial Material							CREUTZFELDT-JAKOB-DISEASE; BLOOD; VARIANT		Univ Hlth Network, Toronto Gen Hosp, Toronto, ON M5G 2C4, Canada; Hlth Canada, Populat & Publ Hlth Branch, Blood Safety Surveillance & Hlth Care Acquired In, Ottawa, ON K1A 0L2, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Health Canada	Wilson, K (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Toronto, ON M5G 2C4, Canada.	Kumanan.Wilson@uhn.on.ca						Boulton F, 2003, TRANSFUS APHER SCI, V28, P107, DOI 10.1016/S1473-0502(03)00011-9; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Brown Paul, 1996, P139; Flanagan P, 1996, TRANSFUSION MED, V6, P213, DOI 10.1111/j.1365-3148.1996.tb00070.x; Frosh A, 2001, BRIT MED J, V322, P1558, DOI 10.1136/bmj.322.7302.1558; Hebert PC, 2003, JAMA-J AM MED ASSOC, V289, P1941, DOI 10.1001/jama.289.15.1941; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; KIRKUP B, DOH PUBLICATION; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Masood E, 2003, NATURE, V426, P224, DOI 10.1038/426224a; MAYOR S, 2003, MJ, V326, P517; Roberts DR, 2000, LANCET, V356, P330, DOI 10.1016/S0140-6736(00)02516-2; *VCJD WORK PART ST, 2004, CREUTZF JAK DIS; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wilson K, 2003, TRANSFUS MED REV, V17, P89, DOI 10.1053/tmrv.2003.50007	19	26	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					477	479		10.1016/S0140-6736(04)16820-7	http://dx.doi.org/10.1016/S0140-6736(04)16820-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302172				2022-12-28	WOS:000223132700003
J	Herkenhoff, KE; Squyres, SW; Arvidson, R; Bass, DS; Bell, JF; Bertelsen, P; Cabrol, NA; Gaddis, L; Hayes, AG; Hviid, SF; Johnson, JR; Kinch, KM; Madsen, MB; Maki, JN; McLennan, SM; McSween, HY; Rice, JW; Sims, M; Smith, PH; Soderblom, LA; Spanovich, N; Sullivan, R; Wang, A				Herkenhoff, KE; Squyres, SW; Arvidson, R; Bass, DS; Bell, JF; Bertelsen, P; Cabrol, NA; Gaddis, L; Hayes, AG; Hviid, SF; Johnson, JR; Kinch, KM; Madsen, MB; Maki, JN; McLennan, SM; McSween, HY; Rice, JW; Sims, M; Smith, PH; Soderblom, LA; Spanovich, N; Sullivan, R; Wang, A			Textures of the soils and rocks at Gusev crater from Spirit's Microscopic Imager	SCIENCE			English	Article							ROVER	The Microscopic Imager on the Spirit rover analyzed the textures of the soil and rocks at Gusev crater on Mars at a resolution of 100 micrometers. Weakly bound agglomerates of dust are present in the soil near the Columbia Memorial Station. Some of the brushed or abraded rock surfaces show igneous textures and evidence for alteration rinds, coatings, and veins consistent with secondary mineralization. The rock textures are consistent with a volcanic origin and subsequent alteration and/or weathering by impact events, wind, and possibly water.	US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Space Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Copenhagen, Danish Space Res Inst, Ctr Planetary Sci, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Niels Bohr Inst Astron Phys & Geophys, DK-1168 Copenhagen, Denmark; NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Aarhus Univ, Inst Phys & Astron, Aarhus, Denmark; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Washington Univ, Dept Earth & Space Sci, St Louis, MO 63130 USA; Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA	United States Department of the Interior; United States Geological Survey; Cornell University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Technical University of Denmark; University of Copenhagen; University of Copenhagen; Niels Bohr Institute; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Max Planck Society; Aarhus University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; Arizona State University; Arizona State University-Tempe; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Arizona; Washington University (WUSTL); Washington University (WUSTL)	Herkenhoff, KE (corresponding author), US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA.	kherkenhoff@usgs.gov	Kinch, Kjartan Bergeron/C-5742-2015; Sullivan, Robert/AAR-8193-2020; Hayes, Alexander G/P-2024-2014; Johnson, Jeffrey R/F-3972-2015; Madsen, Morten Bo/D-2082-2011	Kinch, Kjartan Bergeron/0000-0002-4629-8880; Hayes, Alexander G/0000-0001-6397-2630; Johnson, Jeffrey R/0000-0002-5586-4901; Madsen, Morten Bo/0000-0001-8909-5111; McLennan, Scott/0000-0003-4259-7178; Wang, Aimei/0000-0002-6575-4028				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Butler JB, 2001, J HYDRAUL RES, V39, P1, DOI DOI 10.1080/00221686.2001.9628276; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; LANDIS G, 2004, LUNAR PLANETARY SCI, V35; Maki JN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002077; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Rubin DM, 2004, J SEDIMENT RES, V74, P160, DOI 10.1306/052203740160; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; WAGNER JA, UNPUB; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910	19	110	112	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					824	826		10.1126/science.1100015	http://dx.doi.org/10.1126/science.1100015			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297663				2022-12-28	WOS:000223104900036
J	Hinkov, V; Pailhes, S; Bourges, P; Sidis, Y; Ivanov, A; Kulakov, A; Lin, CT; Chen, DP; Bernhard, C; Keimer, B				Hinkov, V; Pailhes, S; Bourges, P; Sidis, Y; Ivanov, A; Kulakov, A; Lin, CT; Chen, DP; Bernhard, C; Keimer, B			Two-dimensional geometry of spin excitations in the high-transition-temperature superconductor YBa2Cu3O6+x	NATURE			English	Article							SINGLE-CRYSTALS; FLUCTUATIONS	The fundamental building block of the copper oxide superconductors is a Cu4O4 square plaquette. The plaquettes in most of these materials are slightly distorted to forma rectangular lattice, for which an influential theory predicts that high-transition-temperature (high-T-c) superconductivity is nucleated in 'stripes' aligned along one of the axes(1-3). This theory received strong support from experiments that indicated a one-dimensional character for the magnetic excitations in the high-T-c material YBa2Cu3O6.6 ( ref. 4). Here we report neutron scattering data on 'untwinned' YBa2Cu3O6+x crystals, in which the orientation of the rectangular lattice is maintained throughout the entire volume. Contrary to the earlier claim(4), we demonstrate that the geometry of the magnetic fluctuations is two-dimensional. Rigid stripe arrays therefore appear to be ruled out over a wide range of doping levels in YBa2Cu3O6+x, but the data may be consistent with liquid-crystalline stripe order(5). The debate about stripes has therefore been reopened.	Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; Ctr Etud Saclay, CNRS, CEA, Lab Leon Brillouin, F-91191 Gif Sur Yvette, France; Inst Max Von Laue Paul Langevin, F-38042 Grenoble 9, France	Max Planck Society; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut Laue-Langevin (ILL)	Keimer, B (corresponding author), Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany.	b.keimer@fkf.mpg.de	Hinkov, Vladimir/D-1495-2016; pailhès, stéphane/AAA-5774-2021	pailhès, stéphane/0000-0002-9221-7092; Bourges, Philippe/0000-0001-9494-0789; Keimer, Bernhard/0000-0001-5220-9023; Bernhard, Christian/0000-0002-9957-3487				Andersen OK, 1995, J PHYS CHEM SOLIDS, V56, P1573, DOI 10.1016/0022-3697(95)00269-3; Arai M, 1999, PHYS REV LETT, V83, P608, DOI 10.1103/PhysRevLett.83.608; Batista CD, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.172508; Bourges P, 2000, SCIENCE, V288, P1234, DOI 10.1126/science.288.5469.1234; Brinckmann J., 2001, PHYS REV B, V65; FENG DL, 2004, ZOOMING CHARGE ORDER; FINE BV, 2003, HYPOTHESIS 2 DIMENSI; Grevin B, 2000, PHYS REV LETT, V85, P1310, DOI 10.1103/PhysRevLett.85.1310; Halboth CJ, 2000, PHYS REV LETT, V85, P5162, DOI 10.1103/PhysRevLett.85.5162; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kruger F, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.134512; Limonov MF, 2000, PHYS REV B, V61, P12412, DOI 10.1103/PhysRevB.61.12412; LIN CT, 1992, PHYSICA C, V195, P291, DOI 10.1016/0921-4534(92)90353-E; Lu DH, 2001, PHYS REV LETT, V86, P4370, DOI 10.1103/PhysRevLett.86.4370; Mook HA, 2000, NATURE, V404, P729, DOI 10.1038/35008005; Mook HA, 1998, NATURE, V395, P580, DOI 10.1038/26931; Oganesyan V, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195109; Onufrieva F, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.054515; POPOVICI M, 1975, ACTA CRYSTALLOGR A, V31, P507, DOI 10.1107/S0567739475001088; REZNIK D, 2003, DISPERSION MAGNETIC; Stock C, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.014502; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; VORONKOVA VI, 1993, PHYSICA C, V218, P175, DOI 10.1016/0921-4534(93)90280-4; Yamada K, 1998, PHYS REV B, V57, P6165, DOI 10.1103/PhysRevB.57.6165; Yamase H, 2000, J PHYS SOC JPN, V69, P332, DOI 10.1143/JPSJ.69.332; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391	28	196	197	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					650	653		10.1038/nature02774	http://dx.doi.org/10.1038/nature02774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295593	Green Submitted			2022-12-28	WOS:000223085400038
J	Ghofrani, HA; Reichenberger, F; Kohstall, MG; Mrosek, EH; Seeger, T; Olschewski, H; Seeger, W; Grimminger, F				Ghofrani, HA; Reichenberger, F; Kohstall, MG; Mrosek, EH; Seeger, T; Olschewski, H; Seeger, W; Grimminger, F			Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest Base Camp - A randomized, double-blind, placebo-controlled crossover trial	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY PULMONARY-HYPERTENSION; NONINVASIVE MEASUREMENT; INHALED ILOPROST; ORAL SILDENAFIL; NITRIC-OXIDE; BLOOD-FLOW; EDEMA; GENE; ECHOCARDIOGRAPHY; ASSOCIATION	Background: Alveolar hypoxia causes pulmonary hypertension and enhanced right ventricular afterload, which may impair exercise tolerance. The phosphodiesterase-5 inhibitor sildenafil has been reported to cause pulmonary vasodilatation. Objective: To investigate the effects of sildenafil on exercise capacity under conditions of hypoxic pulmonary hypertension. Design: Randomized, double-blind, placebo-controlled crossover study. Setting: University Hospital Giessen, Giessen, Germany, and the base camp on Mount Everest. Participants: 14 healthy mountaineers and trekkers. Measurements: Systolic pulmonary artery pressure, cardiac output, and peripheral arterial oxygen saturation at rest and during assessment of maximum exercise capacity on cycle ergometry 1) while breathing a hypoxic gas mixture with 10% fraction of inspired oxygen at low altitude (Giessen) and 2) at high altitude (the Mount Everest base camp). Intervention: oral sildenafil, 50 mg, or placebo. Results: At low altitude, acute hypoxia reduced arterial oxygen saturation to 72.0% (95% CI, 66.5% to 77.5%) at rest and 60.8% (CI, 56.0% to 64.5%) at maximum exercise capacity. Systolic pulmonary artery pressure increased from 30.5 mm Hg (CI, 26.0 to 35.0 mm Hg) at rest to 42.9 mm Hg (CI, 35.6 to 53.5 mm Hg) during exercise in participants taking placebo. Sildenafil, 50 mg, significantly increased arterial oxygen saturation during exercise (P = 0.005) and reduced systolic pulmonary artery pressure at rest (P < 0.001) and during exercise (P = 0.031). Of note, sildenafil increased maximum workload (172.5 W [CI, 147.5 to 200.0 W]) vs. 130.6 W [CI, 108.8 to 150.0 W]); P < 0.001) and maximum cardiac output (P < 0.001) compared with placebo. At high altitude, sildenafil had no effect on arterial oxygen saturation at rest and during exercise compared with placebo. However, sildenafil reduced systolic pulmonary artery pressure at rest (P = 0.003) and during exercise (P = 0.021) and increased maximum workload (P = 0.002) and cardiac output (P = 0.015). At high altitude, sildenafil exacerbated existing headache in 2 participants. Limitations: The study did not examine the effects of sildenafil on normoxic exercise tolerance. Conclusions: Sildenafil reduces hypoxic pulmonary hypertension at rest and during exercise while maintaining gas exchange and systemic blood pressure. To the authors' knowledge, sildenafil is the first drug shown to increase exercise capacity during severe hypoxia both at sea level and at high altitude.	Univ Hosp Giessen, Dept Internal Med, D-35392 Giessen, Germany; Univ Giessen, Giessen, Germany	University Hospital of Giessen & Marburg; Justus Liebig University Giessen	Grimminger, F (corresponding author), Univ Hosp Giessen, Dept Internal Med, Klinikstr 36, D-35392 Giessen, Germany.	ardeschir.ghofrani@innere.med.uni-giessen.de	Olschewski, Horst/L-3547-2019; Reichenberger, Frank/AAJ-7232-2020; Ghofrani, Ardeschir/AAD-5293-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022	Olschewski, Horst/0000-0002-2834-7466; Reichenberger, Frank/0000-0003-1136-4769; Ghofrani, Ardeschir/0000-0002-2029-4419; Seeger, Werner/0000-0003-1946-0894; Grimminger, Friedrich/0000-0001-8725-6276				AHN HS, 1991, ADV EXP MED BIOL, V308, P191; Allemann Y, 2000, AM J PHYSIOL-HEART C, V279, pH2013, DOI 10.1152/ajpheart.2000.279.4.H2013; Bartsch P, 2001, ADV EXP MED BIOL, V502, P89; Bartsch P, 2001, HIGH ALT MED BIOL, V2, P287, DOI 10.1089/152702901750265378; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BERTOLI L, 1983, RESPIRATION, V44, P282, DOI 10.1159/000194559; Boolell M, 1996, Int J Impot Res, V8, P47; Corbin JD, 2002, INT J CLIN PRACT, V56, P453; Dehnert C, 2002, MED SCI SPORT EXER, V34, P1928, DOI 10.1097/00005768-200212000-00011; Droma Y, 2002, CIRCULATION, V106, P826, DOI 10.1161/01.CIR.0000024409.30143.70; Eddahibi S, 1998, BRIT J PHARMACOL, V125, P681, DOI 10.1038/sj.bjp.0702124; Euler Us V, 1946, ACTA PHYSL SCAND, V12, P301, DOI [10.1111/j.1748-1716.1946.tb00389.x, DOI 10.1111/J.1748-1716.1946.TB00389.X]; Gabrielsen A, 2002, CLIN SCI, V102, P247, DOI 10.1042/CS20010158; Ghofrani HA, 2003, AM J RESP CRIT CARE, V167, P1139, DOI 10.1164/rccm.200210-1157BC; Ghofrani HA, 2002, ANN INTERN MED, V136, P515, DOI 10.7326/0003-4819-136-7-200204020-00008; Ghofrani HA, 2002, LANCET, V360, P895, DOI 10.1016/S0140-6736(02)11024-5; Grunig E, 2000, CIRCULATION, V102, P1145, DOI 10.1161/01.CIR.102.10.1145; Grunig E, 2000, J AM COLL CARDIOL, V35, P980, DOI 10.1016/S0735-1097(99)00633-6; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Jansen GFA, 1999, J APPL PHYSIOL, V86, P681, DOI 10.1152/jappl.1999.86.2.681; Kasper W, 1997, HEART, V77, P346, DOI 10.1136/hrt.77.4.346; Kothari Shyam S, 2002, Indian Heart J, V54, P404; Kruuse C, 2003, BRAIN, V126, P241, DOI 10.1093/brain/awg009; LASSEN NA, 1992, INT J SPORTS MED, V13, pS47, DOI 10.1055/s-2007-1024591; Padma-Nathan H, 2002, UROLOGY, V60, P67, DOI 10.1016/S0090-4295(02)01752-1; Reutershan J, 2004, CLIN SCI, V106, P3, DOI 10.1042/CS20030157; Ribeiro A, 1999, J INTERN MED, V245, P601, DOI 10.1046/j.1365-2796.1999.00498.x; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; Sastry B K S, 2002, Indian Heart J, V54, P410; Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC; Weimann J, 2000, ANESTHESIOLOGY, V92, P1702, DOI 10.1097/00000542-200006000-00030; Weissmann N, 2003, AM J PHYSIOL-HEART C, V284, pH931, DOI 10.1152/ajpheart.00376.2002; Weitzenblum E, 2003, HEART, V89, P225, DOI 10.1136/heart.89.2.225; Wilkens H, 2001, CIRCULATION, V104, P1218, DOI 10.1161/hc3601.096826; YAGI H, 1990, AM REV RESPIR DIS, V142, P796, DOI 10.1164/ajrccm/142.4.796; Zaidi SHE, 2002, CIRCULATION, V105, P516, DOI 10.1161/hc0402.102866; Zhao L, 2001, CIRCULATION, V104, P424, DOI 10.1161/hc2901.093117	37	224	235	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2004	141	3					169	177		10.7326/0003-4819-141-3-200408030-00005	http://dx.doi.org/10.7326/0003-4819-141-3-200408030-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HG	15289213				2022-12-28	WOS:000223068600001
J	Baron, JM; Abuzahra, F				Baron, JM; Abuzahra, F			Evidence-based staging system for malignant melanoma: is new necessarily better?	LANCET			English	Editorial Material									Univ Hosp RWTH Aachen, Dept Dermatol & Allergol, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Baron, JM (corresponding author), Univ Hosp RWTH Aachen, Dept Dermatol & Allergol, D-52074 Aachen, Germany.	jensmalte.baron@post.rwth-aachen.de	Baron, Jens M/N-2934-2016	Baron, Jens M/0000-0002-1174-6946				Abuzahra F, 2004, LANCET ONCOL, V5, P250, DOI 10.1016/S1470-2045(04)01429-9; Balch CM, 2004, CA-CANCER J CLIN, V54, P131, DOI 10.3322/canjclin.54.3.131; Baron J. M., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P393, DOI 10.2174/1568011033482224; Garbe C, 2003, CANCER-AM CANCER SOC, V97, P1737, DOI 10.1002/cncr.11250; KAUFMANN R, 1998, HAUTARZT, V48, P530; Kim Christina J, 2002, Cancer Control, V9, P9; Nambiar S, 2004, EXPERT REV MOL DIAGN, V4, P549, DOI 10.1586/14737159.4.4.549; Roberts DLL, 2002, BRIT J DERMATOL, V146, P7, DOI 10.1046/j.1365-2133.2001.04614.x	8	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					395	396		10.1016/S0140-6736(04)16780-9	http://dx.doi.org/10.1016/S0140-6736(04)16780-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288720				2022-12-28	WOS:000222998600006
J	Little, P				Little, P			Commentary: Advice to parents has limited effect - where next?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England	University of Southampton	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.	psl3@soton.ac.uk		Little, Paul/0000-0003-3664-1873				HEANEY D, 2001, BRIT MED J, V322, P1193; Little P, 2001, BRIT J GEN PRACT, V51, P977; Little P, 2001, BRIT MED J, V322, P1; Macfarlane JT, 1997, BRIT J GEN PRACT, V47, P719; Mohan P, 2004, BRIT MED J, V329, P266, DOI 10.1136/bmj.38149.703380.47; SCAMBLER G, 1991, SOCIOLOGY APPL MED, P33	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2004	329	7460					269	269		10.1136/bmj.329.7460.269	http://dx.doi.org/10.1136/bmj.329.7460.269			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284150	Green Published			2022-12-28	WOS:000223133300019
J	Korotev, RL				Korotev, RL			A unique chunk of the Moon	SCIENCE			English	Editorial Material							LUNAR-SURFACE		Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	Washington University (WUSTL)	Korotev, RL (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.	korotev@wustl.edu						Dalrymple GB, 1996, J GEOPHYS RES-PLANET, V101, P26069, DOI 10.1029/96JE02806; Elphic RC, 2000, J GEOPHYS RES-PLANET, V105, P20333, DOI 10.1029/1999JE001176; Gnos E, 2004, SCIENCE, V305, P657, DOI 10.1126/science.1099397; Haskin LA, 1998, METEORIT PLANET SCI, V33, P959, DOI 10.1111/j.1945-5100.1998.tb01703.x; Haskin LA, 1998, J GEOPHYS RES-PLANET, V103, P1679, DOI 10.1029/97JE03035; Korotev RL, 2003, GEOCHIM COSMOCHIM AC, V67, P4895, DOI 10.1016/j.gca.2003.08.001; Lawrence DJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002050; Lawrence DJ, 1998, SCIENCE, V281, P1484, DOI 10.1126/science.281.5382.1484; MARVIN UB, 1983, GEOPHYS RES LETT, V10, P775, DOI 10.1029/GL010i009p00775; Ryder G, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001583	10	5	5	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					622	623		10.1126/science.1100888	http://dx.doi.org/10.1126/science.1100888			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286354				2022-12-28	WOS:000222992100027
J	Astudillo, LM; Arlet, PM				Astudillo, LM; Arlet, PM			Images in clinical medicine: The chemosis of trichinosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									CHU Purpan, F-31059 Toulouse, France	CHU de Toulouse	Astudillo, LM (corresponding author), CHU Purpan, F-31059 Toulouse, France.			Astudillo, Leonardo/0000-0002-8231-1915					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					487	487		10.1056/NEJMicm990318	http://dx.doi.org/10.1056/NEJMicm990318			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841OJ	15282356				2022-12-28	WOS:000222939700012
J	Kinoshita, T; Wenger, T; Weiss, DS				Kinoshita, T; Wenger, T; Weiss, DS			Observation of a one-dimensional Tonks-Girardeau gas	SCIENCE			English	Article							IMPENETRABLE BOSONS; OPTICAL LATTICES; ULTRACOLD ATOMS; PHASE	We report the observation of a one-dimensional (1D) Tonks-Girardeau (TG) gas of bosons moving freely in 1D. Although TG gas bosons are strongly interacting, they behave very much like noninteracting fermions. We enter the TG regime with cold rubidium-87 atoms by trapping them with a combination of two light traps. By changing the trap intensities, and hence the atomic interaction strength, the atoms can be made to act either like a Bose-Einstein condensate or like a TG gas. We measure the total 1 D energy and the length of the gas. With no free parameters and over a wide range of coupling strengths, our data fit the exact solution for the ground state of a 1 D Bose gas.	Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Weiss, DS (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.	dsweiss@phys.psu.edu	Weiss, David S/B-7886-2010					Berman GP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.030404; Cazalilla MA, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.053606; Chen S, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.063605; DePue MT, 2000, OPT COMMUN, V180, P73, DOI 10.1016/S0030-4018(00)00701-X; DePue MT, 1999, PHYS REV LETT, V82, P2262, DOI 10.1103/PhysRevLett.82.2262; Dunjko V, 2001, PHYS REV LETT, V86, P5413, DOI 10.1103/PhysRevLett.86.5413; Gangardt DM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.010401; GIRARDEAU M, 1960, J MATH PHYS, V1, P516, DOI 10.1063/1.1703687; Gorlitz A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.130402; Greiner M, 2001, APPL PHYS B-LASERS O, V73, P769, DOI 10.1007/s003400100744; Han DJ, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.023405; Ho AF, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.130405; Ketterle W, 1996, PHYS REV A, V54, P656, DOI 10.1103/PhysRevA.54.656; KINOSHITA T, UNPUB; Lieb EH, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.150401; LIEB EH, 1963, PHYS REV, V130, P1305; Moritz H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250402; Olshanii M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090401; Olshanii M, 1998, PHYS REV LETT, V81, P938, DOI 10.1103/PhysRevLett.81.938; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Petrov DS, 2000, PHYS REV LETT, V85, P3745, DOI 10.1103/PhysRevLett.85.3745; PITAEVSKI L, 2003, BOSE EINSTEIN CONDEN, P323; Schmid G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.167208; Soferle T., 2004, PHYS REV LETT, V92; Tolra BL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.190401; Tonks L, 1936, PHYS REV, V50, P955, DOI 10.1103/PhysRev.50.955; vanOtterlo A, 1995, PHYS REV B, V52, P16176, DOI 10.1103/PhysRevB.52.16176; Winoto SL, 1999, PHYS REV A, V59, pR19, DOI 10.1103/PhysRevA.59.R19; YANG CN, 1969, J MATH PHYS, V10, P1115, DOI 10.1063/1.1664947	30	1067	1072	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1125	1128		10.1126/science.1100700	http://dx.doi.org/10.1126/science.1100700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15284454				2022-12-28	WOS:000223557400038
J	Cawood, T; Moriarty, P; O'Shea, D				Cawood, T; Moriarty, P; O'Shea, D			Recent developments in thyroid eye disease	BRITISH MEDICAL JOURNAL			English	Review							ORBITAL PREADIPOCYTE FIBROBLASTS; GRAVES OPHTHALMOPATHY PATIENTS; HUMAN RETROOCULAR FIBROBLASTS; ACTIVATED RECEPTOR-GAMMA; GLYCOSAMINOGLYCAN PRODUCTION; THYROTROPIN RECEPTOR; RADIATION RETINOPATHY; RADIOIODINE THERAPY; TREATMENT OUTCOMES; INCIDENCE COHORT		St Vincents Univ Hosp, Dept Endocrinol, Dublin 4, Ireland; Royal Victoria Eye & Ear Hosp, Dublin 2, Ireland	University College Dublin; Saint Vincent's University Hospital	Cawood, T (corresponding author), St Vincents Univ Hosp, Dept Endocrinol, Elm Pk, Dublin 4, Ireland.	tomjcawood@eircom.net						BAHN RS, 1993, NEW ENGL J MED, V329, P1468; BAHN RS, 1992, BAILLIERE CLIN ENDOC, V6, P95, DOI 10.1016/S0950-351X(05)80333-7; Bartalena L, 2000, ENDOCR REV, V21, P168, DOI 10.1210/er.21.2.168; Bartalena L, 1996, J CLIN ENDOCR METAB, V81, P446, DOI 10.1210/jc.81.2.446; Bartalena L, 1998, ANN INTERN MED, V129, P632, DOI 10.7326/0003-4819-129-8-199810150-00010; BARTALENA L, 1983, J CLIN ENDOCR METAB, V56, P1139, DOI 10.1210/jcem-56-6-1139; Bartalena L, 1998, NEW ENGL J MED, V338, P73, DOI 10.1056/NEJM199801083380201; BARTALENA L, 1989, NEW ENGL J MED, V321, P1349, DOI 10.1056/NEJM198911163212001; BARTH A, 1991, J ENDOCRINOL INVEST, V14, P209, DOI 10.1007/BF03346790; Bartley GB, 1996, AM J OPHTHALMOL, V121, P200, DOI 10.1016/S0002-9394(14)70585-9; BARTLEY GB, 1995, AM J OPHTHALMOL, V120, P511, DOI 10.1016/S0002-9394(14)72666-2; Bartley GB, 1996, OPHTHALMOLOGY, V103, P958, DOI 10.1016/S0161-6420(96)30579-4; BOEHM BO, 1992, CLIN INVESTIGATOR, V70, P956; CHANG TC, 1994, CLIN IMMUNOL IMMUNOP, V71, P113, DOI 10.1006/clin.1994.1059; Eckstein A, 2003, BRIT J OPHTHALMOL, V87, P773, DOI 10.1136/bjo.87.6.773; Farid NR, 2003, J ENDOCRINOL INVEST, V26, P570, DOI 10.1007/BF03345223; Gerding MN, 2000, CLIN ENDOCRINOL, V52, P267, DOI 10.1046/j.1365-2265.2000.00959.x; Gorman CA, 2001, OPHTHALMOLOGY, V108, P1523, DOI 10.1016/S0161-6420(01)00632-7; HEUFELDER AE, 1992, EUR J CLIN INVEST, V22, P529, DOI 10.1111/j.1365-2362.1992.tb01501.x; HEUFELDER AE, 1993, THYROID, V3, P297, DOI 10.1089/thy.1993.3.297; Hiromatsu Y, 2000, J CLIN ENDOCR METAB, V85, P1194, DOI 10.1210/jc.85.3.1194; Kamizono S, 2000, CLIN ENDOCRINOL, V52, P759, DOI 10.1046/j.1365-2265.2000.01011.x; KINYOUN JL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1473; KORDUCKI JM, 1992, INVEST OPHTH VIS SCI, V33, P2037; Kumar S, 2004, J CLIN ENDOCR METAB, V89, P930, DOI 10.1210/jc.2003-031427; Kumar S, 2003, J CLIN ENDOCR METAB, V88, P4246, DOI 10.1210/jc.2003-030380; Lu R, 1999, THYROID, V9, P297, DOI 10.1089/thy.1999.9.297; Ludgate M, 2002, CLIN EXP IMMUNOL, V127, P193, DOI 10.1046/j.1365-2249.2002.01792.x; Manso PG, 1998, THYROID, V8, P49, DOI 10.1089/thy.1998.8.49; Marquez SD, 2001, INT J RADIAT ONCOL, V51, P766, DOI 10.1016/S0360-3016(01)01699-6; METCALFE RA, 1994, CLIN ENDOCRINOL, V40, P67, DOI 10.1111/j.1365-2265.1994.tb02445.x; MILLER ML, 1991, AM J OPHTHALMOL, V112, P600, DOI 10.1016/S0002-9394(14)76869-2; MOURITS MP, 1989, BRIT J OPHTHALMOL, V73, P639, DOI 10.1136/bjo.73.8.639; Mourits MP, 2000, LANCET, V355, P1505, DOI 10.1016/S0140-6736(00)02165-6; Mourits MP, 1997, CLIN ENDOCRINOL, V47, P9, DOI 10.1046/j.1365-2265.1997.2331047.x; Noth D, 2001, SWISS MED WKLY, V131, P603; Ohtsuka K, 1998, AM J OPHTHALMOL, V126, P805, DOI 10.1016/S0002-9394(98)00248-7; Otto EA, 1996, J CLIN ENDOCR METAB, V81, P3045, DOI 10.1210/jc.81.8.3045; Pappa A, 2000, BRIT J OPHTHALMOL, V84, P517, DOI 10.1136/bjo.84.5.517; PERROS P, 1993, CLIN ENDOCRINOL, V38, P367, DOI 10.1111/j.1365-2265.1993.tb00516.x; PERROS P, 1995, CLIN ENDOCRINOL, V42, P45, DOI 10.1111/j.1365-2265.1995.tb02597.x; Pfeilschifter J, 1996, CLIN ENDOCRINOL, V45, P477, DOI 10.1046/j.1365-2265.1996.8220832.x; Pritchard J, 2002, J IMMUNOL, V168, P942, DOI 10.4049/jimmunol.168.2.942; Prummel MF, 2004, J CLIN ENDOCR METAB, V89, P15, DOI 10.1210/jc.2003-030809; PRUMMEL MF, 2002, OXFORD TXB ENDOCRINO; RUNDLE FF, 1957, METABOLISM, V6, P36; Smith TJ, 2002, THYROID, V12, P197, DOI 10.1089/105072502753600133; SMITH TJ, 1991, J CLIN ENDOCR METAB, V72, P1169, DOI 10.1210/jcem-72-5-1169; SnijdersKeilholz A, 1996, RADIOTHER ONCOL, V38, P69, DOI 10.1016/0167-8140(95)01670-8; Sorisky A, 1996, J CLIN ENDOCR METAB, V81, P3428, DOI 10.1210/jc.81.9.3428; Starkey K, 2003, J CLIN ENDOCR METAB, V88, P55, DOI 10.1210/jc.2002-020987; Tallstedt L, 1997, THYROID, V7, P241, DOI 10.1089/thy.1997.7.241; Tan GH, 1996, J CLIN ENDOCR METAB, V81, P449, DOI 10.1210/jc.81.2.449; Terwee C, 2002, EUR J ENDOCRINOL, V146, P751, DOI 10.1530/eje.0.1460751; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; Vaidya B, 2003, CLIN ENDOCRINOL, V58, P732, DOI 10.1046/j.1365-2265.2003.01778.x; Valyasevi RW, 1999, J CLIN ENDOCR METAB, V84, P2557, DOI 10.1210/jc.84.7.2557; Valyasevi RW, 2002, J CLIN ENDOCR METAB, V87, P2352, DOI 10.1210/jc.87.5.2352; Vestergaard P, 2002, EUR J ENDOCRINOL, V146, P153, DOI 10.1530/eje.0.1460153; Wakelkamp IMMJ, 2003, CLIN ENDOCRINOL, V58, P280, DOI 10.1046/j.1365-2265.2003.01708.x; WEETMAN AP, 2002, COMPREHENSIVE CLIN E; WERNER SC, 1977, J CLIN ENDOCR METAB, V44, P203, DOI 10.1210/jcem-44-1-203; WIERSINGA WM, 1988, OPHTHALMOLOGICA, V197, P75, DOI 10.1159/000309924	63	41	49	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 14	2004	329	7462					385	390D		10.1136/bmj.329.7462.385	http://dx.doi.org/10.1136/bmj.329.7462.385			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YI	15310608	Green Published			2022-12-28	WOS:000223433600023
J	Madoff, RD; Parker, SC; Varma, MG; Lowry, AC				Madoff, RD; Parker, SC; Varma, MG; Lowry, AC			Faecal incontinence in adults	LANCET			English	Review							ANAL-SPHINCTER REPAIR; SACRAL NERVE-STIMULATION; QUALITY-OF-LIFE; INJECTABLE SILICONE BIOMATERIAL; RADIOFREQUENCY ENERGY DELIVERY; RANDOMIZED CONTROLLED-TRIAL; ARTIFICIAL BOWEL SPHINCTER; PUDENDAL NEUROPATHY; ANORECTAL INCONTINENCE; TOPICAL PHENYLEPHRINE	Faccal incontinence can affect individuals of all ages and in many cases greatly impairs quality of life, but incontinent patients should not accept their debility as either inevitable or untreatable. Education of the general public and of health-care providers alike is important, because most cases are readily treatable. Many cases of mild incontinence respond to simple medical therapy, whereas patients with more advanced incontinence are best cared for after complete physiological assessment. Recent advances in therapy have led to promising results, even for patients with refractory incontinence. Health-care providers must make every effort to communicate fully with incontinent patients and to help restore their self-esteem, eliminate their self-imposed isolation, and allow them to resume an active and productive lifestyle.	Univ Minnesota, Dept Surg, Div Colon & Rectal Surg, Minneapolis, MN 55455 USA; Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco	Madoff, RD (corresponding author), 393 Dunlap St N,Suite 500, St Paul, MN 55104 USA.	madof001@umn.edu						Altomare DF, 2001, BRIT J SURG, V88, P1481, DOI 10.1046/j.0007-1323.2001.01895.x; BAETEN C, 1988, DIS COLON RECTUM, V31, P134, DOI 10.1007/BF02562646; Baeten GMI, 2000, DIS COLON RECTUM, V43, P743, DOI 10.1007/BF02238008; Baxter NN, 2003, DIS COLON RECTUM, V46, P1591, DOI 10.1007/BF02660762; BORRIE MJ, 1992, CAN MED ASSOC J, V147, P322; Buie WD, 2001, DIS COLON RECTUM, V44, P1255; BUSER WD, 1986, GASTROENTEROLOGY, V91, P1186, DOI 10.1016/S0016-5085(86)80015-4; Carapeti EA, 1999, BRIT J SURG, V86, P267, DOI 10.1046/j.1365-2168.1999.01021.x; Carapeti EA, 2000, BRIT J SURG, V87, P38, DOI 10.1046/j.1365-2168.2000.01306.x; Carapeti EA, 2000, DIS COLON RECTUM, V43, P1059, DOI 10.1007/BF02236550; CARUANA BJ, 1991, GASTROENTEROLOGY, V100, P465, DOI 10.1016/0016-5085(91)90217-9; Chassagne P, 1999, AM J MED, V106, P185, DOI 10.1016/S0002-9343(98)00407-0; Christiansen J, 1999, ANN SURG, V230, P45, DOI 10.1097/00000658-199907000-00007; CHRISTIANSEN J, 1987, LANCET, V2, P244; CONSTANTINIDES CG, 1983, J PEDIATR SURG, V18, P276, DOI 10.1016/S0022-3468(83)80099-2; DEVESA JM, 1992, DIS COLON RECTUM, V35, P339, DOI 10.1007/BF02048111; Donnelly V, 1997, BRIT J OBSTET GYNAEC, V104, P311, DOI 10.1111/j.1471-0528.1997.tb11459.x; Donnelly VS, 1998, DIS COLON RECTUM, V41, P586, DOI 10.1007/BF02235263; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; DUTHIE HL, 1960, BRIT J SURG, V47, P585, DOI 10.1002/bjs.18004720602; Efron JE, 2003, DIS COLON RECTUM, V46, P1606, DOI 10.1007/BF02660763; ENCK P, 1994, DIS COLON RECTUM, V37, P997, DOI 10.1007/BF02049311; ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538; ENGEL AF, 1994, BRIT J SURG, V81, P1231, DOI 10.1002/bjs.1800810853; ENGEL BT, 1974, NEW ENGL J MED, V290, P646, DOI 10.1056/NEJM197403212901202; EYPASCH E, 1995, BRIT J SURG, V82, P216, DOI 10.1002/bjs.1800820229; Faltin DL, 2001, BRIT J OBSTET GYNAEC, V108, P684, DOI 10.1111/j.1471-0528.2001.00185.x; Faltin DL, 2001, INT UROGYNECOL J, V12, P117, DOI 10.1007/PL00004031; Faltin DL, 2000, OBSTET GYNECOL, V95, P643, DOI 10.1016/S0029-7844(99)00631-6; FELTBERSMA RJF, 1990, DIS COLON RECTUM, V33, P479, DOI 10.1007/BF02052142; Feretis C, 2001, DIS COLON RECTUM, V44, P1605, DOI 10.1007/BF02234379; Fynes MM, 1999, DIS COLON RECTUM, V42, P753, DOI 10.1007/BF02236930; Ganio E, 2001, DIS COLON RECTUM, V44, P965, DOI 10.1007/BF02235484; GarciaAguilar J, 1996, DIS COLON RECTUM, V39, P440, DOI 10.1007/BF02054061; GIBBONS CP, 1986, LANCET, V1, P886, DOI 10.1016/S0140-6736(86)90990-6; Gilliland R, 1998, DIS COLON RECTUM, V41, P1516, DOI 10.1007/BF02237299; Giordano P, 2002, DIS COLON RECTUM, V45, P635, DOI 10.1007/s10350-004-6260-7; Gladman MA, 2003, DIS COLON RECTUM, V46, P238, DOI 10.1007/s10350-004-6529-x; GOLDENBERG DA, 1980, AM J GASTROENTEROL, V74, P342; GUILLEMOT F, 1995, DIS COLON RECTUM, V38, P393, DOI 10.1007/BF02054228; HALLGREN T, 1994, DIGEST DIS SCI, V39, P2612, DOI 10.1007/BF02087698; Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6; Hasegawa H, 2000, DIS COLON RECTUM, V43, P961, DOI 10.1007/BF02237359; Heymen S, 2001, DIS COLON RECTUM, V44, P728, DOI 10.1007/BF02234575; Ho YH, 2000, DIS COLON RECTUM, V43, P169, DOI 10.1007/BF02236976; Jensen LL, 1997, DIS COLON RECTUM, V40, P197, DOI 10.1007/BF02054988; Johanson JF, 1996, AM J GASTROENTEROL, V91, P33; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; JORGE JM, 1998, FUNDAMENTALS ANORECT, P1; Karoui S, 2000, DIS COLON RECTUM, V43, P813, DOI 10.1007/BF02238020; Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225; KIFF ES, 1984, BRIT J SURG, V71, P614, DOI 10.1002/bjs.1800710817; KIFF ES, 1984, GUT, V25, P1279, DOI 10.1136/gut.25.11.1279; KONSTEN J, 1993, DIS COLON RECTUM, V36, P559, DOI 10.1007/BF02049862; Kumar D, 1998, BRIT J SURG, V85, P978; KUSUNOKI M, 1990, SURGERY, V107, P311; LATIMER PR, 1984, BIOFEEDBACK SELF-REG, V9, P311, DOI 10.1007/BF00998975; Lehur PA, 2000, DIS COLON RECTUM, V43, P1100, DOI 10.1007/BF02236557; LESTAR B, 1989, INT J COLORECTAL DIS, V4, P118, DOI 10.1007/BF01646870; LEWIS WG, 1995, DIS COLON RECTUM, V38, P259, DOI 10.1007/BF02055598; Liberman H, 2001, DIS COLON RECTUM, V44, P1567, DOI 10.1007/BF02234373; LOENINGBAUCKE V, 1990, GUT, V31, P1395, DOI 10.1136/gut.31.12.1395; LONDONOSCHIMMER EE, 1994, INT J COLORECTAL DIS, V9, P110, DOI 10.1007/BF00699424; MacArthur C, 2001, BRIT J OBSTET GYNAEC, V108, P678, DOI 10.1111/j.1471-0528.2001.00183.x; MACINTYRE IM, 1972, LANCET, V1, P1094; Madoff RD, 1999, GASTROENTEROLOGY, V116, P549, DOI 10.1016/S0016-5085(99)70176-9; Malouf AJ, 2000, AM J ROENTGENOL, V175, P741, DOI 10.2214/ajr.175.3.1750741; Malouf AJ, 2000, LANCET, V355, P2219, DOI 10.1016/S0140-6736(00)02409-0; Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337; Malouf AJ, 2000, LANCET, V355, P260, DOI 10.1016/S0140-6736(99)05218-6; Malouf AJ, 2000, ANN SURG, V232, P143, DOI 10.1097/00000658-200007000-00020; MARCIO J, 1993, DIS COLON RECTUM, V36, P77; MATZEL KE, 1995, LANCET, V346, P1124, DOI 10.1016/S0140-6736(95)91799-3; Matzel KE, 2004, LANCET, V363, P1270, DOI 10.1016/S0140-6736(04)15999-0; MATZEL KE, 1990, DIS COLON RECTUM, V33, P666, DOI 10.1007/BF02150742; Matzel KE, 2001, DIS COLON RECTUM, V44, P59, DOI 10.1007/BF02234822; MCHUGH S, 1986, GASTROENTEROLOGY, V90, P154; MCHUGH SM, 1987, DIGEST DIS SCI, V32, P726, DOI 10.1007/BF01296139; Mellgren A, 1999, DIS COLON RECTUM, V42, P857, DOI 10.1007/BF02237089; MINER PB, 1990, DIGEST DIS SCI, V35, P1291, DOI 10.1007/BF01536422; Morren GL, 2001, BRIT J SURG, V88, P1506, DOI 10.1046/j.0007-1323.2001.01919.x; Nakanishi N, 1999, AGE AGEING, V28, P301, DOI 10.1093/ageing/28.3.301; NEILL ME, 1980, J NEUROL NEUROSUR PS, V43, P343, DOI 10.1136/jnnp.43.4.343; NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559; Nelson R, 1998, DIS COLON RECTUM, V41, P1226, DOI 10.1007/BF02258218; NIELSEN MB, 1992, BRIT J SURG, V79, P104, DOI 10.1002/bjs.1800790204; Norton C, 1999, BRIT J SURG, V86, P1159, DOI 10.1046/j.1365-2168.1999.01215.x; Norton C, 2003, GASTROENTEROLOGY, V125, P1320, DOI 10.1016/j.gastro.2003.09.039; Norton C, 2001, ALIMENT PHARM THER, V15, P1147, DOI 10.1046/j.1365-2036.2001.01039.x; NORTON C, 2000, COCHRANE DB SYST REV; Nyam DCNK, 1999, DIS COLON RECTUM, V42, P1306, DOI 10.1007/BF02234220; O'Brien PE, 2000, DIS COLON RECTUM, V43, P1213, DOI 10.1007/BF02237423; Oberwalder M, 2003, BRIT J SURG, V90, P1333, DOI 10.1002/bjs.4369; Otto IC, 1996, DIS COLON RECTUM, V39, P1423, DOI 10.1007/BF02054533; PARKS AG, 1975, P ROY SOC MED, V68, P681; PARKS AG, 1977, GUT, V18, P656, DOI 10.1136/gut.18.8.656; Pinedo G, 1999, BRIT J SURG, V86, P66, DOI 10.1046/j.1365-2168.1999.00997.x; Porell F, 1998, HEALTH SERV RES, V33, P835; PRIOR A, 1990, GUT, V31, P458, DOI 10.1136/gut.31.4.458; READ MG, 1982, BRIT J SURG, V69, P396, DOI 10.1002/bjs.1800690713; Rieger NA, 1997, DIS COLON RECTUM, V40, P821, DOI 10.1007/BF02055440; Rizk DEE, 2001, DIS COLON RECTUM, V44, P1850, DOI 10.1007/BF02234467; Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236; Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199; ROIG JV, 1995, DIS COLON RECTUM, V38, P952, DOI 10.1007/BF02049731; Rosen HR, 2001, GASTROENTEROLOGY, V121, P536, DOI 10.1053/gast.2001.27120; Rothbarth J, 2000, DIGEST SURG, V17, P390, DOI 10.1159/000018883; Ryn AK, 2000, DIS COLON RECTUM, V43, P1262, DOI 10.1007/BF02237433; Sailer M, 1998, BRIT J SURG, V85, P1716; Sangwan YP, 1996, DIS COLON RECTUM, V39, P686, DOI 10.1007/BF02056951; Santoro GA, 2000, DIS COLON RECTUM, V43, P1676, DOI 10.1007/BF02236848; SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115; SNOOKS SJ, 1985, GASTROENTEROLOGY, V89, P977, DOI 10.1016/0016-5085(85)90196-9; SNOOKS SJ, 1984, LANCET, V2, P546; SNOOKS SJ, 1986, ANN ROY COLL SURG, V68, P45; Solomon MJ, 2003, DIS COLON RECTUM, V46, P703, DOI 10.1007/s10350-004-6643-9; SORENSEN M, 1993, BRIT J SURG, V80, P392, DOI 10.1002/bjs.1800800343; SULTAN AH, 1993, NEW ENGL J MED, V329, P1905, DOI 10.1056/NEJM199312233292601; SULTAN AH, 1994, BRIT J SURG, V81, P463, DOI 10.1002/bjs.1800810349; SULTAN AH, 1994, BRIT MED J, V308, P887, DOI 10.1136/bmj.308.6933.887; Takahashi T, 2003, DIS COLON RECTUM, V46, P711, DOI 10.1007/s10350-004-6644-8; Thomas T M, 1984, Community Med, V6, P216; Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X; Vaizey CJ, 1999, GUT, V44, P407, DOI 10.1136/gut.44.3.407; Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77; vanTets WF, 1996, DIS COLON RECTUM, V39, P992, DOI 10.1007/BF02054687; Varma A, 1999, DIS COLON RECTUM, V42, P1537, DOI 10.1007/BF02236202; Varma A, 1999, DIS COLON RECTUM, V42, P1261, DOI 10.1007/BF02234210; WALD A, 1984, NEW ENGL J MED, V310, P1282, DOI 10.1056/NEJM198405173102003; WALD A, 1981, ANN INTERN MED, V95, P146, DOI 10.7326/0003-4819-95-2-146; Warshaw J., 2001, SEM COLON RECTAL SUR, V12, P90; Weiss KM, 2002, PERSPECT BIOL MED, V45, P46, DOI 10.1353/pbm.2002.0020; WEXNER SD, 1991, DIS COLON RECTUM, V34, P22, DOI 10.1007/BF02050202; WHITEHEAD WE, 1985, J AM GERIATR SOC, V33, P320, DOI 10.1111/j.1532-5415.1985.tb07130.x; Wong WD, 1996, DIS COLON RECTUM, V39, P1345; Wong WD, 2002, DIS COLON RECTUM, V45, P1139, DOI 10.1097/01.DCR.0000027038.03012.E3; WRENN K, 1989, NEW ENGL J MED, V321, P658; Yip B, 2002, DIS COLON RECTUM, V45, P184, DOI 10.1007/s10350-004-6142-z; Young CJ, 1998, DIS COLON RECTUM, V41, P344, DOI 10.1007/BF02237489; Zetterstrom J, 1999, DIS COLON RECTUM, V42, P1253, DOI 10.1007/BF02234209	140	164	172	1	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					621	632		10.1016/S0140-6736(04)16856-6	http://dx.doi.org/10.1016/S0140-6736(04)16856-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313364				2022-12-28	WOS:000223275100036
J	Araki, T; Sasaki, Y; Milbrandt, J				Araki, T; Sasaki, Y; Milbrandt, J			Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration	SCIENCE			English	Article							WALLERIAN DEGENERATION; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; PROTEIN; DEACETYLASE; NEUROPROTECTION; INHIBITORS; LONGEVITY; FAMILY; YEAST	Axonal degeneration is an active program of self-destruction that is observed in many physiological and pathological settings. In Wallerian degeneration slow (wld(s)) mice, Wallerian degeneration in response to axonal injury is delayed because of a mutation that results in overexpression of a chimeric protein (Wld(s)) composed of the ubiquitin assembly protein Ufd2a and the nicotinamide adenine dinucleotide (NAD) biosynthetic enzyme Nmnat1. We demonstrate that increased Nmnat activity is responsible for the axon-sparing activity of the Wlds protein. Furthermore, we demonstrate that SIRT1, a mammalian ortholog of Sir2, is the downstream effector of increased Nmnat activity that leads to axonal protection. These findings suggest that novel therapeutic strategies directed at increasing the supply of NAD and/or Sir2 activation may be effective for treatment of diseases characterized by axonopathy and neurodegeneration.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu	Araki, Toshiyuki/H-4289-2019	Araki, Toshiyuki/0000-0003-3625-2042; Milbrandt, Jeffrey/0000-0002-5477-7689	NIA NIH HHS [AG05681, AG13730] Funding Source: Medline; NINDS NIH HHS [NS40745] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730, P50AG005681] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; ARAKI T, UNPUB; Bruzzone S, 2001, FASEB J, V15, P10; Buck SW, 2004, J LEUKOCYTE BIOL, V75, P939, DOI 10.1189/jlb.0903424; BUCKMASTER EA, 1995, EUR J NEUROSCI, V7, P1596, DOI 10.1111/j.1460-9568.1995.tb01155.x; COLEMAN MP, TRENDS NEUROSCI, V25, P532; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Gillingwater TH, 2004, J CEREBR BLOOD F MET, V24, P62, DOI 10.1097/01.WCB.0000095798.98378.34; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Sajadi A, 2004, CURR BIOL, V14, P326, DOI 10.1016//j.cub.2004.01.053; Skaper SD, 2003, ANN NY ACAD SCI, V993, P217, DOI 10.1111/j.1749-6632.2003.tb07532.x; SKAPER SD, 2003, ANN NY ACAD SCI, V993, P287; Southan GJ, 2003, CURR MED CHEM, V10, P321, DOI 10.2174/0929867033368376; Szabo C, 1996, P NATL ACAD SCI USA, V93, P1753, DOI 10.1073/pnas.93.5.1753; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Zhou TJ, 2002, J BIOL CHEM, V277, P13148, DOI 10.1074/jbc.M111469200	28	861	917	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1010	1013		10.1126/science.1098014	http://dx.doi.org/10.1126/science.1098014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310905				2022-12-28	WOS:000223250700050
J	Christopherson, KW; Hangoc, G; Mantel, CR; Broxmeyer, HE				Christopherson, KW; Hangoc, G; Mantel, CR; Broxmeyer, HE			Modulation of hematopoietic stem cell homing and engraftment by CD26	SCIENCE			English	Article							UMBILICAL-CORD BLOOD; MYELOID PROGENITOR CELLS; BONE-MARROW; FACTOR-I; COMPETITIVE REPOPULATION; NOD/SCID MICE; CXCR4; TRANSPLANTATION; MOBILIZATION; ASSAY	Hematopoietic stem cell homing and engraftment are crucial to transplantation efficiency, and clinical engraftment is severely compromised when donor-cell numbers are limiting. The peptidase CD26 (DPPIV/dipeptidylpeptidase IV) removes dipeptides from the amino terminus of proteins. We present evidence that endogenous CD26 expression on donor cells negatively regulates homing and engraftment. By inhibition or deletion of CD26, it was possible to increase greatly the efficiency of transplantation. These results suggest that hematopoietic stem cell engraftment is not absolute, as previously suggested, and indicate that improvement of bone marrow transplant efficiency may be possible in the clinic.	Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA; Walther Canc Inst, Indianapolis, IN 46208 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Walther Cancer Institute	Broxmeyer, HE (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	hbroxmey@iupui.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067384, R01HL056416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007519, R01DK053674] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL67384, R01 HL56416] Funding Source: Medline; NIDDK NIH HHS [T32 DK07519, R01 DK53674] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; Broxmeyer HE, 2002, BLOOD, V100, p609A; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Broxmeyer HE, 2001, INT J HEMATOL, V74, P9, DOI 10.1007/BF02982544; BROXMEYER HE, 2004, THOMAS HEMATOPOIETIC, P550; Christopherson KW, 2003, EXP HEMATOL, V31, P1126, DOI 10.1016/j.exphem.2003.07.002; Christopherson KW, 2003, BLOOD, V101, P4680, DOI 10.1182/blood-2002-12-3893; Christopherson KW, 2002, J IMMUNOL, V169, P7000, DOI 10.4049/jimmunol.169.12.7000; Ema H, 2004, IMMUNITY, V20, P1, DOI 10.1016/S1074-7613(04)00002-0; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; HARRISON DE, 1993, EXP HEMATOL, V21, P206; HARRISON DE, 1980, BLOOD, V55, P77; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Jaroscak J, 2003, BLOOD, V101, P5061, DOI 10.1182/blood-2001-12-0290; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; Kollet O, 2002, BLOOD, V100, P2778, DOI 10.1182/blood-2002-02-0564; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Shpall EJ, 2002, BIOL BLOOD MARROW TR, V8, P368, DOI 10.1053/bbmt.2002.v8.pm12171483; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Wang JF, 2003, BLOOD, V101, P2924, DOI 10.1182/blood-2002-09-2782; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Yahata T, 2003, BLOOD, V101, P2905, DOI 10.1182/blood-2002-07-1995	30	407	432	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1000	1003		10.1126/science.1097071	http://dx.doi.org/10.1126/science.1097071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310902				2022-12-28	WOS:000223250700047
J	Lesser, MP; Mazel, CH; Gorbunov, MY; Falkowski, PG				Lesser, MP; Mazel, CH; Gorbunov, MY; Falkowski, PG			Discovery of symbiotic nitrogen-fixing cyanobacteria in corals	SCIENCE			English	Article							FLUORESCENT PROTEINS; MARINE CYANOBACTERIUM; DIVERSITY; FIXATION; BACTERIA; PHOTOSYNTHESIS; PHYCOERYTHRIN; EMISSION; FAMILY; LIGHT	Colonies of the Caribbean coral Montastraea cavernosa exhibit a solar-stimulated orange-red fluorescence that is spectrally similar to a variety of fluorescent proteins expressed by corals. The source of this. uorescence is phycoerythrin in unicellular, nonheterocystis, symbiotic cyanobacteria within the host cells of the coral. The cyanobacteria coexist with the symbiotic dinoflagellates (zooxanthellae) of the coral and express the nitrogen. xing enzyme nitrogenase. The presence of this prokaryotic symbiont in a nitrogen-limited zooxanthellate coral suggests that nitrogen fixation may be an important source of this limiting element for the symbiotic association.	Univ New Hampshire, Dept Zool, Durham, NH 03824 USA; Univ New Hampshire, Ctr Marine Biol, Durham, NH 03824 USA; Phys Sci Inc, Andover, MA 01810 USA; Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol Sci, Piscataway, NJ USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; Physical Sciences Inc.; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Lesser, MP (corresponding author), Univ New Hampshire, Dept Zool, Durham, NH 03824 USA.	mpl@cisunix.unh.edu						ADAMS DG, 2001, ECOLOGY CYANOBACTERI, P523; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Dubinsky Z., 1994, Pacific Science, V48, P313; DUCKLOW HW, 1990, CORAL REEFS, P265; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; Gilmore AM, 2003, PHOTOCHEM PHOTOBIOL, V77, P515, DOI 10.1562/0031-8655(2003)077<0515:STROTE>2.0.CO;2; GLAZER AN, 1982, BIOCHEM SYST ECOL, V10, P203, DOI 10.1016/0305-1978(82)90031-X; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Litvaitis MK, 2002, HYDROBIOLOGIA, V468, P135, DOI 10.1023/A:1015262621848; Lokstein H, 1999, BBA-BIOENERGETICS, V1410, P97, DOI 10.1016/S0005-2728(98)00172-8; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P402, DOI 10.4319/lo.2003.48.1_part_2.0402; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Muscatine L, 1990, CORAL REEFS, P75; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Schonhuber W, 1999, APPL ENVIRON MICROB, V65, P1259; SHASHAR N, 1994, MAR ECOL PROG SER, V111, P259, DOI 10.3354/meps111259; Veron J. E. N., 1995, CORALS SPACE TIME; WIEBE WJ, 1975, SCIENCE, V188, P257, DOI 10.1126/science.188.4185.257; WYMAN M, 1985, SCIENCE, V230, P818, DOI 10.1126/science.230.4727.818	28	330	344	13	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					997	1000		10.1126/science.1099128	http://dx.doi.org/10.1126/science.1099128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310901				2022-12-28	WOS:000223250700046
J	Hernando, E; Nahle, Z; Juan, G; Diaz-Rodriguez, E; Alaminos, M; Hemann, M; Michel, L; Mittal, V; Gerald, W; Benezra, R; Lowe, SW; Cordon-Cardo, C				Hernando, E; Nahle, Z; Juan, G; Diaz-Rodriguez, E; Alaminos, M; Hemann, M; Michel, L; Mittal, V; Gerald, W; Benezra, R; Lowe, SW; Cordon-Cardo, C			Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control	NATURE			English	Article							SISTER-CHROMATID SEPARATION; SPINDLE CHECKPOINT; CHROMOSOME INSTABILITY; MAMMALIAN-CELLS; BLADDER-CANCER; GENES; MAD2; E2F; DISRUPTION; PROTEINS	Advanced human cancers are invariably aneuploid, in that they harbour cells with abnormal chromosome numbers(1,2). However, the molecular defects underlying this trait, and whether they are a cause or a consequence of the malignant phenotype, are not clear. Mutations that disable the retinoblastoma (Rb) pathway are also common in human cancers(1). These mutations promote tumour development by deregulating the E2F family of transcription factors leading to uncontrolled cell cycle progression(3). We show that the mitotic checkpoint protein Mad2 is a direct E2F target and, as a consequence, is aberrantly expressed in cells with Rb pathway defects. Concordantly, Mad2 is overexpressed in several tumour types, where it correlates with high E2F activity and poor patient prognosis. Generation of Rb pathway lesions in normal and transformed cells produces aberrant Mad2 expression and mitotic defects leading to aneuploidy, such that elevated Mad2 contributes directly to these defects. These results demonstrate how chromosome instability can arise as a by-product of defects in cell cycle control that compromise the accuracy of mitosis, and suggest a new model to explain the frequent appearance of aneuploidy in human cancer.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA	Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Lowe, SW (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Díaz-Rodriguez, Elena/I-4784-2015; ALAMINOS, MIGUEL/N-9960-2016	Díaz-Rodriguez, Elena/0000-0002-6240-6327; ALAMINOS, MIGUEL/0000-0003-4876-2672; Hernando, Eva/0000-0003-1023-0312	NCI NIH HHS [P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alaminos M, 2003, CANCER RES, V63, P4538; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Arber N, 1997, CANCER RES, V57, P1569; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DALBAGNI G, 1993, LANCET, V342, P469, DOI 10.1016/0140-6736(93)91595-D; Darzynkiewicz Z, 1996, CYTOMETRY, V25, P1; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hernando E, 2001, INT J CANCER, V95, P223, DOI 10.1002/1097-0215(20010720)95:4<223::AID-IJC1038>3.0.CO;2-L; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lentini L, 2002, NEOPLASIA, V4, P380, DOI 10.1038/sj.neo.7900256; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sanchez-Carbayo M, 2002, CANCER RES, V62, P6973; Schuldiner O, 2001, ONCOGENE, V20, P4984, DOI 10.1038/sj.onc.1204459; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	30	432	450	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					797	802		10.1038/nature02820	http://dx.doi.org/10.1038/nature02820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306814	Bronze			2022-12-28	WOS:000223233600046
J	Mannucci, PM				Mannucci, PM			Drug therapy - Treatment of von Willebrand's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VIII-VONWILLEBRAND-FACTOR; INHERITED BLEEDING DISORDERS; INDUCED PLATELET-AGGREGATION; HEMOPHILIA-A; MULTIMERIC COMPOSITION; RISTOCETIN-COFACTOR; DESMOPRESSIN DDAVP; FACTOR CONCENTRATE; ENDOTHELIAL-CELLS; SHEAR-STRESS		Univ Milan, Ist Ricovero & Cura Carattere Sci Maggiore Hosp, Dept Internal Med & Dermatol, Milan, Italy; Univ Milan, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy	University of Milan; University of Milan	Mannucci, PM (corresponding author), Via Pace 9, I-20122 Milan, Italy.	piermannuccio.mannucci@unimi.it						BERGAMASCHINI L, 1995, J LAB CLIN MED, V125, P348; BIGGS R, 1963, BRIT J HAEMATOL, V9, P203, DOI 10.1111/j.1365-2141.1963.tb05458.x; Biron C, 1999, J LAB CLIN MED, V134, P605, DOI 10.1016/S0022-2143(99)90100-2; BLATT PM, 1976, JAMA-J AM MED ASSOC, V236, P2770; BODA Z, 1991, BLOOD COAGUL FIBRIN, V2, P775, DOI 10.1097/00001721-199112000-00013; BOND L, 1988, NEW ENGL J MED, V318, P121; Boyer-Neumann C, 2003, J THROMB HAEMOST, V1, P190, DOI 10.1046/j.1538-7836.2003.00009.x; BROWN JE, 1986, THROMB RES, V43, P303, DOI 10.1016/0049-3848(86)90150-7; BYRNES JJ, 1988, AM J HEMATOL, V28, P63, DOI 10.1002/ajh.2830280115; CASTAMAN G, 1995, BRIT J HAEMATOL, V89, P147, DOI 10.1111/j.1365-2141.1995.tb08921.x; CASTILLO R, 1991, BLOOD, V77, P1901; Castillo R, 1997, TRANSFUSION, V37, P785, DOI 10.1046/j.1537-2995.1997.37897424399.x; Cattaneo M, 1999, THROMB HAEMOSTASIS, V82, P35; Chang AC, 1998, HAEMOPHILIA, V4, P1; CHEDIAK JR, 1986, AM J OBSTET GYNECOL, V155, P618, DOI 10.1016/0002-9378(86)90290-5; Ciavarella N, 1996, HAEMOSTASIS, V26, P150; CONTI M, 1986, OBSTET GYNECOL, V68, P282; Denis CV, 2001, BLOOD, V97, P465, DOI 10.1182/blood.V97.2.465; Dilley A, 2001, OBSTET GYNECOL, V97, P630, DOI 10.1016/S0029-7844(00)01224-2; Dobrkovska A, 1998, HAEMOPHILIA, V4, P33; FAVALORO EJ, 1991, BLOOD COAGUL FIBRIN, V2, P285, DOI 10.1097/00001721-199104000-00011; Federici, 2000, THROMB HAEMOSTASIS, V84, P739; Federici AB, 2004, BLOOD, V103, P2032, DOI 10.1182/blood-2003-06-2072; Federici AB, 2000, THROMB HAEMOSTASIS, V84, P345; Federici AB, 1998, BLOOD, V92, P2707, DOI 10.1182/blood.V92.8.2707.420k25_2707_2711; FOSTER PA, 1995, THROMB HAEMOSTASIS, V74, P784; Fressinaud E, 1998, BLOOD, V91, P1325, DOI 10.1182/blood.V91.4.1325; Gill JC, 2003, HAEMOPHILIA, V9, P688, DOI 10.1046/j.1351-8216.2003.00816.x; GINSBURG D, 1985, SCIENCE, V228, P1401, DOI 10.1126/science.3874428; Goudemand J, 1998, HAEMOPHILIA, V4, P48; GREEN D, 1976, AM J MED, V60, P357, DOI 10.1016/0002-9343(76)90751-8; Grossmann RE, 2000, THROMB HAEMOSTASIS, V83, P633; HANNA WT, 1994, THROMB HAEMOSTASIS, V71, P173; HOLMBERG L, 1983, NEW ENGL J MED, V309, P816, DOI 10.1056/NEJM198310063091402; HOYER LW, 1980, BLOOD, V55, P1056; *IT WORK GROUP, 1977, BRIT J HAEMATOL, V35, P101; JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906; Kadir RA, 1999, HAEMOPHILIA, V5, P40; Kadir RA, 1998, BRIT J OBSTET GYNAEC, V105, P314, DOI 10.1111/j.1471-0528.1998.tb10093.x; Kadir RA, 1998, LANCET, V351, P485, DOI 10.1016/S0140-6736(97)08248-2; Kaufmann JE, 2000, J CLIN INVEST, V106, P107, DOI 10.1172/JCI9516; KAYE JA, 1994, BLOOD, V84, pA276; Keeney S, 2001, CLIN LAB HAEMATOL, V23, P209, DOI 10.1046/j.1365-2257.2001.00400.x; Lak M, 2000, BRIT J HAEMATOL, V111, P1236, DOI 10.1046/j.1365-2141.2000.02507.x; LARRIEU MJ, 1968, AM J MED, V45, P354, DOI 10.1016/0002-9343(68)90070-3; LETHAGEN S, 1992, ANN HEMATOL, V65, P253, DOI 10.1007/BF01836069; Lillicrap D, 2002, THROMB HAEMOSTASIS, V87, P224; MACFARLANE DE, 1975, THROMB DIATH HAEMOST, V34, P306, DOI 10.1055/s-0038-1651343; Makris M, 2002, THROMB HAEMOSTASIS, V88, P387; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; Mannucci P., 2001, NEW ENGL J MED, V345, P384; MANNUCCI PM, 1992, BLOOD, V79, P3130; MANNUCCI PM, 1987, AM J HEMATOL, V25, P55, DOI 10.1002/ajh.2830250106; Mannucci PM, 2002, BLOOD, V99, P450, DOI 10.1182/blood.V99.2.450; Mannucci PM, 1998, NEW ENGL J MED, V339, P245, DOI 10.1056/NEJM199807233390407; MANNUCCI PM, 1981, BLOOD, V57, P25; MANNUCCI PM, 1977, LANCET, V1, P869; MANNUCCI PM, 1992, BRIT J HAEMATOL, V82, P87, DOI 10.1111/j.1365-2141.1992.tb04598.x; MANNUCCI PM, 1981, BRIT J HAEMATOL, V47, P283, DOI 10.1111/j.1365-2141.1981.tb02789.x; MANNUCCI PM, 1975, BRIT J HAEMATOL, V30, P81, DOI 10.1111/j.1365-2141.1975.tb00521.x; Mannucci PM, 2002, THROMB HAEMOSTASIS, V88, P378; MANNUCCI PM, 1985, BLOOD, V66, P796; MANNUCCI PM, 1988, BLOOD, V71, P65; Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307; Mannucci PM, 1995, ADV EXP MED BIOL, V386, P87; MANNUCCI PM, 1987, EUR J HAEMATOL, V39, P467; MANNUCCI PM, 1976, NATURE, V262, P141, DOI 10.1038/262141a0; MANNUCCI PM, 1994, BLOOD, V83, P3018, DOI 10.1182/blood.V83.10.3018.3018; MAZURIER C, 1994, BRIT J HAEMATOL, V88, P849, DOI 10.1111/j.1365-2141.1994.tb05127.x; MAZURIER C, 1990, EUR J HAEMATOL, V75, P228; Menache D, 1996, BRIT J HAEMATOL, V94, P740, DOI 10.1046/j.1365-2141.1996.d01-1860.x; MOAKE JL, 1988, BLOOD, V71, P1366; MOAKE JL, 1986, J CLIN INVEST, V78, P1456, DOI 10.1172/JCI112736; MORFINI M, 1993, THROMB HAEMOSTASIS, V70, P270; NACHMAN R, 1977, J CLIN INVEST, V60, P914, DOI 10.1172/JCI108846; NILSSON IM, 1959, ACTA MED SCAND, V164, P263; NISHINO M, 1989, BLOOD, V74, P1591; NOLLER KL, 1973, OBSTET GYNECOL, V41, P865; Olsen EHN, 2003, BLOOD, V102, P436, DOI 10.1182/blood-2003-01-0290; Pareti FI, 2000, CIRCULATION, V102, P1290, DOI 10.1161/01.CIR.102.11.1290; PASI KJ, 1990, BRIT J HAEMATOL, V75, P228, DOI 10.1111/j.1365-2141.1990.tb02654.x; PERKINS HA, 1967, BLOOD-J HEMATOL, V30, P375, DOI 10.1182/blood.V30.3.375.375; RAMSAHOYE BH, 1995, HAEMOPHILIA, V1, P140, DOI 10.1111/j.1365-2516.1995.tb00056.x; Rodeghiero F, 1996, THROMB HAEMOSTASIS, V76, P692; RODEGHIERO F, 1989, BLOOD, V74, P1997; RODEGHIERO F, 1987, BLOOD, V69, P454; ROSE EH, 1991, ANN INTERN MED, V114, P563, DOI 10.7326/0003-4819-114-7-563; RUGGERI ZM, 1981, BLOOD, V57, P1140; RUGGERI ZM, 1982, BLOOD, V59, P1272; RUGGERI ZM, 1980, J CLIN INVEST, V65, P1318, DOI 10.1172/JCI109795; RUGGERI ZM, 1978, J LAB CLIN MED, V91, P132; SADLER JE, 1994, THROMB HAEMOSTASIS, V71, P520; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schwarz HP, 1997, THROMB HAEMOSTASIS, V78, P571; SILWER J, 1973, ACTA PAEDIATR SCAND, P1; SMITH TJ, 1989, AM J HEMATOL, V31, P199, DOI 10.1002/ajh.2830310310; Thompson AR, 2004, HAEMOPHILIA, V10, P42, DOI 10.1046/j.1351-8216.2003.00809.x; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; Turecek PL, 1997, BLOOD, V90, P3555, DOI 10.1182/blood.V90.9.3555; Vincentelli A, 2003, NEW ENGL J MED, V349, P343, DOI 10.1056/NEJMoa022831; WEISS HJ, 1977, J CLIN INVEST, V60, P390, DOI 10.1172/JCI108788; WEISS HJ, 1973, J CLIN INVEST, V52, P2708, DOI 10.1172/JCI107465; WERNER EJ, 1993, J PEDIATR-US, V123, P893, DOI 10.1016/S0022-3476(05)80384-1; WISE RJ, 1991, J BIOL CHEM, V266, P21948; ZIMMERMAN TS, 1971, J CLIN INVEST, V50, P244, DOI 10.1172/JCI106480	105	312	322	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					683	694		10.1056/NEJMra040403	http://dx.doi.org/10.1056/NEJMra040403			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306670				2022-12-28	WOS:000223225500011
J	Creighton, S; Sethi, G; Edwards, SG; Miller, R				Creighton, S; Sethi, G; Edwards, SG; Miller, R			Dispersal of HIV positive asylum seekers: national survey of UK healthcare providers	BRITISH MEDICAL JOURNAL			English	Article									Camden Primary Care Trust, Dept Genitourinary Med, Mortimer Market Ctr, London WC1E 6AU, England; St Marys Hosp, Dept Genitourinary Med, London W2 1NY, England; UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, Ctr Sexual Hlth & HIV Res, London WC1E 6AU, England	Imperial College London; University of London; University College London	Creighton, S (corresponding author), Camden Primary Care Trust, Dept Genitourinary Med, Mortimer Market Ctr, London WC1E 6AU, England.	sarah.creighton@camdenpct.nhs.uk		Miller, Robert/0000-0003-2067-4291				*ALL PART PARL GRO, IMPR LIV BRIT; HEALTH T, 2003, ASYLUM STAT UK; Johnson R. D., 2003, ASYLUM SEEKERS DISPE	3	18	18	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 7	2004	329	7461					322	323		10.1136/bmj.38189.674213.79	http://dx.doi.org/10.1136/bmj.38189.674213.79			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846FF	15277294	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000223300300016
J	Greeley, R; Squyres, SW; Arvidson, RE; Bartlett, P; Bell, JF; Blaney, D; Cabrol, NA; Farmer, J; Farrand, B; Golombek, MP; Gorevan, SP; Grant, JA; Haldemann, AFC; Herkenhoff, KE; Johnson, J; Landis, G; Madsen, MB; McLennan, SM; Moersch, J; Rice, JW; Richter, L; Ruff, S; Sullivan, RJ; Thompson, SD; Wang, A; Weitz, CM; Whelley, P				Greeley, R; Squyres, SW; Arvidson, RE; Bartlett, P; Bell, JF; Blaney, D; Cabrol, NA; Farmer, J; Farrand, B; Golombek, MP; Gorevan, SP; Grant, JA; Haldemann, AFC; Herkenhoff, KE; Johnson, J; Landis, G; Madsen, MB; McLennan, SM; Moersch, J; Rice, JW; Richter, L; Ruff, S; Sullivan, RJ; Thompson, SD; Wang, A; Weitz, CM; Whelley, P		Athena Sci Team	Wind-related processes detected by the Spirit rover at Gusev Crater, Mars	SCIENCE			English	Article							ROCKS		Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Cornell Univ, Dept Astron, Ithaca, NY USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63031 USA; Honeybee Robot, New York, NY 10012 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Colorado, Space Sci Inst, Boulder, CO 80301 USA; Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Copenhagen, Niels Bohr Inst Astron Phys & Geophys, Ctr Planetary Sci, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Orsted Lab, DK-2100 Copenhagen, Denmark; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Deutsch Zentrum Luft & Raumfart, German Aerosp Ctr, Inst Space Simulat, D-51170 Cologne, Germany; NASA, Washington, DC 20546 USA	Arizona State University; Arizona State University-Tempe; Cornell University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Colorado System; University of Colorado Boulder; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA)	Greeley, R (corresponding author), Arizona State Univ, Dept Geol Sci, Box 871404, Tempe, AZ 85287 USA.	Greeley@asu.edu	Haldemann, Albert F C/I-9224-2012; Madsen, Morten Bo/D-2082-2011; Farmer, Jack D/B-9343-2019; Whelley, Patrick/B-9560-2012; Moersch, Jeffrey E/F-7189-2010	Haldemann, Albert F C/0000-0003-3741-8841; Madsen, Morten Bo/0000-0001-8909-5111; Whelley, Patrick/0000-0003-3266-9772; Moersch, Jeffrey E/0000-0003-3433-9419; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002290; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bell JF, 2002, ICARUS, V158, P56, DOI 10.1006/icar.2002.6865; Bridges NT, 2004, PLANET SPACE SCI, V52, P199, DOI 10.1016/j.pss.2003.08.026; Bridges NT, 1999, J GEOPHYS RES-PLANET, V104, P8595, DOI 10.1029/98JE02550; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Crisp JA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002038; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002035; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; GOLOMBEK MP, 2004, LUNAR PLANET SCI, V35; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Greeley R, 1999, J GEOPHYS RES-PLANET, V104, P8573, DOI 10.1029/98JE02553; GREELEY R, 1987, GEOPHYS RES LETT, V14, P925, DOI 10.1029/GL014i009p00925; Greeley R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002491; GREELEY R, 1982, J GEOPHYS RES, V87, P9, DOI 10.1029/JB087iB12p10009; GREELEY R, 1979, J GEOPHYS RES, V84, P6248, DOI 10.1029/JB084iB11p06248; Greeley R., 1985, WIND GEOLOGICAL PROC, DOI 10.1017/CBO9780511573071; Greeley R., 1992, MARS, P730; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; Pollack J. B., 1977, Journal of Geophysical Research, V82, P4479, DOI 10.1029/JS082i028p04479; Rafkin SCR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002027; RAUPACH MR, 1992, BOUND-LAY METEOROL, V60, P375, DOI 10.1007/BF00155203; RAUPACH MR, 1993, J GEOPHYS RES-ATMOS, V98, P3023, DOI 10.1029/92JD01922; SHARP RP, 1963, J GEOL, V71, P617, DOI 10.1086/626936; Smith PH, 1997, SCIENCE, V278, P1758, DOI 10.1126/science.278.5344.1758; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; TOIGO D, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2003JE002064; Tomasko MG, 1999, J GEOPHYS RES-PLANET, V104, P8987, DOI 10.1029/1998JE900016	33	85	86	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					810	+		10.1126/science.1100108	http://dx.doi.org/10.1126/science.1100108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297660				2022-12-28	WOS:000223104900034
J	Kilner, RM; Madden, JR; Hauber, ME				Kilner, RM; Madden, JR; Hauber, ME			Brood parasitic cowbird nestlings use host young to procure resources	SCIENCE			English	Article							PARENT-OFFSPRING CONFLICT; SIBLING COMPETITION; MODELS; SELFISH; CHICKS; COST; NEST	Young brood parasites that tolerate the company of host offspring challenge the existing evolutionary view of family life. In theory, all parasitic nestlings should be ruthlessly self-interested and should kill host offspring soon after hatching. Yet many species allow host young to live, even though they are rivals for host resources. Here we show that the tolerance of host nestlings by the parasitic brown-headed cowbird Molothrus ater is adaptive. Host young procure the cowbird a higher provisioning rate, so it grows more rapidly. The cowbird's unexpected altruism toward host offspring simply promotes its selfish interests in exploiting host parents.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; Univ Calif Berkeley, Museum Vertebrate Zool, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Cambridge; University of Auckland; University of California System; University of California Berkeley	Kilner, RM (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	rmk1002@hermes.cam.ac.uk	Kilner, Rebecca/B-2867-2012	Kilner, Rebecca/0000-0003-1159-0758				Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Dearborn DC, 1996, CONDOR, V98, P645, DOI 10.2307/1369581; Dearborn DC, 1998, BEHAV ECOL SOCIOBIOL, V43, P259, DOI 10.1007/s002650050490; FORBES LS, 1993, AM NAT, V142, P82, DOI 10.1086/285530; Gebhardt-Henrich S., 1998, AVIAN GROWTH DEV, P324; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; Haig D, 1996, J EVOLUTION BIOL, V9, P357, DOI 10.1046/j.1420-9101.1996.9030357.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hauber Mark E., 2004, Etologia, V10, P1; Hauber ME, 2003, BEHAV ECOL, V14, P227, DOI 10.1093/beheco/14.2.227; Hosoi SA, 2000, ANIM BEHAV, V59, P823, DOI 10.1006/anbe.1999.1370; Johnstone RA, 1999, P NATL ACAD SCI USA, V96, P12644, DOI 10.1073/pnas.96.22.12644; Kilner RM, 2003, ANIM BEHAV, V66, P569, DOI 10.1006/anbe.2003.2204; Kilpatrick AM, 2002, CAN J ZOOL, V80, P145, DOI 10.1139/Z01-217; Lichtenstein G, 1998, P ROY SOC B-BIOL SCI, V265, P249, DOI 10.1098/rspb.1998.0289; Lotem A, 1998, TRENDS ECOL EVOL, V13, P342, DOI 10.1016/S0169-5347(98)01401-3; MACNAIR MR, 1979, ANIM BEHAV, V27, P1202, DOI 10.1016/0003-3472(79)90067-8; MAY RM, 1985, AM NAT, V126, P475, DOI 10.1086/284433; Maynard Smith J., 1991, Animal Behaviour, V42, P1034; PARKER GA, 1989, AM NAT, V133, P846, DOI 10.1086/284956; PARKER GA, 1979, ANIM BEHAV, V27, P1210, DOI 10.1016/0003-3472(79)90068-X; Payne RB, 2001, ANIM BEHAV, V62, P473, DOI 10.1006/anbe.2001.1773; Reeve HK, 1999, MG BEH ECOL, P3; Rodriguez-Girones MA, 1999, P ROY SOC B-BIOL SCI, V266, P2399, DOI 10.1098/rspb.1999.0937; ROTHSTEIN SI, 1975, CONDOR, V77, P250, DOI 10.2307/1366221; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wilson DS, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P43, DOI 10.1007/0-306-47660-6_3; [No title captured]	30	133	143	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					877	879		10.1126/science.1098487	http://dx.doi.org/10.1126/science.1098487			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297677				2022-12-28	WOS:000223104900053
J	Morris, RV; Klingelhofer, G; Bernhardt, B; Schroder, C; Rodionov, DS; de Souza, PA; Yen, A; Gellert, R; Evlanov, EN; Foh, J; Kankeleit, E; Gutlich, P; Ming, DW; Renz, F; Wdowiak, T; Squyres, SW; Arvidson, RE				Morris, RV; Klingelhofer, G; Bernhardt, B; Schroder, C; Rodionov, DS; de Souza, PA; Yen, A; Gellert, R; Evlanov, EN; Foh, J; Kankeleit, E; Gutlich, P; Ming, DW; Renz, F; Wdowiak, T; Squyres, SW; Arvidson, RE			Mineralogy at Gusev crater from the Mossbauer spectrometer on the Spirit rover	SCIENCE			English	Article							ROCKS; MARS; SOILS; SPECTROSCOPY; HEMATITE	Mossbauer spectra measured on Mars by the Spirit rover during the primary mission are characterized by two ferrous iron doublets ( olivine and probably pyroxene) and a ferric iron doublet ( tentatively associated to nanophase ferric iron oxide). Two sextets resulting from nonstoichiometric magnetite are also present, except for a coating on the rock Mazatzal, where a hematite-like sextet is present. Greater proportions of ferric-bearing phases are associated with undisturbed soils and rock surfaces as compared to fresh rock surfaces exposed by grinding. The ubiquitous presence of olivine in soil suggests that physical rather than chemical weathering processes currently dominate at Gusev crater.	NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; IKI, Space Res Inst, Moscow, Russia; CVRD Grp, Vitoria, Brazil; CALTECH, Jet Prop Lab, Pasadena, CA USA; Max Planck Inst Chem, D-55128 Mainz, Germany; Tech Univ Darmstadt, Darmstadt, Germany; Univ Alabama Birmingham, Birmingham, AL USA; Cornell Univ, Ithaca, NY USA; Washington Univ, St Louis, MO USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Johannes Gutenberg University of Mainz; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; Technical University of Darmstadt; University of Alabama System; University of Alabama Birmingham; Cornell University; Washington University (WUSTL)	Morris, RV (corresponding author), NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA.	richard.v.morris@nasa.gov	de Souza, Paulo/P-7294-2019; de Souza, Paulo/W-2993-2019; de Souza, Paulo A/B-8961-2008; Schröder, Christian/B-3870-2009	de Souza, Paulo/0000-0002-0091-8925; de Souza, Paulo A/0000-0002-0091-8925; Schröder, Christian/0000-0002-7935-6039; Renz, Franz/0000-0003-1494-1242				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; BANDFIELD JL, 2002, J GEOPHYS RES, V107, P1626; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Bishop J.L., 1996, SPEC PUBL GEOCHEM SO, V5, P337; BURNS RG, 1989, ACS SYM SER, V415, P262; BURNS RG, 1993, REMOTE GEOCHEMICAL A, P539; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; DANIELS JM, 1969, J PHYS CHEM SOLIDS, V30, P1561, DOI 10.1016/0022-3697(69)90217-0; de Souza PA, 1999, LAB ROBOTICS AUTOMAT, V11, P3, DOI 10.1002/(SICI)1098-2728(1999)11:1<3::AID-LRA2>3.0.CO;2-F; DEGRAVE E, 1991, PHYS CHEM MINER, V18, P337, DOI 10.1007/BF00200191; Dyar MD, 2003, METEORIT PLANET SCI, V38, P1733, DOI 10.1111/j.1945-5100.2003.tb00012.x; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; MCCAMMON C, 1995, AGU REFERENCE SHELF, V2, P332; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; MENZIES ON, 2001, LUNAR PLANET SCI, V32; MORRIS RV, 1995, J GEOPHYS RES-PLANET, V100, P5319, DOI 10.1029/94JE01500; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 1989, J GEOPHYS RES-SOLID, V94, P2760, DOI 10.1029/JB094iB03p02760; MYNENI SCB, 2000, REV MINERALOGY GEOCH, V40; SCHAEFER MW, 1983, NATURE, V303, P325, DOI 10.1038/303325a0; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Stevens J. G., 1998, MOSSBAUER MINERAL HD; VIEIRA VWA, 1986, PHYS SCRIPTA, V33, P180, DOI 10.1088/0031-8949/33/2/016	30	206	209	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					833	836		10.1126/science.1100020	http://dx.doi.org/10.1126/science.1100020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297666				2022-12-28	WOS:000223104900039
J	Rios, RM; Sanchis, A; Tassin, AM; Fedriani, C; Bornens, M				Rios, RM; Sanchis, A; Tassin, AM; Fedriani, C; Bornens, M			GMAP-210 recruits gamma-tubulin complexes to cis-Golgi membranes and is required for Golgi ribbon formation	CELL			English	Article							MAMMALIAN-CELLS; MICROTUBULE DYNAMICS; INTERMEDIATE COMPARTMENT; PROTEIN COMPLEX; APPARATUS; CYCLE; OVEREXPRESSION; MITOCHONDRIA; CENTROSOME; CHAIN	Mammalian cells concentrate Golgi membranes around the centrosome in a microtubule-dependent manner. The mechanisms involved in generating a single Golgi ribbon in the periphery of the centrosome remain unknown. Here we show that GMAP-210, a cis-Golgi microtubule binding protein, recruits gamma-tubulin-containing complexes to Golgi membranes even in conditions where microtubule polymerization is prevented and independently of Golgi apparatus localization within the cell. Under overexpression conditions, very short microtubules, or tubulin oligomers, are stabilized on Golgi membranes. GMAP-210 depletion by RNA interference results in extensive fragmentation of the Golgi apparatus, supporting a role for GMAP-210 in Golgi ribbon formation. Targeting of GMAP-210 or its C terminus to mitochondria induces the recruitment of gamma-tubulin to their surface and redistribution of mitochondria to a pericentrosomal location. All our experiments suggest that GMAP-210 displays microtubule anchoring and membrane fusion activities, thus contributing to the assembly and maintenance of the Golgi ribbon around the centrosome.	Univ Sevilla, Fac Biol, Dept Microbiol, E-41080 Seville, Spain; CNRS, UMR 144, Inst Curie, Sect Rech, F-75248 Paris 05, France	University of Sevilla; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Rios, RM (corresponding author), Univ Sevilla, Fac Biol, Dept Microbiol, Apdo 1095, E-41080 Seville, Spain.	rmrios@us.es	rios, rosa m/G-5742-2015	rios, rosa m/0000-0001-5778-6946				Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; De Vos K, 2000, J CELL BIOL, V149, P1207, DOI 10.1083/jcb.149.6.1207; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Grissom PM, 2002, MOL BIOL CELL, V13, P817, DOI 10.1091/mbc.01-08-0402; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83; JASMIN BJ, 1989, P NATL ACAD SCI USA, V86, P7218, DOI 10.1073/pnas.86.18.7218; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Lippincott-Schwartz J, 2000, HISTOCHEM CELL BIOL, V114, P93; Llanos R, 1999, BIOCHEMISTRY-US, V38, P15712, DOI 10.1021/bi990895w; Maag RS, 2003, CURR OPIN CELL BIOL, V15, P456, DOI 10.1016/S0955-0674(03)00075-9; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Moudjou M, 1996, J CELL SCI, V109, P875; Pernet-Gallay K, 2002, TRAFFIC, V3, P822, DOI 10.1034/j.1600-0854.2002.31107.x; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; Prigozhina NL, 2004, MOL BIOL CELL, V15, P1374, DOI 10.1091/mbc.E03-06-0405; Rios RM, 2003, CURR OPIN CELL BIOL, V15, P60, DOI 10.1016/S0955-0674(02)00013-3; RIOS RM, 1994, J CELL BIOL, V125, P997, DOI 10.1083/jcb.125.5.997; RODIONOV VI, 1993, J CELL BIOL, V123, P1811, DOI 10.1083/jcb.123.6.1811; Saoudi Y, 1998, J CELL BIOL, V142, P1519, DOI 10.1083/jcb.142.6.1519; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tassin AM, 1998, J CELL BIOL, V141, P689, DOI 10.1083/jcb.141.3.689; Terada Y, 2003, J CELL BIOL, V162, P757, DOI 10.1083/jcb.200305048; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Usui T, 2003, EMBO J, V22, P4779, DOI 10.1093/emboj/cdg459; Xu Y, 2002, J CELL BIOL, V158, P293, DOI 10.1083/jcb.200202058; Yoshimura S, 2001, J CELL SCI, V114, P4105	44	182	189	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 6	2004	118	3					323	335						13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294158				2022-12-28	WOS:000223353100009
J	Robinson, LF; Henderson, GM; Hall, L; Matthews, I				Robinson, LF; Henderson, GM; Hall, L; Matthews, I			Climatic control of riverine and Seawater uranium-isotope ratios	SCIENCE			English	Article							NEW-ZEALAND; SOUTHERN ALPS; LAST DEGLACIATION; POLLEN RECORD; VEGETATION; TRANSPORT	The large variation in the ratio of uranium-234 to uranium-238 (U-234/U-238) in rivers is not well understood, but may provide information about past weathering and rainfall and is important because it controls seawater (U-234/U-238). Here, we demonstrate the importance of physical weathering and rainfall for (U-234/U-238), using rivers from South Island, New Zealand. These data allow interpretation of an existing speleothem (U-234/U-238) record and suggest that New Zealand glacier advance 13,000 years ago was influenced by increased rainfall rather than by Younger Dryas-like cooling. A model of seawater (U-234/U-238) during glacial cycles indicates that rejection of corals based on modern (U-234/U-238) +/- < 0.01 is not merited and may reject the highest quality ages.	Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University of Oxford	Robinson, LF (corresponding author), CALTECH, MS 100-23,1200 E Calif Blvd, Pasadena, CA 91125 USA.	laurar@gps.caltech.edu		Robinson, Laura/0000-0001-6811-0140; Henderson, Gideon/0000-0002-6279-7137				ADAMS J, 1980, GEOL SOC AM BULL, V91, P2, DOI 10.1130/0016-7606(1980)91<2:CUAEOT>2.0.CO;2; Allis RG, 1995, NEW ZEAL J GEOL GEOP, V38, P585, DOI 10.1080/00288306.1995.9514687; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Chabaux F, 2003, REV MINERAL GEOCHEM, V52, P533, DOI 10.2113/0520533; Chabaux F, 2001, GEOCHIM COSMOCHIM AC, V65, P3201, DOI 10.1016/S0016-7037(01)00669-X; Cherdyntsev V. V., 1971, URANIUM 234; DENTON GH, 1994, SCIENCE, V264, P1434, DOI 10.1126/science.264.5164.1434; EDWARDS RL, 1986, EARTH PLANET SC LETT, V81, P175; ESAT TM, 1999, EOS T AGU, V80, P581; Hellstrom J, 1998, QUATERNARY RES, V50, P167, DOI 10.1006/qres.1998.1991; Hellstrom JC, 2000, EARTH PLANET SC LETT, V179, P287, DOI 10.1016/S0012-821X(00)00115-1; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Henderson GM, 2002, EARTH PLANET SC LETT, V199, P97, DOI 10.1016/S0012-821X(02)00556-3; Hovius N, 1997, GEOLOGY, V25, P231, DOI 10.1130/0091-7613(1997)025<0231:SFFAMB>2.3.CO;2; HUTCHINSON MF, 1989, J HYDROL, V106, P211, DOI 10.1016/0022-1694(89)90073-5; Jacobson AD, 2003, GEOCHIM COSMOCHIM AC, V67, P29, DOI 10.1016/S0016-7037(02)01053-0; Kaufman A, 1998, EARTH PLANET SC LETT, V156, P141, DOI 10.1016/S0012-821X(98)00002-8; KIGOSHI K, 1971, SCIENCE, V173, P3991; KRONFELD J, 1991, EARTH PLANET SC LETT, V105, P191, DOI 10.1016/0012-821X(91)90130-A; LAMB SH, 1989, J STRUCT GEOL, V11, P473, DOI 10.1016/0191-8141(89)90024-2; LUDWIG KR, 1992, SCIENCE, V258, P284, DOI 10.1126/science.258.5080.284; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; MONGILLO MA, 1984, DSIR GEOTHERMAL REPO, V9; Newnham RM, 2000, GEOLOGY, V28, P759, DOI 10.1130/0091-7613(2000)028<0759:FRPROL>2.3.CO;2; Ota Y, 1996, NEW ZEAL J GEOL GEOP, V39, P51, DOI 10.1080/00288306.1996.9514694; Porcelli D, 1997, GEOCHIM COSMOCHIM AC, V61, P4095, DOI 10.1016/S0016-7037(97)00235-4; Robinson LF, 2002, EARTH PLANET SC LETT, V196, P175, DOI 10.1016/S0012-821X(01)00610-0; Sandiford A, 2003, PALAEOGEOGR PALAEOCL, V210, P235, DOI 10.1016/S0031-0182(03)00611-4; Singer C, 1998, SCIENCE, V281, P812, DOI 10.1126/science.281.5378.812; SOWERS T, 1995, SCIENCE, V269, P210, DOI 10.1126/science.269.5221.210; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; Suggate R. P., 1978, GEOLOGY NZ, V2; Thompson WG, 2003, EARTH PLANET SC LETT, V210, P365, DOI 10.1016/S0012-821X(03)00121-3; TIPPET JM, 1993, J GEOPHYS RES, V16, P16119; Turney CSM, 2003, GEOLOGY, V31, P223, DOI 10.1130/0091-7613(2003)031<0223:ACCBNZ>2.0.CO;2; Vandergoes MJ, 2003, QUATERNARY SCI REV, V22, P1461, DOI 10.1016/S0277-3791(03)00074-X; Wellman H.W., 1979, R SOC N Z B, V18, P13	37	101	102	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					851	854		10.1126/science.1099673	http://dx.doi.org/10.1126/science.1099673			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297670				2022-12-28	WOS:000223104900045
J	Squyres, SW; Arvidson, RE; Bell, JF; Bruckner, J; Cabrol, NA; Calvin, W; Carr, MH; Christensen, PR; Clark, BC; Crumpler, L; Des Marais, DJ; d'Uston, C; Economou, T; Farmer, J; Farrand, W; Folkner, W; Golombek, M; Gorevan, S; Grant, JA; Greeley, R; Grotzinger, J; Haskin, L; Herkenhoff, KE; Hviid, S; Johnson, J; Klingelhofer, G; Knoll, A; Landis, G; Lemmon, M; Li, R; Madsen, MB; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Moersch, J; Morris, RV; Parker, T; Rice, JW; Richter, L; Rieder, R; Sims, M; Smith, M; Smith, P; Soderblom, LA; Sullivan, R; Wanke, H; Wdowiak, T; Wolff, M; Yen, A				Squyres, SW; Arvidson, RE; Bell, JF; Bruckner, J; Cabrol, NA; Calvin, W; Carr, MH; Christensen, PR; Clark, BC; Crumpler, L; Des Marais, DJ; d'Uston, C; Economou, T; Farmer, J; Farrand, W; Folkner, W; Golombek, M; Gorevan, S; Grant, JA; Greeley, R; Grotzinger, J; Haskin, L; Herkenhoff, KE; Hviid, S; Johnson, J; Klingelhofer, G; Knoll, A; Landis, G; Lemmon, M; Li, R; Madsen, MB; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Moersch, J; Morris, RV; Parker, T; Rice, JW; Richter, L; Rieder, R; Sims, M; Smith, M; Smith, P; Soderblom, LA; Sullivan, R; Wanke, H; Wdowiak, T; Wolff, M; Yen, A			The Spirit Rover's Athena Science Investigation at Gusev Crater, Mars	SCIENCE			English	Article							MAGNETIC-PROPERTIES EXPERIMENTS; MOSSBAUER SPECTROMETER; LANDING SITES; ROCKS; MISSION; SOILS	The Mars Exploration Rover Spirit and its Athena science payload have been used to investigate a landing site in Gusev crater. Gusev is hypothesized to be the site of a former lake, but no clear evidence for lacustrine sedimentation has been found to date. Instead, the dominant lithology is basalt, and the dominant geologic processes are impact events and eolian transport. Many rocks exhibit coatings and other characteristics that may be evidence for minor aqueous alteration. Any lacustrine sediments that may exist at this location within Gusev apparently have been buried by lavas that have undergone subsequent impact disruption.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Max Planck Inst Chem, Abt Kosmochem, D-55128 Mainz, Germany; NASA, Ames SETI Inst, Moffett Field, CA 94035 USA; Univ Nevada, Dept Geol Sci, Reno, NV 89557 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Space Sci Inst, Boulder, CO 80301 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Honeybee Robot, New York, NY 10012 USA; Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Johannes Gutenberg Univ Mainz, D-55099 Mainz, Germany; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Texas A&M Univ, Dept Atmospher Sci, College Stn, TX 77843 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Niels Bohr Inst, DK-2100 Copenhagen 0, Denmark; Malin Space Sci Syst, San Diego, CA 92191 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Deutsch Zentrum Luft & Raumfahrt, Inst Raumsimulat, D-51170 Cologne, Germany; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA; Space Sci Inst, Martinez, GA 30907 USA	Cornell University; Washington University (WUSTL); Max Planck Society; National Aeronautics & Space Administration (NASA); Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe; Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Chicago; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Smithsonian Institution; Massachusetts Institute of Technology (MIT); United States Department of the Interior; United States Geological Survey; Max Planck Society; Johannes Gutenberg University of Mainz; Harvard University; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; University of Copenhagen; Niels Bohr Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Arizona; University of Alabama System; University of Alabama Birmingham	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	squyres@astro.cornell.edu	Lemmon, Mark/X-2333-2019; Moersch, Jeffrey E/F-7189-2010; Smith, Michael/C-8875-2012; Sullivan, Robert/AAR-8193-2020; Farmer, Jack D/B-9343-2019; Madsen, Morten Bo/D-2082-2011; Lemmon, Mark T/E-9983-2010	Lemmon, Mark/0000-0002-4504-5136; Moersch, Jeffrey E/0000-0003-3433-9419; Madsen, Morten Bo/0000-0001-8909-5111; Lemmon, Mark T/0000-0002-4504-5136; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; Cabrol NA, 1996, ICARUS, V123, P269, DOI 10.1006/icar.1996.0157; Cabrol NA, 1998, ICARUS, V132, P362, DOI 10.1006/icar.1998.5903; Cabrol NA, 1998, ICARUS, V133, P98, DOI 10.1006/icar.1998.5914; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; CHRISTENSEN PR, 1986, ICARUS, V68, P217, DOI 10.1016/0019-1035(86)90020-5; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Crisp JA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002038; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; GRANT JA, 1993, J GEOPHYS RES-PLANET, V98, P11025, DOI 10.1029/93JE00121; Greeley R, 1999, J GEOPHYS RES-PLANET, V104, P8573, DOI 10.1029/98JE02553; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Greeley R, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002006; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; Maki JN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002077; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Melosh H.L, 1989, IMPACT CRATERING GEO; Milam KA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002023; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Rafkin SCR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002027; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121	32	299	305	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					794	799		10.1126/science.3050794	http://dx.doi.org/10.1126/science.3050794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297657				2022-12-28	WOS:000223104900031
J	Lerner, PI				Lerner, PI			Producing penicillin	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Hosp Cleveland, Div Infect Dis, Cleveland, OH 44106 USA	University Hospitals of Cleveland	Lerner, PI (corresponding author), Univ Hosp Cleveland, Div Infect Dis, Cleveland, OH 44106 USA.							Dowling H., 1977, FIGHTING INFECT CONQ; Keefer CS, 1943, JAMA-J AM MED ASSOC, V122, P1217; Loewe L, 1944, J AMER MED ASSOC, V124, P144, DOI 10.1001/jama.1944.02850030012003	3	9	9	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					524	524		10.1056/NEJMp048179	http://dx.doi.org/10.1056/NEJMp048179			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295042				2022-12-28	WOS:000223069900002
J	Piperno, DR; Weiss, E; Holst, I; Nadel, D				Piperno, DR; Weiss, E; Holst, I; Nadel, D			Processing of wild cereal grains in the Upper Palaeolithic revealed by starch grain analysis	NATURE			English	Article							STONE TOOLS; OHALO-II; IDENTIFICATION	Barley ( Hordeum vulgare L.) and wheat ( Triticum monococcum L. and Triticum turgidum L.) were among the principal 'founder crops' of southwest Asian agriculture(1). Two issues that were central to the cultural transition from foraging to food production are poorly understood. They are the dates at which human groups began to routinely exploit wild varieties of wheat and barley, and when foragers first utilized technologies to pound and grind the hard, fibrous seeds of these and other plants to turn them into easily digestible foodstuffs. Here we report the earliest direct evidence for human processing of grass seeds, including barley and possibly wheat, in the form of starch grains recovered from a ground stone artefact from the Upper Palaeolithic site of Ohalo II in Israel. Associated evidence for an oven-like hearth was also found at this site, suggesting that dough made from grain flour was baked. Our data indicate that routine processing of a selected group of wild cereals, combined with effective methods of cooking ground seeds, were practiced at least 12,000 years before their domestication in southwest Asia.	Smithsonian Trop Res Inst, Balboa, Panama; Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Archaeobiol Program, Washington, DC 20560 USA; Harvard Univ, Peabody Museum, Dept Anthropol, Cambridge, MA 02130 USA; Univ Haifa, Archaeol Inst, IL-31905 Haifa, Israel	Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; Harvard University; University of Haifa	Piperno, DR (corresponding author), Smithsonian Trop Res Inst, Box 2072, Balboa, Panama.	pipernod@tivoli.si.edu; eweiss@fas.harvard.edu	Weiss, Ehud/AAJ-3619-2020; Weiss, Ehud/F-2588-2016	Weiss, Ehud/0000-0002-9730-4726; Weiss, Ehud/0000-0002-9730-4726; Nadel, Dani/0000-0001-7736-1830				Bar-Yosef O, 1989, FORAGING FARMING EVO, P633; CORTELLA AR, 1994, ECON BOT, V48, P171, DOI 10.1007/BF02908212; Flannery K. V., 1969, The domestication and exploitation of plants and animals., P73; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Hawkes K, 1997, TRENDS ECOL EVOL, V12, P29, DOI 10.1016/S0169-5347(96)10060-4; Hobbs J.J, 1989, BEDOUIN LIFE EGYPTIA; Jenkins DJA, 2002, AM J CLIN NUTR, V76, p266S, DOI 10.1093/ajcn/76.1.266S; KENENTT D, IN PRESS FORAGING TH; KISLEV ME, 1992, REV PALAEOBOT PALYNO, V73, P161, DOI 10.1016/0034-6667(92)90054-K; Kuhn SL, 2001, BIOSOCIAL S, V13, P99; NADEL D, 1995, J ARCHAEOL SCI, V22, P811, DOI 10.1016/0305-4403(95)90010-1; Nadel D, 1999, ANTIQUITY, V73, P755, DOI 10.1017/S0003598X00065509; NADEL D, 2002, 20 U HAIF HECHT MUS; NICOLAISEM J, 1963, ECOLOGY CULTURE PAST; Palmer C., 2002, LEVANT, V34, P173, DOI [DOI 10.1179/LEV.2002.34.1.173, 10.1179/lev.2002.34.1.173]; Pearsall DM, 2004, J ARCHAEOL SCI, V31, P423, DOI 10.1016/j.jas.2003.09.010; Perry L, 2002, INTERCIENCIA, V27, P635; Piperno DR, 2000, NATURE, V407, P894, DOI 10.1038/35038055; Piperno DR, 1998, J ARCHAEOL SCI, V25, P765, DOI 10.1006/jasc.1997.0258; Reichert E.T, 1913, DIFFERENTIATION SPEC; Runciman G., 2001, P BR ACAD, V110, P1; SEIDEMANN J, 1966, STARKE ATLAS; Stahl A., 1989, FORAGING FARMING EVO, P171; Torrence R, 2004, J ARCHAEOL SCI, V31, P519, DOI 10.1016/j.jas.2003.09.014; Weiss E, 2004, P NATL ACAD SCI USA, V101, P9551, DOI 10.1073/pnas.0402362101; WEISS E, IN PRESS EC BOT; WRIGHT KI, 1994, AM ANTIQUITY, V59, P238, DOI 10.2307/281929; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	28	284	321	4	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					670	673		10.1038/nature02734	http://dx.doi.org/10.1038/nature02734			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295598				2022-12-28	WOS:000223085400043
J	Barret, JP				Barret, JP			ABC of burns - Burns reconstruction	BRITISH MEDICAL JOURNAL			English	Review									Broomfield Hosp, St Andrews Ctr Plast Surg & Burns, Chelmsford, Essex, England	Mid Essex Hospital Services NHS Trust; Broomfield Hospital	Barret, JP (corresponding author), Broomfield Hosp, St Andrews Ctr Plast Surg & Burns, Chelmsford, Essex, England.			Barret Nerin, Joan-Pere/0000-0001-7115-4830				Achauer BM, 1991, BURN RECONSTRUCTION; BARRET JP, 2001, COLOR ATLAS BURN CAR; Brou J A, 1989, J Burn Care Rehabil, V10, P555, DOI 10.1097/00004630-198911000-00020; ENGRAV LH, 1997, OPERATIVE TECHNIQUES; Herndon DN, 2018, TOTAL BURN CARE	5	12	14	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 31	2004	329	7460					274	276		10.1136/bmj.329.7460.274	http://dx.doi.org/10.1136/bmj.329.7460.274			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284153	Green Published			2022-12-28	WOS:000223133300022
J	Dicke, M; van Loon, JJA; de Jong, PW				Dicke, M; van Loon, JJA; de Jong, PW			Ecogenomics benefits community ecology	SCIENCE			English	Editorial Material									Univ Wageningen & Res Ctr, Entomol Lab, NL-6700 EH Wageningen, Netherlands	Wageningen University & Research	Dicke, M (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, POB 8031, NL-6700 EH Wageningen, Netherlands.	marcel.dicke@wur.nl	van Loon, Joop J.A./B-3744-2009; Dicke, Marcel/B-2300-2010	van Loon, Joop J.A./0000-0002-4260-0501; Dicke, Marcel/0000-0001-8565-8896				Bergelson J, 1996, P ROY SOC B-BIOL SCI, V263, P1659, DOI 10.1098/rspb.1996.0242; Black WC, 2001, ANNU REV ENTOMOL, V46, P441, DOI 10.1146/annurev.ento.46.1.441; Dicke M, 2003, BASIC APPL ECOL, V4, P27, DOI 10.1078/1439-1791-00131; Dicke M, 2000, ENTOMOL EXP APPL, V97, P237, DOI 10.1023/A:1004111624780; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schoonhoven L.M., 1998, INSECT PLANT BIOL PH; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; van Poecke RMP, 2002, J EXP BOT, V53, P1793, DOI 10.1093/jxb/erf022	12	25	25	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					618	619		10.1126/science.1101788	http://dx.doi.org/10.1126/science.1101788			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286351				2022-12-28	WOS:000222992100024
J	McDermott, MM; Liu, K; Greenland, P; Guralnik, JM; Criqui, MH; Chan, CL; Pearce, WH; Schneider, JR; Ferrucci, L; Celic, L; Taylor, LM; Vonesh, E; Martin, GJ; Clark, E				McDermott, MM; Liu, K; Greenland, P; Guralnik, JM; Criqui, MH; Chan, CL; Pearce, WH; Schneider, JR; Ferrucci, L; Celic, L; Taylor, LM; Vonesh, E; Martin, GJ; Clark, E			Functional decline in peripheral arterial disease - Associations with the ankle brachial index and leg symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC HEART-FAILURE; 6-MINUTE WALK TEST; INTERMITTENT CLAUDICATION; CARDIOVASCULAR HEALTH; PHYSICAL-DISABILITY; TREADMILL WALKING; LOWER-EXTREMITIES; LONGITUDINAL DATA; VASCULAR-DISEASE; NATURAL COURSE	Context Among individuals with lower-extremity peripheral arterial disease (PAD), specific leg symptoms and the ankle brachial index (ABI) are cross-sectionally related to the degree of functional impairment. However, relations between these clinical characteristics and objectively measured functional decline are unknown. Objective To define whether PAD, ABI, and specific leg symptoms predict functional decline at 2-year follow-up. Design, Setting, and Participants Prospective cohort study among 676 consecutively identified individuals (aged greater than or equal to55 years) with and without PAD (n=417 and n=259, respectively), with baseline functional assessments occurring between October 1, 1998, and January 31, 2000, and follow-up assessments scheduled 1 and 2 years thereafter. PAD was defined as ABI less than 0.90, and participants with PAD were categorized at baseline into 1 of 5 mutually exclusive symptom groups. Main Outcome Measures Mean annual changes in 6-minute walk performance and in usual-paced and fast-paced 4-m walking velocity, adjusted for age, sex, race, prior-year functioning, comorbid diseases, body mass index, pack-years of cigarette smoking, and patterns of missing data. Results Lower baseline ABI values were associated with greater mean (95% confidence interval) annual decline in 6-minute walk performance (-73.0 [-142 to -4.2] ft for ABI <0.50 vs -58.8 [-83.5 to -34.0] ft for ABI 0.50 to <0.90 vs -12.6 [-40.3 to 15.1] ft for ABI 0.90-1.50, P=.02). Compared with participants without PAD, PAD participants with leg pain on exertion and rest at baseline had greater mean annual decline in 6-minute walk performance (-111 [-173 to -50.0] ft vs -8.67 [-36.9 to 19.5] ft, P=.004), usual-pace 4-meter walking velocity (-0.06 [-0.09 to -0.02] m/sec vs -0.01 (-0.03 to 0.003] m/sec, P=.02), and fastest-pace 4-meter walking velocity (-0.07 [-0.11 to -0.031 m/sec vs -0.02 [-0.04 to -0.006] m/sec, P=.046). Compared with participants without PAD, asymptomatic PAD was associated with greater mean annual decline in 6-minute walk performance (-76.8 (-135 to -18.61 ft vs -8.67 (-36.9 to 19.51 ft, P=.04) and an increased odds ratio for becoming unable to walk for 6 minutes continuously (3.63; 95% confidence interval, 1.58-8.36; P=.002). Conclusions Baseline ABI and the nature of leg symptoms predict the degree of functional decline at 2-year follow-up. Previously reported lack of worsening in claudication symptoms over time in patients with PAD may be more related to declining functional performance to than lack of disease progression.	Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Surg, Div Vasc Surg, Chicago, IL 60611 USA; NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; NIA, Lab Clin Epidemiol, Bethesda, MD 20892 USA; Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; Evanston NW Hosp, Dept Surg, Div Vasc Surg, Evanston, IL USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Catholic Hlth Partners, Dept Surg, Div Vasc Surg, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Diego; NorthShore University Health System; Oregon Health & Science University	McDermott, MM (corresponding author), 675 N St Clair,Suite 18-200, Chicago, IL 60611 USA.	mdm608@northwestern.edu	Greenland, Philip/ABD-5528-2021		NCRR NIH HHS [RR-00048] Funding Source: Medline; NHLBI NIH HHS [R01-HL58099, R01-HL64739] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064739, R01HL058099] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; BENDALL MJ, 1989, AGE AGEING, V18, P327, DOI 10.1093/ageing/18.5.327; BERNSTEIN EF, 1982, SURG CLIN N AM, V62, P473; BITTNER V, 1993, JAMA-J AM MED ASSOC, V270, P1702, DOI 10.1001/jama.270.14.1702; BOYD AM, 1962, P ROY SOC MED, V55, P591, DOI 10.1177/003591576205500717; BRAUNWALD E, 2001, HEART DIS TXB CARDIV, P1467; Braunwald E., 2001, HARRISONS PRINCIPLES; Criqui M H, 1996, Vasc Med, V1, P65; ETTINGER WH, 1994, J AM GERIATR SOC, V42, P1035, DOI 10.1111/j.1532-5415.1994.tb06206.x; Fitzmaurice GM, 2001, STAT MED, V20, P1009, DOI 10.1002/sim.718; FRIED LP, 1994, J CLIN EPIDEMIOL, V47, P747, DOI 10.1016/0895-4356(94)90172-4; Fried LP, 1999, J CLIN EPIDEMIOL, V52, P27, DOI 10.1016/S0895-4356(98)00124-3; Gardner AW, 1998, ANGIOLOGY, V49, P327, DOI 10.1177/000331979804900501; GREIG C, 1993, J AM GERIATR SOC, V41, P15, DOI 10.1111/j.1532-5415.1993.tb05941.x; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Guralnik JM, 1995, NIH PUBLICATION, V95-4009; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; IMPARATO AM, 1975, SURGERY, V78, P795; LITTLE RJA, 1995, J AM STAT ASSOC, V90, P1112, DOI 10.2307/2291350; MCALLISTER FF, 1976, AM J SURG, V132, P593, DOI 10.1016/0002-9610(76)90351-2; McDermott MM, 1998, J AM GERIATR SOC, V46, P1355, DOI 10.1111/j.1532-5415.1998.tb06001.x; McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640; McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; McDermott MM, 2001, J GEN INTERN MED, V16, P384, DOI 10.1046/j.1525-1497.2001.016006384.x; Montgomery PS, 1998, J AM GERIATR SOC, V46, P706, DOI 10.1111/j.1532-5415.1998.tb03804.x; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; OGREN M, 1995, BMJ-BRIT MED J, V310, P1294, DOI 10.1136/bmj.310.6990.1294; OLIN JW, 1998, AM J MED CONTINUING, P10; Ouriel K, 2001, LANCET, V358, P1257, DOI 10.1016/S0140-6736(01)06351-6; OURIEL K, 1982, ARCH SURG-CHICAGO, V117, P1297; Papapetropoulou V, 1998, J CLIN NEUROPHYSIOL, V15, P447, DOI 10.1097/00004691-199809000-00009; Pasini FL, 1996, ANGIOLOGY, V47, P569, DOI 10.1177/000331979604700605; Peeters P, 1996, J GERONTOL A-BIOL, V51, pM147, DOI 10.1093/gerona/51A.4.M147; REGENSTEINER JG, 1993, CIRCULATION, V87, P413, DOI 10.1161/01.CIR.87.2.413; RODRIGUEZSANCHEZ C, 1991, HISTOL HISTOPATHOL, V6, P63; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Simonsick EM, 2000, AGING-CLIN EXP RES, V12, P274, DOI 10.1007/BF03339847; SWERTS PMJ, 1990, PHYS THER, V70, P439, DOI 10.1093/ptj/70.7.439; SWINBURN CR, 1985, THORAX, V40, P581, DOI 10.1136/thx.40.8.581; Weitz JI, 1996, CIRCULATION, V94, P3026, DOI 10.1161/01.CIR.94.11.3026; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; [No title captured]; [No title captured]	48	441	454	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2004	292	4					453	461		10.1001/jama.292.4.453	http://dx.doi.org/10.1001/jama.292.4.453			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841AA	15280343	Bronze			2022-12-28	WOS:000222900500022
J	Ives, NJ; Stowe, RL; Marro, J; Counsell, C; Macleod, A; Clarke, CE; Gray, R; Wheatley, K				Ives, NJ; Stowe, RL; Marro, J; Counsell, C; Macleod, A; Clarke, CE; Gray, R; Wheatley, K			Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INITIAL TREATMENT; SELEGILINE; LEVODOPA; DEPRENYL; PROGRESSION; MORTALITY; DISABILITY; MULTICENTER; RELEVANT; THERAPY	Objective To quanti, more reliably the benefits and risks of monoamine oxidase type B inhibitors (MAOBIs) in early Parkinson's disease. Data sources Searches of the Cochrane Library, Medline, Embase, PubMed, and Web of Science for years 1966-2003, plus major journals in the field, abstract books, and proceedings of meetings, for randomised trials comparing MAOBIs with placebo or levodopa. Data extraction Available data on mortality, motor complications, side effects, treatment compliance, and clinician rated disability (for example, unified Parkinson's disease rating scale) were extracted from 17 trials and combined using standard meta-analytic methods. Results No significant difference in mortality existed between patients on MAOBIs and control patients (odds ratio 1.13, 95% confidence interval 0.94 to 1.34; P=0.2). Patients randomised to MAOBIs had significantly better total scores, motor scores, mid activities of daily living scores on the unified Parkinson's disease rating scale at three months compared with patients taking placebo; they were also less likely to need additional levodopa (0.57, 0.48 to 0.67; P<0.00001) or to develop motor fluctuations (0.75, 0.59 to 0.95; P=0.02). No difference existed between the two groups in the incidence of side effects or withdrawal of patients. Conclusions MAOBIs reduce disability, the need for levodopa, and the incidence of motor fluctuations, without substantial side effects or increased mortality. However, because few trials have compared MAOBIs with other antiparkinsonian drugs, uncertainty remains about the relative benefits and risks of MAOBIs. Further large, long term comparative trials that include patient rated quality of life measures are needed.	Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2RR, W Midlands, England; Aberdeen Royal Infirm, Dept Neurol, Aberdeen AB25 2ZN, Scotland; Univ Aberdeen, Aberdeen AB25 2ZN, Scotland; City Hosp NHS Trust, Dept Neurol, Birmingham B18 7QH, W Midlands, England	University of Birmingham; University of Aberdeen; University of Aberdeen	Ives, NJ (corresponding author), Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2RR, W Midlands, England.	n.j.ives@bham.ac.uk	Marro, Joaquin/C-1432-2011	Marro, Joaquin/0000-0003-3718-8636; Gray, Richard/0000-0003-4440-574X; STOWE, REBECCA/0000-0003-4007-6723; Ives, Natalie/0000-0002-1664-7541; Clarke, Carl/0000-0003-2478-3436				ABE O, 1992, LANCET, V339, P71; ALLAIN H, 1993, MOVEMENT DISORD, V8, pS36, DOI 10.1002/mds.870080508; [Anonymous], 1992, Lancet, V339, P1; [Anonymous], 1996, Ann Neurol, V40, P99; Ben-Shlomo Y, 1998, BRIT MED J, V316, P1191, DOI 10.1136/bmj.316.7139.1191; Caraceni T, 2001, PARKINSONISM RELAT D, V7, P107, DOI 10.1016/S1353-8020(00)00023-7; Counsell C, 1998, BRIT MED J, V317, P1586, DOI 10.1136/bmj.317.7172.1586; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; *EARL BREAST CANC, 2000, TREATM EARL BREAST C, V1; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; HEIKKILA RE, 1984, NATURE, V311, P467, DOI 10.1038/311467a0; IVES NJ, 2003, 6 INT C AD PD SEV SP; Jenkinson C, 1998, PARKINSONS DIS QUEST; KIEBURTZ K, 1993, ANN NEUROL, V33, P350; KIEBURTZ K, 1994, ARCH NEUROL-CHICAGO, V51, P342; Kirollos C, 1996, EUR J CLIN PHARMACOL, V50, P7, DOI 10.1007/s002280050062; LANG AE, 2002, MOV DISORD S4, V17, pS38, DOI DOI 10.1002/MDS.5559; LANG AF, 2002, MOV DISORD S4, V17, P538; Larsen JP, 1999, EUR J NEUROL, V6, P539, DOI 10.1046/j.1468-1331.1999.650539.x; Lees AJ, 1995, BRIT MED J, V311, P1602, DOI 10.1136/bmj.311.7020.1602; Lees AJ, 2001, NEUROLOGY, V57, P1687, DOI 10.1212/WNL.57.9.1687; MALLY J, 1995, J NEUROL SCI, V134, P143, DOI 10.1016/0022-510X(95)00240-1; MANTEL N, 1959, J NATL CANCER I, V22, P719; MYLLYLA VV, 1995, ACTA NEUROL SCAND, V91, P177; Myllyla VV, 1997, ACTA NEUROL SCAND, V95, P211, DOI 10.1111/j.1600-0404.1997.tb00101.x; MYLLYLA VV, 1992, NEUROLOGY, V42, P339, DOI 10.1212/WNL.42.2.339; NAPPI G, 1991, ACTA NEUROL SCAND, V83, P407, DOI 10.1111/j.1600-0404.1991.tb03973.x; Olanow CW, 1998, NEUROLOGY, V51, P825, DOI 10.1212/WNL.51.3.825; OLANOW CW, 1995, ANN NEUROL, V38, P771, DOI 10.1002/ana.410380512; Palhagen S, 1998, NEUROLOGY, V51, P520, DOI 10.1212/WNL.51.2.520; *PARK STUD GROUP, 1989, ARCH NEUROL-CHICAGO, V16, P1052; PARKINSON SG, 1989, ARCH NEUROL-CHICAGO, V46, P1052, DOI DOI 10.1001/archneur.1989.00520460028009; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Przuntek T, 1999, EUR J NEUROL, V6, P141, DOI 10.1111/j.1468-1331.1999.tb00007.x; SHOULSON I, 1989, NEW ENGL J MED, V321, P1364; SHOULSON I, 1993, NEW ENGL J MED, V328, P176, DOI 10.1056/NEJM199301213280305; Shoulson I, 1998, ANN NEUROL, V43, P318; Siderowf A, 2002, ARCH NEUROL-CHICAGO, V59, P1937; TERAVAINEN H, 1990, ACTA NEUROL SCAND, V81, P333; TETRUD JW, 1989, SCIENCE, V245, P519, DOI 10.1126/science.2502843	41	88	90	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2004	329	7466					593	596B		10.1136/bmj.38184.606169.AE	http://dx.doi.org/10.1136/bmj.38184.606169.AE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	854SK	15310558	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000223923400014
J	Foster				Foster			How often are adverse events reported in English hospital statistics?	BMJ-BRITISH MEDICAL JOURNAL			English	Article								About 850 000 medical errors occur in NHS hospitals every year, resulting in 40 000 deaths. In-wl the United Kingdom, the National Patient Safety Agency (NPSA) was created to learn from patient safety incidents occurring in the NHS.(w2) In February 2004, it launched a new patient reporting system, drawing together reports of patient safety errors and systems failures provided by health professionals across England and Wales.(w3) An adverse event can be defined as "an unintended injury caused by medical management rather than a disease process, resulting in death, life threatening illness, disability at the time of discharge, admission to hospital, or prolongation of hospital stay."(w4) A medical or surgical misadventure is an adverse event that might have been avoided if the patient had received ordinary standards of care. We took at four years of hospital episode statistics to examine patterns in the recording of adverse events within this routinely collected source of data and ask whether it could be of use in monitoring this problem.	Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England	Imperial College London	Foster (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England.		Aylin, Paul/A-1073-2014	Aylin, Paul/0000-0003-4589-1743; Bottle, Alex/0000-0001-9978-2011				Australian Institute for Health and Welfare, 2001, REP ADV EV ROUT COLL; EMSLIE S, 2001, RISK MANAGEMENT NATL; Michel P, 2004, BRIT MED J, V328, P199, DOI 10.1136/bmj.328.7433.199; STEEL K, 1981, NEW ENGL J MED, V304, P638, DOI 10.1056/NEJM198103123041104; Wolff AM, 1996, MED J AUSTRALIA, V164, P458, DOI 10.5694/j.1326-5377.1996.tb122120.x	5	26	26	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2004	329	7462					369	+		10.1136/bmj.329.7462.369	http://dx.doi.org/10.1136/bmj.329.7462.369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YI	15310606	Green Published			2022-12-28	WOS:000223433600013
J	Wiechman, SA; Patterson, DR				Wiechman, SA; Patterson, DR			ABC of burns - Psychosocial aspects of burn injuries	BRITISH MEDICAL JOURNAL			English	Review									Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wiechman, SA (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA.							PARTRIDGE J, 1997, BURNS AFFECT WAY YOU; Patterson DR, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P145, DOI 10.1037/10361-007; PATTERSON DR, 1993, PSYCHOL BULL, V113, P362, DOI 10.1037/0033-2909.113.2.362	3	67	70	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 14	2004	329	7462					391	393		10.1136/bmj.329.7462.391	http://dx.doi.org/10.1136/bmj.329.7462.391			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YI	15310609	Green Published			2022-12-28	WOS:000223433600024
J	Lin, FY; Zhang, WY; Jones, A; Doherty, M				Lin, FY; Zhang, WY; Jones, A; Doherty, M			Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							10-PERCENT TROLAMINE SALICYLATE; DOUBLE-BLIND; KNEE OSTEOARTHRITIS; CLINICAL-TRIAL; ORAL IBUPROFEN; DICLOFENAC; PLACEBO; PAIN; GEL; COMPLICATIONS	Objective To assess the efficacy of topical non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of osteoarthritis. Data sources Medline, Embase, Scientific Citation Index, CINAHL, Cochrane Library, and abstracts from conferences. Review methods Inclusion criterion was randomised controlled trials comparing topical NSAIDs with placebo or oral NSAIDs in osteoarthritis. Effect size was calculated for pain, function, and stiffness. Rate ratio was calculated for dichotomous data such as clinical response rate and adverse event rate. Number needed to treat to obtain the clinical response was estimated. Quality of trial was assessed, and sensitivity analyses were undertaken. Results Topical NSAIDs were more effective than placebo in relieving pain due to osteoarthritis only in the first two weeks of treatment. Effect sizes for weeks I and 2 were 0.41 (95% confidence interval, 0.16 to 0.66) and 0.40 (0.15 to 0.65), respectively. No benefit was observed over placebo in weeks 3 and 4. A similar pattern was observed for function, stiffness, and clinical response rate ratio and number needed to treat. Topical NSAIDs were less effective than oral NSAIDs in the first week of treatment and associated with more local side effects such as rash, itch, or burning (rate ratio 5.29, 1.14 to 24.51). Conclusion Randomised controlled trials of short duration only (less than four weeks) have assessed the efficacy of topical NSAIDs in osteoarthritis. After two weeks there was no evidence of efficacy superior to placebo. No trial data support the long term use of topical NSAIDs in osteoarthritis.	Univ Nottingham, City Hosp, Acad Rheumatol, Nottingham NG5 1PB, England; Univ Nottingham, City Hosp, Rheumatol Unit, Nottingham NG5 1PB, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Zhang, WY (corresponding author), Univ Nottingham, City Hosp, Acad Rheumatol, Nottingham NG5 1PB, England.	weiya.zhang@nottingham.ac.uk	Zhang, Weiya/X-9481-2019	Zhang, Weiya/0000-0003-1142-1460; Doherty, Michael/0000-0002-5763-8326				AKERMARK C, 1990, INT J SPORTS MED, V11, P393, DOI 10.1055/s-2007-1024825; ALGOZZINE GJ, 1982, JAMA-J AM MED ASSOC, V247, P1311, DOI 10.1001/jama.247.9.1311; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Bruhlmann P, 2003, CLIN EXP RHEUMATOL, V21, P193; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; CUTTHANN SP, 1997, EPIDEMIOLOGY, V8, P18; DICKSON DJ, 1991, CURR THER RES CLIN E, V49, P199; DIEBSCHLAG W, 1990, J CLIN PHARMACOL, V30, P82, DOI 10.1002/j.1552-4604.1990.tb03443.x; Doherty M, 1998, OSTEOARTHRITIS, P291; DREISER RL, 1993, DRUG EXP CLIN RES, V19, P117; Eberhardt R, 1995, Fortschr Med, V113, P446; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FELSON DT, 1988, EPIDEMIOL REV, V10, P1; Goldstein JL, 2000, AM J GASTROENTEROL, V95, P1681; Grace D, 1999, J RHEUMATOL, V26, P2659; Hedges LV, 1982, J EDUC STATIST, V7, P245, DOI DOI 10.3102/10769986007004245; HOSIE GAC, 1993, BR J CLIN RES, V4, P5; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; KOENEN NJ, 1996, MUNCHEN MED WOCHEN, V138, P534; Mamdani M, 2002, BRIT MED J, V325, P624, DOI 10.1136/bmj.325.7365.624; Moore RA, 1998, BRIT MED J, V316, P333, DOI 10.1136/bmj.316.7128.333; MORRISON WA, 1993, MULTICENTRE RANDOMIS; OTTLINGER B, 2001, OSTEOARTHR CARTILAGE, V9, P272; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Po ALW, 1997, BRIT MED J, V315, P1565, DOI 10.1136/bmj.315.7122.1565; Roth SH, 1995, INT J TISSUE REACT, V17, P129; ROTHACKER D, 1994, CURR THER RES CLIN E, V55, P584, DOI 10.1016/S0011-393X(05)80190-0; Rothacker DQ, 1998, JCR-J CLIN RHEUMATOL, V4, P6, DOI 10.1097/00124743-199802000-00002; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P177; Rovensky J, 2001, DRUG EXP CLIN RES, V27, P209; Sanders L, 1997, ENVIRON PLANN B, V24, P287, DOI 10.1068/b240287; SCOTT DL, 1993, J ROY COLL PHYS LOND, V27, P391; Shackel NA, 1997, MED J AUSTRALIA, V167, P134, DOI 10.5694/j.1326-5377.1997.tb138811.x; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Singh G, 1998, J RHEUMATOL, V25, P8; Vaile JH, 1998, DRUGS, V56, P783, DOI 10.2165/00003495-199856050-00004; VANDERSTRAETEN G, 1990, MED PHYSICA, V13, P139; Waikakul Saranatra, 1997, Journal of the Medical Association of Thailand, V80, P593; Walker-Bone K, 2000, BMJ-BRIT MED J, V321, P936, DOI 10.1136/bmj.321.7266.936; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105; Wynne H A, 1993, Pharmacoeconomics, V3, P107, DOI 10.2165/00019053-199303020-00004; Yelin E, 1997, J RHEUMATOL, V24, P2024; Zacher J, 2001, AKTUEL RHEUMATOL, V26, P7, DOI 10.1055/s-2001-11369; 1982, JAMA, V247, P1311	45	199	226	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2004	329	7461					324	326B		10.1136/bmj.38159.639028.7C	http://dx.doi.org/10.1136/bmj.38159.639028.7C			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846FF	15286056	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000223300300021
J	Remuzzi, G; Lesti, M; Gotti, E; Ganeva, M; Dimitrov, BD; Ene-Iordache, B; Gherardi, G; Donati, D; Salvadori, M; Sandrini, S; Valente, U; Segoloni, G; Mourad, G; Federico, S; Rigotti, P; Sparocino, V; Bosmans, JL; Perico, N; Ruggenenti, P				Remuzzi, G; Lesti, M; Gotti, E; Ganeva, M; Dimitrov, BD; Ene-Iordache, B; Gherardi, G; Donati, D; Salvadori, M; Sandrini, S; Valente, U; Segoloni, G; Mourad, G; Federico, S; Rigotti, P; Sparocino, V; Bosmans, JL; Perico, N; Ruggenenti, P		MYSS Study Grp	Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial	LANCET			English	Article							STEROID WITHDRAWAL; CYCLOSPORINE; MICROEMULSION; IMMUNOSUPPRESSION; PREDNISONE; RECIPIENTS; RS-61443	Background Mycophenolate mofetil has replaced azathioprine in immunosuppression regimens worldwide to prevent graft rejection. However, evidence that its antirejection activity is better than that of azathioprine has been provided only by registration trials with an old formulation of ciclosporin and steroid. We aimed to compare the antirejection activity of these two drugs with a new formulation of ciclosporin. Methods The mycophenolate steroids sparing multicentre, prospective, randomised, parallel-group trial compared acute rejections and adverse events in recipients of cadaver-kidney transplants over 6-month treatment with mycophenolate mofetil or azathioprine along with ciclosporin microemulsion (Neoral) and steroids (phase A), and over 15 more months without steroids (phase B). The primary endpoint was occurrence of acute rejection episodes. Analysis was by intention to treat. Findings 168 patients per group entered phase A. 56 (34%) assigned mycophenolate mofetil and 58 (35%) assigned azathioprine had clinical rejections (risk reduction [RR] on mycophenolate mofetil compared with azathioprine 13.7% [95% CI -25.7% to 40.7%], p=0.44). 88 patients in the mycophenolate mofetil group and 89 in the azathioprine group entered phase B. 14 (16%) taking mycophenolate mofetil and 11 (12%) taking azathioprine had clinical rejections (RR -16.2%, [-157.5% to 47.5%], p=0.71). Average per-patient costs of mycophenolate mofetil treatment greatly exceeded those of azathioprine (phase A E2665 [SD 586] vs E184 [62]; phase B E5095 [2658] vs E322 [170], p<0.0001 for both). Interpretation In recipients of cadaver kidney-transplants given ciclosporin microemulsion, mycophenolate mofetil offers no advantages over azathioprine in preventing acute rejections and is about 15 times more expensive, Standard immunosuppression regimens for transplantation should perhaps include azathioprine rather than mycophenolate mofetil, at least for kidney grafts.	Mario Negri Inst Pharmacol Res, Negri Bergamo Labs, Dept Renal Med, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24125 Bergamo, Italy; Azienda Osped, Osped Riuniti, Dept Med & Transplantat, Bergamo, Italy; Univ Hosp St George, Dept Med Informat Serv, Plovdiv, Bulgaria; Osped Reg Circolo, Unit Nephrol & Dialysis, Varese, Italy; Fdn Macchi, Varese, Italy; Azienda Osped Careggi Monna Tessa, Unit Nephrol & Dialysis, Florence, Italy; Azienda Osped Spedali Civili, Unit Nephrol Dialysis & Transplantat, Brescia, Italy; Azienda Osped San Martino, Unit Gen Surg & Organ Transplantat, Genoa, Italy; Azienda Osped SG Battista, Unit Nephrol Dialysis & Transplantat, Turin, Italy; Ctr Hosp Univ, Hosp Lapeyronie, Dept Nephrol Dialysis & Transplantat, Montpellier, France; Univ Naples Federico II, Dept Nephrol, Naples, Italy; Osped Giustinianeo, Dept Surg & Med Sci, Padua, Italy; Osped Civ, Renal Transplantat Unit, Palermo, Italy; Univ Antwerp, Dept Nephrol & Surg, B-2020 Antwerp, Belgium	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo; Ospedale Circolo & Fondazione Macchi; University of Florence; Azienda Ospedaliero Universitaria Careggi; Hospital Spedali Civili Brescia; University of Genoa; IRCCS AOU San Martino IST; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Universite de Montpellier; CHU de Montpellier; University of Naples Federico II; University of Antwerp	Ruggenenti, P (corresponding author), Mario Negri Inst Pharmacol Res, Negri Bergamo Labs, Dept Renal Med, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Via Gavazzeni 11,Villa Camozzi, I-24125 Bergamo, Italy.	manuelap@marionegri.it	Gherardi, Giulia/ABH-4861-2020; Bosmans, Jean-Louis/C-7139-2017; Lesti, Mariadomenica/ABH-7380-2020; Ene-Iordache, Bogdan/C-6824-2018; Rigotti, Paolo/K-3117-2018; Perico, Norberto/ABH-3222-2020; Dimitrov, Borislav D/A-1246-2010; Remuzzi, Giuseppe/V-9766-2017	Gherardi, Giulia/0000-0001-7700-8324; Bosmans, Jean-Louis/0000-0001-7928-5675; Lesti, Mariadomenica/0000-0001-5338-5926; Ene-Iordache, Bogdan/0000-0002-4011-9343; Perico, Norberto/0000-0002-3147-4327; Dimitrov, Borislav D/0000-0002-5896-2072; Remuzzi, Giuseppe/0000-0002-6194-3446; RIGOTTI, PAOLO/0000-0002-8895-935X				Ahsan N, 1999, TRANSPLANTATION, V68, P1865; DEIERHOI MH, 1993, ANN SURG, V217, P476, DOI 10.1097/00000658-199305010-00007; Fulton B, 1996, DRUGS, V51, P278, DOI 10.2165/00003495-199651020-00007; Gaspari F, 1998, CLIN TRANSPLANT, V12, P379; GRINYO J, 1995, LANCET, V345, P1321; HARIHARAN S, 1993, KIDNEY INT, V44, pS30; HRICIK DE, 1992, TRANSPLANTATION, V53, P1232, DOI 10.1097/00007890-199206000-00012; HRICIK DE, 1993, J AM SOC NEPHROL, V4, P1300; HRICIK DE, 1991, AM J KIDNEY DIS, V18, P353; HRICIK DE, 1991, TRANSPLANTATION, V51, P374, DOI 10.1097/00007890-199102000-00020; Kasiske BL, 2000, J AM SOC NEPHROL, V11, P1910, DOI 10.1681/ASN.V11101910; Keown P, 1998, KIDNEY INT, V54, P938, DOI 10.1046/j.1523-1755.1998.00042.x; Keown P, 1996, TRANSPLANTATION, V61, P1029; KUPIN W, 1988, TRANSPLANTATION, V45, P53, DOI 10.1097/00007890-198801000-00012; MAIORCA R, 1988, TRANSPLANT P, V20, P121; Mele TS, 2000, IMMUNOPHARMACOLOGY, V47, P215, DOI 10.1016/S0162-3109(00)00190-9; Ojo AO, 2000, TRANSPLANTATION, V69, P2405, DOI 10.1097/00007890-200006150-00033; Perico N, 2004, KIDNEY INT, V65, P1084, DOI 10.1111/j.1523-1755.2004.00471.x; Perna A, 1996, J AM SOC NEPHROL, V7, P786; PLATZ KP, 1991, TRANSPLANTATION, V51, P27, DOI 10.1097/00007890-199101000-00003; Pollard SG, 1999, TRANSPLANTATION, V68, P1325, DOI 10.1097/00007890-199911150-00018; REISMAN L, 1990, TRANSPLANTATION, V49, P76, DOI 10.1097/00007890-199001000-00017; SALAMAN JR, 1993, TRANSPLANT P, V25, P695; SCHULAK JA, 1990, TRANSPLANTATION, V49, P327, DOI 10.1097/00007890-199002000-00020; SOLLINGER HW, 1995, TRANSPLANTATION, V60, P225, DOI 10.1097/00007890-199508000-00003; TEJANI A, 1989, TRANSPLANTATION, V47, P229, DOI 10.1097/00007890-198902000-00006	26	121	124	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					503	512		10.1016/S0140-6736(04)16808-6	http://dx.doi.org/10.1016/S0140-6736(04)16808-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302193				2022-12-28	WOS:000223132700029
J	Nickels, BE; Hochschild, A				Nickels, BE; Hochschild, A			Regulation of RNA polymerase through the secondary channel	CELL			English	Review							ANTIBIOTIC MICROCIN J25; CLEAVAGE FACTORS GREA; TRANSCRIPTION ELONGATION; MECHANISM; ARCHITECTURE; PPGPP	High-resolution crystal structures have highlighted functionally important regions in multisubunit RNA polymerases, including the secondary channel, or pore, which is postulated to allow the diffusion of small molecules both into and out of the active center of the enzyme. Recent work from several groups has illustrated how regulatory factors and small molecules can exploit the secondary channel to gain access to the active site and modify the transcription properties of RNA polymerase.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Hochschild, A (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave,Bgd D-1, Boston, MA 02115 USA.	ahochschiid@hms.harvard.edu	Nickels, Bryce/AAF-2549-2020	Nickels, Bryce/0000-0001-7449-8831	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044025] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2004, MOL CELL, V14, P753, DOI 10.1016/j.molcel.2004.05.017; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Delgado MA, 2001, J BACTERIOL, V183, P4543, DOI 10.1128/JB.183.15.4543-4550.2001; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Kulish D, 2000, J BIOL CHEM, V275, P12789, DOI 10.1074/jbc.275.17.12789; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; PAUL BJ, 2004, IN PRESS ANN REV GEN; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Yuzenkova J, 2002, J BIOL CHEM, V277, P50867, DOI 10.1074/jbc.M209425200; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	20	47	47	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					281	284		10.1016/j.cell.2004.07.021	http://dx.doi.org/10.1016/j.cell.2004.07.021			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294154	Bronze			2022-12-28	WOS:000223353100005
J	Harper, NS; McAlpine, D				Harper, NS; McAlpine, D			Optimal neural population coding of an auditory spatial cue	NATURE			English	Article							INTERAURAL TIME DIFFERENCE; INFERIOR COLLICULUS; SOUND LOCALIZATION; FISHER INFORMATION; CENTRAL NUCLEUS; BARN OWL; NEURONS; DELAY; DISCRIMINATION; CAT	A sound, depending on the position of its source, can take more time to reach one ear than the other. This interaural ( between the ears) time difference (ITD) provides a major cue for determining the source location(1,2). Many auditory neurons are sensitive to ITDs(3,4), but the means by which such neurons represent ITD is a contentious issue. Recent studies question whether the classical general model ( the Jeffress model(5)) applies across species(6,7). Here we show that ITD coding strategies of different species can be explained by a unifying principle: that the ITDs an animal naturally encounters should be coded with maximal accuracy. Using statistical techniques and a stochastic neural model, we demonstrate that the optimal coding strategy for ITD depends critically on head size and sound frequency. For small head sizes and/or low-frequency sounds, the optimal coding strategy tends towards two distinct sub-populations tuned to ITDs outside the range created by the head. This is consistent with recent observations in small mammals(6,7). For large head sizes and/or high frequencies, the optimal strategy is a homogeneous distribution of ITD tunings within the range created by the head. This is consistent with observations in the barn owl(8-10). For humans, the optimal strategy to code ITDs from an acoustically measured distribution depends on frequency; above 400 Hz a homogeneous distribution is optimal, and below 400 Hz distinct sub-populations are optimal.	UCL, Dept Physiol, London WC1E 6BT, England; UCL, UCL Ear Inst, London WC1E 6BT, England; UCL, CoMPLEX, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	McAlpine, D (corresponding author), UCL, Dept Physiol, Mortimer St, London WC1E 6BT, England.	d.mcalpine@ucl.ac.uk		Harper, Nicol/0000-0002-7851-4840; McAlpine, David/0000-0001-5467-6725				Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; BERNSTEIN LR, 1985, J ACOUST SOC AM, V78, P514, DOI 10.1121/1.392473; Bethge M, 2002, NEURAL COMPUT, V14, P2317, DOI 10.1162/08997660260293247; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brunel N, 1998, NEURAL COMPUT, V10, P1731, DOI 10.1162/089976698300017115; CARR CE, 1988, P NATL ACAD SCI USA, V85, P8311, DOI 10.1073/pnas.85.21.8311; COLES RB, 1988, J COMP PHYSIOL A, V163, P117, DOI 10.1007/BF00612002; Culling JF, 1998, J ACOUST SOC AM, V103, P3540, DOI 10.1121/1.423061; Dayan P, 2001, COMPUTATIONAL NEUROS; DOMNITZ RH, 1977, J ACOUST SOC AM, V61, P1586, DOI 10.1121/1.381472; HENNING GB, 1974, J ACOUST SOC AM, V55, P84, DOI 10.1121/1.1928135; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; KUWADA S, 1983, J NEUROPHYSIOL, V50, P981, DOI 10.1152/jn.1983.50.4.981; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; Shackleton TM, 2003, J NEUROSCI, V23, P716, DOI 10.1523/JNEUROSCI.23-02-00716.2003; Skottun BC, 2001, P NATL ACAD SCI USA, V98, P14050, DOI 10.1073/pnas.241513998; Strutt J., 1907, PHILOS MAG, V13, P214, DOI [DOI 10.1080/14786440709463595, 10.1080/14786440709463595]; TAKAHASHI T, 1986, J NEUROSCI, V6, P3413; Wagner H, 2002, EUR J NEUROSCI, V15, P1343, DOI 10.1046/j.1460-9568.2002.01970.x; WAGNER H, 1987, J NEUROSCI, V7, P3105; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465	24	210	211	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					682	686		10.1038/nature02768	http://dx.doi.org/10.1038/nature02768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295602				2022-12-28	WOS:000223085400047
J	Newman, LS; Feinberg, MW; LeWine, HE				Newman, LS; Feinberg, MW; LeWine, HE			A bitter tale	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FOXGLOVE EXTRACT		Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; Harvard Vanguard Med Associates, Dept Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Vanguard Medical Associates	Newman, LS (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	lnewman1@partners.org		Feinberg, Mark/0000-0001-9523-3859				ANTMAN EM, 1990, CIRCULATION, V81, P1744, DOI 10.1161/01.CIR.81.6.1744; Gowda R M, 2003, Heart, V89, pe14, DOI 10.1136/heart.89.4.e14; Hauptman PJ, 1999, CIRCULATION, V99, P1265, DOI 10.1161/01.CIR.99.9.1265; HOFFMAN B F, 1990, P814; KELLY RA, 1992, AM J CARDIOL, V69, pG108, DOI 10.1016/0002-9149(92)91259-7; KWAN T, 1992, CHEST, V102, P949, DOI 10.1378/chest.102.3.949; RICH SA, 1993, ANN EMERG MED, V22, P1904, DOI 10.1016/S0196-0644(05)80420-2; SMITH TW, 1973, NEW ENGL J MED, V289, P1125, DOI 10.1056/NEJM197311222892106; Thierry S, 2000, INTENS CARE MED, V26, P1586, DOI 10.1007/s001340000636; Watson WA, 2003, AM J EMERG MED, V21, P353, DOI 10.1016/S0735-6757(03)00088-3	10	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					594	599		10.1056/NEJMcps040238	http://dx.doi.org/10.1056/NEJMcps040238			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295053				2022-12-28	WOS:000223069900014
J	Pincus, T				Pincus, T			Will racial and ethnic disparities in health be resolved primarily outside of standard medical care?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES; DETERMINANTS; BLACKS; WHITES		Vanderbilt Univ, Med Ctr, Div Rheumatol & Immunol, Nashville, TN 37232 USA	Vanderbilt University	Pincus, T (corresponding author), Vanderbilt Univ, Med Ctr, Div Rheumatol & Immunol, 203 Oxford House,Box 5, Nashville, TN 37232 USA.	t.pincus@vanderbilt.edu						Ackerknecht Erwin, 1953, R VIRCHOW DOCTOR STA; Amer College Physicians, 2004, ANN INTERN MED, V141, P226, DOI 10.7326/0003-4819-141-3-200408030-00015; Boulware LE, 2002, MED CARE, V40, P85; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; GURALNIK JM, 1993, NEW ENGL J MED, V329, P110, DOI 10.1056/NEJM199307083290208; Ibrahim SA, 2002, MED CARE, V40, P44; KEPPEL KG, 2002, HLTH PEOPLE 2000 STA, V23, P1; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; Pincus T, 1998, ANN INTERN MED, V129, P406, DOI 10.7326/0003-4819-129-5-199809010-00011; PINCUS T, 1987, J CHRON DIS, V40, P865, DOI 10.1016/0021-9681(87)90186-X; ROGERS RG, 1992, DEMOGRAPHY, V29, P287, DOI 10.2307/2061732; Ross CE, 2000, MILBANK Q, V78, P291, DOI 10.1111/1468-0009.00171	14	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2004	141	3					224	225		10.7326/0003-4819-141-3-200408030-00014	http://dx.doi.org/10.7326/0003-4819-141-3-200408030-00014			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HG	15289222				2022-12-28	WOS:000223068600009
J	Clenney, TL; Viera, AJ				Clenney, TL; Viera, AJ			Evidence based case report - Corticosteroids for HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							POSTPARTUM CORTICOSTEROIDS; ANTENATAL CORTICOSTEROIDS; THERAPY; DEXAMETHASONE		Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Clenney, TL (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA.	t_l_clenney@sar.med.navy.mil						Aghajafari F, 2001, AM J OBSTET GYNECOL, V185, P1073, DOI 10.1067/mob.2001.117635; Crane Joan M G, 2003, J Obstet Gynaecol Can, V25, P650; Ebell MH, 2004, J FAM PRACTICE, V53, P111; GUYATT G, 2002, USERS GUIDES MED LIT, P55; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; MAGANN EF, 1994, AM J OBSTET GYNECOL, V171, P1154, DOI 10.1016/0002-9378(94)90055-8; MAGANN EF, 1994, AM J OBSTET GYNECOL, V171, P1148, DOI 10.1016/0002-9378(94)90054-X; Martin JN, 2003, AM J OBSTET GYNECOL, V189, P830, DOI 10.1067/S0002-9378(03)00763-4; Martin JN, 1997, AM J OBSTET GYNECOL, V177, P1011, DOI 10.1016/S0002-9378(97)70005-X; Matchaba P, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002076.PUB2; Novy MJ, 2001, AM J OBSTET GYNECOL, V185, P1276, DOI 10.1067/mob.2001.118847; O'Brien JM, 2000, AM J OBSTET GYNECOL, V183, P921, DOI 10.1067/mob.2000.108869; Schlembach D, 2000, J PERINAT MED, V28, P502, DOI 10.1515/JPM.2000.068; Thorp JA, 2001, AM J OBSTET GYNECOL, V184, P196, DOI 10.1067/mob.2001.108859; Vigil-De Gracia P, 1997, INT J GYNECOL OBSTET, V59, P217, DOI 10.1016/S0020-7292(97)00214-2; Yalcin OT, 1998, INT J GYNECOL OBSTET, V61, P141, DOI 10.1016/S0020-7292(98)00036-8	16	11	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2004	329	7460					270	272		10.1136/bmj.329.7460.270	http://dx.doi.org/10.1136/bmj.329.7460.270			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284151	Green Published			2022-12-28	WOS:000223133300020
J	Passier, A; Smits-van Herwaarden, A; van Puijenbroek, E				Passier, A; Smits-van Herwaarden, A; van Puijenbroek, E			Photo-onycholysis associated with the use of doxycycline	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Netherlands Pharmacovigilance Ctr Lareb, NL-5327 MH Shertogenbosch, Netherlands		Passier, A (corresponding author), Netherlands Pharmacovigilance Ctr Lareb, Goudsbloemvallei 7, NL-5327 MH Shertogenbosch, Netherlands.	A.Passier@Lareb.nl	van Puijenbroek, Eugene/AAI-3240-2020	Passier, Anneke/0000-0001-5594-6360; van Puijenbroek, Eugene/0000-0002-2236-1398				BRUINSMA W, 2000, GUIDE DRUG ERUPTIONS, P26; CAVENS TR, 1981, CUTIS, V27, P53; FRANK SB, 1971, ARCH DERMATOL, V103, P520, DOI 10.1001/archderm.103.5.520; SHEA CR, 1993, J INVEST DERMATOL, V101, P329, DOI 10.1111/1523-1747.ep12365484; Yong CKK, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.1.e13	5	20	20	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2004	329	7460					265	265		10.1136/bmj.329.7460.265	http://dx.doi.org/10.1136/bmj.329.7460.265			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284149	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000223133300017
J	Lifton, RJ				Lifton, RJ			Human rights: Doctors and torture	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lifton, RJ (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA.							Lifton R. J., 1986, NAZI DOCTORS MED KIL; Slevin Peter, 2004, Washington Post, pA13; SQUITIERI T, 2004, US TODAY        0628; Zernike Kate, 2004, NY TIMES, pA1	4	84	86	0	12	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2004	351	5					415	416		10.1056/NEJMp048065	http://dx.doi.org/10.1056/NEJMp048065			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	841OJ	15282345				2022-12-28	WOS:000222939700001
J	Wilson, DR; Hare, JF				Wilson, DR; Hare, JF			Ground squirrel uses ultrasonic alarms	NATURE			English	Article									Univ Manitoba, Dept Zool, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Wilson, DR (corresponding author), Univ Manitoba, Dept Zool, Winnipeg, MB R3T 2N2, Canada.	harejf@cc.umanitoba.ca	Wilson, David R/E-2869-2010	Wilson, David R/0000-0002-6558-6415				Hare JF, 1998, ANIM BEHAV, V55, P451, DOI 10.1006/anbe.1997.0613; KOEPPL JW, 1978, J MAMMAL, V59, P677, DOI 10.2307/1380133; Sales GD, 1974, ULTRASONIC COMMUNICA; SHERMAN PW, 1977, SCIENCE, V197, P1246, DOI 10.1126/science.197.4310.1246; SIMMONS JA, 1979, SCIENCE, V203, P16, DOI 10.1126/science.758674; SMITH WJ, 1979, AM ZOOL, V19, P531; WITKIN SR, 1977, CONDOR, V79, P490, DOI 10.2307/1367730	8	56	57	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					523	523		10.1038/430523a	http://dx.doi.org/10.1038/430523a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282596	Green Accepted			2022-12-28	WOS:000222946100035
J	Abbott, J; Kirkby, GR				Abbott, J; Kirkby, GR			Lesson of the week - Acute visual loss and pituitary apoplexy after surgery	BRITISH MEDICAL JOURNAL			English	Review									Birmingham & Midland Eye Ctr, Birmingham B18 7QH, W Midlands, England		Abbott, J (corresponding author), Birmingham & Midland Eye Ctr, Birmingham B18 7QH, W Midlands, England.	abbottjoseph@yahoo.com						AHMED M, 1993, ARCH INTERN MED, V153, P2165, DOI 10.1001/archinte.153.18.2165; Alzetani A, 2002, ANN THORAC SURG, V73, P300, DOI 10.1016/S0003-4975(01)02850-8; BILLS DC, 1993, NEUROSURGERY, V33, P602, DOI 10.1227/00006123-199310000-00007; CARDOSO ER, 1984, NEUROSURGERY, V14, P363, DOI 10.1227/00006123-198403000-00021; COOPER DM, 1986, ANN THORAC SURG, V41, P547, DOI 10.1016/S0003-4975(10)63039-1; MCFADZEAN RM, 1991, NEUROSURGERY, V29, P669, DOI 10.1227/00006123-199111000-00005; Meek EN, 1998, ANESTHESIOLOGY, V89, P1580, DOI 10.1097/00000542-199812000-00042; Randeva HS, 1999, CLIN ENDOCRINOL, V51, P181, DOI 10.1046/j.1365-2265.1999.00754.x; Sanno N, 2003, NEUROSURG CLIN N AM, V14, P25, DOI 10.1016/S1042-3680(02)00035-9; Tang-Wai DF, 2002, NEUROLOGY, V58, P500, DOI 10.1212/WNL.58.3.500; THORNER MO, 1998, WILLIAMS TXB ENDOCRI; VIDAL E, 1992, ARCH INTERN MED, V152, P1893, DOI 10.1001/archinte.152.9.1893	12	31	31	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 24	2004	329	7459					218	219		10.1136/bmj.329.7459.218	http://dx.doi.org/10.1136/bmj.329.7459.218			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840NW	15271834	Green Published			2022-12-28	WOS:000222866900022
J	Azzam, R; Chen, SL; Shou, WY; Mah, AS; Alexandru, G; Nasmyth, K; Annan, RS; Carr, SA; Deshaies, RJ				Azzam, R; Chen, SL; Shou, WY; Mah, AS; Alexandru, G; Nasmyth, K; Annan, RS; Carr, SA; Deshaies, RJ			Phosphorylation by cyclin B-Cdk underlies release of mitotic exit activator Cdc14 from the nucleolus	SCIENCE			English	Article							CHROMOSOME SEGREGATION; ANAPHASE TRANSITION; PHOSPHATASE CDC14; BUDDING YEAST; RENT COMPLEX; KINASE CDC5; POLO KINASE; SEPARASE; LOCALIZATION; METAPHASE	Budding yeast protein phosphatase Cdc14 is sequestered in the nucleolus in an inactive state during interphase by the anchor protein Net1. Upon entry into anaphase, the Cdc14 early anaphase release ( FEAR) network initiates dispersal of active Cdc14 throughout the cell. We report that the FEAR network promotes phosphorylation of Net1 by cyclin-dependent kinase (Cdk) complexed with cyclin B1 or cyclin B2. These phosphorylations appear to be required for FEAR and sustain the proper timing of late mitotic events. Thus, a regulatory circuit exists to ensure that the arbiter of the mitotic state, Cdk, sets in motion events that culminate in exit from mitosis.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; GlaxoSmithKline, Dept Computat Analyt & Struct Sci, King Of Prussia, PA 19406 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; GlaxoSmithKline; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Deshaies, RJ (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Carr, Steven A./AAH-8366-2019; Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354; Nasmyth, Kim/0000-0001-7030-4403; Shou, Wenying/0000-0001-5693-381X; Alexandru, Gabriela/0000-0002-7058-5644	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059940] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59940] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AZZAM R, UNPUB; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Hendrickson C, 2001, CURR BIOL, V11, P1781, DOI 10.1016/S0960-9822(01)00564-4; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Johnston LH, 1997, METHOD ENZYMOL, V283, P342; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2002, METHOD ENZYMOL, V351, P279; Shou WY, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-3; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Visintin R, 2000, CURR OPIN CELL BIOL, V12, P752, DOI 10.1016/S0955-0674(00)00165-4; Visintin R, 2003, MOL BIOL CELL, V14, P4486, DOI 10.1091/mbc.E03-02-0095; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Walker Graeme M., 1999, Methods in Cell Science, V21, P87, DOI 10.1023/A:1009824520278; Yuste-Rojas M, 2000, MOL GEN GENET, V263, P60, DOI 10.1007/PL00008676	22	143	146	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2004	305	5683					516	519		10.1126/science.1099402	http://dx.doi.org/10.1126/science.1099402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273393				2022-12-28	WOS:000222828900039
J	Bernard, C; Anderson, A; Becker, A; Poolos, NP; Beck, H; Johnston, D				Bernard, C; Anderson, A; Becker, A; Poolos, NP; Beck, H; Johnston, D			Acquired dendritic channelopathy in temporal lobe epilepsy	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; CA1 PYRAMIDAL NEURONS; STATUS EPILEPTICUS; GABAERGIC INHIBITION; HIPPOCAMPAL-NEURONS; POTASSIUM CHANNELS; UP-REGULATION; K+ CHANNELS; FIRING MODE; H-CHANNELS	Inherited channelopathies are at the origin of many neurological disorders. Here we report a form of channelopathy that is acquired in experimental temporal lobe epilepsy (TLE), the most common form of epilepsy in adults. The excitability of CA1 pyramidal neuron dendrites was increased in TLE because of decreased availability of A-type potassium ion channels due to transcriptional ( loss of channels) and posttranslational ( increased channel phosphorylation by extracellular signal-regulated kinase) mechanisms. Kinase inhibition partly reversed dendritic excitability to control levels. Such acquired channelopathy is likely to amplify neuronal activity and may contribute to the initiation and/or propagation of seizures in TLE.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; INSERM, U29, F-13273 Marseille 09, France; Univ Bonn, Med Ctr, Dept Neuropathol, D-53105 Bonn, Germany; Univ Bonn, Med Ctr, Dept Epileptol, Lab Expt Epileptol, D-53105 Bonn, Germany; Univ Washington, Dept Neurol, Seattle, WA 98104 USA; Univ Washington, Reg Epilepsy Ctr, Seattle, WA 98104 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bonn; University of Bonn; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bernard, C (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	cbernard@inmed.univ-mrs.fr	bernard, christophe/S-5937-2016; Becker, Albert J/F-6248-2012; bernard, christophe/A-4929-2012	bernard, christophe/0000-0003-3014-1966; bernard, christophe/0000-0003-3014-1966	NIMH NIH HHS [MH44754, MH48432] Funding Source: Medline; NINDS NIH HHS [NS39943, NS37444] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH044754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039943, P01NS037444] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Agrawal N, 2003, EPILEPSIA, V44, P1601, DOI 10.1111/j.0013-9580.2003.23103.x; Bernard C, 2003, J NEUROPHYSIOL, V90, P1807, DOI 10.1152/jn.00286.2003; Bernard C, 2000, EPILEPSIA, V41, pS90, DOI 10.1111/j.1528-1157.2000.tb01564.x; Brisman JL, 2002, BRAIN RES, V933, P50, DOI 10.1016/S0006-8993(02)02304-1; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Garrido YCS, 1998, BRAIN RES BULL, V47, P223, DOI 10.1016/S0361-9230(98)00075-6; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kullmann DM, 2002, BRAIN, V125, P1177, DOI 10.1093/brain/awf130; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magee JC, 1998, J NEUROSCI, V18, P7613; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Schiller Y, 2002, J NEUROPHYSIOL, V88, P2954, DOI 10.1152/jn.00525.2001; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Su H, 2002, J NEUROSCI, V22, P3645; Surges R, 2003, EPILEPSIA, V44, P150, DOI 10.1046/j.1528-1157.2003.36802.x; Wheal HV, 1998, TRENDS NEUROSCI, V21, P167, DOI 10.1016/S0166-2236(97)01182-X; WONG RKS, 1978, BRAIN RES, V159, P385, DOI 10.1016/0006-8993(78)90544-9; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002	28	337	356	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2004	305	5683					532	535		10.1126/science.1097065	http://dx.doi.org/10.1126/science.1097065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273397				2022-12-28	WOS:000222828900044
J	Halkic, N; Gillet, M				Halkic, N; Gillet, M			A cystic mass in the liver	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Lausanne, Sch Med, CH-1101 Lausanne, Switzerland	University of Lausanne	Halkic, N (corresponding author), Univ Lausanne, Sch Med, CH-1101 Lausanne, Switzerland.		Halkic, Nermin/J-6670-2017	Halkic, Nermin/0000-0002-0117-0453					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2004	351	4					E3	E3		10.1056/ENEJMicm030356	http://dx.doi.org/10.1056/ENEJMicm030356			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839RC	15269328	Green Published			2022-12-28	WOS:000222801200013
J	MacMahon, E; Brown, LJ; Bexley, S; Snashall, DC; Patel, D				MacMahon, E; Brown, LJ; Bexley, S; Snashall, DC; Patel, D			Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study	BRITISH MEDICAL JOURNAL			English	Article							ZOSTER-VIRUS; INFECTION		Guys & St Thomas NHS Trust, Dept Infect, London SE1 7EH, England; Guys & St Thomas NHS Trust, Dept Occupat Hlth, London SE1 7EH, England; Guys Kings & St Thomas Sch Med, Dept Occupat Hlth, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	MacMahon, E (corresponding author), Guys & St Thomas NHS Trust, Dept Infect, London SE1 7EH, England.	eithne.macmahon@gstt.sthames.nhs.uk						BUCHANAN J, 2000, BRIT MED J, P1067; GARNETT GP, 1993, EPIDEMIOL INFECT, V110, P361, DOI 10.1017/S0950268800068308; ROGERS J, 1997, BMJ S, V315, pS2; Vandersmissen G, 2000, OCCUP ENVIRON MED, V57, P621, DOI 10.1136/oem.57.9.621	4	24	26	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 4	2004	329	7465					551	552		10.1136/bmj.38170.691956.AE	http://dx.doi.org/10.1136/bmj.38170.691956.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853DE	15273160	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000223805800024
J	Chinnery, PF; DiMauro, S; Shanske, S; Schon, EA; Zeviani, M; Mariotti, C; Carrara, F; Lombes, A; Laforet, P; Ogier, H; Jaksch, M; Lochmuller, H; Horvath, R; Deschauer, M; Thorburn, DR; Bindoff, LA; Poulton, J; Taylor, RW; Matthews, JNS; Turnbull, DM				Chinnery, PF; DiMauro, S; Shanske, S; Schon, EA; Zeviani, M; Mariotti, C; Carrara, F; Lombes, A; Laforet, P; Ogier, H; Jaksch, M; Lochmuller, H; Horvath, R; Deschauer, M; Thorburn, DR; Bindoff, LA; Poulton, J; Taylor, RW; Matthews, JNS; Turnbull, DM			Risk of developing a mitochondrial DNA deletion disorder	LANCET			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HUMAN OOCYTES; DUPLICATIONS; MUTATIONS; MYOPATHY; SON	Background Pathogenic mitochondrial DNA (mtDNA) mutations are found in at least one in 8000 individuals. No effective treatment for mtDNA disorders is available, making disease prevention important. Many patients with mtDNA disease harbour a single pathogenic mtDNA deletion, but the risk factors for new cases and disease recurrence are not known. Methods We did a multicentre study of 226 families in which a single mtDNA deletion had been identified in the proband, including patients with chronic progressive external ophthalmoplegia, Kearns Sayre syndrome, or Pearson's syndrome. We studied the relation between maternal age and the risk of unaffected mothers having an affected child, and determined the recurrence risks among the siblings and offspring of affected individuals. Findings We noted no relation between maternal age and the risk of unaffected mothers having children with an mtDNA deletion disorder. None of the 251 siblings of the index cases developed clinical features of mtDNA disease. Risk of recurrence among the offspring of affected women was 4.11% (95% CI 0.86-11.54, or one in 117 to one in nine births). Only one of the mothers who had an affected child had a duplication of mtDNA in skeletal muscle. Interpretation Unlike nuclear chromosomal rearrangements, incidence of mtDNA deletion disorders does not increase with maternal age, and unaffected mothers are unlikely to have more than one affected child. Affected women were previously thought to have a negligible chance of having clinically affected offspring, but the actual risk is, on average, about one in 24 births.	Newcastle Univ, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Dev, New York, NY 10032 USA; Natl Neurol Inst Carlo Besta, Pierfranco & Louisa Mariani Ctr Study Childrens M, Unit Mol Neurogenet, Milan, Italy; Hop La Pitie Salpetriere, Paris, France; Hop Robert Debre, F-75019 Paris, France; Metab Dis Ctr Munich Schwabing, Munich, Germany; Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; Univ Halle Wittenberg, Dept Neurol, Halle An Der Saale, Germany; Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; Univ Oxford, Dept Obstet & Gynaecol, Oxford, England	Newcastle University - UK; Newcastle University - UK; Columbia University; Columbia University; Columbia University; IRCCS Istituto Neurologico Besta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Munich; Martin Luther University Halle Wittenberg; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Bergen; Haukeland University Hospital; University of Oxford	Chinnery, PF (corresponding author), Newcastle Univ, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	P.F.Chinnery@ncl.ac.uk	Mariotti, Caterina/AAP-9425-2021; Thorburn, David R/G-6266-2013; Horvath, Rita/AAY-7042-2020; Lombes, Anne/G-4684-2014; Zeviani, Massimo/K-2891-2014; Matthews, John N S/H-7502-2013; Zeviani, Massimo/AAU-2632-2021	Mariotti, Caterina/0000-0003-2405-3564; Lombes, Anne/0000-0002-9064-0399; Matthews, John N S/0000-0003-2559-037X; Zeviani, Massimo/0000-0002-9067-5508; Bindoff, Laurence/0000-0003-0988-276X; thorburn, david/0000-0002-7725-9470; Chinnery, Patrick/0000-0002-7065-6617; Poulton, Joanna/0000-0002-2460-5587; Lochmuller, Hanns/0000-0003-2324-8001; Horvath, Rita/0000-0002-9841-170X	Telethon [1180] Funding Source: Medline	Telethon(Fondazione Telethon)		Barritt JA, 1999, MOL HUM REPROD, V5, P927, DOI 10.1093/molehr/5.10.927; BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X; Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296; Brenner CA, 1998, MOL HUM REPROD, V4, P887, DOI 10.1093/molehr/4.9.887; CHEN X, 1995, AM J HUM GENET, V57, P239; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P; CORMIER V, 1990, J PEDIATR-US, V117, P599, DOI 10.1016/S0022-3476(05)80698-5; CUCKLE HS, 1987, BRIT J OBSTET GYNAEC, V94, P387, DOI 10.1111/j.1471-0528.1987.tb03115.x; FERGUSONSMITH MA, 1983, BRIT MED BULL, V39, P355, DOI 10.1093/oxfordjournals.bmb.a071848; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586; Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208; Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; Poulton J, 2000, NEUROMUSCULAR DISORD, V10, P484, DOI 10.1016/S0960-8966(00)00130-9; POULTON J, 1991, AM J HUM GENET, V48, P649; POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23; POULTON J, 1994, NAT GENET, V8, P313, DOI 10.1038/ng1294-313; POULTON J, 1995, MUSCLE NERVE       S, V3, P154; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; SCHON EA, 1991, MOL GENETIC APPROACH, P57; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a	32	124	129	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2004	364	9434					592	596		10.1016/S0140-6736(04)16851-7	http://dx.doi.org/10.1016/S0140-6736(04)16851-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313359				2022-12-28	WOS:000223275100031
J	Harding-Pink, D				Harding-Pink, D			Humanitarian medicine: up the garden path and down the slippery slope	BRITISH MEDICAL JOURNAL			English	Article								Twelve years ago, I joined an International Committee of the Red Cross mission to visit detainees in South African police stations under apartheid. As I was leaving, a colleague gave me Medicine Betrayed, the BMA's pioneering report on the participation of doctors in human rights abuses.' It seemed so relevant to the issues with which I was confronted as a "humanitarian" doctor. My missions with the Red Cross and then with Medecins Sans Frontieres took me to countries at war such as Liberia, Tajikistan, Rwanda, Burundi, and Kosovo. These experiences reinforced my conviction that humanitarian medicine was a powerful antidote to the violations I had read about in Medicine Betrayed. I now worry that it can also become an unsuspecting accomplice of these same violations.				harding@bluewin.ch						*BRIT MED ASS, 1992, MED BETR; *COLL CONTR EXP, CTR FERM VOTT MED DE; FICKLER D, 2003, OBSERVER        1221; *ROYAL AUSTR NZ CO, 2002, VOLUNTEER E NEWS, V1, P4; ZINN C, 2004, BRIT MED J, V327, P186	5	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 14	2004	329	7462					398	399		10.1136/bmj.329.7462.398	http://dx.doi.org/10.1136/bmj.329.7462.398			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YI	15310611	Green Published			2022-12-28	WOS:000223433600026
J	Pincock, S				Pincock, S			Francis Harry Compton Crick - Obituary	LANCET			English	Biographical-Item												stephenpincock@blueyonder.co.uk		Pincock, Stephen/0000-0003-1655-2902				CRICK FH, PUBLICATION LIST	1	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					576	576		10.1016/S0140-6736(04)16837-2	http://dx.doi.org/10.1016/S0140-6736(04)16837-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15314836	Bronze			2022-12-28	WOS:000223275100016
J	Vazquez, JA; Reid, MR				Vazquez, JA; Reid, MR			Probing the accumulation history of the voluminous Toba magma	SCIENCE			English	Article							PARTITION-COEFFICIENTS; RESIDENCE TIMES; RHYOLITES; EVOLUTION; ALLANITE; PLUTON; PETROGENESIS; EMPLACEMENT; DYNAMICS; SUMATRA	The age and compositional zonation in crystals from the Youngest Toba Tuff record the prelude to Earth's largest Quaternary eruption. We used allanite crystals to date and decipher this zoning and found that the crystals retain a record of at least 150,000 years of magma storage and evolution. The dominant subvolcanic magma was relatively homogeneous and thermally stagnant for similar to 110,000 years. In the 35,000 years before eruption, the diversity of melts increased substantially as the system grew in size before erupting 75,000 years ago.	Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; No Arizona Univ, Dept Geol, Flagstaff, AZ 86011 USA	University of California System; University of California Los Angeles; Northern Arizona University	Vazquez, JA (corresponding author), Calif State Univ Northridge, Dept Geol Sci, Northridge, CA 91330 USA.	jvazquez@ess.ucla.edu						Anderson AT, 2000, J PETROL, V41, P449, DOI 10.1093/petrology/41.3.449; Bachl CA, 2001, GEOL SOC AM BULL, V113, P1213, DOI 10.1130/0016-7606(2001)113<1213:COAPEF>2.0.CO;2; Bachmann O, 2004, J PETROL, V45, P1565, DOI 10.1093/petrology/egh019; BACHMANN O, 2003, GEOLOGY, V27, P447; Bergantz GW, 2000, J STRUCT GEOL, V22, P1297, DOI 10.1016/S0191-8141(00)00053-5; Bindeman IN, 2000, GEOLOGY, V28, P719, DOI 10.1130/0091-7613(2000)28<719:FOLRAC>2.0.CO;2; BLAKE S, 1981, NATURE, V289, P783, DOI 10.1038/289783a0; BLUNDY J, 1994, NATURE, V372, P452, DOI 10.1038/372452a0; BLUNDY JD, 1991, EARTH PLANET SC LETT, V102, P178, DOI 10.1016/0012-821X(91)90007-5; BROOKS CK, 1981, MINERAL MAG, V44, P157, DOI 10.1180/minmag.1981.044.334.07; CHESNER CA, 1989, AM MINERAL, V74, P750; Chesner CA, 1998, J PETROL, V39, P397, DOI 10.1093/petrology/39.3.397; CHESNER CA, 1991, GEOLOGY, V19, P200, DOI 10.1130/0091-7613(1991)019<0200:EHOESL>2.3.CO;2; Condomines M, 2003, REV MINERAL GEOCHEM, V52, P125, DOI 10.2113/0520125; Couch S, 2001, NATURE, V411, P1037, DOI 10.1038/35082540; Davidson JP, 1997, SCIENCE, V275, P826, DOI 10.1126/science.275.5301.826; DOLLASE WA, 1971, AM MINERAL, V56, P447; DOWTY E, 1980, AM MINERAL, V65, P174; Druitt TH., 1988, T ROY SOC EDIN-EARTH, V79, P289, DOI [10.1017/S0263593300014280, DOI 10.1017/S0263593300014280]; EWART A, 1994, CHEM GEOL, V117, P251, DOI 10.1016/0009-2541(94)90131-7; FORTIER SM, 1989, SCIENCE, V245, P1481, DOI 10.1126/science.245.4925.1481; Gardner JE, 2002, GEOLOGY, V30, P347, DOI 10.1130/0091-7613(2002)030<0347:PVXITY>2.0.CO;2; Glazner A.F., 2004, GSA TODAY, V14, P4, DOI [10.1130/1052-5173(2004)0142.0.CO;2, DOI 10.1130/1052-5173(2004)014<0004:APA0M0>2.0.C0;2, DOI 10.1130/1052-5173(2004)0142.0.CO;2]; HANSON RB, 1995, GEOLOGY, V23, P213; IYER HM, 1992, VOLCANIC SEISMOLOGY, P299; MAHOOD G, 1983, GEOCHIM COSMOCHIM AC, V47, P11, DOI 10.1016/0016-7037(83)90087-X; MARSH BD, 1985, J VOLCANOL GEOTH RES, V24, P95, DOI 10.1016/0377-0273(85)90030-7; MILLER CF, 1982, GEOLOGY, V10, P129, DOI 10.1130/0091-7613(1982)10<129:DOLREI>2.0.CO;2; Murphy MD, 2000, J PETROL, V41, P21, DOI 10.1093/petrology/41.1.21; Nakagawa M, 1999, B VOLCANOL, V61, P15, DOI 10.1007/s004450050259; RAMPINO MR, 1992, NATURE, V359, P50, DOI 10.1038/359050a0; RAMPINO MR, 1993, SCIENCE, V262, P1955, DOI 10.1126/science.8266085; Reid MR, 1997, EARTH PLANET SC LETT, V150, P27, DOI 10.1016/S0012-821X(97)00077-0; REID MR, 2003, TREATISE GEOCHEMISTR, V3; Robinson DM, 1999, AM MINERAL, V84, P1346; ROEDER PL, 1970, CONTRIB MINERAL PETR, V29, P275, DOI 10.1007/BF00371276; THOMAS JB, 2004, ZIRCON, V53, pCH3; Troll VR, 2002, J PETROL, V43, P243, DOI 10.1093/petrology/43.2.243; Turner S, 2003, EARTH PLANET SC LETT, V214, P279, DOI 10.1016/S0012-821X(03)00376-5; Wallace GS, 2002, EARTH PLANET SC LETT, V202, P133, DOI 10.1016/S0012-821X(02)00762-8; Yoshinobu AS, 1998, J STRUCT GEOL, V20, P1205, DOI 10.1016/S0191-8141(98)00064-9	41	105	107	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					991	994		10.1126/science.1096994	http://dx.doi.org/10.1126/science.1096994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310899				2022-12-28	WOS:000223250700044
J	Fincher, RE				Fincher, RE			Becoming a physician: The road less traveled - Attracting students to primary care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Med Coll Georgia, Sch Med, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Fincher, RE (corresponding author), Med Coll Georgia, Sch Med, Augusta, GA 30912 USA.							*COUNC GRAD MED ED, 1995, 6 US DEP HLTH HUM SE; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P2666; Randlett RR, 1996, ACAD MED, V71, P697, DOI 10.1097/00001888-199606000-00028	4	20	20	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					630	632		10.1056/NEJMp048054	http://dx.doi.org/10.1056/NEJMp048054			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306662				2022-12-28	WOS:000223225500003
J	Kang, YB; Massague, J				Kang, YB; Massague, J			Epithelial-mesenchymal transitions: Twist in development and metastasis	CELL			English	Review							BREAST-CANCER; GENE-EXPRESSION; SNAIL; PROGRESSION; GROWTH; SIP1	Epithelial-mesenchymal transitions (EMT) are vital for morphogenesis during embryonic development and are also implicated in the conversion of early stage tumors into invasive malignancies. Several key inducers of EMT are transcription factors that repress E-cadherin expression. A recent report in Cell (Yang et al., 2004) adds Twist to this list and links EMT to the ability of breast cancer cells to enter the circulation and seed metastases.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	j-massague@ski.mskcc.org	Davies, Jamie/AAE-7111-2019	Davies, Jamie/0000-0001-6660-4032; Massague, Joan/0000-0001-9324-8408; Kang, Yibin/0000-0002-1626-6730				Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; HUBER MA, 2004, IN PRESS J CLIN INVE; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Petersen OW, 2003, AM J PATHOL, V162, P391, DOI 10.1016/S0002-9440(10)63834-5; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	19	1174	1282	1	133	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					277	279		10.1016/j.cell.2004.07.011	http://dx.doi.org/10.1016/j.cell.2004.07.011			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294153	Bronze			2022-12-28	WOS:000223353100004
J	Alonso, PD; Milner, AC; Ketcham, RA; Cookson, MJ; Rowe, TB				Alonso, PD; Milner, AC; Ketcham, RA; Cookson, MJ; Rowe, TB			The avian nature of the brain and inner ear of Archaeopteryx	NATURE			English	Article							EVOLUTION; ORIGIN; SIZE	Archaeopteryx, the earliest known flying bird (avialan) from the Late Jurassic period, exhibits many shared primitive characters with more basal coelurosaurian dinosaurs ( the clade including all theropods more bird- like than Allosaurus)(1), such as teeth, a long bony tail and pinnate feathers(2). However, Archaeopteryx possessed asymmetrical flight feathers on its wings and tail, together with a wing feather arrangement shared with modern birds. This suggests some degree of powered flight capability(3) but, until now, little was understood about the extent to which its brain and special senses were adapted for flight. We investigated this problem by computed tomography scanning and three-dimensional reconstruction of the braincase of the London specimen of Archaeopteryx. Here we show the reconstruction of the braincase from which we derived endocasts of the brain and inner ear. These suggest that Archaeopteryx closely resembled modern birds in the dominance of the sense of vision and in the possession of expanded auditory and spatial sensory perception in the ear. We conclude that Archaeopteryx had acquired the derived neurological and structural adaptations necessary for flight. An enlarged forebrain suggests that it had also developed enhanced somatosensory integration with these special senses demanded by a lifestyle involving flying ability(4).	Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; Univ Complutense Madrid, Dept Paleontol, E-28040 Madrid, Spain; Univ Texas, High Resolut Xray CT Facil, Austin, TX 78712 USA; Univ Texas, Dept Geol Sci, Austin, TX 78712 USA; Univ Hertfordshire, Hatfield AL10 9AB, Herts, England	Natural History Museum London; Complutense University of Madrid; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Hertfordshire	Milner, AC (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	A.Milner@nhm.ac.uk	Domínguez Alonso, Patricio/C-2679-2013; Ketcham, Richard/B-5431-2011	Ketcham, Richard/0000-0002-2748-0409				BROCHU CA, 2003, MEMOIR SOC VERTEBRAT, V7, P1, DOI DOI 10.2307/3889334; Dominguez P, 2002, NATURE, V417, P841, DOI 10.1038/nature00805; DUBBELDAM JL, 1998, CENTRAL NERVOUS SYST, V3, P1525; Elzanowski A., 1991, Journal of Vertebrate Paleontology, V11, P90; Elzanowski A, 1996, J VERTEBR PALEONTOL, V16, P81, DOI 10.1080/02724634.1996.10011286; Elzanowski Andrzej, 2002, P129; Franzosa J.W., 2004, THESIS U TEXAS; Gleich O, 2000, SPR HDB AUD, V13, P70; Gray A.A., 1908, LABYRINTH ANIMALS IN, VII; Hopson J.A., 1979, P39; HOPSON JA, 1977, ANNU REV ECOL SYST, V8, P429, DOI 10.1146/annurev.es.08.110177.002241; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; JERISON HJ, 1968, NATURE, V219, P1381, DOI 10.1038/2191381a0; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; OSTROM JH, 1976, BIOL J LINN SOC, V8, P91, DOI 10.1111/j.1095-8312.1976.tb00244.x; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; PALTEL R, 1979, BIOL REPTILIA, V9, P147; PEARSON R, 1972, AVIAN BRAIN; Shimizu Toru, 2001, P135; STARCK D, 1979, BIOL REPTILIA, V9, P1; Walker A., 1985, P123; Wever E.., 1978, REPTILE EAR ITS STRU; WHETSTONE K N, 1983, Journal of Vertebrate Paleontology, V2, P439; Whybrow P.J., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1982, P184; Witmer L.M., 1997, ENCY DINOSAURS, P151; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; WITMER LM, 1990, ZOOL J LINN SOC-LOND, V100, P327, DOI 10.1111/j.1096-3642.1990.tb01865.x	29	141	149	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					666	669		10.1038/nature02706	http://dx.doi.org/10.1038/nature02706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295597	Green Published			2022-12-28	WOS:000223085400042
J	Lewin, MR; Knott, P; Lo, M				Lewin, MR; Knott, P; Lo, M			Seal finger	LANCET			English	Article									Univ Calif San Francisco, Sch Med, Div Emergency Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lewin, MR (corresponding author), Univ Calif San Francisco, Sch Med, Div Emergency Med, San Francisco, CA 94143 USA.	aplysia99@yahoo.com		Lewin, Matthew/0000-0003-4480-9891					0	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					448	448		10.1016/S0140-6736(04)16768-8	http://dx.doi.org/10.1016/S0140-6736(04)16768-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288743				2022-12-28	WOS:000222998600035
J	Soteriou, T				Soteriou, T			Commentary: View from the research and development office	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Avon & Wiltshire Mental Hlth Partnership NHS Trus, Bath BA1 3QE, Avon, England		Soteriou, T (corresponding author), Univ W England, Hlth Training & Res Ctr, Bristol BS16 1QY, Avon, England.	tony.soteriou@uwe.ac.uk						*BRIT ROYAL INF IN, 2001, CM5207; *DEP HLTH, 2003, IS REP INV EV FOLL D; *DEP HLTH, 2001, RES GOV FRAM HLTH SO; Jones AM, 2004, BMJ-BRIT MED J, V329, P280, DOI 10.1136/bmj.329.7460.280; The Royal Liverpool Children's Inquiry, 2001, REP ROYAL LIV CHILDR	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2004	329	7460					281	282		10.1136/bmj.329.7460.281	http://dx.doi.org/10.1136/bmj.329.7460.281			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284156	Green Published			2022-12-28	WOS:000223133300025
J	Yamada, H; Ogawa, Y; Ishii, Y; Sato, H; Kawasaki, M; Akoh, H; Tokura, Y				Yamada, H; Ogawa, Y; Ishii, Y; Sato, H; Kawasaki, M; Akoh, H; Tokura, Y			Engineered interface of magnetic oxides	SCIENCE			English	Article							MAGNETORESISTANCE	Interface-selective probing of magnetism is a key issue for the design and realization of spin-electronic junction devices. Here, magnetization-induced second-harmonic generation was used to probe the local magnetic properties at the interface of the perovskite ferromagnet La0.6Sr0.4MnO3 with nonmagneticat the interface of the perovskite ferromagnet La0.6Sr0.4MnO3 with nonmagnetic insulating layers, as used in spin-tunnel junctions. We show that by grading the doping pro. le on an atomic scale at the interface, robust ferromagnetism can be realized around room temperature. The results should lead to improvements in the performance of spin-tunnel junctions.	Natl Inst Adv Ind Sci & Technol, CERC, Tsukuba, Ibaraki 3058562, Japan; Japan Sci & Technol Agcy, CREST, Tsukuba, Ibaraki 3058562, Japan; ERATO, Spin Superstruct Project, Tsukuba, Ibaraki 3058562, Japan; Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Tohoku University; University of Tokyo	Yamada, H (corresponding author), Natl Inst Adv Ind Sci & Technol, CERC, Tsukuba, Ibaraki 3058562, Japan.		Yamada, Hiroyuki/L-6862-2018; Sato, Hiroshi/N-2032-2018; Kawasaki, Masashi/B-5826-2008; Yamada, Hiroyuki/AAR-8332-2020; Tokura, Yoshinori/C-7352-2009	Yamada, Hiroyuki/0000-0001-9847-5431; Yamada, Hiroyuki/0000-0001-9847-5431; Tokura, Yoshinori/0000-0002-2732-4983; Ogawa, Yoshihiro/0000-0001-8190-4228				Bowen M, 2003, APPL PHYS LETT, V82, P233, DOI 10.1063/1.1534619; Hammerl G, 2000, NATURE, V407, P162, DOI 10.1038/35025014; Izumi M, 1998, APPL PHYS LETT, V73, P2497, DOI 10.1063/1.122494; Izumi M, 2002, J PHYS SOC JPN, V71, P2621, DOI 10.1143/JPSJ.71.2621; Izumi M, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.064429; Kimoto K, 2004, APPL PHYS LETT, V84, P5374, DOI 10.1063/1.1767279; Konishi Y, 1999, J PHYS SOC JPN, V68, P3790, DOI 10.1143/JPSJ.68.3790; Ogawa Y, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.217403; Ogimoto Y, 2003, JPN J APPL PHYS 2, V42, pL369, DOI 10.1143/JJAP.42.L369; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; Pailloux F, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.014417; REIF J, 1991, PHYS REV LETT, V67, P2878, DOI 10.1103/PhysRevLett.67.2878; SPIERINGS G, 1993, J MAGN MAGN MATER, V121, P109, DOI 10.1016/0304-8853(93)91160-9; Sun JZ, 1996, APPL PHYS LETT, V69, P3266, DOI 10.1063/1.118031; Ueda K, 1998, SCIENCE, V280, P1064, DOI 10.1126/science.280.5366.1064; URUSHIBARA A, 1995, PHYS REV B, V51, P14103, DOI 10.1103/PhysRevB.51.14103; Yamada H, 2002, APPL PHYS LETT, V81, P4793, DOI 10.1063/1.1530734	17	336	336	3	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					646	648		10.1126/science.1098867	http://dx.doi.org/10.1126/science.1098867			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286367				2022-12-28	WOS:000222992100040
J	Aspholm-Hurtig, M; Dailide, G; Lahmann, M; Kalia, A; Ilver, D; Roche, N; Vikstrom, S; Sjostrom, R; Linden, S; Backstrom, A; Lundberg, C; Arnqvist, A; Mahdavi, J; Nilsson, UJ; Velapatino, B; Gilman, RH; Gerhard, M; Alarcon, T; Lopez-Brea, M; Nakazawa, T; Fox, JG; Correa, P; Dominguez-Bello, MG; Perez-Perez, GI; Blaser, MJ; Normark, S; Carlstedt, I; Oscarson, S; Teneberg, S; Berg, DE; Boren, T				Aspholm-Hurtig, M; Dailide, G; Lahmann, M; Kalia, A; Ilver, D; Roche, N; Vikstrom, S; Sjostrom, R; Linden, S; Backstrom, A; Lundberg, C; Arnqvist, A; Mahdavi, J; Nilsson, UJ; Velapatino, B; Gilman, RH; Gerhard, M; Alarcon, T; Lopez-Brea, M; Nakazawa, T; Fox, JG; Correa, P; Dominguez-Bello, MG; Perez-Perez, GI; Blaser, MJ; Normark, S; Carlstedt, I; Oscarson, S; Teneberg, S; Berg, DE; Boren, T			Functional adaptation of BabA, the H-pylori ABO blood group antigen binding adhesin	SCIENCE			English	Article							EXPRESSION; INFECTION	Adherence by Helicobacter pylori increases the risk of gastric disease. Here, we report that more than 95% of strains that bind fucosylated blood group antigen bind A, B, and O antigens ( generalists), whereas 60% of adherent South American Amerindian strains bind blood group O antigens best ( specialists). This specialization coincides with the unique predominance of blood group O in these Amerindians. Strains differed about 1500-fold in binding affinities, and diversifying selection was evident in babA sequences. We propose that cycles of selection for increased and decreased bacterial adherence contribute to babA diversity and that these cycles have led to gradual replacement of generalist binding by specialist binding in blood group O - dominant human populations.	Univ Gothenburg, Inst Med Biochem, SE-40530 Gothenburg, Sweden; Umea Univ, Dept Odontol, Sect Oral Microbiol, SE-90187 Umea, Sweden; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Gothenburg, Dept Chem, SE-41296 Gothenburg, Sweden; Lund Univ, Dept Cell & Mol Biol, SE-22184 Lund, Sweden; Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; Lund Univ, SE-22100 Lund, Sweden; Univ Peruana Cayetano Heredia, Dept Microbiol, Lima, Peru; Tech Univ Munich, Klinikum Rechts Isar, Dept Med, DE-81675 Munich, Germany; Hosp Princesa, Dept Microbiol, Madrid 28006, Spain; Yamaguchi Univ, Sch Med, Dept Microbiol, Ube, Yamaguchi 7558505, Japan; MIT, Div Comparat Med, Cambridge, MA 02139 USA; Louisiana State Univ, Med Ctr, New Orleans, LA 70112 USA; Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA; Karolinska Inst, MTC, SE-17177 Stockholm, Sweden; Stockholm Univ, Arrhenius Lab, Dept Organ Chem, SE-10691 Stockholm, Sweden; Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	University of Gothenburg; Umea University; Washington University (WUSTL); University of Gothenburg; Lund University; Umea University; Lund University; Universidad Peruana Cayetano Heredia; Technical University of Munich; Hospital de La Princesa; Yamaguchi University; Massachusetts Institute of Technology (MIT); Louisiana State University System; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; New York University; Karolinska Institutet; Stockholm University; Umea University	Teneberg, S (corresponding author), Univ Gothenburg, Inst Med Biochem, SE-40530 Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se; Berg@borcim.wustl.edu; Thomas.Boren@medchem.umu.se	Nilsson, Ulf J./L-3219-2014; Gerhard, Markus/N-3387-2014; Aspholm, Marina/ABB-5298-2020; Lahmann, Martina/A-3090-2010; Gerhard, Markus/P-8996-2019; Perez, Guillermo Perez/AAJ-3761-2020; Lindén, Sara K/A-3271-2011	Nilsson, Ulf J./0000-0001-5815-9522; Gerhard, Markus/0000-0001-9110-3950; Aspholm, Marina/0000-0003-3175-6022; Lahmann, Martina/0000-0002-8513-1952; Gerhard, Markus/0000-0001-9110-3950; Lindén, Sara K/0000-0002-7751-9586; Kalia, Awdhesh/0000-0001-5365-1702; Ilver, Dag/0000-0002-3618-9496; Perez Perez, Guillermo/0000-0002-0131-5798; Oscarson, Stefan/0000-0002-8273-4918	NIAID NIH HHS [R01 AI38166, R03 AI49161] Funding Source: Medline; NIDDK NIH HHS [R01 DK53727, P30 DK52574, R01 DK63041] Funding Source: Medline; NIGMS NIH HHS [R0IGM62370] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038166, R03AI049161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK053727, R01DK063041] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASPHOLMHURTIG M, UNPUB; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Brown JR, 2003, J BIOL CHEM, V278, P23352, DOI 10.1074/jbc.M303093200; CLARKE CA, 1955, BRIT MED J, V2, P643, DOI 10.1136/bmj.2.4940.643; CLAUSEN H, 1989, VOX SANG, V56, P1, DOI 10.1111/j.1423-0410.1989.tb03040.x; DAILIDE G, UNPUB; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Mourant AE., 1976, DISTRIBUTION HUMAN B; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pride DT, 2002, J MOL BIOL, V316, P629, DOI 10.1006/jmbi.2001.5311; Solnick JV, 2004, P NATL ACAD SCI USA, V101, P2106, DOI 10.1073/pnas.0308573100	15	294	307	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2004	305	5683					519	522		10.1126/science.1098801	http://dx.doi.org/10.1126/science.1098801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273394				2022-12-28	WOS:000222828900040
J	Oganov, AR; Ono, S				Oganov, AR; Ono, S			Theoretical and experimental evidence for a post-perovskite phase of MgSiO3 in Earth's D '' layer	NATURE			English	Article							LOWER MANTLE; ALUMINOUS PHASE; STABILITY; PRESSURE; BASE; DISCONTINUITY; ANISOTROPY; EQUATION; VELOCITY; STATE	The Earth's lower mantle is believed to be composed mainly of (Mg, Fe) SiO3 perovskite, with lesser amounts of (Mg,Fe)O and CaSiO3 (ref. 1). But it has not been possible to explain many unusual properties of the lowermost similar to150 km of the mantle (the D" layer) with this mineralogy. Here, using ab initio simulations and high-pressure experiments, we show that at pressures and temperatures of the D" layer, MgSiO3 transforms from perovskite into a layered CaIrO3-type post-perovskite phase. The elastic properties of the post-perovskite phase and its stability field explain several observed puzzling properties of the D" layer: its seismic anisotropy(2), the strongly undulating shear-wave discontinuity at its top(3-6) and possibly the anticorrelation between shear and bulk sound velocities(7,8).	Swiss Fed Inst Technol, Dept Mat, Crystallog Lab, CH-8093 Zurich, Switzerland; Japan Agcy Marine Earth Sci & Technol, Inst Frontier Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Oganov, AR (corresponding author), Swiss Fed Inst Technol, Dept Mat, Crystallog Lab, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	a.oganov@mat.ethz.ch	Oganov, Artem R/A-1213-2008; Oganov, Artem R./AAA-1478-2021; Oganov, Artem R./O-8234-2019	Oganov, Artem R/0000-0001-7082-9728; Oganov, Artem R./0000-0001-7082-9728; Ono, Shigeaki/0000-0003-1880-7569				Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Fiquet G, 2001, Z KRISTALLOGR, V216, P248, DOI 10.1524/zkri.216.5.248.20374; Fiquet G, 2000, GEOPHYS RES LETT, V27, P21, DOI 10.1029/1999GL008397; Gonze X, 2002, COMP MATER SCI, V25, P478, DOI 10.1016/S0927-0256(02)00325-7; Jeanloz R, 1998, REV MINERAL, V37, P241; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; LAY T, 1983, GEOPHYS RES LETT, V10, P63, DOI 10.1029/GL010i001p00063; Masters G., 2000, EARTHS DEEP INTERIOR, V117, P63, DOI DOI 10.1029/GM117P0063; MONTAGNER JP, 1986, J GEOPHYS RES-SOLID, V91, P511, DOI 10.1029/JB091iB01p00511; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Oganov AR, 2001, EARTH PLANET SC LETT, V184, P555, DOI 10.1016/S0012-821X(00)00363-0; Oganov AR, 2001, NATURE, V411, P934, DOI 10.1038/35082048; Oganov AR, 2000, PHYS CHEM MINER, V27, P430, DOI 10.1007/s002699900081; Ono S, 2002, PHYS CHEM MINER, V29, P527, DOI 10.1007/s00269-002-0263-5; ONO S, IN PRESS AM MINERAL; ONO S, UNPUB AM MINERAL; Panning M, 2004, SCIENCE, V303, P351, DOI 10.1126/science.1091524; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; RODI F, 1965, Z ANORG ALLG CHEM, V336, P17, DOI 10.1002/zaac.19653360104; Saxena SK, 1996, SCIENCE, V274, P1357, DOI 10.1126/science.274.5291.1357; Serghiou G, 1998, SCIENCE, V280, P2093, DOI 10.1126/science.280.5372.2093; Shim SH, 2001, SCIENCE, V293, P2437, DOI 10.1126/science.1061235; Sidorin I, 1998, EARTH PLANET SC LETT, V163, P31, DOI 10.1016/S0012-821X(98)00172-1; Sidorin I, 1999, J GEOPHYS RES-SOL EA, V104, P15005, DOI 10.1029/1999JB900065; Sidorin I, 1999, SCIENCE, V286, P1326, DOI 10.1126/science.286.5443.1326; Su WJ, 1997, PHYS EARTH PLANET IN, V100, P135, DOI 10.1016/S0031-9201(96)03236-0; Urusov V.S., 1987, THEORETICAL CRYSTAL; Wentzcovitch RM, 1998, EARTH PLANET SC LETT, V164, P371, DOI 10.1016/S0012-821X(98)00230-1	30	714	744	2	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2004	430	6998					445	448		10.1038/nature02701	http://dx.doi.org/10.1038/nature02701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269766	Green Submitted			2022-12-28	WOS:000222801400040
J	Pallais, JC; Kifor, O; Chen, YB; Slovik, D; Brown, EM				Pallais, JC; Kifor, O; Chen, YB; Slovik, D; Brown, EM			Brief report - Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY HYPERPARATHYROIDISM; AUTOIMMUNE HYPOPARATHYROIDISM; CA2+-SENSING RECEPTOR; PARATHYROID-HORMONE; ANTIBODIES; DISORDERS		Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Endocrinol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Pallais, JC (corresponding author), Massachusetts Gen Hosp, Dept Med, 55 Fruit St,GRB 740, Boston, MA 02114 USA.	jpallais@partners.org			NIDDK NIH HHS [DK52005, DK48330] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052005, R01DK048330] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATTIE MF, 1983, J CLIN INVEST, V72, P667, DOI 10.1172/JCI111016; BRANDI ML, 1986, P NATL ACAD SCI USA, V83, P8366, DOI 10.1073/pnas.83.21.8366; Bringhurst F, 2003, WILLIAMS TXB ENDOCRI, V10th, P1303; Brown EM, 2000, ENDOCRIN METAB CLIN, V29, P503, DOI 10.1016/S0889-8529(05)70148-1; DENT CE, 1968, LANCET, V2, P662; FATTOROSSI A, 1988, P NATL ACAD SCI USA, V85, P4015, DOI 10.1073/pnas.85.11.4015; FOLEY TP, 1972, J PEDIATR-US, V81, P1060, DOI 10.1016/S0022-3476(72)80232-4; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; HEATH H, 1989, ENDOCRIN METAB CLIN, V18, P723, DOI 10.1016/S0889-8529(18)30362-1; Hebert SC, 1997, J EXP BIOL, V200, P295; Hofmann S, 2002, J INVEST DERMATOL, V119, P1065, DOI 10.1046/j.1523-1747.2002.19529.x; JEFFERIS R, 1994, ANN BIOL CLIN-PARIS, V52, P57; Kifor O, 1997, J BONE MINER RES, V12, P715, DOI 10.1359/jbmr.1997.12.5.715; Kifor O, 2003, J CLIN ENDOCR METAB, V88, P60, DOI 10.1210/jc.2002-020249; Li YX, 1996, J CLIN INVEST, V97, P910, DOI 10.1172/JCI118513; MARX SJ, 1982, NEW ENGL J MED, V306, P257, DOI 10.1056/NEJM198202043060502; Marx SJ, 2000, NEW ENGL J MED, V343, P1863, DOI 10.1056/NEJM200012213432508; MARX SJ, 1980, ANN INTERN MED, V92, P351, DOI 10.7326/0003-4819-92-3-351; NUSSBAUM SR, 1990, NEW ENGL J MED, V323, P1324, DOI 10.1056/NEJM199011083231907; SANDLER LM, 1984, Q J MED, V53, P165; SEYMOUR JF, 1993, BLOOD, V82, P1383; Shoback DM, 2003, J CLIN ENDOCR METAB, V88, P5644, DOI 10.1210/jc.2002-021597; YOSHIMOTO K, 1989, J CLIN ENDOCR METAB, V68, P976, DOI 10.1210/jcem-68-5-976	23	74	83	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2004	351	4					362	369		10.1056/NEJMoa040008	http://dx.doi.org/10.1056/NEJMoa040008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839RC	15269316	Bronze			2022-12-28	WOS:000222801200010
J	Shu, DG; Morris, SC; Han, J; Zhang, ZF; Liu, JN				Shu, DG; Morris, SC; Han, J; Zhang, ZF; Liu, JN			Ancestral echinoderms from the Chengjiang deposits of China	NATURE			English	Article							DEUTEROSTOME EVOLUTION; ORIGIN; SOLUTE; FOSSIL; HEMICHORDATE; EXPRESSION; PHYLOGENY; SEQUENCE; TUNICATE; ANATOMY	Deuterostomes are a remarkably diverse super-phylum, including not only the chordates ( to which we belong) but groups as disparate as the echinoderms and the hemichordates. The phylogeny of deuterostomes is now achieving some degree of stability, especially on account of new molecular data, but this leaves as conjectural the appearance of extinct intermediate forms that would throw light on the sequence of evolutionary events leading to the extant groups. Such data can be supplied from the fossil record, notably those deposits with exceptional soft-part preservation. Excavations near Kunming in southwestern China have revealed a variety of remarkable early deuterostomes, including the vetulicolians and yunnanozoans. Here we describe a new group, the vetulocystids. They appear to have similarities not only to the vetulicolians but also to the homalozoans, a bizarre group of primitive echinoderms whose phylogenetic position has been highly controversial.	China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Dept Geol, Xian 710069, Peoples R China; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	China University of Geosciences; Northwest University Xi'an; Northwest University Xi'an; University of Cambridge	Shu, DG (corresponding author), China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China.	elidgshu@nwu.edu.cn	Zhang, Zhifei/F-2532-2011	Zhang, Zhifei/0000-0003-0325-5116				Babcock Loren E., 2001, Palaeoworld, V13, P66; BEAVER HH, 1967, TREATISE INVERTEBR S, V2, pS300; Bromham LD, 1999, EVOL DEV, V1, P166, DOI 10.1046/j.1525-142x.1999.99026.x; Cameron CB, 2002, BIOL BULL, V202, P192, DOI 10.2307/1543655; CASTER KE, 1967, TREATISE INVERTEB S, V2, pS581; Chen AL, 2003, ACTA GEOL SIN-ENGL, V77, P281; Chen Junyuan, 1997, Bulletin of the National Museum of Natural Science (Taichung), V10, P11; Chen JY, 2003, P NATL ACAD SCI USA, V100, P8314, DOI 10.1073/pnas.1431177100; Daley PEJ, 1996, ZOOL J LINN SOC-LOND, V117, P405; Daley PEJ, 1995, GEOBIOS-LYON, V28, P585, DOI 10.1016/S0016-6995(95)80214-2; DALEY PEJ, 1992, ZOOL J LINN SOC-LOND, V105, P353, DOI 10.1111/j.1096-3642.1992.tb01233.x; David B, 2000, PALEOBIOLOGY, V26, P529, DOI 10.1666/0094-8373(2000)026<0529:AHEAAF>2.0.CO;2; Dominguez P., 1999, P269; Dominguez P, 2002, NATURE, V417, P841, DOI 10.1038/nature00805; Dominguez-Alonso P., 1999, P263; Gee H, 2001, SYST ASSOC SPEC VOL, V61, P1; Gee H., 1996, BACKBONE VIEWS ORIGI; Halanych KM, 1995, MOL PHYLOGENET EVOL, V4, P72, DOI 10.1006/mpev.1995.1007; Holland LZ, 1997, DEVELOPMENT, V124, P1723; Hou X. -G., 1999, CHENGJIANG FAUNA EXC; Jefferies R.P.S., 1986, ANCESTRY VERTEBRATES; Jefferies RPS, 1996, ACTA ZOOL-STOCKHOLM, V77, P101, DOI 10.1111/j.1463-6395.1996.tb01256.x; Jefferies RPS, 1997, LETHAIA, V30, P1; JOLLIE M, 1982, ZOOL J LINN SOC-LOND, V75, P167, DOI 10.1111/j.1096-3642.1982.tb01946.x; Kesling R.V., 1967, TREATISE INVERTEBRAT, V1, pS85; Lacalli TC, 2002, BIOESSAYS, V24, P208, DOI 10.1002/bies.10064; Lefebvre B, 2003, PALAEONTOLOGY, V46, P511, DOI 10.1111/1475-4983.00309; Mallatt J, 2003, J MORPHOL, V258, P1, DOI 10.1002/jmor.10081; Parsley R. L., 1999, P369; PARSLEY RL, 1994, ECHINODERMS THROUGH TIME, P167; Shu D, 1996, NATURE, V380, P428, DOI 10.1038/380428a0; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Shu DG, 2003, CHINESE SCI BULL, V48, P725, DOI 10.1360/03wd0026; Shu DG, 2003, SCIENCE, V299, P1380, DOI 10.1126/science.1079846; Shu DG, 2001, NATURE, V411, P472, DOI 10.1038/35078069; Shu DG, 2001, NATURE, V414, P419, DOI 10.1038/35106514; Sly BJ, 2002, EVOL DEV, V4, P189, DOI 10.1046/j.1525-142X.2002.02002.x; Smith MP, 2001, SYST ASSOC SPEC VOL, V61, P67; SPRINKLE J, 1978, TREATISE INVERTEBR T, V3, pT998; UBAGHS G, 1967, TREATISE INVERTEBR S, V2, pS495; UBAGHS G, 1967, TREATISE INVERTEBR S, V2, pS455; VANNAME WG, 1945, B AM MUS NAT HIST, V84, P1; Winchell CJ, 2002, MOL BIOL EVOL, V19, P762, DOI 10.1093/oxfordjournals.molbev.a004134; Wray GA, 2000, SYST BIOL, V49, P28, DOI 10.1080/10635150050207375; Zhang XL, 2001, J GEOL SOC LONDON, V158, P211, DOI 10.1144/jgs.158.2.211	45	78	97	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2004	430	6998					422	428		10.1038/nature02648	http://dx.doi.org/10.1038/nature02648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	839RD	15269760				2022-12-28	WOS:000222801400034
J	Sordella, R; Bell, DW; Haber, DA; Settleman, J				Sordella, R; Bell, DW; Haber, DA; Settleman, J			Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways	SCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; CELL-CYCLE PROGRESSION; RAS/RAF/MEK/ERK PATHWAY; TYROSINE KINASE; INHIBITOR; ZD1839; TRIAL	Gefitinib (Iressa, AstraZeneca Pharmaceuticals) is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR) and induces dramatic clinical responses in nonsmall. cell lung cancers (NSCLCs) with activating mutations within the EGFR kinase domain. We report that these mutant EGFRS selectively activate Akt and signal transduction and activator of transcription (STAT) signaling pathways, which promote cell survival, but have no effect on extracellular signal-regulated kinase signaling which induces proliferation. NSCLC cells expressing mutant EGFRs underwent extensive apoptosis after small interfering RNA-mediated knockdown of the mutant EGFR or treatment with pharmacological inhibitors of Akt and STAT signaling and were relatively resistant to apoptosis induced by conventional chemotherapeutic drugs. Thus, mutant EGFRs selectively transduce survival signals on which NSCLCs become dependent, inhibition of those signals by gefitinib may contribute to the drug's efficacy.	Massachusetts Gen Hosp, Ctr Canc, Ctr Mol Therapeut, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Settleman, J (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Ctr Mol Therapeut, Bldg 149,13th St, Charlestown, MA 02129 USA.	settleman@helix.mgh.harvard.edu			PHS HHS [P01 95281] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahonen TJ, 2003, J BIOL CHEM, V278, P27287, DOI 10.1074/jbc.M304307200; Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chang FM, 2003, INT J ONCOL, V22, P469; EARP HS, 1995, BREAST CANCER RES TR, V35, P115, DOI 10.1007/BF00694752; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kindler T, 2003, LEUKEMIA, V17, P999, DOI 10.1038/sj.leu.2402940; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paner GP, 2003, ANTICANCER RES, V23, P2253; SORDELLA R, UNPUB; Wakeling AE, 2002, CANCER RES, V62, P5749; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	19	1354	1451	5	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1163	1167		10.1126/science.1101637	http://dx.doi.org/10.1126/science.1101637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15284455				2022-12-28	WOS:000223557400051
J	Bedalov, A; Simon, JA				Bedalov, A; Simon, JA			NAD to the rescue	SCIENCE			English	Editorial Material							WALLERIAN DEGENERATION; TRANSCRIPTION FACTORS; P53		Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Bedalov, A (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA.	abedalov@fhcrc.org; jsimon@fhcrc.org						Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; SADAJI A, 2004, CURR BIOL, V14, P326; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	13	37	41	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					954	955		10.1126/science.1102497	http://dx.doi.org/10.1126/science.1102497			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310883				2022-12-28	WOS:000223250700027
J	Golden, DBK; Kagey-Sobotka, A; Norman, PS; Hamilton, RG; Lichtenstein, LM				Golden, DBK; Kagey-Sobotka, A; Norman, PS; Hamilton, RG; Lichtenstein, LM			Outcomes of allergy to insect stings in children, with and without venom immunotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LARGE LOCAL REACTIONS; QUALITY-OF-LIFE; NATURAL-HISTORY; DISCONTINUATION	Background: Children are thought to "outgrow'' the allergy to insect stings, but there are no reports documenting the natural history of this reaction. We studied the outcome of allergic reactions to insect stings in childhood 10 to 20 years afterward in patients who had not received venom immunotherapy and in those who had been treated. Methods: Between 1978 and 1985, we diagnosed allergic reaction to insect stings in 1033 children, of whom 356 received venom immunotherapy. We conducted a survey of these patients by telephone and mail between January 1997 and January 2000, to determine the outcome of stings that occurred in the period from 1987 through 1999. Results: Of the 1033 patients, 512 patients (50 percent) responded, with a mean follow-up period of 18 years, a mean duration of venom immunotherapy of 3.5 years in treated patients, and an incidence of stings of 43 percent. Systemic reactions occurred less frequently in patients who had received venom immunotherapy (2 of 64 patients, or 3 percent) than in untreated patients (19 of 111 patients, or 17 percent; P=0.007). Patients with a history of moderate-to-severe reactions had a higher rate of reaction if they had not been treated (7 of 22 patients, or 32 percent) than if they had received venom immunotherapy (2 of 43 patients, or 5 percent; P=0.007). In patients who had been treated and who had a history of mild (cutaneous) systemic reaction (i.e., one with only cutaneous manifestations), none of the 21 subjects who received stings had a systemic reaction. Conclusions: A clinically important number of children do not outgrow allergic reactions to insect stings. Venom immunotherapy in children leads to a significantly lower risk of systemic reaction to stings even 10 to 20 years after treatment is stopped, and this prolonged benefit is greater than the benefit seen in adults.	Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Golden, DBK (corresponding author), Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Blvd, Baltimore, MD 21224 USA.	dgolden1@jhmi.edu			NIAID NIH HHS [AI08270] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI008270, R37AI008270] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARNARD JH, 1973, J ALLERGY CLIN IMMUN, V52, P259, DOI 10.1016/0091-6749(73)90044-4; Elberink JNGO, 2002, J ALLERGY CLIN IMMUN, V109, P162, DOI 10.1067/mai.2002.120552; Elberink JNGO, 2002, J ALLERGY CLIN IMMUN, V110, P174, DOI 10.1067/mai.2002.125827; Golden DBK, 2000, J ALLERGY CLIN IMMUN, V105, P385, DOI 10.1016/S0091-6749(00)90092-7; Golden DBK, 2001, J ALLERGY CLIN IMMUN, V107, P925, DOI 10.1067/mai.2001.115095; Graft DF, 1998, J ALLERGY CLIN IMMUN, V101, P573, DOI 10.1016/S0091-6749(98)70161-7; GRAFT DF, 1984, J PEDIATR-US, V104, P664, DOI 10.1016/S0022-3476(84)80940-3; HUNT KJ, 1978, NEW ENGL J MED, V299, P157, DOI 10.1056/NEJM197807272990401; Lerch E, 1998, J ALLERGY CLIN IMMUN, V101, P606, DOI 10.1016/S0091-6749(98)70167-8; LICHTENSTEIN LM, 1974, NEW ENGL J MED, V290, P1223, DOI 10.1056/NEJM197405302902204; Light WC, 2001, J ALLERGY CLIN IMMUN, V107, P925, DOI 10.1067/mai.2001.114985; MAURIELLO PM, 1984, J ALLERGY CLIN IMMUN, V74, P494, DOI 10.1016/0091-6749(84)90384-1; SCHUBERTH KC, 1988, J ALLERGY CLIN IMMUN, V81, P200, DOI 10.1016/0091-6749(88)90364-8; SCHUBERTH KC, 1982, J PEDIATR-US, V100, P546, DOI 10.1016/S0022-3476(82)80750-6; SETTIPANE GA, 1970, ACTA ALLERGOL, V25, P286, DOI 10.1111/j.1398-9995.1970.tb01264.x; VALENTINE MD, 1990, NEW ENGL J MED, V323, P1601, DOI 10.1056/NEJM199012063232305	16	176	185	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					668	674		10.1056/NEJMoa022952	http://dx.doi.org/10.1056/NEJMoa022952			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306668				2022-12-28	WOS:000223225500009
J	Rosenflanz, A; Frey, M; Endres, B; Anderson, T; Richards, E; Schardt, C				Rosenflanz, A; Frey, M; Endres, B; Anderson, T; Richards, E; Schardt, C			Bulk glasses and ultrahard nanoceramics based on alumina and rare-earth oxides	NATURE			English	Article							STRENGTH; LIQUID	Although often regarded as a network-former in conventional silicate glasses, Al2O3 alone cannot be obtained as a bulk glass. Until now, glasses comprising continuously linked [AlOx] polyhedra have been prepared in only a few systems under very fast cooling conditions, which limits their dimensions to a few millimetres(1-3). Yet it is desirable to prepare bulk, or monolithic, alumina-rich glasses, with the prospect of superior mechanical, chemical and optical properties(4). Here we report a novel process for preparing very-high-alumina glasses and nanoscale glass-ceramics. Fully dense bulk articles in net shape are obtained through viscous sintering of glass microbeads. Additional heat treatment of the consolidated glasses leads to fully crystallized transparent glass-converted nanoceramics with a hardness similar to that of alumina. This method avoids the impracticably high applied pressures ( more than 1 GPa) that have been required in most cases to prepare nanocrystalline ceramics by sintering, owing to the concurrent nature of densification and grain growth under pressureless conditions(5,6). The reported techniques can be extended to form glasses and nanoceramics in other oxide systems that do not include a conventional glass-forming component.	3M Co, Cent Res Lab 3M, Corp Res & Dev, St Paul, MN 55144 USA	3M	Rosenflanz, A (corresponding author), 3M Co, Cent Res Lab 3M, Corp Res & Dev, St Paul, MN 55144 USA.	arosenflanz@mmm.com						ANGELL CA, 1988, J NON-CRYST SOLIDS, V102, P205, DOI 10.1016/0022-3093(88)90133-0; BANSAL NP, 1986, HDB GLASS PROPERTIES, pCH11; Beall G. H., 1971, ADV NUCLEATION CRYST, P251; Beall GH, 1999, J AM CERAM SOC, V82, P5, DOI 10.1111/j.1151-2916.1999.tb01716.x; Chen IW, 2000, NATURE, V404, P168, DOI 10.1038/35004548; COHEN MH, 1961, NATURE, V189, P131, DOI 10.1038/189131b0; Freim J, 1996, J MATER RES, V11, P110, DOI 10.1557/JMR.1996.0014; INOUE A, 1993, J NON-CRYST SOLIDS, V156, P473, DOI 10.1016/0022-3093(93)90003-G; JANTZEN CM, 1980, MATER RES BULL, V15, P1313, DOI 10.1016/0025-5408(80)90036-7; KAWAMURA Y, 1995, APPL PHYS LETT, V67, P2008, DOI 10.1063/1.114769; KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0; Liao SC, 1998, NANOSTRUCT MATER, V10, P1063, DOI 10.1016/S0965-9773(98)00125-1; Mayo W. E., 2002, U.S. Patent, Patent No. [6,395,214, 6395214]; MCMILLAN P, 1983, J NON-CRYST SOLIDS, V55, P221, DOI 10.1016/0022-3093(83)90672-5; MCMILLAN PW, 1979, GLASS CERAM, P196; MIZUTA H, 1992, J AM CERAM SOC, V75, P469, DOI 10.1111/j.1151-2916.1992.tb08203.x; RAWSON H, 1967, INORGANIC GLASS FORM, P23; ROSENFLANZ A, 2003, Patent No. 6582488; SARJEANT PT, 1969, J AM CERAM SOC, V52, P57, DOI 10.1111/j.1151-2916.1969.tb12665.x; SARJEANT PT, 1969, REACT SOLID, P725; SHELBY JE, 1985, J AM CERAM SOC, V68, P155, DOI 10.1111/j.1151-2916.1985.tb09656.x; SHELBY JE, 1990, J AM CERAM SOC, V73, P39, DOI 10.1111/j.1151-2916.1990.tb05087.x; Sun K.H., 1949, GLASS IND, V30, p[199, 232]; Waku Y, 2000, MATER RES INNOV, V3, P185, DOI 10.1007/s100190050002; Weber JKR, 2000, J AM CERAM SOC, V83, P1868, DOI 10.1111/j.1151-2916.2000.tb01483.x; Weber R, 2003, P SOC PHOTO-OPT INS, V4990, P70, DOI 10.1117/12.484119; Wilding MC, 2001, J NON-CRYST SOLIDS, V293, P357, DOI 10.1016/S0022-3093(01)00686-X; YAJIMA S, 1980, CHEM LETT, V8, P1313; Yip S, 1998, NATURE, V391, P532, DOI 10.1038/35254	29	205	216	8	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					761	764		10.1038/nature02729	http://dx.doi.org/10.1038/nature02729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306804				2022-12-28	WOS:000223233600036
J	Christensen, PR; Ruff, SW; Fergason, RL; Knudson, AT; Anwar, S; Arvidson, RE; Bandfield, JL; Blaney, DL; Budney, C; Calvin, WM; Glotch, TD; Golombek, MP; Gorelick, N; Graff, TG; Hamilton, VE; Hayes, A; Johnson, JR; McSween, HY; Mehall, GL; Mehall, LK; Moersch, JE; Morris, RV; Rogers, AD; Smith, MD; Squyres, SW; Wolff, MJ; Wyatt, MB				Christensen, PR; Ruff, SW; Fergason, RL; Knudson, AT; Anwar, S; Arvidson, RE; Bandfield, JL; Blaney, DL; Budney, C; Calvin, WM; Glotch, TD; Golombek, MP; Gorelick, N; Graff, TG; Hamilton, VE; Hayes, A; Johnson, JR; McSween, HY; Mehall, GL; Mehall, LK; Moersch, JE; Morris, RV; Rogers, AD; Smith, MD; Squyres, SW; Wolff, MJ; Wyatt, MB			Initial results from the Mini-TES experiment in Gusev crater from the Spirit rover	SCIENCE			English	Article							THERMAL EMISSION-SPECTROSCOPY; ROCKS; TERRESTRIAL	The Miniature Thermal Emission Spectrometer (Mini-TES) on Spirit has studied the mineralogy and thermophysical properties at Gusev crater. Undisturbed soil spectra show evidence for minor carbonates and bound water. Rocks are olivine-rich basalts with varying degrees of dust and other coatings. Dark-toned soils observed on disturbed surfaces may be derived from rocks and have derived mineralogy (+/- 5 to 10%) of 45% pyroxene (20% Ca-rich pyroxene and 25% pigeonite), 40% sodic to intermediate plagioclase, and 15% olivine (forsterite 45% +/- 5 to 10). Two spectrally distinct coatings are observed on rocks, a possible indicator of the interaction of water, rock, and airfall dust. Diurnal temperature data indicate particle sizes from 40 to 80 mum in hollows to similar to0.5 to 3 mm in soils.	Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Nevada, Dept Geol Sci, Reno, NV 89557 USA; Univ Hawaii, Inst Geophys & Planetol, Honolulu, HI 96822 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Space Sci Inst, Martinez, GA 30907 USA	Arizona State University; Arizona State University-Tempe; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Hawaii System; Cornell University; United States Department of the Interior; United States Geological Survey; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Christensen, PR (corresponding author), Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA.	phil.christensen@asu.edu	Moersch, Jeffrey E/F-7189-2010; Rogers, A. Deanne/ABE-8469-2021; Blaney, Diana/M-1756-2019; Hayes, Alexander G/P-2024-2014; Johnson, Jeffrey R/F-3972-2015; Smith, Michael/C-8875-2012; Rogers, Deanne/I-9737-2016; Glotch, Timothy/B-6829-2008	Moersch, Jeffrey E/0000-0003-3433-9419; Rogers, A. Deanne/0000-0002-4671-2551; Blaney, Diana/0000-0002-4267-7939; Hayes, Alexander G/0000-0001-6397-2630; Johnson, Jeffrey R/0000-0002-5586-4901; Rogers, Deanne/0000-0002-4671-2551; Bandfield, Joshua/0000-0003-3571-3716; Gorelick, Noel/0000-0002-5548-2436				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bishop JL, 2004, ICARUS, V169, P311, DOI 10.1016/j.icarus.2003.12.025; CHRISTENSEN PR, 1986, ICARUS, V68, P217, DOI 10.1016/0019-1035(86)90020-5; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9735, DOI 10.1029/1998JE000624; CHRISTENSEN PR, 1993, J GEOPHYS RES-SOL EA, V98, P19819, DOI 10.1029/93JB00135; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23823, DOI 10.1029/2000JE001370; CHRISTENSEN PR, 2003, J GEOPHYS RES, V198; CICCOLLELA SM, 2003, P LUNAR PLANET SCI, V34, P1836; Feely KC, 1999, J GEOPHYS RES-PLANET, V104, P24195, DOI 10.1029/1999JE001034; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Hamilton VE, 2001, J GEOPHYS RES-PLANET, V106, P14733, DOI 10.1029/2000JE001353; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KIEFFER HH, 1973, J GEOPHYS RES, V78, P4291, DOI 10.1029/JB078i020p04291; LANE MD, 2004, P LUNAR PLANET SCI, V35; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; Presley MA, 1997, J GEOPHYS RES-PLANET, V102, P6551, DOI 10.1029/96JE03303; Ramsey MS, 1998, J GEOPHYS RES-SOL EA, V103, P577, DOI 10.1029/97JB02784; Ruff SW, 2004, ICARUS, V168, P131, DOI 10.1016/j.icarus.2003.11.003; Smith M.R., UNPUB; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Wyatt MB, 2001, J GEOPHYS RES-PLANET, V106, P14711, DOI 10.1029/2000JE001356	26	139	141	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					837	842		10.1126/science.1100564	http://dx.doi.org/10.1126/science.1100564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297667				2022-12-28	WOS:000223104900040
J	Parham, P				Parham, P			NK cells lose their inhibition	SCIENCE			English	Editorial Material							HEPATITIS-C VIRUS; NATURAL-KILLER-CELLS; ENVELOPE PROTEIN; RECEPTORS; BINDING; CD81		Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Parham, P (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	peropa@stanford.edu						Cohen J, 1999, SCIENCE, V285, P26, DOI 10.1126/science.285.5424.26; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Crotta S, 2002, J EXP MED, V195, P35, DOI 10.1084/jem.20011124; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Racanelli V, 2003, TRENDS IMMUNOL, V24, P456, DOI 10.1016/S1471-4906(03)00178-9; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Simmonds P, 2001, PHILOS T R SOC B, V356, P1013, DOI 10.1098/rstb.2001.0890; Snyder MR, 2004, TRENDS IMMUNOL, V25, P25, DOI 10.1016/j.it.2003.10.011; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; *WHO, 1997, WKLY EPIDEMIOL REC, V72, P341; Winter CC, 1998, J IMMUNOL, V161, P571	14	42	44	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					786	787		10.1126/science.1102025	http://dx.doi.org/10.1126/science.1102025			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297654				2022-12-28	WOS:000223104900028
J	Muller, DA; Nakagawa, N; Ohtomo, A; Grazul, JL; Hwang, HY				Muller, DA; Nakagawa, N; Ohtomo, A; Grazul, JL; Hwang, HY			Atomic-scale imaging of nanoengineered oxygen vacancy profiles in SrTiO3	NATURE			English	Article							INDIVIDUAL DOPANT ATOMS; ELECTRONIC-STRUCTURE; SCATTERING; GROWTH; TC	At the heart of modern oxide chemistry lies the recognition that beneficial ( as well as deleterious) materials properties can be obtained by deliberate deviations of oxygen atom occupancy from the ideal stoichiometry(1,2). Conversely, the capability to control and confine oxygen vacancies will be important to realize the full potential of perovskite ferroelectric materials, varistors and field-effect devices(3,4). In transition metal oxides, oxygen vacancies are generally electron donors, and in strontium titanate (SrTiO3) thin films, oxygen vacancies ( unlike impurity dopants) are particularly important because they tend to retain high carrier mobilities, even at high carrier densities(5). Here we report the successful fabrication, using a pulsed laser deposition technique, of SrTiO3 superlattice films with oxygen doping profiles that exhibit subnanometre abruptness. We profile the vacancy concentrations on an atomic scale using annular-dark-field electron microscopy and core-level spectroscopy, and demonstrate absolute detection sensitivities of one to four oxygen vacancies. Our findings open a pathway to the microscopic study of individual vacancies and their clustering, not only in oxides, but in crystalline materials more generally.	Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA; Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14583 USA; Univ Tokyo, Dept Adv Mat Sci, Chiba 2778561, Japan; Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; Japan Sci & Technol Agcy, Kawaguchi 3320012, Japan	Alcatel-Lucent; Lucent Technologies; AT&T; Cornell University; University of Tokyo; Tohoku University; Japan Science & Technology Agency (JST)	Muller, DA (corresponding author), Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA.	davidm@ccmr.cornell.edu	Muller, David/A-7745-2010; Hwang, Harold Y/I-6943-2012; Ohtomo, Akira/C-4944-2008	Muller, David/0000-0003-4129-0473; Ohtomo, Akira/0000-0003-0300-4712				ABBATE M, 1991, PHYS REV B, V44, P5419, DOI 10.1103/PhysRevB.44.5419; Ahn CH, 2003, NATURE, V424, P1015, DOI 10.1038/nature01878; BATSON PE, 1993, NATURE, V366, P727, DOI 10.1038/366727a0; Browning ND, 1998, PHYS REV B, V58, P8289, DOI 10.1103/PhysRevB.58.8289; BROWNING ND, 1993, NATURE, V366, P143, DOI 10.1038/366143a0; Burgy J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.277202; Egerton R.F., 2011, ELECT ENERGY LOSS SP; GONG WH, 1991, J SOLID STATE CHEM, V90, P320, DOI 10.1016/0022-4596(91)90149-C; GREUTER F, 1990, SEMICOND SCI TECH, V5, P111, DOI 10.1088/0268-1242/5/2/001; HILLYARD S, 1995, ULTRAMICROSCOPY, V58, P6, DOI 10.1016/0304-3991(94)00173-K; HOWIE A, 1979, J MICROSC-OXFORD, V117, P11, DOI 10.1111/j.1365-2818.1979.tb00228.x; Jia CL, 2003, SCIENCE, V299, P870, DOI 10.1126/science.1079121; Kaiser U, 2002, NAT MATER, V1, P102, DOI 10.1038/nmat729; KIRKLAND EJ, 1987, ULTRAMICROSCOPY, V23, P77, DOI 10.1016/0304-3991(87)90229-4; MAJEWSKI P, 1994, ADV MATER, V6, P460, DOI 10.1002/adma.19940060604; Muller DA, 1999, NATURE, V399, P758, DOI 10.1038/21602; Muller DA, 2001, J ELECTRON MICROSC, V50, P219, DOI 10.1093/jmicro/50.3.219; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; Ohtomo A, 2002, APPL PHYS LETT, V80, P3922, DOI 10.1063/1.1481767; Pellegrino L, 2002, APPL PHYS LETT, V81, P3849, DOI 10.1063/1.1521583; PEROVIC DD, 1993, ULTRAMICROSCOPY, V52, P353, DOI 10.1016/0304-3991(93)90046-Z; SHIMAKAWA Y, 1989, PHYS REV B, V40, P11400, DOI 10.1103/PhysRevB.40.11400; SZE SM, 1986, SEMICONDUCTOR DEVICE; Szot K, 1999, PHYS REV B, V60, P5909, DOI 10.1103/PhysRevB.60.5909; Szot K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.075508; TUFTE ON, 1967, PHYS REV, V155, P796, DOI 10.1103/PhysRev.155.796; Voyles PM, 2004, MICROSC MICROANAL, V10, P291, DOI 10.1017/S1431927604040012; Voyles PM, 2002, NATURE, V416, P826, DOI 10.1038/416826a; YAMADA H, 1973, J SOLID STATE CHEM, V6, P169, DOI 10.1016/0022-4596(73)90216-8; Zhang ZL, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.094108	30	501	509	11	544	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					657	661		10.1038/nature02756	http://dx.doi.org/10.1038/nature02756			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295595				2022-12-28	WOS:000223085400040
J	Palmer, BF				Palmer, BF			Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CONVERTING-ENZYME-INHIBITORS; HEART-FAILURE; SELECTIVE ALDOSTERONE; RECEPTOR BLOCKER; RENAL-TRANSPLANT; RANDOMIZED TRIAL; COMBINED THERAPY; ACE-INHIBITORS; POTASSIUM; SPIRONOLACTONE		Univ Texas, SW Med Sch, Dept Med, Div Nephrol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Palmer, BF (corresponding author), Univ Texas, SW Med Sch, Dept Med, Div Nephrol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	biff.palmer@utsouthwestern.edu						Abraham SC, 2001, AM J SURG PATHOL, V25, P637, DOI 10.1097/00000478-200105000-00011; Acker CG, 1998, ARCH INTERN MED, V158, P917, DOI 10.1001/archinte.158.8.917; Ahuja TS, 2000, AM J NEPHROL, V20, P268, DOI 10.1159/000013599; ARRUDA JAL, 1981, AM J NEPHROL, V1, P160, DOI 10.1159/000166533; Bozkurt B, 2003, J AM COLL CARDIOL, V41, P211, DOI 10.1016/S0735-1097(02)02694-3; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; CAMPBELL WB, 1979, J CLIN INVEST, V64, P1552, DOI 10.1172/JCI109615; CASTELLINO P, 1987, AM J PHYSIOL, V252, pE68, DOI 10.1152/ajpendo.1987.252.1.E68; Cheng TO, 2000, ARCH INTERN MED, V160, P870, DOI 10.1001/archinte.160.6.870; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Cruz CS, 2003, NEPHROL DIAL TRANSPL, V18, P1814, DOI 10.1093/ndt/gfg295; Dardik A, 2000, SOUTH MED J, V93, P511; DEFRONZO RA, 1980, KIDNEY INT, V17, P118, DOI 10.1038/ki.1980.14; Georges B, 2000, LANCET, V355, P1369, DOI 10.1016/S0140-6736(05)72606-4; Hay E, 2002, J EMERG MED, V22, P349, DOI 10.1016/S0736-4679(02)00434-1; *HOPE, 2000, NEW ENGL J MED, V342, P748; *HOPE, 2000, NEW ENGL J MED, V342, P1376; Hostetter TH, 2003, J AM SOC NEPHROL, V14, P2395, DOI 10.1097/01.ASN.0000086472.65806.73; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; KAMEL KS, 1992, J AM SOC NEPHROL, V2, P1279; Kaplan B, 1996, TRANSPLANTATION, V62, P1174, DOI 10.1097/00007890-199610270-00025; Keilani T, 1999, AM J KIDNEY DIS, V33, P450, DOI 10.1016/S0272-6386(99)70181-2; KLEYMAN TR, 1995, ANN INTERN MED, V122, P103, DOI 10.7326/0003-4819-122-2-199501150-00004; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lin J, 2002, TRANSPLANTATION, V73, P783, DOI 10.1097/00007890-200203150-00022; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; McCauley J, 2002, AM J NEPHROL, V22, P347, DOI 10.1159/000065225; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; Miller LG, 1998, ARCH INTERN MED, V158, P2200, DOI 10.1001/archinte.158.20.2200; Mueller BA, 2000, AM J KIDNEY DIS, V35, P310, DOI 10.1016/S0272-6386(00)70342-8; Nakao N, 2003, LANCET, V361, P1230; Nakao N, 2003, LANCET, V361, P117, DOI 10.1016/S0140-6736(03)12229-5; OSTER JR, 1995, AM J MED, V98, P575, DOI 10.1016/S0002-9343(99)80017-5; Palmer BF, 1995, J INVEST MED, V43, P516; Palmer BF, 2002, NEW ENGL J MED, V347, P1256, DOI 10.1056/NEJMra020676; PALMER BF, 1996, BRENNER RECTORS KIDN, P2274; Pantanowitz L, 2002, AM J MED, V112, P334, DOI 10.1016/S0002-9343(01)00688-X; Perazella M A, 1997, Am J Ther, V4, P343, DOI 10.1097/00045391-199709000-00010; Perazella MA, 2000, AM J MED, V109, P307, DOI 10.1016/S0002-9343(00)00496-4; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; PRATT JH, 1989, ENDOCRINOLOGY, V125, P2463, DOI 10.1210/endo-125-5-2463; Ray KK, 1999, J HUM HYPERTENS, V13, P717, DOI 10.1038/sj.jhh.1000890; Reardon LC, 1998, ARCH INTERN MED, V158, P26, DOI 10.1001/archinte.158.1.26; RIMMER JM, 1987, ARCH INTERN MED, V147, P867, DOI 10.1001/archinte.147.5.867; Schepkens H, 2001, AM J MED, V110, P438, DOI 10.1016/S0002-9343(01)00642-8; SHIER DN, 1989, ENDOCRINOLOGY, V125, P486, DOI 10.1210/endo-125-1-486; Shlipak MG, 2003, ANN INTERN MED, V138, P917, DOI 10.7326/0003-4819-138-11-200306030-00013; Wilmer WA, 2003, J AM SOC NEPHROL, V14, P3217, DOI 10.1097/01.ASN.0000100145.27188.33; YOUNG DB, 1984, AM J PHYSIOL, V247, pE328, DOI 10.1152/ajpendo.1984.247.3.E328; Yusuf S, 2000, NEW ENGL J MED, V342, P145; ZIMRAN A, 1985, BRIT MED J, V291, P107, DOI 10.1136/bmj.291.6488.107; 1995, MMWR MORB MORTAL WKL, V44, P861; 2002, AM J KIDNEY DIS S1, V39, pS76; 1995, MMWR MORB MORTAL WKL, V44, P853	59	404	504	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					585	592		10.1056/NEJMra035279	http://dx.doi.org/10.1056/NEJMra035279			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295051				2022-12-28	WOS:000223069900011
J	Hippisley-Cox, J; Pringle, M				Hippisley-Cox, J; Pringle, M			Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: cross sectional survey	LANCET			English	Article							MICROVASCULAR COMPLICATIONS; BLOOD-PRESSURE; TYPE-2; ASSOCIATION; POPULATION; MELLITUS; DISEASE; ADULTS	Background Tight glycaemic control reduces microvascular complications in patients with type 1 and type 2 diabetes. We aimed to establish the proportion with type 2 diabetes treated through diet only and to determine levels of complications and quality of care received compared with patients on hypoglycaemic medication. Methods We undertook a cross-sectional study of 7870 patients with type 2 diabetes from a population of 253 618 patients from 42 general practices in the UK. Our primary outcome was process of care measures and diabetes-related complications. Findings 31.3% of all patients with type 2 diabetes are being managed with diet only (1% of the total population). More than four-fold variation between practices exists (range 15.6-73.2%). Patients treated with diet only are much less likely to have HbA(1c) (glycosylated haemoglobin) measurements, blood pressure, cholesterol, smoking, microalbuminuria testing, or screening for foot pulses recorded. 38.4% of patients with type 2 diabetes on medication have a HbA(1c) above 7.5% compared with 17.3% of those treated with diet only. Compared with those on medication, patients treated by diet only are more likely to have raised blood pressure and less likely to be on antihypertensive medication; they are 45% more likely to have raised cholesterol and less likely to be prescribed lipid-lowering medication. Although fewer of those treated by diet (68%) have diabetes-related complications compared with those on medication (80%), the rate is much higher than for the population without diabetes. Interpretation Diabetics treated by diet only. have significant rates of complications and are less likely than those on medication to be adequately monitored. There is great scope for improved management within general practice.	Div Gen Practice, Nottingham NG7 2RD, England		Hippisley-Cox, J (corresponding author), Div Gen Practice, Tower Bldg Univ Pk, Nottingham NG7 2RD, England.	julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283				Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Connolly V, 2000, J EPIDEMIOL COMMUN H, V54, P173, DOI 10.1136/jech.54.3.173; Cooper ME, 2000, JAMA-J AM MED ASSOC, V283, P3177, DOI 10.1001/jama.283.24.3177; *DCCT RES GROUP, 1993, NEW ENGL J MED, V329, P978; Department of Health, 2003, NAT SERV FRAM DIAB D; Egede LE, 2002, ARCH INTERN MED, V162, P427, DOI 10.1001/archinte.162.4.427; Goyder E, 2003, BRIT J GEN PRACT, V53, P642; Goyder EC, 1998, BRIT MED J, V316, P1505, DOI 10.1136/bmj.316.7143.1505; Gray A, 2002, BRIT MED J, V325, P860, DOI 10.1136/bmj.325.7369.860; Gray J, 2003, BRIT MED J, V326, P1130, DOI 10.1136/bmj.326.7399.1130; Guthrie B, 2003, BRIT J GEN PRACT, V53, P709; Hammersley V, 2002, BRIT J GEN PRACT, V52, P463; Hippisley-Cox J, 2003, BRIT MED J, V326, P1439, DOI 10.1136/bmj.326.7404.1439; Khunti K, 2001, BRIT J GEN PRACT, V51, P583; KLIMT CR, 1970, DIABETES, V19, P747; KO GTC, 1995, BRIT J HOSP MED, V54, P469; Nathan DM, 1998, LANCET, V352, P832, DOI 10.1016/S0140-6736(98)22937-0; *NHS CONF, 2003, NEW GMS CONTR, P108; *NHSIA, 2003, PREF TERMS PRIM CAR, P38; *NICE, 2003, GUID US GLIT TREATM, P22; *OFF NAT STAT, 2000, KEY HLTH STAT GEN PR; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Roper NA, 2001, BRIT MED J, V322, P1389, DOI 10.1136/bmj.322.7299.1389; Stovring H, 2003, LANCET, V362, P537, DOI 10.1016/S0140-6736(03)14116-5; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; United Kingdom Prospective Diabetes Study (UKPDS), 1995, BMJ-BRIT MED J, V310, P83, DOI DOI 10.1136/BMJ.310.6972.83; Wills CJ, 2003, BRIT MED J, V327, P260, DOI 10.1136/bmj.327.7409.260	30	75	76	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					423	428		10.1016/S0140-6736(04)16765-2	http://dx.doi.org/10.1016/S0140-6736(04)16765-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288740				2022-12-28	WOS:000222998600032
J	Wald, DS				Wald, DS			Bureaucracy of ethics applications	BRITISH MEDICAL JOURNAL			English	Article								One research group decided to determine exactly how much effort is required to get ethical approval by recording the submission of its first application under the new UK system.	Wolfson Inst Prevent Med, London EC1M 6BQ, England	University of London; Queen Mary University London	Wald, DS (corresponding author), Wolfson Inst Prevent Med, London EC1M 6BQ, England.	d.s.wald@qmul.ac.uk							0	64	64	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 31	2004	329	7460					282	284		10.1136/bmj.329.7460.282	http://dx.doi.org/10.1136/bmj.329.7460.282			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284157	Green Published			2022-12-28	WOS:000223133300026
J	Fine, PVA; Mesones, I; Coley, PD				Fine, PVA; Mesones, I; Coley, PD			Herbivores promote habitat specialization by trees in amazonian forests	SCIENCE			English	Article							RAIN-FOREST; RECRUITMENT; VEGETATION; DIVERSITY; PATTERNS; STRESS; SHRUB	In an edaphically heterogeneous area in the Peruvian Amazon, clay soils and nutrient-poor white sands each harbor distinctive plant communities. To determine whether a trade-off between growth and antiherbivore defense enforces habitat specialization on these two soil types, we conducted a reciprocal transplant study of seedlings of 20 species from six genera of phylogenetically independent pairs of edaphic specialist trees and manipulated the presence of herbivores. Clay specialist species grew significantly faster than white-sand specialists in both soil types when protected from herbivores. However, when unprotected, white-sand specialists dominated in white-sand forests and clay specialists dominated in clay forests. Therefore, habitat specialization in this system results from an interaction of herbivore pressure with soil type.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Field Museum Nat Hist, Environm Program, Chicago, IL 60605 USA; Field Museum Nat Hist, Conservat Program, Chicago, IL 60605 USA; Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA; Univ Nacl Amazonia Peruana, Dept Forestry, Iquitos, Peru	Utah System of Higher Education; University of Utah; Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago); Universidad Nacional de la Amazonia Peruana	Fine, PVA (corresponding author), Univ Utah, Dept Biol, 257 S 1400 East, Salt Lake City, UT 84112 USA.	fine@biology.utah.edu		Fine, Paul/0000-0002-0550-5628				CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Cobb NS, 1997, OECOLOGIA, V109, P389, DOI 10.1007/s004420050098; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Coomes DA, 1996, VEGETATIO, V122, P167, DOI 10.1007/BF00044699; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; Endler J.A., 1977, Monographs in Population Biology, pi; FINE PVA, UNPUB; GARCIAVILLACORT.R, 2002, FOLIA AMAZONICA, V14, P11; Gentry A.H., 1986, CONSERVATION BIOL SC, P153; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Harley CDG, 2003, ECOLOGY, V84, P1477, DOI 10.1890/0012-9658(2003)084[1477:ASAHIT]2.0.CO;2; Harper J. L., 1977, Population biology of plants.; JANZEN D H, 1974, Biotropica, V6, P69, DOI 10.2307/2989823; Jorgensen P. M., 1999, CATALOGUE VASCULAR P; King RT, 2003, BIOTROPICA, V35, P462, DOI 10.1111/j.1744-7429.2003.tb00603.x; Louda S. M., 1990, Perspectives on plant competition., P413; Louda SM, 1996, J ECOL, V84, P229, DOI 10.2307/2261358; LOUDA SM, 1983, ECOLOGY, V64, P511, DOI 10.2307/1939971; LOUDA SM, 1982, ECOL MONOGR, V52, P25, DOI 10.2307/2937343; Mark AF, 2001, AUSTRAL ECOL, V26, P423, DOI 10.1046/j.1442-9993.2001.01127.x; MCKEY D, 1978, SCIENCE, V202, P61; Medina E., 1989, Mineral nutrients in tropical forest and savanna ecosystems., P217; Moran JA, 2000, BIOTROPICA, V32, P2, DOI 10.1111/j.1744-7429.2000.tb00442.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; PARKER MA, 1981, ECOLOGY, V62, P1390, DOI 10.2307/1937302; Proctor John, 1999, Botanical Journal of Scotland, V51, P1; Ruokolainen K, 1997, J TROP ECOL, V13, P243, DOI 10.1017/S0266467400010439; Ruokolainen K., 1998, GEOECOLOGIA DESARROL, P253; Sollins P, 1998, ECOLOGY, V79, P23, DOI 10.1890/0012-9658(1998)079[0023:FISCIT]2.0.CO;2; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Vasquez R, 1997, FLORULA RESERVAS BIO; YOUNG KR, 1989, BRITTONIA, V41, P388, DOI 10.2307/2807552	38	393	409	5	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					663	665		10.1126/science.1098982	http://dx.doi.org/10.1126/science.1098982			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286371				2022-12-28	WOS:000222992100046
J	Gnos, E; Hofmann, BA; Al-Kathiri, A; Lorenzetti, S; Eugster, O; Whitehouse, MJ; Villa, IM; Jull, AJT; Eikenberg, J; Spettel, B; Krahenbuhl, U; Franchi, IA; Greenwood, RC				Gnos, E; Hofmann, BA; Al-Kathiri, A; Lorenzetti, S; Eugster, O; Whitehouse, MJ; Villa, IM; Jull, AJT; Eikenberg, J; Spettel, B; Krahenbuhl, U; Franchi, IA; Greenwood, RC			Pinpointing the source of a lunar meteorite: Implications for the evolution of the moon	SCIENCE			English	Article							PROCELLARUM KREEP TERRANE; IMPACT-MELT BRECCIAS; ABSOLUTE AGES; SURFACE	The lunar meteorite Sayh al Uhaymir 169 consists of an impact melt breccia extremely enriched with potassium, rare earth elements, and phosphorus [thorium, 32.7 parts per million (ppm); uranium, 8.6 ppm; potassium oxide, 0.54 weight percent], and adherent regolith. The isotope systematics of the meteorite record four lunar impact events at 3909 +/- 13 million years ago (Ma), similar to 2800 Ma, similar to 200 Ma, and < 0.34 Ma, and collision with Earth sometime after 9.7 &PLUSMN; 1.3 thousand years ago. With these data, we can link the impact-melt breccia to Imbrium and pinpoint the source region of the meteorite to the Lalande impact crater.	Univ Bern, Inst Geol, CH-3012 Bern, Switzerland; Nat Hist Museum Burgergemeinde Bern, CH-3005 Bern, Switzerland; Univ Bern, Inst Phys, Abt Weltraumforsch & Planetol, CH-3012 Bern, Switzerland; Swedish Museum Nat Hist, Lab Isotope Geol, SE-10405 Stockholm, Sweden; Univ Arizona, Natl Sci Fdn, Arizona Accelerator Mass Spectrometry Lab, Tucson, AZ 85721 USA; Paul Scherrer Inst, CH-5232 Villigen, Switzerland; Max Planck Inst Chem, Abt Kosmochem, D-55020 Mainz, Germany; Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England	University of Bern; University of Bern; Swedish Museum of Natural History; National Science Foundation (NSF); University of Arizona; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Max Planck Society; University of Bern; Open University - UK	Gnos, E (corresponding author), Univ Bern, Inst Geol, Baltzerstr 1, CH-3012 Bern, Switzerland.	gnos@geo.unibe.ch	Gnos, Edwin/AAI-7477-2020; Whitehouse, Martin J/E-1425-2013; Lorenzetti, Silvio Rene/B-1188-2009	Gnos, Edwin/0000-0003-0940-8435; Whitehouse, Martin J/0000-0003-2227-577X; Lorenzetti, Silvio Rene/0000-0002-8339-8960; Greenwood, Richard/0000-0002-5544-8027; Hofmann, Beda/0000-0003-2738-8466				BALDWIN RB, 1985, ICARUS, V61, P63, DOI 10.1016/0019-1035(85)90156-3; BALDWIN RB, 1987, ICARUS, V71, P19, DOI 10.1016/0019-1035(87)90159-X; Cohen BA, 2000, SCIENCE, V290, P1754, DOI 10.1126/science.290.5497.1754; Dalrymple GB, 1996, J GEOPHYS RES-PLANET, V101, P26069, DOI 10.1029/96JE02806; ELPHIC RC, 2002, J GEOPHYS RES, V107, pE4; EUGSTER O, 1995, GEOCHIM COSMOCHIM AC, V59, P177, DOI 10.1016/0016-7037(94)00327-I; Feldman M., 2001, NATL IDENTITIES, V3, P5; Haskin LA, 2000, J GEOPHYS RES-PLANET, V105, P20403, DOI 10.1029/1999JE001128; Heiken G., 1991, LUNAR SOURCE BOOK US; HOHENBERG CM, 1978, P LUNAR PLANET SCI C, V9, P2311; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Jolliff BL, 1998, INT GEOL REV, V40, P916, DOI 10.1080/00206819809465245; Korotev RL, 2000, J GEOPHYS RES-PLANET, V105, P4317, DOI 10.1029/1999JE001063; Lawrence DJ, 1999, GEOPHYS RES LETT, V26, P2681, DOI 10.1029/1999GL008361; METZGER AE, 1973, SCIENCE, V179, P800, DOI 10.1126/science.179.4075.800; Min KW, 2000, GEOCHIM COSMOCHIM AC, V64, P73, DOI 10.1016/S0016-7037(99)00204-5; Russell SS, 2003, METEORIT PLANET SCI, V38, pA189, DOI 10.1111/j.1945-5100.2003.tb00328.x; Stoffler D, 2001, SPACE SCI REV, V96, P9, DOI 10.1023/A:1011937020193; TUNIZ C, 1983, GEOPHYS RES LETT, V10, P804, DOI 10.1029/GL010i009p00804; WARREN PH, 1994, ICARUS, V111, P338, DOI 10.1006/icar.1994.1149; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Wieczorek MA, 2000, J GEOPHYS RES-PLANET, V105, P20417, DOI 10.1029/1999JE001092; Wilhelms D. E., 1987, US GEOL SURV PROF PA, V1348, P1	23	120	128	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2004	305	5684					657	659		10.1126/science.1099397	http://dx.doi.org/10.1126/science.1099397			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286369				2022-12-28	WOS:000222992100044
J	Ma, E				Ma, E			Watching the nanograins roll	SCIENCE			English	Editorial Material							DEFORMATION; STRAIN		Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Ma, E (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	ema@jhu.edu	Ma, En/A-3232-2010					Budrovic Z, 2004, SCIENCE, V304, P273, DOI 10.1126/science.1095071; Chen MW, 2003, SCIENCE, V300, P1275, DOI 10.1126/science.1083727; Cheng S, 2003, ACTA MATER, V51, P4505, DOI 10.1016/S1359-6454(03)00286-6; Derlet PM, 2002, PHILOS MAG A, V82, P1, DOI 10.1080/01418610110058310; Hugo RC, 2003, ACTA MATER, V51, P1937, DOI 10.1016/S1359-6454(02)00599-2; KE M, 1995, NANOSTRUCT MATER, V5, P689, DOI 10.1016/0965-9773(95)00281-I; Knapp JA, 2004, J MATER RES, V19, P218, DOI 10.1557/jmr.2004.19.1.218; Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/j.actamat.2003.08.032; Liao XZ, 2004, APPL PHYS LETT, V84, P592, DOI 10.1063/1.1644051; Rosner H, 2004, PHIL MAG LETT, V84, P321, DOI 10.1080/09500830410001675687; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Shan ZW, 2004, SCIENCE, V305, P654, DOI 10.1126/science.1098741; Van Swygenhoven H, 2004, NAT MATER, V3, P399, DOI 10.1038/nmat1136; Wang YM, 2002, NATURE, V419, P912, DOI 10.1038/nature01133	14	89	92	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					623	624		10.1126/science.1101589	http://dx.doi.org/10.1126/science.1101589			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286355				2022-12-28	WOS:000222992100028
J	Short, RV				Short, RV			Teaching safe sex in English schools	LANCET			English	Editorial Material									Univ Melbourne, Dept Obstet & Gynaecol, Carlton, Vic 3053, Australia	University of Melbourne	Short, RV (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Carlton, Vic 3053, Australia.	r.short@unimelb.edu.au						Bankole A, 1999, INT FAM PLAN PERSPEC, V25, P68, DOI 10.2307/2991944; Doppenberg H, 1993, BR J FAMILY PLANNING, V18, P123; Gao Y, 2001, REPROD FERT DEVELOP, V13, P729, DOI 10.1071/RD01082; Short RV, 2000, AUST NZ J OBSTET GYN, V40, P7, DOI 10.1111/j.1479-828X.2000.tb03158.x; *SOC ED UN DEP HLT, 1999, TEEN PREGN; WELLINGTS K, 1994, SEXUAL BEHAV BRITAIN	6	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 24	2004	364	9431					307	308		10.1016/S0140-6736(04)16735-4	http://dx.doi.org/10.1016/S0140-6736(04)16735-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840IZ	15276369				2022-12-28	WOS:000222853300004
J	Newsome, TP; Scaplehorn, N; Way, M				Newsome, TP; Scaplehorn, N; Way, M			Src mediates a switch from microtubule- to actin-based motility of vaccinia virus	SCIENCE			English	Article							INTRACELLULAR ENVELOPED VIRIONS; FUNCTIONAL-ANALYSIS; N-WASP; MOVEMENT; PROTEIN; TRANSPORT; DOMAINS; A33R	The cascade of events that leads to vaccinia-induced actin polymerization requires Src-dependent tyrosine phosphorylation of the viral membrane protein A36R. We found that a localized outside-in signaling cascade induced by the viral membrane protein B5R is required to potently activate Src and induce A36R phosphorylation at the plasma membrane. In addition, Src-mediated phosphorylation of A36R regulated the ability of virus particles to recruit and release conventional kinesin. Thus, Src activity regulates the transition between cytoplasmic microtubule transport and actin-based motility at the plasma membrane.	Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Cell Motil Lab, London WC2A 3PX, England	Cancer Research UK	Way, M (corresponding author), Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Cell Motil Lab, Room 529,44 Lincolns Inn Fields, London WC2A 3PX, England.	michael.way@cancer.org.uk	Newsome, Timothy P/AAB-4033-2019	Newsome, Timothy P/0000-0002-2193-596X; Scaplehorn, Niki/0000-0001-9451-8748; Way, Michael/0000-0001-7207-2722				Cudmore S, 1996, J CELL SCI, V109, P1739; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Geada MM, 2001, J GEN VIROL, V82, P2747, DOI 10.1099/0022-1317-82-11-2747; Herrera E, 1998, J VIROL, V72, P294, DOI 10.1128/JVI.72.1.294-302.1998; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Katz E, 2003, J VIROL, V77, P12266, DOI 10.1128/JVI.77.22.12266-12275.2003; Mathew E, 1998, J VIROL, V72, P2429, DOI 10.1128/JVI.72.3.2429-2438.1998; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Scaplehorn N, 2002, CURR BIOL, V12, P740, DOI 10.1016/S0960-9822(02)00812-6; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van Eijl H, 2000, VIROLOGY, V271, P26, DOI 10.1006/viro.2000.0260; Ward BM, 2004, J VIROL, V78, P2486, DOI 10.1128/JVI.78.5.2486-2493.2004; Ward BM, 2003, J VIROL, V77, P4113, DOI 10.1128/JVI.77.7.4113-4126.2003; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001; Ward BM, 2001, J VIROL, V75, P4802, DOI 10.1128/JVI.75.10.4802-4813.2001; Zettl M, 2002, CURR BIOL, V12, P1617, DOI 10.1016/S0960-9822(02)01112-0	24	124	131	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					124	129		10.1126/science.1101509	http://dx.doi.org/10.1126/science.1101509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15297625				2022-12-28	WOS:000224304000052
J	Um, SH; Frigerio, F; Watanabe, M; Picard, F; Joaquin, M; Sticker, M; Fumagalli, S; Allegrini, PR; Kozma, SC; Auwerx, J; Thomas, G				Um, SH; Frigerio, F; Watanabe, M; Picard, F; Joaquin, M; Sticker, M; Fumagalli, S; Allegrini, PR; Kozma, SC; Auwerx, J; Thomas, G			Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity	NATURE			English	Article							SKELETAL-MUSCLE; RECEPTOR SUBSTRATE-1; AMINO-ACID; CELL SIZE; RESISTANCE; PHOSPHORYLATION; KINASE; GENES; ACTIVATION; GLUCOSE	Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabetes(1). Recently, mice deficient for S6 Kinase 1 (S6K1), an effector of the mammalian target of rapamycin (mTOR) that acts to integrate nutrient and insulin signals(2), were shown to be hypoinsulinaemic, glucose intolerant and have reduced beta-cell mass(3). However, S6K1-deficient mice maintain normal glucose levels during fasting, suggesting hypersensitivity to insulin(3), raising the question of their metabolic fate as a function of age and diet. Here, we report that S6K1-deficient mice are protected against obesity owing to enhanced beta-oxidation. However on a high fat diet, levels of glucose and free fatty acids still rise in S6K1-deficient mice, resulting in insulin receptor desensitization. Nevertheless, S6K1-deficient mice remain sensitive to insulin owing to the apparent loss of a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1), which blunts S307 and S636/S639 phosphorylation; sites involved in insulin resistance(4,5). Moreover, wild-type mice on a high fat diet as well as K/K A(y) and ob/ob (also known as Lep/Lep) mice-two genetic models of obesity-have markedly elevated S6K1 activity and, unlike S6K1-deficient mice, increased phosphorylation of IRS1 S307 and S636/S639. Thus under conditions of nutrient satiation S6K1 negatively regulates insulin signalling.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Genopole Strasbourg, Inst Clin Souris, F-67404 Illkirch Graffenstaden, France; Novartis Pharma AG, CH-4057 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Novartis	Thomas, G (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	gthomas@fmi.ch	Thomas, George/K-9235-2014; Joaquin, Manel/E-2216-2015; Auwerx, Johan/ABE-9307-2021; Joaquin, Manel/O-6533-2019; FUMAGALLI, Stefano/C-2914-2019	Thomas, George/0000-0003-3518-8149; Joaquin, Manel/0000-0001-8973-5916; Joaquin, Manel/0000-0001-8973-5916; Auwerx, Johan/0000-0002-5065-5393; Fumagalli, Stefano/0000-0001-5832-8680				Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Doty FD, 1999, J MAGN RESON, V138, P144, DOI 10.1006/jmre.1998.1703; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Greiwe JS, 2001, AM J PHYSIOL-ENDOC M, V281, pE466, DOI 10.1152/ajpendo.2001.281.3.E466; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; IWATSUKA H, 1970, ENDOCRINOL JAPON, V17, P23; Jiang GQ, 2002, FRONT BIOSCI-LANDMRK, V7, pD904; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Le Marchand-Brustel Y, 2003, BIOCHEM SOC T, V31, P1152; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; MARETTE A, 1991, INT J OBESITY, V15, P823; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Patti ME, 1999, ANN NY ACAD SCI, V892, P187, DOI 10.1111/j.1749-6632.1999.tb07796.x; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Proietto J, 1999, MOL CELL ENDOCRINOL, V151, P143, DOI 10.1016/S0303-7207(99)00050-7; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Tremblay F, 2001, J BIOL CHEM, V276, P38052; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)02129-8	30	1310	1373	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					200	205		10.1038/nature02866	http://dx.doi.org/10.1038/nature02866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15306821				2022-12-28	WOS:000223746000048
J	Little, MP; Blettner, M; Boice, JD; Bridges, BA; Cardis, E; Charles, MW; de Vathaire, F; Doll, R; Fujimoto, K; Goodhead, D; Grosche, B; Hall, P; Heidenreich, WF; Jacob, P; Moolgovkar, SH; Muirhead, CR; Niwa, O; Paretzke, HG; Richardson, RB; Samet, JM; Sasaki, Y; Shore, RE; Straume, T; Wakeford, R				Little, MP; Blettner, M; Boice, JD; Bridges, BA; Cardis, E; Charles, MW; de Vathaire, F; Doll, R; Fujimoto, K; Goodhead, D; Grosche, B; Hall, P; Heidenreich, WF; Jacob, P; Moolgovkar, SH; Muirhead, CR; Niwa, O; Paretzke, HG; Richardson, RB; Samet, JM; Sasaki, Y; Shore, RE; Straume, T; Wakeford, R			Potential funding crisis for the Radiation Effects Research Foundation	LANCET			English	Editorial Material							ATOMIC-BOMB SURVIVORS; NONCANCER DISEASE INCIDENCE; CANCER		Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England	Imperial College London	Little, MP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England.	mark.little@imperial.ac.uk	Cardis, Elisabeth/C-3904-2017; de Vathaire, Florent/L-2983-2016; Wakeford, Richard/I-1978-2019	Cardis, Elisabeth/0000-0003-0999-6839; Wakeford, Richard/0000-0002-2934-0987; Shore, Roy/0000-0002-6842-2248; Muirhead, Colin/0000-0001-5394-1267; Little, Mark/0000-0003-0980-7567; de Vathaire, Florent/0000-0002-8374-9281; Grosche, Bernd/0000-0003-2024-3555				Adelstein SJ, 2004, RADIAT RES, V161, P621, DOI 10.1667/0033-7587(2004)161[0621:ASMADM]2.0.CO;2; CULLINGS HM, 2003, RERF UPDATE, V14, P17; HYUBER T, 2003, RADIAT ENVIRON BIOPH, V42, P27; ICRP, 1991, ANN ICRP, V21, P1; Malakoff D, 2004, SCIENCE, V304, P33; Pierce DA, 2000, RADIAT RES, V154, P178, DOI 10.1667/0033-7587(2000)154[0178:RRCRAL]2.0.CO;2; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Preston DL, 1994, RADIAT RES, V137, P68; ROESSLER G, 2003, HLTH PHYS NEWS, V31, P4; Straume T, 2003, NATURE, V424, P539, DOI 10.1038/nature01815; THOMPSON DE, 1994, RAD RES S, V137, P17; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2000, SOURC EFF ION RAD, VII; *US NAT AC SCI, 1990, HLTH EFF EXP LOW LEV; WONG FL, 1993, RADIAT RES, V135, P418, DOI 10.2307/3578884; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183; 2004, JAPAN TIMES     0403	16	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					557	558		10.1016/S0140-6736(04)16861-X	http://dx.doi.org/10.1016/S0140-6736(04)16861-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313337				2022-12-28	WOS:000223275100003
J	Fricchione, G				Fricchione, G			Generalized anxiety disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; LONG-TERM TREATMENT; PRIMARY-CARE; DOUBLE-BLIND; FOLLOW-UP; PLACEBO; PREVALENCE; PAROXETINE; EFFICACY; ANTIDEPRESSANTS		Massachusetts Gen Hosp, Div Psychiat & Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Fricchione, G (corresponding author), Massachusetts Gen Hosp, Div Psychiat & Med, Warren 6,55 Fruit St, Boston, MA 02114 USA.	gfricchione@partners.org						*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P435, DOI DOI 10.1176/APPI.BOOKS.9780890425596.DSM07; Borkovec TD, 2003, CNS SPECTR, V8, P382, DOI 10.1017/S1092852900018642; Brantley PJ, 1999, J NERV MENT DIS, V187, P435, DOI 10.1097/00005053-199907000-00007; BRESLAU N, 1993, AM J PSYCHIAT, V150, P941; Brown ES, 2000, COMPR PSYCHIAT, V41, P19, DOI 10.1016/S0010-440X(00)90126-3; BUTLER G, 1991, J CONSULT CLIN PSYCH, V59, P167, DOI 10.1037/0022-006X.59.1.167; CHOUINARD G, 1982, PSYCHOPHARMACOLOGY, V77, P229, DOI 10.1007/BF00464571; COHEN LS, 2004, MASSACHUSETTS GEN HO, P593; COPLAN JD, 1993, J CLIN PSYCHIAT, V54, P69; Durham RC, 2003, PSYCHOL MED, V33, P499, DOI 10.1017/S0033291702007079; Fisher PL, 1999, PSYCHOL MED, V29, P1425, DOI 10.1017/S0033291799001336; Foa EB, 2002, BIOL PSYCHIAT, V52, P987, DOI 10.1016/S0006-3223(02)01552-4; Furukawa TA, 2002, COCHRANE DB SYST REV, V1, DOI [10.1002/14651858.cd001026, DOI 10.1002/14651858.CD001026, 10.1002/14651858.CD001026]; GOLDBERG RJ, 2000, PSYCHIAT CARE MED PA, P165; Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hendrick V, 2003, AM J PSYCHIAT, V160, P993, DOI 10.1176/appi.ajp.160.5.993; Johnson JG, 2000, JAMA-J AM MED ASSOC, V284, P2348, DOI 10.1001/jama.284.18.2348; KAPCZINSKI S, 2002, COCHRANE DATABASE SY, V2; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Khan A, 2003, AM J PSYCHIAT, V160, P790, DOI 10.1176/appi.ajp.160.4.790; Lang AJ, 2002, GEN HOSP PSYCHIAT, V24, P365, DOI 10.1016/S0163-8343(02)00216-5; Levine RE, 2003, AM J PERINAT, V20, P239, DOI 10.1055/s-2003-42342; Montgomery SA, 2002, J PSYCHIAT RES, V36, P209, DOI 10.1016/S0022-3956(02)00005-5; Noyes R, 2001, PSYCHIAT CLIN N AM, V24, P41, DOI 10.1016/S0193-953X(05)70205-7; Olfson M, 1996, J GEN INTERN MED, V11, P447, DOI 10.1007/BF02599038; Olfson M, 1997, AM J PSYCHIAT, V154, P1734, DOI 10.1176/ajp.154.12.1734; Ost LG, 2000, BEHAV RES THER, V38, P777, DOI 10.1016/S0005-7967(99)00095-9; Pollack MH, 1998, MGH GUIDE TO PSYCHIATRY IN PRIMARY CARE, P23; Pollack MH, 2001, J CLIN PSYCHIAT, V62, P20; Pollack MH, 1998, AM J PSYCHIAT, V155, P992, DOI 10.1176/ajp.155.7.992; Pollack MH, 2001, J CLIN PSYCHIAT, V62, P658; Rickels K, 2000, AM J PSYCHIAT, V157, P1973, DOI 10.1176/appi.ajp.157.12.1973; RICKELS K, 1986, J CLIN PSYCHOPHARM, V6, P32; Rickels K, 2003, AM J PSYCHIAT, V160, P749, DOI 10.1176/appi.ajp.160.4.749; RICKELS K, 1993, ARCH GEN PSYCHIAT, V50, P884; Rocca P, 1997, ACTA PSYCHIAT SCAND, V95, P444, DOI 10.1111/j.1600-0447.1997.tb09660.x; ROGERS MP, 1994, INT J PSYCHIAT MED, V24, P83, DOI 10.2190/TXM9-EVX8-Q4WT-G03J; ROSENBAUM JF, 1997, MASSACHUSETTS GEN HO, P173; Schwartz Thomas L, 2002, Psychopharmacol Bull, V36, P53; Seligman M. E. P., 1999, PREVENTION TREATMENT, V2, P8, DOI DOI 10.1037/1522-3736.2.1.28A; Simon GE, 2002, AM J PSYCHIAT, V159, P2055, DOI 10.1176/appi.ajp.159.12.2055; Simon NM, 2002, J AFFECT DISORDERS, V69, P209, DOI 10.1016/S0165-0327(01)00378-0; Sramek JJ, 1996, J CLIN PSYCHIAT, V57, P287; Stocchi F, 2003, J CLIN PSYCHIAT, V64, P250, DOI 10.4088/JCP.v64n0305; Thompson PM, 1996, PSYCHIAT ANN, V26, P227, DOI 10.3928/0048-5713-19960401-13; Varia I, 2002, INT CLIN PSYCHOPHARM, V17, P103, DOI 10.1097/00004850-200205000-00002; Waugh J, 2003, CNS DRUGS, V17, P343, DOI 10.2165/00023210-200317050-00004; Wisner KL, 2002, NEW ENGL J MED, V347, P194, DOI 10.1056/NEJMcp011542; Wittchen HU, 2000, INT CLIN PSYCHOPHARM, V15, P319, DOI 10.1097/00004850-200015060-00002; Wittchen HU, 1998, BRIT J PSYCHIAT, V173, P10, DOI 10.1192/S000712500029346X; Wittchen HU, 2000, ACTA PSYCHIAT SCAND, V102, P14, DOI 10.1111/j.0065-1591.2000.acp29[dash]03.x; Yonkers KA, 2000, BRIT J PSYCHIAT, V176, P544, DOI 10.1192/bjp.176.6.544	53	56	61	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					675	682		10.1056/NEJMcp022342	http://dx.doi.org/10.1056/NEJMcp022342			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	845FZ	15306669				2022-12-28	WOS:000223225500010
J	Nummela, S; Thewissen, JGM; Bajpai, S; Hussain, ST; Kumar, K				Nummela, S; Thewissen, JGM; Bajpai, S; Hussain, ST; Kumar, K			Eocene evolution of whale hearing	NATURE			English	Article							CETACEA; ORIGIN	The origin of whales ( order Cetacea) is one of the best-documented examples of macroevolutionary change in vertebrates(1-3). As the earliest whales became obligately marine, all of their organ systems adapted to the new environment. The fossil record indicates that this evolutionary transition took less than 15 million years, and that different organ systems followed different evolutionary trajectories. Here we document the evolutionary changes that took place in the sound transmission mechanism of the outer and middle ear in early whales. Sound transmission mechanisms change early on in whale evolution and pass through a stage ( in pakicetids) in which hearing in both air and water is unsophisticated. This intermediate stage is soon abandoned and is replaced ( in remingtonocetids and protocetids) by a sound transmission mechanism similar to that in modern toothed whales. The mechanism of these fossil whales lacks sophistication, and still retains some of the key elements that land mammals use to hear airborne sound.	Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA; Indian Inst Technol, Dept Earth Sci, Roorkee 427667, Uttaranchel, India; Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA; Wadia Inst Himalayan Geol, Dehra Dun 248001, Uttar Pradesh, India	Northeast Ohio Medical University (NEOMED); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Howard University; Department of Science & Technology (India); Wadia Institute of Himalayan Geology (WIHG)	Thewissen, JGM (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA.	thewisse@neoucom.edu	Bajpai, Sunil/E-8416-2010; KUMAR, Kishor/H-7232-2013	KUMAR, Kishor/0000-0003-0875-9735; Thewissen, J. G. M./0000-0002-0973-4137				BERTA A, 1994, SCIENCE, V263, P180, DOI 10.1126/science.263.5144.180; Brill RL, 2001, J ACOUST SOC AM, V109, P1717, DOI 10.1121/1.1356704; FLEISCHER G, 1976, J PALEONTOL, V50, P133; Fleischer G., 1978, Advances in Anatomy Embryology and Cell Biology, V55, P1; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; Gingerich PD, 2003, PALEOBIOLOGY, V29, P429, DOI 10.1666/0094-8373(2003)029<0429:LTIEWE>2.0.CO;2; GINGERICH PD, 1983, SCIENCE, V220, P403, DOI 10.1126/science.220.4595.403; Hemila S, 2001, HEARING RES, V151, P221, DOI 10.1016/S0378-5955(00)00232-X; Hemila S, 1999, HEARING RES, V133, P82, DOI 10.1016/S0378-5955(99)00055-6; HEMILA S, 1995, HEARING RES, V85, P31, DOI 10.1016/0378-5955(95)00031-X; KETTEN DR, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P717; Lancaster W.C., 1990, Journal of Vertebrate Paleontology, V10, P117; Lombard R. Eric, 1993, P241; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; Luo ZX, 1998, ADV VERT PALEOBIOL, P269; Mason MJ, 2001, J ZOOL, V255, P467; Moller A. R., 1974, HDB SENSORY PHYSL AU, VV, P491; Norris K. S., 1964, P317; Nummela S, 1999, HEARING RES, V133, P61, DOI 10.1016/S0378-5955(99)00053-2; Nummela S, 1999, HEARING RES, V133, P71, DOI 10.1016/S0378-5955(99)00054-4; NUMMELA S, 1995, HEARING RES, V85, P18, DOI 10.1016/0378-5955(95)00030-8; OELSCHLAGER HA, 1990, NATO ADV SCI I A-LIF, V196, P137; Spoor F, 2002, NATURE, V417, P163, DOI 10.1038/417163a; Thewissen JGM, 2002, ANNU REV ECOL SYST, V33, P73, DOI 10.1146/annurev.ecolsys.33.020602.095426; THEWISSEN JGM, 1993, NATURE, V361, P444, DOI 10.1038/361444a0; Thewissen JGM, 1996, NATURE, V381, P379, DOI 10.1038/381379b0; Tonndorf J., 1968, ARCH OTOLARYNGOL, V87, P49; Uhen MD, 1998, ADV VERT PALEOBIOL, P29; Wagner GP, 2000, EVOL BIOL, V31, P155; Wyss AR, 1987, AM MUS NAT HIST NOVI, V2871, P1	30	66	70	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					776	778		10.1038/nature02720	http://dx.doi.org/10.1038/nature02720			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306808				2022-12-28	WOS:000223233600040
J	Chen-Scarabelli, C; Scarabelli, TM				Chen-Scarabelli, C; Scarabelli, TM			Neurocardiogenic syncope	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SEROTONIN REUPTAKE INHIBITOR; VASOVAGAL SYNCOPE; DOUBLE-BLIND; MANAGEMENT; MIDODRINE; PATHOPHYSIOLOGY; FLUDROCORTISONE; PLACEBO; TRIAL; HYDROCHLORIDE		VA Ann Arbor Healthcare Syst, Div Cardiol 111A, Ann Arbor, MI 48105 USA; Wayne State Univ, Detroit, MI 48236 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Wayne State University	Chen-Scarabelli, C (corresponding author), VA Ann Arbor Healthcare Syst, Div Cardiol 111A, 2215 Fuller Rd, Ann Arbor, MI 48105 USA.	carol.chen-scarabelli@med.va.gov						*AM HEART ASS, SYNC; Benditt DG, 1996, J AM COLL CARDIOL, V28, P263, DOI 10.1016/0735-1097(96)00236-7; Brignole M, 2001, EUR HEART J, V22, P1256, DOI 10.1053/euhj.2001.2739; Connolly SJ, 1999, J AM COLL CARDIOL, V33, P16, DOI 10.1016/S0735-1097(98)00549-X; DACOSTA D, 1993, BRIT HEART J, V69, P308; Di Girolamo E, 1999, J AM COLL CARDIOL, V33, P1227, DOI 10.1016/S0735-1097(98)00694-9; Flevari P, 2002, J AM COLL CARDIOL, V40, P499, DOI 10.1016/S0735-1097(02)01974-5; FOGOROS RN, 1999, PRACTICAL CARDIAC DI; Frishman William H, 2003, Heart Dis, V5, P49, DOI 10.1097/01.HDX.0000050416.53995.43; Gregoratos G, 1998, CIRCULATION, V97, P1325, DOI 10.1161/01.CIR.97.13.1325; Hussain RM, 1996, HEART, V76, P507, DOI 10.1136/hrt.76.6.507; Kapoor WN, 2000, NEW ENGL J MED, V343, P1856, DOI 10.1056/NEJM200012213432507; Kaufmann H, 2002, ANN NEUROL, V52, P342, DOI 10.1002/ana.10293; Kenny RA, 2002, CLIN GERIATR MED, V18, P191, DOI 10.1016/S0749-0690(02)00005-8; Krediet CTP, 2002, CIRCULATION, V106, P1684, DOI 10.1161/01.CIR.0000030939.12646.8F; Lu CC, 2003, CIRCULATION, V108, P2660, DOI 10.1161/01.CIR.0000101966.24899.CB; Madrid AH, 2001, J AM COLL CARDIOL, V37, P554, DOI 10.1016/S0735-1097(00)01155-4; MAHANONDA N, 1995, AM HEART J, V130, P1250, DOI 10.1016/0002-8703(95)90150-7; Mitro P, 1999, PACE, V22, P1620, DOI 10.1111/j.1540-8159.1999.tb00381.x; Nair N, 2003, AM J MANAG CARE, V9, P327; Natale A, 1998, AM J CARDIOL, V82, P1210, DOI 10.1016/S0002-9149(98)00606-7; OMAHONY D, 1995, LANCET, V346, P950, DOI 10.1016/S0140-6736(95)91563-X; Perez-Lugones A, 2001, J CARDIOVASC ELECTR, V12, P935, DOI 10.1046/j.1540-8167.2001.00935.x; SCOTT WA, 1995, AM J CARDIOL, V76, P400, DOI 10.1016/S0002-9149(99)80110-6; SUTTON R, 1995, J CARDIOVASC ELECTR, V6, P569, DOI 10.1111/j.1540-8167.1995.tb00429.x; Takata TS, 2002, CIRCULATION, V106, P1500, DOI 10.1161/01.CIR.0000029748.94931.96; Ventura R, 2002, PACE, V25, P816, DOI 10.1046/j.1460-9592.2002.t01-1-00816.x; Ward CR, 1998, HEART, V79, P45, DOI 10.1136/hrt.79.1.45; White CM, 2000, PHARMACOTHERAPY, V20, P158, DOI 10.1592/phco.20.3.158.34786; Yu JCL, 1997, CARDIOVASC DRUG THER, V10, P687, DOI 10.1007/BF00053025; Zaqqa M, 2000, TEX HEART I J, V27, P268	31	101	114	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2004	329	7461					336	341		10.1136/bmj.329.7461.336	http://dx.doi.org/10.1136/bmj.329.7461.336			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846FF	15297344	Green Published			2022-12-28	WOS:000223300300026
J	Hoppe, T; Cassata, G; Barral, JM; Springer, W; Hutagalung, AH; Epstein, HF; Baumeister, R				Hoppe, T; Cassata, G; Barral, JM; Springer, W; Hutagalung, AH; Epstein, HF; Baumeister, R			Regulation of the myosin-directed chaperone UNC-45 by a novel E3/E4-multiubiquitylation complex in C. elegans	CELL			English	Article							E3 UBIQUITIN LIGASE; CAENORHABDITIS-ELEGANS; QUALITY-CONTROL; DOMAIN PROTEIN; HEAVY-CHAIN; CHIP; GENE; IDENTIFICATION; FAMILY	The organization of the motor protein myosin into motile cellular structures requires precise temporal and spatial control. Caenorhabditis elegans UNC-45 facilitates this by functioning both as a chaperone and as a Hsp90 cochaperone for myosin during thick filament assembly. Consequently, mutations in C. elegans unc45 result in paralyzed animals with severe myofibril disorganization in striated body wall muscles. Here, we report a new E3/E4 complex, formed by CHN-1, the C. elegans ortholog of CHIP (carboxyl terminus of Hsc70-interacting protein), and UFD-2, an enzyme known to have ubiquitin conjugating E4 activity in yeast, as necessary and sufficient to multiubiquitylate UNC-45 in vitro. The phenotype of unc-45 temperature-sensitive animals is partially suppressed by chn-1 loss of function, while UNC-45 overexpression in worms deficient for chn-1 results in severely disorganized muscle cells. These results identify CHN-1 and UFD-2 as a functional E3/E4 complex and UNC-45 as its physiologically relevant substrate.	Univ Munich, Adolph Butenandt Inst, Dept Mol Neurogenet, D-80336 Munich, Germany; Univ Freiburg, Dept Bioinformat & Mol Genet, D-79104 Freiburg, Germany; Univ Hamburg, Ctr Mol Neurobiol, D-20251 Hamburg, Germany; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Munich; University of Freiburg; University of Hamburg; Baylor College of Medicine; Baylor College of Medicine	Baumeister, R (corresponding author), Univ Munich, Adolph Butenandt Inst, Dept Mol Neurogenet, Schillerstr 44, D-80336 Munich, Germany.	baumeister@celegans.de	Hoppe, Thorsten/AAC-7880-2020; Hutagalung, Alex/AAH-5795-2021	Hoppe, Thorsten/0000-0002-4734-9352; Springer, Wolfdieter/0000-0002-1178-3149				Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 1999, BIOESSAYS, V21, P813, DOI 10.1002/(SICI)1521-1878(199910)21:10<813::AID-BIES3>3.0.CO;2-0; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; BRENNER S, 1974, GENETICS, V77, P71; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; EPSTEIN HF, 1974, J MOL BIOL, V90, P291, DOI 10.1016/0022-2836(74)90374-X; Etheridge L, 2002, DEV DYNAM, V224, P457, DOI 10.1002/dvdy.10123; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jones D, 2002, GENOME BIOL, V3; Kaneko C, 2003, BIOCHEM BIOPH RES CO, V300, P297, DOI 10.1016/S0006-291X(02)02834-6; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mahoney JA, 2002, BIOCHEM J, V361, P587, DOI 10.1042/0264-6021:3610587; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Venolia L, 1999, CELL MOTIL CYTOSKEL, V42, P163, DOI 10.1002/(SICI)1097-0169(1999)42:3&lt;163::AID-CM1&gt;3.0.CO;2-E; VENOLIA L, 1990, GENETICS, V126, P345; Waterston R., 1988, NEMATODE C ELEGANS, P281; Wong KCY, 2000, J CELL SCI, V113, P2421; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899	35	113	118	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					337	349		10.1016/j.cell.2004.07.014	http://dx.doi.org/10.1016/j.cell.2004.07.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294159	Bronze			2022-12-28	WOS:000223353100010
J	Spiegel, PB; Salama, P; Maloney, S; van der Veen, A				Spiegel, PB; Salama, P; Maloney, S; van der Veen, A			Quality of malnutrition assessment surveys conducted during famine in Ethiopia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITIONAL-STATUS; DISPLACED PERSONS; PUBLIC-HEALTH; MORTALITY; MORBIDITY; REFUGEE; CAMPS	Context During 1999 and 2000, approximately 10 million people were affected by famine in Ethiopia. Results of nutrition assessments and surveys conducted by humanitarian organizations were used by donors and government agencies to determine needs for food aid and to make other decisions on geographic allocation of limited resources; however, accurate results might have been hampered by methodological errors. Objectives To identify common methodological errors in nutrition assessments and surveys and to provide practical recommendations for improvement. Design and Setting Nutrition assessments and surveys (n=125) conducted by 14 nongovernmental organizations (NGOs) in 54 woredas (districts) in Ethiopia from May 1, 1999, through July 31, 2000. Surveys were ranked as valid and precise according to 5 criteria: use of population proportional to size sampling, sample size, number of clusters, number of children per cluster, and use of weight-for-height index. Main Outcome Measures Number and proportion of surveys that used standard, internationally accepted methods and reported valid and precise results. Results Fifty-eight of the 125 surveys (46%) were not intended to be standard 30 X 30 cluster surveys. Of the remaining 67 surveys, 6 (9%) met predetermined criteria for validity and precision. All 67 used the anthropometric index of weight-for-height, with 58 (87%) reporting z scores. Fifty-four (81%) used nonrandom sampling without consideration of population size and 6 (9%) had sample sizes of fewer than 500 persons. Conclusions Major methodological errors were identified among 30 X 30 cluster surveys designed to measure acute malnutrition prevalence in Ethiopia during the famine of 1999-2000. Donor agencies and NGOs should be educated about the need for improved quality of nutrition assessments and their essential role in directing allocation of scarce food resources.	Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Emergency & Environm Hlth Serv, Int Emergency & Refugee Hlth Branch, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; WHO, Off Reg Humanitarian Emergency Coordinator, Addis Ababa, Ethiopia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization	Spiegel, PB (corresponding author), UNHCR, Case Postale 2500, CH-1211 Geneva, Switzerland.	spiegel@unhcr.ch	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				[Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1997, REF HLTH APPR EM SIT; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; BINKIN N, 1992, DISASTERS, V16, P97, DOI 10.1111/j.1467-7717.1992.tb00383.x; BOSS LP, 1994, JAMA-J AM MED ASSOC, V272, P371, DOI 10.1001/jama.272.5.371; Brogan Donna, 1994, Annals of Epidemiology, V4, P302, DOI 10.1016/1047-2797(94)90086-8; Cochran W.G., 2007, SAMPLING TECHNIQUES; DEGOYET CD, 1979, MANAGEMENT NUTR EMER; *EV BAS WORK GROUP, CLIN EP GLOSS; Garfield R, 2000, NUTR REV, V58, P269, DOI 10.1111/j.1753-4887.2000.tb01880.x; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; KATZ J, 1995, AM J CLIN NUTR, V61, P155, DOI 10.1093/ajcn/61.1.155; LEMESHOW S, 1985, INT J EPIDEMIOL, V14, P473, DOI 10.1093/ije/14.3.473; LINDTJORN B, 1990, BMJ-BRIT MED J, V301, P1123, DOI 10.1136/bmj.301.6761.1123; MERCER A, 1992, DISASTERS, V16, P28, DOI 10.1111/j.1467-7717.1992.tb00373.x; *MSF, 1995, NUTR GUID; MURRAY MJ, 1976, LANCET, V1, P1283; *OG WELF SOC, 1999, WORLD FOOD PROGR SUM; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; SEAMAN J, 1978, INT J EPIDEMIOL, V7, P31, DOI 10.1093/ije/7.1.31; Spiegel PB, 2001, DISASTERS, V25, P172, DOI 10.1111/1467-7717.00169; SULLIVAN K, 1995, ANN M SOC EP RES JUN; TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TOOLE MJ, 1993, JAMA-J AM MED ASSOC, V270, P600, DOI 10.1001/jama.270.5.600; TOOLE MJ, 1995, INFECT DIS CLIN N AM, V9, P353; *TRANS GOV ETH REL, 1995, GUID NUTR STAT DAT F; *UNICEF, 2000, SIT REP ETH; *USAID, 2000, US AG INT DEV COMB T; World Health Organization, 2000, MAN NUTR MAJ EM	30	44	44	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2004	292	5					613	618		10.1001/jama.292.5.613	http://dx.doi.org/10.1001/jama.292.5.613			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843AE	15292087	Bronze			2022-12-28	WOS:000223045500019
J	Mogridge, J				Mogridge, J			Anthrax and bioterrorism: are we prepared?	LANCET			English	Editorial Material							LETHAL TOXIN		Univ Toronto, Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Mogridge, J (corresponding author), Univ Toronto, Lab Med & Pathobiol, Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	jeremy.mogridge@utoronto.ca						Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; Matsumoto G, 2003, SCIENCE, V302, P1492, DOI 10.1126/science.302.5650.1492; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; OBRIEN J, 1985, INFECT IMMUN, V47, P306, DOI 10.1128/IAI.47.1.306-310.1985; Wein LM, 2003, P NATL ACAD SCI USA, V100, P4346, DOI 10.1073/pnas.0636861100	10	4	4	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					393	395		10.1016/S0140-6736(04)16779-2	http://dx.doi.org/10.1016/S0140-6736(04)16779-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288719	Bronze			2022-12-28	WOS:000222998600005
J	Urbakh, M; Klafter, J; Gourdon, D; Israelachvili, J				Urbakh, M; Klafter, J; Gourdon, D; Israelachvili, J			The nonlinear nature of friction	NATURE			English	Article							STICK-SLIP MOTION; DYNAMIC FORCE SPECTROSCOPY; CONFINED LIQUIDS; STATIC FRICTION; SHEAR; LUBRICATION; ORIGIN; FILMS; FLUCTUATIONS; TRANSITIONS	Tribology Is the study of adhesion, friction, lubrication and wear of surfaces in relative motion. It remains as important today as it was in ancient times, arising in the fields of physics, chemistry, geology, biology and engineering. The more we learn about tribology the more complex it appears. Nevertheless, recent experiments coupled to theoretical modelling have made great advances in unifying apparently diverse phenomena and revealed many subtle and often non-intuitive aspects of matter in motion, which stem from the nonlinear nature of the problem.	Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Chem, IL-69978 Tel Aviv, Israel; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	Tel Aviv University; University of California System; University of California Santa Barbara	Urbakh, M (corresponding author), Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Chem, IL-69978 Tel Aviv, Israel.		Urbakh, Michael/AAU-4993-2021; Hoelscher, Hendrik/G-5165-2013	Hoelscher, Hendrik/0000-0002-1033-1669				Aranson IS, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.125402; Barrat JL, 1999, FARADAY DISCUSS, V112, P119, DOI 10.1039/a809733j; Bhushan B, 1997, NATO ADV SCI I E-APP, V330, P1; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Braiman Y, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.094301; Carlson JM, 1996, PHYS REV E, V53, P4153, DOI 10.1103/PhysRevE.53.4153; Chang KC, 2000, BIOPHYS J, V79, P1891, DOI 10.1016/S0006-3495(00)76439-3; Cochard A, 2003, J APPL MECH-T ASME, V70, P220, DOI 10.1115/1.1546241; Demirel AL, 1996, PHYS REV LETT, V77, P4330, DOI 10.1103/PhysRevLett.77.4330; Drummond C, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011705; Drummond C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066110; Drummond C, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041506; Drummond C, 2000, MACROMOLECULES, V33, P4910, DOI 10.1021/ma9919918; Dudko OK, 2002, CHEM PHYS LETT, V352, P499, DOI 10.1016/S0009-2614(01)01469-5; Dudko OK, 2003, P NATL ACAD SCI USA, V100, P11378, DOI 10.1073/pnas.1534554100; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Filippov AE, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.275506; Filippov AE, 2002, J CHEM PHYS, V116, P6871, DOI 10.1063/1.1471242; Gao JP, 1998, J PHYS CHEM B, V102, P5033, DOI 10.1021/jp982150q; Gao JP, 1997, PHYS REV LETT, V79, P705, DOI 10.1103/PhysRevLett.79.705; Gao JP, 2004, J PHYS CHEM B, V108, P3410, DOI 10.1021/jp036362l; GOETZ DJ, 1994, BIOPHYS J, V66, P2202, DOI 10.1016/S0006-3495(94)81016-1; Gourdon D, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021602; He G, 1999, SCIENCE, V284, P1650, DOI 10.1126/science.284.5420.1650; Heuberger M, 1998, J PHYS CHEM B, V102, P5038, DOI 10.1021/jp9823143; HU HW, 1991, PHYS REV LETT, V66, P2758, DOI 10.1103/PhysRevLett.66.2758; ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975; ISRAELACHVILI JN, 1986, J COLLOID INTERF SCI, V110, P263, DOI 10.1016/0021-9797(86)90376-0; KLEIN J, 1995, SCIENCE, V269, P816, DOI 10.1126/science.269.5225.816; LANDMAN U, 1992, NATO ADV SCI I E-APP, V220, P463; Lemaitre A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.195503; LEMAITRE A, IN PRESS PHYS REV E; Muser MH, 2003, ADV CHEM PHYS, V126, P187, DOI 10.1002/0471428019.ch5; Muser MH, 2001, PHYS REV LETT, V86, P1295, DOI 10.1103/PhysRevLett.86.1295; Persson BNJ, 2000, SLIDING FRICTION PHY; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Riedo E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.084502; ROBBINS MO, 2001, TRIBOLOGY HDB, P717; Rozman MG, 1996, PHYS REV E, V54, P6485, DOI 10.1103/PhysRevE.54.6485; Rozman MG, 1998, J PHYS CHEM B, V102, P7924, DOI 10.1021/jp981332h; Rozman MG, 1996, PHYS REV LETT, V77, P683, DOI 10.1103/PhysRevLett.77.683; Rozman MG, 1998, PHYS REV E, V57, P7340, DOI 10.1103/PhysRevE.57.7340; RUINA A, 1983, J GEOPHYS RES, V88, P359, DOI 10.1029/JB088iB12p10359; Sang Y, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.174301; Stills S., 2003, PHYS REV LETT, V91; THOMPSON PA, 1995, ISR J CHEM, V35, P93; THOMPSON PA, 1990, SCIENCE, V250, P792, DOI 10.1126/science.250.4982.792; URBAKH M, 1995, PHYS REV E, V51, P2137, DOI 10.1103/PhysRevE.51.2137; YOSHIZAWA H, 1993, J PHYS CHEM-US, V97, P4128, DOI 10.1021/j100118a033; Zaloj V, 1999, PHYS REV LETT, V82, P4823, DOI 10.1103/PhysRevLett.82.4823	50	521	535	18	332	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					525	528		10.1038/nature02750	http://dx.doi.org/10.1038/nature02750			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282597				2022-12-28	WOS:000222946100038
J	Whelan, T; Levine, M; Willan, A; Gafni, A; Sanders, K; Mirsky, D; Chambers, S; O'Brien, MA; Reid, S; Dubois, S				Whelan, T; Levine, M; Willan, A; Gafni, A; Sanders, K; Mirsky, D; Chambers, S; O'Brien, MA; Reid, S; Dubois, S			Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPARING TOTAL MASTECTOMY; 20-YEAR FOLLOW-UP; QUALITY-OF-LIFE; CONSERVING SURGERY; RADICAL-MASTECTOMY; ADJUVANT CHEMOTHERAPY; INFORMED CHOICES; CLINICAL-TRIAL; STAGE-I; THERAPY	Context The long-term results of randomized trials have demonstrated equivalent survival rates for mastectomy and breast-conserving therapy for the treatment of early stage breast cancer. Consequently, the choice of treatment should be based on a patient's preferences. Objective To evaluate the impact of a decision aid regarding the different surgical treatment options on patient decision making. Design and Setting A cluster randomized trial for which general surgeons in the communities of central-west, and eastern Ontario, Canada, were randomly assigned to use the decision aid or not in the surgical consultation. Patients received the decision aid or not based on the surgeon seen. Participants Twenty surgeons participated in the study. Of the 208 eligible women with newly diagnosed clinical stage I or 11 breast cancer seen by study surgeons, 201 agreed to be evaluated: 94 were assigned to the decision board and 107 to usual practice. Patients were recruited from November 1999 to April 2002. Intervention The decision board is a decision aid designed to help physicians inform their patients about different treatment options and to enable patients to express a preference for treatment. Main Outcome Measures Patient knowledge about the surgical treatment of breast cancer; decisional conflict; satisfaction with decision making; and the treatment decision following the consultation. Results Patients in the decision board group had higher knowledge scores about their treatment options (66.9 vs 58.7; P<.001), had less decisional conflict (1.40 vs 1.62, P=.02), and were more satisfied with decision making (4.50 vs 4.32, P=.05) following the consultation. Patients who used the decision board were more likely to choose BCT (94% vs 76%, P=.03). Conclusions The decision board was helpful in improving communication and enabling women to make a choice regarding treatment. Such instruments should be considered by surgeons when communicating the different surgical options to women with breast cancer.	Juravinski Canc Ctr, Hamilton, ON L8V 5C2, Canada; McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada; McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; Hamilton Hlth Sci, Hamilton, ON, Canada; Queensway Carleton Hosp, Ottawa, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Whelan, T (corresponding author), Juravinski Canc Ctr, 699 Concess St, Hamilton, ON L8V 5C2, Canada.	tim.whelan@hrcc.on.ca	Whelan, Timothy/D-3185-2017; Evans, Diane/F-9258-2017	Whelan, Timothy/0000-0001-9844-2023; 				ABE O, 1995, NEW ENGL J MED, V333, P1444; Blichert-Toft M, 1992, J Natl Cancer Inst Monogr, P19; BROWMAN GP, 1995, J CLIN ONCOL, V13, P502, DOI 10.1200/JCO.1995.13.2.502; Brown J., 1973, AV INSTRUCTION TECHN; Clauson J, 2002, CANCER-AM CANCER SOC, V94, P889, DOI 10.1002/cncr.10318; Curran D, 1998, EUR J CANCER, V34, P307, DOI 10.1016/S0959-8049(97)00312-2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devins G.M., 1988, PSYCHOL HLTH, V2, P139, DOI [10.1080/08870448808400349, DOI 10.1080/08870448808400349]; Elit LM, 1996, GYNECOL ONCOL, V62, P329, DOI 10.1006/gyno.1996.0244; Estabrooks C, 2001, J Health Serv Res Policy, V6, P170, DOI 10.1258/1355819011927431; FALLOWFIELD LJ, 1990, BRIT MED J, V301, P575, DOI 10.1136/bmj.301.6752.575; Falvo D., 2004, EFFECTIVE PATIENT ED; FISHER B, 1985, NEW ENGL J MED, V312, P665, DOI 10.1056/NEJM198503143121101; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Goel V, 2001, MED DECIS MAKING, V21, P1, DOI 10.1177/0272989X0102100101; Graham ID, 2003, PATIENT EDUC COUNS, V50, P279, DOI 10.1016/S0738-3991(03)00050-8; Guadagnoli E, 1998, J CLIN ONCOL, V16, P101, DOI 10.1200/JCO.1998.16.1.101; HALL WH, 1991, JAMA-J AM MED ASSOC, V265, P391; HSIEH FY, 1988, STAT MED, V7, P1195, DOI 10.1002/sim.4780071113; Jefford M, 2002, LANCET ONCOL, V3, P629, DOI 10.1016/S1470-2045(02)00877-X; LEVINE MN, 1992, ANN INTERN MED, V117, P53, DOI 10.7326/0003-4819-117-1-53; Liang WH, 2002, J CLIN ONCOL, V20, P1008, DOI 10.1200/JCO.20.4.1008; LICHTER AS, 1992, J CLIN ONCOL, V10, P976, DOI 10.1200/JCO.1992.10.6.976; MAGUIRE P, 1988, BRIT MED J, V297, P907, DOI 10.1136/bmj.297.6653.907; Mandelblatt JS, 1999, J CLIN ONCOL, V17, P2614, DOI 10.1200/JCO.1999.17.8.2614; Molenaar S, 2001, J CLIN ONCOL, V19, P1676, DOI 10.1200/JCO.2001.19.6.1676; Morris AD, 1997, CANCER J, V3, P6; Moyer A, 1997, HEALTH PSYCHOL, V16, P284, DOI 10.1037//0278-6133.16.3.284; Murray DM, 1998, DESIGN ANAL GROUP RA; O'Connor AM, 2003, JNCI-J NATL CANCER I, V95, P570, DOI 10.1093/jnci/95.8.570; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; OCONNOR AM, 2004, DECISION AIDS PATIEN; SARRAZIN D, 1989, RADIOTHER ONCOL, V14, P177, DOI 10.1016/0167-8140(89)90165-5; Spielberger C., 1983, STAI MANUAL; STREET RL, 1995, CANCER, V76, P2275, DOI 10.1002/1097-0142(19951201)76:11<2275::AID-CNCR2820761115>3.0.CO;2-S; Thompson SG, 1997, STAT MED, V16, P2063, DOI 10.1002/(SICI)1097-0258(19970930)16:18<2063::AID-SIM642>3.0.CO;2-8; van Dongen J A, 1992, J Natl Cancer Inst Monogr, P15; VERONESI U, 1981, NEW ENGL J MED, V305, P6, DOI 10.1056/NEJM198107023050102; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Whelan T, 2003, J NATL CANCER I, V95, P581, DOI 10.1093/jnci/95.8.581; Whelan T, 1999, J CLIN ONCOL, V17, P1727, DOI 10.1200/JCO.1999.17.6.1727; Whelan Tim, 2000, Health Expect, V3, P69, DOI 10.1046/j.1369-6513.2000.00084.x; WHELAN TJ, 1995, J CLIN ONCOL, V13, P847, DOI 10.1200/JCO.1995.13.4.847; WHELAN TJ, 2002, AHRQ PUBLICATION	44	312	319	0	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2004	292	4					435	441		10.1001/jama.292.4.435	http://dx.doi.org/10.1001/jama.292.4.435			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	841AA	15280341	Bronze			2022-12-28	WOS:000222900500020
J	Laporte, R; Pernes, P; Pronni, P; Gottrand, F; Vincent, P				Laporte, R; Pernes, P; Pronni, P; Gottrand, F; Vincent, P			Acquisition of Helicobacter pylori infection after outbreaks of gastroenteritis: prospective cohort survey in institutionalised young people	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; ISCHEMIC-HEART-DISEASE; PASSIVE SMOKING; COTININE; MORTALITY; EXPOSURE; RISK; POPULATION; NONSMOKERS		Univ Lille II JE 2225, INSERM E9919, Lille, France; Ctr Antoine Saint Exupery, Vendin Le Vieil, France; Hop Jeanne Flandre, Pediat Clin, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Vincent, P (corresponding author), Ctr Hosp Reg & Univ Lille, Hop Calmette, Lab Bacteriol Hyg, 1 Blvd J, F-59037 Lille, France.	p-vincent@chru-lille.fr	gottrand, frederic F/G-7370-2015	gottrand, frederic F/0000-0002-5290-0436; Laporte, Remi/0000-0003-4097-462X				Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; BUTLER TL, 1988, THESIS U CALIFORNIA; Enstrom JE, 2003, BMJ-BRIT MED J, V326, P1057, DOI 10.1136/bmj.326.7398.1057; FEYERABEND C, 1990, J PHARM PHARMACOL, V42, P450, DOI 10.1111/j.2042-7158.1990.tb06592.x; GARLAND C, 1985, AM J EPIDEMIOL, V121, P645, DOI 10.1093/aje/121.5.645; Gisbert JP, 2001, AM J GASTROENTEROL, V96, P2829, DOI 10.1111/j.1572-0241.2001.04235.x; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HIRAYAMA T, 1990, NEW ZEAL MED J, V103, P54; HOLE DJ, 1989, BRIT MED J, V299, P423, DOI 10.1136/bmj.299.6696.423; HUMBLE C, 1990, AM J PUBLIC HEALTH, V80, P599, DOI 10.2105/AJPH.80.5.599; JARVIS M, 1984, J EPIDEMIOL COMMUN H, V38, P335, DOI 10.1136/jech.38.4.335; Jarvis MJ, 2000, BRIT MED J, V321, P343, DOI 10.1136/bmj.321.7257.343; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; JARVIS MJ, 1992, BRIT J ADDICT, V87, P111; Jarvis MJ, 2001, TOB CONTROL, V10, P368, DOI 10.1136/tc.10.4.368; Kawachi I, 1997, CIRCULATION, V95, P2374, DOI 10.1161/01.CIR.95.10.2374; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Leung WK, 1999, AM J GASTROENTEROL, V94, P2881, DOI 10.1111/j.1572-0241.1999.01431.x; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Parsonnet J, 1999, JAMA-J AM MED ASSOC, V282, P2240, DOI 10.1001/jama.282.23.2240; SANDLER DP, 1989, AM J PUBLIC HEALTH, V79, P163, DOI 10.2105/AJPH.79.2.163; SHAPER AG, 1988, J HUM HYPERTENS, V2, P71; SHAPER AG, 1991, BRIT HEART J, V66, P384; Steenland K, 1996, CIRCULATION, V94, P622, DOI 10.1161/01.CIR.94.4.622; SVENDSEN KH, 1987, AM J EPIDEMIOL, V126, P783, DOI 10.1093/oxfordjournals.aje.a114715; THOMAS JE, 1992, LANCET, V340, P1194, DOI 10.1016/0140-6736(92)92894-L; TUNSTALLPEDOE H, 1995, J EPIDEMIOL COMMUN H, V49, P139, DOI 10.1136/jech.49.2.139; Walker A, 2002, LIVING BRITAIN RESUL; Walker M, 2000, J PUBLIC HEALTH MED, V22, P479, DOI 10.1093/pubmed/22.4.479	31	16	17	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2004	329	7459					204	205		10.1136/bmj.329.7459.204	http://dx.doi.org/10.1136/bmj.329.7459.204			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840NW	15271830	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000222866900017
J	Tagle, R; Claeys, P				Tagle, R; Claeys, P			Comet or asteroid shower in the late Eocene?	SCIENCE			English	Article									Vrije Univ Brussel, Dept Geol, Pl Laan 2, B-1050 Brussels, Belgium; Museum Nat Kunde, Inst Mineral, D-10099 Berlin, Germany	Vrije Universiteit Brussel; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Claeys, P (corresponding author), Vrije Univ Brussel, Dept Geol, Pl Laan 2, B-1050 Brussels, Belgium.	phclaeys@vub.ac.be	(VUB), VRIJE UNIVERSITEIT BRUSSEL/B-4895-2008	(VUB), VRIJE UNIVERSITEIT BRUSSEL/0000-0002-4585-7687				Farley KA, 1998, SCIENCE, V280, P1250, DOI 10.1126/science.280.5367.1250; FRENCH BM, 1998, CONTRIBUTION LUNEAR, V954; Montanari A, 2000, LECT NOTES EARTH SCI, V93; Morbidelli A, 1998, METEORIT PLANET SCI, V33, P999, DOI 10.1111/j.1945-5100.1998.tb01707.x; Schmitz B, 2003, SCIENCE, V300, P961, DOI 10.1126/science.1082182; Weissman PR, 1997, ASTROPHYS J, V488, pL133, DOI 10.1086/310940	6	37	38	3	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2004	305	5683					492	492		10.1126/science.1098481	http://dx.doi.org/10.1126/science.1098481			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840AH	15273387	Green Submitted			2022-12-28	WOS:000222828900031
J	De Luca, A; Di Giambenedetto, S				De Luca, A; Di Giambenedetto, S			Triple-nucleoside regimens versus efavirenz	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							ANTIRETROVIRAL THERAPY; INFECTION		Catholic Univ, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	De Luca, A (corresponding author), Catholic Univ, I-00168 Rome, Italy.	andrea.deluca@rm.unicatt.it	digiambenedetto, simona/AAL-4429-2020; Soriano, Vicente/O-5730-2018; De Luca, Andrea/G-8810-2011	Soriano, Vicente/0000-0002-4624-5199; De Luca, Andrea/0000-0002-9561-9193				Bucher HC, 2003, AIDS, V17, P2451, DOI 10.1097/00002030-200311210-00007; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Martinez E, 2003, NEW ENGL J MED, V349, P1036, DOI 10.1056/NEJMoa021589; Trotta MP, 2002, JAIDS, V31, pS128, DOI 10.1097/00126334-200212153-00008	4	2	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					717	718						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306677				2022-12-28	WOS:000223225500026
J	Kawasaki, H; Taira, K				Kawasaki, H; Taira, K			RETRACTED: Induction of DNA methylation and gene silencing by short interfering RNAs in human cells (Retracted article. See vol 441, pg 1176, 2006)	NATURE			English	Article; Retracted Publication							DOUBLE-STRANDED-RNA; CPG ISLAND METHYLATION; HUMAN CANCER-CELLS; EXPRESSION; DROSOPHILA; CYTOPLASM; PLANTS; DNMT1	Double-stranded RNAs (dsRNAs) induce post-transcriptional gene silencing in several species of animal and plant(1-2). In plants, dsRNAs targeted to CpG islands within a promoter can also induce RNA-directed DNA methylation(3-8); however, it remains unclear whether gene silencing mediated by DNA methylation can be induced by dsRNAs in mammalian cells. Here, we demonstrate that short interfering RNAs (siRNAs; 21-25-nucleotide RNA molecules) induce DNA methylation and histone H3 methylation in human cells. Synthetic siRNAs targeted to CpG islands of an E-cadherin promoter induced significant DNA methylation and histone H3 lysine 9 methylation in both MCF-7 and normal mammary epithelial cells. As a result, these siRNAs repressed expression of the E-cadherin gene at the transcriptional level. In addition, disrupting the expression of either one of two DNA methyltransferases (DNMT1 or DNMT3B) by specific siRNAs abolished the siRNA-mediated methylation of DNA. Moreover, vector-based siRNAs targeted to the erbB2 (also known as HER2) promoter also induced DNA methylation in MCF-7 cells. Thus, siRNAs targeted to CpG islands within the promoter of a specific gene can induce transcriptional gene silencing by means of DNA-methyltransferase-dependent methylation of DNA in human cells, and might have potential as a new type of gene therapeutic agent.	Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Natl Inst Adv Ind Sci & Technol, Gene Funct Res Ctr, Tsukuba 3058562, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Kawasaki, H (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	kawasaki@chembio.t.u-tokyo.ac.jp	Hu, Ruogu/B-2203-2008					Aufsatz W, 2002, EMBO J, V21, P6832, DOI 10.1093/emboj/cdf663; Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Corn PG, 2000, CLIN CANCER RES, V6, P4243; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hattori M, 2001, CANCER LETT, V169, P155, DOI 10.1016/S0304-3835(01)00499-2; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Kawasaki H, 2003, NUCLEIC ACIDS RES, V31, P700, DOI 10.1093/nar/gkg158; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pelissier T, 2000, RNA, V6, P55, DOI 10.1017/S135583820099201X; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng Y, 2002, RNA, V8, P855, DOI 10.1017/S1355838202020071; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	30	333	414	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					211	217		10.1038/nature02889	http://dx.doi.org/10.1038/nature02889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15311210				2022-12-28	WOS:000223746000050
